data_2l05_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l05 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 109.943 -0.392 . . . . 75.109999999999999 109.943 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.98 130.74 25.18 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.727 1.618 . . . . 74.239999999999995 111.114 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.03 166.54 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 113.428 0.899 . . . . 72.540000000000006 113.428 -171.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 171' ' ' ALA . 58.3 t -124.55 137.52 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.36 -0.836 . . . . 75.150000000000006 110.439 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.504 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 23.0 mtp85 -100.54 105.54 16.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.828 0.347 . . . . 72.129999999999995 111.375 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.477 HG23 HD21 ' A' ' 181' ' ' LEU . 54.4 t -107.23 122.9 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.986 0.422 . . . . 64.329999999999998 111.919 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -93.68 119.29 32.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.119 0.485 . . . . 75.230000000000004 111.135 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 92.9 mt -93.17 155.68 40.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.804 -0.634 . . . . 72.120000000000005 111.897 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.19 159.53 26.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.608 2.206 . . . . 74.450000000000003 113.099 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HH22 ' A' ' 188' ' ' ARG . 85.7 m-20 64.76 39.24 6.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.993 -0.549 . . . . 71.420000000000002 111.993 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 66.18 27.0 10.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.18 0.807 . . . . 75.200000000000003 113.18 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.9 mm-40 -104.61 166.88 10.1 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.019 -0.425 . . . . 72.150000000000006 111.419 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -159.32 157.23 30.08 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.094 -0.379 . . . . 65.329999999999998 111.494 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -154.3 159.37 41.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.026 0.441 . . . . 72.549999999999997 111.51 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 128.74 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.322 -0.399 . . . . 74.099999999999994 110.733 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.4 141.96 40.32 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 111.835 0.309 . . . . 64.409999999999997 111.835 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.47 123.59 11.0 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.83 2.353 . . . . 71.140000000000001 113.374 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -73.68 102.76 4.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.085 0.469 . . . . 74.510000000000005 111.275 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -112.85 137.78 50.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.098 -0.501 . . . . 74.299999999999997 111.231 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -74.23 126.4 30.52 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.787 0.327 . . . . 64.010000000000005 111.372 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.73 -28.6 11.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.375 -0.44 . . . . 73.319999999999993 112.608 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.41 133.62 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.717 0.294 . . . . 71.019999999999996 111.127 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 56.7 p -82.48 155.3 24.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.009 0.433 . . . . 73.329999999999998 111.482 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 212' ' ' THR . 63.3 t -54.68 -39.03 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.05 0.452 . . . . 75.400000000000006 110.894 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.3 ttm-85 -59.94 -53.29 59.58 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 74.510000000000005 111.07 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.0 -19.76 64.95 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 74.230000000000004 111.405 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.0 m -80.66 -44.58 18.59 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.08 0.467 . . . . 72.319999999999993 111.467 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.477 HD21 HG23 ' A' ' 159' ' ' VAL . 95.9 mt -92.07 -0.01 57.46 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.778 0.658 . . . . 54.310000000000002 112.778 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -51.65 -36.91 48.06 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.225 0.454 . . . . 72.310000000000002 112.225 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -67.69 -46.1 73.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.986 0.422 . . . . 75.5 111.235 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -61.3 -43.22 99.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.127 -0.488 . . . . 74.099999999999994 111.334 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 94.5 mt -64.78 -45.45 86.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.317 -0.401 . . . . 75.430000000000007 111.205 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.1 tpt -56.87 -49.57 75.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.383 -0.371 . . . . 75.120000000000005 111.696 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.8 ptm -67.2 -17.22 64.73 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.886 0.328 . . . . 74.310000000000002 111.886 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 42.2 mmm-85 -95.93 -13.71 23.67 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.153 -0.342 . . . . 62.109999999999999 111.413 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.17 27.58 61.78 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.342 -0.456 . . . . 72.540000000000006 113.106 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 90.6 mt -112.82 131.07 55.86 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.887 0.375 . . . . 74.340000000000003 111.738 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.26 142.45 38.08 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.644 -0.253 . . . . 75.430000000000007 110.885 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.02 -24.35 57.15 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.711 2.274 . . . . 64.120000000000005 113.45 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.2 -14.62 58.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.131 0.419 . . . . 70.530000000000001 112.131 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.47 11.37 32.65 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.132 0.492 . . . . 74.150000000000006 110.864 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.2 m -129.95 133.17 46.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.293 -0.412 . . . . 75.329999999999998 111.303 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.22 144.82 38.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.668 0.27 . . . . 74.200000000000003 111.265 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.18 140.49 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.852 0.358 . . . . 74.519999999999996 111.574 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.67 158.67 43.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.188 0.518 . . . . 72.450000000000003 111.8 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -122.84 161.22 24.48 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.8 -0.636 . . . . 74.530000000000001 110.41 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.0 mt -104.64 114.44 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.153 0.501 . . . . 75.329999999999998 111.536 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -124.06 119.6 29.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.732 -0.667 . . . . 73.340000000000003 110.203 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 57.19 31.97 20.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.169 0.509 . . . . 74.340000000000003 111.214 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 85.24 -2.92 87.94 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.227 -0.511 . . . . 73.530000000000001 113.715 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -101.85 139.16 37.87 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.345 -0.503 . . . . 72.299999999999997 112.092 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -89.14 103.43 16.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.147 -0.478 . . . . 72.109999999999999 110.869 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 207' ' ' PRO . 45.4 mmtm -104.11 127.54 29.02 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.685 0.279 . . . . 73.109999999999999 111.587 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 22.6 Cg_exo -65.75 152.28 82.05 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.204 2.602 . . . . 73.400000000000006 113.758 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.504 HG21 HD13 ' A' ' 217' ' ' LEU . 70.6 mt -129.85 138.57 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 74.420000000000002 111.007 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.98 134.42 12.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.062 -0.589 . . . . 64.430000000000007 112.927 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.6 m95 -57.27 -30.51 64.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.287 0.477 . . . . 75.340000000000003 112.287 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -87.24 7.79 26.95 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.131 0.419 . . . . 62.039999999999999 112.131 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.8 m -82.6 140.55 33.15 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.296 -0.252 . . . . 72.310000000000002 110.797 174.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 4.2 m-20 -59.1 126.9 29.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 72.329999999999998 111.595 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.1 tt -60.24 -21.48 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.134 -0.485 . . . . 75.329999999999998 111.819 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 76.8 p -60.65 -27.5 67.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.681 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 15.6 m95 -70.37 -16.33 62.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.955 0.407 . . . . 74.209999999999994 111.484 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 208' ' ' ILE . 80.1 mt -112.77 22.52 14.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.31 -0.404 . . . . 75.530000000000001 111.936 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.8 m -56.74 108.42 0.5 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.853 0.359 . . . . 75.450000000000003 111.919 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.46 11.12 61.25 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.171 -0.538 . . . . 70.109999999999999 114.048 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -93.8 151.32 19.69 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.342 0.571 . . . . 65.409999999999997 111.628 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.504 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -105.46 114.35 28.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.082 0.468 . . . . 73.409999999999997 110.654 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 58.1 mt -97.48 150.57 20.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.085 0.469 . . . . 73.519999999999996 111.761 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.61 127.61 44.13 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.6 -0.273 . . . . 74.299999999999997 110.458 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.73 137.51 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.399 0.518 . . . . 73.549999999999997 112.399 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.78 144.24 43.31 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.059 -0.519 . . . . 70.420000000000002 111.02 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.36 116.4 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.526 0.203 . . . . 74.329999999999998 110.95 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.72 0.295 . . . . 74.420000000000002 111.629 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 111.855 0.317 . . . . 74.510000000000005 111.855 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.486 ' HB2' HG21 ' A' ' 218' ' ' THR . 43.3 Cg_endo -65.79 144.6 78.14 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.823 2.348 . . . . 64.530000000000001 112.928 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.6 pt -132.21 162.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.068 0.766 . . . . 74.540000000000006 113.068 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.02 123.23 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.251 -0.886 . . . . 72.129999999999995 109.65 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 221' ' ' GLU . 49.5 mtt180 -88.91 95.05 10.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.805 0.336 . . . . 72.219999999999999 111.092 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.572 HG22 HD22 ' A' ' 181' ' ' LEU . 57.6 t -93.52 114.71 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.977 -0.452 . . . . 75.409999999999997 112.206 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.8 123.92 30.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.647 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 184' ' ' ALA . 96.3 mt -100.38 156.43 35.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.251 0.463 . . . . 73.310000000000002 112.251 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.505 ' HG2' HH12 ' A' ' 188' ' ' ARG . 19.4 Cg_endo -59.38 165.78 8.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.298 1.999 . . . . 73.219999999999999 112.115 175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 68.22 25.11 7.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.027 0.441 . . . . 73.420000000000002 111.11 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 62.94 43.24 6.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.659 -0.701 . . . . 71.120000000000005 112.111 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -118.51 -179.74 3.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.672 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 159.82 35.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.001 0.429 . . . . 75.319999999999993 112.148 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -155.41 129.01 8.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.018 0.437 . . . . 64.329999999999998 111.503 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.21 119.55 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.696 0.284 . . . . 74.109999999999999 110.314 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.45 138.54 29.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.555 0.217 . . . . 72.200000000000003 111.372 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.8 132.26 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.566 2.178 . . . . 72.109999999999999 113.039 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.78 103.46 5.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.045 0.45 . . . . 73.340000000000003 110.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.2 mtt-85 -106.5 126.35 52.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.305 -0.407 . . . . 75.099999999999994 111.395 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.8 t -75.02 115.71 14.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.813 0.34 . . . . 55.409999999999997 111.146 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.61 -1.04 27.66 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.244 -0.503 . . . . 42.299999999999997 112.58 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.72 133.03 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.743 0.306 . . . . 71.129999999999995 110.874 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 33.0 p -81.59 161.59 23.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.852 0.358 . . . . 70.430000000000007 111.585 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 81.3 t -56.33 -34.48 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.439 0.638 . . . . 62.210000000000001 110.424 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 47.2 ttp180 -67.35 -56.04 11.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 74.530000000000001 111.619 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.648 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 6.6 m-20 -72.22 -12.36 61.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.818 0.673 . . . . 74.439999999999998 112.818 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 62.0 p -89.18 -50.94 5.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.943 0.402 . . . . 71.239999999999995 110.767 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.572 HD22 HG22 ' A' ' 159' ' ' VAL . 78.5 mt -79.73 -7.54 58.68 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.426 0.898 . . . . 73.450000000000003 113.426 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 14.0 ptpt -55.92 -27.64 53.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.979 -0.45 . . . . 75.219999999999999 111.209 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.99 -45.48 81.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.191 0.519 . . . . 73.400000000000006 110.773 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HA ' ' HE3' ' A' ' 187' ' ' MET . . . -66.77 -30.55 70.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.021 -0.536 . . . . 64.310000000000002 111.618 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.17 -43.69 50.86 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.006 0.431 . . . . 73.409999999999997 110.709 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.17 -53.86 47.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.762 -0.653 . . . . 70.230000000000004 112.0 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.473 ' HE3' ' HA ' ' A' ' 184' ' ' ALA . 26.4 ptt? -64.62 -8.58 14.8 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.623 0.601 . . . . 63.420000000000002 112.623 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.505 HH12 ' HG2' ' A' ' 162' ' ' PRO . 63.2 mtm180 -119.23 5.37 11.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.849 0.315 . . . . 75.540000000000006 111.849 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.44 95.69 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.294 -0.479 . . . . 64.239999999999995 113.431 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.43 149.87 46.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.32 0.581 . . . . 73.219999999999999 111.753 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.7 pt -104.15 152.72 39.21 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 111.088 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 -20.72 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.762 2.308 . . . . 74.200000000000003 113.825 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.65 -16.55 53.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.847 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.7 t -90.36 -9.2 48.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.02 0.378 . . . . 72.439999999999998 112.02 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.1 m -136.41 147.69 47.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.04 0.448 . . . . 72.209999999999994 111.8 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.437 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -125.25 131.55 53.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.875 0.369 . . . . 71.010000000000005 111.466 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 224' ' ' VAL . 57.9 t -94.44 132.54 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.333 -0.394 . . . . 75.209999999999994 110.844 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.458 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 37.8 p90 -148.87 163.05 38.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 62.32 111.09 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -134.62 143.49 47.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.496 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.42 97.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 110.133 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 108.61 19.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 75.230000000000004 110.791 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 60.73 30.99 20.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.538 0.685 . . . . 74.409999999999997 110.723 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -12.86 68.82 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.051 -0.522 . . . . 65.239999999999995 113.491 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.45 132.71 37.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 122.251 -0.558 . . . . 75.150000000000006 111.762 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 55.0 mtpt -78.07 94.88 4.74 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.917 0.389 . . . . 71.310000000000002 110.708 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -96.58 109.73 49.53 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 71.099999999999994 111.19 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.29 125.76 13.37 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.876 2.384 . . . . 72.420000000000002 112.561 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -100.27 122.09 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.285 -0.416 . . . . 73.230000000000004 111.066 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 139.72 46.55 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.319 -0.467 . . . . 41.520000000000003 113.105 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.6 m95 -60.02 -22.8 63.09 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.969 0.414 . . . . 71.409999999999997 111.603 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -78.47 -6.75 56.26 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.474 0.546 . . . . 75.319999999999993 112.474 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 29.5 m -75.47 140.49 42.87 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.716 0.265 . . . . 74.430000000000007 111.716 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.18 126.86 30.02 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.111 0.481 . . . . 73.439999999999998 110.929 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.1 tt -67.05 -23.65 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.503 0.557 . . . . 74.099999999999994 112.503 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -67.44 -12.17 59.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.88 0.372 . . . . 71.120000000000005 111.708 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -70.82 -23.28 62.33 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.176 0.512 . . . . 73.25 111.197 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.523 HD12 HD22 ' A' ' 222' ' ' LEU . 28.7 mt -108.66 19.93 19.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.907 -0.588 . . . . 75.510000000000005 111.531 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.486 HG21 ' HB2' ' A' ' 155' ' ' PRO . 96.7 m -58.48 115.46 3.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.791 0.664 . . . . 73.219999999999999 112.791 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.19 -27.98 10.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.114 -0.565 . . . . 64.310000000000002 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.64 172.78 6.66 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.371 0.605 . . . . 73.239999999999995 112.161 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.692 ' HB3' ' HB2' ' A' ' 158' ' ' ARG . 1.4 pm0 -108.34 149.53 28.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.545 0.688 . . . . 74.150000000000006 112.305 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.523 HD22 HD12 ' A' ' 217' ' ' LEU . 85.9 mt -113.51 163.71 14.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 71.019999999999996 111.186 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.44 130.52 46.04 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.556 -0.293 . . . . 72.400000000000006 110.317 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 197' ' ' VAL . 40.1 t -118.25 119.05 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.63 0.252 . . . . 74.329999999999998 111.496 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.96 164.29 12.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 71.340000000000003 111.672 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.3 t -77.6 144.6 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.038 0.447 . . . . 75.510000000000005 112.025 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.391 -0.368 . . . . 71.140000000000001 111.766 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 110.616 -0.142 . . . . 72.230000000000004 110.616 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.56 111.24 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.133 1.889 . . . . 73.030000000000001 111.926 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.2 pt -112.46 161.84 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.681 0.623 . . . . 75.219999999999999 112.681 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 171' ' ' ALA . 57.8 t -122.56 128.76 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.786 -0.643 . . . . 75.510000000000005 110.279 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.561 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 18.9 mtp180 -96.52 107.9 20.39 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.012 0.434 . . . . 74.239999999999995 110.963 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.94 125.46 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.478 0.548 . . . . 72.420000000000002 112.478 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -82.74 113.71 20.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.261 -0.427 . . . . 70.409999999999997 110.76 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.55 146.88 32.62 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.286 -0.415 . . . . 74.430000000000007 111.046 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.07 160.33 19.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.346 2.031 . . . . 71.030000000000001 112.646 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 69.21 36.48 2.37 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 112.04 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 67.95 36.33 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.633 -0.712 . . . . 74.319999999999993 112.424 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -117.64 171.23 8.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 112.171 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.51 162.14 37.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.491 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.13 163.42 40.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.452 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.6 t -121.69 128.72 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.914 0.388 . . . . 74.219999999999999 111.364 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.62 145.02 45.94 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.446 -0.343 . . . . 73.549999999999997 111.47 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.13 126.51 7.85 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 75.230000000000004 112.666 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -90.96 110.0 21.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.893 0.378 . . . . 73.409999999999997 111.969 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 172' ' ' ARG . 49.7 mtt180 -101.72 167.5 10.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 74.430000000000007 111.105 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.74 128.96 34.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.505 -0.316 . . . . 75.400000000000006 111.1 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.34 33.33 28.85 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.99 -0.624 . . . . 71.239999999999995 113.171 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.1 t -131.35 109.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.104 -0.332 . . . . 74.030000000000001 110.104 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.9 p -63.18 157.09 23.37 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 72.510000000000005 112.399 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 212' ' ' THR . 65.6 t -56.77 -30.53 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 75.230000000000004 110.648 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 18.9 ttp180 -68.99 -53.07 22.53 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.983 -0.553 . . . . 74.310000000000002 111.195 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.545 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 34.7 m-20 -63.3 -35.11 79.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.356 0.598 . . . . 73.439999999999998 111.247 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 39.9 t -66.49 -62.79 1.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.079 -0.51 . . . . 73.040000000000006 111.585 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.6 mt -83.09 -12.27 57.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.202 1.186 . . . . 71.439999999999998 114.202 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 17.9 ptpt -56.05 -28.88 59.32 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.75 0.705 . . . . 73.019999999999996 111.848 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 180' ' ' SER . 7.9 ptpp? -74.17 -29.78 61.94 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.792 0.329 . . . . 75.439999999999998 111.524 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.4 72.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.229 0.538 . . . . 73.109999999999999 110.647 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.92 -29.13 58.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.168 -0.469 . . . . 72.549999999999997 111.029 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 45.4 ttm -54.81 -49.64 70.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 74.219999999999999 111.534 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.2 ptp -68.52 -10.09 53.4 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 111.883 0.327 . . . . 73.340000000000003 111.883 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -95.58 -10.38 29.72 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.658 -0.246 . . . . 74.349999999999994 111.031 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.02 20.04 63.88 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.385 -0.436 . . . . 73.549999999999997 112.76 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 226' ' ' VAL . 80.9 mt -120.88 153.96 36.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.997 0.427 . . . . 75.319999999999993 111.439 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.0 pt -104.97 141.3 22.27 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.788 0.327 . . . . 74.150000000000006 111.455 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HG3' ' HB3' ' A' ' 182' ' ' LYS . 22.0 Cg_endo -60.95 -29.25 87.66 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.541 2.161 . . . . 75.25 113.05 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.409 ' OE2' ' HD2' ' A' ' 178' ' ' ARG . 5.5 mm-40 -55.74 -32.84 63.75 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.998 0.428 . . . . 72.540000000000006 111.705 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 194' ' ' CYS . 52.0 t -104.18 21.77 15.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.067 0.461 . . . . 71.420000000000002 111.966 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.1 m -125.0 161.88 25.74 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.056 0.455 . . . . 74.439999999999998 111.654 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.93 131.8 47.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.835 0.35 . . . . 74.129999999999995 111.726 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.53 HG23 HG23 ' A' ' 224' ' ' VAL . 20.8 t -112.44 139.03 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.396 -0.365 . . . . 72.340000000000003 110.762 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -147.86 158.61 44.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.334 0.588 . . . . 75.310000000000002 111.942 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -135.34 138.8 43.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.676 -0.693 . . . . 73.450000000000003 110.988 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 56.3 mt -84.36 118.0 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 72.109999999999999 111.381 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 24.3 mt-30 -122.66 113.92 19.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.261 -0.427 . . . . 72.019999999999996 111.212 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 59.27 20.72 8.86 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.495 0.664 . . . . 75.409999999999997 111.657 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 109.39 -22.64 24.28 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.244 -0.435 . . . . 71.420000000000002 113.899 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 10.2 pt-20 -84.12 155.2 22.74 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.578 0.689 . . . . 74.219999999999999 111.533 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.06 100.24 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 109.642 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -87.69 112.72 50.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.978 -0.555 . . . . 71.219999999999999 111.581 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.64 127.54 12.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.568 2.179 . . . . 61.420000000000002 112.271 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 217' ' ' LEU . 60.4 mt -96.7 129.99 45.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.685 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 131.66 11.81 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.052 -0.594 . . . . 74.120000000000005 112.218 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.6 m95 -59.87 -27.11 66.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.183 0.438 . . . . 74.099999999999994 112.183 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -80.3 -5.91 57.06 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.211 0.449 . . . . 71.150000000000006 112.211 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 177' ' ' VAL . 63.7 m -71.19 141.5 50.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.308 -0.245 . . . . 71.209999999999994 111.017 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.66 129.36 39.49 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.077 0.465 . . . . 71.349999999999994 110.824 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.91 -24.64 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.145 -0.48 . . . . 74.150000000000006 111.868 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 86.0 p -64.89 -16.24 62.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.802 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -76.44 -11.4 59.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.015 0.436 . . . . 63.130000000000003 111.439 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.443 HD12 HG21 ' A' ' 208' ' ' ILE . 66.8 mt -114.04 14.43 18.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.074 0.464 . . . . 75.230000000000004 111.241 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.8 m -53.84 119.67 5.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.633 0.605 . . . . 72.150000000000006 112.633 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 88.88 -9.93 74.61 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.194 -0.457 . . . . 64.299999999999997 113.997 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.29 157.84 18.05 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.643 0.608 . . . . 73.439999999999998 112.643 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.561 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.4 mt-10 -103.99 114.38 28.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.965 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.2 mt -95.79 158.99 15.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.162 0.506 . . . . 74.329999999999998 111.973 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -122.28 121.72 37.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.452 -0.34 . . . . 72.109999999999999 110.38 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.53 HG23 HG23 ' A' ' 197' ' ' VAL . 62.1 t -119.07 135.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.204 0.525 . . . . 75.129999999999995 112.09 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.3 148.95 40.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.118 -0.492 . . . . 75.400000000000006 110.914 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.411 HG21 HD12 ' A' ' 190' ' ' LEU . 36.0 t -85.8 137.51 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.819 0.342 . . . . 72.310000000000002 111.879 -174.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 116.375 -0.375 . . . . 73.519999999999996 111.102 178.759 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 110.472 -0.195 . . . . 75.5 110.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.81 147.2 95.94 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.675 2.25 . . . . 51.020000000000003 112.761 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 pt -129.37 160.24 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.472 0.653 . . . . 75.420000000000002 112.74 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 171' ' ' ALA . 88.5 t -127.1 134.61 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.554 -0.748 . . . . 74.200000000000003 110.302 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -97.48 96.79 8.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.79 0.328 . . . . 74.140000000000001 111.401 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.401 HG21 HD22 ' A' ' 181' ' ' LEU . 48.0 t -98.43 124.05 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.585 0.587 . . . . 73.540000000000006 112.585 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -95.28 106.36 18.39 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.264 -0.426 . . . . 74.5 111.179 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.7 mt -85.29 157.21 59.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.234 -0.439 . . . . 45.32 111.336 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.6 153.39 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.602 2.201 . . . . 75.230000000000004 113.011 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 31.6 m-80 68.93 55.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.763 0.425 . . . . 72.409999999999997 111.533 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt 51.08 23.1 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.56 1.144 . . . . 72.540000000000006 114.037 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.8 mm-40 -93.26 144.4 25.34 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.484 0.549 . . . . 64.209999999999994 112.484 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -138.69 142.95 38.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.776 0.322 . . . . 74.030000000000001 110.643 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.9 t -145.25 159.69 42.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.397 . . . . 74.439999999999998 111.707 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.35 120.25 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.282 -0.417 . . . . 72.409999999999997 110.969 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.53 152.57 55.58 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 116.377 -0.374 . . . . 63.219999999999999 111.336 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.09 127.73 11.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.44 2.094 . . . . 74.420000000000002 113.326 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.47 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -81.4 103.82 11.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.254 -0.43 . . . . 39.310000000000002 111.31 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -109.84 128.87 55.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.829 0.347 . . . . 75.140000000000001 111.599 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.23 110.56 4.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 110.792 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.16 -6.42 15.07 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.347 -0.454 . . . . 71.120000000000005 112.274 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.426 ' O ' HG21 ' A' ' 214' ' ' ILE . 98.0 t -110.86 133.01 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.68 0.392 . . . . 75.25 110.64 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 80.8 p -87.02 156.0 19.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 71.349999999999994 111.739 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.7 t -50.18 -42.01 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.079 0.466 . . . . 71.129999999999995 111.405 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 23.0 ttt180 -63.62 -46.69 84.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.248 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.68 -31.46 72.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.843 0.354 . . . . 75.420000000000002 111.944 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.0 t -79.73 -44.29 21.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.89 0.376 . . . . 72.439999999999998 111.846 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.401 HD22 HG21 ' A' ' 159' ' ' VAL . 91.2 mt -84.87 -15.26 45.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.193 0.812 . . . . 64.219999999999999 113.193 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.91 -45.22 41.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.993 0.425 . . . . 74.120000000000005 111.935 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -66.86 -39.51 87.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.324 -0.398 . . . . 73.310000000000002 111.969 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.12 93.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.151 0.5 . . . . 74.340000000000003 111.409 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.65 -52.33 21.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.083 -0.508 . . . . 74.400000000000006 111.459 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.4 tpt -50.03 -53.0 29.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.752 0.649 . . . . 70.310000000000002 112.752 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.9 ptp -62.98 -23.7 67.56 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.345 0.498 . . . . 61.030000000000001 112.345 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -101.61 0.24 35.98 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.067 0.395 . . . . 73.030000000000001 112.067 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 89.07 23.75 34.06 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.117 -0.563 . . . . 65.219999999999999 114.071 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.04 148.4 35.24 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.323 -0.516 . . . . 72.349999999999994 111.329 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.74 148.54 59.64 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.671 -0.24 . . . . 73.319999999999993 110.955 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 -39.0 88.68 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 122.81 2.34 . . . . 71.219999999999999 113.537 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -60.43 -24.92 65.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.927 0.394 . . . . 74.430000000000007 111.773 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 39.8 t -93.97 -2.26 53.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.787 0.327 . . . . 72.439999999999998 111.855 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.449 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 68.6 m -128.69 139.71 52.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 72.120000000000005 112.003 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -120.07 119.91 34.72 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.687 0.279 . . . . 71.219999999999999 111.373 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 224' ' ' VAL . 76.2 t -95.37 124.41 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.81 0.338 . . . . 73.409999999999997 111.486 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -136.23 155.46 50.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.425 0.631 . . . . 74.0 111.408 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 208' ' ' ILE . 10.2 ptm85 -109.66 133.04 53.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.845 -0.616 . . . . 75.310000000000002 111.42 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.4 mt -89.61 91.75 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.445 0.641 . . . . 73.129999999999995 109.978 173.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.52 123.93 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.573 -0.739 . . . . 71.239999999999995 111.382 -173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 62.52 17.67 9.78 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.353 0.596 . . . . 61.43 110.86 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.28 -4.43 70.41 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.272 -0.422 . . . . 65.420000000000002 113.427 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -101.95 140.28 36.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.447 -0.443 . . . . 70.349999999999994 112.014 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.31 105.58 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.726 0.298 . . . . 75.530000000000001 110.814 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 123.07 38.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.818 -0.173 . . . . 74.230000000000004 111.308 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 143.36 55.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.563 2.176 . . . . 73.230000000000004 113.498 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 199' ' ' ARG . 57.3 mt -122.91 145.93 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.875 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.57 143.38 16.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.077 -0.582 . . . . 74.010000000000005 112.808 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 95.6 m95 -61.34 -23.76 65.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 122.306 -0.526 . . . . 75.120000000000005 111.66 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -87.03 0.77 54.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.239 0.459 . . . . 75.299999999999997 112.239 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 85.7 m -75.89 142.48 42.09 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 71.219999999999999 111.194 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.54 140.4 57.98 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.419 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 175' ' ' VAL . 14.7 tt -79.18 -23.21 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.584 0.587 . . . . 72.299999999999997 112.584 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 89.2 p -62.0 -21.89 65.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.867 0.365 . . . . 75.319999999999993 111.842 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.12 -23.62 66.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.976 0.417 . . . . 74.510000000000005 111.814 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.448 HD13 HD12 ' A' ' 222' ' ' LEU . 21.9 mt -108.38 21.93 16.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.874 -0.603 . . . . 74.099999999999994 112.093 -169.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 79.4 m -65.16 118.12 8.75 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.834 0.679 . . . . 74.239999999999995 112.834 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.6 -26.04 25.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.144 0.417 . . . . 74.150000000000006 114.144 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -98.81 172.36 7.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.153 0.502 . . . . 75.239999999999995 111.787 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -109.95 137.57 47.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.336 0.865 . . . . 75.430000000000007 113.336 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 217' ' ' LEU . 63.0 mt -102.48 155.92 17.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.404 -0.816 . . . . 74.329999999999998 110.713 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -126.57 127.62 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.132 -0.355 . . . . 71.340000000000003 110.755 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 197' ' ' VAL . 54.5 t -107.23 125.01 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.188 0.44 . . . . 74.310000000000002 112.188 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -100.33 168.71 9.6 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 111.259 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.85 114.31 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.398 -0.364 . . . . 74.329999999999998 111.354 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 110.741 175.444 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.501 0.191 . . . . 64.430000000000007 110.838 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.41 137.2 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.067 1.845 . . . . 65.040000000000006 111.211 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 168' ' ' VAL . 2.8 pp -133.9 165.79 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.053 0.76 . . . . 74.129999999999995 113.053 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.26 135.67 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.559 -0.746 . . . . 73.319999999999993 110.703 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.548 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.7 100.01 12.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.923 0.392 . . . . 72.540000000000006 111.329 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.49 HG21 HD22 ' A' ' 181' ' ' LEU . 47.9 t -95.85 109.92 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.961 0.41 . . . . 74.5 111.658 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -80.8 117.98 21.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.931 0.396 . . . . 72.209999999999994 111.104 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.72 157.68 37.84 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.124 -0.489 . . . . 63.350000000000001 110.707 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 226' ' ' VAL . 29.9 Cg_endo -63.57 168.67 11.12 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.231 1.954 . . . . 72.310000000000002 112.986 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.38 33.59 18.72 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.168 0.432 . . . . 73.420000000000002 112.168 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 70.14 23.89 5.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.278 0.631 . . . . 75.040000000000006 112.434 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -99.62 163.56 12.44 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.04 -0.413 . . . . 74.120000000000005 111.443 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.42 159.47 31.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.036 0.446 . . . . 72.510000000000005 112.117 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -155.62 150.99 26.96 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.974 -0.557 . . . . 71.129999999999995 111.294 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 156' ' ' ILE . 39.0 t -117.8 119.41 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.761 0.315 . . . . 72.120000000000005 110.635 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.495 HG12 HD23 ' A' ' 181' ' ' LEU . 29.7 m -116.0 150.36 44.94 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.144 0.424 . . . . 75.519999999999996 112.144 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 124.98 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.511 2.141 . . . . 62.149999999999999 113.606 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.76 103.78 8.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.172 0.51 . . . . 74.540000000000006 110.847 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -115.93 160.61 19.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.054 -0.521 . . . . 72.450000000000003 111.764 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.4 t -87.02 137.87 31.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 111.072 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.62 -11.74 18.19 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.145 -0.55 . . . . 60.32 113.722 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 48.4 t -93.6 123.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 122.438 -0.448 . . . . 74.239999999999995 110.959 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 29.3 p -74.73 168.54 19.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.184 0.516 . . . . 74.329999999999998 111.899 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 212' ' ' THR . 60.7 t -61.64 -33.78 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.278 0.561 . . . . 74.420000000000002 110.231 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 8.7 ttm105 -66.18 -51.32 58.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.815 -0.629 . . . . 73.329999999999998 111.365 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.94 -21.14 65.99 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.241 0.46 . . . . 74.019999999999996 112.241 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.9 m -86.02 -48.88 8.26 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.838 0.31 . . . . 71.310000000000002 111.838 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 169' ' ' VAL . 78.3 mt -82.83 -2.27 54.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.717 0.636 . . . . 72.209999999999994 112.717 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -55.46 -25.81 38.7 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.977 0.417 . . . . 74.209999999999994 111.772 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.32 -48.85 11.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.957 0.408 . . . . 71.430000000000007 111.04 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.52 94.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.117 -0.492 . . . . 62.5 111.973 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.416 HD13 ' CH2' ' A' ' 210' ' ' TRP . 90.9 mt -62.76 -46.57 87.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.861 0.362 . . . . 71.200000000000003 111.239 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.571 ' HA ' ' HE2' ' A' ' 186' ' ' MET . 5.6 tpt -59.12 -46.86 87.25 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.287 -0.415 . . . . 74.019999999999996 111.647 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.6 ptm -67.75 -8.61 36.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.772 0.32 . . . . 72.439999999999998 111.849 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -112.11 2.52 16.79 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.131 -0.356 . . . . 73.120000000000005 111.249 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.5 11.76 82.56 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.569 -0.348 . . . . 54.219999999999999 113.821 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.0 176.21 6.88 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 73.120000000000005 111.846 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 194' ' ' CYS . 17.6 pt -140.1 143.24 33.17 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 111.328 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.74 -49.68 15.0 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.956 2.437 . . . . 73.510000000000005 113.857 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -73.57 5.54 3.79 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.804 0.668 . . . . 74.439999999999998 112.804 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.521 ' HB3' HG13 ' A' ' 191' ' ' ILE . 43.2 t -128.29 15.35 6.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.048 0.451 . . . . 72.230000000000004 111.349 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.49 137.1 50.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.848 0.356 . . . . 73.040000000000006 110.939 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.75 120.94 44.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.727 0.299 . . . . 55.109999999999999 111.747 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.522 HG23 HG21 ' A' ' 224' ' ' VAL . 43.4 t -98.88 139.13 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.496 -0.32 . . . . 75.409999999999997 110.614 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -146.89 153.35 40.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.38 0.61 . . . . 74.120000000000005 111.926 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.54 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.7 ptm180 -114.29 159.56 20.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.652 -0.703 . . . . 73.540000000000006 110.469 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.0 mt -101.91 95.57 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 110.759 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -108.74 128.11 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.824 -0.625 . . . . 74.239999999999995 110.555 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 t70 64.71 20.17 12.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.463 0.649 . . . . 65.450000000000003 111.18 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.16 -20.09 52.19 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.333 -0.461 . . . . 64.209999999999994 113.557 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -108.36 162.2 14.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.112 0.482 . . . . 73.140000000000001 111.578 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -82.2 143.27 31.51 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.28 0.562 . . . . 62.409999999999997 111.912 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -139.89 120.58 9.33 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.89 -0.595 . . . . 71.019999999999996 111.207 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -65.76 144.2 76.82 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.698 2.266 . . . . 63.020000000000003 113.484 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 199' ' ' ARG . 66.4 mt -118.83 124.17 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.056 -0.52 . . . . 73.319999999999993 111.396 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.12 141.52 34.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.995 -0.622 . . . . 65.430000000000007 112.517 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.9 m95 -65.64 -16.08 63.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.389 0.595 . . . . 75.420000000000002 111.282 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.99 -16.37 61.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.842 -0.617 . . . . 75.540000000000006 111.762 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.2 m -69.47 136.96 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 111.509 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 4.7 m-20 -69.45 128.08 35.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.329999999999998 110.939 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.07 -20.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.138 0.494 . . . . 64.120000000000005 111.522 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.8 p -59.84 -26.71 66.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.221 -0.445 . . . . 70.549999999999997 112.073 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -69.48 -21.56 63.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.858 0.361 . . . . 73.230000000000004 111.83 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 220' ' ' GLU . 46.5 mt -110.49 21.02 17.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.186 0.517 . . . . 72.219999999999999 111.393 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.8 m -58.8 121.32 10.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.897 0.703 . . . . 75.540000000000006 112.897 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.01 4.23 90.08 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.279 0.872 . . . . 71.340000000000003 115.279 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 217' ' ' LEU . 12.9 pt-20 -111.82 172.7 6.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.978 0.889 . . . . 71.109999999999999 111.71 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 4.2 mp0 -102.98 127.2 50.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.233 0.54 . . . . 73.109999999999999 111.572 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.459 HD13 HG23 ' A' ' 159' ' ' VAL . 74.0 mt -103.67 159.62 15.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.986 -0.552 . . . . 72.450000000000003 111.148 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -128.75 127.12 41.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.652 0.263 . . . . 74.439999999999998 110.633 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 197' ' ' VAL . 46.8 t -117.84 146.78 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.283 0.563 . . . . 72.209999999999994 112.064 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.88 140.93 33.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 110.883 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.533 HG21 ' HG3' ' A' ' 162' ' ' PRO . 61.8 t -82.9 132.45 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.047 0.451 . . . . 70.099999999999994 111.871 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.537 0.463 0 CA-C-N 116.324 -0.398 . . . . 70.310000000000002 111.457 -178.79 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 112.825 0.676 . . . . 72.140000000000001 112.825 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB2' HG21 ' A' ' 218' ' ' THR . 21.9 Cg_endo -60.08 137.9 78.43 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.579 2.186 . . . . 64.540000000000006 111.722 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.91 158.16 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.847 0.684 . . . . 74.010000000000005 112.847 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.56 127.67 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.608 -0.724 . . . . 74.519999999999996 110.367 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 99.0 mtt180 -89.69 100.44 13.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.16 0.505 . . . . 71.439999999999998 111.37 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.583 HG23 HD22 ' A' ' 181' ' ' LEU . 47.8 t -99.5 118.23 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.284 -0.416 . . . . 73.200000000000003 112.03 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.85 123.32 33.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.902 0.382 . . . . 74.409999999999997 110.536 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.3 mt -95.49 163.49 21.37 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.511 -0.313 . . . . 73.439999999999998 111.578 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.72 153.62 5.53 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.851 2.367 . . . . 71.420000000000002 113.994 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.89 42.37 10.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.757 -0.656 . . . . 72.310000000000002 111.532 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 63.47 9.25 4.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.066 0.765 . . . . 74.319999999999993 113.066 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -72.59 164.36 26.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.894 0.378 . . . . 75.420000000000002 110.814 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -156.43 151.7 26.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.857 -0.527 . . . . 75.510000000000005 112.093 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.0 t -156.19 171.21 20.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.945 -0.571 . . . . 74.519999999999996 111.137 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.87 120.34 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.844 0.355 . . . . 73.420000000000002 110.587 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.1 m -115.61 140.6 26.2 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.003 0.372 . . . . 61.43 112.003 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.4 127.28 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.45 2.1 . . . . 75.519999999999996 112.682 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -70.74 103.21 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 73.299999999999997 110.831 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -100.38 128.05 46.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.976 -0.556 . . . . 72.430000000000007 111.807 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.24 123.19 21.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.446 -0.343 . . . . 64.5 111.121 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.46 -14.94 60.52 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.974 -0.631 . . . . 73.209999999999994 113.349 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.85 127.51 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.503 -0.41 . . . . 64.409999999999997 110.805 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.5 p -78.07 160.68 27.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.084 0.468 . . . . 74.319999999999993 111.541 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.06 -36.32 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.429 0.633 . . . . 72.420000000000002 110.163 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -60.29 -52.7 64.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.174 -0.921 . . . . 74.030000000000001 111.157 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.08 -34.8 78.45 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 112.123 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.4 t -72.85 -49.95 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.442 0.534 . . . . 71.540000000000006 112.442 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.583 HD22 HG23 ' A' ' 159' ' ' VAL . 78.7 mt -85.09 -16.52 40.32 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.474 0.916 . . . . 74.120000000000005 113.474 -173.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.71 -32.55 52.39 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.844 0.683 . . . . 74.230000000000004 112.844 -173.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.74 -39.21 67.05 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 75.530000000000001 111.404 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.2 70.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.193 0.521 . . . . 72.430000000000007 110.784 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.78 -49.38 25.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.836 -0.62 . . . . 74.209999999999994 111.02 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.3 tpt -53.24 -47.8 68.73 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.079 -0.509 . . . . 75.510000000000005 112.006 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 ptm -64.61 -9.14 17.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.291 0.478 . . . . 71.120000000000005 112.291 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -110.91 -6.17 14.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.598 0.237 . . . . 75.239999999999995 111.514 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.66 36.9 14.91 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.122 -0.561 . . . . 60.149999999999999 112.752 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.51 154.71 43.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.541 0.336 . . . . 75.049999999999997 111.394 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.62 149.57 67.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 122.362 0.265 . . . . 74.140000000000001 111.009 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.42 -37.02 60.53 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.936 2.424 . . . . 72.450000000000003 113.734 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -69.87 -18.45 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.35 0.5 . . . . 72.120000000000005 112.35 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.1 -10.33 20.56 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.499 0.555 . . . . 74.099999999999994 112.499 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.9 m -131.98 171.27 13.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.238 0.542 . . . . 72.510000000000005 112.244 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -133.08 141.26 48.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.003 -0.544 . . . . 53.350000000000001 111.549 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.52 HG21 HG23 ' A' ' 224' ' ' VAL . 48.3 t -109.58 126.17 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.368 -0.378 . . . . 73.120000000000005 110.73 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -141.93 152.63 43.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.179 0.514 . . . . 73.209999999999994 111.936 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.59 160.13 16.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.88 -0.6 . . . . 72.040000000000006 110.578 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.5 mt -117.24 119.46 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.0 0.429 . . . . 75.510000000000005 111.469 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.06 149.69 29.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 109.872 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 62.93 16.46 9.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.78 0.324 . . . . 71.420000000000002 111.447 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.79 4.4 88.13 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.304 -0.474 . . . . 74.0 112.775 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -107.09 154.57 20.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.954 0.501 . . . . 71.329999999999998 111.986 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -94.82 126.19 39.98 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.88 0.371 . . . . 75.299999999999997 110.681 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.12 94.85 32.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.015 -0.365 . . . . 63.130000000000003 110.015 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.37 121.9 10.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.714 2.276 . . . . 75.200000000000003 112.443 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 58.8 mt -101.85 132.68 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 111.584 -175.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.73 126.09 26.56 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.77 -0.728 . . . . 71.010000000000005 112.358 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -51.63 -33.17 32.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.664 0.616 . . . . 74.540000000000006 112.664 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -85.74 21.37 1.89 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.426 0.528 . . . . 45.229999999999997 112.426 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 49.9 m -97.09 143.28 28.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 122.336 -0.228 . . . . 75.349999999999994 111.112 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.501 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.9 m-20 -58.2 128.27 36.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.126 0.489 . . . . 72.519999999999996 111.823 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 217' ' ' LEU . 9.3 tp -63.66 -21.2 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.98 0.419 . . . . 73.329999999999998 111.722 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.529 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 78.4 p -60.62 -26.09 66.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.216 0.45 . . . . 72.549999999999997 112.216 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 22.3 m95 -67.21 -21.53 65.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.359 . . . . 74.400000000000006 111.968 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 214' ' ' ILE . 33.9 mt -103.83 22.07 15.16 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.138 0.494 . . . . 75.209999999999994 111.896 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.421 HG21 ' HB2' ' A' ' 155' ' ' PRO . 77.4 m -53.71 124.71 15.95 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.893 0.701 . . . . 73.109999999999999 112.893 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.3 -5.87 66.04 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 114.401 0.521 . . . . 70.129999999999995 114.401 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.67 158.15 16.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.331 0.566 . . . . 65.120000000000005 111.742 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 51.8 mt-10 -100.69 117.84 35.62 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 110.809 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 159' ' ' VAL . 82.1 mt -93.01 148.16 22.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.056 0.455 . . . . 74.120000000000005 111.012 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -121.35 113.28 19.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.541 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.52 HG23 HG21 ' A' ' 197' ' ' VAL . 43.5 t -108.46 130.76 60.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.209999999999994 111.22 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.92 157.68 45.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 73.239999999999995 111.435 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.95 130.0 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.044 -0.525 . . . . 64.230000000000004 111.453 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 110.433 176.045 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 9.2 mmpt? . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.799 0.296 . . . . 72.219999999999999 111.799 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.97 114.86 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.229 1.953 . . . . 65.310000000000002 110.95 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -114.65 160.7 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.102 0.778 . . . . 75.049999999999997 113.102 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.35 139.21 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.553 -0.749 . . . . 53.399999999999999 110.518 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.551 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 1.5 mpt_? -92.88 111.71 23.42 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.546 0.212 . . . . 74.349999999999994 110.543 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.23 122.33 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.35 0.5 . . . . 61.32 112.35 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.96 99.76 11.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 110.399 174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.1 mt -65.97 144.0 98.65 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.654 -0.248 . . . . 73.120000000000005 111.27 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.23 143.52 52.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.552 2.168 . . . . 74.239999999999995 112.945 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 74.5 54.43 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.122 0.569 . . . . 73.519999999999996 111.534 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 67.59 22.02 9.25 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.938 1.088 . . . . 70.319999999999993 113.938 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 71.7 mm-40 -107.84 175.27 5.54 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.603 -0.686 . . . . 73.519999999999996 112.539 -175.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -146.98 152.68 39.02 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.159 0.504 . . . . 75.120000000000005 112.325 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.6 t -157.09 160.5 38.94 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.013 -0.539 . . . . 72.540000000000006 110.893 170.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.82 120.2 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.978 0.418 . . . . 75.030000000000001 110.722 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.05 141.13 37.62 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 111.909 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.4 Cg_endo -77.14 132.55 12.76 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.69 2.26 . . . . 74.519999999999996 113.487 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -70.78 128.85 37.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.194 0.521 . . . . 70.409999999999997 111.802 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -129.69 131.53 46.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.067 -0.515 . . . . 74.049999999999997 110.931 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -71.99 109.83 6.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 73.319999999999993 111.163 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.3 19.6 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.326 -0.464 . . . . 73.230000000000004 112.668 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.418 ' O ' HG21 ' A' ' 214' ' ' ILE . 96.0 t -117.72 125.84 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.939 0.399 . . . . 73.420000000000002 110.948 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 p -82.69 167.38 18.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 65.340000000000003 111.736 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.55 -36.63 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.304 0.574 . . . . 64.319999999999993 110.459 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 41.3 ttt180 -67.06 -57.68 6.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.735 -0.666 . . . . 75.299999999999997 111.187 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -28.22 58.72 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.116 0.413 . . . . 71.310000000000002 112.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 36.7 t -78.78 -47.42 16.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.709 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.13 -1.53 54.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.157 0.799 . . . . 73.109999999999999 113.157 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.34 -41.47 76.14 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 73.519999999999996 112.136 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.24 -32.31 68.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.058 0.456 . . . . 73.040000000000006 111.09 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.496 ' HA ' ' HE2' ' A' ' 187' ' ' MET . . . -64.8 -38.55 91.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.035 0.445 . . . . 72.230000000000004 111.051 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -75.68 -38.69 58.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.848 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 24.7 ttt -54.67 -50.6 67.81 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.935 -0.575 . . . . 75.109999999999999 111.713 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.496 ' HE2' ' HA ' ' A' ' 184' ' ' ALA . 26.7 ptt? -69.78 -4.29 19.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.52 0.563 . . . . 64.219999999999999 112.52 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -118.28 2.42 11.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.055 0.391 . . . . 72.420000000000002 112.055 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.83 38.64 89.52 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 73.129999999999995 113.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.98 154.99 36.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.912 0.387 . . . . 75.420000000000002 111.685 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.83 146.54 46.18 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.366 -0.379 . . . . 74.420000000000002 111.396 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.6 -44.27 45.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.113 2.542 . . . . 72.310000000000002 114.141 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.01 -4.1 12.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.371 0.508 . . . . 75.120000000000005 112.371 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -100.5 -5.39 27.04 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.928 0.394 . . . . 73.109999999999999 111.425 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.36 144.12 42.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 111.993 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 227' ' ' LEU . . . -112.22 137.44 50.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.779 0.323 . . . . 51.119999999999997 111.483 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 224' ' ' VAL . 47.4 t -102.48 140.09 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.276 -0.42 . . . . 64.329999999999998 110.26 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -157.77 158.47 35.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.254 0.55 . . . . 73.400000000000006 112.023 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.811 HH11 ' HG3' ' A' ' 220' ' ' GLU . 79.1 mtm180 -110.41 139.46 45.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.141 -0.481 . . . . 73.140000000000001 111.239 175.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.95 96.41 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.299 0.571 . . . . 71.230000000000004 110.111 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.75 107.54 18.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 74.310000000000002 110.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.0 20.05 7.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.298 0.571 . . . . 74.209999999999994 111.567 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.62 38.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.474 -0.393 . . . . 71.129999999999995 113.257 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.18 117.34 23.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.944 0.35 . . . . 70.040000000000006 111.944 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -80.72 109.34 15.17 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.546 0.212 . . . . 74.530000000000001 111.222 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -102.9 106.82 52.43 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.599 0.238 . . . . 72.129999999999995 111.195 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.51 116.53 4.28 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.873 2.382 . . . . 73.519999999999996 113.036 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.44 HD13 ' HG3' ' A' ' 199' ' ' ARG . 64.1 mt -101.06 133.26 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.236 0.541 . . . . 73.049999999999997 111.908 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.7 143.3 28.92 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.199 -0.524 . . . . 62.350000000000001 112.888 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 96.4 m95 -60.4 -21.89 62.72 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.352 0.576 . . . . 74.030000000000001 111.011 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.05 -5.16 50.54 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.987 -0.551 . . . . 75.409999999999997 112.204 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 177' ' ' VAL . 40.8 m -74.25 136.76 42.7 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.551 0.215 . . . . 74.129999999999995 111.353 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 18.1 t70 -72.09 129.24 38.03 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.04 0.448 . . . . 75.519999999999996 110.88 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.418 HG21 ' O ' ' A' ' 175' ' ' VAL . 12.5 tt -66.02 -22.63 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.731 0.641 . . . . 75.019999999999996 112.731 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 41.2 t -63.39 -21.05 66.05 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.821 -0.549 . . . . 71.040000000000006 111.425 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 16.8 m95 -80.18 -10.65 59.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.013 0.435 . . . . 72.109999999999999 111.356 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.518 HD13 HD21 ' A' ' 222' ' ' LEU . 49.6 mt -111.42 15.04 21.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.227 -0.442 . . . . 65.430000000000007 111.571 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.3 m -56.29 126.32 25.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.355 0.502 . . . . 75.409999999999997 112.355 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.29 10.14 84.06 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.299 -0.477 . . . . 73.019999999999996 114.087 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . 0.811 ' HG3' HH11 ' A' ' 199' ' ' ARG . 36.5 mm-40 -107.37 171.89 7.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.126 0.489 . . . . 71.530000000000001 111.53 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.1 mp0 -111.01 121.01 44.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 110.866 172.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 217' ' ' LEU . 80.2 mt -94.01 117.65 30.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.916 0.388 . . . . 75.430000000000007 111.197 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -94.41 118.74 32.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.612 -0.267 . . . . 72.310000000000002 110.484 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.479 HG22 HG23 ' A' ' 197' ' ' VAL . 21.7 t -110.15 139.93 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.13 0.491 . . . . 74.310000000000002 111.158 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.98 170.45 15.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.454 -0.339 . . . . 74.420000000000002 111.369 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.29 127.04 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.862 0.363 . . . . 74.340000000000003 111.644 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.52 HD21 ' HB1' ' A' ' 196' ' ' ALA . 86.4 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 111.99 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mttm . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 111.396 0.147 . . . . 72.450000000000003 111.396 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.42 135.86 44.43 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.347 2.031 . . . . 75.219999999999999 111.738 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.8 pt -123.62 161.11 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 74.0 113.051 -173.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.411 HG23 HG13 ' A' ' 214' ' ' ILE . 44.5 t -127.12 131.92 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.8 -0.636 . . . . 74.099999999999994 110.459 174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -100.96 105.14 16.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.941 0.4 . . . . 73.450000000000003 111.632 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.591 HG21 HD12 ' A' ' 222' ' ' LEU . 60.0 t -99.6 119.08 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 111.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -92.13 113.51 25.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.351 0.596 . . . . 75.209999999999994 111.888 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.5 mt -91.14 169.15 12.09 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 115.435 -0.802 . . . . 74.400000000000006 111.04 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 165.29 3.14 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.427 2.085 . . . . 74.319999999999993 113.479 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.83 28.76 18.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.776 0.43 . . . . 73.439999999999998 111.954 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp 63.29 22.96 13.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.987 0.515 . . . . 75.230000000000004 112.087 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 80.3 mm-40 -82.81 168.33 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 111.048 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -156.43 161.75 40.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 75.319999999999993 112.124 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.6 t -150.41 151.08 32.24 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.655 -0.702 . . . . 74.340000000000003 110.525 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.52 119.61 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.988 0.423 . . . . 75.450000000000003 111.443 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 27.1 m -120.38 144.51 38.38 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.318 -0.401 . . . . 61.109999999999999 111.449 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.8 Cg_exo -65.56 132.66 31.71 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.645 2.23 . . . . 73.030000000000001 112.992 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -73.97 117.65 16.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 75.420000000000002 111.604 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -130.37 143.55 50.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.283 -0.417 . . . . 74.099999999999994 111.194 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.41 140.99 37.24 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.636 0.255 . . . . 74.230000000000004 110.642 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.08 -25.29 10.35 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.116 -0.564 . . . . 72.140000000000001 112.314 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.91 117.54 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.926 0.394 . . . . 73.129999999999995 110.899 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 39.5 p -80.15 156.91 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.484 -0.325 . . . . 75.430000000000007 111.254 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.75 -31.7 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.552 0.692 . . . . 70.439999999999998 110.756 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.4 ttp85 -70.18 -35.23 73.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.448 -0.796 . . . . 74.230000000000004 111.59 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.27 -43.33 21.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.196 -0.456 . . . . 62.210000000000001 111.903 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -61.14 -49.81 75.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.129 0.49 . . . . 71.340000000000003 111.978 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.71 14.43 2.13 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.972 0.73 . . . . 74.420000000000002 112.972 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 183' ' ' LYS . 9.5 ptpp? -53.12 -48.3 67.96 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.286 0.476 . . . . 73.409999999999997 112.286 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.458 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 65.6 pttt -79.05 -29.75 43.66 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.05 -0.406 . . . . 71.450000000000003 111.311 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.29 88.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.142 0.496 . . . . 52.100000000000001 111.434 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -46.34 70.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.103 0.477 . . . . 74.109999999999999 110.689 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 41.2 ttm -50.93 -51.5 51.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.731 -0.668 . . . . 72.230000000000004 112.156 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.41 -19.91 65.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.298 0.481 . . . . 74.019999999999996 112.298 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -98.91 -4.47 32.8 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.821 0.344 . . . . 75.510000000000005 111.421 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 25.81 63.81 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.184 -0.531 . . . . 54.340000000000003 113.006 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.2 mt -113.89 153.97 28.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.447 . . . . 73.420000000000002 111.486 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 192' ' ' PRO . 31.0 pt -128.69 156.89 76.76 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 116.305 -0.407 . . . . 75.519999999999996 110.318 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 191' ' ' ILE . 11.3 Cg_endo -53.78 -42.87 62.84 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.507 2.138 . . . . 73.450000000000003 113.159 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.65 -7.62 28.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.16 0.43 . . . . 61.219999999999999 112.16 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.547 ' HG ' HG13 ' A' ' 226' ' ' VAL . 40.9 t -109.87 -2.45 17.22 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.803 0.297 . . . . 63.450000000000003 111.803 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.08 162.53 34.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.08 0.467 . . . . 71.230000000000004 111.778 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.452 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.19 139.98 48.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.927 0.394 . . . . 54.109999999999999 111.586 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 224' ' ' VAL . 54.1 t -107.95 135.19 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.177 -0.465 . . . . 72.239999999999995 111.024 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.62 158.2 43.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.982 0.42 . . . . 73.319999999999993 111.148 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -127.58 149.1 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 110.883 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.85 95.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.546 0.689 . . . . 73.019999999999996 110.206 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.46 109.14 20.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.554 -0.748 . . . . 72.299999999999997 111.259 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.8 t70 60.78 26.54 16.36 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.475 0.655 . . . . 74.540000000000006 111.006 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.55 -13.25 59.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.166 -0.47 . . . . 61.109999999999999 113.441 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 125.18 35.9 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.107 0.41 . . . . 62.439999999999998 112.107 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.02 93.92 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.147 0.498 . . . . 74.150000000000006 109.8 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -99.7 115.57 65.5 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.184 -0.462 . . . . 75.299999999999997 111.725 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.55 127.18 20.07 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.692 2.261 . . . . 75.030000000000001 112.806 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -102.34 120.47 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.117 -0.492 . . . . 70.420000000000002 110.872 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.81 135.09 46.78 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.889 -0.672 . . . . 62.310000000000002 113.197 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 83.3 m95 -55.72 -32.81 63.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.523 0.564 . . . . 72.450000000000003 112.523 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.62 11.75 8.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.852 0.686 . . . . 75.420000000000002 112.852 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.3 m -79.85 141.91 35.73 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.158 -0.339 . . . . 72.310000000000002 110.862 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 118.29 5.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.895 0.378 . . . . 65.219999999999999 111.145 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.411 HG13 HG23 ' A' ' 157' ' ' VAL . 10.7 tp -57.34 -22.3 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.09 0.471 . . . . 71.439999999999998 111.845 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 23.3 t -61.28 -23.89 66.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.159 0.429 . . . . 72.319999999999993 112.159 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -66.51 -22.46 66.18 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.062 0.458 . . . . 72.510000000000005 111.388 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.0 mt -108.02 30.11 6.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.707 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 93.9 m -62.65 116.65 5.36 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.711 0.634 . . . . 74.450000000000003 112.711 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 85.01 8.91 81.59 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.99 0.756 . . . . 64.010000000000005 114.99 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 167.34 10.96 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.73 0.765 . . . . 71.340000000000003 112.126 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -102.47 120.89 41.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.794 -0.639 . . . . 75.150000000000006 111.717 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.591 HD12 HG21 ' A' ' 159' ' ' VAL . 68.4 mt -94.03 143.77 26.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.082 -0.508 . . . . 74.219999999999999 111.45 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -109.03 109.47 20.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.735 0.303 . . . . 74.310000000000002 110.203 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 197' ' ' VAL . 61.6 t -107.77 148.86 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.077 0.465 . . . . 74.530000000000001 111.517 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.21 160.24 42.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.968 0.413 . . . . 73.310000000000002 111.049 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.547 HG13 ' HG ' ' A' ' 194' ' ' CYS . 47.8 t -83.29 132.25 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 111.771 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 196' ' ' ALA . 94.8 mt . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.121 0.486 . . . . 74.319999999999993 110.335 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 120.467 0.175 . . . . 74.319999999999993 111.447 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.43 142.72 99.43 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.378 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 2.9 pp -123.05 161.73 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.538 0.685 . . . . 72.430000000000007 112.814 -175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.43 141.21 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 115.73 -0.668 . . . . 75.409999999999997 110.919 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.28 106.5 18.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.644 0.259 . . . . 70.549999999999997 111.132 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.602 HG21 HD22 ' A' ' 181' ' ' LEU . 55.6 t -109.19 124.45 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.123 0.487 . . . . 75.109999999999999 112.12 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.446 ' HD1' ' HG3' ' A' ' 166' ' ' ARG . 20.6 m-85 -99.78 113.74 26.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.187 -0.46 . . . . 74.049999999999997 110.961 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 86.3 mt -90.9 160.87 37.13 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.037 -0.529 . . . . 71.209999999999994 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 29.6 Cg_endo -61.88 167.26 10.68 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.929 2.419 . . . . 75.030000000000001 113.672 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.19 29.7 18.9 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.353 0.597 . . . . 75.310000000000002 111.341 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 60.37 59.03 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.354 -0.839 . . . . 72.239999999999995 111.718 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.1 mm-40 -118.91 143.61 46.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.889 -0.596 . . . . 73.340000000000003 110.455 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.446 ' HG3' ' HD1' ' A' ' 160' ' ' PHE . 3.4 mpt_? -126.19 147.18 49.7 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.952 -0.468 . . . . 73.319999999999993 111.698 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.49 161.74 40.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.046 -0.525 . . . . 64.310000000000002 111.357 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 156' ' ' ILE . 61.9 t -126.89 120.14 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.837 0.351 . . . . 74.150000000000006 111.197 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -111.44 153.76 44.03 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 116.396 -0.365 . . . . 71.019999999999996 111.764 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.14 151.6 30.47 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.543 2.162 . . . . 72.129999999999995 113.532 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -105.09 112.49 25.64 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.068 -0.514 . . . . 75.439999999999998 111.882 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -126.34 148.28 49.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.522 0.329 . . . . 75.310000000000002 111.046 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.12 135.64 37.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.712 0.292 . . . . 74.200000000000003 110.921 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.12 -30.57 7.94 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.142 -0.552 . . . . 75.129999999999995 112.277 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.8 t -80.89 109.72 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.108 0.48 . . . . 72.430000000000007 110.346 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 36.9 p -76.36 163.31 27.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.272 -0.422 . . . . 72.430000000000007 111.324 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 212' ' ' THR . 60.8 t -54.02 -37.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.288 0.566 . . . . 75.010000000000005 110.23 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 3.4 tmt_? -65.64 -39.34 91.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.492 -0.776 . . . . 72.540000000000006 111.187 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 31.8 t70 -79.34 -29.07 42.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.935 0.346 . . . . 75.239999999999995 111.935 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -78.56 -55.74 4.97 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.093 0.473 . . . . 71.439999999999998 111.496 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.602 HD22 HG21 ' A' ' 159' ' ' VAL . 62.4 mt -72.48 -3.56 25.09 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.797 0.665 . . . . 72.340000000000003 112.797 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 24.6 pttm -61.75 -20.65 63.77 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.026 -0.421 . . . . 75.340000000000003 110.747 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.08 -53.46 6.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.025 0.44 . . . . 75.450000000000003 110.877 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.28 70.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.055 -0.52 . . . . 65.420000000000002 111.869 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -81.79 -26.21 34.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.56 -0.291 . . . . 75.219999999999999 111.58 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.734 ' HA ' ' HE2' ' A' ' 186' ' ' MET . 3.0 tpt -64.39 -41.76 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.818 0.342 . . . . 71.439999999999998 111.013 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.46 -21.3 64.64 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.013 0.435 . . . . 71.540000000000006 110.948 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -83.75 -21.16 32.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.31 -0.405 . . . . 72.129999999999995 110.808 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.61 29.61 26.39 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.41 -0.424 . . . . 55.210000000000001 113.064 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 84.4 mt -131.31 164.93 24.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.17 0.51 . . . . 75.420000000000002 111.829 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.36 143.16 26.63 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.125 -0.489 . . . . 75.319999999999993 111.159 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.42 -42.96 57.82 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 73.230000000000004 113.978 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.414 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.6 pm0 -70.29 -0.78 8.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.375 0.509 . . . . 72.430000000000007 112.375 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 52.9 t -107.15 9.83 30.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.964 0.412 . . . . 63.399999999999999 111.024 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 62.0 m -131.38 172.16 12.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.223 -0.444 . . . . 61.340000000000003 111.215 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -136.98 126.93 25.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.804 0.335 . . . . 70.310000000000002 111.638 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 224' ' ' VAL . 43.4 t -99.08 125.22 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 110.805 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -136.28 146.52 46.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.525 0.678 . . . . 74.299999999999997 111.365 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HB3' HD12 ' A' ' 208' ' ' ILE . 0.5 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.533 -0.758 . . . . 74.439999999999998 110.24 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -77.72 87.61 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.875 0.845 . . . . 63.009999999999998 109.944 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -115.66 136.73 52.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.111 -0.949 . . . . 65.340000000000003 111.105 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.19 26.24 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.285 0.564 . . . . 73.409999999999997 112.327 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.2 58.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.153 -0.546 . . . . 61.210000000000001 114.402 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.71 151.93 47.57 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.416 0.608 . . . . 72.040000000000006 111.877 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -77.73 94.65 4.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.661 -0.496 . . . . 72.219999999999999 109.661 170.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.25 114.07 64.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 120.626 0.251 . . . . 75.420000000000002 111.439 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.64 155.36 43.0 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.891 2.394 . . . . 74.409999999999997 113.762 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 199' ' ' ARG . 60.9 mt -127.28 133.45 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.788 -0.642 . . . . 71.400000000000006 110.588 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.59 132.98 23.0 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.86 -0.686 . . . . 72.409999999999997 112.816 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 82.4 m95 -62.31 -22.37 65.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.269 0.47 . . . . 74.420000000000002 112.269 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.55 -11.76 59.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.962 0.356 . . . . 71.140000000000001 111.962 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 m -66.54 134.26 52.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.685 0.279 . . . . 74.150000000000006 111.501 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.451 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 2.3 m-20 -58.94 130.58 47.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.821 0.343 . . . . 74.340000000000003 111.141 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.12 -21.58 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.193 0.521 . . . . 72.129999999999995 111.373 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 98.9 p -61.16 -26.07 67.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.064 -0.516 . . . . 65.209999999999994 111.847 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.6 m95 -66.58 -24.72 66.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.154 0.502 . . . . 65.420000000000002 111.815 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.87 21.42 17.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.021 -0.536 . . . . 74.329999999999998 111.511 -173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.7 m -56.86 112.24 1.26 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.798 0.666 . . . . 71.329999999999998 112.798 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.49 75.32 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 115.093 0.797 . . . . 71.310000000000002 115.093 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.44 172.21 7.15 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.145 0.972 . . . . 54.399999999999999 111.737 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . 19.0 mp0 -96.28 134.25 39.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.095 -0.502 . . . . 75.230000000000004 111.565 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.46 144.67 45.82 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.499 -0.319 . . . . 72.120000000000005 110.815 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -115.34 116.3 28.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.688 0.28 . . . . 70.120000000000005 110.381 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 197' ' ' VAL . 51.0 t -115.31 127.16 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.866 0.365 . . . . 73.230000000000004 111.391 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.96 161.08 29.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.993 0.425 . . . . 70.010000000000005 111.427 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.423 HG21 ' HG3' ' A' ' 162' ' ' PRO . 16.7 t -90.5 138.32 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 64.420000000000002 111.583 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 111.389 179.516 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 112.372 0.508 . . . . 74.310000000000002 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.08 145.85 97.47 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.321 2.68 . . . . 64.140000000000001 114.55 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.41 168.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.927 -0.579 . . . . 74.019999999999996 112.268 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 171' ' ' ALA . 63.4 t -133.05 140.3 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.289 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -104.23 102.17 11.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.801 0.334 . . . . 74.230000000000004 111.642 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 181' ' ' LEU . 43.9 t -103.01 141.71 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.634 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -113.3 113.43 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.056 0.455 . . . . 75.439999999999998 111.219 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 90.8 mt -85.74 160.76 52.42 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.866 -0.606 . . . . 75.019999999999996 111.039 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 25.3 Cg_endo -61.67 169.05 7.49 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.112 1.875 . . . . 75.010000000000005 112.496 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.38 32.09 16.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.12 0.415 . . . . 70.030000000000001 112.12 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.7 22.94 7.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.124 0.787 . . . . 75.310000000000002 113.124 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -99.69 163.9 12.28 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.886 0.374 . . . . 73.420000000000002 111.595 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -154.9 165.0 38.06 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.006 -0.434 . . . . 74.010000000000005 111.924 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.8 t -156.01 155.71 33.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.89 0.376 . . . . 64.319999999999993 111.33 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 62.2 t -122.92 120.12 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.765 0.317 . . . . 75.340000000000003 110.97 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.7 147.89 38.61 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.084 0.402 . . . . 64.530000000000001 112.084 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.02 127.9 15.88 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.371 2.047 . . . . 71.510000000000005 112.91 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -85.78 118.71 25.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.003 0.43 . . . . 75.099999999999994 112.046 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -136.71 157.07 47.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.195 0.521 . . . . 75.239999999999995 111.898 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 50.5 t -81.55 144.49 31.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.549 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.94 -12.47 61.84 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.997 -0.621 . . . . 44.439999999999998 112.527 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.66 116.82 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.574 -0.368 . . . . 73.239999999999995 110.171 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 p -81.41 161.34 23.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 111.64 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.48 -31.63 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.152 0.501 . . . . 71.430000000000007 110.714 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.611 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 46.9 ttp85 -72.97 -56.53 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 110.864 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.427 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.7 m-20 -61.38 -26.17 67.66 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 111.742 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.5 t -77.73 -61.8 1.87 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.149 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 159' ' ' VAL . 66.1 mt -71.89 -21.65 61.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.298 0.851 . . . . 74.530000000000001 113.298 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 20.7 pttp -64.6 -12.22 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.661 0.664 . . . . 74.549999999999997 111.359 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -79.07 -49.01 13.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.143 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.101 -0.499 . . . . 74.439999999999998 111.31 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.05 -39.35 79.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.375 -0.375 . . . . 74.519999999999996 111.044 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 28.1 ttt -58.19 -47.73 82.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.856 0.36 . . . . 71.439999999999998 111.513 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.5 ptm -70.84 -8.11 50.27 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.861 0.362 . . . . 75.530000000000001 111.694 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 188' ' ' ARG . 3.5 mmp_? -106.65 -15.63 14.72 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.901 0.334 . . . . 73.349999999999994 111.901 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.55 40.35 9.94 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.186 -0.53 . . . . 74.019999999999996 112.891 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.87 168.62 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.717 0.407 . . . . 72.010000000000005 111.073 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.5 pt -132.52 149.37 72.88 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.54 -0.3 . . . . 73.120000000000005 111.406 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.86 -48.65 13.83 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.269 2.646 . . . . 74.5 114.113 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.33 4.75 3.4 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.681 0.623 . . . . 73.129999999999995 112.681 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.94 -8.15 18.81 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.862 0.363 . . . . 73.530000000000001 111.321 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 70.8 m -130.85 166.57 20.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.14 0.422 . . . . 74.019999999999996 112.14 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.89 121.3 19.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.431 -0.35 . . . . 75.140000000000001 111.809 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.04 121.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.905 0.383 . . . . 73.239999999999995 111.558 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.639 ' CE1' ' HG3' ' A' ' 225' ' ' GLU . 27.7 p90 -138.84 142.29 38.65 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.211 0.529 . . . . 73.349999999999994 111.533 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 199' ' ' ARG . 1.3 ptm180 -110.72 124.43 51.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.884 -0.598 . . . . 75.25 110.001 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.12 107.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 71.5 111.668 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -135.19 135.93 41.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.1 -0.5 . . . . 61.539999999999999 110.202 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.36 27.46 16.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.23 0.538 . . . . 73.030000000000001 110.908 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.14 68.88 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.879 -0.6 . . . . 38.219999999999999 113.149 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -95.75 126.22 40.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.815 0.446 . . . . 74.5 112.167 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 97.5 mttt -76.98 98.82 5.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.668 0.27 . . . . 72.540000000000006 110.369 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -90.1 107.29 18.49 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.675 -0.238 . . . . 65.340000000000003 111.219 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 3.2 Cg_exo -75.31 129.1 11.77 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.776 2.317 . . . . 72.540000000000006 111.95 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.594 HG23 HD12 ' A' ' 217' ' ' LEU . 3.9 mp -98.89 122.39 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.74 -0.209 . . . . 73.299999999999997 110.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.51 126.7 38.02 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.714 -0.755 . . . . 54.340000000000003 111.782 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 69.4 m95 -55.06 -33.49 62.76 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.686 0.624 . . . . 73.209999999999994 112.686 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.47 17.68 3.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.897 0.703 . . . . 74.340000000000003 112.897 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.4 m -88.8 140.03 29.86 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.231 -0.293 . . . . 62.310000000000002 110.663 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.467 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 5.9 m-20 -57.58 125.68 23.98 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.077 0.399 . . . . 74.329999999999998 112.077 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.417 HG13 HG23 ' A' ' 157' ' ' VAL . 10.9 tp -59.45 -21.83 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.407 0.622 . . . . 74.25 110.965 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -55.34 -27.88 50.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.57 -0.741 . . . . 44.240000000000002 112.092 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -77.44 -7.02 55.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 111.859 0.318 . . . . 73.310000000000002 111.859 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 208' ' ' ILE . 36.8 mt -122.15 22.34 10.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.283 0.563 . . . . 75.329999999999998 110.892 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -62.03 127.28 30.63 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.135 0.791 . . . . 62.32 113.135 -174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.63 11.8 84.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.393 0.917 . . . . 74.420000000000002 115.393 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -126.83 173.26 9.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.244 1.022 . . . . 74.409999999999997 112.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.25 126.74 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.678 -0.692 . . . . 75.019999999999996 112.332 -172.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.12 141.5 44.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 109.911 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -120.33 142.57 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.088 -0.382 . . . . 73.319999999999993 110.516 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 70.7 t -118.09 126.43 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.051 0.76 . . . . 75.319999999999993 113.051 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.639 ' HG3' ' CE1' ' A' ' 198' ' ' TYR . 34.2 mt-10 -101.28 164.75 11.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.133 -0.485 . . . . 72.200000000000003 110.886 171.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.26 119.88 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.819 0.342 . . . . 74.129999999999995 111.48 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 196' ' ' ALA . 84.1 mt . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.029 0.442 . . . . 75.120000000000005 110.639 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 111.715 0.265 . . . . 75.430000000000007 111.715 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.41 147.08 86.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.538 2.158 . . . . 74.109999999999999 112.294 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.01 166.04 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.232 0.827 . . . . 74.010000000000005 113.232 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.69 128.12 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.821 -1.081 . . . . 70.299999999999997 109.334 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 83.8 mtt180 -91.45 97.29 10.98 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.987 0.422 . . . . 74.150000000000006 111.488 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 222' ' ' LEU . 44.7 t -95.69 112.55 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.17 0.434 . . . . 75.310000000000002 112.17 -176.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.6 119.6 23.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.022 0.439 . . . . 71.409999999999997 110.945 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 93.1 mt -95.99 159.44 32.26 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 111.304 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.524 ' HG3' ' HA ' ' A' ' 225' ' ' GLU . 70.8 Cg_exo -52.27 162.87 1.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.537 2.158 . . . . 74.340000000000003 113.068 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.0 t30 65.96 28.97 10.44 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.162 0.506 . . . . 73.299999999999997 110.961 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 65.64 19.45 11.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.58 0.585 . . . . 74.099999999999994 112.58 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.3 mm-40 -84.04 171.87 12.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.087 0.47 . . . . 72.25 111.606 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.2 ptt-85 -160.34 140.56 11.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.015 0.436 . . . . 72.310000000000002 111.845 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -139.53 141.54 37.27 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.027 0.442 . . . . 75.349999999999994 111.209 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.94 119.23 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.026 0.441 . . . . 75.409999999999997 110.887 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 m -119.83 149.08 47.84 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.446 -0.343 . . . . 73.219999999999999 111.582 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.2 Cg_exo -65.17 144.84 82.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.413 2.076 . . . . 74.25 113.18 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.06 15.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.198 0.523 . . . . 74.019999999999996 111.314 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -115.63 136.46 53.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.273 0.558 . . . . 74.310000000000002 112.421 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 37.2 t -99.94 133.64 44.01 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.832 -0.622 . . . . 72.140000000000001 110.518 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.18 -21.32 31.95 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.683 -0.77 . . . . 72.040000000000006 112.327 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.45 125.09 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 75.540000000000006 110.384 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 44.3 p -72.95 156.13 39.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 111.492 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.73 -36.03 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.396 0.617 . . . . 74.219999999999999 110.535 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 42.9 ttt180 -60.39 -59.59 5.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.388 -0.824 . . . . 74.420000000000002 111.905 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.78 -18.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.081 0.467 . . . . 71.129999999999995 111.398 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.2 t -82.13 -37.33 26.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.872 0.367 . . . . 75.140000000000001 111.51 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.9 mt -97.21 2.34 50.81 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.209 0.448 . . . . 75.430000000000007 112.209 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -52.55 -33.24 44.72 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.26 0.467 . . . . 75.319999999999993 112.26 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.503 ' HZ3' ' HB3' ' A' ' 183' ' ' LYS . 6.9 mtpm? -79.36 -37.83 36.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.794 0.33 . . . . 74.219999999999999 111.289 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -62.96 -46.23 88.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.14 0.495 . . . . 71.530000000000001 111.086 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.7 -44.49 96.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.189 -0.46 . . . . 74.530000000000001 110.694 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.8 ttt -53.08 -53.36 51.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.909 -0.587 . . . . 72.030000000000001 111.88 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.0 ptp -68.69 -14.14 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.474 0.546 . . . . 74.010000000000005 112.474 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 32.5 mmt180 -100.5 -8.22 23.34 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.224 -0.298 . . . . 75.230000000000004 111.671 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 79.33 18.1 74.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.213 -0.517 . . . . 64.310000000000002 112.855 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -101.74 156.8 17.28 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.085 0.469 . . . . 71.519999999999996 111.553 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 pt -127.23 138.29 32.44 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.73 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.08 -39.71 84.52 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.944 2.429 . . . . 73.409999999999997 113.56 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.03 -19.53 66.04 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.821 0.343 . . . . 73.129999999999995 111.888 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.7 20.29 17.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.092 0.472 . . . . 71.349999999999994 111.387 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.3 m -137.49 137.26 38.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.061 0.458 . . . . 71.049999999999997 111.252 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 227' ' ' LEU . . . -110.54 123.67 50.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.389 -0.368 . . . . 54.5 111.65 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 224' ' ' VAL . 43.1 t -99.95 138.19 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.452 -0.34 . . . . 75.5 110.852 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -146.44 151.3 37.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 75.329999999999998 110.967 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.499 ' HB3' HD11 ' A' ' 208' ' ' ILE . 16.8 ptt-85 -120.01 152.58 37.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 74.209999999999994 110.681 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.523 HG12 ' HG2' ' A' ' 205' ' ' LYS . 37.6 mt -106.35 86.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.394 0.616 . . . . 74.099999999999994 110.11 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -104.97 120.47 41.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.654 -0.703 . . . . 63.25 110.38 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 59.34 30.89 20.67 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.081 0.467 . . . . 71.439999999999998 111.701 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.72 -9.24 77.87 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.327 -0.397 . . . . 74.319999999999993 113.628 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -95.26 125.4 39.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.358 0.503 . . . . 73.349999999999994 112.358 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.523 ' HG2' HG12 ' A' ' 200' ' ' ILE . 98.7 mttt -84.36 96.27 9.0 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.902 0.382 . . . . 71.120000000000005 110.221 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.58 129.68 24.56 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.374 -0.376 . . . . 73.420000000000002 111.989 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.3 125.56 11.45 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.892 2.394 . . . . 72.129999999999995 113.063 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 199' ' ' ARG . 68.5 mt -97.67 126.08 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 111.357 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.46 136.21 18.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.153 -0.546 . . . . 54.119999999999997 112.46 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 98.9 m95 -59.6 -21.0 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.182 0.515 . . . . 72.530000000000001 111.464 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -79.02 -12.52 60.03 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.549 -0.75 . . . . 72.209999999999994 112.671 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.1 m -79.27 145.83 33.33 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.773 0.32 . . . . 73.450000000000003 111.762 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.0 m-20 -64.19 134.41 54.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 73.540000000000006 111.5 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tt -67.56 -19.11 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.038 0.447 . . . . 73.329999999999998 111.218 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 88.5 p -60.26 -29.23 68.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.203 0.446 . . . . 61.439999999999998 112.203 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -60.01 -27.0 66.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.395 0.617 . . . . 73.239999999999995 111.125 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -104.69 15.54 27.75 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 111.772 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.4 m -56.3 109.43 0.6 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.664 0.616 . . . . 71.230000000000004 112.664 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.79 -17.06 50.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.79 0.676 . . . . 72.530000000000001 114.79 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.62 173.41 6.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.025 0.913 . . . . 73.540000000000006 112.501 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 35.8 mt-10 -105.59 124.4 49.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.886 -0.597 . . . . 65.430000000000007 111.868 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.484 HD13 HG21 ' A' ' 159' ' ' VAL . 47.5 mt -98.3 160.14 14.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.031 0.443 . . . . 72.319999999999993 111.462 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -129.56 120.04 24.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.525 -0.307 . . . . 71.319999999999993 110.648 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 197' ' ' VAL . 24.5 t -116.12 138.32 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 73.409999999999997 111.507 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.524 ' HA ' ' HG3' ' A' ' 162' ' ' PRO . 9.9 pt-20 -138.76 152.91 48.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.959 0.409 . . . . 74.430000000000007 111.598 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 45.8 t -81.71 143.52 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.887 0.375 . . . . 71.25 111.713 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.436 HD22 ' HB2' ' A' ' 196' ' ' ALA . 87.9 mt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.18 0.514 . . . . 74.299999999999997 110.982 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HB3' ' HD2' ' A' ' 155' ' ' PRO . 66.9 mttm . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 112.098 0.407 . . . . 74.340000000000003 112.098 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 154' ' ' LYS . 41.7 Cg_endo -65.25 146.7 86.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.679 2.252 . . . . 74.329999999999998 113.368 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.51 HD13 HG13 ' A' ' 168' ' ' VAL . 40.0 pt -130.06 167.82 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.455 0.645 . . . . 75.040000000000006 112.634 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.82 133.66 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 71.329999999999998 109.968 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 57.5 mtp180 -105.09 106.17 16.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.121 0.486 . . . . 74.409999999999997 111.594 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -109.57 128.83 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.541 0.571 . . . . 73.409999999999997 112.541 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.56 115.12 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.24 -0.436 . . . . 75.099999999999994 110.93 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -89.97 155.45 47.4 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 111.65 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.46 141.55 68.07 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.6 2.2 . . . . 65.530000000000001 113.346 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 72.57 65.6 0.12 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.788 0.835 . . . . 62.450000000000003 112.676 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 58.2 41.38 23.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.013 0.746 . . . . 74.519999999999996 113.013 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -129.06 152.76 48.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.23 0.538 . . . . 72.209999999999994 111.831 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.424 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -157.41 146.44 19.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.03 -0.532 . . . . 74.450000000000003 110.572 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -156.32 147.44 22.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.178 0.513 . . . . 74.540000000000006 111.821 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.51 HG13 HD13 ' A' ' 156' ' ' ILE . 99.3 t -109.92 122.34 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.11 -0.495 . . . . 73.409999999999997 111.372 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.468 HG22 HD12 ' A' ' 214' ' ' ILE . 12.2 m -118.25 138.04 25.22 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.35 -0.386 . . . . 71.040000000000006 111.553 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 34.0 Cg_exo -60.8 139.33 84.72 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.93 2.42 . . . . 71.209999999999994 113.946 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.29 103.91 13.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.24 -0.436 . . . . 72.239999999999995 111.648 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -124.39 141.87 51.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.451 -0.34 . . . . 75.319999999999993 111.271 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.2 t -74.98 151.04 38.83 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.667 0.27 . . . . 55.210000000000001 110.771 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.11 -37.18 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.011 -0.614 . . . . 51.130000000000003 112.572 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 214' ' ' ILE . 55.8 t -80.41 113.3 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.911 0.386 . . . . 74.230000000000004 110.582 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 72.0 p -75.83 159.78 30.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.547 -0.297 . . . . 55.219999999999999 111.454 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -30.45 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.611 0.72 . . . . 72.340000000000003 110.565 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 51.3 ttt180 -66.68 -48.65 68.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.533 -0.758 . . . . 75.120000000000005 111.337 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 5.2 t70 -75.86 -24.23 55.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 73.230000000000004 111.679 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 92.8 p -74.0 -48.58 29.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.024 0.44 . . . . 73.040000000000006 111.154 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.62 -4.02 59.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 73.510000000000005 112.858 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 18.0 ptmt -53.86 -45.49 70.99 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 111.868 0.321 . . . . 74.530000000000001 111.868 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.17 -25.79 47.35 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.143 -0.348 . . . . 75.299999999999997 111.675 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.63 82.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.225 0.536 . . . . 74.25 110.857 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.8 mt -79.09 -31.74 44.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.191 -0.459 . . . . 71.319999999999993 110.808 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -54.97 -47.84 74.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.505 -0.316 . . . . 74.200000000000003 111.27 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.9 ptp -68.66 -7.88 37.28 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.125 0.417 . . . . 73.340000000000003 112.125 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -101.3 -16.22 17.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.887 0.375 . . . . 74.319999999999993 111.163 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.4 30.15 25.54 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.305 -0.474 . . . . 62.310000000000002 112.727 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.8 173.55 6.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.867 0.365 . . . . 54.210000000000001 111.496 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.74 146.37 56.89 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.437 -0.347 . . . . 73.109999999999999 110.693 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.7 -41.82 74.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.604 2.203 . . . . 73.109999999999999 113.61 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.4 mp0 -63.63 -12.11 30.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.524 0.564 . . . . 75.120000000000005 112.524 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.54 -8.4 50.37 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.93 0.395 . . . . 71.230000000000004 111.563 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.6 m -123.5 171.75 9.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 70.409999999999997 112.055 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.408 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -143.68 129.72 19.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.43 -0.35 . . . . 71.439999999999998 111.286 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 224' ' ' VAL . 54.3 t -95.26 121.05 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.516 -0.311 . . . . 65.420000000000002 111.097 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -132.27 145.11 51.07 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.178 0.513 . . . . 75.25 111.254 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.536 ' HG2' HD11 ' A' ' 208' ' ' ILE . 40.2 ptt180 -122.83 161.37 24.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.046 0.45 . . . . 74.439999999999998 111.163 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.453 HG12 ' HG2' ' A' ' 205' ' ' LYS . 52.7 mt -110.14 101.62 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.147 -0.479 . . . . 72.209999999999994 110.682 177.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -120.29 123.78 44.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.994 -0.548 . . . . 65.239999999999995 110.543 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.66 30.45 19.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.202 0.525 . . . . 74.510000000000005 110.948 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 -12.41 54.45 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.036 -0.529 . . . . 75.019999999999996 113.361 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.8 120.33 25.91 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.15 0.426 . . . . 75.120000000000005 112.15 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG2' HG12 ' A' ' 200' ' ' ILE . 87.5 mttt -86.34 101.41 13.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.285 -0.416 . . . . 72.530000000000001 110.535 172.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -121.9 120.88 28.31 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 120.611 0.243 . . . . 63.200000000000003 111.432 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.62 126.15 13.07 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.714 2.276 . . . . 74.400000000000006 113.319 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.536 HD11 ' HG2' ' A' ' 199' ' ' ARG . 3.6 mp -86.63 131.68 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.404 -0.362 . . . . 75.049999999999997 110.381 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.55 133.16 41.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.79 -0.719 . . . . 73.140000000000001 112.937 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -57.74 -22.05 44.51 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.071 0.462 . . . . 71.420000000000002 111.936 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.12 -10.74 59.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.426 0.528 . . . . 75.209999999999994 112.426 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.9 m -75.21 137.93 41.6 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.783 0.29 . . . . 71.310000000000002 111.783 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -62.04 130.26 44.73 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.875 0.369 . . . . 74.510000000000005 111.008 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.468 HD12 HG22 ' A' ' 169' ' ' VAL . 9.8 tt -60.99 -23.67 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.014 0.435 . . . . 65.049999999999997 111.96 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 80.9 p -59.12 -24.98 63.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.295 0.48 . . . . 72.219999999999999 112.295 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -67.27 -27.48 67.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.961 0.356 . . . . 75.340000000000003 111.961 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 208' ' ' ILE . 51.3 mt -109.09 37.81 2.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.239 0.542 . . . . 74.519999999999996 111.712 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.6 m -67.36 120.2 13.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.73 0.641 . . . . 73.340000000000003 112.73 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.18 81.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 115.255 0.862 . . . . 74.420000000000002 115.255 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.65 172.1 7.92 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.187 0.993 . . . . 65.219999999999999 111.989 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.4 mt-10 -108.61 114.52 28.4 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.941 -0.572 . . . . 74.209999999999994 111.635 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 83.2 mt -94.81 157.53 15.89 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.102 0.477 . . . . 73.010000000000005 111.694 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -127.85 134.03 49.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.494 -0.321 . . . . 73.510000000000005 110.152 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 197' ' ' VAL . 48.0 t -119.74 136.05 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.371 0.508 . . . . 74.230000000000004 112.371 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.67 173.93 7.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.186 -0.461 . . . . 75.519999999999996 110.597 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.6 t -100.37 129.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.77 0.319 . . . . 75.109999999999999 111.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.0 mt . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.629 0.252 . . . . 75.040000000000006 111.425 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 112.581 0.586 . . . . 73.349999999999994 112.581 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.22 136.46 72.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.956 2.437 . . . . 73.340000000000003 113.096 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.93 162.71 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.455 0.645 . . . . 73.140000000000001 112.566 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 171' ' ' ALA . 47.3 t -130.88 130.47 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.549 -0.75 . . . . 73.239999999999995 109.847 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -98.66 101.16 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.987 0.422 . . . . 71.310000000000002 111.597 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 222' ' ' LEU . 42.9 t -96.3 117.54 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.922 0.391 . . . . 74.420000000000002 111.964 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -91.75 117.57 29.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.967 0.413 . . . . 74.519999999999996 111.196 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -97.68 160.17 29.25 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.274 -0.421 . . . . 72.120000000000005 111.431 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.76 173.02 6.12 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.397 2.065 . . . . 72.120000000000005 112.324 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 64.34 28.31 13.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.999 0.428 . . . . 73.239999999999995 111.72 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 64.13 34.86 10.74 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.891 -0.595 . . . . 74.010000000000005 111.964 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -110.33 160.76 16.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.003 0.43 . . . . 74.340000000000003 111.465 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -156.62 153.73 29.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.825 0.345 . . . . 74.310000000000002 111.182 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -152.11 137.31 17.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 111.843 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.4 t -104.77 120.78 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.39 -0.368 . . . . 72.430000000000007 110.553 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.36 151.77 48.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 111.871 0.323 . . . . 64.329999999999998 111.871 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 129.18 13.2 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.562 2.175 . . . . 63.130000000000003 113.357 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.401 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -78.79 112.31 15.8 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.219 -0.446 . . . . 52.520000000000003 111.493 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.67 159.59 33.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.534 0.334 . . . . 74.409999999999997 111.452 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -95.28 147.54 23.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.688 0.28 . . . . 75.530000000000001 110.533 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.14 -25.3 6.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.696 -0.764 . . . . 63.520000000000003 112.262 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.58 111.82 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 110.528 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 76.6 p -75.91 157.71 32.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.267 -0.424 . . . . 71.230000000000004 111.594 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.8 t -53.8 -40.9 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.261 0.553 . . . . 72.129999999999995 110.782 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 48.2 ttp180 -61.25 -37.81 84.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.571 -0.74 . . . . 74.040000000000006 111.424 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.47 -53.85 7.54 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.967 -0.56 . . . . 71.329999999999998 111.518 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.7 t -57.94 -41.14 82.17 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.222 0.453 . . . . 73.239999999999995 112.222 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.9 mt -80.76 6.57 12.55 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.957 0.725 . . . . 75.219999999999999 112.957 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HZ1' ' HB3' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -55.06 -36.64 65.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.992 0.425 . . . . 74.140000000000001 110.878 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -67.35 -37.45 83.25 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.231 -0.441 . . . . 74.219999999999999 111.571 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.528 ' HA ' ' HE2' ' A' ' 187' ' ' MET . . . -70.62 -50.9 32.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.986 0.422 . . . . 73.25 110.899 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 88.4 mt -55.45 -42.91 74.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.87 -0.605 . . . . 75.040000000000006 111.241 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 52.6 ttm -59.45 -57.16 14.21 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.779 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 184' ' ' ALA . 27.2 ptt? -68.8 -23.13 64.24 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.462 0.541 . . . . 73.129999999999995 112.462 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -103.99 3.32 33.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.794 0.665 . . . . 73.340000000000003 112.794 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.04 48.5 85.6 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.149 -0.548 . . . . 73.310000000000002 113.559 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 89.3 mt -127.5 159.84 33.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.899 0.381 . . . . 73.400000000000006 111.467 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.74 154.79 73.33 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.491 -0.322 . . . . 75.010000000000005 111.168 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.12 -31.86 29.85 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.188 2.592 . . . . 75.049999999999997 114.525 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.65 -15.3 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.992 -0.443 . . . . 75.030000000000001 112.135 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.18 -8.74 29.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.014 0.375 . . . . 74.409999999999997 112.014 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 77.7 m -142.55 149.33 38.95 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.0 0.429 . . . . 75.120000000000005 111.869 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.79 134.53 55.2 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.29 -0.414 . . . . 54.450000000000003 111.429 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.545 HG21 HG22 ' A' ' 224' ' ' VAL . 34.1 t -108.4 125.05 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 122.529 0.331 . . . . 70.430000000000007 111.075 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.9 152.0 46.07 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.89 0.376 . . . . 74.540000000000006 111.338 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 199' ' ' ARG . 6.8 ptt180 -122.92 154.97 37.64 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.321 -0.251 . . . . 74.5 110.321 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.6 mt -110.85 131.4 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.211 0.529 . . . . 74.430000000000007 111.84 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.668 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 27.1 tt0 -137.7 119.62 15.35 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.093 -0.503 . . . . 72.519999999999996 110.79 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.46 16.28 3.18 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.420000000000002 112.144 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.59 -10.02 38.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 121.331 -0.461 . . . . 62.039999999999999 114.159 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 12.3 pt-20 -88.02 134.66 33.69 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.948 0.874 . . . . 75.549999999999997 111.924 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.74 103.81 15.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.455 -0.338 . . . . 75.319999999999993 110.425 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.49 113.7 65.56 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 111.905 0.335 . . . . 75.540000000000006 111.905 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.04 113.07 2.05 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.969 2.446 . . . . 65.109999999999999 112.14 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.71 129.25 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 70.329999999999998 111.484 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.55 126.13 21.4 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.678 -0.773 . . . . 62.049999999999997 112.259 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 73.7 m95 -52.05 -28.69 18.22 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.84 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.74 14.94 2.87 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.751 0.649 . . . . 72.099999999999994 112.751 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 56.6 m -93.28 140.74 29.21 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.031 -0.418 . . . . 75.129999999999995 111.707 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.85 122.12 13.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.98 0.419 . . . . 72.019999999999996 111.223 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.0 -19.51 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.597 0.591 . . . . 64.140000000000001 112.597 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 33.8 t -61.11 -19.68 61.76 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.053 0.39 . . . . 71.209999999999994 112.053 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -78.23 -8.04 57.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.904 0.335 . . . . 75.5 111.904 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 42.6 mt -110.67 18.97 19.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.141 0.496 . . . . 72.25 111.412 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -61.56 123.17 17.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.914 0.709 . . . . 62.119999999999997 112.914 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.35 -37.33 3.61 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.712 0.645 . . . . 62.229999999999997 114.712 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.78 172.62 7.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.629 0.715 . . . . 73.420000000000002 112.684 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -93.75 139.55 30.71 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.581 -0.736 . . . . 74.120000000000005 112.596 -173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 159' ' ' VAL . 54.6 mt -103.57 140.63 37.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.066 -0.516 . . . . 73.329999999999998 110.542 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -115.51 117.37 30.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.513 -0.312 . . . . 73.519999999999996 110.565 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.545 HG22 HG21 ' A' ' 197' ' ' VAL . 39.8 t -112.6 129.42 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.759 0.314 . . . . 73.030000000000001 111.547 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.21 155.02 51.38 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.928 0.394 . . . . 73.230000000000004 111.348 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.93 130.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.564 0.579 . . . . 64.319999999999993 112.564 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.536 0.413 0 CA-C-N 115.831 -0.622 . . . . 71.439999999999998 110.73 175.587 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.474 0.178 . . . . 74.409999999999997 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 135.69 23.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.263 1.975 . . . . 74.299999999999997 111.496 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.29 163.27 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 113.133 0.79 . . . . 72.319999999999993 113.133 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.5 t -122.54 137.29 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.851 -0.613 . . . . 71.040000000000006 110.917 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.423 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 71.8 mtt85 -96.78 101.4 12.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 74.120000000000005 111.312 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 181' ' ' LEU . 60.3 t -102.03 125.73 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.966 0.412 . . . . 73.140000000000001 111.726 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -91.52 106.4 18.46 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.35 -0.386 . . . . 74.120000000000005 111.175 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.8 mt -80.09 153.25 74.65 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.302 -0.408 . . . . 75.439999999999998 111.208 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 72.5 Cg_exo -49.96 140.45 31.47 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.896 2.397 . . . . 72.120000000000005 113.921 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 86.1 m-20 75.96 46.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.486 0.714 . . . . 71.030000000000001 112.47 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 64.2 20.32 12.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.773 0.657 . . . . 73.030000000000001 112.773 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.4 mm-40 -89.35 141.56 28.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 72.109999999999999 111.188 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -117.64 143.06 46.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.246 0.546 . . . . 75.439999999999998 111.877 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 159' ' ' VAL . 9.2 t -145.5 137.93 25.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.826 -0.625 . . . . 74.519999999999996 110.724 172.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.21 120.26 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.672 0.272 . . . . 72.019999999999996 110.833 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 31.2 m -114.62 147.87 39.07 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 75.439999999999998 111.813 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 11.4 Cg_exo -71.55 125.0 10.78 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.789 2.326 . . . . 75.329999999999998 112.695 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 120.81 17.61 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 111.754 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 61.9 mtt-85 -127.13 159.39 34.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.368 -0.378 . . . . 70.409999999999997 111.087 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.3 t -99.17 139.32 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.445 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.77 84.1 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.765 -0.731 . . . . 71.420000000000002 112.006 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.8 t -127.1 119.3 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.952 0.501 . . . . 74.439999999999998 110.269 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.9 p -80.43 168.48 18.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.257 0.551 . . . . 72.530000000000001 112.201 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.75 -37.92 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.352 0.596 . . . . 74.409999999999997 110.236 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.528 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 21.3 ttt85 -63.91 -35.19 79.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.664 -0.698 . . . . 75.420000000000002 111.094 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.541 ' HA ' ' HE2' ' A' ' 182' ' ' LYS . 2.1 m-20 -76.53 -51.97 10.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.392 -0.367 . . . . 71.450000000000003 111.707 175.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -56.0 -42.73 76.87 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.111 0.411 . . . . 73.519999999999996 112.111 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 159' ' ' VAL . 78.9 mt -92.08 -10.04 40.46 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.812 1.042 . . . . 74.219999999999999 113.812 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.61 ' HZ1' ' HB3' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -58.12 -28.71 64.9 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.909 0.777 . . . . 70.0 111.483 -176.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.82 -45.61 64.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.095 0.474 . . . . 75.219999999999999 110.607 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.54 90.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.949 -0.568 . . . . 74.209999999999994 111.665 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.66 -47.32 69.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 72.519999999999996 110.797 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.7 ttm -57.48 -39.13 75.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.002 -0.544 . . . . 60.0 112.245 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.8 ptm -75.26 -21.69 58.37 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.071 -0.393 . . . . 75.409999999999997 111.906 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -96.25 -13.68 23.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.097 0.406 . . . . 75.219999999999999 112.097 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.22 41.51 10.17 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.95 -0.643 . . . . 73.420000000000002 112.479 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.31 158.26 34.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.683 0.393 . . . . 74.409999999999997 110.829 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.2 pt -133.33 137.7 29.77 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.682 -0.235 . . . . 72.319999999999993 111.342 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.6 -44.31 35.95 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.172 2.581 . . . . 73.25 113.654 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.02 -21.65 59.41 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.522 0.564 . . . . 70.409999999999997 112.522 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.515 ' SG ' HG13 ' A' ' 226' ' ' VAL . 32.7 t -101.18 -12.42 18.77 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.948 0.404 . . . . 74.200000000000003 112.014 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.9 m -119.55 164.41 15.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.173 0.511 . . . . 72.120000000000005 111.983 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.83 133.82 38.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.439 -0.346 . . . . 74.129999999999995 111.909 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 224' ' ' VAL . 68.0 t -98.79 138.54 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.731 0.301 . . . . 73.329999999999998 110.816 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.75 158.86 41.58 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.179 0.514 . . . . 74.129999999999995 111.738 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.553 ' HG2' ' HB3' ' A' ' 206' ' ' LYS . 6.4 ptm180 -110.11 154.25 23.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.873 -0.603 . . . . 71.439999999999998 110.111 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.433 HG12 ' HG2' ' A' ' 205' ' ' LYS . 59.0 mt -118.62 120.65 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.985 0.421 . . . . 64.230000000000004 111.575 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -154.78 144.28 21.36 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.031 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 57.06 31.44 19.95 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.334 0.588 . . . . 70.150000000000006 111.22 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.66 -19.66 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.874 -0.603 . . . . 54.329999999999998 113.82 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.06 170.27 8.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.575 0.702 . . . . 75.420000000000002 112.732 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.0 mttp -113.45 139.58 48.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.32 -0.855 . . . . 73.310000000000002 110.947 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.553 ' HB3' ' HG2' ' A' ' 199' ' ' ARG . 87.4 tttt -114.69 105.35 53.54 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.662 -0.245 . . . . 72.219999999999999 110.593 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -61.96 113.38 1.84 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.789 2.326 . . . . 73.150000000000006 112.412 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 217' ' ' LEU . 61.2 mt -96.64 134.22 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.540000000000006 111.615 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.3 135.17 29.3 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.145 -0.55 . . . . 72.420000000000002 113.039 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 75.9 m95 -55.34 -43.42 74.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.712 0.634 . . . . 74.430000000000007 112.712 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.56 27.93 0.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.85 0.685 . . . . 61.439999999999998 112.85 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 48.7 m -92.51 137.62 32.21 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 122.354 -0.216 . . . . 71.439999999999998 110.612 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.99 124.15 15.85 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.926 0.394 . . . . 74.349999999999994 111.794 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.25 -24.21 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.178 -0.465 . . . . 75.540000000000006 111.698 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 t -56.54 -30.61 63.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.115 0.413 . . . . 74.120000000000005 112.115 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.68 -19.1 65.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.842 0.353 . . . . 73.019999999999996 111.939 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 208' ' ' ILE . 44.0 mt -115.45 19.13 15.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.173 0.511 . . . . 75.540000000000006 111.676 -173.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' THR . . . . . 0.538 ' HA ' HG22 ' A' ' 157' ' ' VAL . 75.5 m -61.38 132.0 52.08 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.547 0.573 . . . . 73.010000000000005 112.547 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 93.4 -22.07 37.18 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.717 0.647 . . . . 74.420000000000002 114.717 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.16 172.78 6.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.684 0.742 . . . . 74.040000000000006 112.677 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 42.4 mt-10 -105.91 114.7 29.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.755 -0.657 . . . . 72.540000000000006 111.765 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.03 164.3 13.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.138 0.494 . . . . 75.540000000000006 111.291 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -131.7 139.1 48.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.839 0.352 . . . . 73.439999999999998 111.472 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 197' ' ' VAL . 46.4 t -123.12 126.38 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.107 -0.497 . . . . 63.049999999999997 110.746 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.72 145.72 46.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.397 . . . . 75.310000000000002 111.274 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.515 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.7 t -83.87 103.09 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 110.079 -0.341 . . . . 74.420000000000002 110.079 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.983 0.42 . . . . 75.430000000000007 111.692 -176.44 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.639 ' H ' ' HD3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 120.602 0.239 . . . . 74.219999999999999 111.392 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.59 131.03 31.82 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.663 2.242 . . . . 75.25 112.793 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.03 156.68 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.223 0.535 . . . . 72.120000000000005 112.173 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' A' ' 171' ' ' ALA . 56.7 t -122.39 131.27 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.69 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.505 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 99.9 mtt180 -84.92 134.89 34.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.522 -0.308 . . . . 75.109999999999999 110.891 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.55 HG22 HD21 ' A' ' 181' ' ' LEU . 59.7 t -130.18 119.51 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.1 0.476 . . . . 75.25 111.676 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -93.93 114.43 26.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.129 -0.487 . . . . 72.439999999999998 111.037 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 87.9 mt -98.19 158.33 32.93 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.088 -0.506 . . . . 74.420000000000002 111.181 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 172.2 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.27 1.98 . . . . 75.109999999999999 111.886 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 62.46 23.23 13.77 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.09 0.471 . . . . 74.299999999999997 110.778 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 63.02 26.91 15.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.513 0.725 . . . . 64.349999999999994 112.332 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 79.3 mm-40 -88.02 152.49 22.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.193 0.521 . . . . 74.5 111.98 -177.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -132.78 139.18 47.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.239 -0.437 . . . . 74.030000000000001 110.96 -176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.3 t -152.45 148.52 27.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.889 0.376 . . . . 74.209999999999994 111.745 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.7 129.7 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.87 0.366 . . . . 74.0 111.057 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.33 154.55 72.16 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.603 -0.271 . . . . 74.310000000000002 111.723 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 141.07 24.53 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.524 2.149 . . . . 73.209999999999994 113.163 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -103.4 122.23 44.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.942 0.349 . . . . 54.509999999999998 111.942 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -133.89 152.28 51.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.976 0.417 . . . . 75.530000000000001 111.817 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.3 t -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 111.007 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.2 -25.77 16.14 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.961 -0.638 . . . . 73.219999999999999 112.741 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.2 t -82.59 125.93 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.777 0.323 . . . . 73.530000000000001 110.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 45.5 p -84.25 164.49 19.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.199 0.523 . . . . 74.150000000000006 112.041 -177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 210' ' ' TRP . 61.4 t -59.2 -33.07 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.397 0.618 . . . . 72.030000000000001 110.722 174.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -63.48 -53.63 48.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.934 -0.575 . . . . 72.519999999999996 110.776 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 59.3 m-20 -59.81 -38.61 82.44 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.231 0.456 . . . . 75.400000000000006 112.231 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.0 p -76.59 -31.22 57.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.92 0.711 . . . . 60.109999999999999 112.92 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.55 HD21 HG22 ' A' ' 159' ' ' VAL . 71.5 mt -106.45 -20.49 13.36 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.498 1.296 . . . . 65.400000000000006 114.498 -174.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 22.7 pttp -54.61 -33.67 60.84 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.427 0.899 . . . . 75.239999999999995 113.427 -172.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.99 -44.78 53.47 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.082 -0.386 . . . . 73.140000000000001 111.05 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.42 69.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.334 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.556 HD13 ' CH2' ' A' ' 210' ' ' TRP . 86.4 mt -69.2 -48.96 60.63 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.033 -0.53 . . . . 62.200000000000003 110.901 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.0 tpt -56.84 -45.64 82.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.88 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -70.09 -8.81 52.49 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.557 0.577 . . . . 73.150000000000006 112.557 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.46 -20.61 12.15 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.954 0.353 . . . . 73.299999999999997 111.954 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.51 38.22 3.07 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.161 -0.542 . . . . 51.329999999999998 113.571 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . 0.408 ' HB3' ' SG ' ' A' ' 195' ' ' CYS . 5.0 mp -122.05 169.63 10.65 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.451 -0.441 . . . . 72.540000000000006 111.59 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.87 134.58 13.02 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.04 -0.527 . . . . 72.329999999999998 110.562 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.56 -39.9 73.9 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.792 2.328 . . . . 75.319999999999993 113.708 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.33 -11.1 56.77 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.11 0.781 . . . . 75.409999999999997 113.11 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.41 9.94 9.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.985 0.421 . . . . 60.350000000000001 111.467 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 190' ' ' LEU . 73.3 m -123.43 144.06 49.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.769 0.318 . . . . 74.430000000000007 111.611 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -122.46 119.47 31.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.524 -0.307 . . . . 75.219999999999999 111.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 224' ' ' VAL . 25.1 t -98.75 134.07 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.699 -0.228 . . . . 72.340000000000003 110.899 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.446 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 47.9 p90 -138.5 155.49 48.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.301 0.572 . . . . 74.310000000000002 111.715 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -121.27 152.17 39.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.686 -0.688 . . . . 73.420000000000002 111.192 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.5 mt -105.8 97.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.815 0.34 . . . . 73.129999999999995 110.795 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 12.8 pt20 -112.23 128.54 56.28 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.618 -0.265 . . . . 74.310000000000002 110.92 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.0 t70 60.16 19.09 8.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.546 0.689 . . . . 72.200000000000003 111.687 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.13 72.42 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.197 -0.525 . . . . 65.310000000000002 113.295 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.06 126.24 52.08 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.525 -0.397 . . . . 73.420000000000002 111.273 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 58.1 mtpt -80.68 94.4 6.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.069 0.461 . . . . 75.340000000000003 110.677 174.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -94.29 118.4 67.07 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 111.389 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.1 148.83 87.91 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.67 2.247 . . . . 72.430000000000007 112.559 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.493 HD12 HG11 ' A' ' 197' ' ' VAL . 50.1 mt -118.07 148.52 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.841 0.353 . . . . 71.519999999999996 111.222 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.38 139.05 14.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.953 -0.642 . . . . 63.100000000000001 112.13 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.556 ' CH2' HD13 ' A' ' 185' ' ' LEU . 94.2 m95 -62.7 -23.28 67.07 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.359 -0.495 . . . . 73.349999999999994 111.543 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.41 15.14 11.19 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.018 -0.537 . . . . 74.409999999999997 112.032 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 177' ' ' VAL . 69.0 m -96.2 147.53 23.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.397 0.279 . . . . 74.120000000000005 110.952 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.427 ' HB2' ' HD1' ' A' ' 216' ' ' TRP . 5.1 m-20 -65.13 126.65 28.75 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.166 0.508 . . . . 72.049999999999997 111.87 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 217' ' ' LEU . 9.5 tp -62.03 -20.64 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 116.128 -0.487 . . . . 63.329999999999998 111.366 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.6 p -60.63 -23.19 64.56 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.441 -0.345 . . . . 73.239999999999995 111.903 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . 0.427 ' HD1' ' HB2' ' A' ' 213' ' ' ASP . 42.3 m95 -70.37 -20.13 62.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.038 0.446 . . . . 75.400000000000006 111.739 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.637 HD11 HD13 ' A' ' 214' ' ' ILE . 23.2 mt -104.97 9.81 34.41 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.098 -0.501 . . . . 75.209999999999994 111.748 -174.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.0 m -56.64 109.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.646 0.61 . . . . 75.310000000000002 112.646 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.53 1.61 60.44 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.097 -0.573 . . . . 72.319999999999993 113.981 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -103.65 158.96 16.01 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.478 . . . . 72.540000000000006 111.826 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.3 mt-10 -105.72 114.82 29.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.067 0.461 . . . . 74.129999999999995 110.683 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 mt -92.8 156.11 17.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 75.439999999999998 111.715 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -129.33 132.55 47.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 72.140000000000001 110.197 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 197' ' ' VAL . 58.5 t -109.73 123.62 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.22 0.452 . . . . 72.349999999999994 112.22 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -100.66 157.39 16.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.178 -0.464 . . . . 72.0 111.228 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.55 130.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.741 0.305 . . . . 62.329999999999998 111.016 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 196' ' ' ALA . 89.1 mt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 111.802 0.297 . . . . 64.530000000000001 111.802 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.713 0.292 . . . . 73.519999999999996 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.76 128.55 19.14 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.46 2.107 . . . . 75.310000000000002 112.013 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.72 157.14 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.531 0.681 . . . . 72.0 112.76 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.77 135.37 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.436 -0.802 . . . . 74.209999999999994 110.186 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.43 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 50.0 mtt180 -90.32 98.56 11.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.936 0.398 . . . . 75.129999999999995 110.803 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.673 HG22 HD22 ' A' ' 181' ' ' LEU . 60.5 t -96.78 108.01 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.34 0.59 . . . . 74.510000000000005 111.806 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 73.1 m-85 -76.53 104.09 6.86 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.041 0.448 . . . . 65.519999999999996 110.762 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.39 157.87 89.15 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.931 -0.577 . . . . 74.349999999999994 112.274 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 11.1 Cg_endo -54.1 160.09 6.74 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.668 2.246 . . . . 63.25 112.843 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 65.0 t30 68.57 31.34 4.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.536 0.684 . . . . 64.400000000000006 110.839 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 65.6 23.03 11.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.31 -0.859 . . . . 74.319999999999993 113.031 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.92 -177.04 4.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.99 0.424 . . . . 75.349999999999994 111.776 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 28.1 ptt180 -157.84 156.86 32.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.162 0.505 . . . . 72.219999999999999 111.902 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.3 t -156.27 160.51 39.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.997 -0.547 . . . . 73.049999999999997 110.352 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.8 t -116.53 119.75 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.757 0.313 . . . . 74.120000000000005 111.041 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.23 152.67 49.37 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 111.852 0.315 . . . . 73.239999999999995 111.852 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.59 147.66 32.08 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.491 2.128 . . . . 65.310000000000002 113.273 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -103.67 126.73 51.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.959 0.409 . . . . 64.129999999999995 111.69 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -128.74 146.18 50.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.98 0.419 . . . . 63.119999999999997 111.623 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.69 132.21 40.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.834 0.35 . . . . 73.540000000000006 110.896 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.06 -23.7 30.14 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.076 -0.583 . . . . 44.340000000000003 112.437 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.26 125.26 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 111.131 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.0 p -82.74 165.92 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.93 0.395 . . . . 74.150000000000006 111.491 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 212' ' ' THR . 62.0 t -56.96 -32.38 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.352 0.596 . . . . 73.209999999999994 110.243 172.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 4.2 tmt_? -68.04 -45.77 73.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.703 -0.681 . . . . 65.310000000000002 111.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -67.83 -33.42 74.75 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.918 0.39 . . . . 72.129999999999995 111.669 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.0 t -74.31 -44.01 54.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.25 0.463 . . . . 64.140000000000001 112.25 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 159' ' ' VAL . 68.3 mt -95.79 -4.78 43.27 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.72 1.007 . . . . 71.540000000000006 113.72 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -58.24 -43.51 87.82 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.246 0.461 . . . . 74.319999999999993 112.246 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -80.92 -27.85 36.03 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 111.022 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.77 92.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.209 0.528 . . . . 74.439999999999998 111.173 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.27 -29.7 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.309 -0.405 . . . . 73.430000000000007 111.108 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.423 ' C ' ' SD ' ' A' ' 186' ' ' MET . 0.2 OUTLIER -54.63 -48.08 72.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.33 -0.396 . . . . 71.310000000000002 111.293 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -64.99 -19.12 65.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.023 0.379 . . . . 70.25 112.023 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -87.37 -5.97 58.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.774 0.321 . . . . 74.430000000000007 111.317 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.15 16.22 70.09 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.394 -0.431 . . . . 54.509999999999998 112.665 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.9 mt -117.3 171.76 7.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.016 0.436 . . . . 73.310000000000002 111.622 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 25.4 pt -133.44 143.9 49.97 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 116.086 -0.506 . . . . 74.219999999999999 111.039 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.81 -29.69 82.06 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.749 2.299 . . . . 75.340000000000003 112.941 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.34 -32.38 68.46 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.998 -0.546 . . . . 74.019999999999996 111.934 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.28 9.96 31.86 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.365 0.506 . . . . 64.120000000000005 112.365 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.0 m -118.27 166.87 12.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.98 0.419 . . . . 74.519999999999996 111.614 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HB2' HD22 ' A' ' 227' ' ' LEU . . . -132.08 138.9 48.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 73.120000000000005 111.335 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 224' ' ' VAL . 61.9 t -111.17 132.11 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.288 -0.414 . . . . 74.230000000000004 111.267 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -139.06 146.89 41.33 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.252 0.548 . . . . 74.5 111.312 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.523 ' HG2' HD12 ' A' ' 208' ' ' ILE . 9.1 ptm180 -116.62 169.15 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.519999999999996 110.294 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.04 115.69 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 110.101 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.27 119.69 22.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.952 -0.567 . . . . 75.430000000000007 110.253 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.31 27.01 15.96 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.335 0.588 . . . . 64.319999999999993 111.57 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.96 2.51 74.77 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.243 -0.435 . . . . 65.239999999999995 113.882 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.02 133.03 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.428 -0.454 . . . . 64.129999999999995 111.629 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -78.13 99.0 6.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.074 0.464 . . . . 72.439999999999998 110.895 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -93.67 112.09 55.32 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.991 -0.55 . . . . 74.120000000000005 111.859 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.19 110.23 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.92 2.413 . . . . 74.409999999999997 112.654 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.523 HD12 ' HG2' ' A' ' 199' ' ' ARG . 62.6 mt -89.13 138.59 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.26 -0.427 . . . . 73.230000000000004 112.039 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.06 138.59 34.94 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.14 -0.553 . . . . 74.340000000000003 113.219 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.1 m95 -59.45 -22.99 62.32 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.901 0.381 . . . . 70.409999999999997 111.746 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.09 -11.84 60.93 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.095 0.558 . . . . 75.109999999999999 112.228 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.4 ' O ' HG21 ' A' ' 177' ' ' VAL . 20.7 m -75.75 135.11 40.33 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.279 -0.419 . . . . 72.329999999999998 111.892 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.03 127.21 30.29 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.513 -0.312 . . . . 74.510000000000005 111.54 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -61.31 -22.75 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 111.284 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.9 t -54.89 -29.12 55.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.048 -0.524 . . . . 53.310000000000002 112.036 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -68.79 -26.74 65.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.143 0.497 . . . . 75.5 111.496 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 222' ' ' LEU . 51.8 mt -105.47 10.88 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.0 -0.546 . . . . 72.329999999999998 112.104 -172.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 70.7 m -50.38 119.22 3.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.178 0.436 . . . . 61.130000000000003 112.178 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.73 -21.44 45.87 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.276 -0.488 . . . . 75.349999999999994 113.993 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -86.42 172.47 10.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.424 0.63 . . . . 73.010000000000005 112.418 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.1 mt-10 -111.18 119.96 40.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.875 -0.602 . . . . 75.409999999999997 111.249 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 217' ' ' LEU . 77.6 mt -97.39 155.23 17.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 111.116 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -127.52 120.53 28.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.029 -0.36 . . . . 71.200000000000003 110.029 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 197' ' ' VAL . 52.5 t -115.95 140.6 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.1 0.476 . . . . 70.409999999999997 111.711 -175.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 162' ' ' PRO . 12.6 pt-20 -144.26 160.72 40.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.301 -0.409 . . . . 74.120000000000005 110.754 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.78 139.01 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.64 -0.254 . . . . 74.049999999999997 111.166 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 196' ' ' ALA . 96.5 mt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.886 0.328 . . . . 73.400000000000006 111.886 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.587 0.232 . . . . 74.019999999999996 111.103 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.76 120.49 7.68 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.95 1.767 . . . . 72.420000000000002 111.661 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.3 pt -113.94 161.84 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.637 0.732 . . . . 73.329999999999998 112.883 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.45 133.58 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.342 -0.845 . . . . 74.239999999999995 110.275 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -95.99 96.39 8.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.011 0.434 . . . . 72.099999999999994 111.34 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.56 HG21 HD11 ' A' ' 222' ' ' LEU . 41.5 t -94.33 117.17 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.031 0.443 . . . . 75.239999999999995 112.108 -176.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.99 100.13 12.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.188 0.518 . . . . 75.540000000000006 111.112 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 98.1 mt -69.95 161.77 73.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.696 -0.683 . . . . 71.430000000000007 111.614 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 9.8 Cg_endo -52.09 153.24 12.83 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.768 2.312 . . . . 73.530000000000001 113.345 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 61.96 44.6 8.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.495 0.664 . . . . 71.439999999999998 110.901 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 61.47 23.77 13.98 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.096 0.776 . . . . 74.219999999999999 113.096 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.9 mm-40 -86.88 157.76 19.47 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.068 -0.395 . . . . 64.439999999999998 111.101 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -139.74 145.44 38.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.443 0.534 . . . . 74.540000000000006 112.443 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.1 t -148.1 161.9 40.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.795 -0.639 . . . . 72.120000000000005 110.19 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.34 120.32 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.954 0.407 . . . . 72.140000000000001 111.254 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.04 137.05 26.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.461 -0.336 . . . . 75.099999999999994 111.449 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HG2' HH21 ' A' ' 172' ' ' ARG . 65.0 Cg_endo -74.12 126.16 10.32 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 75.549999999999997 113.007 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.74 35.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.092 0.472 . . . . 70.430000000000007 112.165 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.493 HH21 ' HG2' ' A' ' 170' ' ' PRO . 11.5 ptp180 -167.71 161.97 13.69 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.001 -0.545 . . . . 74.209999999999994 111.604 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.7 t -95.47 154.32 17.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.306 -0.407 . . . . 64.329999999999998 111.351 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 66.5 18.66 68.03 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.248 -0.501 . . . . 74.25 113.266 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 172' ' ' ARG . 40.8 t -132.8 124.72 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.644 0.378 . . . . 72.120000000000005 110.468 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.6 p -82.84 158.05 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 64.209999999999994 111.622 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.62 -35.77 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.617 0.722 . . . . 73.329999999999998 110.017 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.9 ttp180 -56.42 -54.65 43.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.948 -1.024 . . . . 73.150000000000006 111.319 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -74.16 -12.53 60.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.18 -0.464 . . . . 72.25 111.718 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.5 m -82.79 -46.78 12.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.037 0.446 . . . . 63.43 110.944 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.72 4.94 48.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.311 0.486 . . . . 64.340000000000003 112.311 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -54.92 -26.63 37.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.878 0.37 . . . . 75.019999999999996 111.8 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.02 -52.11 6.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.68 0.276 . . . . 74.129999999999995 111.556 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.34 64.11 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.005 0.431 . . . . 75.019999999999996 112.117 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.03 -53.78 13.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.934 0.397 . . . . 73.439999999999998 111.483 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.2 tpp -57.05 -42.09 79.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.358 0.503 . . . . 72.430000000000007 112.358 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.3 ptp -66.63 -15.44 63.47 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.118 0.414 . . . . 74.340000000000003 112.118 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -110.14 5.2 21.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 111.551 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.05 35.54 89.34 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.464 -0.398 . . . . 75.329999999999998 113.229 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.6 159.95 15.81 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.086 0.469 . . . . 74.299999999999997 111.54 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.01 151.7 77.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.959 -0.564 . . . . 75.450000000000003 110.816 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.53 -34.3 51.42 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.683 2.255 . . . . 71.319999999999993 113.292 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -64.02 -22.03 66.75 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.2 0.524 . . . . 64.349999999999994 111.906 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.6 t -96.4 -7.49 34.86 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.335 0.494 . . . . 73.150000000000006 112.335 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.4 m -134.89 131.65 37.59 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.683 0.623 . . . . 72.230000000000004 112.683 -172.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -111.31 127.33 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.18 -0.463 . . . . 55.43 111.324 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 224' ' ' VAL . 47.0 t -100.07 133.36 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.536 -0.302 . . . . 75.340000000000003 111.405 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -152.37 160.62 43.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.257 0.551 . . . . 73.439999999999998 111.812 175.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -122.93 155.94 35.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 110.677 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.95 120.75 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.8 0.333 . . . . 75.230000000000004 111.03 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -129.74 115.94 18.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.832 0.349 . . . . 73.030000000000001 111.207 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.1 t70 63.43 31.36 15.07 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.312 0.577 . . . . 73.010000000000005 111.155 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.55 50.25 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.258 -0.496 . . . . 42.009999999999998 114.221 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -102.34 155.7 18.07 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.399 0.599 . . . . 65.040000000000006 112.314 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 205' ' ' LYS . 5.5 mtpm? -103.8 136.19 43.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.739 -0.664 . . . . 73.409999999999997 112.445 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -118.66 116.28 34.9 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 111.205 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.14 121.78 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.02 2.48 . . . . 74.239999999999995 112.911 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.85 122.79 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.171 0.51 . . . . 74.299999999999997 111.478 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.37 145.47 33.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.18 -0.533 . . . . 64.219999999999999 113.206 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.6 m95 -61.93 -27.55 68.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.922 0.391 . . . . 75.430000000000007 111.909 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.87 -10.3 59.31 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.675 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 90.5 m -69.52 136.97 52.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.209999999999994 111.663 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.99 126.23 27.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.89 0.376 . . . . 70.099999999999994 111.272 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . 0.4 HG23 ' H ' ' A' ' 172' ' ' ARG . 12.7 tt -58.43 -19.92 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.977 0.418 . . . . 75.349999999999994 111.894 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -52.42 -33.63 44.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.255 0.465 . . . . 65.209999999999994 112.255 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -65.15 -28.34 69.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.15 0.5 . . . . 73.310000000000002 111.766 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.459 HD13 HD22 ' A' ' 222' ' ' LEU . 35.7 mt -98.75 14.91 27.05 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.554 0.576 . . . . 73.219999999999999 112.554 -169.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.3 m -54.93 108.35 0.39 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.134 0.492 . . . . 74.129999999999995 112.237 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.9 69.66 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.457 -0.402 . . . . 70.450000000000003 113.954 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -84.53 163.46 19.36 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.321 0.581 . . . . 71.430000000000007 112.209 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -106.42 118.15 35.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.816 -0.629 . . . . 72.420000000000002 110.375 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 159' ' ' VAL . 59.2 mt -93.01 111.86 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.006 0.431 . . . . 71.109999999999999 110.876 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -92.11 103.31 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.506 -0.316 . . . . 72.219999999999999 110.338 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 197' ' ' VAL . 35.3 t -99.0 123.35 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 111.998 0.37 . . . . 74.319999999999993 111.998 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -115.92 177.02 4.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.963 0.411 . . . . 74.239999999999995 111.366 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.6 138.03 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.691 0.626 . . . . 75.409999999999997 112.691 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.6 mt . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.989 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 110.362 -0.236 . . . . 64.430000000000007 110.362 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.55 140.01 75.41 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.743 2.295 . . . . 74.439999999999998 113.066 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -137.48 167.71 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.342 0.591 . . . . 75.450000000000003 112.496 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 171' ' ' ALA . 46.8 t -129.92 139.09 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.816 -0.629 . . . . 64.430000000000007 110.349 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.738 ' HG2' HG22 ' A' ' 168' ' ' VAL . 98.9 mtt180 -108.69 117.86 35.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.292 0.568 . . . . 73.219999999999999 111.574 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 181' ' ' LEU . 75.3 t -109.92 131.69 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.292 0.478 . . . . 71.010000000000005 112.292 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -89.53 94.58 9.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.125 0.488 . . . . 63.140000000000001 110.934 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 81.9 mt -68.81 154.9 94.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 111.201 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.75 154.01 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.463 2.109 . . . . 64.010000000000005 112.375 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . 0.451 HD21 ' NH2' ' A' ' 188' ' ' ARG . 60.4 m-20 72.09 12.74 5.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.935 0.494 . . . . 74.299999999999997 110.78 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt 64.59 59.39 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.191 0.596 . . . . 73.439999999999998 112.445 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 83.8 mm-40 -113.41 135.95 53.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.004 -0.544 . . . . 74.049999999999997 110.481 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 4.7 mpt_? -105.89 128.67 53.92 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.026 0.441 . . . . 75.519999999999996 111.889 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -136.96 156.17 48.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.436 -0.347 . . . . 75.340000000000003 111.16 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.738 HG22 ' HG2' ' A' ' 158' ' ' ARG . 38.7 t -126.38 132.78 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.934 0.397 . . . . 71.549999999999997 111.57 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.53 146.95 56.37 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.31 -0.405 . . . . 72.219999999999999 111.011 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . 0.487 ' HA ' HG23 ' A' ' 156' ' ' ILE . 57.5 Cg_endo -70.46 122.44 8.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.336 2.024 . . . . 42.520000000000003 113.261 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -74.03 114.81 12.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.919 0.39 . . . . 63.229999999999997 111.134 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HG3' HG21 ' A' ' 175' ' ' VAL . 19.2 ptt-85 -132.67 142.34 49.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 72.540000000000006 111.896 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 45.7 t -77.58 140.22 39.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 111.66 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.77 55.99 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.238 -0.506 . . . . 63.140000000000001 113.242 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . 0.496 HG21 ' HG3' ' A' ' 172' ' ' ARG . 45.5 t -134.51 135.36 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 122.476 0.31 . . . . 75.439999999999998 110.751 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.8 p -81.63 159.71 23.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.123 0.487 . . . . 74.150000000000006 111.697 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 212' ' ' THR . 81.2 t -58.09 -37.69 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.286 0.565 . . . . 74.25 110.574 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 36.9 ttp180 -59.83 -56.76 17.71 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.673 -0.694 . . . . 74.109999999999999 111.511 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 68.2 m-20 -64.19 -17.04 63.15 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 73.230000000000004 112.347 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -93.69 -39.05 10.99 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.098 -0.376 . . . . 65.230000000000004 111.775 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 159' ' ' VAL . 65.2 mt -91.83 -5.54 53.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.753 0.649 . . . . 75.420000000000002 112.753 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 20.4 ptmt -54.28 -34.42 60.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.772 0.32 . . . . 71.540000000000006 111.751 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.58 -39.91 77.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.05 0.452 . . . . 72.129999999999995 111.361 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.53 ' HA ' ' HE1' ' A' ' 187' ' ' MET . . . -63.36 -42.75 98.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.986 0.422 . . . . 70.140000000000001 111.223 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.47 -43.11 91.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.125 -0.489 . . . . 64.040000000000006 110.768 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.5 ttp -55.66 -50.71 69.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.116 -0.493 . . . . 74.540000000000006 111.488 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' MET . . . . . 0.53 ' HE1' ' HA ' ' A' ' 184' ' ' ALA . 27.0 ptt? -72.71 -0.5 13.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 111.872 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.451 ' NH2' HD21 ' A' ' 163' ' ' ASN . 19.3 mmm180 -117.41 1.68 12.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.787 0.292 . . . . 74.230000000000004 111.787 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 63.28 47.1 90.79 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.339 -0.458 . . . . 63.25 113.424 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 92.4 mt -132.86 159.92 38.45 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.987 0.422 . . . . 73.219999999999999 111.915 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.78 147.36 38.04 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.136 -0.484 . . . . 73.209999999999994 110.773 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.76 -47.08 26.78 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.608 2.205 . . . . 71.299999999999997 113.753 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.63 -3.47 21.76 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.727 0.64 . . . . 70.219999999999999 112.727 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -94.47 -8.54 38.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.047 0.451 . . . . 74.010000000000005 111.339 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 93.3 m -135.29 158.72 43.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.049 0.452 . . . . 75.109999999999999 111.811 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -124.93 131.72 53.39 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.304 -0.407 . . . . 70.25 111.379 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.527 HG23 HG22 ' A' ' 224' ' ' VAL . 58.2 t -103.05 125.44 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.097 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.404 ' HE1' ' HG2' ' A' ' 225' ' ' GLU . 40.6 p90 -137.36 151.56 48.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.008 0.432 . . . . 74.109999999999999 111.111 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.457 ' HG2' HD13 ' A' ' 208' ' ' ILE . 37.4 ptt180 -111.7 142.2 44.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.031 -0.359 . . . . 73.109999999999999 110.031 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.419 HG12 ' HG2' ' A' ' 205' ' ' LYS . 48.8 mt -82.79 103.45 10.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 74.299999999999997 109.732 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -102.82 109.77 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 75.099999999999994 110.827 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.4 t70 60.68 16.95 7.07 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.765 -0.652 . . . . 64.230000000000004 111.366 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.99 -19.45 30.15 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.519 -0.372 . . . . 74.120000000000005 113.572 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.43 123.97 33.5 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.294 -0.533 . . . . 73.439999999999998 111.969 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.419 ' HG2' HG12 ' A' ' 200' ' ' ILE . 96.6 mttt -79.89 104.2 10.31 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.405 -0.362 . . . . 71.209999999999994 110.611 174.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.06 115.24 40.88 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.9 0.381 . . . . 72.019999999999996 111.892 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.05 133.94 46.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.515 2.81 . . . . 72.019999999999996 113.861 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.457 HD13 ' HG2' ' A' ' 199' ' ' ARG . 50.0 mt -110.03 153.05 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.623 -0.717 . . . . 74.420000000000002 110.758 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.38 150.42 21.28 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.844 -0.694 . . . . 73.219999999999999 112.9 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 90.5 m95 -67.76 -27.67 66.97 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.178 -0.601 . . . . 73.099999999999994 111.634 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.78 -3.57 51.44 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.941 0.348 . . . . 64.299999999999997 111.941 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 177' ' ' VAL . 88.7 m -68.55 141.9 55.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.938 0.399 . . . . 70.329999999999998 111.071 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.12 117.71 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.063 0.458 . . . . 72.430000000000007 111.426 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.55 -22.07 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 N-CA-C 112.392 0.516 . . . . 74.519999999999996 112.392 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.5 p -59.91 -18.21 43.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.335 0.494 . . . . 74.340000000000003 112.335 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.39 -14.43 58.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.945 0.403 . . . . 72.329999999999998 111.954 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.53 22.87 14.94 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.175 0.512 . . . . 72.409999999999997 111.491 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.9 m -61.72 121.44 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.807 0.669 . . . . 74.239999999999995 112.807 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.6 -23.44 33.94 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.32 0.888 . . . . 71.140000000000001 115.32 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -99.32 172.25 7.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.981 0.89 . . . . 73.239999999999995 112.487 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 25.7 mp0 -93.26 139.87 30.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.945 -0.571 . . . . 72.510000000000005 111.936 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 90.6 mt -111.92 152.89 27.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.303 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -117.14 134.49 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.567 0.222 . . . . 75.430000000000007 111.138 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 197' ' ' VAL . 64.4 t -115.79 116.47 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 72.140000000000001 111.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.404 ' HG2' ' HE1' ' A' ' 198' ' ' TYR . 61.8 mm-40 -102.97 137.43 41.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.405 -0.361 . . . . 70.540000000000006 111.016 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.88 108.83 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.842 0.353 . . . . 74.409999999999997 110.837 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 196' ' ' ALA . 95.8 mt . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.095 0.474 . . . . 72.140000000000001 111.548 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.686 0.279 . . . . 74.310000000000002 111.671 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.08 130.53 38.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.415 . . . . 72.540000000000006 113.13 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -132.33 169.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.962 0.411 . . . . 75.430000000000007 111.797 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 171' ' ' ALA . 55.0 t -130.6 132.42 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 71.140000000000001 110.531 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.494 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 85.8 mtt180 -89.13 98.41 11.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.722 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.597 HG22 HD22 ' A' ' 181' ' ' LEU . 35.6 t -99.13 111.14 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.24 0.543 . . . . 61.420000000000002 112.051 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -89.45 111.97 23.0 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.673 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.5 mt -90.75 161.74 35.28 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.252 -0.431 . . . . 74.140000000000001 111.624 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 50.8 Cg_exo -55.54 162.51 6.22 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.555 2.17 . . . . 72.439999999999998 113.353 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.83 36.59 22.01 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.617 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.2 13.44 9.15 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.103 0.779 . . . . 72.310000000000002 113.103 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.5 mm-40 -76.72 159.7 29.96 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.89 0.376 . . . . 74.340000000000003 111.46 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.56 154.07 38.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.328 0.585 . . . . 74.040000000000006 112.28 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' THR . . . . . 0.405 HG21 ' HB ' ' A' ' 159' ' ' VAL . 7.9 t -157.63 150.84 23.44 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 111.054 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.47 119.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.777 0.323 . . . . 74.349999999999994 110.244 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.57 152.41 58.34 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.495 -0.321 . . . . 74.219999999999999 111.768 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.2 132.36 19.37 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.595 2.197 . . . . 75.200000000000003 113.583 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -89.48 104.7 17.23 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.029 0.442 . . . . 53.409999999999997 111.431 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.42 140.71 52.4 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.4 -0.363 . . . . 74.430000000000007 111.917 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.98 122.35 19.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.429 -0.351 . . . . 75.040000000000006 110.79 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.67 -29.5 7.8 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.233 -0.508 . . . . 63.229999999999997 112.428 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 62.7 t -89.55 126.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.736 0.303 . . . . 73.439999999999998 111.052 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 69.6 p -87.32 160.83 18.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.896 0.379 . . . . 64.299999999999997 111.46 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.93 -39.39 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.019 0.438 . . . . 75.209999999999994 111.668 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 24.5 ttp180 -74.23 -21.16 59.91 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.34 . . . . 74.319999999999993 111.744 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 17.4 t70 -84.05 -34.38 24.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.288 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 78.4 p -80.84 -55.1 5.03 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.114 0.483 . . . . 74.129999999999995 111.632 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.597 HD22 HG22 ' A' ' 159' ' ' VAL . 86.0 mt -73.54 -2.31 22.24 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.681 0.993 . . . . 74.200000000000003 113.681 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 22.0 pttp -60.72 -29.08 69.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.619 0.645 . . . . 75.400000000000006 112.236 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -76.69 -38.94 53.59 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.167 -0.333 . . . . 72.409999999999997 110.998 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -60.15 -54.68 42.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.91 0.386 . . . . 64.25 110.958 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.4 mt -55.52 -45.74 77.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.789 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -55.19 -55.79 27.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 111.961 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.0 ptp -67.53 -22.18 65.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.559 0.577 . . . . 74.409999999999997 112.559 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 67.9 mmt-85 -91.97 -23.07 19.68 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.28 -0.262 . . . . 72.310000000000002 111.679 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.16 42.42 4.64 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.534 -0.365 . . . . 44.229999999999997 113.246 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.15 162.94 24.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.989 0.423 . . . . 75.319999999999993 111.417 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.81 142.86 46.44 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.564 -0.289 . . . . 74.430000000000007 111.291 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.19 -19.68 58.24 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.812 2.342 . . . . 70.209999999999994 113.782 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.15 -28.8 57.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.797 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 226' ' ' VAL . 51.2 t -106.89 19.1 20.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.506 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.6 m -130.65 130.28 43.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.295 0.569 . . . . 73.209999999999994 111.911 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -110.0 119.44 39.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.795 -0.639 . . . . 73.25 111.209 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 224' ' ' VAL . 43.9 t -99.78 122.32 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.526 0.203 . . . . 74.549999999999997 111.051 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.404 ' HE2' ' HG3' ' A' ' 225' ' ' GLU . 42.4 p90 -134.07 152.13 51.7 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 111.479 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 199' ' ' ARG . 4.1 ptm180 -115.5 142.88 46.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.582 . . . . 74.430000000000007 110.454 176.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . 0.48 HG12 ' HG2' ' A' ' 205' ' ' LYS . 55.9 mt -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.904 0.383 . . . . 75.209999999999994 111.355 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -161.62 133.41 5.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.142 -0.481 . . . . 73.040000000000006 110.827 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.72 28.65 18.37 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.895 0.379 . . . . 55.520000000000003 112.006 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.49 10.7 85.98 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.002 -0.618 . . . . 74.409999999999997 113.415 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.47 145.17 42.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.142 0.496 . . . . 75.150000000000006 111.781 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . 0.48 ' HG2' HG12 ' A' ' 200' ' ' ILE . 97.9 mttt -102.36 102.44 12.78 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 74.519999999999996 110.22 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.83 113.67 56.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.333 -0.394 . . . . 75.329999999999998 111.733 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.69 139.52 63.76 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.645 2.23 . . . . 70.530000000000001 112.488 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.22 142.39 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.981 0.42 . . . . 74.219999999999999 111.41 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.25 137.8 14.62 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.127 -0.558 . . . . 74.120000000000005 112.651 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -63.29 -17.17 62.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.373 -0.486 . . . . 75.010000000000005 111.8 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.49 -10.46 59.47 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.974 -0.557 . . . . 74.409999999999997 112.281 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 68.6 m -80.32 143.87 33.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.076 0.398 . . . . 73.439999999999998 112.076 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.42 132.52 52.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 64.120000000000005 111.961 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -65.38 -18.37 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 111.492 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.0 p -62.16 -23.65 66.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.975 0.417 . . . . 55.549999999999997 111.821 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -71.81 -15.77 62.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.045 0.45 . . . . 72.150000000000006 111.173 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.2 mt -113.85 13.56 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.052 -0.522 . . . . 72.219999999999999 111.307 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 98.1 m -51.9 113.77 1.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.708 0.633 . . . . 75.420000000000002 112.708 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 90.77 -17.93 52.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.308 -0.472 . . . . 73.140000000000001 113.821 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -73.99 168.06 20.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 112.121 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . 0.494 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.6 mt-10 -112.72 114.74 27.47 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.586 -0.734 . . . . 74.140000000000001 110.77 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 159' ' ' VAL . 68.3 mt -93.33 147.72 22.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.122 0.487 . . . . 74.010000000000005 111.342 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -127.54 117.67 22.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.054 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.56 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 40.2 t -103.96 144.68 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.07 0.462 . . . . 72.329999999999998 112.215 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 198' ' ' TYR . 22.4 mt-10 -130.75 177.85 7.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 111.633 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.0 t -91.94 140.44 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.837 0.351 . . . . 73.510000000000005 111.815 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.144 0.424 . . . . 73.439999999999998 112.144 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 109.95 -0.389 . . . . 74.340000000000003 109.95 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.02 129.81 25.91 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.839 2.359 . . . . 75.519999999999996 113.367 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.62 160.92 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.36 0.6 . . . . 73.439999999999998 112.086 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 129.86 65.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 110.535 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 158' ' ' ARG . 68.2 mtt85 -96.21 98.46 10.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.736 0.303 . . . . 71.530000000000001 111.416 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 222' ' ' LEU . 41.2 t -96.26 120.09 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 112.043 -176.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.09 115.32 27.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.128 0.49 . . . . 72.400000000000006 110.747 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 91.9 mt -93.47 165.71 17.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.947 -0.57 . . . . 75.200000000000003 111.527 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 20.6 Cg_endo -60.5 168.01 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.246 1.964 . . . . 73.019999999999996 112.534 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.94 27.2 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.081 0.4 . . . . 72.129999999999995 112.081 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.34 26.76 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.728 0.411 . . . . 74.209999999999994 111.795 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 76.9 mm-40 -92.43 162.21 14.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.92 0.39 . . . . 72.150000000000006 111.131 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -151.56 156.12 39.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.938 0.399 . . . . 72.0 111.786 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 t -156.85 126.99 6.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.274 -0.421 . . . . 74.120000000000005 111.535 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.62 119.73 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.29 -0.256 . . . . 74.150000000000006 110.557 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.74 144.87 39.83 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 112.014 0.376 . . . . 71.230000000000004 112.014 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.24 139.73 67.47 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.608 2.206 . . . . 74.409999999999997 112.923 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.31 109.7 21.24 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 70.209999999999994 111.606 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -97.22 132.39 43.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.386 -0.37 . . . . 74.340000000000003 110.997 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.1 t -70.7 121.25 17.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.774 0.321 . . . . 73.120000000000005 111.122 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.2 -9.69 50.32 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.369 -0.444 . . . . 55.25 113.168 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.88 135.28 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 122.432 -0.452 . . . . 71.299999999999997 110.526 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 69.8 p -81.54 167.04 19.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.299 0.571 . . . . 63.229999999999997 112.266 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 212' ' ' THR . 77.9 t -59.49 -37.66 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.371 0.605 . . . . 60.329999999999998 110.773 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 31.5 ttp180 -66.36 -55.87 13.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.811 -0.631 . . . . 61.420000000000002 111.226 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.549 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 17.0 t70 -60.83 -36.0 77.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 112.004 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 81.8 p -77.14 -59.0 2.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.906 0.384 . . . . 61.100000000000001 111.874 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.89 -23.66 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.335 0.865 . . . . 64.030000000000001 113.335 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 23.3 pttp -59.96 -22.69 62.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.613 0.642 . . . . 73.129999999999995 111.538 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.458 ' HZ3' ' HB2' ' A' ' 183' ' ' LYS . 9.1 mtmp? -75.68 -41.42 53.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.139 0.495 . . . . 74.319999999999993 110.562 174.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.79 81.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 74.420000000000002 110.692 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.27 -38.29 68.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.744 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 26.3 ttt -53.7 -48.93 69.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 111.748 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -65.97 -27.07 67.87 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.752 0.311 . . . . 64.409999999999997 111.583 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.09 -22.31 31.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.934 0.397 . . . . 75.530000000000001 111.383 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.51 17.38 45.82 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.364 -0.446 . . . . 74.239999999999995 113.124 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.55 168.63 9.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.261 0.553 . . . . 74.129999999999995 111.96 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -129.77 139.73 36.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.343 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.24 -36.74 97.46 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.947 2.432 . . . . 74.209999999999994 113.898 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.41 -18.85 60.74 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.947 0.403 . . . . 63.140000000000001 111.923 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.14 -5.81 32.8 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.22 0.452 . . . . 74.310000000000002 112.22 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.5 m -119.07 151.53 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.365 0.506 . . . . 73.200000000000003 112.365 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -127.64 122.71 33.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.246 -0.434 . . . . 60.350000000000001 111.362 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' VAL . . . . . 0.522 HG23 HG23 ' A' ' 224' ' ' VAL . 56.5 t -98.12 136.26 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.641 -0.254 . . . . 54.509999999999998 111.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -149.31 165.63 31.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 111.165 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -141.28 158.03 44.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.276 -0.42 . . . . 74.209999999999994 110.332 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.1 mt -92.21 113.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.286 0.565 . . . . 74.540000000000006 111.719 -174.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 206' ' ' LYS . 33.8 tt0 -139.02 142.19 38.27 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.566 -0.743 . . . . 74.430000000000007 110.494 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.65 21.86 10.55 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.534 0.683 . . . . 74.310000000000002 111.021 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.8 82.96 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.252 -0.431 . . . . 73.349999999999994 113.149 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -125.82 151.54 46.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.26 0.552 . . . . 72.049999999999997 111.819 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -82.64 97.27 8.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.087 -0.506 . . . . 73.140000000000001 110.198 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 201' ' ' GLN . 67.2 mttm -96.63 111.66 57.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.938 0.347 . . . . 75.430000000000007 111.938 -175.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.48 142.94 96.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.996 2.464 . . . . 73.150000000000006 113.387 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' ILE . . . . . 0.442 HG23 HD12 ' A' ' 217' ' ' LEU . 66.5 mt -113.5 134.34 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.99 -0.55 . . . . 75.319999999999993 111.016 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.34 133.74 16.8 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.886 -0.673 . . . . 44.530000000000001 112.887 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.1 m95 -60.57 -26.17 66.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 111.31 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.11 5.81 24.72 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.437 0.532 . . . . 74.109999999999999 112.437 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.3 m -83.84 141.46 31.32 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.492 0.187 . . . . 75.230000000000004 110.98 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.3 130.52 45.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.857 0.361 . . . . 73.439999999999998 111.238 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.0 tp -59.62 -22.55 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.07 0.462 . . . . 72.25 111.654 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 71.2 p -62.65 -26.87 68.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 112.001 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -65.37 -22.64 66.83 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.292 0.568 . . . . 74.109999999999999 111.082 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.499 HD13 HD23 ' A' ' 222' ' ' LEU . 46.6 mt -108.3 13.52 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.763 -0.653 . . . . 74.209999999999994 111.622 -175.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.9 m -52.8 118.06 3.4 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.166 0.432 . . . . 74.409999999999997 112.166 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.33 79.19 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.269 0.468 . . . . 72.010000000000005 114.269 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -105.52 164.33 11.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.497 0.665 . . . . 71.310000000000002 112.451 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -103.25 117.04 33.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.392 -0.822 . . . . 74.140000000000001 110.566 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 217' ' ' LEU . 60.3 mt -93.68 145.92 24.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.013 0.435 . . . . 75.25 111.016 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -121.95 117.02 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.561 -0.291 . . . . 75.239999999999995 110.451 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' VAL . . . . . 0.522 HG23 HG23 ' A' ' 197' ' ' VAL . 73.3 t -104.84 121.17 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.603 0.594 . . . . 73.200000000000003 112.603 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -106.69 164.58 11.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.008 -0.542 . . . . 72.409999999999997 110.832 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.89 124.64 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.774 0.321 . . . . 74.109999999999999 111.478 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 75.2 mt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.947 0.403 . . . . 73.019999999999996 111.508 177.356 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.909 0.385 . . . . 74.439999999999998 111.73 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.5 mtm -131.76 153.6 81.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.026 -0.534 . . . . 75.5 110.163 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.51 171.88 8.76 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.286 1.991 . . . . 64.310000000000002 112.747 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.631 ' HB3' ' HZ3' ' A' ' 150' ' ' LYS . 0.3 OUTLIER -63.93 144.75 56.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.802 0.335 . . . . 72.329999999999998 111.289 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.1 t -132.57 80.76 61.38 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-O 120.972 0.415 . . . . 74.230000000000004 111.631 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -88.5 37.9 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.548 2.832 . . . . 74.349999999999994 112.932 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -80.35 32.71 0.29 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.756 0.788 . . . . 74.219999999999999 111.483 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -113.56 152.52 45.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.114 -0.493 . . . . 75.109999999999999 109.943 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.98 130.74 25.18 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.727 1.618 . . . . 74.239999999999995 111.114 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.03 166.54 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 113.428 0.899 . . . . 72.540000000000006 113.428 -171.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.4 HG21 ' HB2' ' A' ' 171' ' ' ALA . 58.3 t -124.55 137.52 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.36 -0.836 . . . . 75.150000000000006 110.439 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.504 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 23.0 mtp85 -100.54 105.54 16.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.828 0.347 . . . . 72.129999999999995 111.375 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.477 HG23 HD21 ' A' ' 181' ' ' LEU . 54.4 t -107.23 122.9 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.986 0.422 . . . . 64.329999999999998 111.919 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -93.68 119.29 32.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.119 0.485 . . . . 75.230000000000004 111.135 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.425 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 92.9 mt -93.17 155.68 40.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.804 -0.634 . . . . 72.120000000000005 111.897 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.19 159.53 26.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.608 2.206 . . . . 74.450000000000003 113.099 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.479 ' HB2' HH22 ' A' ' 188' ' ' ARG . 85.7 m-20 64.76 39.24 6.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.993 -0.549 . . . . 71.420000000000002 111.993 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 66.18 27.0 10.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.18 0.807 . . . . 75.200000000000003 113.18 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.425 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.9 mm-40 -104.61 166.88 10.1 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.019 -0.425 . . . . 72.150000000000006 111.419 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.407 ' HD3' ' N ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -159.32 157.23 30.08 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.094 -0.379 . . . . 65.329999999999998 111.494 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -154.3 159.37 41.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.026 0.441 . . . . 72.549999999999997 111.51 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 128.74 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.322 -0.399 . . . . 74.099999999999994 110.733 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.3 m -125.4 141.96 40.32 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 111.835 0.309 . . . . 64.409999999999997 111.835 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.47 123.59 11.0 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.83 2.353 . . . . 71.140000000000001 113.374 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.4 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -73.68 102.76 4.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.085 0.469 . . . . 74.510000000000005 111.275 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -112.85 137.78 50.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.098 -0.501 . . . . 74.299999999999997 111.231 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -74.23 126.4 30.52 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.787 0.327 . . . . 64.010000000000005 111.372 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.73 -28.6 11.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.375 -0.44 . . . . 73.319999999999993 112.608 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.41 133.62 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.717 0.294 . . . . 71.019999999999996 111.127 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 56.7 p -82.48 155.3 24.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.009 0.433 . . . . 73.329999999999998 111.482 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 212' ' ' THR . 63.3 t -54.68 -39.03 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.05 0.452 . . . . 75.400000000000006 110.894 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.3 ttm-85 -59.94 -53.29 59.58 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 74.510000000000005 111.07 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.0 -19.76 64.95 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 74.230000000000004 111.405 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.0 m -80.66 -44.58 18.59 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.08 0.467 . . . . 72.319999999999993 111.467 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.477 HD21 HG23 ' A' ' 159' ' ' VAL . 95.9 mt -92.07 -0.01 57.46 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.778 0.658 . . . . 54.310000000000002 112.778 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -51.65 -36.91 48.06 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.225 0.454 . . . . 72.310000000000002 112.225 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -67.69 -46.1 73.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.986 0.422 . . . . 75.5 111.235 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.5 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -61.3 -43.22 99.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.127 -0.488 . . . . 74.099999999999994 111.334 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.464 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 94.5 mt -64.78 -45.45 86.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.317 -0.401 . . . . 75.430000000000007 111.205 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.1 tpt -56.87 -49.57 75.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.383 -0.371 . . . . 75.120000000000005 111.696 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.8 ptm -67.2 -17.22 64.73 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.886 0.328 . . . . 74.310000000000002 111.886 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 42.2 mmm-85 -95.93 -13.71 23.67 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.153 -0.342 . . . . 62.109999999999999 111.413 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.17 27.58 61.78 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.342 -0.456 . . . . 72.540000000000006 113.106 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 90.6 mt -112.82 131.07 55.86 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.887 0.375 . . . . 74.340000000000003 111.738 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.26 142.45 38.08 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.644 -0.253 . . . . 75.430000000000007 110.885 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.02 -24.35 57.15 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.711 2.274 . . . . 64.120000000000005 113.45 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.2 -14.62 58.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.131 0.419 . . . . 70.530000000000001 112.131 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.47 11.37 32.65 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.132 0.492 . . . . 74.150000000000006 110.864 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.2 m -129.95 133.17 46.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.293 -0.412 . . . . 75.329999999999998 111.303 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.22 144.82 38.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.668 0.27 . . . . 74.200000000000003 111.265 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.18 140.49 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.852 0.358 . . . . 74.519999999999996 111.574 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.67 158.67 43.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.188 0.518 . . . . 72.450000000000003 111.8 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -122.84 161.22 24.48 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.8 -0.636 . . . . 74.530000000000001 110.41 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.0 mt -104.64 114.44 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.153 0.501 . . . . 75.329999999999998 111.536 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -124.06 119.6 29.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.732 -0.667 . . . . 73.340000000000003 110.203 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 57.19 31.97 20.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.169 0.509 . . . . 74.340000000000003 111.214 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 85.24 -2.92 87.94 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.227 -0.511 . . . . 73.530000000000001 113.715 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -101.85 139.16 37.87 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.345 -0.503 . . . . 72.299999999999997 112.092 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -89.14 103.43 16.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.147 -0.478 . . . . 72.109999999999999 110.869 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.439 ' HA ' ' HD3' ' A' ' 207' ' ' PRO . 45.4 mmtm -104.11 127.54 29.02 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.685 0.279 . . . . 73.109999999999999 111.587 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 22.6 Cg_exo -65.75 152.28 82.05 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.204 2.602 . . . . 73.400000000000006 113.758 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.504 HG21 HD13 ' A' ' 217' ' ' LEU . 70.6 mt -129.85 138.57 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 74.420000000000002 111.007 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.98 134.42 12.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.062 -0.589 . . . . 64.430000000000007 112.927 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.6 m95 -57.27 -30.51 64.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.287 0.477 . . . . 75.340000000000003 112.287 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -87.24 7.79 26.95 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.131 0.419 . . . . 62.039999999999999 112.131 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.445 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.8 m -82.6 140.55 33.15 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.296 -0.252 . . . . 72.310000000000002 110.797 174.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.45 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 4.2 m-20 -59.1 126.9 29.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 72.329999999999998 111.595 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.1 tt -60.24 -21.48 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.134 -0.485 . . . . 75.329999999999998 111.819 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 76.8 p -60.65 -27.5 67.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.681 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.45 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 15.6 m95 -70.37 -16.33 62.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.955 0.407 . . . . 74.209999999999994 111.484 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.504 HD13 HG21 ' A' ' 208' ' ' ILE . 80.1 mt -112.77 22.52 14.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.31 -0.404 . . . . 75.530000000000001 111.936 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.8 m -56.74 108.42 0.5 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.853 0.359 . . . . 75.450000000000003 111.919 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.46 11.12 61.25 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.171 -0.538 . . . . 70.109999999999999 114.048 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -93.8 151.32 19.69 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.342 0.571 . . . . 65.409999999999997 111.628 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.504 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -105.46 114.35 28.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.082 0.468 . . . . 73.409999999999997 110.654 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 58.1 mt -97.48 150.57 20.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.085 0.469 . . . . 73.519999999999996 111.761 -176.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.61 127.61 44.13 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.6 -0.273 . . . . 74.299999999999997 110.458 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.73 137.51 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.399 0.518 . . . . 73.549999999999997 112.399 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.78 144.24 43.31 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.059 -0.519 . . . . 70.420000000000002 111.02 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.36 116.4 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.526 0.203 . . . . 74.329999999999998 110.95 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 77.4 mt -70.45 -47.95 58.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.72 0.295 . . . . 74.420000000000002 111.629 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -125.73 114.21 18.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.888 0.375 . . . . 71.299999999999997 110.678 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.27 -34.88 63.71 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.364 0.505 . . . . 75.030000000000001 112.364 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.57 115.37 49.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 120.568 0.223 . . . . 75.299999999999997 111.222 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.79 111.58 2.27 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.786 2.324 . . . . 74.420000000000002 113.554 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.253 1.241 0 CA-C-O 118.812 -0.613 . . . . 74.310000000000002 111.298 176.224 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.3 m80 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.282 0.087 . . . . 73.099999999999994 110.976 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtt 70.63 118.27 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 123.233 0.613 . . . . 72.5 112.604 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 95.62 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.775 2.317 . . . . 74.030000000000001 111.477 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.86 115.54 4.94 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.765 0.317 . . . . 74.439999999999998 111.698 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.4 m 64.88 85.21 0.16 Allowed Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 115.819 -0.628 . . . . 74.120000000000005 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.53 136.49 74.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.656 2.237 . . . . 73.040000000000006 112.389 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -72.78 99.18 2.57 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.245 0.545 . . . . 75.109999999999999 111.281 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.79 156.44 52.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.969 -0.559 . . . . 74.510000000000005 111.855 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.486 ' HB2' HG21 ' A' ' 218' ' ' THR . 43.3 Cg_endo -65.79 144.6 78.14 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.823 2.348 . . . . 64.530000000000001 112.928 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.6 pt -132.21 162.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.068 0.766 . . . . 74.540000000000006 113.068 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.02 123.23 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.251 -0.886 . . . . 72.129999999999995 109.65 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.692 ' HB2' ' HB3' ' A' ' 221' ' ' GLU . 49.5 mtt180 -88.91 95.05 10.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.805 0.336 . . . . 72.219999999999999 111.092 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.572 HG22 HD22 ' A' ' 181' ' ' LEU . 57.6 t -93.52 114.71 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.977 -0.452 . . . . 75.409999999999997 112.206 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.8 123.92 30.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.647 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 184' ' ' ALA . 96.3 mt -100.38 156.43 35.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.251 0.463 . . . . 73.310000000000002 112.251 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.505 ' HG2' HH12 ' A' ' 188' ' ' ARG . 19.4 Cg_endo -59.38 165.78 8.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.298 1.999 . . . . 73.219999999999999 112.115 175.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 68.22 25.11 7.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.027 0.441 . . . . 73.420000000000002 111.11 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 62.94 43.24 6.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.659 -0.701 . . . . 71.120000000000005 112.111 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -118.51 -179.74 3.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.02 0.438 . . . . 75.329999999999998 111.672 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 159.82 35.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.001 0.429 . . . . 75.319999999999993 112.148 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -155.41 129.01 8.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.018 0.437 . . . . 64.329999999999998 111.503 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.21 119.55 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.696 0.284 . . . . 74.109999999999999 110.314 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.45 138.54 29.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.555 0.217 . . . . 72.200000000000003 111.372 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.8 132.26 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.566 2.178 . . . . 72.109999999999999 113.039 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.78 103.46 5.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.045 0.45 . . . . 73.340000000000003 110.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.2 mtt-85 -106.5 126.35 52.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.305 -0.407 . . . . 75.099999999999994 111.395 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.8 t -75.02 115.71 14.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.813 0.34 . . . . 55.409999999999997 111.146 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.61 -1.04 27.66 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.244 -0.503 . . . . 42.299999999999997 112.58 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.72 133.03 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.743 0.306 . . . . 71.129999999999995 110.874 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 33.0 p -81.59 161.59 23.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.852 0.358 . . . . 70.430000000000007 111.585 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 81.3 t -56.33 -34.48 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.439 0.638 . . . . 62.210000000000001 110.424 174.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.559 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 47.2 ttp180 -67.35 -56.04 11.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 74.530000000000001 111.619 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.648 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 6.6 m-20 -72.22 -12.36 61.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.818 0.673 . . . . 74.439999999999998 112.818 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 62.0 p -89.18 -50.94 5.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.943 0.402 . . . . 71.239999999999995 110.767 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.572 HD22 HG22 ' A' ' 159' ' ' VAL . 78.5 mt -79.73 -7.54 58.68 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.426 0.898 . . . . 73.450000000000003 113.426 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.648 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 14.0 ptpt -55.92 -27.64 53.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.979 -0.45 . . . . 75.219999999999999 111.209 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.99 -45.48 81.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.191 0.519 . . . . 73.400000000000006 110.773 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HA ' ' HE3' ' A' ' 187' ' ' MET . . . -66.77 -30.55 70.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.021 -0.536 . . . . 64.310000000000002 111.618 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.6 mt -75.17 -43.69 50.86 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.006 0.431 . . . . 73.409999999999997 110.709 174.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.17 -53.86 47.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.762 -0.653 . . . . 70.230000000000004 112.0 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.473 ' HE3' ' HA ' ' A' ' 184' ' ' ALA . 26.4 ptt? -64.62 -8.58 14.8 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.623 0.601 . . . . 63.420000000000002 112.623 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.505 HH12 ' HG2' ' A' ' 162' ' ' PRO . 63.2 mtm180 -119.23 5.37 11.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.849 0.315 . . . . 75.540000000000006 111.849 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.44 95.69 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.294 -0.479 . . . . 64.239999999999995 113.431 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 95.1 mt -124.43 149.87 46.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.32 0.581 . . . . 73.219999999999999 111.753 -178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.7 pt -104.15 152.72 39.21 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 111.088 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 -20.72 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.762 2.308 . . . . 74.200000000000003 113.825 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.65 -16.55 53.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.847 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.7 t -90.36 -9.2 48.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.02 0.378 . . . . 72.439999999999998 112.02 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.1 m -136.41 147.69 47.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.04 0.448 . . . . 72.209999999999994 111.8 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.437 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -125.25 131.55 53.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.875 0.369 . . . . 71.010000000000005 111.466 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 224' ' ' VAL . 57.9 t -94.44 132.54 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.333 -0.394 . . . . 75.209999999999994 110.844 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.458 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 37.8 p90 -148.87 163.05 38.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 62.32 111.09 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -134.62 143.49 47.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.496 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.42 97.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 110.133 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 108.61 19.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 75.230000000000004 110.791 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 60.73 30.99 20.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.538 0.685 . . . . 74.409999999999997 110.723 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -12.86 68.82 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.051 -0.522 . . . . 65.239999999999995 113.491 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -93.45 132.71 37.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 122.251 -0.558 . . . . 75.150000000000006 111.762 -178.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.458 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 55.0 mtpt -78.07 94.88 4.74 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.917 0.389 . . . . 71.310000000000002 110.708 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -96.58 109.73 49.53 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 71.099999999999994 111.19 -179.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.29 125.76 13.37 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.876 2.384 . . . . 72.420000000000002 112.561 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -100.27 122.09 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.285 -0.416 . . . . 73.230000000000004 111.066 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 139.72 46.55 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.319 -0.467 . . . . 41.520000000000003 113.105 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.559 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.6 m95 -60.02 -22.8 63.09 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.969 0.414 . . . . 71.409999999999997 111.603 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -78.47 -6.75 56.26 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.474 0.546 . . . . 75.319999999999993 112.474 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 29.5 m -75.47 140.49 42.87 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.716 0.265 . . . . 74.430000000000007 111.716 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.18 126.86 30.02 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.111 0.481 . . . . 73.439999999999998 110.929 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.1 tt -67.05 -23.65 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.503 0.557 . . . . 74.099999999999994 112.503 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -67.44 -12.17 59.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.88 0.372 . . . . 71.120000000000005 111.708 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -70.82 -23.28 62.33 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.176 0.512 . . . . 73.25 111.197 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.523 HD12 HD22 ' A' ' 222' ' ' LEU . 28.7 mt -108.66 19.93 19.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.907 -0.588 . . . . 75.510000000000005 111.531 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.486 HG21 ' HB2' ' A' ' 155' ' ' PRO . 96.7 m -58.48 115.46 3.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.791 0.664 . . . . 73.219999999999999 112.791 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.19 -27.98 10.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.114 -0.565 . . . . 64.310000000000002 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.64 172.78 6.66 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.371 0.605 . . . . 73.239999999999995 112.161 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.692 ' HB3' ' HB2' ' A' ' 158' ' ' ARG . 1.4 pm0 -108.34 149.53 28.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.545 0.688 . . . . 74.150000000000006 112.305 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.523 HD22 HD12 ' A' ' 217' ' ' LEU . 85.9 mt -113.51 163.71 14.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 71.019999999999996 111.186 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.44 130.52 46.04 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.556 -0.293 . . . . 72.400000000000006 110.317 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.467 HG23 HG23 ' A' ' 197' ' ' VAL . 40.1 t -118.25 119.05 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.63 0.252 . . . . 74.329999999999998 111.496 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.96 164.29 12.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 71.340000000000003 111.672 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.3 t -77.6 144.6 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.038 0.447 . . . . 75.510000000000005 112.025 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt -104.51 -50.39 3.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.391 -0.368 . . . . 71.140000000000001 111.766 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.91 167.11 26.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.981 0.419 . . . . 71.150000000000006 112.026 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -150.77 100.89 2.87 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 111.093 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 46.3 t 63.42 88.07 0.12 Allowed Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 121.12 0.486 . . . . 72.329999999999998 112.004 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.69 99.13 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.872 2.382 . . . . 65.150000000000006 113.456 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.251 1.132 0 CA-C-O 119.006 -0.521 . . . . 73.120000000000005 110.073 176.683 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.695 0.283 . . . . 65.140000000000001 111.683 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 148' ' ' MET . 1.0 OUTLIER -89.09 112.88 53.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 120.699 0.285 . . . . 70.219999999999999 111.511 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.41 98.95 1.15 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.768 2.312 . . . . 71.409999999999997 112.901 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -95.7 7.23 46.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 72.200000000000003 111.079 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.7 t -136.46 70.98 60.12 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.308 -0.406 . . . . 74.540000000000006 111.347 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.27 138.7 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.797 2.331 . . . . 74.430000000000007 111.846 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.14 83.46 1.0 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.374 0.607 . . . . 74.120000000000005 111.829 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -112.97 156.77 42.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.332 -0.849 . . . . 72.230000000000004 110.616 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.56 111.24 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.133 1.889 . . . . 73.030000000000001 111.926 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.2 pt -112.46 161.84 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.681 0.623 . . . . 75.219999999999999 112.681 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.472 HG22 ' HB2' ' A' ' 171' ' ' ALA . 57.8 t -122.56 128.76 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.786 -0.643 . . . . 75.510000000000005 110.279 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.561 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 18.9 mtp180 -96.52 107.9 20.39 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.012 0.434 . . . . 74.239999999999995 110.963 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.94 125.46 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.478 0.548 . . . . 72.420000000000002 112.478 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -82.74 113.71 20.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.261 -0.427 . . . . 70.409999999999997 110.76 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.55 146.88 32.62 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.286 -0.415 . . . . 74.430000000000007 111.046 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.07 160.33 19.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.346 2.031 . . . . 71.030000000000001 112.646 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 69.21 36.48 2.37 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 112.04 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 67.95 36.33 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.633 -0.712 . . . . 74.319999999999993 112.424 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -117.64 171.23 8.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 112.171 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.51 162.14 37.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.491 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.13 163.42 40.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.879 0.371 . . . . 74.109999999999999 111.452 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.6 t -121.69 128.72 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.914 0.388 . . . . 74.219999999999999 111.364 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.62 145.02 45.94 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.446 -0.343 . . . . 73.549999999999997 111.47 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.13 126.51 7.85 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 75.230000000000004 112.666 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.472 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -90.96 110.0 21.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.893 0.378 . . . . 73.409999999999997 111.969 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 172' ' ' ARG . 49.7 mtt180 -101.72 167.5 10.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 74.430000000000007 111.105 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.74 128.96 34.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.505 -0.316 . . . . 75.400000000000006 111.1 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.34 33.33 28.85 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.99 -0.624 . . . . 71.239999999999995 113.171 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.1 t -131.35 109.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.104 -0.332 . . . . 74.030000000000001 110.104 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.9 p -63.18 157.09 23.37 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 72.510000000000005 112.399 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.454 HG22 ' O ' ' A' ' 212' ' ' THR . 65.6 t -56.77 -30.53 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 75.230000000000004 110.648 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.531 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 18.9 ttp180 -68.99 -53.07 22.53 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.983 -0.553 . . . . 74.310000000000002 111.195 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.545 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 34.7 m-20 -63.3 -35.11 79.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.356 0.598 . . . . 73.439999999999998 111.247 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.459 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 39.9 t -66.49 -62.79 1.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.079 -0.51 . . . . 73.040000000000006 111.585 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.6 mt -83.09 -12.27 57.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.202 1.186 . . . . 71.439999999999998 114.202 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.545 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 17.9 ptpt -56.05 -28.88 59.32 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.75 0.705 . . . . 73.019999999999996 111.848 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.459 ' HG2' ' O ' ' A' ' 180' ' ' SER . 7.9 ptpp? -74.17 -29.78 61.94 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.792 0.329 . . . . 75.439999999999998 111.524 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.26 -42.4 72.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.229 0.538 . . . . 73.109999999999999 110.647 176.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.92 -29.13 58.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.168 -0.469 . . . . 72.549999999999997 111.029 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 45.4 ttm -54.81 -49.64 70.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 74.219999999999999 111.534 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.2 ptp -68.52 -10.09 53.4 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 111.883 0.327 . . . . 73.340000000000003 111.883 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 15.3 mmm180 -95.58 -10.38 29.72 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.658 -0.246 . . . . 74.349999999999994 111.031 175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.02 20.04 63.88 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.385 -0.436 . . . . 73.549999999999997 112.76 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.411 HD12 HG21 ' A' ' 226' ' ' VAL . 80.9 mt -120.88 153.96 36.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.997 0.427 . . . . 75.319999999999993 111.439 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.0 pt -104.97 141.3 22.27 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.788 0.327 . . . . 74.150000000000006 111.455 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.409 ' HG3' ' HB3' ' A' ' 182' ' ' LYS . 22.0 Cg_endo -60.95 -29.25 87.66 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.541 2.161 . . . . 75.25 113.05 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.409 ' OE2' ' HD2' ' A' ' 178' ' ' ARG . 5.5 mm-40 -55.74 -32.84 63.75 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.998 0.428 . . . . 72.540000000000006 111.705 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 228' ' ' GLU . 52.0 t -104.18 21.77 15.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.067 0.461 . . . . 71.420000000000002 111.966 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.1 m -125.0 161.88 25.74 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.056 0.455 . . . . 74.439999999999998 111.654 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.93 131.8 47.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.835 0.35 . . . . 74.129999999999995 111.726 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.53 HG23 HG23 ' A' ' 224' ' ' VAL . 20.8 t -112.44 139.03 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.396 -0.365 . . . . 72.340000000000003 110.762 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -147.86 158.61 44.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.334 0.588 . . . . 75.310000000000002 111.942 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -135.34 138.8 43.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.676 -0.693 . . . . 73.450000000000003 110.988 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.409 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 56.3 mt -84.36 118.0 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 72.109999999999999 111.381 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.527 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 24.3 mt-30 -122.66 113.92 19.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.261 -0.427 . . . . 72.019999999999996 111.212 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 59.27 20.72 8.86 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.495 0.664 . . . . 75.409999999999997 111.657 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 109.39 -22.64 24.28 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.244 -0.435 . . . . 71.420000000000002 113.899 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.527 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 10.2 pt-20 -84.12 155.2 22.74 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.578 0.689 . . . . 74.219999999999999 111.533 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.06 100.24 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.212 0.53 . . . . 74.230000000000004 109.642 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -87.69 112.72 50.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.978 -0.555 . . . . 71.219999999999999 111.581 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.64 127.54 12.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.568 2.179 . . . . 61.420000000000002 112.271 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.443 HG21 HD12 ' A' ' 217' ' ' LEU . 60.4 mt -96.7 129.99 45.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.685 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 131.66 11.81 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.052 -0.594 . . . . 74.120000000000005 112.218 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.531 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.6 m95 -59.87 -27.11 66.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.183 0.438 . . . . 74.099999999999994 112.183 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -80.3 -5.91 57.06 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.211 0.449 . . . . 71.150000000000006 112.211 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 177' ' ' VAL . 63.7 m -71.19 141.5 50.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.308 -0.245 . . . . 71.209999999999994 111.017 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.66 129.36 39.49 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.077 0.465 . . . . 71.349999999999994 110.824 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.91 -24.64 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.145 -0.48 . . . . 74.150000000000006 111.868 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 86.0 p -64.89 -16.24 62.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.802 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -76.44 -11.4 59.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.015 0.436 . . . . 63.130000000000003 111.439 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.443 HD12 HG21 ' A' ' 208' ' ' ILE . 66.8 mt -114.04 14.43 18.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.074 0.464 . . . . 75.230000000000004 111.241 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.8 m -53.84 119.67 5.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.633 0.605 . . . . 72.150000000000006 112.633 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 88.88 -9.93 74.61 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.194 -0.457 . . . . 64.299999999999997 113.997 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.29 157.84 18.05 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.643 0.608 . . . . 73.439999999999998 112.643 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.561 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.4 mt-10 -103.99 114.38 28.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.965 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.2 mt -95.79 158.99 15.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.162 0.506 . . . . 74.329999999999998 111.973 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -122.28 121.72 37.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.452 -0.34 . . . . 72.109999999999999 110.38 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.53 HG23 HG23 ' A' ' 197' ' ' VAL . 62.1 t -119.07 135.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.204 0.525 . . . . 75.129999999999995 112.09 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.3 148.95 40.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.118 -0.492 . . . . 75.400000000000006 110.914 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.411 HG21 HD12 ' A' ' 190' ' ' LEU . 36.0 t -85.8 137.51 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.819 0.342 . . . . 72.310000000000002 111.879 -174.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.44 -67.38 0.72 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.375 -0.375 . . . . 73.519999999999996 111.102 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.622 ' HB2' ' SG ' ' A' ' 194' ' ' CYS . 72.5 mm-40 -105.39 138.32 41.78 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.942 0.401 . . . . 74.209999999999994 111.392 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.79 74.67 1.59 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.259 0.552 . . . . 63.340000000000003 111.357 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.27 92.22 48.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.276 -0.42 . . . . 73.129999999999995 111.525 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -88.89 127.73 1.88 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.166 2.577 . . . . 72.310000000000002 112.126 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.44 ' N ' HD13 ' A' ' 232' ' ' LEU . 7.0 mp . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.575 -0.726 . . . . 75.400000000000006 111.819 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.8 t60 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.544 0.211 . . . . 73.430000000000007 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.7 tpp -86.06 116.17 64.72 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.24 -0.287 . . . . 64.25 111.532 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.77 166.27 21.63 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.661 2.241 . . . . 73.120000000000005 113.397 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.42 ' HB3' ' HZ1' ' A' ' 150' ' ' LYS . 0.3 OUTLIER -139.82 171.07 14.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.889 -0.596 . . . . 74.519999999999996 110.852 176.6 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 82.4 p -159.29 103.08 1.53 Allowed Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 112.122 0.416 . . . . 61.450000000000003 112.122 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.56 153.76 64.46 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.416 2.077 . . . . 74.129999999999995 112.031 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.67 115.24 3.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.703 0.631 . . . . 75.430000000000007 112.703 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -113.09 151.02 43.84 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.979 -0.555 . . . . 75.5 110.472 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.81 147.2 95.94 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.675 2.25 . . . . 51.020000000000003 112.761 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 pt -129.37 160.24 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.472 0.653 . . . . 75.420000000000002 112.74 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.47 HG22 ' HB2' ' A' ' 171' ' ' ALA . 88.5 t -127.1 134.61 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.554 -0.748 . . . . 74.200000000000003 110.302 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -97.48 96.79 8.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.79 0.328 . . . . 74.140000000000001 111.401 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.401 HG21 HD22 ' A' ' 181' ' ' LEU . 48.0 t -98.43 124.05 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.585 0.587 . . . . 73.540000000000006 112.585 -174.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -95.28 106.36 18.39 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.264 -0.426 . . . . 74.5 111.179 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.51 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.7 mt -85.29 157.21 59.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.234 -0.439 . . . . 45.32 111.336 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.6 153.39 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.602 2.201 . . . . 75.230000000000004 113.011 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.487 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 31.6 m-80 68.93 55.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.763 0.425 . . . . 72.409999999999997 111.533 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt 51.08 23.1 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.56 1.144 . . . . 72.540000000000006 114.037 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.51 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.8 mm-40 -93.26 144.4 25.34 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.484 0.549 . . . . 64.209999999999994 112.484 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -138.69 142.95 38.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.776 0.322 . . . . 74.030000000000001 110.643 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.9 t -145.25 159.69 42.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.397 . . . . 74.439999999999998 111.707 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.35 120.25 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.282 -0.417 . . . . 72.409999999999997 110.969 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.53 152.57 55.58 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 116.377 -0.374 . . . . 63.219999999999999 111.336 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.09 127.73 11.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.44 2.094 . . . . 74.420000000000002 113.326 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.47 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -81.4 103.82 11.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.254 -0.43 . . . . 39.310000000000002 111.31 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -109.84 128.87 55.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.829 0.347 . . . . 75.140000000000001 111.599 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.23 110.56 4.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 110.792 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.16 -6.42 15.07 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.347 -0.454 . . . . 71.120000000000005 112.274 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.426 ' O ' HG21 ' A' ' 214' ' ' ILE . 98.0 t -110.86 133.01 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.68 0.392 . . . . 75.25 110.64 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 80.8 p -87.02 156.0 19.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 71.349999999999994 111.739 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.7 t -50.18 -42.01 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.079 0.466 . . . . 71.129999999999995 111.405 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.58 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 23.0 ttt180 -63.62 -46.69 84.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.248 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.68 -31.46 72.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.843 0.354 . . . . 75.420000000000002 111.944 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.0 t -79.73 -44.29 21.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.89 0.376 . . . . 72.439999999999998 111.846 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.401 HD22 HG21 ' A' ' 159' ' ' VAL . 91.2 mt -84.87 -15.26 45.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.193 0.812 . . . . 64.219999999999999 113.193 -176.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.91 -45.22 41.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.993 0.425 . . . . 74.120000000000005 111.935 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -66.86 -39.51 87.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.324 -0.398 . . . . 73.310000000000002 111.969 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.12 93.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.151 0.5 . . . . 74.340000000000003 111.409 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.65 -52.33 21.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.083 -0.508 . . . . 74.400000000000006 111.459 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.4 tpt -50.03 -53.0 29.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.752 0.649 . . . . 70.310000000000002 112.752 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.9 ptp -62.98 -23.7 67.56 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.345 0.498 . . . . 61.030000000000001 112.345 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -101.61 0.24 35.98 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.067 0.395 . . . . 73.030000000000001 112.067 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 89.07 23.75 34.06 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.117 -0.563 . . . . 65.219999999999999 114.071 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.04 148.4 35.24 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.323 -0.516 . . . . 72.349999999999994 111.329 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.74 148.54 59.64 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.671 -0.24 . . . . 73.319999999999993 110.955 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 -39.0 88.68 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 122.81 2.34 . . . . 71.219999999999999 113.537 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -60.43 -24.92 65.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.927 0.394 . . . . 74.430000000000007 111.773 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 39.8 t -93.97 -2.26 53.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.787 0.327 . . . . 72.439999999999998 111.855 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.449 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 68.6 m -128.69 139.71 52.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 72.120000000000005 112.003 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -120.07 119.91 34.72 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.687 0.279 . . . . 71.219999999999999 111.373 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.484 HG21 HG22 ' A' ' 224' ' ' VAL . 76.2 t -95.37 124.41 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.81 0.338 . . . . 73.409999999999997 111.486 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -136.23 155.46 50.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.425 0.631 . . . . 74.0 111.408 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.49 ' HB3' HD12 ' A' ' 208' ' ' ILE . 10.2 ptm85 -109.66 133.04 53.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.845 -0.616 . . . . 75.310000000000002 111.42 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.4 mt -89.61 91.75 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.445 0.641 . . . . 73.129999999999995 109.978 173.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.52 123.93 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.573 -0.739 . . . . 71.239999999999995 111.382 -173.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 62.52 17.67 9.78 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.353 0.596 . . . . 61.43 110.86 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.28 -4.43 70.41 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.272 -0.422 . . . . 65.420000000000002 113.427 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -101.95 140.28 36.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.447 -0.443 . . . . 70.349999999999994 112.014 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.31 105.58 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.726 0.298 . . . . 75.530000000000001 110.814 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 123.07 38.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.818 -0.173 . . . . 74.230000000000004 111.308 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 143.36 55.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.563 2.176 . . . . 73.230000000000004 113.498 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.49 HD12 ' HB3' ' A' ' 199' ' ' ARG . 57.3 mt -122.91 145.93 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.816 0.341 . . . . 72.209999999999994 110.875 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.57 143.38 16.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.077 -0.582 . . . . 74.010000000000005 112.808 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.58 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 95.6 m95 -61.34 -23.76 65.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 122.306 -0.526 . . . . 75.120000000000005 111.66 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -87.03 0.77 54.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.239 0.459 . . . . 75.299999999999997 112.239 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 85.7 m -75.89 142.48 42.09 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 71.219999999999999 111.194 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.54 140.4 57.98 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.419 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.426 HG21 ' O ' ' A' ' 175' ' ' VAL . 14.7 tt -79.18 -23.21 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.584 0.587 . . . . 72.299999999999997 112.584 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 89.2 p -62.0 -21.89 65.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.867 0.365 . . . . 75.319999999999993 111.842 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.12 -23.62 66.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.976 0.417 . . . . 74.510000000000005 111.814 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.448 HD13 HD12 ' A' ' 222' ' ' LEU . 21.9 mt -108.38 21.93 16.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.874 -0.603 . . . . 74.099999999999994 112.093 -169.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 79.4 m -65.16 118.12 8.75 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.834 0.679 . . . . 74.239999999999995 112.834 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.6 -26.04 25.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.144 0.417 . . . . 74.150000000000006 114.144 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -98.81 172.36 7.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.153 0.502 . . . . 75.239999999999995 111.787 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -109.95 137.57 47.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.336 0.865 . . . . 75.430000000000007 113.336 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.448 HD12 HD13 ' A' ' 217' ' ' LEU . 63.0 mt -102.48 155.92 17.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.404 -0.816 . . . . 74.329999999999998 110.713 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -126.57 127.62 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.132 -0.355 . . . . 71.340000000000003 110.755 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 197' ' ' VAL . 54.5 t -107.23 125.01 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.188 0.44 . . . . 74.310000000000002 112.188 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -100.33 168.71 9.6 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.234 -0.439 . . . . 75.230000000000004 111.259 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.85 114.31 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.398 -0.364 . . . . 74.329999999999998 111.354 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.12 -63.05 1.49 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 110.741 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.0 107.34 19.26 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.0 -0.546 . . . . 72.439999999999998 110.872 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -73.46 72.72 1.37 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.4 0.619 . . . . 74.25 110.137 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.08 100.07 9.76 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.72 -0.673 . . . . 71.329999999999998 111.27 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.21 98.88 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.048 1.832 . . . . 73.150000000000006 111.491 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.733 -0.651 . . . . 74.239999999999995 111.644 -174.059 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.687 0.28 . . . . 75.319999999999993 111.324 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 89.7 mmm -104.01 115.72 62.78 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 73.200000000000003 110.612 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.56 72.57 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.689 2.259 . . . . 62.299999999999997 112.748 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -82.78 134.37 35.12 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.081 -0.509 . . . . 75.230000000000004 111.456 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 t -151.02 87.24 4.7 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.311 -0.404 . . . . 73.319999999999993 111.242 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.61 87.99 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.693 2.262 . . . . 73.340000000000003 111.925 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -106.84 13.67 27.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.339 0.496 . . . . 72.439999999999998 112.339 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 157.49 82.09 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.307 -0.406 . . . . 64.430000000000007 110.838 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.41 137.2 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.067 1.845 . . . . 65.040000000000006 111.211 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.408 ' HB ' HG12 ' A' ' 168' ' ' VAL . 2.8 pp -133.9 165.79 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.053 0.76 . . . . 74.129999999999995 113.053 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.26 135.67 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.559 -0.746 . . . . 73.319999999999993 110.703 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.548 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.7 100.01 12.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.923 0.392 . . . . 72.540000000000006 111.329 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.49 HG21 HD22 ' A' ' 181' ' ' LEU . 47.9 t -95.85 109.92 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.961 0.41 . . . . 74.5 111.658 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -80.8 117.98 21.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.931 0.396 . . . . 72.209999999999994 111.104 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 89.0 mt -93.72 157.68 37.84 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.124 -0.489 . . . . 63.350000000000001 110.707 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.533 ' HG3' HG21 ' A' ' 226' ' ' VAL . 29.9 Cg_endo -63.57 168.67 11.12 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.231 1.954 . . . . 72.310000000000002 112.986 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.38 33.59 18.72 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.168 0.432 . . . . 73.420000000000002 112.168 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 70.14 23.89 5.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.278 0.631 . . . . 75.040000000000006 112.434 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -99.62 163.56 12.44 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.04 -0.413 . . . . 74.120000000000005 111.443 178.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.42 159.47 31.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.036 0.446 . . . . 72.510000000000005 112.117 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -155.62 150.99 26.96 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.974 -0.557 . . . . 71.129999999999995 111.294 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.408 HG12 ' HB ' ' A' ' 156' ' ' ILE . 39.0 t -117.8 119.41 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.761 0.315 . . . . 72.120000000000005 110.635 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.495 HG12 HD23 ' A' ' 181' ' ' LEU . 29.7 m -116.0 150.36 44.94 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.144 0.424 . . . . 75.519999999999996 112.144 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 124.98 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.511 2.141 . . . . 62.149999999999999 113.606 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.76 103.78 8.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.172 0.51 . . . . 74.540000000000006 110.847 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -115.93 160.61 19.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.054 -0.521 . . . . 72.450000000000003 111.764 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.4 t -87.02 137.87 31.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 111.072 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.62 -11.74 18.19 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.145 -0.55 . . . . 60.32 113.722 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 48.4 t -93.6 123.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 122.438 -0.448 . . . . 74.239999999999995 110.959 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 29.3 p -74.73 168.54 19.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.184 0.516 . . . . 74.329999999999998 111.899 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 212' ' ' THR . 60.7 t -61.64 -33.78 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.278 0.561 . . . . 74.420000000000002 110.231 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.545 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 8.7 ttm105 -66.18 -51.32 58.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.815 -0.629 . . . . 73.329999999999998 111.365 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.94 -21.14 65.99 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.241 0.46 . . . . 74.019999999999996 112.241 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.9 m -86.02 -48.88 8.26 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.838 0.31 . . . . 71.310000000000002 111.838 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.495 HD23 HG12 ' A' ' 169' ' ' VAL . 78.3 mt -82.83 -2.27 54.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.717 0.636 . . . . 72.209999999999994 112.717 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -55.46 -25.81 38.7 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.977 0.417 . . . . 74.209999999999994 111.772 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.32 -48.85 11.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.957 0.408 . . . . 71.430000000000007 111.04 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -59.85 -44.52 94.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.117 -0.492 . . . . 62.5 111.973 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.416 HD13 ' CH2' ' A' ' 210' ' ' TRP . 90.9 mt -62.76 -46.57 87.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.861 0.362 . . . . 71.200000000000003 111.239 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.571 ' HA ' ' HE2' ' A' ' 186' ' ' MET . 5.6 tpt -59.12 -46.86 87.25 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.287 -0.415 . . . . 74.019999999999996 111.647 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.6 ptm -67.75 -8.61 36.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.772 0.32 . . . . 72.439999999999998 111.849 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 22.3 mmm180 -112.11 2.52 16.79 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.131 -0.356 . . . . 73.120000000000005 111.249 174.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.5 11.76 82.56 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.569 -0.348 . . . . 54.219999999999999 113.821 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.0 176.21 6.88 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 73.120000000000005 111.846 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.521 HG13 ' HB3' ' A' ' 194' ' ' CYS . 17.6 pt -140.1 143.24 33.17 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 111.328 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.74 -49.68 15.0 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.956 2.437 . . . . 73.510000000000005 113.857 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -73.57 5.54 3.79 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.804 0.668 . . . . 74.439999999999998 112.804 -174.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.521 ' HB3' HG13 ' A' ' 191' ' ' ILE . 43.2 t -128.29 15.35 6.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.048 0.451 . . . . 72.230000000000004 111.349 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.49 137.1 50.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.848 0.356 . . . . 73.040000000000006 110.939 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.75 120.94 44.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.727 0.299 . . . . 55.109999999999999 111.747 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.522 HG23 HG21 ' A' ' 224' ' ' VAL . 43.4 t -98.88 139.13 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.496 -0.32 . . . . 75.409999999999997 110.614 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -146.89 153.35 40.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.38 0.61 . . . . 74.120000000000005 111.926 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.54 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.7 ptm180 -114.29 159.56 20.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.652 -0.703 . . . . 73.540000000000006 110.469 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.0 mt -101.91 95.57 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.277 0.56 . . . . 73.129999999999995 110.759 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -108.74 128.11 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.824 -0.625 . . . . 74.239999999999995 110.555 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 t70 64.71 20.17 12.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.463 0.649 . . . . 65.450000000000003 111.18 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.16 -20.09 52.19 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.333 -0.461 . . . . 64.209999999999994 113.557 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -108.36 162.2 14.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.112 0.482 . . . . 73.140000000000001 111.578 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -82.2 143.27 31.51 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.28 0.562 . . . . 62.409999999999997 111.912 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -139.89 120.58 9.33 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.89 -0.595 . . . . 71.019999999999996 111.207 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -65.76 144.2 76.82 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.698 2.266 . . . . 63.020000000000003 113.484 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.54 HD11 ' HB3' ' A' ' 199' ' ' ARG . 66.4 mt -118.83 124.17 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.056 -0.52 . . . . 73.319999999999993 111.396 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.12 141.52 34.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.995 -0.622 . . . . 65.430000000000007 112.517 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.545 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.9 m95 -65.64 -16.08 63.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.389 0.595 . . . . 75.420000000000002 111.282 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.99 -16.37 61.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.842 -0.617 . . . . 75.540000000000006 111.762 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.417 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.2 m -69.47 136.96 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.226 -0.443 . . . . 74.340000000000003 111.509 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 4.7 m-20 -69.45 128.08 35.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 73.329999999999998 110.939 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.0 tp -59.07 -20.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.138 0.494 . . . . 64.120000000000005 111.522 -179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.8 p -59.84 -26.71 66.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.221 -0.445 . . . . 70.549999999999997 112.073 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -69.48 -21.56 63.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.858 0.361 . . . . 73.230000000000004 111.83 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.411 ' O ' ' HG2' ' A' ' 220' ' ' GLU . 46.5 mt -110.49 21.02 17.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.186 0.517 . . . . 72.219999999999999 111.393 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.8 m -58.8 121.32 10.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.897 0.703 . . . . 75.540000000000006 112.897 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.01 4.23 90.08 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.279 0.872 . . . . 71.340000000000003 115.279 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 217' ' ' LEU . 12.9 pt-20 -111.82 172.7 6.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.978 0.889 . . . . 71.109999999999999 111.71 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.548 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 4.2 mp0 -102.98 127.2 50.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.233 0.54 . . . . 73.109999999999999 111.572 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.459 HD13 HG23 ' A' ' 159' ' ' VAL . 74.0 mt -103.67 159.62 15.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.986 -0.552 . . . . 72.450000000000003 111.148 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -128.75 127.12 41.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.652 0.263 . . . . 74.439999999999998 110.633 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.522 HG21 HG23 ' A' ' 197' ' ' VAL . 46.8 t -117.84 146.78 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.283 0.563 . . . . 72.209999999999994 112.064 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.88 140.93 33.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 110.883 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.533 HG21 ' HG3' ' A' ' 162' ' ' PRO . 61.8 t -82.9 132.45 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.047 0.451 . . . . 70.099999999999994 111.871 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 59.6 mt -77.92 -52.93 8.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.324 -0.398 . . . . 70.310000000000002 111.457 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.464 ' O ' ' SG ' ' A' ' 194' ' ' CYS . 50.5 mt-10 -126.1 151.55 47.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.243 0.544 . . . . 73.409999999999997 111.655 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -88.42 28.44 1.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.438 -0.346 . . . . 64.349999999999994 111.703 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.462 HG12 ' HB3' ' A' ' 228' ' ' GLU . 4.6 p -115.16 108.0 48.8 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 113.109 0.781 . . . . 74.430000000000007 113.109 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -90.29 -176.81 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.86 2.373 . . . . 61.509999999999998 111.905 169.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.535 ' N ' HD23 ' A' ' 232' ' ' LEU . 1.2 pt? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.221 -0.895 . . . . 75.329999999999998 112.083 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.708 0.29 . . . . 75.140000000000001 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.6 ttt -74.38 122.1 86.75 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.606 -0.27 . . . . 72.319999999999993 110.445 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.63 85.8 0.29 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.339 2.026 . . . . 75.299999999999997 112.543 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.14 85.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.581 0.705 . . . . 73.140000000000001 110.973 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 48.9 p -130.37 141.84 43.32 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.409 -0.814 . . . . 74.129999999999995 110.876 -176.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -63.49 104.38 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.615 2.21 . . . . 65.439999999999998 113.38 -179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -83.41 122.17 28.14 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.939 -0.393 . . . . 72.129999999999995 109.939 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.14 153.23 36.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.825 0.676 . . . . 72.140000000000001 112.825 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HB2' HG21 ' A' ' 218' ' ' THR . 21.9 Cg_endo -60.08 137.9 78.43 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.579 2.186 . . . . 64.540000000000006 111.722 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.91 158.16 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.847 0.684 . . . . 74.010000000000005 112.847 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.56 127.67 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.608 -0.724 . . . . 74.519999999999996 110.367 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.524 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 99.0 mtt180 -89.69 100.44 13.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.16 0.505 . . . . 71.439999999999998 111.37 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.583 HG23 HD22 ' A' ' 181' ' ' LEU . 47.8 t -99.5 118.23 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.284 -0.416 . . . . 73.200000000000003 112.03 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.85 123.32 33.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.902 0.382 . . . . 74.409999999999997 110.536 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.515 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.3 mt -95.49 163.49 21.37 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.511 -0.313 . . . . 73.439999999999998 111.578 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.72 153.62 5.53 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.851 2.367 . . . . 71.420000000000002 113.994 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.89 42.37 10.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.757 -0.656 . . . . 72.310000000000002 111.532 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 63.47 9.25 4.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.066 0.765 . . . . 74.319999999999993 113.066 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.515 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -72.59 164.36 26.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.894 0.378 . . . . 75.420000000000002 110.814 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.445 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -156.43 151.7 26.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.857 -0.527 . . . . 75.510000000000005 112.093 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.0 t -156.19 171.21 20.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.945 -0.571 . . . . 74.519999999999996 111.137 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.87 120.34 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.844 0.355 . . . . 73.420000000000002 110.587 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.1 m -115.61 140.6 26.2 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.003 0.372 . . . . 61.43 112.003 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -67.4 127.28 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.45 2.1 . . . . 75.519999999999996 112.682 176.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.529 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -70.74 103.21 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 73.299999999999997 110.831 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -100.38 128.05 46.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.976 -0.556 . . . . 72.430000000000007 111.807 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.24 123.19 21.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.446 -0.343 . . . . 64.5 111.121 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.46 -14.94 60.52 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.974 -0.631 . . . . 73.209999999999994 113.349 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.85 127.51 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.503 -0.41 . . . . 64.409999999999997 110.805 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.5 p -78.07 160.68 27.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.084 0.468 . . . . 74.319999999999993 111.541 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.06 -36.32 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.429 0.633 . . . . 72.420000000000002 110.163 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -60.29 -52.7 64.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.174 -0.921 . . . . 74.030000000000001 111.157 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.08 -34.8 78.45 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.102 -0.499 . . . . 74.219999999999999 112.123 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.4 t -72.85 -49.95 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.442 0.534 . . . . 71.540000000000006 112.442 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.583 HD22 HG23 ' A' ' 159' ' ' VAL . 78.7 mt -85.09 -16.52 40.32 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.474 0.916 . . . . 74.120000000000005 113.474 -173.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.71 -32.55 52.39 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.844 0.683 . . . . 74.230000000000004 112.844 -173.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.74 -39.21 67.05 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 75.530000000000001 111.404 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.2 70.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.193 0.521 . . . . 72.430000000000007 110.784 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.78 -49.38 25.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.836 -0.62 . . . . 74.209999999999994 111.02 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.3 tpt -53.24 -47.8 68.73 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.079 -0.509 . . . . 75.510000000000005 112.006 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 ptm -64.61 -9.14 17.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.291 0.478 . . . . 71.120000000000005 112.291 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -110.91 -6.17 14.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.598 0.237 . . . . 75.239999999999995 111.514 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.66 36.9 14.91 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.122 -0.561 . . . . 60.149999999999999 112.752 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.51 154.71 43.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.541 0.336 . . . . 75.049999999999997 111.394 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.62 149.57 67.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 122.362 0.265 . . . . 74.140000000000001 111.009 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.42 -37.02 60.53 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.936 2.424 . . . . 72.450000000000003 113.734 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -69.87 -18.45 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.35 0.5 . . . . 72.120000000000005 112.35 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.1 -10.33 20.56 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.499 0.555 . . . . 74.099999999999994 112.499 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.9 m -131.98 171.27 13.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.238 0.542 . . . . 72.510000000000005 112.244 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -133.08 141.26 48.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.003 -0.544 . . . . 53.350000000000001 111.549 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.52 HG21 HG23 ' A' ' 224' ' ' VAL . 48.3 t -109.58 126.17 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.368 -0.378 . . . . 73.120000000000005 110.73 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -141.93 152.63 43.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.179 0.514 . . . . 73.209999999999994 111.936 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.59 160.13 16.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.88 -0.6 . . . . 72.040000000000006 110.578 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.5 mt -117.24 119.46 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.0 0.429 . . . . 75.510000000000005 111.469 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.06 149.69 29.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 109.872 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 62.93 16.46 9.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.78 0.324 . . . . 71.420000000000002 111.447 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.79 4.4 88.13 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.304 -0.474 . . . . 74.0 112.775 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -107.09 154.57 20.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.954 0.501 . . . . 71.329999999999998 111.986 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -94.82 126.19 39.98 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.88 0.371 . . . . 75.299999999999997 110.681 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.12 94.85 32.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.015 -0.365 . . . . 63.130000000000003 110.015 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.37 121.9 10.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.714 2.276 . . . . 75.200000000000003 112.443 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 58.8 mt -101.85 132.68 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 111.584 -175.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.73 126.09 26.56 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.77 -0.728 . . . . 71.010000000000005 112.358 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -51.63 -33.17 32.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.664 0.616 . . . . 74.540000000000006 112.664 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -85.74 21.37 1.89 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.426 0.528 . . . . 45.229999999999997 112.426 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 49.9 m -97.09 143.28 28.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 122.336 -0.228 . . . . 75.349999999999994 111.112 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.501 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.9 m-20 -58.2 128.27 36.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.126 0.489 . . . . 72.519999999999996 111.823 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.467 HD13 HD11 ' A' ' 217' ' ' LEU . 9.3 tp -63.66 -21.2 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.98 0.419 . . . . 73.329999999999998 111.722 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.529 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 78.4 p -60.62 -26.09 66.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.216 0.45 . . . . 72.549999999999997 112.216 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.501 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 22.3 m95 -67.21 -21.53 65.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.359 . . . . 74.400000000000006 111.968 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.467 HD11 HD13 ' A' ' 214' ' ' ILE . 33.9 mt -103.83 22.07 15.16 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.138 0.494 . . . . 75.209999999999994 111.896 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.421 HG21 ' HB2' ' A' ' 155' ' ' PRO . 77.4 m -53.71 124.71 15.95 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.893 0.701 . . . . 73.109999999999999 112.893 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.3 -5.87 66.04 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 114.401 0.521 . . . . 70.129999999999995 114.401 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.67 158.15 16.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.331 0.566 . . . . 65.120000000000005 111.742 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 51.8 mt-10 -100.69 117.84 35.62 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 110.809 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.512 HD11 HG22 ' A' ' 159' ' ' VAL . 82.1 mt -93.01 148.16 22.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.056 0.455 . . . . 74.120000000000005 111.012 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -121.35 113.28 19.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 72.239999999999995 110.541 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.52 HG23 HG21 ' A' ' 197' ' ' VAL . 43.5 t -108.46 130.76 60.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 74.209999999999994 111.22 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.92 157.68 45.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 73.239999999999995 111.435 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.95 130.0 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.044 -0.525 . . . . 64.230000000000004 111.453 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.45 -56.35 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 110.433 176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.76 135.97 36.85 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.744 -0.662 . . . . 63.450000000000003 110.971 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -72.97 76.77 1.18 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 72.319999999999993 110.864 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.0 m -98.18 118.75 63.2 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.294 0.568 . . . . 54.140000000000001 112.483 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -92.74 113.56 0.28 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.018 2.479 . . . . 65.219999999999999 112.194 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.97 -0.538 . . . . 74.120000000000005 111.797 -178.863 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.8 m80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.609 0.242 . . . . 72.430000000000007 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 148' ' ' MET . 3.0 mpp? -92.34 111.84 52.42 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.995 0.369 . . . . 74.549999999999997 111.995 -173.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.29 105.27 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.344 2.029 . . . . 64.109999999999999 111.484 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -115.87 149.39 38.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.19 0.811 . . . . 75.219999999999999 113.19 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.3 t -133.6 82.62 50.73 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.578 -0.737 . . . . 70.439999999999998 109.751 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.21 126.24 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.68 2.253 . . . . 74.409999999999997 113.827 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -82.16 39.18 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.243 0.544 . . . . 72.239999999999995 111.223 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 9.2 mmpt? -97.62 152.05 37.95 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.961 -0.563 . . . . 72.219999999999999 111.799 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.97 114.86 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.229 1.953 . . . . 65.310000000000002 110.95 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.422 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -114.65 160.7 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.102 0.778 . . . . 75.049999999999997 113.102 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.35 139.21 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.553 -0.749 . . . . 53.399999999999999 110.518 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.551 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 1.5 mpt_? -92.88 111.71 23.42 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.546 0.212 . . . . 74.349999999999994 110.543 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.23 122.33 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.35 0.5 . . . . 61.32 112.35 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.96 99.76 11.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 110.399 174.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.498 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.1 mt -65.97 144.0 98.65 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.654 -0.248 . . . . 73.120000000000005 111.27 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.23 143.52 52.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.552 2.168 . . . . 74.239999999999995 112.945 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 74.5 54.43 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.122 0.569 . . . . 73.519999999999996 111.534 179.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 67.59 22.02 9.25 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.938 1.088 . . . . 70.319999999999993 113.938 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 71.7 mm-40 -107.84 175.27 5.54 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.603 -0.686 . . . . 73.519999999999996 112.539 -175.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -146.98 152.68 39.02 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.159 0.504 . . . . 75.120000000000005 112.325 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.6 t -157.09 160.5 38.94 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.013 -0.539 . . . . 72.540000000000006 110.893 170.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.82 120.2 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.978 0.418 . . . . 75.030000000000001 110.722 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.05 141.13 37.62 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 111.909 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.4 Cg_endo -77.14 132.55 12.76 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.69 2.26 . . . . 74.519999999999996 113.487 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.513 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -70.78 128.85 37.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.194 0.521 . . . . 70.409999999999997 111.802 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -129.69 131.53 46.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.067 -0.515 . . . . 74.049999999999997 110.931 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -71.99 109.83 6.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 73.319999999999993 111.163 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.3 19.6 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.326 -0.464 . . . . 73.230000000000004 112.668 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.418 ' O ' HG21 ' A' ' 214' ' ' ILE . 96.0 t -117.72 125.84 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.939 0.399 . . . . 73.420000000000002 110.948 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 p -82.69 167.38 18.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 65.340000000000003 111.736 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.404 HG21 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.55 -36.63 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.304 0.574 . . . . 64.319999999999993 110.459 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 41.3 ttt180 -67.06 -57.68 6.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.735 -0.666 . . . . 75.299999999999997 111.187 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -28.22 58.72 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.116 0.413 . . . . 71.310000000000002 112.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 36.7 t -78.78 -47.42 16.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.709 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.13 -1.53 54.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.157 0.799 . . . . 73.109999999999999 113.157 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.34 -41.47 76.14 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 73.519999999999996 112.136 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.24 -32.31 68.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.058 0.456 . . . . 73.040000000000006 111.09 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.496 ' HA ' ' HE2' ' A' ' 187' ' ' MET . . . -64.8 -38.55 91.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.035 0.445 . . . . 72.230000000000004 111.051 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -75.68 -38.69 58.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.848 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 24.7 ttt -54.67 -50.6 67.81 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.935 -0.575 . . . . 75.109999999999999 111.713 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.496 ' HE2' ' HA ' ' A' ' 184' ' ' ALA . 26.7 ptt? -69.78 -4.29 19.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.52 0.563 . . . . 64.219999999999999 112.52 -178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -118.28 2.42 11.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.055 0.391 . . . . 72.420000000000002 112.055 179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.83 38.64 89.52 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 73.129999999999995 113.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.98 154.99 36.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.912 0.387 . . . . 75.420000000000002 111.685 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.83 146.54 46.18 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.366 -0.379 . . . . 74.420000000000002 111.396 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.6 -44.27 45.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.113 2.542 . . . . 72.310000000000002 114.141 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.01 -4.1 12.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.371 0.508 . . . . 75.120000000000005 112.371 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -100.5 -5.39 27.04 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.928 0.394 . . . . 73.109999999999999 111.425 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.36 144.12 42.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 111.993 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.52 ' HB1' HD21 ' A' ' 227' ' ' LEU . . . -112.22 137.44 50.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.779 0.323 . . . . 51.119999999999997 111.483 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.479 HG23 HG22 ' A' ' 224' ' ' VAL . 47.4 t -102.48 140.09 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.276 -0.42 . . . . 64.329999999999998 110.26 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -157.77 158.47 35.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.254 0.55 . . . . 73.400000000000006 112.023 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.811 HH11 ' HG3' ' A' ' 220' ' ' GLU . 79.1 mtm180 -110.41 139.46 45.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.141 -0.481 . . . . 73.140000000000001 111.239 175.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.95 96.41 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.299 0.571 . . . . 71.230000000000004 110.111 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.75 107.54 18.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 74.310000000000002 110.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.0 20.05 7.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.298 0.571 . . . . 74.209999999999994 111.567 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.62 38.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.474 -0.393 . . . . 71.129999999999995 113.257 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.18 117.34 23.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.944 0.35 . . . . 70.040000000000006 111.944 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -80.72 109.34 15.17 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.546 0.212 . . . . 74.530000000000001 111.222 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -102.9 106.82 52.43 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.599 0.238 . . . . 72.129999999999995 111.195 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.51 116.53 4.28 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.873 2.382 . . . . 73.519999999999996 113.036 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.44 HD13 ' HG3' ' A' ' 199' ' ' ARG . 64.1 mt -101.06 133.26 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.236 0.541 . . . . 73.049999999999997 111.908 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.7 143.3 28.92 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.199 -0.524 . . . . 62.350000000000001 112.888 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 96.4 m95 -60.4 -21.89 62.72 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.352 0.576 . . . . 74.030000000000001 111.011 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.05 -5.16 50.54 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.987 -0.551 . . . . 75.409999999999997 112.204 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.404 ' O ' HG21 ' A' ' 177' ' ' VAL . 40.8 m -74.25 136.76 42.7 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.551 0.215 . . . . 74.129999999999995 111.353 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.458 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 18.1 t70 -72.09 129.24 38.03 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.04 0.448 . . . . 75.519999999999996 110.88 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.418 HG21 ' O ' ' A' ' 175' ' ' VAL . 12.5 tt -66.02 -22.63 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.731 0.641 . . . . 75.019999999999996 112.731 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.513 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 41.2 t -63.39 -21.05 66.05 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.821 -0.549 . . . . 71.040000000000006 111.425 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.458 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 16.8 m95 -80.18 -10.65 59.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.013 0.435 . . . . 72.109999999999999 111.356 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.518 HD13 HD21 ' A' ' 222' ' ' LEU . 49.6 mt -111.42 15.04 21.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.227 -0.442 . . . . 65.430000000000007 111.571 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.3 m -56.29 126.32 25.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.355 0.502 . . . . 75.409999999999997 112.355 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.29 10.14 84.06 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.299 -0.477 . . . . 73.019999999999996 114.087 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . 0.811 ' HG3' HH11 ' A' ' 199' ' ' ARG . 36.5 mm-40 -107.37 171.89 7.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.126 0.489 . . . . 71.530000000000001 111.53 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.551 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.1 mp0 -111.01 121.01 44.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 110.866 172.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.518 HD21 HD13 ' A' ' 217' ' ' LEU . 80.2 mt -94.01 117.65 30.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.916 0.388 . . . . 75.430000000000007 111.197 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -94.41 118.74 32.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.612 -0.267 . . . . 72.310000000000002 110.484 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.479 HG22 HG23 ' A' ' 197' ' ' VAL . 21.7 t -110.15 139.93 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.13 0.491 . . . . 74.310000000000002 111.158 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.98 170.45 15.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.454 -0.339 . . . . 74.420000000000002 111.369 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.29 127.04 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.862 0.363 . . . . 74.340000000000003 111.644 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.52 HD21 ' HB1' ' A' ' 196' ' ' ALA . 86.4 mt -66.44 -45.24 80.49 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 111.99 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.431 ' HG3' ' H ' ' A' ' 230' ' ' VAL . 16.2 pt-20 -80.33 170.08 16.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.287 0.565 . . . . 73.140000000000001 111.887 -177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -81.29 9.69 6.68 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.68 0.622 . . . . 73.5 112.68 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.431 ' H ' ' HG3' ' A' ' 228' ' ' GLU . 57.5 t -127.83 91.6 44.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.043 0.386 . . . . 74.239999999999995 112.043 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.17 115.64 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.258 2.639 . . . . 70.349999999999994 112.199 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.252 1.22 0 N-CA-C 112.064 0.394 . . . . 73.540000000000006 112.064 -178.092 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.726 0.298 . . . . 73.200000000000003 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mtt -130.12 150.67 76.71 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 122.432 0.293 . . . . 75.319999999999993 110.946 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.74 154.27 68.0 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.577 2.185 . . . . 72.510000000000005 113.529 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.53 152.95 27.04 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 74.219999999999999 111.815 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 79.3 p 47.52 87.45 0.12 Allowed Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.15 0.796 . . . . 74.329999999999998 113.15 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.44 97.99 0.63 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.686 2.257 . . . . 73.349999999999994 112.9 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -91.4 4.74 51.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.011 0.434 . . . . 72.430000000000007 111.187 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -67.94 132.22 92.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.996 -0.547 . . . . 72.450000000000003 111.396 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.42 135.86 44.43 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.347 2.031 . . . . 75.219999999999999 111.738 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.8 pt -123.62 161.11 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 74.0 113.051 -173.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.411 HG23 HG13 ' A' ' 214' ' ' ILE . 44.5 t -127.12 131.92 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.8 -0.636 . . . . 74.099999999999994 110.459 174.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 64.0 mtt85 -100.96 105.14 16.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.941 0.4 . . . . 73.450000000000003 111.632 -176.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.591 HG21 HD12 ' A' ' 222' ' ' LEU . 60.0 t -99.6 119.08 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.575 -0.284 . . . . 75.439999999999998 111.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -92.13 113.51 25.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.351 0.596 . . . . 75.209999999999994 111.888 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.443 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.5 mt -91.14 169.15 12.09 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 115.435 -0.802 . . . . 74.400000000000006 111.04 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -55.26 165.29 3.14 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.427 2.085 . . . . 74.319999999999993 113.479 175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.83 28.76 18.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.776 0.43 . . . . 73.439999999999998 111.954 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp 63.29 22.96 13.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.987 0.515 . . . . 75.230000000000004 112.087 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.443 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 80.3 mm-40 -82.81 168.33 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 111.048 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -156.43 161.75 40.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 75.319999999999993 112.124 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.6 t -150.41 151.08 32.24 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.655 -0.702 . . . . 74.340000000000003 110.525 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.52 119.61 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.988 0.423 . . . . 75.450000000000003 111.443 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 27.1 m -120.38 144.51 38.38 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.318 -0.401 . . . . 61.109999999999999 111.449 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.8 Cg_exo -65.56 132.66 31.71 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.645 2.23 . . . . 73.030000000000001 112.992 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.483 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -73.97 117.65 16.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 75.420000000000002 111.604 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -130.37 143.55 50.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.283 -0.417 . . . . 74.099999999999994 111.194 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.41 140.99 37.24 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.636 0.255 . . . . 74.230000000000004 110.642 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.08 -25.29 10.35 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.116 -0.564 . . . . 72.140000000000001 112.314 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.91 117.54 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.926 0.394 . . . . 73.129999999999995 110.899 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 39.5 p -80.15 156.91 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.484 -0.325 . . . . 75.430000000000007 111.254 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.75 -31.7 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.552 0.692 . . . . 70.439999999999998 110.756 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.606 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.4 ttp85 -70.18 -35.23 73.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.448 -0.796 . . . . 74.230000000000004 111.59 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.27 -43.33 21.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.196 -0.456 . . . . 62.210000000000001 111.903 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -61.14 -49.81 75.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.129 0.49 . . . . 71.340000000000003 111.978 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.71 14.43 2.13 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.972 0.73 . . . . 74.420000000000002 112.972 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.458 ' HG3' ' N ' ' A' ' 183' ' ' LYS . 9.5 ptpp? -53.12 -48.3 67.96 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.286 0.476 . . . . 73.409999999999997 112.286 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.458 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 65.6 pttt -79.05 -29.75 43.66 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.05 -0.406 . . . . 71.450000000000003 111.311 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.29 88.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.142 0.496 . . . . 52.100000000000001 111.434 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -46.34 70.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.103 0.477 . . . . 74.109999999999999 110.689 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 41.2 ttm -50.93 -51.5 51.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.731 -0.668 . . . . 72.230000000000004 112.156 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.41 -19.91 65.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.298 0.481 . . . . 74.019999999999996 112.298 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -98.91 -4.47 32.8 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.821 0.344 . . . . 75.510000000000005 111.421 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 25.81 63.81 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.184 -0.531 . . . . 54.340000000000003 113.006 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.2 mt -113.89 153.97 28.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.447 . . . . 73.420000000000002 111.486 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.404 ' HB ' ' HD2' ' A' ' 192' ' ' PRO . 31.0 pt -128.69 156.89 76.76 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 116.305 -0.407 . . . . 75.519999999999996 110.318 174.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . 0.404 ' HD2' ' HB ' ' A' ' 191' ' ' ILE . 11.3 Cg_endo -53.78 -42.87 62.84 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.507 2.138 . . . . 73.450000000000003 113.159 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.65 -7.62 28.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.16 0.43 . . . . 61.219999999999999 112.16 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.547 ' HG ' HG13 ' A' ' 226' ' ' VAL . 40.9 t -109.87 -2.45 17.22 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.803 0.297 . . . . 63.450000000000003 111.803 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.08 162.53 34.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.08 0.467 . . . . 71.230000000000004 111.778 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.452 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.19 139.98 48.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.927 0.394 . . . . 54.109999999999999 111.586 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.476 HG21 HG22 ' A' ' 224' ' ' VAL . 54.1 t -107.95 135.19 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.177 -0.465 . . . . 72.239999999999995 111.024 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.62 158.2 43.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.982 0.42 . . . . 73.319999999999993 111.148 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -127.58 149.1 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.89 0.376 . . . . 75.120000000000005 110.883 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.85 95.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.546 0.689 . . . . 73.019999999999996 110.206 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.46 109.14 20.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.554 -0.748 . . . . 72.299999999999997 111.259 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.8 t70 60.78 26.54 16.36 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.475 0.655 . . . . 74.540000000000006 111.006 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.55 -13.25 59.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.166 -0.47 . . . . 61.109999999999999 113.441 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 125.18 35.9 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.107 0.41 . . . . 62.439999999999998 112.107 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.02 93.92 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.147 0.498 . . . . 74.150000000000006 109.8 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -99.7 115.57 65.5 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.184 -0.462 . . . . 75.299999999999997 111.725 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.55 127.18 20.07 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.692 2.261 . . . . 75.030000000000001 112.806 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -102.34 120.47 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.117 -0.492 . . . . 70.420000000000002 110.872 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.81 135.09 46.78 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.889 -0.672 . . . . 62.310000000000002 113.197 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.606 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 83.3 m95 -55.72 -32.81 63.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.523 0.564 . . . . 72.450000000000003 112.523 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.62 11.75 8.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.852 0.686 . . . . 75.420000000000002 112.852 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.3 m -79.85 141.91 35.73 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.158 -0.339 . . . . 72.310000000000002 110.862 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 118.29 5.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.895 0.378 . . . . 65.219999999999999 111.145 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.411 HG13 HG23 ' A' ' 157' ' ' VAL . 10.7 tp -57.34 -22.3 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.09 0.471 . . . . 71.439999999999998 111.845 -178.669 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.483 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 23.3 t -61.28 -23.89 66.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.159 0.429 . . . . 72.319999999999993 112.159 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -66.51 -22.46 66.18 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.062 0.458 . . . . 72.510000000000005 111.388 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.0 mt -108.02 30.11 6.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.707 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 93.9 m -62.65 116.65 5.36 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.711 0.634 . . . . 74.450000000000003 112.711 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 85.01 8.91 81.59 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.99 0.756 . . . . 64.010000000000005 114.99 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 167.34 10.96 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.73 0.765 . . . . 71.340000000000003 112.126 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -102.47 120.89 41.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.794 -0.639 . . . . 75.150000000000006 111.717 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.591 HD12 HG21 ' A' ' 159' ' ' VAL . 68.4 mt -94.03 143.77 26.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.082 -0.508 . . . . 74.219999999999999 111.45 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -109.03 109.47 20.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.735 0.303 . . . . 74.310000000000002 110.203 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.476 HG22 HG21 ' A' ' 197' ' ' VAL . 61.6 t -107.77 148.86 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.077 0.465 . . . . 74.530000000000001 111.517 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.21 160.24 42.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.968 0.413 . . . . 73.310000000000002 111.049 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.547 HG13 ' HG ' ' A' ' 194' ' ' CYS . 47.8 t -83.29 132.25 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.8 0.333 . . . . 72.219999999999999 111.771 -177.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.452 HD21 ' HB2' ' A' ' 196' ' ' ALA . 94.8 mt -68.34 -44.57 75.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.121 0.486 . . . . 74.319999999999993 110.335 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -69.33 110.81 4.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.944 -0.571 . . . . 72.219999999999999 110.588 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -74.8 64.59 1.28 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.246 0.546 . . . . 71.219999999999999 111.791 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.18 110.12 9.85 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.159 -0.473 . . . . 74.030000000000001 110.839 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.53 -176.9 2.7 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.646 2.231 . . . . 73.329999999999998 112.606 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.416 ' N ' HD23 ' A' ' 232' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.707 -0.663 . . . . 73.099999999999994 110.624 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.606 0.241 . . . . 72.019999999999996 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 84.4 mtp 60.77 84.94 0.19 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 122.869 0.468 . . . . 73.349999999999994 112.199 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.27 113.32 3.42 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.722 2.281 . . . . 73.209999999999994 112.479 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.538 ' HD2' ' O ' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -68.46 145.47 54.04 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 111.582 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 77.6 p -172.48 108.15 0.35 Allowed Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 120.763 0.316 . . . . 74.120000000000005 111.747 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.59 111.89 3.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.601 2.201 . . . . 74.549999999999997 112.195 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -89.36 2.27 54.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 64.230000000000004 111.247 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -77.08 150.87 81.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.168 -0.469 . . . . 74.319999999999993 111.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.43 142.72 99.43 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.378 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.424 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 2.9 pp -123.05 161.73 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.538 0.685 . . . . 72.430000000000007 112.814 -175.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.43 141.21 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 115.73 -0.668 . . . . 75.409999999999997 110.919 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.28 106.5 18.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.644 0.259 . . . . 70.549999999999997 111.132 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.602 HG21 HD22 ' A' ' 181' ' ' LEU . 55.6 t -109.19 124.45 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.123 0.487 . . . . 75.109999999999999 112.12 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.446 ' HD1' ' HG3' ' A' ' 166' ' ' ARG . 20.6 m-85 -99.78 113.74 26.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.187 -0.46 . . . . 74.049999999999997 110.961 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 86.3 mt -90.9 160.87 37.13 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.037 -0.529 . . . . 71.209999999999994 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.502 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 29.6 Cg_endo -61.88 167.26 10.68 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.929 2.419 . . . . 75.030000000000001 113.672 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.19 29.7 18.9 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.353 0.597 . . . . 75.310000000000002 111.341 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 60.37 59.03 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.354 -0.839 . . . . 72.239999999999995 111.718 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.1 mm-40 -118.91 143.61 46.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.889 -0.596 . . . . 73.340000000000003 110.455 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.446 ' HG3' ' HD1' ' A' ' 160' ' ' PHE . 3.4 mpt_? -126.19 147.18 49.7 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.952 -0.468 . . . . 73.319999999999993 111.698 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.49 161.74 40.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.046 -0.525 . . . . 64.310000000000002 111.357 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.424 ' CG1' ' HB ' ' A' ' 156' ' ' ILE . 61.9 t -126.89 120.14 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.837 0.351 . . . . 74.150000000000006 111.197 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -111.44 153.76 44.03 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 116.396 -0.365 . . . . 71.019999999999996 111.764 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.14 151.6 30.47 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.543 2.162 . . . . 72.129999999999995 113.532 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.452 ' HB3' ' HA ' ' A' ' 215' ' ' SER . . . -105.09 112.49 25.64 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.068 -0.514 . . . . 75.439999999999998 111.882 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -126.34 148.28 49.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.522 0.329 . . . . 75.310000000000002 111.046 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.12 135.64 37.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.712 0.292 . . . . 74.200000000000003 110.921 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.12 -30.57 7.94 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.142 -0.552 . . . . 75.129999999999995 112.277 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.8 t -80.89 109.72 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.108 0.48 . . . . 72.430000000000007 110.346 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 36.9 p -76.36 163.31 27.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.272 -0.422 . . . . 72.430000000000007 111.324 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.465 HG23 ' O ' ' A' ' 212' ' ' THR . 60.8 t -54.02 -37.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.288 0.566 . . . . 75.010000000000005 110.23 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.562 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 3.4 tmt_? -65.64 -39.34 91.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.492 -0.776 . . . . 72.540000000000006 111.187 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 31.8 t70 -79.34 -29.07 42.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.935 0.346 . . . . 75.239999999999995 111.935 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -78.56 -55.74 4.97 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.093 0.473 . . . . 71.439999999999998 111.496 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.602 HD22 HG21 ' A' ' 159' ' ' VAL . 62.4 mt -72.48 -3.56 25.09 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.797 0.665 . . . . 72.340000000000003 112.797 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 24.6 pttm -61.75 -20.65 63.77 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.026 -0.421 . . . . 75.340000000000003 110.747 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.08 -53.46 6.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.025 0.44 . . . . 75.450000000000003 110.877 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.28 70.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.055 -0.52 . . . . 65.420000000000002 111.869 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -81.79 -26.21 34.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.56 -0.291 . . . . 75.219999999999999 111.58 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.734 ' HA ' ' HE2' ' A' ' 186' ' ' MET . 3.0 tpt -64.39 -41.76 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.818 0.342 . . . . 71.439999999999998 111.013 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.46 -21.3 64.64 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.013 0.435 . . . . 71.540000000000006 110.948 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -83.75 -21.16 32.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.31 -0.405 . . . . 72.129999999999995 110.808 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.61 29.61 26.39 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.41 -0.424 . . . . 55.210000000000001 113.064 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 84.4 mt -131.31 164.93 24.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.17 0.51 . . . . 75.420000000000002 111.829 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.36 143.16 26.63 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.125 -0.489 . . . . 75.319999999999993 111.159 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -52.42 -42.96 57.82 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 73.230000000000004 113.978 -178.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.414 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.6 pm0 -70.29 -0.78 8.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.375 0.509 . . . . 72.430000000000007 112.375 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 52.9 t -107.15 9.83 30.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.964 0.412 . . . . 63.399999999999999 111.024 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 62.0 m -131.38 172.16 12.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.223 -0.444 . . . . 61.340000000000003 111.215 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -136.98 126.93 25.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.804 0.335 . . . . 70.310000000000002 111.638 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.513 HG21 HG23 ' A' ' 224' ' ' VAL . 43.4 t -99.08 125.22 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 110.805 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -136.28 146.52 46.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.525 0.678 . . . . 74.299999999999997 111.365 175.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HB3' HD12 ' A' ' 208' ' ' ILE . 0.5 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.533 -0.758 . . . . 74.439999999999998 110.24 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -77.72 87.61 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.875 0.845 . . . . 63.009999999999998 109.944 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -115.66 136.73 52.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.111 -0.949 . . . . 65.340000000000003 111.105 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.19 26.24 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.285 0.564 . . . . 73.409999999999997 112.327 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.2 58.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.153 -0.546 . . . . 61.210000000000001 114.402 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.71 151.93 47.57 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.416 0.608 . . . . 72.040000000000006 111.877 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -77.73 94.65 4.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.661 -0.496 . . . . 72.219999999999999 109.661 170.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.25 114.07 64.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 120.626 0.251 . . . . 75.420000000000002 111.439 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.64 155.36 43.0 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.891 2.394 . . . . 74.409999999999997 113.762 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 199' ' ' ARG . 60.9 mt -127.28 133.45 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.788 -0.642 . . . . 71.400000000000006 110.588 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.59 132.98 23.0 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.86 -0.686 . . . . 72.409999999999997 112.816 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 82.4 m95 -62.31 -22.37 65.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.269 0.47 . . . . 74.420000000000002 112.269 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.55 -11.76 59.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.962 0.356 . . . . 71.140000000000001 111.962 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.465 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 m -66.54 134.26 52.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.685 0.279 . . . . 74.150000000000006 111.501 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.451 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 2.3 m-20 -58.94 130.58 47.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.821 0.343 . . . . 74.340000000000003 111.141 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.12 -21.58 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.193 0.521 . . . . 72.129999999999995 111.373 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' SER . . . . . 0.452 ' HA ' ' HB3' ' A' ' 171' ' ' ALA . 98.9 p -61.16 -26.07 67.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.064 -0.516 . . . . 65.209999999999994 111.847 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.451 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.6 m95 -66.58 -24.72 66.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.154 0.502 . . . . 65.420000000000002 111.815 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.87 21.42 17.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.021 -0.536 . . . . 74.329999999999998 111.511 -173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.7 m -56.86 112.24 1.26 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.798 0.666 . . . . 71.329999999999998 112.798 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.49 75.32 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 115.093 0.797 . . . . 71.310000000000002 115.093 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.44 172.21 7.15 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.145 0.972 . . . . 54.399999999999999 111.737 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.427 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . 19.0 mp0 -96.28 134.25 39.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.095 -0.502 . . . . 75.230000000000004 111.565 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.46 144.67 45.82 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.499 -0.319 . . . . 72.120000000000005 110.815 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -115.34 116.3 28.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.688 0.28 . . . . 70.120000000000005 110.381 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.513 HG23 HG21 ' A' ' 197' ' ' VAL . 51.0 t -115.31 127.16 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.866 0.365 . . . . 73.230000000000004 111.391 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.96 161.08 29.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.993 0.425 . . . . 70.010000000000005 111.427 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.423 HG21 ' HG3' ' A' ' 162' ' ' PRO . 16.7 t -90.5 138.32 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 64.420000000000002 111.583 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.04 -63.98 1.22 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.977 0.418 . . . . 71.409999999999997 111.389 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -106.8 168.27 9.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.161 0.505 . . . . 74.209999999999994 111.519 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -100.06 91.06 4.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.983 0.42 . . . . 64.340000000000003 111.099 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 5.9 p -147.8 87.94 5.74 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 121.481 0.658 . . . . 74.519999999999996 111.674 178.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.37 162.01 4.53 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.011 2.474 . . . . 74.329999999999998 113.365 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.426 ' N ' HD21 ' A' ' 232' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.256 1.419 0 CA-C-O 118.734 -0.65 . . . . 74.120000000000005 111.651 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.3 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.815 0.341 . . . . 75.319999999999993 111.561 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.445 ' HE1' ' HD2' ' A' ' 149' ' ' PRO . 96.6 mmm -98.84 149.84 36.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.57 -0.286 . . . . 74.200000000000003 110.842 177.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.445 ' HD2' ' HE1' ' A' ' 148' ' ' MET . 11.3 Cg_endo -53.68 125.71 19.49 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.659 2.239 . . . . 73.319999999999993 113.369 -178.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -114.95 150.82 35.13 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.038 0.447 . . . . 72.540000000000006 111.937 -177.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.5 m -77.89 134.89 63.87 Favored Pre-proline 0 N--CA 1.473 0.698 0 CA-C-N 116.057 -0.519 . . . . 74.329999999999998 111.965 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.18 117.35 4.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.675 2.25 . . . . 73.409999999999997 112.716 176.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -113.59 -23.93 9.5 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.522 0.564 . . . . 73.219999999999999 112.522 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -66.98 150.96 97.61 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 112.372 0.508 . . . . 74.310000000000002 112.372 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.08 145.85 97.47 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.321 2.68 . . . . 64.140000000000001 114.55 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.41 168.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.927 -0.579 . . . . 74.019999999999996 112.268 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 171' ' ' ALA . 63.4 t -133.05 140.3 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.142 -0.481 . . . . 73.140000000000001 110.289 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -104.23 102.17 11.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.801 0.334 . . . . 74.230000000000004 111.642 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.447 HG21 HD22 ' A' ' 181' ' ' LEU . 43.9 t -103.01 141.71 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.634 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -113.3 113.43 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.056 0.455 . . . . 75.439999999999998 111.219 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.419 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 90.8 mt -85.74 160.76 52.42 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.866 -0.606 . . . . 75.019999999999996 111.039 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 25.3 Cg_endo -61.67 169.05 7.49 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.112 1.875 . . . . 75.010000000000005 112.496 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.38 32.09 16.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.12 0.415 . . . . 70.030000000000001 112.12 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.7 22.94 7.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.124 0.787 . . . . 75.310000000000002 113.124 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -99.69 163.9 12.28 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.886 0.374 . . . . 73.420000000000002 111.595 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -154.9 165.0 38.06 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.006 -0.434 . . . . 74.010000000000005 111.924 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.8 t -156.01 155.71 33.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.89 0.376 . . . . 64.319999999999993 111.33 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 62.2 t -122.92 120.12 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.765 0.317 . . . . 75.340000000000003 110.97 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.7 147.89 38.61 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.084 0.402 . . . . 64.530000000000001 112.084 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.02 127.9 15.88 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.371 2.047 . . . . 71.510000000000005 112.91 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -85.78 118.71 25.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.003 0.43 . . . . 75.099999999999994 112.046 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -136.71 157.07 47.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.195 0.521 . . . . 75.239999999999995 111.898 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 50.5 t -81.55 144.49 31.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.549 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.94 -12.47 61.84 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.997 -0.621 . . . . 44.439999999999998 112.527 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.66 116.82 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.574 -0.368 . . . . 73.239999999999995 110.171 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 p -81.41 161.34 23.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 74.420000000000002 111.64 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.48 -31.63 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.152 0.501 . . . . 71.430000000000007 110.714 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.611 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 46.9 ttp85 -72.97 -56.53 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.118 -0.492 . . . . 73.109999999999999 110.864 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.427 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.7 m-20 -61.38 -26.17 67.66 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 111.742 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.5 t -77.73 -61.8 1.87 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.149 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.447 HD22 HG21 ' A' ' 159' ' ' VAL . 66.1 mt -71.89 -21.65 61.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.298 0.851 . . . . 74.530000000000001 113.298 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.427 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 20.7 pttp -64.6 -12.22 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.661 0.664 . . . . 74.549999999999997 111.359 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -79.07 -49.01 13.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.028 0.442 . . . . 74.120000000000005 110.143 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.101 -0.499 . . . . 74.439999999999998 111.31 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.05 -39.35 79.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.375 -0.375 . . . . 74.519999999999996 111.044 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 28.1 ttt -58.19 -47.73 82.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.856 0.36 . . . . 71.439999999999998 111.513 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.5 ptm -70.84 -8.11 50.27 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.861 0.362 . . . . 75.530000000000001 111.694 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.478 ' NE ' ' HA ' ' A' ' 188' ' ' ARG . 3.5 mmp_? -106.65 -15.63 14.72 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.901 0.334 . . . . 73.349999999999994 111.901 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.55 40.35 9.94 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.186 -0.53 . . . . 74.019999999999996 112.891 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.87 168.62 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.717 0.407 . . . . 72.010000000000005 111.073 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.461 HD13 HD11 ' A' ' 232' ' ' LEU . 22.5 pt -132.52 149.37 72.88 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.54 -0.3 . . . . 73.120000000000005 111.406 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.86 -48.65 13.83 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.269 2.646 . . . . 74.5 114.113 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.33 4.75 3.4 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.681 0.623 . . . . 73.129999999999995 112.681 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.94 -8.15 18.81 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.862 0.363 . . . . 73.530000000000001 111.321 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 70.8 m -130.85 166.57 20.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.14 0.422 . . . . 74.019999999999996 112.14 -175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.89 121.3 19.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.431 -0.35 . . . . 75.140000000000001 111.809 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 57.2 t -95.04 121.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.905 0.383 . . . . 73.239999999999995 111.558 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.639 ' CE1' ' HG3' ' A' ' 225' ' ' GLU . 27.7 p90 -138.84 142.29 38.65 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.211 0.529 . . . . 73.349999999999994 111.533 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 199' ' ' ARG . 1.3 ptm180 -110.72 124.43 51.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.884 -0.598 . . . . 75.25 110.001 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.12 107.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 71.5 111.668 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -135.19 135.93 41.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.1 -0.5 . . . . 61.539999999999999 110.202 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.36 27.46 16.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.23 0.538 . . . . 73.030000000000001 110.908 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.14 68.88 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.879 -0.6 . . . . 38.219999999999999 113.149 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -95.75 126.22 40.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.815 0.446 . . . . 74.5 112.167 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 97.5 mttt -76.98 98.82 5.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.668 0.27 . . . . 72.540000000000006 110.369 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -90.1 107.29 18.49 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.675 -0.238 . . . . 65.340000000000003 111.219 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . 0.43 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 3.2 Cg_exo -75.31 129.1 11.77 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.776 2.317 . . . . 72.540000000000006 111.95 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.594 HG23 HD12 ' A' ' 217' ' ' LEU . 3.9 mp -98.89 122.39 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.74 -0.209 . . . . 73.299999999999997 110.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.51 126.7 38.02 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.714 -0.755 . . . . 54.340000000000003 111.782 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.611 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 69.4 m95 -55.06 -33.49 62.76 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.686 0.624 . . . . 73.209999999999994 112.686 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.47 17.68 3.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.897 0.703 . . . . 74.340000000000003 112.897 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.401 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.4 m -88.8 140.03 29.86 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.231 -0.293 . . . . 62.310000000000002 110.663 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.467 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 5.9 m-20 -57.58 125.68 23.98 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.077 0.399 . . . . 74.329999999999998 112.077 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.417 HG13 HG23 ' A' ' 157' ' ' VAL . 10.9 tp -59.45 -21.83 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.407 0.622 . . . . 74.25 110.965 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -55.34 -27.88 50.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.57 -0.741 . . . . 44.240000000000002 112.092 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.467 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -77.44 -7.02 55.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 111.859 0.318 . . . . 73.310000000000002 111.859 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 208' ' ' ILE . 36.8 mt -122.15 22.34 10.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.283 0.563 . . . . 75.329999999999998 110.892 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -62.03 127.28 30.63 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.135 0.791 . . . . 62.32 113.135 -174.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.63 11.8 84.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.393 0.917 . . . . 74.420000000000002 115.393 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -126.83 173.26 9.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.244 1.022 . . . . 74.409999999999997 112.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.25 126.74 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.678 -0.692 . . . . 75.019999999999996 112.332 -172.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.12 141.5 44.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 109.911 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -120.33 142.57 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.088 -0.382 . . . . 73.319999999999993 110.516 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 70.7 t -118.09 126.43 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.051 0.76 . . . . 75.319999999999993 113.051 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.639 ' HG3' ' CE1' ' A' ' 198' ' ' TYR . 34.2 mt-10 -101.28 164.75 11.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.133 -0.485 . . . . 72.200000000000003 110.886 171.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.26 119.88 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.819 0.342 . . . . 74.129999999999995 111.48 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.454 HD21 ' HB2' ' A' ' 196' ' ' ALA . 84.1 mt -68.35 -63.66 1.02 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.029 0.442 . . . . 75.120000000000005 110.639 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -138.12 145.76 42.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.002 -0.545 . . . . 73.140000000000001 110.071 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.44 80.01 3.16 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.347 0.594 . . . . 63.009999999999998 112.03 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.93 88.66 53.87 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 120.96 0.409 . . . . 72.420000000000002 111.767 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -93.18 101.23 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.906 2.404 . . . . 74.239999999999995 112.194 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.461 HD11 HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.283 -0.865 . . . . 75.400000000000006 112.368 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.0 m80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.317 0.58 . . . . 71.450000000000003 111.818 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.04 149.01 17.46 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.391 -0.822 . . . . 60.420000000000002 109.811 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.86 116.71 3.72 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.192 1.928 . . . . 73.439999999999998 113.152 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -76.8 20.04 0.26 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.979 0.363 . . . . 73.420000000000002 111.979 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t 72.83 86.74 0.1 Allowed Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.432 0.693 . . . . 74.420000000000002 112.204 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 58.01 6.59 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.948 2.432 . . . . 73.519999999999996 112.455 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 62.78 22.8 13.6 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.434 0.635 . . . . 71.420000000000002 111.006 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -63.38 143.04 97.87 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.103 -0.498 . . . . 75.430000000000007 111.715 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.41 147.08 86.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.538 2.158 . . . . 74.109999999999999 112.294 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.01 166.04 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.232 0.827 . . . . 74.010000000000005 113.232 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.69 128.12 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.821 -1.081 . . . . 70.299999999999997 109.334 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.511 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 83.8 mtt180 -91.45 97.29 10.98 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.987 0.422 . . . . 74.150000000000006 111.488 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.484 HG21 HD13 ' A' ' 222' ' ' LEU . 44.7 t -95.69 112.55 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.17 0.434 . . . . 75.310000000000002 112.17 -176.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.6 119.6 23.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.022 0.439 . . . . 71.409999999999997 110.945 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 93.1 mt -95.99 159.44 32.26 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.213 -0.449 . . . . 72.519999999999996 111.304 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.524 ' HG3' ' HA ' ' A' ' 225' ' ' GLU . 70.8 Cg_exo -52.27 162.87 1.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.537 2.158 . . . . 74.340000000000003 113.068 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.0 t30 65.96 28.97 10.44 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.162 0.506 . . . . 73.299999999999997 110.961 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 65.64 19.45 11.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.58 0.585 . . . . 74.099999999999994 112.58 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.423 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.3 mm-40 -84.04 171.87 12.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.087 0.47 . . . . 72.25 111.606 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.2 ptt-85 -160.34 140.56 11.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.015 0.436 . . . . 72.310000000000002 111.845 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -139.53 141.54 37.27 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.027 0.442 . . . . 75.349999999999994 111.209 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.94 119.23 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.026 0.441 . . . . 75.409999999999997 110.887 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 30.8 m -119.83 149.08 47.84 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.446 -0.343 . . . . 73.219999999999999 111.582 -177.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.2 Cg_exo -65.17 144.84 82.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.413 2.076 . . . . 74.25 113.18 179.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.06 15.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.198 0.523 . . . . 74.019999999999996 111.314 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 59.6 mtt180 -115.63 136.46 53.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.273 0.558 . . . . 74.310000000000002 112.421 -173.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 37.2 t -99.94 133.64 44.01 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.832 -0.622 . . . . 72.140000000000001 110.518 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.18 -21.32 31.95 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.683 -0.77 . . . . 72.040000000000006 112.327 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.45 125.09 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 75.540000000000006 110.384 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.411 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 44.3 p -72.95 156.13 39.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 111.492 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.73 -36.03 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.396 0.617 . . . . 74.219999999999999 110.535 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 42.9 ttt180 -60.39 -59.59 5.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.388 -0.824 . . . . 74.420000000000002 111.905 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.78 -18.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.081 0.467 . . . . 71.129999999999995 111.398 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.2 t -82.13 -37.33 26.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.872 0.367 . . . . 75.140000000000001 111.51 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.9 mt -97.21 2.34 50.81 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.209 0.448 . . . . 75.430000000000007 112.209 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -52.55 -33.24 44.72 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.26 0.467 . . . . 75.319999999999993 112.26 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.503 ' HZ3' ' HB3' ' A' ' 183' ' ' LYS . 6.9 mtpm? -79.36 -37.83 36.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.794 0.33 . . . . 74.219999999999999 111.289 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.487 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -62.96 -46.23 88.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.14 0.495 . . . . 71.530000000000001 111.086 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.7 -44.49 96.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.189 -0.46 . . . . 74.530000000000001 110.694 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.8 ttt -53.08 -53.36 51.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.909 -0.587 . . . . 72.030000000000001 111.88 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.0 ptp -68.69 -14.14 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.474 0.546 . . . . 74.010000000000005 112.474 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.487 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 32.5 mmt180 -100.5 -8.22 23.34 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.224 -0.298 . . . . 75.230000000000004 111.671 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 79.33 18.1 74.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.213 -0.517 . . . . 64.310000000000002 112.855 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.406 HD21 HD21 ' A' ' 232' ' ' LEU . 89.0 mt -101.74 156.8 17.28 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.085 0.469 . . . . 71.519999999999996 111.553 -177.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 pt -127.23 138.29 32.44 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.73 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.08 -39.71 84.52 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.944 2.429 . . . . 73.409999999999997 113.56 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.03 -19.53 66.04 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.821 0.343 . . . . 73.129999999999995 111.888 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.553 ' SG ' ' HB2' ' A' ' 228' ' ' GLU . 42.3 t -111.7 20.29 17.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.092 0.472 . . . . 71.349999999999994 111.387 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.3 m -137.49 137.26 38.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.061 0.458 . . . . 71.049999999999997 111.252 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.436 ' HB2' HD22 ' A' ' 227' ' ' LEU . . . -110.54 123.67 50.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.389 -0.368 . . . . 54.5 111.65 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.533 HG22 HG23 ' A' ' 224' ' ' VAL . 43.1 t -99.95 138.19 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.452 -0.34 . . . . 75.5 110.852 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -146.44 151.3 37.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 75.329999999999998 110.967 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.499 ' HB3' HD11 ' A' ' 208' ' ' ILE . 16.8 ptt-85 -120.01 152.58 37.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 74.209999999999994 110.681 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.523 HG12 ' HG2' ' A' ' 205' ' ' LYS . 37.6 mt -106.35 86.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.394 0.616 . . . . 74.099999999999994 110.11 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -104.97 120.47 41.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.654 -0.703 . . . . 63.25 110.38 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 59.34 30.89 20.67 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.081 0.467 . . . . 71.439999999999998 111.701 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.72 -9.24 77.87 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.327 -0.397 . . . . 74.319999999999993 113.628 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 37.9 mm-40 -95.26 125.4 39.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.358 0.503 . . . . 73.349999999999994 112.358 -176.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.523 ' HG2' HG12 ' A' ' 200' ' ' ILE . 98.7 mttt -84.36 96.27 9.0 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.902 0.382 . . . . 71.120000000000005 110.221 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.58 129.68 24.56 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.374 -0.376 . . . . 73.420000000000002 111.989 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.3 125.56 11.45 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.892 2.394 . . . . 72.129999999999995 113.063 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.499 HD11 ' HB3' ' A' ' 199' ' ' ARG . 68.5 mt -97.67 126.08 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.139 -0.482 . . . . 72.230000000000004 111.357 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.46 136.21 18.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.153 -0.546 . . . . 54.119999999999997 112.46 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 98.9 m95 -59.6 -21.0 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.182 0.515 . . . . 72.530000000000001 111.464 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -79.02 -12.52 60.03 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.549 -0.75 . . . . 72.209999999999994 112.671 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.1 m -79.27 145.83 33.33 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.773 0.32 . . . . 73.450000000000003 111.762 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.427 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.0 m-20 -64.19 134.41 54.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 73.540000000000006 111.5 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tt -67.56 -19.11 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.038 0.447 . . . . 73.329999999999998 111.218 177.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 88.5 p -60.26 -29.23 68.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.203 0.446 . . . . 61.439999999999998 112.203 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.427 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -60.01 -27.0 66.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.395 0.617 . . . . 73.239999999999995 111.125 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -104.69 15.54 27.75 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 111.772 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.4 m -56.3 109.43 0.6 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.664 0.616 . . . . 71.230000000000004 112.664 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.79 -17.06 50.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.79 0.676 . . . . 72.530000000000001 114.79 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.62 173.41 6.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.025 0.913 . . . . 73.540000000000006 112.501 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.511 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 35.8 mt-10 -105.59 124.4 49.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.886 -0.597 . . . . 65.430000000000007 111.868 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.484 HD13 HG21 ' A' ' 159' ' ' VAL . 47.5 mt -98.3 160.14 14.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.031 0.443 . . . . 72.319999999999993 111.462 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -129.56 120.04 24.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.525 -0.307 . . . . 71.319999999999993 110.648 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.533 HG23 HG22 ' A' ' 197' ' ' VAL . 24.5 t -116.12 138.32 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 73.409999999999997 111.507 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.524 ' HA ' ' HG3' ' A' ' 162' ' ' PRO . 9.9 pt-20 -138.76 152.91 48.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.959 0.409 . . . . 74.430000000000007 111.598 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 45.8 t -81.71 143.52 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.887 0.375 . . . . 71.25 111.713 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.436 HD22 ' HB2' ' A' ' 196' ' ' ALA . 87.9 mt -84.75 -60.25 2.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.18 0.514 . . . . 74.299999999999997 110.982 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . 0.553 ' HB2' ' SG ' ' A' ' 194' ' ' CYS . 41.7 mt-10 -76.78 94.61 3.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.941 0.401 . . . . 75.319999999999993 111.16 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -70.57 79.35 0.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.120000000000005 110.32 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.58 163.04 43.23 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.652 -0.704 . . . . 71.150000000000006 111.131 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.03 119.64 6.61 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.33 2.02 . . . . 64.0 112.497 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.406 HD21 HD21 ' A' ' 190' ' ' LEU . 7.5 mp . . . . . 0 C--O 1.253 1.271 0 CA-C-O 118.636 -0.697 . . . . 73.219999999999999 110.903 175.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.5 p80 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.552 0.205 . . . . 72.409999999999997 111.552 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.6 mtm 66.27 149.44 0.12 Allowed Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 122.891 0.476 . . . . 74.129999999999995 112.251 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.89 164.7 26.17 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.81 2.34 . . . . 73.549999999999997 113.174 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.609 ' HB3' ' HZ1' ' A' ' 150' ' ' LYS . 0.2 OUTLIER -84.58 8.21 17.5 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.382 -0.372 . . . . 73.010000000000005 111.665 179.099 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -68.99 113.95 19.86 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 112.25 0.463 . . . . 53.210000000000001 112.25 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' HB2' ' HG3' ' A' ' 154' ' ' LYS . 41.1 Cg_endo -100.72 -176.47 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.51 2.807 . . . . 62.43 113.891 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.64 18.28 20.44 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.419 0.628 . . . . 63.530000000000001 110.458 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.424 ' HB3' ' HD2' ' A' ' 155' ' ' PRO . 66.9 mttm -73.47 157.76 87.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.654 -0.703 . . . . 74.340000000000003 112.098 -176.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 154' ' ' LYS . 41.7 Cg_endo -65.25 146.7 86.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.679 2.252 . . . . 74.329999999999998 113.368 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.51 HD13 HG13 ' A' ' 168' ' ' VAL . 40.0 pt -130.06 167.82 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.455 0.645 . . . . 75.040000000000006 112.634 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.82 133.66 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 71.329999999999998 109.968 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.447 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 57.5 mtp180 -105.09 106.17 16.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.121 0.486 . . . . 74.409999999999997 111.594 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -109.57 128.83 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.541 0.571 . . . . 73.409999999999997 112.541 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.56 115.12 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.24 -0.436 . . . . 75.099999999999994 110.93 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.434 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -89.97 155.45 47.4 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 111.65 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.46 141.55 68.07 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.6 2.2 . . . . 65.530000000000001 113.346 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 72.57 65.6 0.12 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.788 0.835 . . . . 62.450000000000003 112.676 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 58.2 41.38 23.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.013 0.746 . . . . 74.519999999999996 113.013 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -129.06 152.76 48.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.23 0.538 . . . . 72.209999999999994 111.831 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.424 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -157.41 146.44 19.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.03 -0.532 . . . . 74.450000000000003 110.572 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -156.32 147.44 22.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.178 0.513 . . . . 74.540000000000006 111.821 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.51 HG13 HD13 ' A' ' 156' ' ' ILE . 99.3 t -109.92 122.34 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.11 -0.495 . . . . 73.409999999999997 111.372 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.468 HG22 HD12 ' A' ' 214' ' ' ILE . 12.2 m -118.25 138.04 25.22 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.35 -0.386 . . . . 71.040000000000006 111.553 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 34.0 Cg_exo -60.8 139.33 84.72 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.93 2.42 . . . . 71.209999999999994 113.946 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.29 103.91 13.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.24 -0.436 . . . . 72.239999999999995 111.648 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -124.39 141.87 51.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.451 -0.34 . . . . 75.319999999999993 111.271 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.2 t -74.98 151.04 38.83 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.667 0.27 . . . . 55.210000000000001 110.771 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.11 -37.18 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.011 -0.614 . . . . 51.130000000000003 112.572 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.43 ' O ' HG21 ' A' ' 214' ' ' ILE . 55.8 t -80.41 113.3 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.911 0.386 . . . . 74.230000000000004 110.582 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 72.0 p -75.83 159.78 30.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.547 -0.297 . . . . 55.219999999999999 111.454 179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -30.45 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.611 0.72 . . . . 72.340000000000003 110.565 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 51.3 ttt180 -66.68 -48.65 68.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.533 -0.758 . . . . 75.120000000000005 111.337 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 5.2 t70 -75.86 -24.23 55.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 73.230000000000004 111.679 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 92.8 p -74.0 -48.58 29.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.024 0.44 . . . . 73.040000000000006 111.154 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.62 -4.02 59.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 73.510000000000005 112.858 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.44 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 18.0 ptmt -53.86 -45.49 70.99 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 111.868 0.321 . . . . 74.530000000000001 111.868 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.17 -25.79 47.35 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.143 -0.348 . . . . 75.299999999999997 111.675 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.63 82.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.225 0.536 . . . . 74.25 110.857 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.8 mt -79.09 -31.74 44.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.191 -0.459 . . . . 71.319999999999993 110.808 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -54.97 -47.84 74.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.505 -0.316 . . . . 74.200000000000003 111.27 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.9 ptp -68.66 -7.88 37.28 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.125 0.417 . . . . 73.340000000000003 112.125 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -101.3 -16.22 17.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.887 0.375 . . . . 74.319999999999993 111.163 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.4 30.15 25.54 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.305 -0.474 . . . . 62.310000000000002 112.727 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.8 173.55 6.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.867 0.365 . . . . 54.210000000000001 111.496 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.74 146.37 56.89 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.437 -0.347 . . . . 73.109999999999999 110.693 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.7 -41.82 74.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.604 2.203 . . . . 73.109999999999999 113.61 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . 0.403 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.4 mp0 -63.63 -12.11 30.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.524 0.564 . . . . 75.120000000000005 112.524 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.54 -8.4 50.37 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.93 0.395 . . . . 71.230000000000004 111.563 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.6 m -123.5 171.75 9.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 70.409999999999997 112.055 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.408 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -143.68 129.72 19.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.43 -0.35 . . . . 71.439999999999998 111.286 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 224' ' ' VAL . 54.3 t -95.26 121.05 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.516 -0.311 . . . . 65.420000000000002 111.097 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -132.27 145.11 51.07 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.178 0.513 . . . . 75.25 111.254 176.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.536 ' HG2' HD11 ' A' ' 208' ' ' ILE . 40.2 ptt180 -122.83 161.37 24.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.046 0.45 . . . . 74.439999999999998 111.163 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.453 HG12 ' HG2' ' A' ' 205' ' ' LYS . 52.7 mt -110.14 101.62 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.147 -0.479 . . . . 72.209999999999994 110.682 177.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -120.29 123.78 44.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.994 -0.548 . . . . 65.239999999999995 110.543 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.66 30.45 19.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.202 0.525 . . . . 74.510000000000005 110.948 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 -12.41 54.45 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.036 -0.529 . . . . 75.019999999999996 113.361 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.8 120.33 25.91 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.15 0.426 . . . . 75.120000000000005 112.15 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.453 ' HG2' HG12 ' A' ' 200' ' ' ILE . 87.5 mttt -86.34 101.41 13.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.285 -0.416 . . . . 72.530000000000001 110.535 172.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -121.9 120.88 28.31 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 120.611 0.243 . . . . 63.200000000000003 111.432 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -69.62 126.15 13.07 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.714 2.276 . . . . 74.400000000000006 113.319 177.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.536 HD11 ' HG2' ' A' ' 199' ' ' ARG . 3.6 mp -86.63 131.68 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.404 -0.362 . . . . 75.049999999999997 110.381 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.55 133.16 41.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.79 -0.719 . . . . 73.140000000000001 112.937 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -57.74 -22.05 44.51 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.071 0.462 . . . . 71.420000000000002 111.936 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.12 -10.74 59.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.426 0.528 . . . . 75.209999999999994 112.426 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.9 m -75.21 137.93 41.6 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.783 0.29 . . . . 71.310000000000002 111.783 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -62.04 130.26 44.73 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.875 0.369 . . . . 74.510000000000005 111.008 175.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.468 HD12 HG22 ' A' ' 169' ' ' VAL . 9.8 tt -60.99 -23.67 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.014 0.435 . . . . 65.049999999999997 111.96 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 80.9 p -59.12 -24.98 63.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.295 0.48 . . . . 72.219999999999999 112.295 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -67.27 -27.48 67.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.961 0.356 . . . . 75.340000000000003 111.961 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 208' ' ' ILE . 51.3 mt -109.09 37.81 2.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.239 0.542 . . . . 74.519999999999996 111.712 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.6 m -67.36 120.2 13.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.73 0.641 . . . . 73.340000000000003 112.73 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.18 81.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 115.255 0.862 . . . . 74.420000000000002 115.255 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.65 172.1 7.92 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.187 0.993 . . . . 65.219999999999999 111.989 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.447 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.4 mt-10 -108.61 114.52 28.4 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.941 -0.572 . . . . 74.209999999999994 111.635 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 83.2 mt -94.81 157.53 15.89 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.102 0.477 . . . . 73.010000000000005 111.694 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -127.85 134.03 49.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.494 -0.321 . . . . 73.510000000000005 110.152 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 197' ' ' VAL . 48.0 t -119.74 136.05 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.371 0.508 . . . . 74.230000000000004 112.371 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.67 173.93 7.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.186 -0.461 . . . . 75.519999999999996 110.597 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.6 t -100.37 129.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.77 0.319 . . . . 75.109999999999999 111.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.408 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.0 mt -76.92 -78.22 0.13 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.629 0.252 . . . . 75.040000000000006 111.425 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.63 100.91 10.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.708 0.29 . . . . 71.129999999999995 110.862 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -75.86 76.19 2.79 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.255 0.55 . . . . 71.129999999999995 110.107 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.69 144.25 52.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.192 0.441 . . . . 73.450000000000003 112.192 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.74 96.76 1.11 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.178 1.919 . . . . 75.129999999999995 110.809 168.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.828 -0.606 . . . . 64.450000000000003 112.172 -173.308 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 112.309 0.485 . . . . 73.239999999999995 112.309 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 69.2 mtm 65.49 111.4 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 122.905 0.482 . . . . 51.240000000000002 112.219 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.4 127.08 22.67 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.375 2.05 . . . . 73.019999999999996 112.149 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.647 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 11.1 mmpt? -103.59 150.1 24.28 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.046 0.45 . . . . 73.230000000000004 112.126 -174.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.3 t -95.45 96.48 2.2 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.097 -0.501 . . . . 65.310000000000002 109.956 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 150' ' ' LYS . 7.6 Cg_exo -72.94 107.64 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.773 2.315 . . . . 54.109999999999999 113.735 -171.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -87.81 88.92 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.543 0.687 . . . . 72.409999999999997 110.06 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -89.69 154.29 48.07 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.581 0.586 . . . . 73.349999999999994 112.581 -171.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.22 136.46 72.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.956 2.437 . . . . 73.340000000000003 113.096 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.93 162.71 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.455 0.645 . . . . 73.140000000000001 112.566 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 171' ' ' ALA . 47.3 t -130.88 130.47 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.549 -0.75 . . . . 73.239999999999995 109.847 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -98.66 101.16 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.987 0.422 . . . . 71.310000000000002 111.597 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.594 HG23 HD12 ' A' ' 222' ' ' LEU . 42.9 t -96.3 117.54 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.922 0.391 . . . . 74.420000000000002 111.964 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -91.75 117.57 29.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.967 0.413 . . . . 74.519999999999996 111.196 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -97.68 160.17 29.25 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.274 -0.421 . . . . 72.120000000000005 111.431 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.76 173.02 6.12 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.397 2.065 . . . . 72.120000000000005 112.324 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 64.34 28.31 13.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.999 0.428 . . . . 73.239999999999995 111.72 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 64.13 34.86 10.74 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.891 -0.595 . . . . 74.010000000000005 111.964 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -110.33 160.76 16.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.003 0.43 . . . . 74.340000000000003 111.465 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -156.62 153.73 29.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.825 0.345 . . . . 74.310000000000002 111.182 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -152.11 137.31 17.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 111.843 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.4 t -104.77 120.78 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.39 -0.368 . . . . 72.430000000000007 110.553 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.36 151.77 48.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 111.871 0.323 . . . . 64.329999999999998 111.871 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 129.18 13.2 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.562 2.175 . . . . 63.130000000000003 113.357 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.401 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -78.79 112.31 15.8 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.219 -0.446 . . . . 52.520000000000003 111.493 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.67 159.59 33.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.534 0.334 . . . . 74.409999999999997 111.452 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -95.28 147.54 23.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.688 0.28 . . . . 75.530000000000001 110.533 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.14 -25.3 6.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.696 -0.764 . . . . 63.520000000000003 112.262 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.58 111.82 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 110.528 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 76.6 p -75.91 157.71 32.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.267 -0.424 . . . . 71.230000000000004 111.594 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.8 t -53.8 -40.9 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.261 0.553 . . . . 72.129999999999995 110.782 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.575 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 48.2 ttp180 -61.25 -37.81 84.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.571 -0.74 . . . . 74.040000000000006 111.424 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.47 -53.85 7.54 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.967 -0.56 . . . . 71.329999999999998 111.518 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.7 t -57.94 -41.14 82.17 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.222 0.453 . . . . 73.239999999999995 112.222 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 69.9 mt -80.76 6.57 12.55 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.957 0.725 . . . . 75.219999999999999 112.957 -177.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.607 ' HZ1' ' HB3' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -55.06 -36.64 65.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.992 0.425 . . . . 74.140000000000001 110.878 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -67.35 -37.45 83.25 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.231 -0.441 . . . . 74.219999999999999 111.571 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.528 ' HA ' ' HE2' ' A' ' 187' ' ' MET . . . -70.62 -50.9 32.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.986 0.422 . . . . 73.25 110.899 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.468 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 88.4 mt -55.45 -42.91 74.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.87 -0.605 . . . . 75.040000000000006 111.241 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 52.6 ttm -59.45 -57.16 14.21 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.779 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.528 ' HE2' ' HA ' ' A' ' 184' ' ' ALA . 27.2 ptt? -68.8 -23.13 64.24 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.462 0.541 . . . . 73.129999999999995 112.462 -176.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -103.99 3.32 33.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.794 0.665 . . . . 73.340000000000003 112.794 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.04 48.5 85.6 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.149 -0.548 . . . . 73.310000000000002 113.559 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.468 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 89.3 mt -127.5 159.84 33.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.899 0.381 . . . . 73.400000000000006 111.467 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.74 154.79 73.33 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.491 -0.322 . . . . 75.010000000000005 111.168 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.12 -31.86 29.85 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.188 2.592 . . . . 75.049999999999997 114.525 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.65 -15.3 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.992 -0.443 . . . . 75.030000000000001 112.135 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.18 -8.74 29.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.014 0.375 . . . . 74.409999999999997 112.014 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 77.7 m -142.55 149.33 38.95 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.0 0.429 . . . . 75.120000000000005 111.869 -177.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.79 134.53 55.2 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.29 -0.414 . . . . 54.450000000000003 111.429 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.545 HG21 HG22 ' A' ' 224' ' ' VAL . 34.1 t -108.4 125.05 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 122.529 0.331 . . . . 70.430000000000007 111.075 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.9 152.0 46.07 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.89 0.376 . . . . 74.540000000000006 111.338 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 199' ' ' ARG . 6.8 ptt180 -122.92 154.97 37.64 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.321 -0.251 . . . . 74.5 110.321 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.532 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.6 mt -110.85 131.4 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.211 0.529 . . . . 74.430000000000007 111.84 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.668 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 27.1 tt0 -137.7 119.62 15.35 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.093 -0.503 . . . . 72.519999999999996 110.79 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.46 16.28 3.18 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.420000000000002 112.144 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.59 -10.02 38.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 121.331 -0.461 . . . . 62.039999999999999 114.159 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . 0.668 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 12.3 pt-20 -88.02 134.66 33.69 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.948 0.874 . . . . 75.549999999999997 111.924 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -97.74 103.81 15.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.455 -0.338 . . . . 75.319999999999993 110.425 173.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.49 113.7 65.56 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 111.905 0.335 . . . . 75.540000000000006 111.905 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.04 113.07 2.05 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.969 2.446 . . . . 65.109999999999999 112.14 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.71 129.25 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 70.329999999999998 111.484 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.55 126.13 21.4 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.678 -0.773 . . . . 62.049999999999997 112.259 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.575 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 73.7 m95 -52.05 -28.69 18.22 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.84 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.74 14.94 2.87 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.751 0.649 . . . . 72.099999999999994 112.751 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 56.6 m -93.28 140.74 29.21 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.031 -0.418 . . . . 75.129999999999995 111.707 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.85 122.12 13.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.98 0.419 . . . . 72.019999999999996 111.223 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.0 -19.51 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.597 0.591 . . . . 64.140000000000001 112.597 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 33.8 t -61.11 -19.68 61.76 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.053 0.39 . . . . 71.209999999999994 112.053 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -78.23 -8.04 57.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.904 0.335 . . . . 75.5 111.904 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 42.6 mt -110.67 18.97 19.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.141 0.496 . . . . 72.25 111.412 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -61.56 123.17 17.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.914 0.709 . . . . 62.119999999999997 112.914 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.35 -37.33 3.61 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.712 0.645 . . . . 62.229999999999997 114.712 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.78 172.62 7.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.629 0.715 . . . . 73.420000000000002 112.684 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -93.75 139.55 30.71 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.581 -0.736 . . . . 74.120000000000005 112.596 -173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.594 HD12 HG23 ' A' ' 159' ' ' VAL . 54.6 mt -103.57 140.63 37.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.066 -0.516 . . . . 73.329999999999998 110.542 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -115.51 117.37 30.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.513 -0.312 . . . . 73.519999999999996 110.565 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.545 HG22 HG21 ' A' ' 197' ' ' VAL . 39.8 t -112.6 129.42 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.759 0.314 . . . . 73.030000000000001 111.547 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.21 155.02 51.38 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.928 0.394 . . . . 73.230000000000004 111.348 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.93 130.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.564 0.579 . . . . 64.319999999999993 112.564 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.17 -62.72 1.43 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.831 -0.622 . . . . 71.439999999999998 110.73 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -108.34 113.51 26.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.151 -0.477 . . . . 74.549999999999997 111.209 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -78.57 72.77 5.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.1 0.476 . . . . 62.350000000000001 111.255 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.0 t -111.72 96.44 32.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.122 -0.49 . . . . 74.230000000000004 111.611 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -87.82 161.51 7.61 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 73.049999999999997 112.578 175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 N-CA-C 112.141 0.422 . . . . 73.219999999999999 112.141 -179.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.629 0.252 . . . . 74.040000000000006 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 23.3 ptp -101.8 109.1 58.7 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 120.864 0.364 . . . . 71.010000000000005 111.343 -177.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -71.74 124.11 9.95 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.588 2.192 . . . . 74.450000000000003 112.677 178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.717 ' HZ3' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -64.69 122.2 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.94 0.4 . . . . 75.340000000000003 110.889 177.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 50.3 m -60.84 122.01 65.76 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.357 0.502 . . . . 64.409999999999997 112.357 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 122.29 8.18 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.376 2.051 . . . . 75.450000000000003 111.414 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -65.52 89.28 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.193 0.521 . . . . 72.349999999999994 111.98 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -101.91 153.0 38.26 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.843 -0.617 . . . . 74.409999999999997 111.153 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 135.69 23.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.263 1.975 . . . . 74.299999999999997 111.496 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.29 163.27 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 113.133 0.79 . . . . 72.319999999999993 113.133 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.538 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.5 t -122.54 137.29 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.851 -0.613 . . . . 71.040000000000006 110.917 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.423 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 71.8 mtt85 -96.78 101.4 12.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 74.120000000000005 111.312 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.517 HG21 HD21 ' A' ' 181' ' ' LEU . 60.3 t -102.03 125.73 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.966 0.412 . . . . 73.140000000000001 111.726 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -91.52 106.4 18.46 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.35 -0.386 . . . . 74.120000000000005 111.175 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.505 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.8 mt -80.09 153.25 74.65 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.302 -0.408 . . . . 75.439999999999998 111.208 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 72.5 Cg_exo -49.96 140.45 31.47 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.896 2.397 . . . . 72.120000000000005 113.921 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 86.1 m-20 75.96 46.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.486 0.714 . . . . 71.030000000000001 112.47 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 64.2 20.32 12.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.773 0.657 . . . . 73.030000000000001 112.773 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.505 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.4 mm-40 -89.35 141.56 28.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 72.109999999999999 111.188 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -117.64 143.06 46.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.246 0.546 . . . . 75.439999999999998 111.877 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.427 HG21 ' HB ' ' A' ' 159' ' ' VAL . 9.2 t -145.5 137.93 25.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.826 -0.625 . . . . 74.519999999999996 110.724 172.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.21 120.26 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.672 0.272 . . . . 72.019999999999996 110.833 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 31.2 m -114.62 147.87 39.07 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 75.439999999999998 111.813 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 11.4 Cg_exo -71.55 125.0 10.78 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.789 2.326 . . . . 75.329999999999998 112.695 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 120.81 17.61 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.042 0.449 . . . . 71.510000000000005 111.754 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 61.9 mtt-85 -127.13 159.39 34.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.368 -0.378 . . . . 70.409999999999997 111.087 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.3 t -99.17 139.32 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.445 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.77 84.1 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.765 -0.731 . . . . 71.420000000000002 112.006 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.8 t -127.1 119.3 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.952 0.501 . . . . 74.439999999999998 110.269 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.9 p -80.43 168.48 18.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.257 0.551 . . . . 72.530000000000001 112.201 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.75 -37.92 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.352 0.596 . . . . 74.409999999999997 110.236 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.528 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 21.3 ttt85 -63.91 -35.19 79.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.664 -0.698 . . . . 75.420000000000002 111.094 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.541 ' HA ' ' HE2' ' A' ' 182' ' ' LYS . 2.1 m-20 -76.53 -51.97 10.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.392 -0.367 . . . . 71.450000000000003 111.707 175.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -56.0 -42.73 76.87 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.111 0.411 . . . . 73.519999999999996 112.111 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 159' ' ' VAL . 78.9 mt -92.08 -10.04 40.46 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.812 1.042 . . . . 74.219999999999999 113.812 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.61 ' HZ1' ' HB3' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -58.12 -28.71 64.9 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.909 0.777 . . . . 70.0 111.483 -176.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.82 -45.61 64.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.095 0.474 . . . . 75.219999999999999 110.607 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.54 90.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.949 -0.568 . . . . 74.209999999999994 111.665 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.66 -47.32 69.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 72.519999999999996 110.797 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.7 ttm -57.48 -39.13 75.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.002 -0.544 . . . . 60.0 112.245 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.8 ptm -75.26 -21.69 58.37 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.071 -0.393 . . . . 75.409999999999997 111.906 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -96.25 -13.68 23.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.097 0.406 . . . . 75.219999999999999 112.097 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.22 41.51 10.17 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.95 -0.643 . . . . 73.420000000000002 112.479 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.31 158.26 34.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.683 0.393 . . . . 74.409999999999997 110.829 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.2 pt -133.33 137.7 29.77 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.682 -0.235 . . . . 72.319999999999993 111.342 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.6 -44.31 35.95 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.172 2.581 . . . . 73.25 113.654 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.02 -21.65 59.41 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.522 0.564 . . . . 70.409999999999997 112.522 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.515 ' SG ' HG13 ' A' ' 226' ' ' VAL . 32.7 t -101.18 -12.42 18.77 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.948 0.404 . . . . 74.200000000000003 112.014 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.9 m -119.55 164.41 15.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.173 0.511 . . . . 72.120000000000005 111.983 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.83 133.82 38.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.439 -0.346 . . . . 74.129999999999995 111.909 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 224' ' ' VAL . 68.0 t -98.79 138.54 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.731 0.301 . . . . 73.329999999999998 110.816 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.75 158.86 41.58 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.179 0.514 . . . . 74.129999999999995 111.738 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.553 ' HG2' ' HB3' ' A' ' 206' ' ' LYS . 6.4 ptm180 -110.11 154.25 23.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.873 -0.603 . . . . 71.439999999999998 110.111 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.433 HG12 ' HG2' ' A' ' 205' ' ' LYS . 59.0 mt -118.62 120.65 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.985 0.421 . . . . 64.230000000000004 111.575 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -154.78 144.28 21.36 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.031 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 57.06 31.44 19.95 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.334 0.588 . . . . 70.150000000000006 111.22 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.66 -19.66 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.874 -0.603 . . . . 54.329999999999998 113.82 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.06 170.27 8.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.575 0.702 . . . . 75.420000000000002 112.732 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.433 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.0 mttp -113.45 139.58 48.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.32 -0.855 . . . . 73.310000000000002 110.947 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.553 ' HB3' ' HG2' ' A' ' 199' ' ' ARG . 87.4 tttt -114.69 105.35 53.54 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.662 -0.245 . . . . 72.219999999999999 110.593 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -61.96 113.38 1.84 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.789 2.326 . . . . 73.150000000000006 112.412 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.461 HG22 HD12 ' A' ' 217' ' ' LEU . 61.2 mt -96.64 134.22 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 74.540000000000006 111.615 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.3 135.17 29.3 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.145 -0.55 . . . . 72.420000000000002 113.039 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.528 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 75.9 m95 -55.34 -43.42 74.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.712 0.634 . . . . 74.430000000000007 112.712 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.56 27.93 0.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.85 0.685 . . . . 61.439999999999998 112.85 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 48.7 m -92.51 137.62 32.21 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 122.354 -0.216 . . . . 71.439999999999998 110.612 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.99 124.15 15.85 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.926 0.394 . . . . 74.349999999999994 111.794 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.25 -24.21 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.178 -0.465 . . . . 75.540000000000006 111.698 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 t -56.54 -30.61 63.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.115 0.413 . . . . 74.120000000000005 112.115 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.68 -19.1 65.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.842 0.353 . . . . 73.019999999999996 111.939 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.461 HD12 HG22 ' A' ' 208' ' ' ILE . 44.0 mt -115.45 19.13 15.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.173 0.511 . . . . 75.540000000000006 111.676 -173.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' THR . . . . . 0.538 ' HA ' HG22 ' A' ' 157' ' ' VAL . 75.5 m -61.38 132.0 52.08 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.547 0.573 . . . . 73.010000000000005 112.547 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 93.4 -22.07 37.18 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.717 0.647 . . . . 74.420000000000002 114.717 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.16 172.78 6.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.684 0.742 . . . . 74.040000000000006 112.677 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.423 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 42.4 mt-10 -105.91 114.7 29.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.755 -0.657 . . . . 72.540000000000006 111.765 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.03 164.3 13.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.138 0.494 . . . . 75.540000000000006 111.291 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -131.7 139.1 48.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.839 0.352 . . . . 73.439999999999998 111.472 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.515 HG23 HG23 ' A' ' 197' ' ' VAL . 46.4 t -123.12 126.38 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.107 -0.497 . . . . 63.049999999999997 110.746 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.72 145.72 46.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.397 . . . . 75.310000000000002 111.274 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.515 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.7 t -83.87 103.09 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 110.079 -0.341 . . . . 74.420000000000002 110.079 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -55.43 -50.19 70.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.983 0.42 . . . . 75.430000000000007 111.692 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.9 117.25 25.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.444 0.64 . . . . 63.130000000000003 110.107 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -72.56 27.37 0.05 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.126 1.158 . . . . 74.010000000000005 114.126 -168.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.06 89.58 42.92 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 121.886 -0.509 . . . . 74.349999999999994 111.487 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.79 121.91 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.2 2.6 . . . . 73.430000000000007 112.33 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 232' ' ' LEU . 6.5 mp . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.572 -0.728 . . . . 74.129999999999995 111.487 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 112.021 0.378 . . . . 72.310000000000002 112.021 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.0 mtt 66.82 102.47 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 123.007 0.523 . . . . 64.340000000000003 111.744 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -90.71 129.46 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.755 2.303 . . . . 73.450000000000003 112.621 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.626 ' HB2' ' HZ2' ' A' ' 150' ' ' LYS . 10.1 mtmp? -72.22 77.28 0.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.469 0.652 . . . . 75.540000000000006 109.563 174.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 t -76.31 120.39 81.47 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 115.318 -0.855 . . . . 71.329999999999998 112.694 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.8 -160.12 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.79 2.326 . . . . 73.439999999999998 111.865 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -80.48 99.93 8.27 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.898 -0.501 . . . . 62.140000000000001 111.07 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.639 ' HD3' ' H ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -100.98 145.83 31.08 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.321 -0.4 . . . . 74.219999999999999 111.392 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.59 131.03 31.82 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.663 2.242 . . . . 75.25 112.793 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.03 156.68 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.223 0.535 . . . . 72.120000000000005 112.173 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.481 HG21 ' HB2' ' A' ' 171' ' ' ALA . 56.7 t -122.39 131.27 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.69 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.505 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 99.9 mtt180 -84.92 134.89 34.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.522 -0.308 . . . . 75.109999999999999 110.891 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.55 HG22 HD21 ' A' ' 181' ' ' LEU . 59.7 t -130.18 119.51 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.1 0.476 . . . . 75.25 111.676 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -93.93 114.43 26.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.129 -0.487 . . . . 72.439999999999998 111.037 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 87.9 mt -98.19 158.33 32.93 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.088 -0.506 . . . . 74.420000000000002 111.181 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 172.2 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.27 1.98 . . . . 75.109999999999999 111.886 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 62.46 23.23 13.77 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.09 0.471 . . . . 74.299999999999997 110.778 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 63.02 26.91 15.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.513 0.725 . . . . 64.349999999999994 112.332 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 79.3 mm-40 -88.02 152.49 22.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.193 0.521 . . . . 74.5 111.98 -177.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -132.78 139.18 47.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.239 -0.437 . . . . 74.030000000000001 110.96 -176.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.3 t -152.45 148.52 27.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.889 0.376 . . . . 74.209999999999994 111.745 177.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.7 129.7 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.87 0.366 . . . . 74.0 111.057 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.33 154.55 72.16 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.603 -0.271 . . . . 74.310000000000002 111.723 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 141.07 24.53 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.524 2.149 . . . . 73.209999999999994 113.163 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.481 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -103.4 122.23 44.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.942 0.349 . . . . 54.509999999999998 111.942 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -133.89 152.28 51.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.976 0.417 . . . . 75.530000000000001 111.817 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.3 t -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 111.007 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.2 -25.77 16.14 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.961 -0.638 . . . . 73.219999999999999 112.741 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.2 t -82.59 125.93 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.777 0.323 . . . . 73.530000000000001 110.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 45.5 p -84.25 164.49 19.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.199 0.523 . . . . 74.150000000000006 112.041 -177.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.463 ' HB ' ' HA ' ' A' ' 210' ' ' TRP . 61.4 t -59.2 -33.07 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.397 0.618 . . . . 72.030000000000001 110.722 174.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -63.48 -53.63 48.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.934 -0.575 . . . . 72.519999999999996 110.776 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.538 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 59.3 m-20 -59.81 -38.61 82.44 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.231 0.456 . . . . 75.400000000000006 112.231 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.0 p -76.59 -31.22 57.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.92 0.711 . . . . 60.109999999999999 112.92 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.55 HD21 HG22 ' A' ' 159' ' ' VAL . 71.5 mt -106.45 -20.49 13.36 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.498 1.296 . . . . 65.400000000000006 114.498 -174.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 22.7 pttp -54.61 -33.67 60.84 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.427 0.899 . . . . 75.239999999999995 113.427 -172.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.99 -44.78 53.47 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.082 -0.386 . . . . 73.140000000000001 111.05 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.42 69.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.089 0.471 . . . . 74.219999999999999 111.334 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.556 HD13 ' CH2' ' A' ' 210' ' ' TRP . 86.4 mt -69.2 -48.96 60.63 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.033 -0.53 . . . . 62.200000000000003 110.901 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.0 tpt -56.84 -45.64 82.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.88 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -70.09 -8.81 52.49 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.557 0.577 . . . . 73.150000000000006 112.557 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.46 -20.61 12.15 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.954 0.353 . . . . 73.299999999999997 111.954 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.51 38.22 3.07 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.161 -0.542 . . . . 51.329999999999998 113.571 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . 0.408 ' HB3' ' SG ' ' A' ' 195' ' ' CYS . 5.0 mp -122.05 169.63 10.65 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.451 -0.441 . . . . 72.540000000000006 111.59 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.87 134.58 13.02 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.04 -0.527 . . . . 72.329999999999998 110.562 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.56 -39.9 73.9 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.792 2.328 . . . . 75.319999999999993 113.708 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.33 -11.1 56.77 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.11 0.781 . . . . 75.409999999999997 113.11 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.41 9.94 9.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.985 0.421 . . . . 60.350000000000001 111.467 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 190' ' ' LEU . 73.3 m -123.43 144.06 49.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.769 0.318 . . . . 74.430000000000007 111.611 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -122.46 119.47 31.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.524 -0.307 . . . . 75.219999999999999 111.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.529 HG21 HG23 ' A' ' 224' ' ' VAL . 25.1 t -98.75 134.07 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.699 -0.228 . . . . 72.340000000000003 110.899 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.446 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 47.9 p90 -138.5 155.49 48.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.301 0.572 . . . . 74.310000000000002 111.715 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -121.27 152.17 39.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.686 -0.688 . . . . 73.420000000000002 111.192 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.5 mt -105.8 97.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.815 0.34 . . . . 73.129999999999995 110.795 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.427 ' O ' ' HG3' ' A' ' 201' ' ' GLN . 12.8 pt20 -112.23 128.54 56.28 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.618 -0.265 . . . . 74.310000000000002 110.92 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.0 t70 60.16 19.09 8.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.546 0.689 . . . . 72.200000000000003 111.687 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.13 72.42 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.197 -0.525 . . . . 65.310000000000002 113.295 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.06 126.24 52.08 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.525 -0.397 . . . . 73.420000000000002 111.273 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.446 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 58.1 mtpt -80.68 94.4 6.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.069 0.461 . . . . 75.340000000000003 110.677 174.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -94.29 118.4 67.07 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.231 -0.44 . . . . 74.239999999999995 111.389 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.1 148.83 87.91 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.67 2.247 . . . . 72.430000000000007 112.559 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.493 HD12 HG11 ' A' ' 197' ' ' VAL . 50.1 mt -118.07 148.52 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.841 0.353 . . . . 71.519999999999996 111.222 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.38 139.05 14.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.953 -0.642 . . . . 63.100000000000001 112.13 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.556 ' CH2' HD13 ' A' ' 185' ' ' LEU . 94.2 m95 -62.7 -23.28 67.07 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.359 -0.495 . . . . 73.349999999999994 111.543 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.41 15.14 11.19 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.018 -0.537 . . . . 74.409999999999997 112.032 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 177' ' ' VAL . 69.0 m -96.2 147.53 23.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.397 0.279 . . . . 74.120000000000005 110.952 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.427 ' HB2' ' HD1' ' A' ' 216' ' ' TRP . 5.1 m-20 -65.13 126.65 28.75 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.166 0.508 . . . . 72.049999999999997 111.87 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.637 HD13 HD11 ' A' ' 217' ' ' LEU . 9.5 tp -62.03 -20.64 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 116.128 -0.487 . . . . 63.329999999999998 111.366 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.6 p -60.63 -23.19 64.56 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.441 -0.345 . . . . 73.239999999999995 111.903 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . 0.427 ' HD1' ' HB2' ' A' ' 213' ' ' ASP . 42.3 m95 -70.37 -20.13 62.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.038 0.446 . . . . 75.400000000000006 111.739 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.637 HD11 HD13 ' A' ' 214' ' ' ILE . 23.2 mt -104.97 9.81 34.41 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.098 -0.501 . . . . 75.209999999999994 111.748 -174.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.0 m -56.64 109.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.646 0.61 . . . . 75.310000000000002 112.646 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.53 1.61 60.44 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.097 -0.573 . . . . 72.319999999999993 113.981 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -103.65 158.96 16.01 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.478 . . . . 72.540000000000006 111.826 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.505 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.3 mt-10 -105.72 114.82 29.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.067 0.461 . . . . 74.129999999999995 110.683 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 mt -92.8 156.11 17.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 75.439999999999998 111.715 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -129.33 132.55 47.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 72.140000000000001 110.197 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 197' ' ' VAL . 58.5 t -109.73 123.62 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.22 0.452 . . . . 72.349999999999994 112.22 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -100.66 157.39 16.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.178 -0.464 . . . . 72.0 111.228 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.55 130.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.741 0.305 . . . . 62.329999999999998 111.016 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 196' ' ' ALA . 89.1 mt -82.47 -71.77 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 111.802 0.297 . . . . 64.530000000000001 111.802 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.55 109.91 5.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.393 0.277 . . . . 73.450000000000003 111.029 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.45 74.05 4.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.639 0.733 . . . . 73.439999999999998 111.214 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 27.7 m -95.56 131.34 29.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.058 -0.519 . . . . 73.409999999999997 111.757 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 6.4 Cg_exo -75.51 135.36 18.06 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.956 2.437 . . . . 74.239999999999995 112.265 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . 0.404 ' N ' HD22 ' A' ' 232' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.523 -0.751 . . . . 71.049999999999997 112.002 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.688 0.28 . . . . 74.540000000000006 111.597 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 80.3 mtp 65.18 149.76 0.11 Allowed Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.12 0.568 . . . . 72.219999999999999 112.259 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.28 113.62 1.99 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.424 2.083 . . . . 73.120000000000005 112.376 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.73 ' HZ2' ' HB3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -68.8 93.39 0.54 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.321 0.581 . . . . 74.420000000000002 111.877 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -92.07 106.22 16.78 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-N 115.859 -0.61 . . . . 72.439999999999998 111.201 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.1 60.46 7.38 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.849 2.366 . . . . 64.450000000000003 112.675 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.87 -10.71 46.98 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.967 0.413 . . . . 74.109999999999999 112.039 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.28 138.33 71.73 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 122.218 -0.301 . . . . 73.519999999999996 111.486 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.76 128.55 19.14 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.46 2.107 . . . . 75.310000000000002 112.013 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.72 157.14 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.531 0.681 . . . . 72.0 112.76 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.77 135.37 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.436 -0.802 . . . . 74.209999999999994 110.186 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.43 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 50.0 mtt180 -90.32 98.56 11.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.936 0.398 . . . . 75.129999999999995 110.803 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.673 HG22 HD22 ' A' ' 181' ' ' LEU . 60.5 t -96.78 108.01 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.34 0.59 . . . . 74.510000000000005 111.806 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 73.1 m-85 -76.53 104.09 6.86 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.041 0.448 . . . . 65.519999999999996 110.762 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.39 157.87 89.15 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.931 -0.577 . . . . 74.349999999999994 112.274 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.475 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 11.1 Cg_endo -54.1 160.09 6.74 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.668 2.246 . . . . 63.25 112.843 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 65.0 t30 68.57 31.34 4.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.536 0.684 . . . . 64.400000000000006 110.839 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 65.6 23.03 11.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.31 -0.859 . . . . 74.319999999999993 113.031 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.92 -177.04 4.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.99 0.424 . . . . 75.349999999999994 111.776 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.543 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 28.1 ptt180 -157.84 156.86 32.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.162 0.505 . . . . 72.219999999999999 111.902 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.3 t -156.27 160.51 39.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.997 -0.547 . . . . 73.049999999999997 110.352 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.8 t -116.53 119.75 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.757 0.313 . . . . 74.120000000000005 111.041 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.23 152.67 49.37 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 111.852 0.315 . . . . 73.239999999999995 111.852 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.59 147.66 32.08 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.491 2.128 . . . . 65.310000000000002 113.273 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -103.67 126.73 51.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.959 0.409 . . . . 64.129999999999995 111.69 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -128.74 146.18 50.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.98 0.419 . . . . 63.119999999999997 111.623 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.69 132.21 40.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.834 0.35 . . . . 73.540000000000006 110.896 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.06 -23.7 30.14 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.076 -0.583 . . . . 44.340000000000003 112.437 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.26 125.26 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 111.131 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.0 p -82.74 165.92 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.93 0.395 . . . . 74.150000000000006 111.491 -179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.4 HG21 ' O ' ' A' ' 212' ' ' THR . 62.0 t -56.96 -32.38 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.352 0.596 . . . . 73.209999999999994 110.243 172.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 4.2 tmt_? -68.04 -45.77 73.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.703 -0.681 . . . . 65.310000000000002 111.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -67.83 -33.42 74.75 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.918 0.39 . . . . 72.129999999999995 111.669 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.0 t -74.31 -44.01 54.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.25 0.463 . . . . 64.140000000000001 112.25 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.673 HD22 HG22 ' A' ' 159' ' ' VAL . 68.3 mt -95.79 -4.78 43.27 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.72 1.007 . . . . 71.540000000000006 113.72 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -58.24 -43.51 87.82 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.246 0.461 . . . . 74.319999999999993 112.246 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -80.92 -27.85 36.03 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 111.022 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.77 92.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.209 0.528 . . . . 74.439999999999998 111.173 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.27 -29.7 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.309 -0.405 . . . . 73.430000000000007 111.108 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.423 ' C ' ' SD ' ' A' ' 186' ' ' MET . 0.2 OUTLIER -54.63 -48.08 72.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.33 -0.396 . . . . 71.310000000000002 111.293 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -64.99 -19.12 65.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.023 0.379 . . . . 70.25 112.023 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -87.37 -5.97 58.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.774 0.321 . . . . 74.430000000000007 111.317 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.15 16.22 70.09 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.394 -0.431 . . . . 54.509999999999998 112.665 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.9 mt -117.3 171.76 7.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.016 0.436 . . . . 73.310000000000002 111.622 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 25.4 pt -133.44 143.9 49.97 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 116.086 -0.506 . . . . 74.219999999999999 111.039 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.81 -29.69 82.06 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.749 2.299 . . . . 75.340000000000003 112.941 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.34 -32.38 68.46 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.998 -0.546 . . . . 74.019999999999996 111.934 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.28 9.96 31.86 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.365 0.506 . . . . 64.120000000000005 112.365 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.0 m -118.27 166.87 12.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.98 0.419 . . . . 74.519999999999996 111.614 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HB2' HD22 ' A' ' 227' ' ' LEU . . . -132.08 138.9 48.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 73.120000000000005 111.335 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 224' ' ' VAL . 61.9 t -111.17 132.11 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.288 -0.414 . . . . 74.230000000000004 111.267 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -139.06 146.89 41.33 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.252 0.548 . . . . 74.5 111.312 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.523 ' HG2' HD12 ' A' ' 208' ' ' ILE . 9.1 ptm180 -116.62 169.15 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 71.519999999999996 110.294 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -104.04 115.69 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 110.101 174.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.27 119.69 22.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.952 -0.567 . . . . 75.430000000000007 110.253 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.31 27.01 15.96 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.335 0.588 . . . . 64.319999999999993 111.57 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.96 2.51 74.77 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.243 -0.435 . . . . 65.239999999999995 113.882 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.02 133.03 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.428 -0.454 . . . . 64.129999999999995 111.629 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 63.7 mttp -78.13 99.0 6.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.074 0.464 . . . . 72.439999999999998 110.895 175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -93.67 112.09 55.32 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.991 -0.55 . . . . 74.120000000000005 111.859 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.19 110.23 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.92 2.413 . . . . 74.409999999999997 112.654 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.523 HD12 ' HG2' ' A' ' 199' ' ' ARG . 62.6 mt -89.13 138.59 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.26 -0.427 . . . . 73.230000000000004 112.039 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.06 138.59 34.94 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.14 -0.553 . . . . 74.340000000000003 113.219 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.494 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.1 m95 -59.45 -22.99 62.32 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.901 0.381 . . . . 70.409999999999997 111.746 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.09 -11.84 60.93 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.095 0.558 . . . . 75.109999999999999 112.228 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.4 ' O ' HG21 ' A' ' 177' ' ' VAL . 20.7 m -75.75 135.11 40.33 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.279 -0.419 . . . . 72.329999999999998 111.892 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -62.03 127.21 30.29 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.513 -0.312 . . . . 74.510000000000005 111.54 176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -61.31 -22.75 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 111.284 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.9 t -54.89 -29.12 55.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.048 -0.524 . . . . 53.310000000000002 112.036 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -68.79 -26.74 65.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.143 0.497 . . . . 75.5 111.496 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.626 HD13 HD22 ' A' ' 222' ' ' LEU . 51.8 mt -105.47 10.88 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.0 -0.546 . . . . 72.329999999999998 112.104 -172.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 70.7 m -50.38 119.22 3.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.178 0.436 . . . . 61.130000000000003 112.178 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.73 -21.44 45.87 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.276 -0.488 . . . . 75.349999999999994 113.993 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -86.42 172.47 10.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.424 0.63 . . . . 73.010000000000005 112.418 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.43 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.1 mt-10 -111.18 119.96 40.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.875 -0.602 . . . . 75.409999999999997 111.249 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.626 HD22 HD13 ' A' ' 217' ' ' LEU . 77.6 mt -97.39 155.23 17.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 111.116 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -127.52 120.53 28.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.029 -0.36 . . . . 71.200000000000003 110.029 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.489 HG23 HG23 ' A' ' 197' ' ' VAL . 52.5 t -115.95 140.6 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.1 0.476 . . . . 70.409999999999997 111.711 -175.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.475 ' HA ' ' HB3' ' A' ' 162' ' ' PRO . 12.6 pt-20 -144.26 160.72 40.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.301 -0.409 . . . . 74.120000000000005 110.754 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.78 139.01 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.64 -0.254 . . . . 74.049999999999997 111.166 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.425 HD22 ' HB2' ' A' ' 196' ' ' ALA . 96.5 mt -60.57 -42.44 96.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.886 0.328 . . . . 73.400000000000006 111.886 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -146.03 143.13 29.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.978 0.418 . . . . 74.409999999999997 110.753 172.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -78.1 37.62 0.26 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.231 0.456 . . . . 71.230000000000004 112.231 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.2 90.39 47.35 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.966 0.358 . . . . 71.5 111.966 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.05 151.25 23.71 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.553 2.169 . . . . 74.439999999999998 112.672 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.787 -0.625 . . . . 63.210000000000001 112.104 -179.145 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m80 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.728 0.299 . . . . 74.430000000000007 111.051 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.492 ' N ' ' SD ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -72.53 150.06 91.21 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.638 0.256 . . . . 74.219999999999999 111.468 178.919 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -57.93 107.61 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.427 2.084 . . . . 75.030000000000001 112.768 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -107.9 97.59 7.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.662 0.744 . . . . 63.049999999999997 110.859 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.7 p -137.62 157.27 73.98 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 115.791 -0.641 . . . . 73.099999999999994 111.407 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.84 60.53 2.94 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.988 2.459 . . . . 74.430000000000007 113.389 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -73.68 84.25 1.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.389 0.614 . . . . 75.299999999999997 111.419 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.61 161.48 27.26 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.563 -0.744 . . . . 74.019999999999996 111.103 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.76 120.49 7.68 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.95 1.767 . . . . 72.420000000000002 111.661 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.3 pt -113.94 161.84 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.637 0.732 . . . . 73.329999999999998 112.883 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.45 133.58 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.342 -0.845 . . . . 74.239999999999995 110.275 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -95.99 96.39 8.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.011 0.434 . . . . 72.099999999999994 111.34 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.56 HG21 HD11 ' A' ' 222' ' ' LEU . 41.5 t -94.33 117.17 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.031 0.443 . . . . 75.239999999999995 112.108 -176.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.99 100.13 12.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.188 0.518 . . . . 75.540000000000006 111.112 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.496 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 98.1 mt -69.95 161.77 73.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.696 -0.683 . . . . 71.430000000000007 111.614 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 9.8 Cg_endo -52.09 153.24 12.83 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.768 2.312 . . . . 73.530000000000001 113.345 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 61.96 44.6 8.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.495 0.664 . . . . 71.439999999999998 110.901 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 61.47 23.77 13.98 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.096 0.776 . . . . 74.219999999999999 113.096 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.496 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.9 mm-40 -86.88 157.76 19.47 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.068 -0.395 . . . . 64.439999999999998 111.101 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -139.74 145.44 38.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.443 0.534 . . . . 74.540000000000006 112.443 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.1 t -148.1 161.9 40.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.795 -0.639 . . . . 72.120000000000005 110.19 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.34 120.32 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.954 0.407 . . . . 72.140000000000001 111.254 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.04 137.05 26.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.461 -0.336 . . . . 75.099999999999994 111.449 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.493 ' HG2' HH21 ' A' ' 172' ' ' ARG . 65.0 Cg_endo -74.12 126.16 10.32 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 75.549999999999997 113.007 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.74 35.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.092 0.472 . . . . 70.430000000000007 112.165 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.493 HH21 ' HG2' ' A' ' 170' ' ' PRO . 11.5 ptp180 -167.71 161.97 13.69 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.001 -0.545 . . . . 74.209999999999994 111.604 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.7 t -95.47 154.32 17.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.306 -0.407 . . . . 64.329999999999998 111.351 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 66.5 18.66 68.03 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.248 -0.501 . . . . 74.25 113.266 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.48 ' HB ' ' HG3' ' A' ' 172' ' ' ARG . 40.8 t -132.8 124.72 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.644 0.378 . . . . 72.120000000000005 110.468 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.6 p -82.84 158.05 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 64.209999999999994 111.622 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.62 -35.77 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.617 0.722 . . . . 73.329999999999998 110.017 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.511 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.9 ttp180 -56.42 -54.65 43.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.948 -1.024 . . . . 73.150000000000006 111.319 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -74.16 -12.53 60.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.18 -0.464 . . . . 72.25 111.718 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.5 m -82.79 -46.78 12.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.037 0.446 . . . . 63.43 110.944 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.72 4.94 48.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.311 0.486 . . . . 64.340000000000003 112.311 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -54.92 -26.63 37.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.878 0.37 . . . . 75.019999999999996 111.8 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.02 -52.11 6.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.68 0.276 . . . . 74.129999999999995 111.556 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.34 64.11 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.005 0.431 . . . . 75.019999999999996 112.117 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.2 mt -71.03 -53.78 13.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.934 0.397 . . . . 73.439999999999998 111.483 178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.2 tpp -57.05 -42.09 79.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.358 0.503 . . . . 72.430000000000007 112.358 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.3 ptp -66.63 -15.44 63.47 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.118 0.414 . . . . 74.340000000000003 112.118 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -110.14 5.2 21.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 111.551 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.05 35.54 89.34 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.464 -0.398 . . . . 75.329999999999998 113.229 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.6 159.95 15.81 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.086 0.469 . . . . 74.299999999999997 111.54 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.01 151.7 77.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.959 -0.564 . . . . 75.450000000000003 110.816 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.53 -34.3 51.42 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.683 2.255 . . . . 71.319999999999993 113.292 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -64.02 -22.03 66.75 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.2 0.524 . . . . 64.349999999999994 111.906 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.6 t -96.4 -7.49 34.86 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.335 0.494 . . . . 73.150000000000006 112.335 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.4 m -134.89 131.65 37.59 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.683 0.623 . . . . 72.230000000000004 112.683 -172.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -111.31 127.33 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.18 -0.463 . . . . 55.43 111.324 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.473 HG21 HG23 ' A' ' 224' ' ' VAL . 47.0 t -100.07 133.36 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.536 -0.302 . . . . 75.340000000000003 111.405 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -152.37 160.62 43.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.257 0.551 . . . . 73.439999999999998 111.812 175.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -122.93 155.94 35.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 110.677 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.95 120.75 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.8 0.333 . . . . 75.230000000000004 111.03 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -129.74 115.94 18.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.832 0.349 . . . . 73.030000000000001 111.207 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.1 t70 63.43 31.36 15.07 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.312 0.577 . . . . 73.010000000000005 111.155 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.55 50.25 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.258 -0.496 . . . . 42.009999999999998 114.221 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -102.34 155.7 18.07 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.399 0.599 . . . . 65.040000000000006 112.314 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.451 ' HZ2' ' HB2' ' A' ' 205' ' ' LYS . 5.5 mtpm? -103.8 136.19 43.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.739 -0.664 . . . . 73.409999999999997 112.445 -177.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -118.66 116.28 34.9 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 116.227 -0.442 . . . . 75.420000000000002 111.205 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.14 121.78 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.02 2.48 . . . . 74.239999999999995 112.911 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.85 122.79 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.171 0.51 . . . . 74.299999999999997 111.478 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.37 145.47 33.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.18 -0.533 . . . . 64.219999999999999 113.206 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.511 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.6 m95 -61.93 -27.55 68.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.922 0.391 . . . . 75.430000000000007 111.909 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.87 -10.3 59.31 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.675 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 90.5 m -69.52 136.97 52.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.209999999999994 111.663 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.99 126.23 27.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.89 0.376 . . . . 70.099999999999994 111.272 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . 0.4 HG23 ' H ' ' A' ' 172' ' ' ARG . 12.7 tt -58.43 -19.92 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.977 0.418 . . . . 75.349999999999994 111.894 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -52.42 -33.63 44.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.255 0.465 . . . . 65.209999999999994 112.255 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -65.15 -28.34 69.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.15 0.5 . . . . 73.310000000000002 111.766 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.459 HD13 HD22 ' A' ' 222' ' ' LEU . 35.7 mt -98.75 14.91 27.05 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.554 0.576 . . . . 73.219999999999999 112.554 -169.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.3 m -54.93 108.35 0.39 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.134 0.492 . . . . 74.129999999999995 112.237 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.9 69.66 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.457 -0.402 . . . . 70.450000000000003 113.954 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -84.53 163.46 19.36 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.321 0.581 . . . . 71.430000000000007 112.209 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -106.42 118.15 35.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.816 -0.629 . . . . 72.420000000000002 110.375 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.56 HD11 HG21 ' A' ' 159' ' ' VAL . 59.2 mt -93.01 111.86 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.006 0.431 . . . . 71.109999999999999 110.876 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -92.11 103.31 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.506 -0.316 . . . . 72.219999999999999 110.338 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.473 HG23 HG21 ' A' ' 197' ' ' VAL . 35.3 t -99.0 123.35 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 111.998 0.37 . . . . 74.319999999999993 111.998 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -115.92 177.02 4.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.963 0.411 . . . . 74.239999999999995 111.366 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.6 138.03 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.691 0.626 . . . . 75.409999999999997 112.691 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.455 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.6 mt -100.92 -72.39 0.68 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.989 175.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.43 156.11 19.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.882 0.373 . . . . 75.420000000000002 111.436 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -100.85 -29.5 12.21 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.313 0.486 . . . . 73.109999999999999 112.313 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.66 125.55 59.02 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.196 0.443 . . . . 73.030000000000001 112.196 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -87.39 145.91 7.19 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.642 2.228 . . . . 74.140000000000001 113.05 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.778 -0.629 . . . . 70.219999999999999 110.345 177.082 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.3 t60 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.419 0.152 . . . . 73.310000000000002 111.187 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -81.32 141.25 49.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 120.575 0.226 . . . . 71.439999999999998 110.856 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.68 126.78 7.57 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.512 2.141 . . . . 74.25 113.227 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 143.09 41.98 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.791 0.329 . . . . 75.209999999999994 111.116 177.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -128.45 134.17 25.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-O 120.826 0.346 . . . . 73.409999999999997 111.85 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 62.43 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.803 2.335 . . . . 73.25 112.624 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.72 38.65 0.52 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.256 0.55 . . . . 74.209999999999994 111.711 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.1 155.31 43.63 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.002 -0.545 . . . . 64.430000000000007 110.362 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.55 140.01 75.41 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.743 2.295 . . . . 74.439999999999998 113.066 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . 0.487 HG23 ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -137.48 167.71 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.342 0.591 . . . . 75.450000000000003 112.496 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.454 HG21 ' HB2' ' A' ' 171' ' ' ALA . 46.8 t -129.92 139.09 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.816 -0.629 . . . . 64.430000000000007 110.349 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.738 ' HG2' HG22 ' A' ' 168' ' ' VAL . 98.9 mtt180 -108.69 117.86 35.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.292 0.568 . . . . 73.219999999999999 111.574 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.402 HG21 HD22 ' A' ' 181' ' ' LEU . 75.3 t -109.92 131.69 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.292 0.478 . . . . 71.010000000000005 112.292 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -89.53 94.58 9.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.125 0.488 . . . . 63.140000000000001 110.934 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.438 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 81.9 mt -68.81 154.9 94.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 111.201 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.75 154.01 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.463 2.109 . . . . 64.010000000000005 112.375 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . 0.451 HD21 ' NH2' ' A' ' 188' ' ' ARG . 60.4 m-20 72.09 12.74 5.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.935 0.494 . . . . 74.299999999999997 110.78 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt 64.59 59.39 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.191 0.596 . . . . 73.439999999999998 112.445 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 83.8 mm-40 -113.41 135.95 53.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.004 -0.544 . . . . 74.049999999999997 110.481 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . 0.421 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 4.7 mpt_? -105.89 128.67 53.92 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.026 0.441 . . . . 75.519999999999996 111.889 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -136.96 156.17 48.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.436 -0.347 . . . . 75.340000000000003 111.16 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.738 HG22 ' HG2' ' A' ' 158' ' ' ARG . 38.7 t -126.38 132.78 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.934 0.397 . . . . 71.549999999999997 111.57 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.53 146.95 56.37 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.31 -0.405 . . . . 72.219999999999999 111.011 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . 0.487 ' HA ' HG23 ' A' ' 156' ' ' ILE . 57.5 Cg_endo -70.46 122.44 8.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.336 2.024 . . . . 42.520000000000003 113.261 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.454 ' HB2' HG21 ' A' ' 157' ' ' VAL . . . -74.03 114.81 12.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.919 0.39 . . . . 63.229999999999997 111.134 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.496 ' HG3' HG21 ' A' ' 175' ' ' VAL . 19.2 ptt-85 -132.67 142.34 49.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 72.540000000000006 111.896 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 45.7 t -77.58 140.22 39.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 111.66 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.77 55.99 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.238 -0.506 . . . . 63.140000000000001 113.242 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . 0.496 HG21 ' HG3' ' A' ' 172' ' ' ARG . 45.5 t -134.51 135.36 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 122.476 0.31 . . . . 75.439999999999998 110.751 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.8 p -81.63 159.71 23.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.123 0.487 . . . . 74.150000000000006 111.697 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 212' ' ' THR . 81.2 t -58.09 -37.69 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.286 0.565 . . . . 74.25 110.574 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.553 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 36.9 ttp180 -59.83 -56.76 17.71 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.673 -0.694 . . . . 74.109999999999999 111.511 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.407 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 68.2 m-20 -64.19 -17.04 63.15 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 73.230000000000004 112.347 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -93.69 -39.05 10.99 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.098 -0.376 . . . . 65.230000000000004 111.775 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.402 HD22 HG21 ' A' ' 159' ' ' VAL . 65.2 mt -91.83 -5.54 53.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.753 0.649 . . . . 75.420000000000002 112.753 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 20.4 ptmt -54.28 -34.42 60.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.772 0.32 . . . . 71.540000000000006 111.751 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.58 -39.91 77.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.05 0.452 . . . . 72.129999999999995 111.361 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.53 ' HA ' ' HE1' ' A' ' 187' ' ' MET . . . -63.36 -42.75 98.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.986 0.422 . . . . 70.140000000000001 111.223 178.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.47 -43.11 91.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.125 -0.489 . . . . 64.040000000000006 110.768 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.5 ttp -55.66 -50.71 69.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.116 -0.493 . . . . 74.540000000000006 111.488 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' MET . . . . . 0.53 ' HE1' ' HA ' ' A' ' 184' ' ' ALA . 27.0 ptt? -72.71 -0.5 13.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 111.872 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.451 ' NH2' HD21 ' A' ' 163' ' ' ASN . 19.3 mmm180 -117.41 1.68 12.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.787 0.292 . . . . 74.230000000000004 111.787 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 63.28 47.1 90.79 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.339 -0.458 . . . . 63.25 113.424 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 92.4 mt -132.86 159.92 38.45 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.987 0.422 . . . . 73.219999999999999 111.915 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.78 147.36 38.04 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.136 -0.484 . . . . 73.209999999999994 110.773 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.76 -47.08 26.78 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.608 2.205 . . . . 71.299999999999997 113.753 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.63 -3.47 21.76 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.727 0.64 . . . . 70.219999999999999 112.727 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -94.47 -8.54 38.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.047 0.451 . . . . 74.010000000000005 111.339 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 93.3 m -135.29 158.72 43.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.049 0.452 . . . . 75.109999999999999 111.811 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.48 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -124.93 131.72 53.39 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.304 -0.407 . . . . 70.25 111.379 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.527 HG23 HG22 ' A' ' 224' ' ' VAL . 58.2 t -103.05 125.44 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.097 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.404 ' HE1' ' HG2' ' A' ' 225' ' ' GLU . 40.6 p90 -137.36 151.56 48.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.008 0.432 . . . . 74.109999999999999 111.111 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.457 ' HG2' HD13 ' A' ' 208' ' ' ILE . 37.4 ptt180 -111.7 142.2 44.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.031 -0.359 . . . . 73.109999999999999 110.031 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.419 HG12 ' HG2' ' A' ' 205' ' ' LYS . 48.8 mt -82.79 103.45 10.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 74.299999999999997 109.732 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -102.82 109.77 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 75.099999999999994 110.827 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.4 t70 60.68 16.95 7.07 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.765 -0.652 . . . . 64.230000000000004 111.366 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.99 -19.45 30.15 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.519 -0.372 . . . . 74.120000000000005 113.572 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.43 123.97 33.5 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.294 -0.533 . . . . 73.439999999999998 111.969 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.419 ' HG2' HG12 ' A' ' 200' ' ' ILE . 96.6 mttt -79.89 104.2 10.31 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.405 -0.362 . . . . 71.209999999999994 110.611 174.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.06 115.24 40.88 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.9 0.381 . . . . 72.019999999999996 111.892 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.05 133.94 46.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.515 2.81 . . . . 72.019999999999996 113.861 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.457 HD13 ' HG2' ' A' ' 199' ' ' ARG . 50.0 mt -110.03 153.05 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.623 -0.717 . . . . 74.420000000000002 110.758 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.38 150.42 21.28 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.844 -0.694 . . . . 73.219999999999999 112.9 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.553 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 90.5 m95 -67.76 -27.67 66.97 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.178 -0.601 . . . . 73.099999999999994 111.634 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.78 -3.57 51.44 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.941 0.348 . . . . 64.299999999999997 111.941 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.418 ' O ' HG21 ' A' ' 177' ' ' VAL . 88.7 m -68.55 141.9 55.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.938 0.399 . . . . 70.329999999999998 111.071 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.12 117.71 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.063 0.458 . . . . 72.430000000000007 111.426 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.55 -22.07 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 N-CA-C 112.392 0.516 . . . . 74.519999999999996 112.392 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.5 p -59.91 -18.21 43.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.335 0.494 . . . . 74.340000000000003 112.335 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.39 -14.43 58.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.945 0.403 . . . . 72.329999999999998 111.954 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.53 22.87 14.94 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.175 0.512 . . . . 72.409999999999997 111.491 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.9 m -61.72 121.44 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.807 0.669 . . . . 74.239999999999995 112.807 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.6 -23.44 33.94 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.32 0.888 . . . . 71.140000000000001 115.32 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -99.32 172.25 7.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.981 0.89 . . . . 73.239999999999995 112.487 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.459 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 25.7 mp0 -93.26 139.87 30.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.945 -0.571 . . . . 72.510000000000005 111.936 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 90.6 mt -111.92 152.89 27.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.303 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -117.14 134.49 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.567 0.222 . . . . 75.430000000000007 111.138 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.527 HG22 HG23 ' A' ' 197' ' ' VAL . 64.4 t -115.79 116.47 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 72.140000000000001 111.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.404 ' HG2' ' HE1' ' A' ' 198' ' ' TYR . 61.8 mm-40 -102.97 137.43 41.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.405 -0.361 . . . . 70.540000000000006 111.016 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.88 108.83 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.842 0.353 . . . . 74.409999999999997 110.837 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.48 HD21 ' HB2' ' A' ' 196' ' ' ALA . 95.8 mt -63.43 -63.82 1.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.095 0.474 . . . . 72.140000000000001 111.548 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -118.98 119.11 33.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.12 0.486 . . . . 73.450000000000003 111.097 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.86 -25.69 65.26 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.041 0.756 . . . . 71.219999999999999 113.041 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.1 t -94.37 109.41 42.64 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 120.501 0.191 . . . . 74.549999999999997 111.419 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.99 168.63 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.929 2.419 . . . . 74.099999999999994 113.006 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--O 1.255 1.387 0 CA-C-O 119.051 -0.499 . . . . 65.530000000000001 111.677 178.126 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 112.124 0.416 . . . . 74.219999999999999 112.124 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.6 mtm 67.3 96.83 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 122.965 0.506 . . . . 72.400000000000006 111.86 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.1 159.96 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.734 2.289 . . . . 71.010000000000005 113.392 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -97.24 145.14 26.36 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.078 0.466 . . . . 75.219999999999999 111.355 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.0 p -79.77 136.15 55.31 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 116.232 -0.44 . . . . 74.409999999999997 111.428 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.55 160.76 46.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.531 2.154 . . . . 75.310000000000002 112.649 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.57 84.75 0.43 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.283 0.563 . . . . 75.439999999999998 110.741 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? -71.81 148.16 92.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.854 -0.612 . . . . 74.310000000000002 111.671 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.08 130.53 38.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.415 . . . . 72.540000000000006 113.13 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -132.33 169.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.962 0.411 . . . . 75.430000000000007 111.797 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.484 HG22 ' HB2' ' A' ' 171' ' ' ALA . 55.0 t -130.6 132.42 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 71.140000000000001 110.531 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.494 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 85.8 mtt180 -89.13 98.41 11.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.722 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.597 HG22 HD22 ' A' ' 181' ' ' LEU . 35.6 t -99.13 111.14 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.24 0.543 . . . . 61.420000000000002 112.051 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -89.45 111.97 23.0 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.673 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.5 mt -90.75 161.74 35.28 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.252 -0.431 . . . . 74.140000000000001 111.624 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 50.8 Cg_exo -55.54 162.51 6.22 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.555 2.17 . . . . 72.439999999999998 113.353 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.83 36.59 22.01 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.617 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.2 13.44 9.15 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.103 0.779 . . . . 72.310000000000002 113.103 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.456 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.5 mm-40 -76.72 159.7 29.96 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.89 0.376 . . . . 74.340000000000003 111.46 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.56 154.07 38.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.328 0.585 . . . . 74.040000000000006 112.28 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . 0.405 HG21 ' HB ' ' A' ' 159' ' ' VAL . 7.9 t -157.63 150.84 23.44 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 111.054 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.47 119.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.777 0.323 . . . . 74.349999999999994 110.244 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.57 152.41 58.34 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.495 -0.321 . . . . 74.219999999999999 111.768 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.2 132.36 19.37 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.595 2.197 . . . . 75.200000000000003 113.583 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.484 ' HB2' HG22 ' A' ' 157' ' ' VAL . . . -89.48 104.7 17.23 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.029 0.442 . . . . 53.409999999999997 111.431 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.42 140.71 52.4 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.4 -0.363 . . . . 74.430000000000007 111.917 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.98 122.35 19.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.429 -0.351 . . . . 75.040000000000006 110.79 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.67 -29.5 7.8 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.233 -0.508 . . . . 63.229999999999997 112.428 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 62.7 t -89.55 126.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.736 0.303 . . . . 73.439999999999998 111.052 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 69.6 p -87.32 160.83 18.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.896 0.379 . . . . 64.299999999999997 111.46 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.93 -39.39 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.019 0.438 . . . . 75.209999999999994 111.668 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.567 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 24.5 ttp180 -74.23 -21.16 59.91 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.34 . . . . 74.319999999999993 111.744 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.409 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 17.4 t70 -84.05 -34.38 24.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.112 0.482 . . . . 74.430000000000007 111.288 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 78.4 p -80.84 -55.1 5.03 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.114 0.483 . . . . 74.129999999999995 111.632 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.597 HD22 HG22 ' A' ' 159' ' ' VAL . 86.0 mt -73.54 -2.31 22.24 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.681 0.993 . . . . 74.200000000000003 113.681 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.409 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 22.0 pttp -60.72 -29.08 69.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.619 0.645 . . . . 75.400000000000006 112.236 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -76.69 -38.94 53.59 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.167 -0.333 . . . . 72.409999999999997 110.998 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.467 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -60.15 -54.68 42.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.91 0.386 . . . . 64.25 110.958 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.4 mt -55.52 -45.74 77.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.789 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -55.19 -55.79 27.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 111.961 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.0 ptp -67.53 -22.18 65.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.559 0.577 . . . . 74.409999999999997 112.559 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 67.9 mmt-85 -91.97 -23.07 19.68 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.28 -0.262 . . . . 72.310000000000002 111.679 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.16 42.42 4.64 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.534 -0.365 . . . . 44.229999999999997 113.246 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.15 162.94 24.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.989 0.423 . . . . 75.319999999999993 111.417 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.81 142.86 46.44 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.564 -0.289 . . . . 74.430000000000007 111.291 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.19 -19.68 58.24 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.812 2.342 . . . . 70.209999999999994 113.782 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.15 -28.8 57.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.797 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . 0.476 ' SG ' HG13 ' A' ' 226' ' ' VAL . 51.2 t -106.89 19.1 20.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.506 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.6 m -130.65 130.28 43.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.295 0.569 . . . . 73.209999999999994 111.911 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.514 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -110.0 119.44 39.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.795 -0.639 . . . . 73.25 111.209 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.503 HG22 HG23 ' A' ' 224' ' ' VAL . 43.9 t -99.78 122.32 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.526 0.203 . . . . 74.549999999999997 111.051 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.404 ' HE2' ' HG3' ' A' ' 225' ' ' GLU . 42.4 p90 -134.07 152.13 51.7 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 111.479 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 199' ' ' ARG . 4.1 ptm180 -115.5 142.88 46.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.582 . . . . 74.430000000000007 110.454 176.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . 0.48 HG12 ' HG2' ' A' ' 205' ' ' LYS . 55.9 mt -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.904 0.383 . . . . 75.209999999999994 111.355 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -161.62 133.41 5.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.142 -0.481 . . . . 73.040000000000006 110.827 177.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 60.72 28.65 18.37 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.895 0.379 . . . . 55.520000000000003 112.006 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.49 10.7 85.98 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.002 -0.618 . . . . 74.409999999999997 113.415 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.47 145.17 42.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.142 0.496 . . . . 75.150000000000006 111.781 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . 0.48 ' HG2' HG12 ' A' ' 200' ' ' ILE . 97.9 mttt -102.36 102.44 12.78 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 74.519999999999996 110.22 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.83 113.67 56.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.333 -0.394 . . . . 75.329999999999998 111.733 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.69 139.52 63.76 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.645 2.23 . . . . 70.530000000000001 112.488 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.22 142.39 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.981 0.42 . . . . 74.219999999999999 111.41 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.25 137.8 14.62 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.127 -0.558 . . . . 74.120000000000005 112.651 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.567 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -63.29 -17.17 62.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.373 -0.486 . . . . 75.010000000000005 111.8 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.49 -10.46 59.47 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.974 -0.557 . . . . 74.409999999999997 112.281 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 68.6 m -80.32 143.87 33.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.076 0.398 . . . . 73.439999999999998 112.076 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.42 132.52 52.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 64.120000000000005 111.961 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -65.38 -18.37 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 111.492 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.0 p -62.16 -23.65 66.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.975 0.417 . . . . 55.549999999999997 111.821 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -71.81 -15.77 62.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.045 0.45 . . . . 72.150000000000006 111.173 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.2 mt -113.85 13.56 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.052 -0.522 . . . . 72.219999999999999 111.307 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 98.1 m -51.9 113.77 1.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.708 0.633 . . . . 75.420000000000002 112.708 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 90.77 -17.93 52.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.308 -0.472 . . . . 73.140000000000001 113.821 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -73.99 168.06 20.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 112.121 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . 0.494 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.6 mt-10 -112.72 114.74 27.47 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.586 -0.734 . . . . 74.140000000000001 110.77 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.473 HD12 HG21 ' A' ' 159' ' ' VAL . 68.3 mt -93.33 147.72 22.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.122 0.487 . . . . 74.010000000000005 111.342 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -127.54 117.67 22.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.054 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.56 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 40.2 t -103.96 144.68 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.07 0.462 . . . . 72.329999999999998 112.215 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.404 ' HG3' ' HE2' ' A' ' 198' ' ' TYR . 22.4 mt-10 -130.75 177.85 7.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 111.633 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . 0.476 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.0 t -91.94 140.44 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.837 0.351 . . . . 73.510000000000005 111.815 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . 0.491 HD22 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt -106.96 -86.21 0.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.144 0.424 . . . . 73.439999999999998 112.144 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.01 106.26 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.448 0.642 . . . . 73.430000000000007 111.682 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -80.56 42.29 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.659 0.743 . . . . 63.039999999999999 111.321 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.7 m -137.53 66.36 50.25 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 121.023 0.44 . . . . 71.099999999999994 111.364 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.0 102.18 1.21 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.402 2.068 . . . . 64.140000000000001 112.59 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.622 -0.704 . . . . 72.129999999999995 111.673 -179.204 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.617 0.246 . . . . 73.329999999999998 111.598 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.1 ptm -104.72 114.9 63.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 120.996 0.426 . . . . 74.430000000000007 111.035 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.92 -166.56 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.731 2.287 . . . . 72.329999999999998 112.854 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 25.0 pttm -138.94 99.88 3.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.495 0.664 . . . . 74.349999999999994 111.384 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 78.9 p -95.3 110.97 53.4 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.357 -0.383 . . . . 75.230000000000004 110.377 175.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.98 54.38 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.776 2.317 . . . . 70.209999999999994 112.55 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.31 39.17 0.38 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.217 0.532 . . . . 75.099999999999994 112.295 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -98.12 151.89 37.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.283 -0.417 . . . . 74.340000000000003 109.95 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -50.02 129.81 25.91 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.839 2.359 . . . . 75.519999999999996 113.367 -175.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.62 160.92 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.36 0.6 . . . . 73.439999999999998 112.086 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 129.86 65.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 110.535 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 158' ' ' ARG . 68.2 mtt85 -96.21 98.46 10.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.736 0.303 . . . . 71.530000000000001 111.416 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.473 HG21 HD12 ' A' ' 222' ' ' LEU . 41.2 t -96.26 120.09 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 112.043 -176.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.09 115.32 27.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.128 0.49 . . . . 72.400000000000006 110.747 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LEU . . . . . 0.521 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 91.9 mt -93.47 165.71 17.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.947 -0.57 . . . . 75.200000000000003 111.527 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 20.6 Cg_endo -60.5 168.01 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.246 1.964 . . . . 73.019999999999996 112.534 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.94 27.2 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.081 0.4 . . . . 72.129999999999995 112.081 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.34 26.76 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.728 0.411 . . . . 74.209999999999994 111.795 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.501 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 76.9 mm-40 -92.43 162.21 14.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.92 0.39 . . . . 72.150000000000006 111.131 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -151.56 156.12 39.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.938 0.399 . . . . 72.0 111.786 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 t -156.85 126.99 6.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.274 -0.421 . . . . 74.120000000000005 111.535 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.62 119.73 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.29 -0.256 . . . . 74.150000000000006 110.557 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.74 144.87 39.83 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 112.014 0.376 . . . . 71.230000000000004 112.014 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.24 139.73 67.47 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.608 2.206 . . . . 74.409999999999997 112.923 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -93.31 109.7 21.24 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 70.209999999999994 111.606 -178.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -97.22 132.39 43.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.386 -0.37 . . . . 74.340000000000003 110.997 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.1 t -70.7 121.25 17.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.774 0.321 . . . . 73.120000000000005 111.122 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.2 -9.69 50.32 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.369 -0.444 . . . . 55.25 113.168 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.88 135.28 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 122.432 -0.452 . . . . 71.299999999999997 110.526 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 69.8 p -81.54 167.04 19.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.299 0.571 . . . . 63.229999999999997 112.266 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 212' ' ' THR . 77.9 t -59.49 -37.66 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.371 0.605 . . . . 60.329999999999998 110.773 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 31.5 ttp180 -66.36 -55.87 13.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.811 -0.631 . . . . 61.420000000000002 111.226 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.549 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 17.0 t70 -60.83 -36.0 77.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.162 -0.472 . . . . 73.310000000000002 112.004 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 81.8 p -77.14 -59.0 2.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.906 0.384 . . . . 61.100000000000001 111.874 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.89 -23.66 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.335 0.865 . . . . 64.030000000000001 113.335 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 23.3 pttp -59.96 -22.69 62.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.613 0.642 . . . . 73.129999999999995 111.538 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.458 ' HZ3' ' HB2' ' A' ' 183' ' ' LYS . 9.1 mtmp? -75.68 -41.42 53.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.139 0.495 . . . . 74.319999999999993 110.562 174.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.79 81.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 74.420000000000002 110.692 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.27 -38.29 68.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.744 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 26.3 ttt -53.7 -48.93 69.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 111.748 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -65.97 -27.07 67.87 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.752 0.311 . . . . 64.409999999999997 111.583 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.09 -22.31 31.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.934 0.397 . . . . 75.530000000000001 111.383 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.51 17.38 45.82 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.364 -0.446 . . . . 74.239999999999995 113.124 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.55 168.63 9.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.261 0.553 . . . . 74.129999999999995 111.96 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -129.77 139.73 36.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.343 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.24 -36.74 97.46 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.947 2.432 . . . . 74.209999999999994 113.898 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.41 -18.85 60.74 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.947 0.403 . . . . 63.140000000000001 111.923 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.14 -5.81 32.8 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.22 0.452 . . . . 74.310000000000002 112.22 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.5 m -119.07 151.53 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.365 0.506 . . . . 73.200000000000003 112.365 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -127.64 122.71 33.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.246 -0.434 . . . . 60.350000000000001 111.362 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' VAL . . . . . 0.522 HG23 HG23 ' A' ' 224' ' ' VAL . 56.5 t -98.12 136.26 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.641 -0.254 . . . . 54.509999999999998 111.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -149.31 165.63 31.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 111.165 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -141.28 158.03 44.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.276 -0.42 . . . . 74.209999999999994 110.332 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.1 mt -92.21 113.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.286 0.565 . . . . 74.540000000000006 111.719 -174.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 206' ' ' LYS . 33.8 tt0 -139.02 142.19 38.27 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.566 -0.743 . . . . 74.430000000000007 110.494 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.65 21.86 10.55 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.534 0.683 . . . . 74.310000000000002 111.021 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.8 82.96 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.252 -0.431 . . . . 73.349999999999994 113.149 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -125.82 151.54 46.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.26 0.552 . . . . 72.049999999999997 111.819 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -82.64 97.27 8.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.087 -0.506 . . . . 73.140000000000001 110.198 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 201' ' ' GLN . 67.2 mttm -96.63 111.66 57.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.938 0.347 . . . . 75.430000000000007 111.938 -175.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.48 142.94 96.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.996 2.464 . . . . 73.150000000000006 113.387 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' ILE . . . . . 0.442 HG23 HD12 ' A' ' 217' ' ' LEU . 66.5 mt -113.5 134.34 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.99 -0.55 . . . . 75.319999999999993 111.016 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.34 133.74 16.8 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.886 -0.673 . . . . 44.530000000000001 112.887 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.1 m95 -60.57 -26.17 66.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.017 0.437 . . . . 75.129999999999995 111.31 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.11 5.81 24.72 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.437 0.532 . . . . 74.109999999999999 112.437 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.3 m -83.84 141.46 31.32 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.492 0.187 . . . . 75.230000000000004 110.98 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.427 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.3 130.52 45.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.857 0.361 . . . . 73.439999999999998 111.238 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.0 tp -59.62 -22.55 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.07 0.462 . . . . 72.25 111.654 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 71.2 p -62.65 -26.87 68.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.244 -0.435 . . . . 74.109999999999999 112.001 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.2 m0 -65.37 -22.64 66.83 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.292 0.568 . . . . 74.109999999999999 111.082 175.687 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.499 HD13 HD23 ' A' ' 222' ' ' LEU . 46.6 mt -108.3 13.52 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.763 -0.653 . . . . 74.209999999999994 111.622 -175.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.9 m -52.8 118.06 3.4 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.166 0.432 . . . . 74.409999999999997 112.166 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.33 79.19 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.269 0.468 . . . . 72.010000000000005 114.269 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -105.52 164.33 11.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.497 0.665 . . . . 71.310000000000002 112.451 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -103.25 117.04 33.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.392 -0.822 . . . . 74.140000000000001 110.566 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.499 HD23 HD13 ' A' ' 217' ' ' LEU . 60.3 mt -93.68 145.92 24.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.013 0.435 . . . . 75.25 111.016 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -121.95 117.02 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.561 -0.291 . . . . 75.239999999999995 110.451 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' VAL . . . . . 0.522 HG23 HG23 ' A' ' 197' ' ' VAL . 73.3 t -104.84 121.17 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.603 0.594 . . . . 73.200000000000003 112.603 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -106.69 164.58 11.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.008 -0.542 . . . . 72.409999999999997 110.832 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.89 124.64 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.774 0.321 . . . . 74.109999999999999 111.478 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 75.2 mt -75.8 -48.41 21.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.947 0.403 . . . . 73.019999999999996 111.508 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.99 168.97 25.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.173 -0.467 . . . . 74.430000000000007 111.296 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.36 5.72 46.34 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.201 -0.454 . . . . 62.350000000000001 111.037 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 40.0 t 57.28 80.0 0.3 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 121.186 0.517 . . . . 71.430000000000007 110.427 -172.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.66 -172.29 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.926 2.417 . . . . 71.519999999999996 113.913 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.839 -0.601 . . . . 74.319999999999993 110.852 179.163 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 109.943 -0.392 . . . . 73.33 109.943 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.98 130.74 25.18 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.727 1.618 . . . . 74.24 111.114 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.03 166.54 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 113.428 0.899 . . . . 60.21 113.428 -171.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 171' ' ' ALA . 58.3 t -124.55 137.52 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.36 -0.836 . . . . 74.32 110.439 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 23.0 mtp85 -100.54 105.54 16.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.828 0.347 . . . . 72.13 111.375 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 181' ' ' LEU . 54.4 t -107.23 122.9 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.986 0.422 . . . . 64.33 111.919 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -93.68 119.29 32.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.119 0.485 . . . . 55.32 111.135 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 92.9 mt -93.17 155.68 40.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.804 -0.634 . . . . 72.12 111.897 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.19 159.53 26.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.608 2.206 . . . . 64.42 113.099 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.507 ' HB2' HH22 ' A' ' 188' ' ' ARG . 85.7 m-20 64.76 39.24 6.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.993 -0.549 . . . . 43.2 111.993 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 66.18 27.0 10.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.18 0.807 . . . . 62.35 113.18 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.9 mm-40 -104.61 166.88 10.1 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.019 -0.425 . . . . 45.34 111.419 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.414 ' N ' ' HD3' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -159.32 157.23 30.08 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.094 -0.379 . . . . 65.33 111.494 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -154.3 159.37 41.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.026 0.441 . . . . 72.55 111.51 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 128.74 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.733 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.419 HG23 HD11 ' A' ' 214' ' ' ILE . 17.3 m -125.4 141.96 40.32 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 111.835 0.309 . . . . 64.41 111.835 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.47 123.59 11.0 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.83 2.353 . . . . 65.44 113.374 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -73.68 102.76 4.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.085 0.469 . . . . 74.51 111.275 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -112.85 137.78 50.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.098 -0.501 . . . . 65.34 111.231 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -74.23 126.4 30.52 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.787 0.327 . . . . 55.12 111.372 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.73 -28.6 11.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.375 -0.44 . . . . 73.32 112.608 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.41 133.62 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.717 0.294 . . . . 54.31 111.127 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 56.7 p -82.48 155.3 24.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.009 0.433 . . . . 73.33 111.482 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 212' ' ' THR . 63.3 t -54.68 -39.03 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.05 0.452 . . . . 51.02 110.894 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.3 ttm-85 -59.94 -53.29 59.58 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 74.51 111.07 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.0 -19.76 64.95 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 73.45 111.405 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.0 m -80.66 -44.58 18.59 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.08 0.467 . . . . 72.32 111.467 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 159' ' ' VAL . 95.9 mt -92.07 -0.01 57.46 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.778 0.658 . . . . 54.31 112.778 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -51.65 -36.91 48.06 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.225 0.454 . . . . 54.24 112.225 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -67.69 -46.1 73.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.986 0.422 . . . . 75.41 111.235 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -61.3 -43.22 99.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.127 -0.488 . . . . 74.1 111.334 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 94.5 mt -64.78 -45.45 86.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.317 -0.401 . . . . 75.43 111.205 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.1 tpt -56.87 -49.57 75.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.383 -0.371 . . . . 72.32 111.696 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.8 ptm -67.2 -17.22 64.73 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.886 0.328 . . . . 74.11 111.886 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 42.2 mmm-85 -95.93 -13.71 23.67 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.153 -0.342 . . . . 61.22 111.413 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.17 27.58 61.78 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.342 -0.456 . . . . 61.35 113.106 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 90.6 mt -112.82 131.07 55.86 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.887 0.375 . . . . 74.34 111.738 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.26 142.45 38.08 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.644 -0.253 . . . . 71.22 110.885 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.02 -24.35 57.15 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.711 2.274 . . . . 63.42 113.45 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.2 -14.62 58.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.131 0.419 . . . . 70.12 112.131 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.47 11.37 32.65 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.132 0.492 . . . . 74.15 110.864 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.2 m -129.95 133.17 46.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.293 -0.412 . . . . 64.24 111.303 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.22 144.82 38.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.668 0.27 . . . . 73.43 111.265 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.18 140.49 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.852 0.358 . . . . 54.51 111.574 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.67 158.67 43.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.188 0.518 . . . . 72.45 111.8 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -122.84 161.22 24.48 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.8 -0.636 . . . . 74.53 110.41 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.0 mt -104.64 114.44 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.153 0.501 . . . . 74.04 111.536 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -124.06 119.6 29.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.732 -0.667 . . . . 72.43 110.203 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 57.19 31.97 20.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.169 0.509 . . . . 74.34 111.214 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 85.24 -2.92 87.94 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.227 -0.511 . . . . 73.53 113.715 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -101.85 139.16 37.87 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.345 -0.503 . . . . 72.3 112.092 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -89.14 103.43 16.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.147 -0.478 . . . . 65.05 110.869 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 207' ' ' PRO . 45.4 mmtm -104.11 127.54 29.02 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.685 0.279 . . . . 72.0 111.587 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 22.6 Cg_exo -65.75 152.28 82.05 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.204 2.602 . . . . 54.41 113.758 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 217' ' ' LEU . 70.6 mt -129.85 138.57 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 73.54 111.007 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.98 134.42 12.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.062 -0.589 . . . . 43.31 112.927 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.6 m95 -57.27 -30.51 64.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.287 0.477 . . . . 61.13 112.287 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -87.24 7.79 26.95 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.131 0.419 . . . . 62.04 112.131 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.8 m -82.6 140.55 33.15 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.296 -0.252 . . . . 72.31 110.797 174.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 4.2 m-20 -59.1 126.9 29.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 72.33 111.595 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 169' ' ' VAL . 12.1 tt -60.24 -21.48 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.134 -0.485 . . . . 75.33 111.819 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 76.8 p -60.65 -27.5 67.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.809 0.338 . . . . 74.45 111.681 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 15.6 m95 -70.37 -16.33 62.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.955 0.407 . . . . 73.1 111.484 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 208' ' ' ILE . 80.1 mt -112.77 22.52 14.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.31 -0.404 . . . . 71.2 111.936 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.8 m -56.74 108.42 0.5 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.853 0.359 . . . . 75.45 111.919 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.46 11.12 61.25 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.171 -0.538 . . . . 50.2 114.048 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -93.8 151.32 19.69 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.342 0.571 . . . . 65.41 111.628 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -105.46 114.35 28.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.082 0.468 . . . . 64.12 110.654 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.406 HD22 HD12 ' A' ' 208' ' ' ILE . 58.1 mt -97.48 150.57 20.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.085 0.469 . . . . 43.23 111.761 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.61 127.61 44.13 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.6 -0.273 . . . . 60.44 110.458 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.73 137.51 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.399 0.518 . . . . 73.55 112.399 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.78 144.24 43.31 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.059 -0.519 . . . . 70.42 111.02 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.36 116.4 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.526 0.203 . . . . 74.33 110.95 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.72 0.295 . . . . 73.14 111.629 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 111.855 0.317 . . . . 71.51 111.855 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 218' ' ' THR . 43.3 Cg_endo -65.79 144.6 78.14 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.823 2.348 . . . . 64.53 112.928 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.6 pt -132.21 162.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.068 0.766 . . . . 74.54 113.068 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.02 123.23 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.251 -0.886 . . . . 54.11 109.65 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.716 ' HB2' ' HB3' ' A' ' 221' ' ' GLU . 49.5 mtt180 -88.91 95.05 10.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.805 0.336 . . . . 62.3 111.092 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 181' ' ' LEU . 57.6 t -93.52 114.71 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.977 -0.452 . . . . 64.33 112.206 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.8 123.92 30.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.85 0.357 . . . . 75.11 110.647 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.473 HD11 ' HB1' ' A' ' 184' ' ' ALA . 96.3 mt -100.38 156.43 35.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.251 0.463 . . . . 63.22 112.251 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.508 ' HG2' HH12 ' A' ' 188' ' ' ARG . 19.4 Cg_endo -59.38 165.78 8.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.298 1.999 . . . . 53.21 112.115 175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 68.22 25.11 7.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.027 0.441 . . . . 73.42 111.11 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 62.94 43.24 6.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.659 -0.701 . . . . 53.24 112.111 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -118.51 -179.74 3.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.02 0.438 . . . . 55.21 111.672 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 159.82 35.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.001 0.429 . . . . 62.01 112.148 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -155.41 129.01 8.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.018 0.437 . . . . 64.12 111.503 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.21 119.55 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.696 0.284 . . . . 74.11 110.314 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.45 138.54 29.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.555 0.217 . . . . 72.14 111.372 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.8 132.26 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.566 2.178 . . . . 72.11 113.039 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.78 103.46 5.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.045 0.45 . . . . 73.34 110.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.2 mtt-85 -106.5 126.35 52.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.305 -0.407 . . . . 72.15 111.395 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.8 t -75.02 115.71 14.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.813 0.34 . . . . 55.41 111.146 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.61 -1.04 27.66 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.244 -0.503 . . . . 32.3 112.58 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.72 133.03 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.743 0.306 . . . . 64.33 110.874 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 33.0 p -81.59 161.59 23.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.852 0.358 . . . . 70.43 111.585 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 212' ' ' THR . 81.3 t -56.33 -34.48 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.439 0.638 . . . . 44.21 110.424 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 47.2 ttp180 -67.35 -56.04 11.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 63.24 111.619 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.665 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 6.6 m-20 -72.22 -12.36 61.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.818 0.673 . . . . 74.44 112.818 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 62.0 p -89.18 -50.94 5.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.943 0.402 . . . . 63.25 110.767 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 159' ' ' VAL . 78.5 mt -79.73 -7.54 58.68 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.426 0.898 . . . . 71.23 113.426 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 14.0 ptpt -55.92 -27.64 53.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.979 -0.45 . . . . 75.22 111.209 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.99 -45.48 81.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.191 0.519 . . . . 70.34 110.773 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -66.77 -30.55 70.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.021 -0.536 . . . . 64.31 111.618 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 91.6 mt -75.17 -43.69 50.86 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.006 0.431 . . . . 71.42 110.709 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.17 -53.86 47.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.762 -0.653 . . . . 70.23 112.0 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' HG3' ' A' ' 188' ' ' ARG . 26.4 ptt? -64.62 -8.58 14.8 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.623 0.601 . . . . 63.42 112.623 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.508 HH12 ' HG2' ' A' ' 162' ' ' PRO . 63.2 mtm180 -119.23 5.37 11.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.849 0.315 . . . . 72.1 111.849 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.44 95.69 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.294 -0.479 . . . . 41.41 113.431 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 95.1 mt -124.43 149.87 46.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.32 0.581 . . . . 72.54 111.753 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.7 pt -104.15 152.72 39.21 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.113 -0.494 . . . . 74.41 111.088 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 -20.72 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.762 2.308 . . . . 74.2 113.825 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.65 -16.55 53.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.982 0.42 . . . . 75.33 111.847 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.7 t -90.36 -9.2 48.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.02 0.378 . . . . 72.44 112.02 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.1 m -136.41 147.69 47.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.04 0.448 . . . . 72.21 111.8 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -125.25 131.55 53.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.875 0.369 . . . . 64.44 111.466 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 224' ' ' VAL . 57.9 t -94.44 132.54 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.333 -0.394 . . . . 75.21 110.844 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 37.8 p90 -148.87 163.05 38.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 62.32 111.09 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -134.62 143.49 47.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 73.43 110.496 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.42 97.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.307 0.575 . . . . 74.42 110.133 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 108.61 19.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 75.23 110.791 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 60.73 30.99 20.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.538 0.685 . . . . 74.41 110.723 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -12.86 68.82 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.051 -0.522 . . . . 65.24 113.491 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 39.5 mt-10 -93.45 132.71 37.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 122.251 -0.558 . . . . 75.15 111.762 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 55.0 mtpt -78.07 94.88 4.74 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.917 0.389 . . . . 63.45 110.708 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 204' ' ' GLU . 33.7 mmtp -96.58 109.73 49.53 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 71.1 111.19 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.29 125.76 13.37 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.876 2.384 . . . . 72.42 112.561 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -100.27 122.09 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.285 -0.416 . . . . 53.33 111.066 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 139.72 46.55 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.319 -0.467 . . . . 41.25 113.105 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.6 m95 -60.02 -22.8 63.09 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.969 0.414 . . . . 71.41 111.603 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -78.47 -6.75 56.26 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.474 0.546 . . . . 75.32 112.474 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 177' ' ' VAL . 29.5 m -75.47 140.49 42.87 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.716 0.265 . . . . 74.43 111.716 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.18 126.86 30.02 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.111 0.481 . . . . 73.44 110.929 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.1 tt -67.05 -23.65 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.503 0.557 . . . . 74.1 112.503 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -67.44 -12.17 59.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.88 0.372 . . . . 71.12 111.708 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -70.82 -23.28 62.33 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.176 0.512 . . . . 71.45 111.197 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 222' ' ' LEU . 28.7 mt -108.66 19.93 19.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.907 -0.588 . . . . 75.51 111.531 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 155' ' ' PRO . 96.7 m -58.48 115.46 3.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.791 0.664 . . . . 62.31 112.791 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.19 -27.98 10.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.114 -0.565 . . . . 64.31 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.64 172.78 6.66 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.371 0.605 . . . . 64.24 112.161 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 158' ' ' ARG . 1.4 pm0 -108.34 149.53 28.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.545 0.688 . . . . 74.15 112.305 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 217' ' ' LEU . 85.9 mt -113.51 163.71 14.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 63.21 111.186 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.44 130.52 46.04 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.556 -0.293 . . . . 72.4 110.317 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 197' ' ' VAL . 40.1 t -118.25 119.05 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.63 0.252 . . . . 54.0 111.496 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.96 164.29 12.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 71.34 111.672 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.3 t -77.6 144.6 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.038 0.447 . . . . 71.45 112.025 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.391 -0.368 . . . . 71.14 111.766 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 110.616 -0.142 . . . . 71.2 110.616 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.56 111.24 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.133 1.889 . . . . 54.24 111.926 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.2 pt -112.46 161.84 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.681 0.623 . . . . 62.2 112.681 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 57.8 t -122.56 128.76 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.786 -0.643 . . . . 75.35 110.279 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.592 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 18.9 mtp180 -96.52 107.9 20.39 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.012 0.434 . . . . 74.24 110.963 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.94 125.46 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.478 0.548 . . . . 65.53 112.478 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -82.74 113.71 20.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.261 -0.427 . . . . 45.02 110.76 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.55 146.88 32.62 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.286 -0.415 . . . . 74.41 111.046 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.07 160.33 19.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.346 2.031 . . . . 63.1 112.646 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 69.21 36.48 2.37 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.185 -0.461 . . . . 73.23 112.04 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 67.95 36.33 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.633 -0.712 . . . . 74.32 112.424 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -117.64 171.23 8.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 72.33 112.171 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.51 162.14 37.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.491 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.13 163.42 40.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.879 0.371 . . . . 64.52 111.452 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.6 t -121.69 128.72 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.914 0.388 . . . . 74.22 111.364 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.62 145.02 45.94 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.446 -0.343 . . . . 55.05 111.47 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.13 126.51 7.85 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 75.23 112.666 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -90.96 110.0 21.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.893 0.378 . . . . 73.41 111.969 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 172' ' ' ARG . 49.7 mtt180 -101.72 167.5 10.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 72.44 111.105 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.74 128.96 34.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.505 -0.316 . . . . 61.22 111.1 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.34 33.33 28.85 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.99 -0.624 . . . . 71.24 113.171 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.1 t -131.35 109.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.104 -0.332 . . . . 74.03 110.104 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.9 p -63.18 157.09 23.37 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 72.51 112.399 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 212' ' ' THR . 65.6 t -56.77 -30.53 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 75.23 110.648 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 18.9 ttp180 -68.99 -53.07 22.53 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.983 -0.553 . . . . 61.1 111.195 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.551 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 34.7 m-20 -63.3 -35.11 79.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.356 0.598 . . . . 73.44 111.247 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 39.9 t -66.49 -62.79 1.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.079 -0.51 . . . . 73.04 111.585 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.6 mt -83.09 -12.27 57.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.202 1.186 . . . . 71.44 114.202 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 17.9 ptpt -56.05 -28.88 59.32 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.75 0.705 . . . . 62.25 111.848 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 180' ' ' SER . 7.9 ptpp? -74.17 -29.78 61.94 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.792 0.329 . . . . 74.52 111.524 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -70.26 -42.4 72.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.229 0.538 . . . . 34.33 110.647 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.92 -29.13 58.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.168 -0.469 . . . . 63.12 111.029 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 45.4 ttm -54.81 -49.64 70.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 74.22 111.534 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.2 ptp -68.52 -10.09 53.4 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 111.883 0.327 . . . . 64.44 111.883 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 15.3 mmm180 -95.58 -10.38 29.72 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.658 -0.246 . . . . 72.34 111.031 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.02 20.04 63.88 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.385 -0.436 . . . . 73.55 112.76 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 226' ' ' VAL . 80.9 mt -120.88 153.96 36.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.997 0.427 . . . . 63.41 111.439 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.0 pt -104.97 141.3 22.27 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.788 0.327 . . . . 74.15 111.455 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.433 ' HG3' ' HB3' ' A' ' 182' ' ' LYS . 22.0 Cg_endo -60.95 -29.25 87.66 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.541 2.161 . . . . 72.14 113.05 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 178' ' ' ARG . 5.5 mm-40 -55.74 -32.84 63.75 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.998 0.428 . . . . 72.54 111.705 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 194' ' ' CYS . 52.0 t -104.18 21.77 15.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.067 0.461 . . . . 54.03 111.966 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.1 m -125.0 161.88 25.74 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.056 0.455 . . . . 74.44 111.654 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.93 131.8 47.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.835 0.35 . . . . 72.23 111.726 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 224' ' ' VAL . 20.8 t -112.44 139.03 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.396 -0.365 . . . . 62.13 110.762 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -147.86 158.61 44.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.334 0.588 . . . . 75.31 111.942 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -135.34 138.8 43.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.676 -0.693 . . . . 73.21 110.988 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 56.3 mt -84.36 118.0 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 65.4 111.381 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 24.3 mt-30 -122.66 113.92 19.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.212 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 59.27 20.72 8.86 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.495 0.664 . . . . 75.41 111.657 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 109.39 -22.64 24.28 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.244 -0.435 . . . . 71.13 113.899 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 10.2 pt-20 -84.12 155.2 22.74 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.578 0.689 . . . . 74.22 111.533 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.06 100.24 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.212 0.53 . . . . 73.32 109.642 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -87.69 112.72 50.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.978 -0.555 . . . . 64.0 111.581 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.64 127.54 12.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.568 2.179 . . . . 45.52 112.271 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 217' ' ' LEU . 60.4 mt -96.7 129.99 45.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 74.3 111.685 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 131.66 11.81 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.052 -0.594 . . . . 74.12 112.218 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.6 m95 -59.87 -27.11 66.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.183 0.438 . . . . 61.33 112.183 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -80.3 -5.91 57.06 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.211 0.449 . . . . 71.15 112.211 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 m -71.19 141.5 50.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.308 -0.245 . . . . 61.33 111.017 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.66 129.36 39.49 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.077 0.465 . . . . 71.35 110.824 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.91 -24.64 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.145 -0.48 . . . . 55.1 111.868 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 86.0 p -64.89 -16.24 62.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.781 0.324 . . . . 73.24 111.802 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -76.44 -11.4 59.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.015 0.436 . . . . 63.13 111.439 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.454 HD11 HG21 ' A' ' 208' ' ' ILE . 66.8 mt -114.04 14.43 18.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.074 0.464 . . . . 75.23 111.241 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.8 m -53.84 119.67 5.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.633 0.605 . . . . 60.22 112.633 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 88.88 -9.93 74.61 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.194 -0.457 . . . . 55.13 113.997 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.29 157.84 18.05 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.643 0.608 . . . . 73.44 112.643 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.4 mt-10 -103.99 114.38 28.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.821 -0.627 . . . . 74.31 110.965 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.2 mt -95.79 158.99 15.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.162 0.506 . . . . 74.33 111.973 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -122.28 121.72 37.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.452 -0.34 . . . . 72.11 110.38 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 197' ' ' VAL . 62.1 t -119.07 135.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.204 0.525 . . . . 75.13 112.09 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.3 148.95 40.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.914 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 190' ' ' LEU . 36.0 t -85.8 137.51 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.819 0.342 . . . . 70.14 111.879 -174.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 116.375 -0.375 . . . . 73.52 111.102 178.759 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 110.472 -0.195 . . . . 71.02 110.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.81 147.2 95.94 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.675 2.25 . . . . 51.02 112.761 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 pt -129.37 160.24 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.472 0.653 . . . . 74.22 112.74 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 171' ' ' ALA . 88.5 t -127.1 134.61 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.554 -0.748 . . . . 74.2 110.302 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -97.48 96.79 8.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.79 0.328 . . . . 73.23 111.401 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -98.43 124.05 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.585 0.587 . . . . 73.54 112.585 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -95.28 106.36 18.39 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.264 -0.426 . . . . 71.42 111.179 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.7 mt -85.29 157.21 59.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.234 -0.439 . . . . 41.23 111.336 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.6 153.39 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.602 2.201 . . . . 75.23 113.011 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 31.6 m-80 68.93 55.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.763 0.425 . . . . 72.41 111.533 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt 51.08 23.1 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.56 1.144 . . . . 72.13 114.037 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.8 mm-40 -93.26 144.4 25.34 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.484 0.549 . . . . 44.34 112.484 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -138.69 142.95 38.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.776 0.322 . . . . 72.11 110.643 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.9 t -145.25 159.69 42.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.397 . . . . 71.24 111.707 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.35 120.25 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.282 -0.417 . . . . 72.41 110.969 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.53 152.57 55.58 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 116.377 -0.374 . . . . 54.42 111.336 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.09 127.73 11.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.44 2.094 . . . . 73.33 113.326 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -81.4 103.82 11.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.254 -0.43 . . . . 33.15 111.31 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -109.84 128.87 55.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.829 0.347 . . . . 74.35 111.599 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.23 110.56 4.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.125 0.488 . . . . 75.53 110.792 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.16 -6.42 15.07 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.347 -0.454 . . . . 71.12 112.274 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 214' ' ' ILE . 98.0 t -110.86 133.01 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.68 0.392 . . . . 75.25 110.64 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 80.8 p -87.02 156.0 19.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 71.35 111.739 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.7 t -50.18 -42.01 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.079 0.466 . . . . 64.33 111.405 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.588 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 23.0 ttt180 -63.62 -46.69 84.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.248 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.68 -31.46 72.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.843 0.354 . . . . 75.42 111.944 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.0 t -79.73 -44.29 21.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.89 0.376 . . . . 72.44 111.846 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.87 -15.26 45.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.193 0.812 . . . . 64.21 113.193 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.91 -45.22 41.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.993 0.425 . . . . 70.13 111.935 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -66.86 -39.51 87.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.324 -0.398 . . . . 71.41 111.969 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.12 93.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.151 0.5 . . . . 73.22 111.409 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.65 -52.33 21.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.083 -0.508 . . . . 71.41 111.459 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.4 tpt -50.03 -53.0 29.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.752 0.649 . . . . 55.44 112.752 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.9 ptp -62.98 -23.7 67.56 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.345 0.498 . . . . 61.03 112.345 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -101.61 0.24 35.98 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.067 0.395 . . . . 73.03 112.067 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 89.07 23.75 34.06 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.117 -0.563 . . . . 65.22 114.071 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.04 148.4 35.24 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.323 -0.516 . . . . 71.4 111.329 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.74 148.54 59.64 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.671 -0.24 . . . . 73.32 110.955 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 -39.0 88.68 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 122.81 2.34 . . . . 61.31 113.537 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -60.43 -24.92 65.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.927 0.394 . . . . 74.43 111.773 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 39.8 t -93.97 -2.26 53.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.787 0.327 . . . . 72.44 111.855 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 68.6 m -128.69 139.71 52.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 72.12 112.003 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -120.07 119.91 34.72 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.687 0.279 . . . . 71.22 111.373 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 224' ' ' VAL . 76.2 t -95.37 124.41 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.81 0.338 . . . . 71.3 111.486 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -136.23 155.46 50.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.425 0.631 . . . . 74.0 111.408 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 208' ' ' ILE . 10.2 ptm85 -109.66 133.04 53.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.845 -0.616 . . . . 71.53 111.42 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.4 mt -89.61 91.75 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.445 0.641 . . . . 70.23 109.978 173.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.52 123.93 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.573 -0.739 . . . . 71.24 111.382 -173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 62.52 17.67 9.78 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.353 0.596 . . . . 61.43 110.86 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.28 -4.43 70.41 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.272 -0.422 . . . . 65.42 113.427 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -101.95 140.28 36.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.447 -0.443 . . . . 55.1 112.014 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.31 105.58 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.726 0.298 . . . . 75.52 110.814 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 123.07 38.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.818 -0.173 . . . . 74.23 111.308 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 143.36 55.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.563 2.176 . . . . 73.23 113.498 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 199' ' ' ARG . 57.3 mt -122.91 145.93 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.816 0.341 . . . . 71.3 110.875 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.57 143.38 16.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.077 -0.582 . . . . 74.01 112.808 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 95.6 m95 -61.34 -23.76 65.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 122.306 -0.526 . . . . 75.12 111.66 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -87.03 0.77 54.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.239 0.459 . . . . 74.21 112.239 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 85.7 m -75.89 142.48 42.09 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 51.44 111.194 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.54 140.4 57.98 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.987 0.422 . . . . 74.41 111.419 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 175' ' ' VAL . 14.7 tt -79.18 -23.21 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.584 0.587 . . . . 70.4 112.584 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 89.2 p -62.0 -21.89 65.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.867 0.365 . . . . 74.51 111.842 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.12 -23.62 66.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.976 0.417 . . . . 74.51 111.814 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 222' ' ' LEU . 21.9 mt -108.38 21.93 16.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.874 -0.603 . . . . 74.1 112.093 -169.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 79.4 m -65.16 118.12 8.75 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.834 0.679 . . . . 74.24 112.834 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.6 -26.04 25.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.144 0.417 . . . . 74.15 114.144 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -98.81 172.36 7.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.153 0.502 . . . . 75.24 111.787 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -109.95 137.57 47.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.336 0.865 . . . . 62.03 113.336 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 217' ' ' LEU . 63.0 mt -102.48 155.92 17.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.404 -0.816 . . . . 74.33 110.713 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -126.57 127.62 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.132 -0.355 . . . . 64.13 110.755 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 197' ' ' VAL . 54.5 t -107.23 125.01 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.188 0.44 . . . . 55.35 112.188 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -100.33 168.71 9.6 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.234 -0.439 . . . . 54.23 111.259 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.85 114.31 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.398 -0.364 . . . . 73.22 111.354 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 121.219 0.533 . . . . 73.31 110.741 175.444 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.501 0.191 . . . . 61.3 110.838 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.41 137.2 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.067 1.845 . . . . 65.04 111.211 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 168' ' ' VAL . 2.8 pp -133.9 165.79 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.053 0.76 . . . . 52.4 113.053 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 171' ' ' ALA . 49.0 t -130.26 135.67 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.559 -0.746 . . . . 64.4 110.703 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.7 100.01 12.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.923 0.392 . . . . 71.13 111.329 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 181' ' ' LEU . 47.9 t -95.85 109.92 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.961 0.41 . . . . 70.14 111.658 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -80.8 117.98 21.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.931 0.396 . . . . 72.21 111.104 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.0 mt -93.72 157.68 37.84 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.124 -0.489 . . . . 63.35 110.707 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.581 ' HG3' HG23 ' A' ' 226' ' ' VAL . 29.9 Cg_endo -63.57 168.67 11.12 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.231 1.954 . . . . 72.31 112.986 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.38 33.59 18.72 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.168 0.432 . . . . 73.42 112.168 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 70.14 23.89 5.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.278 0.631 . . . . 71.41 112.434 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.6 mm-40 -99.62 163.56 12.44 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.04 -0.413 . . . . 74.12 111.443 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.42 159.47 31.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.036 0.446 . . . . 63.3 112.117 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -155.62 150.99 26.96 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.974 -0.557 . . . . 71.13 111.294 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 156' ' ' ILE . 39.0 t -117.8 119.41 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.761 0.315 . . . . 65.44 110.635 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 181' ' ' LEU . 29.7 m -116.0 150.36 44.94 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.144 0.424 . . . . 71.42 112.144 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 124.98 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.511 2.141 . . . . 62.15 113.606 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.76 103.78 8.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.172 0.51 . . . . 63.32 110.847 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -115.93 160.61 19.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.054 -0.521 . . . . 72.45 111.764 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.4 t -87.02 137.87 31.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.072 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.62 -11.74 18.19 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.145 -0.55 . . . . 60.32 113.722 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 214' ' ' ILE . 48.4 t -93.6 123.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 122.438 -0.448 . . . . 74.24 110.959 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 29.3 p -74.73 168.54 19.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.184 0.516 . . . . 74.33 111.899 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 212' ' ' THR . 60.7 t -61.64 -33.78 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.278 0.561 . . . . 74.42 110.231 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 8.7 ttm105 -66.18 -51.32 58.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.815 -0.629 . . . . 72.41 111.365 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.94 -21.14 65.99 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.241 0.46 . . . . 74.02 112.241 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.9 m -86.02 -48.88 8.26 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.838 0.31 . . . . 71.31 111.838 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 169' ' ' VAL . 78.3 mt -82.83 -2.27 54.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.717 0.636 . . . . 72.21 112.717 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -55.46 -25.81 38.7 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.977 0.417 . . . . 74.21 111.772 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.32 -48.85 11.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.957 0.408 . . . . 51.15 111.04 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -59.85 -44.52 94.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.117 -0.492 . . . . 51.32 111.973 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.428 HD11 ' CH2' ' A' ' 210' ' ' TRP . 90.9 mt -62.76 -46.57 87.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.861 0.362 . . . . 51.55 111.239 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.6 tpt -59.12 -46.86 87.25 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.287 -0.415 . . . . 61.13 111.647 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.6 ptm -67.75 -8.61 36.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.772 0.32 . . . . 62.42 111.849 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 22.3 mmm180 -112.11 2.52 16.79 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.131 -0.356 . . . . 73.12 111.249 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.5 11.76 82.56 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.569 -0.348 . . . . 54.22 113.821 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.0 176.21 6.88 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 61.12 111.846 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.552 HG13 ' HB3' ' A' ' 194' ' ' CYS . 17.6 pt -140.1 143.24 33.17 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.224 -0.444 . . . . 73.11 111.328 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.74 -49.68 15.0 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.956 2.437 . . . . 72.12 113.857 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 193' ' ' GLU . 1.3 pm0 -73.57 5.54 3.79 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 -174.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' CYS . . . . . 0.552 ' HB3' HG13 ' A' ' 191' ' ' ILE . 43.2 t -128.29 15.35 6.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.048 0.451 . . . . 65.44 111.349 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.49 137.1 50.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.848 0.356 . . . . 70.13 110.939 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.75 120.94 44.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.727 0.299 . . . . 53.31 111.747 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -98.88 139.13 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.496 -0.32 . . . . 75.41 110.614 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -146.89 153.35 40.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.38 0.61 . . . . 74.12 111.926 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.549 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.7 ptm180 -114.29 159.56 20.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.652 -0.703 . . . . 65.22 110.469 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.0 mt -101.91 95.57 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.277 0.56 . . . . 41.03 110.759 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -108.74 128.11 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.824 -0.625 . . . . 64.11 110.555 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 t70 64.71 20.17 12.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.463 0.649 . . . . 64.31 111.18 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.16 -20.09 52.19 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.333 -0.461 . . . . 45.01 113.557 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -108.36 162.2 14.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.112 0.482 . . . . 73.14 111.578 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -82.2 143.27 31.51 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.28 0.562 . . . . 52.22 111.912 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -139.89 120.58 9.33 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.89 -0.595 . . . . 64.03 111.207 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -65.76 144.2 76.82 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.698 2.266 . . . . 63.02 113.484 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 199' ' ' ARG . 66.4 mt -118.83 124.17 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.056 -0.52 . . . . 73.32 111.396 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.12 141.52 34.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.995 -0.622 . . . . 65.43 112.517 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.9 m95 -65.64 -16.08 63.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.389 0.595 . . . . 75.42 111.282 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.99 -16.37 61.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.842 -0.617 . . . . 75.54 111.762 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.2 m -69.47 136.96 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.509 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 4.7 m-20 -69.45 128.08 35.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 62.01 110.939 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.0 tp -59.07 -20.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.138 0.494 . . . . 54.21 111.522 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.8 p -59.84 -26.71 66.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.221 -0.445 . . . . 65.44 112.073 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -69.48 -21.56 63.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.858 0.361 . . . . 60.2 111.83 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 220' ' ' GLU . 46.5 mt -110.49 21.02 17.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.186 0.517 . . . . 70.44 111.393 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.8 m -58.8 121.32 10.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.897 0.703 . . . . 63.11 112.897 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.01 4.23 90.08 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.279 0.872 . . . . 71.34 115.279 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 217' ' ' LEU . 12.9 pt-20 -111.82 172.7 6.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.978 0.889 . . . . 64.31 111.71 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 4.2 mp0 -102.98 127.2 50.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.233 0.54 . . . . 64.41 111.572 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 159' ' ' VAL . 74.0 mt -103.67 159.62 15.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.986 -0.552 . . . . 40.54 111.148 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -128.75 127.12 41.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.652 0.263 . . . . 74.44 110.633 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 197' ' ' VAL . 46.8 t -117.84 146.78 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.283 0.563 . . . . 72.21 112.064 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.88 140.93 33.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.883 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 162' ' ' PRO . 61.8 t -82.9 132.45 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.047 0.451 . . . . 64.2 111.871 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.537 0.463 0 CA-C-N 116.324 -0.398 . . . . 70.31 111.457 -178.79 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 112.825 0.676 . . . . 52.14 112.825 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.466 ' HB2' HG23 ' A' ' 218' ' ' THR . 21.9 Cg_endo -60.08 137.9 78.43 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.579 2.186 . . . . 64.54 111.722 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.91 158.16 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.847 0.684 . . . . 62.42 112.847 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.56 127.67 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.608 -0.724 . . . . 74.52 110.367 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 99.0 mtt180 -89.69 100.44 13.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.16 0.505 . . . . 71.44 111.37 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 181' ' ' LEU . 47.8 t -99.5 118.23 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.284 -0.416 . . . . 73.2 112.03 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.85 123.32 33.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.902 0.382 . . . . 70.44 110.536 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.3 mt -95.49 163.49 21.37 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.511 -0.313 . . . . 61.43 111.578 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.72 153.62 5.53 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.851 2.367 . . . . 64.12 113.994 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.89 42.37 10.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.757 -0.656 . . . . 54.25 111.532 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 63.47 9.25 4.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.066 0.765 . . . . 72.32 113.066 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -72.59 164.36 26.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.894 0.378 . . . . 75.42 110.814 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -156.43 151.7 26.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.857 -0.527 . . . . 75.51 112.093 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.0 t -156.19 171.21 20.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.945 -0.571 . . . . 74.52 111.137 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.87 120.34 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.844 0.355 . . . . 52.23 110.587 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 34.1 m -115.61 140.6 26.2 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.003 0.372 . . . . 61.43 112.003 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 19.6 Cg_exo -67.4 127.28 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.45 2.1 . . . . 75.52 112.682 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.74 103.21 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 42.45 110.831 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -100.38 128.05 46.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.976 -0.556 . . . . 72.43 111.807 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.24 123.19 21.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.446 -0.343 . . . . 52.42 111.121 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.46 -14.94 60.52 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.974 -0.631 . . . . 73.21 113.349 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.85 127.51 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.503 -0.41 . . . . 60.03 110.805 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.5 p -78.07 160.68 27.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.084 0.468 . . . . 74.32 111.541 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.06 -36.32 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.429 0.633 . . . . 71.34 110.163 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -60.29 -52.7 64.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.174 -0.921 . . . . 73.43 111.157 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.08 -34.8 78.45 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.102 -0.499 . . . . 71.43 112.123 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.4 t -72.85 -49.95 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.442 0.534 . . . . 71.54 112.442 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.604 HD21 HG21 ' A' ' 159' ' ' VAL . 78.7 mt -85.09 -16.52 40.32 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.474 0.916 . . . . 63.14 113.474 -173.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.71 -32.55 52.39 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.844 0.683 . . . . 74.23 112.844 -173.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.74 -39.21 67.05 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 75.53 111.404 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.2 70.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.193 0.521 . . . . 72.43 110.784 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.78 -49.38 25.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.836 -0.62 . . . . 72.51 111.02 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.3 tpt -53.24 -47.8 68.73 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.079 -0.509 . . . . 74.31 112.006 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 ptm -64.61 -9.14 17.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.291 0.478 . . . . 64.42 112.291 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -110.91 -6.17 14.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.598 0.237 . . . . 72.31 111.514 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.66 36.9 14.91 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.122 -0.561 . . . . 54.42 112.752 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.51 154.71 43.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.541 0.336 . . . . 62.32 111.394 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.62 149.57 67.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 122.362 0.265 . . . . 72.55 111.009 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.42 -37.02 60.53 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.936 2.424 . . . . 72.45 113.734 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -69.87 -18.45 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.35 0.5 . . . . 64.3 112.35 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.1 -10.33 20.56 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.499 0.555 . . . . 52.03 112.499 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.9 m -131.98 171.27 13.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.238 0.542 . . . . 71.35 112.244 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -133.08 141.26 48.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.003 -0.544 . . . . 53.35 111.549 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 224' ' ' VAL . 48.3 t -109.58 126.17 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.368 -0.378 . . . . 73.12 110.73 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -141.93 152.63 43.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.179 0.514 . . . . 73.21 111.936 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.59 160.13 16.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.88 -0.6 . . . . 72.04 110.578 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.5 mt -117.24 119.46 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.0 0.429 . . . . 74.41 111.469 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.06 149.69 29.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.14 -0.482 . . . . 73.22 109.872 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 62.93 16.46 9.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.78 0.324 . . . . 71.42 111.447 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.79 4.4 88.13 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.304 -0.474 . . . . 74.0 112.775 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -107.09 154.57 20.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.954 0.501 . . . . 71.33 111.986 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -94.82 126.19 39.98 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.88 0.371 . . . . 74.21 110.681 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.12 94.85 32.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.015 -0.365 . . . . 63.13 110.015 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.37 121.9 10.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.714 2.276 . . . . 75.2 112.443 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 58.8 mt -101.85 132.68 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.584 -175.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.73 126.09 26.56 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.77 -0.728 . . . . 71.01 112.358 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -51.63 -33.17 32.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.664 0.616 . . . . 73.4 112.664 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -85.74 21.37 1.89 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.426 0.528 . . . . 44.42 112.426 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 49.9 m -97.09 143.28 28.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 122.336 -0.228 . . . . 73.33 111.112 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.9 m-20 -58.2 128.27 36.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.126 0.489 . . . . 72.52 111.823 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 217' ' ' LEU . 9.3 tp -63.66 -21.2 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.98 0.419 . . . . 71.42 111.722 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.557 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 78.4 p -60.62 -26.09 66.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.216 0.45 . . . . 72.55 112.216 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.517 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 22.3 m95 -67.21 -21.53 65.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.359 . . . . 73.21 111.968 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.488 HD12 HD12 ' A' ' 214' ' ' ILE . 33.9 mt -103.83 22.07 15.16 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.138 0.494 . . . . 75.21 111.896 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 155' ' ' PRO . 77.4 m -53.71 124.71 15.95 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.893 0.701 . . . . 73.11 112.893 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.3 -5.87 66.04 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 114.401 0.521 . . . . 70.13 114.401 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.67 158.15 16.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.331 0.566 . . . . 54.12 111.742 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 51.8 mt-10 -100.69 117.84 35.62 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.143 -0.48 . . . . 70.45 110.809 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 159' ' ' VAL . 82.1 mt -93.01 148.16 22.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.056 0.455 . . . . 63.3 111.012 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -121.35 113.28 19.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 54.41 110.541 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 197' ' ' VAL . 43.5 t -108.46 130.76 60.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 71.34 111.22 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.92 157.68 45.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 61.24 111.435 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.95 130.0 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.044 -0.525 . . . . 55.0 111.453 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 121.165 0.507 . . . . 64.3 110.433 176.045 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 9.2 mmpt? . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.799 0.296 . . . . 72.22 111.799 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.97 114.86 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.229 1.953 . . . . 65.31 110.95 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -114.65 160.7 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.102 0.778 . . . . 75.05 113.102 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.35 139.21 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.553 -0.749 . . . . 50.13 110.518 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 1.5 mpt_? -92.88 111.71 23.42 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.546 0.212 . . . . 73.42 110.543 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.23 122.33 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.35 0.5 . . . . 50.23 112.35 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.96 99.76 11.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.305 -0.407 . . . . 72.41 110.399 174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.1 mt -65.97 144.0 98.65 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.654 -0.248 . . . . 64.33 111.27 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.23 143.52 52.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.552 2.168 . . . . 74.24 112.945 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.414 ' HB3' HH22 ' A' ' 188' ' ' ARG . 25.0 t-20 74.5 54.43 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.122 0.569 . . . . 73.52 111.534 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 67.59 22.02 9.25 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.938 1.088 . . . . 70.32 113.938 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 71.7 mm-40 -107.84 175.27 5.54 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.603 -0.686 . . . . 73.52 112.539 -175.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -146.98 152.68 39.02 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.159 0.504 . . . . 74.54 112.325 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.6 t -157.09 160.5 38.94 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.013 -0.539 . . . . 72.54 110.893 170.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.82 120.2 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.978 0.418 . . . . 75.03 110.722 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.05 141.13 37.62 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.305 -0.407 . . . . 72.41 111.909 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.4 Cg_endo -77.14 132.55 12.76 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.69 2.26 . . . . 51.2 113.487 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.78 128.85 37.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.194 0.521 . . . . 62.42 111.802 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -129.69 131.53 46.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.931 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -71.99 109.83 6.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 52.11 111.163 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.3 19.6 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.326 -0.464 . . . . 73.23 112.668 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 214' ' ' ILE . 96.0 t -117.72 125.84 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.939 0.399 . . . . 73.42 110.948 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 p -82.69 167.38 18.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 65.12 111.736 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.55 -36.63 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.304 0.574 . . . . 52.25 110.459 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 41.3 ttt180 -67.06 -57.68 6.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.735 -0.666 . . . . 74.44 111.187 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -28.22 58.72 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.116 0.413 . . . . 71.31 112.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 36.7 t -78.78 -47.42 16.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.896 0.379 . . . . 73.13 111.709 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.13 -1.53 54.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.157 0.799 . . . . 73.1 113.157 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.34 -41.47 76.14 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 72.42 112.136 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.24 -32.31 68.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.058 0.456 . . . . 70.13 111.09 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.55 91.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.035 0.445 . . . . 72.23 111.051 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -75.68 -38.69 58.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.848 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 24.7 ttt -54.67 -50.6 67.81 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.935 -0.575 . . . . 73.13 111.713 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -69.78 -4.29 19.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.52 0.563 . . . . 64.22 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 163' ' ' ASN . 70.4 mtp180 -118.28 2.42 11.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.055 0.391 . . . . 71.35 112.055 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.83 38.64 89.52 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 73.13 113.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.98 154.99 36.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.912 0.387 . . . . 75.42 111.685 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.83 146.54 46.18 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.366 -0.379 . . . . 74.21 111.396 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.6 -44.27 45.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.113 2.542 . . . . 72.31 114.141 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.01 -4.1 12.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.371 0.508 . . . . 75.12 112.371 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -100.5 -5.39 27.04 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.928 0.394 . . . . 73.11 111.425 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.36 144.12 42.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.108 0.48 . . . . 74.42 111.993 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.575 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -112.22 137.44 50.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.779 0.323 . . . . 51.12 111.483 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 224' ' ' VAL . 47.4 t -102.48 140.09 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.276 -0.42 . . . . 64.33 110.26 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -157.77 158.47 35.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.254 0.55 . . . . 62.21 112.023 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.846 HH11 ' HG3' ' A' ' 220' ' ' GLU . 79.1 mtm180 -110.41 139.46 45.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.141 -0.481 . . . . 65.23 111.239 175.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.95 96.41 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.299 0.571 . . . . 62.24 110.111 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -103.75 107.54 18.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 74.31 110.097 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.0 20.05 7.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.298 0.571 . . . . 74.21 111.567 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.62 38.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.474 -0.393 . . . . 41.01 113.257 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.18 117.34 23.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.944 0.35 . . . . 63.44 111.944 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -80.72 109.34 15.17 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.546 0.212 . . . . 72.12 111.222 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -102.9 106.82 52.43 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.599 0.238 . . . . 72.13 111.195 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.51 116.53 4.28 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.873 2.382 . . . . 73.52 113.036 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.453 HD11 ' HG3' ' A' ' 199' ' ' ARG . 64.1 mt -101.06 133.26 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.236 0.541 . . . . 73.05 111.908 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.7 143.3 28.92 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.199 -0.524 . . . . 61.23 112.888 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 96.4 m95 -60.4 -21.89 62.72 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.352 0.576 . . . . 73.54 111.011 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.05 -5.16 50.54 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.987 -0.551 . . . . 75.41 112.204 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 177' ' ' VAL . 40.8 m -74.25 136.76 42.7 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.551 0.215 . . . . 74.13 111.353 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 18.1 t70 -72.09 129.24 38.03 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.04 0.448 . . . . 75.52 110.88 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.5 tt -66.02 -22.63 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.731 0.641 . . . . 71.31 112.731 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.544 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 41.2 t -63.39 -21.05 66.05 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.821 -0.549 . . . . 60.32 111.425 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 16.8 m95 -80.18 -10.65 59.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.013 0.435 . . . . 72.11 111.356 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 222' ' ' LEU . 49.6 mt -111.42 15.04 21.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.227 -0.442 . . . . 65.43 111.571 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.3 m -56.29 126.32 25.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.355 0.502 . . . . 74.24 112.355 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.29 10.14 84.06 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.299 -0.477 . . . . 73.02 114.087 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . 0.846 ' HG3' HH11 ' A' ' 199' ' ' ARG . 36.5 mm-40 -107.37 171.89 7.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.126 0.489 . . . . 61.23 111.53 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.1 mp0 -111.01 121.01 44.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.192 -0.458 . . . . 71.33 110.866 172.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 217' ' ' LEU . 80.2 mt -94.01 117.65 30.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.916 0.388 . . . . 60.31 111.197 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -94.41 118.74 32.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.612 -0.267 . . . . 65.32 110.484 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 197' ' ' VAL . 21.7 t -110.15 139.93 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.13 0.491 . . . . 72.21 111.158 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.98 170.45 15.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.454 -0.339 . . . . 65.41 111.369 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.29 127.04 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.862 0.363 . . . . 73.21 111.644 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 196' ' ' ALA . 86.4 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 116.228 -0.442 . . . . 75.13 111.99 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mttm . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 111.396 0.147 . . . . 55.43 111.396 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.42 135.86 44.43 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.347 2.031 . . . . 75.22 111.738 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.8 pt -123.62 161.11 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 71.45 113.051 -173.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.12 131.92 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.8 -0.636 . . . . 74.1 110.459 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 158' ' ' ARG . 64.0 mtt85 -100.96 105.14 16.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.941 0.4 . . . . 73.45 111.632 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.615 HG22 HD12 ' A' ' 222' ' ' LEU . 60.0 t -99.6 119.08 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.575 -0.284 . . . . 72.33 111.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -92.13 113.51 25.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.351 0.596 . . . . 65.12 111.888 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.5 mt -91.14 169.15 12.09 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 115.435 -0.802 . . . . 74.11 111.04 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 52.5 Cg_exo -55.26 165.29 3.14 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.427 2.085 . . . . 74.32 113.479 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 59.83 28.76 18.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.776 0.43 . . . . 73.44 111.954 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp 63.29 22.96 13.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.987 0.515 . . . . 75.23 112.087 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 80.3 mm-40 -82.81 168.33 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.847 0.356 . . . . 73.23 111.048 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -156.43 161.75 40.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 71.33 112.124 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.6 t -150.41 151.08 32.24 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.655 -0.702 . . . . 74.34 110.525 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.52 119.61 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.988 0.423 . . . . 73.33 111.443 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 27.1 m -120.38 144.51 38.38 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.318 -0.401 . . . . 61.11 111.449 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.8 Cg_exo -65.56 132.66 31.71 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.645 2.23 . . . . 73.03 112.992 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -73.97 117.65 16.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 75.42 111.604 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -130.37 143.55 50.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.283 -0.417 . . . . 72.34 111.194 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.41 140.99 37.24 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.636 0.255 . . . . 74.23 110.642 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.08 -25.29 10.35 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.116 -0.564 . . . . 50.13 112.314 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.91 117.54 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.926 0.394 . . . . 73.13 110.899 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 39.5 p -80.15 156.91 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.484 -0.325 . . . . 75.43 111.254 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.75 -31.7 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.552 0.692 . . . . 65.03 110.756 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.621 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.4 ttp85 -70.18 -35.23 73.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.448 -0.796 . . . . 74.23 111.59 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.27 -43.33 21.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.196 -0.456 . . . . 62.21 111.903 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -61.14 -49.81 75.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.129 0.49 . . . . 71.34 111.978 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.71 14.43 2.13 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.972 0.73 . . . . 73.02 112.972 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 183' ' ' LYS . 9.5 ptpp? -53.12 -48.3 67.96 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.286 0.476 . . . . 73.41 112.286 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 65.6 pttt -79.05 -29.75 43.66 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.05 -0.406 . . . . 64.24 111.311 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.29 88.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.142 0.496 . . . . 52.1 111.434 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -46.34 70.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.103 0.477 . . . . 74.11 110.689 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 41.2 ttm -50.93 -51.5 51.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.731 -0.668 . . . . 71.34 112.156 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.41 -19.91 65.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.298 0.481 . . . . 74.02 112.298 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -98.91 -4.47 32.8 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.821 0.344 . . . . 62.42 111.421 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 25.81 63.81 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.184 -0.531 . . . . 54.34 113.006 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.2 mt -113.89 153.97 28.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.447 . . . . 71.43 111.486 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.0 pt -128.69 156.89 76.76 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 116.305 -0.407 . . . . 70.41 110.318 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.78 -42.87 62.84 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.507 2.138 . . . . 62.53 113.159 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.65 -7.62 28.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.16 0.43 . . . . 60.44 112.16 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 -2.45 17.22 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.803 0.297 . . . . 63.31 111.803 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.08 162.53 34.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.08 0.467 . . . . 71.23 111.778 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.19 139.98 48.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.927 0.394 . . . . 54.11 111.586 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 224' ' ' VAL . 54.1 t -107.95 135.19 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.177 -0.465 . . . . 42.44 111.024 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.62 158.2 43.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.982 0.42 . . . . 73.32 111.148 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -127.58 149.1 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.89 0.376 . . . . 61.23 110.883 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.85 95.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.546 0.689 . . . . 63.01 110.206 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.46 109.14 20.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.554 -0.748 . . . . 64.12 111.259 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.8 t70 60.78 26.54 16.36 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.475 0.655 . . . . 73.31 111.006 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.55 -13.25 59.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.166 -0.47 . . . . 35.53 113.441 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 125.18 35.9 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.107 0.41 . . . . 53.23 112.107 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.02 93.92 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.147 0.498 . . . . 73.34 109.8 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -99.7 115.57 65.5 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.184 -0.462 . . . . 75.3 111.725 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.55 127.18 20.07 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.692 2.261 . . . . 64.01 112.806 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -102.34 120.47 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.117 -0.492 . . . . 70.42 110.872 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.81 135.09 46.78 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.889 -0.672 . . . . 62.31 113.197 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 83.3 m95 -55.72 -32.81 63.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.523 0.564 . . . . 72.45 112.523 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.62 11.75 8.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.852 0.686 . . . . 75.42 112.852 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.3 m -79.85 141.91 35.73 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.158 -0.339 . . . . 65.03 110.862 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 118.29 5.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.895 0.378 . . . . 65.22 111.145 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.34 -22.3 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.09 0.471 . . . . 64.04 111.845 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.488 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 23.3 t -61.28 -23.89 66.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.159 0.429 . . . . 64.32 112.159 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -66.51 -22.46 66.18 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.062 0.458 . . . . 64.45 111.388 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.0 mt -108.02 30.11 6.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.201 0.524 . . . . 74.14 111.707 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 93.9 m -62.65 116.65 5.36 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.711 0.634 . . . . 71.23 112.711 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 85.01 8.91 81.59 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.99 0.756 . . . . 64.01 114.99 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 167.34 10.96 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.73 0.765 . . . . 71.34 112.126 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -102.47 120.89 41.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.794 -0.639 . . . . 75.15 111.717 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 159' ' ' VAL . 68.4 mt -94.03 143.77 26.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.082 -0.508 . . . . 74.22 111.45 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -109.03 109.47 20.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.735 0.303 . . . . 74.31 110.203 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 197' ' ' VAL . 61.6 t -107.77 148.86 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.077 0.465 . . . . 73.3 111.517 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.21 160.24 42.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.968 0.413 . . . . 73.31 111.049 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.29 132.25 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.8 0.333 . . . . 61.52 111.771 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 196' ' ' ALA . 94.8 mt . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.121 0.486 . . . . 72.13 110.335 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 120.467 0.175 . . . . 72.21 111.447 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.43 142.72 99.43 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.684 2.256 . . . . 72.1 112.378 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 2.9 pp -123.05 161.73 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.538 0.685 . . . . 63.14 112.814 -175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.43 141.21 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 115.73 -0.668 . . . . 75.41 110.919 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.28 106.5 18.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.644 0.259 . . . . 70.55 111.132 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 181' ' ' LEU . 55.6 t -109.19 124.45 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.123 0.487 . . . . 73.21 112.12 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.462 ' HD1' ' HG3' ' A' ' 166' ' ' ARG . 20.6 m-85 -99.78 113.74 26.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.187 -0.46 . . . . 74.05 110.961 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 86.3 mt -90.9 160.87 37.13 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.037 -0.529 . . . . 65.03 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 29.6 Cg_endo -61.88 167.26 10.68 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.929 2.419 . . . . 75.03 113.672 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.19 29.7 18.9 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.353 0.597 . . . . 64.44 111.341 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 60.37 59.03 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.354 -0.839 . . . . 72.24 111.718 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.1 mm-40 -118.91 143.61 46.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.889 -0.596 . . . . 44.52 110.455 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' HD1' ' A' ' 160' ' ' PHE . 3.4 mpt_? -126.19 147.18 49.7 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.952 -0.468 . . . . 73.32 111.698 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.49 161.74 40.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.046 -0.525 . . . . 64.31 111.357 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 156' ' ' ILE . 61.9 t -126.89 120.14 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.837 0.351 . . . . 64.42 111.197 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -111.44 153.76 44.03 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 116.396 -0.365 . . . . 54.31 111.764 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.14 151.6 30.47 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.543 2.162 . . . . 55.45 113.532 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -105.09 112.49 25.64 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.068 -0.514 . . . . 75.44 111.882 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -126.34 148.28 49.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.522 0.329 . . . . 73.14 111.046 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.12 135.64 37.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.712 0.292 . . . . 74.2 110.921 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.12 -30.57 7.94 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.142 -0.552 . . . . 75.13 112.277 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.8 t -80.89 109.72 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.108 0.48 . . . . 63.23 110.346 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 36.9 p -76.36 163.31 27.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.272 -0.422 . . . . 61.4 111.324 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 212' ' ' THR . 60.8 t -54.02 -37.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.288 0.566 . . . . 75.01 110.23 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 3.4 tmt_? -65.64 -39.34 91.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.492 -0.776 . . . . 72.33 111.187 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 31.8 t70 -79.34 -29.07 42.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.935 0.346 . . . . 75.24 111.935 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -78.56 -55.74 4.97 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.093 0.473 . . . . 71.44 111.496 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 159' ' ' VAL . 62.4 mt -72.48 -3.56 25.09 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.797 0.665 . . . . 64.0 112.797 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 24.6 pttm -61.75 -20.65 63.77 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.026 -0.421 . . . . 75.34 110.747 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.08 -53.46 6.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.025 0.44 . . . . 75.45 110.877 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.28 70.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.055 -0.52 . . . . 50.45 111.869 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -81.79 -26.21 34.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.56 -0.291 . . . . 75.22 111.58 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.0 tpt -64.39 -41.76 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.818 0.342 . . . . 65.2 111.013 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.46 -21.3 64.64 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.013 0.435 . . . . 71.54 110.948 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -83.75 -21.16 32.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.31 -0.405 . . . . 62.23 110.808 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.61 29.61 26.39 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.41 -0.424 . . . . 55.21 113.064 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 84.4 mt -131.31 164.93 24.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.17 0.51 . . . . 75.42 111.829 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.36 143.16 26.63 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.125 -0.489 . . . . 75.32 111.159 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 178' ' ' ARG . 53.8 Cg_exo -52.42 -42.96 57.82 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 53.12 113.978 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.6 pm0 -70.29 -0.78 8.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.375 0.509 . . . . 72.43 112.375 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 52.9 t -107.15 9.83 30.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.964 0.412 . . . . 63.4 111.024 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 62.0 m -131.38 172.16 12.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.223 -0.444 . . . . 44.55 111.215 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -136.98 126.93 25.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.804 0.335 . . . . 70.31 111.638 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -99.08 125.22 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.328 -0.396 . . . . 73.42 110.805 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 55.2 p90 -136.28 146.52 46.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.525 0.678 . . . . 74.3 111.365 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.5 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.533 -0.758 . . . . 74.44 110.24 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -77.72 87.61 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.875 0.845 . . . . 63.01 109.944 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -115.66 136.73 52.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.111 -0.949 . . . . 65.34 111.105 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.19 26.24 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.285 0.564 . . . . 63.44 112.327 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.2 58.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.153 -0.546 . . . . 61.21 114.402 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.71 151.93 47.57 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.416 0.608 . . . . 72.04 111.877 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 53.6 mtpt -77.73 94.65 4.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.661 -0.496 . . . . 72.22 109.661 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.25 114.07 64.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 120.626 0.251 . . . . 73.41 111.439 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.64 155.36 43.0 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.891 2.394 . . . . 45.1 113.762 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 199' ' ' ARG . 60.9 mt -127.28 133.45 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.788 -0.642 . . . . 71.4 110.588 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.59 132.98 23.0 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.86 -0.686 . . . . 71.55 112.816 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 82.4 m95 -62.31 -22.37 65.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.269 0.47 . . . . 53.33 112.269 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.55 -11.76 59.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.962 0.356 . . . . 64.04 111.962 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 m -66.54 134.26 52.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.685 0.279 . . . . 74.15 111.501 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 2.3 m-20 -58.94 130.58 47.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.821 0.343 . . . . 74.34 111.141 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.12 -21.58 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.193 0.521 . . . . 35.05 111.373 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' SER . . . . . 0.453 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 98.9 p -61.16 -26.07 67.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.064 -0.516 . . . . 65.21 111.847 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.461 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.6 m95 -66.58 -24.72 66.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.154 0.502 . . . . 65.42 111.815 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.87 21.42 17.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.021 -0.536 . . . . 74.33 111.511 -173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.7 m -56.86 112.24 1.26 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.798 0.666 . . . . 71.33 112.798 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.49 75.32 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 115.093 0.797 . . . . 33.21 115.093 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.44 172.21 7.15 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.145 0.972 . . . . 52.43 111.737 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . 19.0 mp0 -96.28 134.25 39.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.095 -0.502 . . . . 75.23 111.565 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.46 144.67 45.82 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.499 -0.319 . . . . 54.22 110.815 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -115.34 116.3 28.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.688 0.28 . . . . 63.22 110.381 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 197' ' ' VAL . 51.0 t -115.31 127.16 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.866 0.365 . . . . 73.23 111.391 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.96 161.08 29.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.993 0.425 . . . . 70.01 111.427 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 162' ' ' PRO . 16.7 t -90.5 138.32 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 61.22 111.583 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.977 0.418 . . . . 61.44 111.389 179.516 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 112.372 0.508 . . . . 74.31 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.08 145.85 97.47 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.321 2.68 . . . . 53.33 114.55 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.41 168.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.927 -0.579 . . . . 74.02 112.268 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 171' ' ' ALA . 63.4 t -133.05 140.3 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.142 -0.481 . . . . 44.35 110.289 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -104.23 102.17 11.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.801 0.334 . . . . 72.25 111.642 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 181' ' ' LEU . 43.9 t -103.01 141.71 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.999 0.428 . . . . 74.32 111.634 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -113.3 113.43 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.056 0.455 . . . . 73.41 111.219 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 90.8 mt -85.74 160.76 52.42 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.866 -0.606 . . . . 74.53 111.039 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 25.3 Cg_endo -61.67 169.05 7.49 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.112 1.875 . . . . 74.24 112.496 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.38 32.09 16.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.12 0.415 . . . . 62.04 112.12 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.7 22.94 7.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.124 0.787 . . . . 70.2 113.124 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -99.69 163.9 12.28 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.886 0.374 . . . . 64.32 111.595 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -154.9 165.0 38.06 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.006 -0.434 . . . . 74.01 111.924 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.8 t -156.01 155.71 33.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.89 0.376 . . . . 64.32 111.33 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 62.2 t -122.92 120.12 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.765 0.317 . . . . 75.34 110.97 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.7 147.89 38.61 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.084 0.402 . . . . 64.53 112.084 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.02 127.9 15.88 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.371 2.047 . . . . 71.51 112.91 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.538 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -85.78 118.71 25.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.003 0.43 . . . . 75.1 112.046 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -136.71 157.07 47.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.195 0.521 . . . . 60.24 111.898 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 50.5 t -81.55 144.49 31.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.164 -0.471 . . . . 74.41 110.549 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.94 -12.47 61.84 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.997 -0.621 . . . . 44.44 112.527 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.66 116.82 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.574 -0.368 . . . . 73.24 110.171 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 p -81.41 161.34 23.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 62.35 111.64 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.48 -31.63 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.152 0.501 . . . . 71.43 110.714 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 46.9 ttp85 -72.97 -56.53 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.118 -0.492 . . . . 60.12 110.864 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.7 m-20 -61.38 -26.17 67.66 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.958 0.409 . . . . 75.41 111.742 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.5 t -77.73 -61.8 1.87 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.149 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 159' ' ' VAL . 66.1 mt -71.89 -21.65 61.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.298 0.851 . . . . 71.54 113.298 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 20.7 pttp -64.6 -12.22 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.661 0.664 . . . . 52.21 111.359 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -79.07 -49.01 13.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.028 0.442 . . . . 72.52 110.143 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.101 -0.499 . . . . 74.44 111.31 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.05 -39.35 79.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.375 -0.375 . . . . 74.52 111.044 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 28.1 ttt -58.19 -47.73 82.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.856 0.36 . . . . 60.55 111.513 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.5 ptm -70.84 -8.11 50.27 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.861 0.362 . . . . 71.24 111.694 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 3.5 mmp_? -106.65 -15.63 14.72 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.901 0.334 . . . . 73.35 111.901 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.55 40.35 9.94 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.186 -0.53 . . . . 70.51 112.891 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.87 168.62 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.717 0.407 . . . . 72.01 111.073 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.5 pt -132.52 149.37 72.88 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.54 -0.3 . . . . 73.12 111.406 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.86 -48.65 13.83 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.269 2.646 . . . . 74.34 114.113 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.33 4.75 3.4 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.681 0.623 . . . . 73.13 112.681 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.94 -8.15 18.81 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.862 0.363 . . . . 43.15 111.321 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.402 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 70.8 m -130.85 166.57 20.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.14 0.422 . . . . 74.02 112.14 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.49 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -135.89 121.3 19.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.431 -0.35 . . . . 75.14 111.809 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 224' ' ' VAL . 57.2 t -95.04 121.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.905 0.383 . . . . 72.04 111.558 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.646 ' CE1' ' HG3' ' A' ' 225' ' ' GLU . 27.7 p90 -138.84 142.29 38.65 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.211 0.529 . . . . 73.35 111.533 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 199' ' ' ARG . 1.3 ptm180 -110.72 124.43 51.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.884 -0.598 . . . . 71.0 110.001 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.12 107.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 71.32 111.668 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -135.19 135.93 41.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.1 -0.5 . . . . 61.54 110.202 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.36 27.46 16.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.23 0.538 . . . . 73.03 110.908 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.14 68.88 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.879 -0.6 . . . . 25.11 113.149 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -95.75 126.22 40.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.815 0.446 . . . . 73.13 112.167 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 97.5 mttt -76.98 98.82 5.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.668 0.27 . . . . 63.24 110.369 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -90.1 107.29 18.49 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.675 -0.238 . . . . 62.12 111.219 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 3.2 Cg_exo -75.31 129.1 11.77 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.776 2.317 . . . . 65.32 111.95 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.613 HG21 HD11 ' A' ' 217' ' ' LEU . 3.9 mp -98.89 122.39 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.74 -0.209 . . . . 63.4 110.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.51 126.7 38.02 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.714 -0.755 . . . . 54.34 111.782 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 69.4 m95 -55.06 -33.49 62.76 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.686 0.624 . . . . 73.21 112.686 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.47 17.68 3.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.897 0.703 . . . . 74.34 112.897 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.4 m -88.8 140.03 29.86 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.231 -0.293 . . . . 62.31 110.663 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 5.9 m-20 -57.58 125.68 23.98 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.077 0.399 . . . . 74.33 112.077 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.436 HG13 HG21 ' A' ' 157' ' ' VAL . 10.9 tp -59.45 -21.83 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.407 0.622 . . . . 74.25 110.965 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -55.34 -27.88 50.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.57 -0.741 . . . . 44.24 112.092 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -77.44 -7.02 55.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 111.859 0.318 . . . . 73.31 111.859 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.613 HD11 HG21 ' A' ' 208' ' ' ILE . 36.8 mt -122.15 22.34 10.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.283 0.563 . . . . 71.03 110.892 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 85.4 m -62.03 127.28 30.63 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.135 0.791 . . . . 62.32 113.135 -174.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.63 11.8 84.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.393 0.917 . . . . 74.42 115.393 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -126.83 173.26 9.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.244 1.022 . . . . 74.41 112.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.25 126.74 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.678 -0.692 . . . . 64.03 112.332 -172.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.12 141.5 44.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 73.11 109.911 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -120.33 142.57 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.088 -0.382 . . . . 73.32 110.516 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 70.7 t -118.09 126.43 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.051 0.76 . . . . 71.35 113.051 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.646 ' HG3' ' CE1' ' A' ' 198' ' ' TYR . 34.2 mt-10 -101.28 164.75 11.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.133 -0.485 . . . . 72.2 110.886 171.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.26 119.88 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.819 0.342 . . . . 53.54 111.48 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 196' ' ' ALA . 84.1 mt . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.029 0.442 . . . . 53.4 110.639 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 111.715 0.265 . . . . 75.43 111.715 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.41 147.08 86.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.538 2.158 . . . . 71.24 112.294 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.01 166.04 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.232 0.827 . . . . 62.31 113.232 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.69 128.12 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.821 -1.081 . . . . 63.52 109.334 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 83.8 mtt180 -91.45 97.29 10.98 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.987 0.422 . . . . 62.42 111.488 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 222' ' ' LEU . 44.7 t -95.69 112.55 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.17 0.434 . . . . 75.31 112.17 -176.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.6 119.6 23.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.022 0.439 . . . . 71.41 110.945 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 93.1 mt -95.99 159.44 32.26 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.213 -0.449 . . . . 65.3 111.304 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 225' ' ' GLU . 70.8 Cg_exo -52.27 162.87 1.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.537 2.158 . . . . 74.34 113.068 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.0 t30 65.96 28.97 10.44 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.162 0.506 . . . . 73.3 110.961 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 65.64 19.45 11.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.58 0.585 . . . . 73.11 112.58 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.3 mm-40 -84.04 171.87 12.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.087 0.47 . . . . 63.51 111.606 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 166' ' ' ARG . 22.2 ptt-85 -160.34 140.56 11.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.015 0.436 . . . . 72.31 111.845 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -139.53 141.54 37.27 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.027 0.442 . . . . 75.35 111.209 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.94 119.23 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.026 0.441 . . . . 75.41 110.887 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.83 149.08 47.84 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.446 -0.343 . . . . 73.22 111.582 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.17 144.84 82.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.413 2.076 . . . . 63.31 113.18 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.06 15.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.198 0.523 . . . . 74.02 111.314 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.447 ' H ' HG23 ' A' ' 214' ' ' ILE . 59.6 mtt180 -115.63 136.46 53.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.273 0.558 . . . . 53.32 112.421 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 37.2 t -99.94 133.64 44.01 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.832 -0.622 . . . . 72.14 110.518 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.18 -21.32 31.95 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.683 -0.77 . . . . 40.45 112.327 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.45 125.09 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 61.15 110.384 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 44.3 p -72.95 156.13 39.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 74.14 111.492 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.73 -36.03 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.396 0.617 . . . . 74.22 110.535 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.649 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 42.9 ttt180 -60.39 -59.59 5.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.388 -0.824 . . . . 73.1 111.905 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.78 -18.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.081 0.467 . . . . 71.13 111.398 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.2 t -82.13 -37.33 26.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.872 0.367 . . . . 63.34 111.51 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.9 mt -97.21 2.34 50.81 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.209 0.448 . . . . 75.23 112.209 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -52.55 -33.24 44.72 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.26 0.467 . . . . 75.32 112.26 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.493 ' NZ ' ' HB3' ' A' ' 183' ' ' LYS . 6.9 mtpm? -79.36 -37.83 36.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.794 0.33 . . . . 74.22 111.289 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -62.96 -46.23 88.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.14 0.495 . . . . 42.52 111.086 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.7 -44.49 96.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.189 -0.46 . . . . 63.42 110.694 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.8 ttt -53.08 -53.36 51.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.909 -0.587 . . . . 71.22 111.88 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.0 ptp -68.69 -14.14 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.474 0.546 . . . . 74.01 112.474 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 32.5 mmt180 -100.5 -8.22 23.34 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.224 -0.298 . . . . 75.23 111.671 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 79.33 18.1 74.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.213 -0.517 . . . . 64.31 112.855 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -101.74 156.8 17.28 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.085 0.469 . . . . 71.52 111.553 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 pt -127.23 138.29 32.44 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.73 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.08 -39.71 84.52 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.944 2.429 . . . . 70.44 113.56 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.03 -19.53 66.04 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.821 0.343 . . . . 73.13 111.888 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.7 20.29 17.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.092 0.472 . . . . 71.35 111.387 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.3 m -137.49 137.26 38.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.061 0.458 . . . . 71.05 111.252 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.54 123.67 50.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.389 -0.368 . . . . 54.42 111.65 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 224' ' ' VAL . 43.1 t -99.95 138.19 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.452 -0.34 . . . . 75.5 110.852 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -146.44 151.3 37.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 75.33 110.967 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 208' ' ' ILE . 16.8 ptt-85 -120.01 152.58 37.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 72.33 110.681 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.548 HG12 ' HG2' ' A' ' 205' ' ' LYS . 37.6 mt -106.35 86.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.394 0.616 . . . . 74.1 110.11 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -104.97 120.47 41.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.654 -0.703 . . . . 60.43 110.38 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 59.34 30.89 20.67 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.081 0.467 . . . . 60.02 111.701 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.72 -9.24 77.87 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.327 -0.397 . . . . 51.41 113.628 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 206' ' ' LYS . 37.9 mm-40 -95.26 125.4 39.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.358 0.503 . . . . 73.35 112.358 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.548 ' HG2' HG12 ' A' ' 200' ' ' ILE . 98.7 mttt -84.36 96.27 9.0 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.902 0.382 . . . . 71.12 110.221 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 204' ' ' GLU . 12.8 mptt -104.58 129.68 24.56 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.374 -0.376 . . . . 73.42 111.989 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.3 125.56 11.45 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.892 2.394 . . . . 54.43 113.063 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 199' ' ' ARG . 68.5 mt -97.67 126.08 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.139 -0.482 . . . . 55.41 111.357 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.46 136.21 18.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.153 -0.546 . . . . 54.12 112.46 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 98.9 m95 -59.6 -21.0 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.182 0.515 . . . . 72.53 111.464 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -79.02 -12.52 60.03 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.549 -0.75 . . . . 72.21 112.671 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.1 m -79.27 145.83 33.33 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.773 0.32 . . . . 63.12 111.762 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.0 m-20 -64.19 134.41 54.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 73.54 111.5 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.447 HG23 ' H ' ' A' ' 172' ' ' ARG . 10.1 tt -67.56 -19.11 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.038 0.447 . . . . 73.33 111.218 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 88.5 p -60.26 -29.23 68.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.203 0.446 . . . . 61.44 112.203 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -60.01 -27.0 66.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.395 0.617 . . . . 73.24 111.125 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -104.69 15.54 27.75 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.643 -0.708 . . . . 73.33 111.772 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.4 m -56.3 109.43 0.6 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.664 0.616 . . . . 71.23 112.664 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.79 -17.06 50.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.79 0.676 . . . . 54.4 114.79 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.62 173.41 6.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.025 0.913 . . . . 73.54 112.501 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 35.8 mt-10 -105.59 124.4 49.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.886 -0.597 . . . . 65.43 111.868 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 159' ' ' VAL . 47.5 mt -98.3 160.14 14.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.031 0.443 . . . . 72.32 111.462 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -129.56 120.04 24.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.525 -0.307 . . . . 54.31 110.648 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 197' ' ' VAL . 24.5 t -116.12 138.32 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 53.33 111.507 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 162' ' ' PRO . 9.9 pt-20 -138.76 152.91 48.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.959 0.409 . . . . 74.43 111.598 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 45.8 t -81.71 143.52 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.887 0.375 . . . . 71.25 111.713 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' ALA . 87.9 mt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.18 0.514 . . . . 73.04 110.982 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 155' ' ' PRO . 66.9 mttm . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 112.098 0.407 . . . . 74.34 112.098 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 154' ' ' LYS . 41.7 Cg_endo -65.25 146.7 86.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.679 2.252 . . . . 72.25 113.368 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 168' ' ' VAL . 40.0 pt -130.06 167.82 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.455 0.645 . . . . 75.04 112.634 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.82 133.66 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 61.23 109.968 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 57.5 mtp180 -105.09 106.17 16.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.121 0.486 . . . . 71.32 111.594 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -109.57 128.83 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.541 0.571 . . . . 73.41 112.541 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.56 115.12 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.24 -0.436 . . . . 75.1 110.93 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -89.97 155.45 47.4 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.14 -0.482 . . . . 74.21 111.65 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.46 141.55 68.07 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.6 2.2 . . . . 64.1 113.346 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 72.57 65.6 0.12 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.788 0.835 . . . . 62.45 112.676 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 58.2 41.38 23.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.013 0.746 . . . . 74.33 113.013 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -129.06 152.76 48.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.23 0.538 . . . . 53.55 111.831 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -157.41 146.44 19.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.03 -0.532 . . . . 74.45 110.572 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -156.32 147.44 22.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.178 0.513 . . . . 64.24 111.821 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 156' ' ' ILE . 99.3 t -109.92 122.34 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.11 -0.495 . . . . 63.04 111.372 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 HD11 ' A' ' 214' ' ' ILE . 12.2 m -118.25 138.04 25.22 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.35 -0.386 . . . . 71.04 111.553 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 34.0 Cg_exo -60.8 139.33 84.72 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.93 2.42 . . . . 54.0 113.946 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.29 103.91 13.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.24 -0.436 . . . . 62.31 111.648 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -124.39 141.87 51.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.451 -0.34 . . . . 62.24 111.271 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.2 t -74.98 151.04 38.83 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.667 0.27 . . . . 53.21 110.771 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.11 -37.18 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.011 -0.614 . . . . 51.13 112.572 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 214' ' ' ILE . 55.8 t -80.41 113.3 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.911 0.386 . . . . 74.23 110.582 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 72.0 p -75.83 159.78 30.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.547 -0.297 . . . . 55.14 111.454 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -30.45 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.611 0.72 . . . . 43.25 110.565 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 51.3 ttt180 -66.68 -48.65 68.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.533 -0.758 . . . . 71.34 111.337 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 5.2 t70 -75.86 -24.23 55.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 73.23 111.679 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 92.8 p -74.0 -48.58 29.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.024 0.44 . . . . 73.04 111.154 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.62 -4.02 59.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 63.32 112.858 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 18.0 ptmt -53.86 -45.49 70.99 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 111.868 0.321 . . . . 54.25 111.868 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.17 -25.79 47.35 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.143 -0.348 . . . . 70.14 111.675 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.63 82.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.225 0.536 . . . . 74.25 110.857 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.8 mt -79.09 -31.74 44.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.808 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -54.97 -47.84 74.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.505 -0.316 . . . . 74.2 111.27 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.9 ptp -68.66 -7.88 37.28 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.125 0.417 . . . . 71.01 112.125 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -101.3 -16.22 17.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.887 0.375 . . . . 74.32 111.163 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.4 30.15 25.54 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.305 -0.474 . . . . 62.31 112.727 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.8 173.55 6.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.867 0.365 . . . . 54.21 111.496 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.74 146.37 56.89 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.437 -0.347 . . . . 64.11 110.693 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.7 -41.82 74.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.604 2.203 . . . . 73.11 113.61 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.4 mp0 -63.63 -12.11 30.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.524 0.564 . . . . 75.12 112.524 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.54 -8.4 50.37 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.93 0.395 . . . . 71.23 111.563 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.6 m -123.5 171.75 9.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 64.24 112.055 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -143.68 129.72 19.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.43 -0.35 . . . . 71.44 111.286 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 224' ' ' VAL . 54.3 t -95.26 121.05 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.516 -0.311 . . . . 65.42 111.097 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 207' ' ' PRO . 17.9 p90 -132.27 145.11 51.07 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.178 0.513 . . . . 75.25 111.254 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HG2' HD11 ' A' ' 208' ' ' ILE . 40.2 ptt180 -122.83 161.37 24.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.046 0.45 . . . . 74.44 111.163 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 205' ' ' LYS . 52.7 mt -110.14 101.62 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.147 -0.479 . . . . 70.41 110.682 177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -120.29 123.78 44.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.994 -0.548 . . . . 65.24 110.543 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.66 30.45 19.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.202 0.525 . . . . 74.51 110.948 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 -12.41 54.45 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.036 -0.529 . . . . 75.02 113.361 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.8 120.33 25.91 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.15 0.426 . . . . 75.12 112.15 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.481 ' HG2' HG12 ' A' ' 200' ' ' ILE . 87.5 mttt -86.34 101.41 13.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.285 -0.416 . . . . 72.53 110.535 172.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -121.9 120.88 28.31 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 120.611 0.243 . . . . 63.2 111.432 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 198' ' ' TYR . 16.5 Cg_exo -69.62 126.15 13.07 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.714 2.276 . . . . 71.31 113.319 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 199' ' ' ARG . 3.6 mp -86.63 131.68 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.404 -0.362 . . . . 65.41 110.381 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.55 133.16 41.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.79 -0.719 . . . . 54.22 112.937 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -57.74 -22.05 44.51 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.071 0.462 . . . . 71.42 111.936 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.12 -10.74 59.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.426 0.528 . . . . 70.41 112.426 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.9 m -75.21 137.93 41.6 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.783 0.29 . . . . 71.31 111.783 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.04 130.26 44.73 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.875 0.369 . . . . 73.52 111.008 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 169' ' ' VAL . 9.8 tt -60.99 -23.67 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.014 0.435 . . . . 65.05 111.96 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 80.9 p -59.12 -24.98 63.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.295 0.48 . . . . 72.22 112.295 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -67.27 -27.48 67.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.961 0.356 . . . . 73.53 111.961 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 208' ' ' ILE . 51.3 mt -109.09 37.81 2.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.239 0.542 . . . . 74.52 111.712 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.6 m -67.36 120.2 13.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.73 0.641 . . . . 73.34 112.73 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.18 81.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 115.255 0.862 . . . . 74.42 115.255 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.65 172.1 7.92 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.187 0.993 . . . . 65.22 111.989 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.4 mt-10 -108.61 114.52 28.4 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.941 -0.572 . . . . 74.21 111.635 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 83.2 mt -94.81 157.53 15.89 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.102 0.477 . . . . 73.01 111.694 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -127.85 134.03 49.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.494 -0.321 . . . . 73.2 110.152 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 197' ' ' VAL . 48.0 t -119.74 136.05 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.371 0.508 . . . . 74.23 112.371 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.67 173.93 7.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.186 -0.461 . . . . 75.52 110.597 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.6 t -100.37 129.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.77 0.319 . . . . 72.31 111.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.0 mt . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.629 0.252 . . . . 43.3 111.425 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 112.581 0.586 . . . . 73.14 112.581 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.22 136.46 72.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.956 2.437 . . . . 51.15 113.096 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.93 162.71 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.455 0.645 . . . . 73.14 112.566 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 171' ' ' ALA . 47.3 t -130.88 130.47 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.549 -0.75 . . . . 73.24 109.847 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -98.66 101.16 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.987 0.422 . . . . 71.31 111.597 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 222' ' ' LEU . 42.9 t -96.3 117.54 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.922 0.391 . . . . 64.4 111.964 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -91.75 117.57 29.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.967 0.413 . . . . 74.52 111.196 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -97.68 160.17 29.25 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.274 -0.421 . . . . 72.12 111.431 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.76 173.02 6.12 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.397 2.065 . . . . 72.12 112.324 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 64.34 28.31 13.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.999 0.428 . . . . 73.24 111.72 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 64.13 34.86 10.74 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.891 -0.595 . . . . 71.21 111.964 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -110.33 160.76 16.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.003 0.43 . . . . 74.33 111.465 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -156.62 153.73 29.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.825 0.345 . . . . 74.31 111.182 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -152.11 137.31 17.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.058 0.456 . . . . 72.3 111.843 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.4 t -104.77 120.78 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.39 -0.368 . . . . 72.01 110.553 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.36 151.77 48.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 111.871 0.323 . . . . 53.11 111.871 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 129.18 13.2 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.562 2.175 . . . . 53.1 113.357 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.79 112.31 15.8 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.219 -0.446 . . . . 41.35 111.493 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.67 159.59 33.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.534 0.334 . . . . 74.41 111.452 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -95.28 147.54 23.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.688 0.28 . . . . 75.53 110.533 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.14 -25.3 6.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.696 -0.764 . . . . 63.52 112.262 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.58 111.82 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.048 0.451 . . . . 74.34 110.528 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 76.6 p -75.91 157.71 32.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.267 -0.424 . . . . 53.43 111.594 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.8 t -53.8 -40.9 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.261 0.553 . . . . 41.34 110.782 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 48.2 ttp180 -61.25 -37.81 84.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.571 -0.74 . . . . 72.44 111.424 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.47 -53.85 7.54 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.967 -0.56 . . . . 71.33 111.518 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.7 t -57.94 -41.14 82.17 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.222 0.453 . . . . 73.24 112.222 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 159' ' ' VAL . 69.9 mt -80.76 6.57 12.55 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.957 0.725 . . . . 74.42 112.957 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -55.06 -36.64 65.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.992 0.425 . . . . 74.14 110.878 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -67.35 -37.45 83.25 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.231 -0.441 . . . . 61.13 111.571 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.9 32.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.986 0.422 . . . . 44.34 110.899 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 88.4 mt -55.45 -42.91 74.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.87 -0.605 . . . . 75.03 111.241 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 52.6 ttm -59.45 -57.16 14.21 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.779 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -68.8 -23.13 64.24 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.462 0.541 . . . . 65.44 112.462 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -103.99 3.32 33.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.794 0.665 . . . . 73.34 112.794 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.04 48.5 85.6 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.149 -0.548 . . . . 73.31 113.559 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 89.3 mt -127.5 159.84 33.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.899 0.381 . . . . 52.12 111.467 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.74 154.79 73.33 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.491 -0.322 . . . . 75.01 111.168 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.12 -31.86 29.85 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.188 2.592 . . . . 71.33 114.525 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.65 -15.3 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.992 -0.443 . . . . 72.14 112.135 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.18 -8.74 29.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.014 0.375 . . . . 74.41 112.014 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 190' ' ' LEU . 77.7 m -142.55 149.33 38.95 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.0 0.429 . . . . 74.14 111.869 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.79 134.53 55.2 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.29 -0.414 . . . . 54.32 111.429 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 224' ' ' VAL . 34.1 t -108.4 125.05 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 122.529 0.331 . . . . 53.32 111.075 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.9 152.0 46.07 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.89 0.376 . . . . 73.12 111.338 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 199' ' ' ARG . 6.8 ptt180 -122.92 154.97 37.64 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.321 -0.251 . . . . 74.5 110.321 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.6 mt -110.85 131.4 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.211 0.529 . . . . 74.43 111.84 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 27.1 tt0 -137.7 119.62 15.35 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.093 -0.503 . . . . 72.52 110.79 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.46 16.28 3.18 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.42 112.144 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.59 -10.02 38.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 121.331 -0.461 . . . . 62.04 114.159 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' GLU . . . . . 0.673 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 12.3 pt-20 -88.02 134.66 33.69 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.948 0.874 . . . . 75.55 111.924 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 99.7 mttt -97.74 103.81 15.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.455 -0.338 . . . . 72.25 110.425 173.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.49 113.7 65.56 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 111.905 0.335 . . . . 75.54 111.905 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.04 113.07 2.05 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.969 2.446 . . . . 51.11 112.14 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.71 129.25 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 70.33 111.484 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.55 126.13 21.4 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.678 -0.773 . . . . 62.05 112.259 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 73.7 m95 -52.05 -28.69 18.22 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.965 0.412 . . . . 75.54 111.84 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.74 14.94 2.87 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.751 0.649 . . . . 72.1 112.751 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 56.6 m -93.28 140.74 29.21 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.031 -0.418 . . . . 75.13 111.707 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.85 122.12 13.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.98 0.419 . . . . 63.45 111.223 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.0 -19.51 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.597 0.591 . . . . 52.31 112.597 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 33.8 t -61.11 -19.68 61.76 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.053 0.39 . . . . 71.21 112.053 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -78.23 -8.04 57.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.904 0.335 . . . . 71.43 111.904 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 42.6 mt -110.67 18.97 19.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.141 0.496 . . . . 72.25 111.412 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -61.56 123.17 17.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.914 0.709 . . . . 61.33 112.914 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.35 -37.33 3.61 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.712 0.645 . . . . 62.23 114.712 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.78 172.62 7.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.629 0.715 . . . . 73.42 112.684 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -93.75 139.55 30.71 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.581 -0.736 . . . . 74.12 112.596 -173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 159' ' ' VAL . 54.6 mt -103.57 140.63 37.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.066 -0.516 . . . . 53.24 110.542 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -115.51 117.37 30.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.513 -0.312 . . . . 73.52 110.565 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 197' ' ' VAL . 39.8 t -112.6 129.42 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.759 0.314 . . . . 73.03 111.547 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.21 155.02 51.38 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.928 0.394 . . . . 73.23 111.348 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.93 130.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.564 0.579 . . . . 64.32 112.564 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.536 0.413 0 CA-C-N 115.831 -0.622 . . . . 71.44 110.73 175.587 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.474 0.178 . . . . 74.41 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 135.69 23.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.263 1.975 . . . . 74.14 111.496 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.29 163.27 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 113.133 0.79 . . . . 72.32 113.133 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.5 t -122.54 137.29 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.851 -0.613 . . . . 70.32 110.917 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 71.8 mtt85 -96.78 101.4 12.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 74.12 111.312 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.519 HG21 HD21 ' A' ' 181' ' ' LEU . 60.3 t -102.03 125.73 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.966 0.412 . . . . 65.32 111.726 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -91.52 106.4 18.46 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.35 -0.386 . . . . 74.12 111.175 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.8 mt -80.09 153.25 74.65 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.302 -0.408 . . . . 73.14 111.208 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 72.5 Cg_exo -49.96 140.45 31.47 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.896 2.397 . . . . 55.24 113.921 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 86.1 m-20 75.96 46.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.486 0.714 . . . . 71.03 112.47 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 64.2 20.32 12.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.773 0.657 . . . . 73.03 112.773 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.4 mm-40 -89.35 141.56 28.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 71.52 111.188 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -117.64 143.06 46.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.246 0.546 . . . . 74.4 111.877 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.448 HG23 ' HB ' ' A' ' 159' ' ' VAL . 9.2 t -145.5 137.93 25.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.826 -0.625 . . . . 74.52 110.724 172.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.21 120.26 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.672 0.272 . . . . 72.02 110.833 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 31.2 m -114.62 147.87 39.07 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 75.44 111.813 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 11.4 Cg_exo -71.55 125.0 10.78 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.789 2.326 . . . . 75.33 112.695 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 120.81 17.61 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.042 0.449 . . . . 51.11 111.754 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 61.9 mtt-85 -127.13 159.39 34.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.368 -0.378 . . . . 64.45 111.087 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.3 t -99.17 139.32 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.678 0.275 . . . . 72.33 110.445 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.77 84.1 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.765 -0.731 . . . . 63.42 112.006 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.8 t -127.1 119.3 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.952 0.501 . . . . 73.22 110.269 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.9 p -80.43 168.48 18.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.257 0.551 . . . . 63.02 112.201 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.75 -37.92 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.352 0.596 . . . . 74.41 110.236 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 21.3 ttt85 -63.91 -35.19 79.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.664 -0.698 . . . . 75.42 111.094 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' A' ' 182' ' ' LYS . 2.1 m-20 -76.53 -51.97 10.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.392 -0.367 . . . . 44.01 111.707 175.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -56.0 -42.73 76.87 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.111 0.411 . . . . 71.24 112.111 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 159' ' ' VAL . 78.9 mt -92.08 -10.04 40.46 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.812 1.042 . . . . 64.44 113.812 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 179' ' ' ASP . 0.1 OUTLIER -58.12 -28.71 64.9 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.909 0.777 . . . . 70.0 111.483 -176.127 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.82 -45.61 64.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.095 0.474 . . . . 73.33 110.607 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.54 90.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.949 -0.568 . . . . 65.43 111.665 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.66 -47.32 69.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 60.14 110.797 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.7 ttm -57.48 -39.13 75.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.002 -0.544 . . . . 45.41 112.245 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.8 ptm -75.26 -21.69 58.37 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.071 -0.393 . . . . 75.12 111.906 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -96.25 -13.68 23.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.097 0.406 . . . . 75.22 112.097 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.22 41.51 10.17 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.95 -0.643 . . . . 73.42 112.479 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.31 158.26 34.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.683 0.393 . . . . 62.21 110.829 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.2 pt -133.33 137.7 29.77 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.682 -0.235 . . . . 72.32 111.342 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.6 -44.31 35.95 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.172 2.581 . . . . 73.25 113.654 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.02 -21.65 59.41 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.522 0.564 . . . . 53.45 112.522 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' CYS . . . . . 0.522 ' SG ' HG13 ' A' ' 226' ' ' VAL . 32.7 t -101.18 -12.42 18.77 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.948 0.404 . . . . 64.42 112.014 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.9 m -119.55 164.41 15.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.173 0.511 . . . . 44.42 111.983 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.83 133.82 38.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.439 -0.346 . . . . 74.13 111.909 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 224' ' ' VAL . 68.0 t -98.79 138.54 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.731 0.301 . . . . 72.11 110.816 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.75 158.86 41.58 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.179 0.514 . . . . 71.35 111.738 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 206' ' ' LYS . 6.4 ptm180 -110.11 154.25 23.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.873 -0.603 . . . . 64.33 110.111 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.448 HG12 ' HG2' ' A' ' 205' ' ' LYS . 59.0 mt -118.62 120.65 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.985 0.421 . . . . 64.23 111.575 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -154.78 144.28 21.36 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.43 -0.35 . . . . 64.32 111.031 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 57.06 31.44 19.95 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.334 0.588 . . . . 70.15 111.22 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.66 -19.66 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.874 -0.603 . . . . 42.04 113.82 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.06 170.27 8.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.575 0.702 . . . . 65.33 112.732 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.0 mttp -113.45 139.58 48.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.32 -0.855 . . . . 73.31 110.947 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 199' ' ' ARG . 87.4 tttt -114.69 105.35 53.54 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.662 -0.245 . . . . 72.22 110.593 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -61.96 113.38 1.84 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.789 2.326 . . . . 64.44 112.412 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 217' ' ' LEU . 61.2 mt -96.64 134.22 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 72.43 111.615 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.3 135.17 29.3 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.145 -0.55 . . . . 72.42 113.039 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 75.9 m95 -55.34 -43.42 74.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.712 0.634 . . . . 74.43 112.712 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.56 27.93 0.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.85 0.685 . . . . 61.44 112.85 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 48.7 m -92.51 137.62 32.21 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 122.354 -0.216 . . . . 43.44 110.612 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.99 124.15 15.85 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.926 0.394 . . . . 74.32 111.794 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.25 -24.21 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.178 -0.465 . . . . 75.54 111.698 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 t -56.54 -30.61 63.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.115 0.413 . . . . 74.12 112.115 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.68 -19.1 65.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.842 0.353 . . . . 73.02 111.939 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 208' ' ' ILE . 44.0 mt -115.45 19.13 15.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.173 0.511 . . . . 72.23 111.676 -173.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.567 ' HA ' HG22 ' A' ' 157' ' ' VAL . 75.5 m -61.38 132.0 52.08 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.547 0.573 . . . . 73.01 112.547 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 93.4 -22.07 37.18 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.717 0.647 . . . . 74.42 114.717 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.16 172.78 6.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.684 0.742 . . . . 74.04 112.677 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 42.4 mt-10 -105.91 114.7 29.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.755 -0.657 . . . . 72.54 111.765 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.03 164.3 13.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.138 0.494 . . . . 75.54 111.291 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -131.7 139.1 48.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.839 0.352 . . . . 64.35 111.472 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 197' ' ' VAL . 46.4 t -123.12 126.38 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.107 -0.497 . . . . 63.05 110.746 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.72 145.72 46.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.397 . . . . 63.22 111.274 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.522 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.7 t -83.87 103.09 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 110.079 -0.341 . . . . 71.51 110.079 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.983 0.42 . . . . 61.02 111.692 -176.44 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 120.602 0.239 . . . . 73.41 111.392 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.59 131.03 31.82 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.663 2.242 . . . . 75.25 112.793 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.03 156.68 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.223 0.535 . . . . 72.12 112.173 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 171' ' ' ALA . 56.7 t -122.39 131.27 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.004 -0.544 . . . . 74.42 110.69 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.537 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 99.9 mtt180 -84.92 134.89 34.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.522 -0.308 . . . . 75.11 110.891 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 181' ' ' LEU . 59.7 t -130.18 119.51 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.1 0.476 . . . . 75.25 111.676 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -93.93 114.43 26.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.129 -0.487 . . . . 65.23 111.037 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 87.9 mt -98.19 158.33 32.93 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.088 -0.506 . . . . 72.34 111.181 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 172.2 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.27 1.98 . . . . 75.11 111.886 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 62.46 23.23 13.77 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.09 0.471 . . . . 74.3 110.778 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 63.02 26.91 15.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.513 0.725 . . . . 64.35 112.332 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 79.3 mm-40 -88.02 152.49 22.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.193 0.521 . . . . 74.5 111.98 -177.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -132.78 139.18 47.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.239 -0.437 . . . . 63.21 110.96 -176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.406 HG23 ' HB ' ' A' ' 159' ' ' VAL . 8.3 t -152.45 148.52 27.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.889 0.376 . . . . 64.11 111.745 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.7 129.7 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.87 0.366 . . . . 71.15 111.057 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.33 154.55 72.16 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.603 -0.271 . . . . 74.31 111.723 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 141.07 24.53 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.524 2.149 . . . . 73.21 113.163 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -103.4 122.23 44.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.942 0.349 . . . . 54.22 111.942 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -133.89 152.28 51.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.976 0.417 . . . . 75.53 111.817 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.3 t -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.007 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.2 -25.77 16.14 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.961 -0.638 . . . . 72.11 112.741 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.2 t -82.59 125.93 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.777 0.323 . . . . 73.53 110.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 45.5 p -84.25 164.49 19.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.199 0.523 . . . . 71.23 112.041 -177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 210' ' ' TRP . 61.4 t -59.2 -33.07 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.397 0.618 . . . . 72.03 110.722 174.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -63.48 -53.63 48.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.934 -0.575 . . . . 72.44 110.776 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.549 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 59.3 m-20 -59.81 -38.61 82.44 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.231 0.456 . . . . 75.4 112.231 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.0 p -76.59 -31.22 57.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.92 0.711 . . . . 54.24 112.92 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 159' ' ' VAL . 71.5 mt -106.45 -20.49 13.36 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.498 1.296 . . . . 65.21 114.498 -174.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 22.7 pttp -54.61 -33.67 60.84 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.427 0.899 . . . . 70.53 113.427 -172.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.99 -44.78 53.47 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.082 -0.386 . . . . 73.14 111.05 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.42 69.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.089 0.471 . . . . 71.22 111.334 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.57 HD11 ' CH2' ' A' ' 210' ' ' TRP . 86.4 mt -69.2 -48.96 60.63 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.033 -0.53 . . . . 62.2 110.901 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.0 tpt -56.84 -45.64 82.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.172 -0.467 . . . . 74.23 111.88 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -70.09 -8.81 52.49 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.557 0.577 . . . . 73.15 112.557 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.46 -20.61 12.15 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.954 0.353 . . . . 73.3 111.954 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.51 38.22 3.07 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.161 -0.542 . . . . 31.12 113.571 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 195' ' ' CYS . 5.0 mp -122.05 169.63 10.65 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.451 -0.441 . . . . 65.42 111.59 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.87 134.58 13.02 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.04 -0.527 . . . . 72.33 110.562 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.56 -39.9 73.9 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.792 2.328 . . . . 35.44 113.708 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.33 -11.1 56.77 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.11 0.781 . . . . 75.41 113.11 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.41 9.94 9.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.985 0.421 . . . . 60.35 111.467 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 190' ' ' LEU . 73.3 m -123.43 144.06 49.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.769 0.318 . . . . 74.43 111.611 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -122.46 119.47 31.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.524 -0.307 . . . . 75.22 111.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 224' ' ' VAL . 25.1 t -98.75 134.07 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.699 -0.228 . . . . 72.34 110.899 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.464 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 47.9 p90 -138.5 155.49 48.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.301 0.572 . . . . 64.02 111.715 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -121.27 152.17 39.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.686 -0.688 . . . . 73.41 111.192 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.5 mt -105.8 97.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.815 0.34 . . . . 73.13 110.795 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 12.8 pt20 -112.23 128.54 56.28 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.618 -0.265 . . . . 61.11 110.92 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.0 t70 60.16 19.09 8.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.546 0.689 . . . . 44.5 111.687 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.13 72.42 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.197 -0.525 . . . . 65.31 113.295 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.06 126.24 52.08 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.525 -0.397 . . . . 73.42 111.273 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.464 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 58.1 mtpt -80.68 94.4 6.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.069 0.461 . . . . 63.42 110.677 174.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -94.29 118.4 67.07 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.231 -0.44 . . . . 74.23 111.389 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.1 148.83 87.91 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.67 2.247 . . . . 64.43 112.559 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.533 HD12 HG12 ' A' ' 197' ' ' VAL . 50.1 mt -118.07 148.52 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.841 0.353 . . . . 71.52 111.222 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.38 139.05 14.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.953 -0.642 . . . . 61.3 112.13 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.57 ' CH2' HD11 ' A' ' 185' ' ' LEU . 94.2 m95 -62.7 -23.28 67.07 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.359 -0.495 . . . . 71.21 111.543 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.41 15.14 11.19 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.018 -0.537 . . . . 72.24 112.032 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 m -96.2 147.53 23.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.397 0.279 . . . . 74.12 110.952 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 216' ' ' TRP . 5.1 m-20 -65.13 126.65 28.75 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.166 0.508 . . . . 72.05 111.87 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 217' ' ' LEU . 9.5 tp -62.03 -20.64 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.366 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.6 p -60.63 -23.19 64.56 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.441 -0.345 . . . . 73.24 111.903 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 213' ' ' ASP . 42.3 m95 -70.37 -20.13 62.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.038 0.446 . . . . 75.4 111.739 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 HD12 ' A' ' 214' ' ' ILE . 23.2 mt -104.97 9.81 34.41 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.098 -0.501 . . . . 62.32 111.748 -174.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.0 m -56.64 109.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.646 0.61 . . . . 75.31 112.646 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.53 1.61 60.44 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.097 -0.573 . . . . 72.32 113.981 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -103.65 158.96 16.01 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.478 . . . . 72.54 111.826 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.537 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.3 mt-10 -105.72 114.82 29.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.067 0.461 . . . . 70.3 110.683 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 mt -92.8 156.11 17.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 63.11 111.715 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -129.33 132.55 47.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 72.14 110.197 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 197' ' ' VAL . 58.5 t -109.73 123.62 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.22 0.452 . . . . 72.35 112.22 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -100.66 157.39 16.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.178 -0.464 . . . . 70.41 111.228 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.55 130.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.741 0.305 . . . . 62.33 111.016 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 196' ' ' ALA . 89.1 mt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 111.802 0.297 . . . . 63.41 111.802 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.713 0.292 . . . . 73.52 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.76 128.55 19.14 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.46 2.107 . . . . 75.31 112.013 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.72 157.14 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.531 0.681 . . . . 65.34 112.76 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.77 135.37 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.436 -0.802 . . . . 74.14 110.186 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 50.0 mtt180 -90.32 98.56 11.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.936 0.398 . . . . 75.13 110.803 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.688 HG21 HD21 ' A' ' 181' ' ' LEU . 60.5 t -96.78 108.01 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.34 0.59 . . . . 74.51 111.806 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 73.1 m-85 -76.53 104.09 6.86 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.041 0.448 . . . . 64.32 110.762 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.39 157.87 89.15 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.931 -0.577 . . . . 74.35 112.274 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 11.1 Cg_endo -54.1 160.09 6.74 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.668 2.246 . . . . 61.35 112.843 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 65.0 t30 68.57 31.34 4.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.536 0.684 . . . . 64.4 110.839 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 65.6 23.03 11.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.31 -0.859 . . . . 74.32 113.031 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.92 -177.04 4.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.99 0.424 . . . . 75.35 111.776 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 28.1 ptt180 -157.84 156.86 32.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.162 0.505 . . . . 71.01 111.902 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.3 t -156.27 160.51 39.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.997 -0.547 . . . . 60.0 110.352 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.8 t -116.53 119.75 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.757 0.313 . . . . 43.22 111.041 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.23 152.67 49.37 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 111.852 0.315 . . . . 73.24 111.852 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.59 147.66 32.08 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.491 2.128 . . . . 63.44 113.273 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -103.67 126.73 51.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.959 0.409 . . . . 64.13 111.69 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -128.74 146.18 50.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.98 0.419 . . . . 62.15 111.623 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.69 132.21 40.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.834 0.35 . . . . 73.54 110.896 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.06 -23.7 30.14 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.076 -0.583 . . . . 44.25 112.437 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.26 125.26 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.097 0.475 . . . . 74.34 111.131 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 30.0 p -82.74 165.92 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.93 0.395 . . . . 74.15 111.491 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 212' ' ' THR . 62.0 t -56.96 -32.38 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.352 0.596 . . . . 73.21 110.243 172.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 4.2 tmt_? -68.04 -45.77 73.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.703 -0.681 . . . . 44.25 111.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -67.83 -33.42 74.75 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.918 0.39 . . . . 72.13 111.669 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.0 t -74.31 -44.01 54.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.25 0.463 . . . . 64.14 112.25 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 159' ' ' VAL . 68.3 mt -95.79 -4.78 43.27 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.72 1.007 . . . . 62.21 113.72 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -58.24 -43.51 87.82 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.246 0.461 . . . . 51.44 112.246 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -80.92 -27.85 36.03 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.984 0.421 . . . . 74.14 111.022 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.77 92.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.209 0.528 . . . . 65.54 111.173 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.27 -29.7 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.309 -0.405 . . . . 73.43 111.108 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.423 ' SD ' ' C ' ' A' ' 186' ' ' MET . 0.2 OUTLIER -54.63 -48.08 72.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.33 -0.396 . . . . 71.31 111.293 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -64.99 -19.12 65.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.023 0.379 . . . . 62.23 112.023 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -87.37 -5.97 58.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.774 0.321 . . . . 74.43 111.317 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.15 16.22 70.09 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.394 -0.431 . . . . 53.15 112.665 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.9 mt -117.3 171.76 7.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.016 0.436 . . . . 71.24 111.622 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 25.4 pt -133.44 143.9 49.97 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 116.086 -0.506 . . . . 65.14 111.039 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.81 -29.69 82.06 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.749 2.299 . . . . 75.34 112.941 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.34 -32.38 68.46 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.998 -0.546 . . . . 74.02 111.934 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.28 9.96 31.86 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.365 0.506 . . . . 60.41 112.365 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.0 m -118.27 166.87 12.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.98 0.419 . . . . 74.52 111.614 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.08 138.9 48.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 73.12 111.335 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 224' ' ' VAL . 61.9 t -111.17 132.11 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.288 -0.414 . . . . 71.32 111.267 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -139.06 146.89 41.33 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.252 0.548 . . . . 73.14 111.312 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' HD11 ' A' ' 208' ' ' ILE . 9.1 ptm180 -116.62 169.15 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 64.13 110.294 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' A' ' 205' ' ' LYS . 54.4 mt -104.04 115.69 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 71.14 110.101 174.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -131.27 119.69 22.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.952 -0.567 . . . . 75.43 110.253 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.31 27.01 15.96 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.335 0.588 . . . . 64.32 111.57 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.96 2.51 74.77 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.243 -0.435 . . . . 65.24 113.882 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.02 133.03 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.428 -0.454 . . . . 64.13 111.629 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.7 mttp -78.13 99.0 6.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.074 0.464 . . . . 72.44 110.895 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -93.67 112.09 55.32 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.991 -0.55 . . . . 74.12 111.859 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.19 110.23 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.92 2.413 . . . . 74.41 112.654 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.547 HD11 ' HG2' ' A' ' 199' ' ' ARG . 62.6 mt -89.13 138.59 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.26 -0.427 . . . . 61.22 112.039 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.06 138.59 34.94 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.14 -0.553 . . . . 52.5 113.219 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.1 m95 -59.45 -22.99 62.32 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.901 0.381 . . . . 70.41 111.746 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.09 -11.84 60.93 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.095 0.558 . . . . 62.51 112.228 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 177' ' ' VAL . 20.7 m -75.75 135.11 40.33 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.279 -0.419 . . . . 72.33 111.892 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 2.3 m-20 -62.03 127.21 30.29 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.513 -0.312 . . . . 41.25 111.54 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -61.31 -22.75 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.058 0.456 . . . . 73.22 111.284 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.9 t -54.89 -29.12 55.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.048 -0.524 . . . . 53.31 112.036 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -68.79 -26.74 65.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.143 0.497 . . . . 74.23 111.496 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.638 HD13 HD21 ' A' ' 222' ' ' LEU . 51.8 mt -105.47 10.88 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.0 -0.546 . . . . 72.33 112.104 -172.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 70.7 m -50.38 119.22 3.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.178 0.436 . . . . 55.13 112.178 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.73 -21.44 45.87 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.276 -0.488 . . . . 75.35 113.993 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -86.42 172.47 10.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.424 0.63 . . . . 73.01 112.418 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.1 mt-10 -111.18 119.96 40.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.875 -0.602 . . . . 74.51 111.249 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 217' ' ' LEU . 77.6 mt -97.39 155.23 17.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.908 0.385 . . . . 75.11 111.116 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -127.52 120.53 28.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.029 -0.36 . . . . 64.03 110.029 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 197' ' ' VAL . 52.5 t -115.95 140.6 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.1 0.476 . . . . 62.12 111.711 -175.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 162' ' ' PRO . 12.6 pt-20 -144.26 160.72 40.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.301 -0.409 . . . . 55.24 110.754 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.78 139.01 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.64 -0.254 . . . . 52.11 111.166 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.5 mt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.886 0.328 . . . . 73.4 111.886 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.587 0.232 . . . . 71.42 111.103 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.76 120.49 7.68 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.95 1.767 . . . . 71.31 111.661 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.3 pt -113.94 161.84 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.637 0.732 . . . . 73.31 112.883 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.45 133.58 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.342 -0.845 . . . . 74.24 110.275 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -95.99 96.39 8.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.011 0.434 . . . . 53.13 111.34 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.602 HG22 HD12 ' A' ' 222' ' ' LEU . 41.5 t -94.33 117.17 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.031 0.443 . . . . 54.24 112.108 -176.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.99 100.13 12.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.188 0.518 . . . . 74.23 111.112 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 98.1 mt -69.95 161.77 73.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.696 -0.683 . . . . 71.43 111.614 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 9.8 Cg_endo -52.09 153.24 12.83 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.768 2.312 . . . . 64.34 113.345 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 61.96 44.6 8.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.495 0.664 . . . . 71.22 110.901 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 61.47 23.77 13.98 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.096 0.776 . . . . 74.22 113.096 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.9 mm-40 -86.88 157.76 19.47 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.068 -0.395 . . . . 64.44 111.101 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -139.74 145.44 38.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.443 0.534 . . . . 74.54 112.443 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.1 t -148.1 161.9 40.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.795 -0.639 . . . . 64.33 110.19 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.34 120.32 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.954 0.407 . . . . 71.34 111.254 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.04 137.05 26.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.461 -0.336 . . . . 43.22 111.449 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.513 ' HG2' HH21 ' A' ' 172' ' ' ARG . 65.0 Cg_endo -74.12 126.16 10.32 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 72.14 113.007 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.74 35.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.092 0.472 . . . . 61.44 112.165 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.513 HH21 ' HG2' ' A' ' 170' ' ' PRO . 11.5 ptp180 -167.71 161.97 13.69 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.001 -0.545 . . . . 73.12 111.604 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.7 t -95.47 154.32 17.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.306 -0.407 . . . . 63.02 111.351 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 66.5 18.66 68.03 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.248 -0.501 . . . . 60.23 113.266 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.495 ' HB ' ' HG3' ' A' ' 172' ' ' ARG . 40.8 t -132.8 124.72 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.644 0.378 . . . . 72.12 110.468 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.6 p -82.84 158.05 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 64.21 111.622 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.62 -35.77 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.617 0.722 . . . . 73.33 110.017 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.9 ttp180 -56.42 -54.65 43.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.948 -1.024 . . . . 72.23 111.319 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -74.16 -12.53 60.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.18 -0.464 . . . . 71.01 111.718 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.5 m -82.79 -46.78 12.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.037 0.446 . . . . 63.43 110.944 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.72 4.94 48.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.311 0.486 . . . . 54.33 112.311 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -54.92 -26.63 37.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.878 0.37 . . . . 74.32 111.8 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.02 -52.11 6.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.68 0.276 . . . . 70.34 111.556 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.34 64.11 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.005 0.431 . . . . 65.51 112.117 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.401 HD11 ' CH2' ' A' ' 210' ' ' TRP . 87.2 mt -71.03 -53.78 13.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.934 0.397 . . . . 43.42 111.483 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.2 tpp -57.05 -42.09 79.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.358 0.503 . . . . 71.43 112.358 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.3 ptp -66.63 -15.44 63.47 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.118 0.414 . . . . 74.34 112.118 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -110.14 5.2 21.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.864 0.364 . . . . 74.34 111.551 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.05 35.54 89.34 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.464 -0.398 . . . . 75.33 113.229 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.6 159.95 15.81 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.086 0.469 . . . . 74.3 111.54 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.01 151.7 77.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.959 -0.564 . . . . 70.42 110.816 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.53 -34.3 51.42 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.683 2.255 . . . . 70.33 113.292 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -64.02 -22.03 66.75 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.2 0.524 . . . . 64.35 111.906 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.6 t -96.4 -7.49 34.86 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.335 0.494 . . . . 63.45 112.335 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' CYS . . . . . 0.403 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.4 m -134.89 131.65 37.59 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.683 0.623 . . . . 72.23 112.683 -172.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -111.31 127.33 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.18 -0.463 . . . . 55.43 111.324 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 224' ' ' VAL . 47.0 t -100.07 133.36 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.536 -0.302 . . . . 54.4 111.405 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -152.37 160.62 43.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.257 0.551 . . . . 72.51 111.812 175.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -122.93 155.94 35.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.074 -0.512 . . . . 64.32 110.677 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.95 120.75 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.8 0.333 . . . . 73.22 111.03 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -129.74 115.94 18.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.832 0.349 . . . . 72.2 111.207 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.1 t70 63.43 31.36 15.07 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.312 0.577 . . . . 73.01 111.155 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.55 50.25 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.258 -0.496 . . . . 42.01 114.221 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -102.34 155.7 18.07 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.399 0.599 . . . . 65.04 112.314 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -103.8 136.19 43.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.739 -0.664 . . . . 72.45 112.445 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -118.66 116.28 34.9 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 116.227 -0.442 . . . . 73.21 111.205 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.14 121.78 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.02 2.48 . . . . 74.24 112.911 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.85 122.79 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.171 0.51 . . . . 71.11 111.478 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.37 145.47 33.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.18 -0.533 . . . . 64.22 113.206 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.6 m95 -61.93 -27.55 68.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.922 0.391 . . . . 75.43 111.909 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.87 -10.3 59.31 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.222 -0.445 . . . . 75.32 111.675 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 90.5 m -69.52 136.97 52.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.21 111.663 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.99 126.23 27.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.89 0.376 . . . . 70.1 111.272 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 172' ' ' ARG . 12.7 tt -58.43 -19.92 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.977 0.418 . . . . 75.35 111.894 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -52.42 -33.63 44.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.255 0.465 . . . . 65.21 112.255 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -65.15 -28.34 69.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.15 0.5 . . . . 73.14 111.766 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 222' ' ' LEU . 35.7 mt -98.75 14.91 27.05 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.554 0.576 . . . . 73.22 112.554 -169.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.3 m -54.93 108.35 0.39 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.134 0.492 . . . . 74.13 112.237 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.9 69.66 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.457 -0.402 . . . . 70.45 113.954 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -84.53 163.46 19.36 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.321 0.581 . . . . 61.2 112.209 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -106.42 118.15 35.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.816 -0.629 . . . . 72.42 110.375 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.602 HD12 HG22 ' A' ' 159' ' ' VAL . 59.2 mt -93.01 111.86 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.006 0.431 . . . . 65.11 110.876 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -92.11 103.31 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.506 -0.316 . . . . 72.22 110.338 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 197' ' ' VAL . 35.3 t -99.0 123.35 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 111.998 0.37 . . . . 74.32 111.998 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -115.92 177.02 4.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.963 0.411 . . . . 74.24 111.366 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.6 138.03 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.691 0.626 . . . . 72.34 112.691 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.6 mt . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.14 -0.482 . . . . 74.34 110.989 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 110.362 -0.236 . . . . 60.14 110.362 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.55 140.01 75.41 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.743 2.295 . . . . 73.14 113.066 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -137.48 167.71 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.342 0.591 . . . . 75.45 112.496 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 46.8 t -129.92 139.09 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.816 -0.629 . . . . 63.03 110.349 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.758 ' HG2' HG22 ' A' ' 168' ' ' VAL . 98.9 mtt180 -108.69 117.86 35.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.292 0.568 . . . . 65.11 111.574 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 181' ' ' LEU . 75.3 t -109.92 131.69 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.292 0.478 . . . . 71.01 112.292 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -89.53 94.58 9.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.125 0.488 . . . . 63.14 110.934 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 81.9 mt -68.81 154.9 94.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.904 -0.589 . . . . 73.14 111.201 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.75 154.01 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.463 2.109 . . . . 64.01 112.375 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.8 m120 72.09 12.74 5.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.935 0.494 . . . . 63.33 110.78 -173.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt 64.59 59.39 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.191 0.596 . . . . 73.04 112.445 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 83.8 mm-40 -113.41 135.95 53.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.004 -0.544 . . . . 74.05 110.481 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.7 mpt_? -105.89 128.67 53.92 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.026 0.441 . . . . 75.52 111.889 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -136.96 156.17 48.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.436 -0.347 . . . . 75.34 111.16 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.758 HG22 ' HG2' ' A' ' 158' ' ' ARG . 38.7 t -126.38 132.78 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.934 0.397 . . . . 71.55 111.57 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.53 146.95 56.37 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.31 -0.405 . . . . 72.22 111.011 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 156' ' ' ILE . 57.5 Cg_endo -70.46 122.44 8.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.336 2.024 . . . . 42.52 113.261 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -74.03 114.81 12.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.919 0.39 . . . . 63.23 111.134 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' ' 175' ' ' VAL . 19.2 ptt-85 -132.67 142.34 49.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 72.54 111.896 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 45.7 t -77.58 140.22 39.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.242 -0.436 . . . . 72.01 111.66 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.77 55.99 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.238 -0.506 . . . . 63.14 113.242 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' VAL . . . . . 0.453 HG21 ' HG3' ' A' ' 172' ' ' ARG . 45.5 t -134.51 135.36 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 122.476 0.31 . . . . 75.21 110.751 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.8 p -81.63 159.71 23.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.123 0.487 . . . . 74.15 111.697 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 212' ' ' THR . 81.2 t -58.09 -37.69 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.286 0.565 . . . . 55.04 110.574 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 36.9 ttp180 -59.83 -56.76 17.71 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.673 -0.694 . . . . 71.14 111.511 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 68.2 m-20 -64.19 -17.04 63.15 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 71.12 112.347 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -93.69 -39.05 10.99 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.098 -0.376 . . . . 65.23 111.775 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 159' ' ' VAL . 65.2 mt -91.83 -5.54 53.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.753 0.649 . . . . 75.42 112.753 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 20.4 ptmt -54.28 -34.42 60.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.772 0.32 . . . . 71.54 111.751 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.58 -39.91 77.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.05 0.452 . . . . 63.55 111.361 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.75 98.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.986 0.422 . . . . 70.14 111.223 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.47 -43.11 91.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.125 -0.489 . . . . 44.24 110.768 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.5 ttp -55.66 -50.71 69.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.116 -0.493 . . . . 73.44 111.488 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -72.71 -0.5 13.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.789 0.328 . . . . 74.43 111.872 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -117.41 1.68 12.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.787 0.292 . . . . 74.23 111.787 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 63.28 47.1 90.79 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.339 -0.458 . . . . 63.25 113.424 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 92.4 mt -132.86 159.92 38.45 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.987 0.422 . . . . 73.22 111.915 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.78 147.36 38.04 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.773 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.76 -47.08 26.78 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.608 2.205 . . . . 71.3 113.753 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.63 -3.47 21.76 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.727 0.64 . . . . 70.22 112.727 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -94.47 -8.54 38.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.047 0.451 . . . . 74.01 111.339 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 93.3 m -135.29 158.72 43.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.049 0.452 . . . . 75.11 111.811 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.445 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -124.93 131.72 53.39 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.304 -0.407 . . . . 70.25 111.379 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 224' ' ' VAL . 58.2 t -103.05 125.44 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.436 -0.347 . . . . 74.01 111.097 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.431 ' HE1' ' HG2' ' A' ' 225' ' ' GLU . 40.6 p90 -137.36 151.56 48.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.008 0.432 . . . . 74.11 111.111 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.456 ' HG2' HD11 ' A' ' 208' ' ' ILE . 37.4 ptt180 -111.7 142.2 44.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.031 -0.359 . . . . 70.21 110.031 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 205' ' ' LYS . 48.8 mt -82.79 103.45 10.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 74.3 109.732 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -102.82 109.77 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 75.1 110.827 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.4 t70 60.68 16.95 7.07 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.765 -0.652 . . . . 64.23 111.366 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.99 -19.45 30.15 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.519 -0.372 . . . . 70.51 113.572 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.43 123.97 33.5 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.294 -0.533 . . . . 73.04 111.969 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 200' ' ' ILE . 96.6 mttt -79.89 104.2 10.31 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.405 -0.362 . . . . 63.21 110.611 174.593 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.06 115.24 40.88 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.9 0.381 . . . . 72.02 111.892 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.05 133.94 46.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.515 2.81 . . . . 72.02 113.861 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.456 HD11 ' HG2' ' A' ' 199' ' ' ARG . 50.0 mt -110.03 153.05 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.623 -0.717 . . . . 61.32 110.758 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.38 150.42 21.28 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.844 -0.694 . . . . 73.22 112.9 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 90.5 m95 -67.76 -27.67 66.97 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.178 -0.601 . . . . 73.1 111.634 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.78 -3.57 51.44 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.941 0.348 . . . . 54.51 111.941 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 177' ' ' VAL . 88.7 m -68.55 141.9 55.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.938 0.399 . . . . 70.33 111.071 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.12 117.71 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.063 0.458 . . . . 72.43 111.426 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.55 -22.07 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 N-CA-C 112.392 0.516 . . . . 74.52 112.392 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.5 p -59.91 -18.21 43.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.335 0.494 . . . . 74.34 112.335 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.39 -14.43 58.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.945 0.403 . . . . 72.33 111.954 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.53 22.87 14.94 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.175 0.512 . . . . 72.41 111.491 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.9 m -61.72 121.44 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.807 0.669 . . . . 74.24 112.807 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.6 -23.44 33.94 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.32 0.888 . . . . 61.14 115.32 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -99.32 172.25 7.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.981 0.89 . . . . 73.24 112.487 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 25.7 mp0 -93.26 139.87 30.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.945 -0.571 . . . . 71.34 111.936 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 90.6 mt -111.92 152.89 27.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.436 -0.347 . . . . 74.01 111.303 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -117.14 134.49 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.567 0.222 . . . . 75.43 111.138 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 197' ' ' VAL . 64.4 t -115.79 116.47 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 71.13 111.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.431 ' HG2' ' HE1' ' A' ' 198' ' ' TYR . 61.8 mm-40 -102.97 137.43 41.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.405 -0.361 . . . . 70.54 111.016 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.88 108.83 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.842 0.353 . . . . 70.11 110.837 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 196' ' ' ALA . 95.8 mt . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.095 0.474 . . . . 41.42 111.548 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.686 0.279 . . . . 74.31 111.671 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.08 130.53 38.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.415 . . . . 72.54 113.13 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -132.33 169.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.962 0.411 . . . . 53.41 111.797 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 171' ' ' ALA . 55.0 t -130.6 132.42 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 71.14 110.531 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 85.8 mtt180 -89.13 98.41 11.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.76 0.314 . . . . 74.03 110.722 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 181' ' ' LEU . 35.6 t -99.13 111.14 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.24 0.543 . . . . 51.31 112.051 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -89.45 111.97 23.0 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.104 -0.498 . . . . 74.54 110.673 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.5 mt -90.75 161.74 35.28 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.252 -0.431 . . . . 64.35 111.624 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 50.8 Cg_exo -55.54 162.51 6.22 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.555 2.17 . . . . 63.33 113.353 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.83 36.59 22.01 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.056 0.455 . . . . 75.13 111.617 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.2 13.44 9.15 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.103 0.779 . . . . 62.45 113.103 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.5 mm-40 -76.72 159.7 29.96 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.89 0.376 . . . . 74.34 111.46 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.56 154.07 38.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.328 0.585 . . . . 72.51 112.28 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' THR . . . . . 0.425 HG23 ' HB ' ' A' ' 159' ' ' VAL . 7.9 t -157.63 150.84 23.44 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.771 -0.65 . . . . 75.41 111.054 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.47 119.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.777 0.323 . . . . 63.23 110.244 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.57 152.41 58.34 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.495 -0.321 . . . . 74.22 111.768 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.2 132.36 19.37 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.595 2.197 . . . . 75.2 113.583 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -89.48 104.7 17.23 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.029 0.442 . . . . 51.23 111.431 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.42 140.71 52.4 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.4 -0.363 . . . . 60.04 111.917 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.98 122.35 19.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.429 -0.351 . . . . 61.1 110.79 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.67 -29.5 7.8 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.233 -0.508 . . . . 63.23 112.428 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 62.7 t -89.55 126.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.736 0.303 . . . . 54.24 111.052 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 69.6 p -87.32 160.83 18.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.896 0.379 . . . . 62.41 111.46 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.93 -39.39 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.019 0.438 . . . . 73.44 111.668 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 24.5 ttp180 -74.23 -21.16 59.91 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.34 . . . . 71.24 111.744 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 17.4 t70 -84.05 -34.38 24.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.112 0.482 . . . . 72.25 111.288 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 78.4 p -80.84 -55.1 5.03 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.114 0.483 . . . . 74.13 111.632 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 159' ' ' VAL . 86.0 mt -73.54 -2.31 22.24 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.681 0.993 . . . . 64.23 113.681 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 22.0 pttp -60.72 -29.08 69.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.619 0.645 . . . . 72.02 112.236 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -76.69 -38.94 53.59 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.167 -0.333 . . . . 72.41 110.998 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -60.15 -54.68 42.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.91 0.386 . . . . 54.44 110.958 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.4 HD11 ' CH2' ' A' ' 210' ' ' TRP . 85.4 mt -55.52 -45.74 77.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.164 -0.471 . . . . 71.43 110.789 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -55.19 -55.79 27.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.118 -0.492 . . . . 64.32 111.961 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.0 ptp -67.53 -22.18 65.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.559 0.577 . . . . 71.44 112.559 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 67.9 mmt-85 -91.97 -23.07 19.68 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.28 -0.262 . . . . 72.31 111.679 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.16 42.42 4.64 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.534 -0.365 . . . . 44.23 113.246 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.15 162.94 24.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.989 0.423 . . . . 75.2 111.417 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.81 142.86 46.44 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.564 -0.289 . . . . 72.23 111.291 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.19 -19.68 58.24 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.812 2.342 . . . . 70.21 113.782 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.15 -28.8 57.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 74.12 111.797 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 226' ' ' VAL . 51.2 t -106.89 19.1 20.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.911 0.386 . . . . 73.33 111.506 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.6 m -130.65 130.28 43.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.295 0.569 . . . . 73.21 111.911 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.0 119.44 39.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.795 -0.639 . . . . 65.41 111.209 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 224' ' ' VAL . 43.9 t -99.78 122.32 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.526 0.203 . . . . 72.41 111.051 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.411 ' HE2' ' HG3' ' A' ' 225' ' ' GLU . 42.4 p90 -134.07 152.13 51.7 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.238 0.542 . . . . 65.24 111.479 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 199' ' ' ARG . 4.1 ptm180 -115.5 142.88 46.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.582 . . . . 74.43 110.454 176.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ILE . . . . . 0.5 HG12 ' HG2' ' A' ' 205' ' ' LYS . 55.9 mt -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.904 0.383 . . . . 75.21 111.355 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.403 ' HG2' ' OD2' ' A' ' 202' ' ' ASP . 25.7 tt0 -161.62 133.41 5.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.142 -0.481 . . . . 71.11 110.827 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD2' ' HG2' ' A' ' 201' ' ' GLN . 11.1 m-20 60.72 28.65 18.37 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.895 0.379 . . . . 54.22 112.006 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.49 10.7 85.98 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.002 -0.618 . . . . 74.21 113.415 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.47 145.17 42.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.142 0.496 . . . . 62.15 111.781 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 200' ' ' ILE . 97.9 mttt -102.36 102.44 12.78 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 74.52 110.22 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.83 113.67 56.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.333 -0.394 . . . . 70.11 111.733 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.69 139.52 63.76 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.645 2.23 . . . . 70.53 112.488 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.22 142.39 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.981 0.42 . . . . 62.22 111.41 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.25 137.8 14.62 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.127 -0.558 . . . . 74.12 112.651 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -63.29 -17.17 62.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.373 -0.486 . . . . 71.41 111.8 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.49 -10.46 59.47 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.974 -0.557 . . . . 61.13 112.281 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 68.6 m -80.32 143.87 33.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.076 0.398 . . . . 54.14 112.076 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.42 132.52 52.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 64.12 111.961 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -65.38 -18.37 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.189 -0.46 . . . . 73.51 111.492 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.0 p -62.16 -23.65 66.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.975 0.417 . . . . 55.55 111.821 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -71.81 -15.77 62.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.045 0.45 . . . . 64.0 111.173 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.2 mt -113.85 13.56 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.052 -0.522 . . . . 61.51 111.307 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 98.1 m -51.9 113.77 1.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.708 0.633 . . . . 75.42 112.708 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 90.77 -17.93 52.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.308 -0.472 . . . . 73.14 113.821 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -73.99 168.06 20.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.544 0.688 . . . . 72.14 112.121 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . 0.51 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.6 mt-10 -112.72 114.74 27.47 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.586 -0.734 . . . . 74.14 110.77 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 159' ' ' VAL . 68.3 mt -93.33 147.72 22.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.122 0.487 . . . . 74.01 111.342 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -127.54 117.67 22.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 74.15 110.054 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.59 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 40.2 t -103.96 144.68 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.07 0.462 . . . . 71.53 112.215 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.411 ' HG3' ' HE2' ' A' ' 198' ' ' TYR . 22.4 mt-10 -130.75 177.85 7.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.205 -0.452 . . . . 72.2 111.633 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' VAL . . . . . 0.495 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.0 t -91.94 140.44 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.837 0.351 . . . . 73.51 111.815 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.144 0.424 . . . . 71.12 112.144 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 109.95 -0.389 . . . . 61.34 109.95 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 9.3 Cg_endo -50.02 129.81 25.91 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.839 2.359 . . . . 75.52 113.367 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.62 160.92 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.36 0.6 . . . . 65.2 112.086 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 129.86 65.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.805 -0.634 . . . . 74.22 110.535 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 158' ' ' ARG . 68.2 mtt85 -96.21 98.46 10.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.736 0.303 . . . . 62.35 111.416 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 222' ' ' LEU . 41.2 t -96.26 120.09 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.068 0.461 . . . . 74.22 112.043 -176.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.09 115.32 27.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.128 0.49 . . . . 71.1 110.747 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -93.47 165.71 17.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.947 -0.57 . . . . 74.44 111.527 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 20.6 Cg_endo -60.5 168.01 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.246 1.964 . . . . 71.44 112.534 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.94 27.2 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.081 0.4 . . . . 72.13 112.081 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.34 26.76 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.728 0.411 . . . . 53.32 111.795 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 76.9 mm-40 -92.43 162.21 14.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.92 0.39 . . . . 44.3 111.131 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -151.56 156.12 39.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.938 0.399 . . . . 72.0 111.786 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 t -156.85 126.99 6.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.274 -0.421 . . . . 74.12 111.535 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.62 119.73 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.29 -0.256 . . . . 74.15 110.557 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.74 144.87 39.83 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 112.014 0.376 . . . . 63.42 112.014 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.24 139.73 67.47 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.608 2.206 . . . . 74.41 112.923 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -93.31 109.7 21.24 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 55.23 111.606 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -97.22 132.39 43.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.386 -0.37 . . . . 74.34 110.997 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.1 t -70.7 121.25 17.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.774 0.321 . . . . 73.12 111.122 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.2 -9.69 50.32 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.369 -0.444 . . . . 55.25 113.168 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.88 135.28 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 122.432 -0.452 . . . . 71.3 110.526 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 69.8 p -81.54 167.04 19.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.299 0.571 . . . . 51.24 112.266 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 212' ' ' THR . 77.9 t -59.49 -37.66 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.371 0.605 . . . . 55.44 110.773 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.561 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 31.5 ttp180 -66.36 -55.87 13.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.811 -0.631 . . . . 50.33 111.226 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.575 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 17.0 t70 -60.83 -36.0 77.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.162 -0.472 . . . . 72.43 112.004 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 81.8 p -77.14 -59.0 2.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.906 0.384 . . . . 61.1 111.874 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.89 -23.66 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.335 0.865 . . . . 64.03 113.335 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 23.3 pttp -59.96 -22.69 62.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.613 0.642 . . . . 73.13 111.538 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.68 -41.42 53.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.139 0.495 . . . . 74.32 110.562 174.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.79 81.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 74.42 110.692 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.27 -38.29 68.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.17 -0.468 . . . . 53.32 110.744 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 26.3 ttt -53.7 -48.93 69.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.305 -0.407 . . . . 73.3 111.748 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -65.97 -27.07 67.87 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.752 0.311 . . . . 64.41 111.583 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.09 -22.31 31.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.934 0.397 . . . . 71.15 111.383 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.51 17.38 45.82 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.364 -0.446 . . . . 74.24 113.124 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.55 168.63 9.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.261 0.553 . . . . 72.44 111.96 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -129.77 139.73 36.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.127 -0.488 . . . . 75.24 111.343 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.24 -36.74 97.46 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.947 2.432 . . . . 74.21 113.898 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.41 -18.85 60.74 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.947 0.403 . . . . 62.33 111.923 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.14 -5.81 32.8 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.22 0.452 . . . . 74.31 112.22 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.5 m -119.07 151.53 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.365 0.506 . . . . 63.4 112.365 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -127.64 122.71 33.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.246 -0.434 . . . . 60.35 111.362 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 224' ' ' VAL . 56.5 t -98.12 136.26 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.641 -0.254 . . . . 54.4 111.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -149.31 165.63 31.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.037 0.446 . . . . 75.42 111.165 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -141.28 158.03 44.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.332 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.1 mt -92.21 113.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.286 0.565 . . . . 74.54 111.719 -174.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 206' ' ' LYS . 33.8 tt0 -139.02 142.19 38.27 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.566 -0.743 . . . . 74.43 110.494 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.65 21.86 10.55 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.534 0.683 . . . . 74.31 111.021 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.8 82.96 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.252 -0.431 . . . . 61.31 113.149 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -125.82 151.54 46.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.26 0.552 . . . . 72.05 111.819 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -82.64 97.27 8.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.087 -0.506 . . . . 73.14 110.198 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 201' ' ' GLN . 67.2 mttm -96.63 111.66 57.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.938 0.347 . . . . 62.32 111.938 -175.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.48 142.94 96.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.996 2.464 . . . . 73.15 113.387 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 217' ' ' LEU . 66.5 mt -113.5 134.34 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.99 -0.55 . . . . 74.1 111.016 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.34 133.74 16.8 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.886 -0.673 . . . . 15.31 112.887 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' TRP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.1 m95 -60.57 -26.17 66.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.017 0.437 . . . . 73.22 111.31 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.11 5.81 24.72 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.437 0.532 . . . . 54.42 112.437 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.3 m -83.84 141.46 31.32 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.492 0.187 . . . . 64.24 110.98 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.3 130.52 45.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.857 0.361 . . . . 72.25 111.238 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.0 tp -59.62 -22.55 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.07 0.462 . . . . 72.25 111.654 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 71.2 p -62.65 -26.87 68.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.244 -0.435 . . . . 64.3 112.001 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' TRP . . . . . 0.407 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.2 m0 -65.37 -22.64 66.83 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.292 0.568 . . . . 74.11 111.082 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 222' ' ' LEU . 46.6 mt -108.3 13.52 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.763 -0.653 . . . . 74.21 111.622 -175.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.9 m -52.8 118.06 3.4 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.166 0.432 . . . . 74.41 112.166 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.33 79.19 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.269 0.468 . . . . 72.01 114.269 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -105.52 164.33 11.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.497 0.665 . . . . 64.34 112.451 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -103.25 117.04 33.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.392 -0.822 . . . . 74.14 110.566 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 217' ' ' LEU . 60.3 mt -93.68 145.92 24.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.013 0.435 . . . . 75.25 111.016 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -121.95 117.02 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.561 -0.291 . . . . 75.24 110.451 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 197' ' ' VAL . 73.3 t -104.84 121.17 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.603 0.594 . . . . 71.35 112.603 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -106.69 164.58 11.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.008 -0.542 . . . . 72.41 110.832 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.89 124.64 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.774 0.321 . . . . 73.15 111.478 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 196' ' ' ALA . 75.2 mt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.947 0.403 . . . . 72.02 111.508 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.909 0.385 . . . . 74.44 111.73 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.5 mtm -131.76 153.6 81.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.026 -0.534 . . . . 75.5 110.163 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.51 171.88 8.76 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.286 1.991 . . . . 64.31 112.747 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.421 ' HB3' ' NZ ' ' A' ' 150' ' ' LYS . 0.3 OUTLIER -63.93 144.75 56.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.802 0.335 . . . . 64.11 111.289 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.1 t -132.57 80.76 61.38 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-O 120.972 0.415 . . . . 70.12 111.631 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -88.5 37.9 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.548 2.832 . . . . 74.35 112.932 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -80.35 32.71 0.29 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.756 0.788 . . . . 74.22 111.483 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -113.56 152.52 45.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.114 -0.493 . . . . 73.33 109.943 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.98 130.74 25.18 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.727 1.618 . . . . 74.24 111.114 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.03 166.54 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 113.428 0.899 . . . . 60.21 113.428 -171.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 171' ' ' ALA . 58.3 t -124.55 137.52 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.36 -0.836 . . . . 74.32 110.439 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 23.0 mtp85 -100.54 105.54 16.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.828 0.347 . . . . 72.13 111.375 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 181' ' ' LEU . 54.4 t -107.23 122.9 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.986 0.422 . . . . 64.33 111.919 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -93.68 119.29 32.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.119 0.485 . . . . 55.32 111.135 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 92.9 mt -93.17 155.68 40.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.804 -0.634 . . . . 72.12 111.897 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.19 159.53 26.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.608 2.206 . . . . 64.42 113.099 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.507 ' HB2' HH22 ' A' ' 188' ' ' ARG . 85.7 m-20 64.76 39.24 6.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.993 -0.549 . . . . 43.2 111.993 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 66.18 27.0 10.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.18 0.807 . . . . 62.35 113.18 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.9 mm-40 -104.61 166.88 10.1 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.019 -0.425 . . . . 45.34 111.419 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.414 ' N ' ' HD3' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -159.32 157.23 30.08 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.094 -0.379 . . . . 65.33 111.494 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -154.3 159.37 41.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.026 0.441 . . . . 72.55 111.51 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 128.74 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.322 -0.399 . . . . 73.2 110.733 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.419 HG23 HD11 ' A' ' 214' ' ' ILE . 17.3 m -125.4 141.96 40.32 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 111.835 0.309 . . . . 64.41 111.835 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.47 123.59 11.0 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.83 2.353 . . . . 65.44 113.374 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -73.68 102.76 4.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.085 0.469 . . . . 74.51 111.275 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -112.85 137.78 50.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.098 -0.501 . . . . 65.34 111.231 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -74.23 126.4 30.52 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.787 0.327 . . . . 55.12 111.372 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.73 -28.6 11.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.375 -0.44 . . . . 73.32 112.608 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.41 133.62 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.717 0.294 . . . . 54.31 111.127 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 56.7 p -82.48 155.3 24.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.009 0.433 . . . . 73.33 111.482 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 212' ' ' THR . 63.3 t -54.68 -39.03 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.05 0.452 . . . . 51.02 110.894 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.3 ttm-85 -59.94 -53.29 59.58 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 74.51 111.07 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.0 -19.76 64.95 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 73.45 111.405 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.0 m -80.66 -44.58 18.59 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.08 0.467 . . . . 72.32 111.467 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 159' ' ' VAL . 95.9 mt -92.07 -0.01 57.46 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.778 0.658 . . . . 54.31 112.778 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -51.65 -36.91 48.06 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.225 0.454 . . . . 54.24 112.225 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -67.69 -46.1 73.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.986 0.422 . . . . 75.41 111.235 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -61.3 -43.22 99.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.127 -0.488 . . . . 74.1 111.334 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 94.5 mt -64.78 -45.45 86.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.317 -0.401 . . . . 75.43 111.205 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.1 tpt -56.87 -49.57 75.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.383 -0.371 . . . . 72.32 111.696 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.8 ptm -67.2 -17.22 64.73 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.886 0.328 . . . . 74.11 111.886 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 42.2 mmm-85 -95.93 -13.71 23.67 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.153 -0.342 . . . . 61.22 111.413 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.17 27.58 61.78 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.342 -0.456 . . . . 61.35 113.106 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 90.6 mt -112.82 131.07 55.86 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.887 0.375 . . . . 74.34 111.738 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.26 142.45 38.08 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.644 -0.253 . . . . 71.22 110.885 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.02 -24.35 57.15 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.711 2.274 . . . . 63.42 113.45 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.2 -14.62 58.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.131 0.419 . . . . 70.12 112.131 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.47 11.37 32.65 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.132 0.492 . . . . 74.15 110.864 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.2 m -129.95 133.17 46.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.293 -0.412 . . . . 64.24 111.303 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.22 144.82 38.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.668 0.27 . . . . 73.43 111.265 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.18 140.49 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.852 0.358 . . . . 54.51 111.574 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.67 158.67 43.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.188 0.518 . . . . 72.45 111.8 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -122.84 161.22 24.48 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.8 -0.636 . . . . 74.53 110.41 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.0 mt -104.64 114.44 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.153 0.501 . . . . 74.04 111.536 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -124.06 119.6 29.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.732 -0.667 . . . . 72.43 110.203 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 57.19 31.97 20.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.169 0.509 . . . . 74.34 111.214 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 85.24 -2.92 87.94 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.227 -0.511 . . . . 73.53 113.715 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -101.85 139.16 37.87 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.345 -0.503 . . . . 72.3 112.092 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -89.14 103.43 16.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.147 -0.478 . . . . 65.05 110.869 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 207' ' ' PRO . 45.4 mmtm -104.11 127.54 29.02 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.685 0.279 . . . . 72.0 111.587 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 22.6 Cg_exo -65.75 152.28 82.05 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.204 2.602 . . . . 54.41 113.758 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 217' ' ' LEU . 70.6 mt -129.85 138.57 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 73.54 111.007 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.98 134.42 12.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.062 -0.589 . . . . 43.31 112.927 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.6 m95 -57.27 -30.51 64.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.287 0.477 . . . . 61.13 112.287 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -87.24 7.79 26.95 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.131 0.419 . . . . 62.04 112.131 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.8 m -82.6 140.55 33.15 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.296 -0.252 . . . . 72.31 110.797 174.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 4.2 m-20 -59.1 126.9 29.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 72.33 111.595 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 169' ' ' VAL . 12.1 tt -60.24 -21.48 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.134 -0.485 . . . . 75.33 111.819 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 76.8 p -60.65 -27.5 67.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.809 0.338 . . . . 74.45 111.681 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 15.6 m95 -70.37 -16.33 62.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.955 0.407 . . . . 73.1 111.484 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 208' ' ' ILE . 80.1 mt -112.77 22.52 14.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.31 -0.404 . . . . 71.2 111.936 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.8 m -56.74 108.42 0.5 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.853 0.359 . . . . 75.45 111.919 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.46 11.12 61.25 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.171 -0.538 . . . . 50.2 114.048 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -93.8 151.32 19.69 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.342 0.571 . . . . 65.41 111.628 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -105.46 114.35 28.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.082 0.468 . . . . 64.12 110.654 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.406 HD22 HD12 ' A' ' 208' ' ' ILE . 58.1 mt -97.48 150.57 20.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.085 0.469 . . . . 43.23 111.761 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.61 127.61 44.13 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.6 -0.273 . . . . 60.44 110.458 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.73 137.51 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.399 0.518 . . . . 73.55 112.399 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.78 144.24 43.31 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.059 -0.519 . . . . 70.42 111.02 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.36 116.4 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.526 0.203 . . . . 74.33 110.95 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 77.4 mt -70.45 -47.95 58.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.72 0.295 . . . . 73.14 111.629 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -125.73 114.21 18.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.888 0.375 . . . . 71.3 110.678 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.27 -34.88 63.71 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.364 0.505 . . . . 71.15 112.364 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.57 115.37 49.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 120.568 0.223 . . . . 75.3 111.222 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.79 111.58 2.27 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.786 2.324 . . . . 74.42 113.554 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.253 1.241 0 CA-C-O 118.812 -0.613 . . . . 60.2 111.298 176.224 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.3 m80 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.282 0.087 . . . . 73.1 110.976 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtt 70.63 118.27 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 123.233 0.613 . . . . 72.5 112.604 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 95.62 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.775 2.317 . . . . 63.53 111.477 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.86 115.54 4.94 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.765 0.317 . . . . 65.24 111.698 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.4 m 64.88 85.21 0.16 Allowed Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 115.819 -0.628 . . . . 74.12 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.53 136.49 74.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.656 2.237 . . . . 73.04 112.389 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -72.78 99.18 2.57 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.245 0.545 . . . . 74.31 111.281 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.79 156.44 52.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.969 -0.559 . . . . 71.51 111.855 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 218' ' ' THR . 43.3 Cg_endo -65.79 144.6 78.14 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.823 2.348 . . . . 64.53 112.928 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.6 pt -132.21 162.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.068 0.766 . . . . 74.54 113.068 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.02 123.23 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.251 -0.886 . . . . 54.11 109.65 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.716 ' HB2' ' HB3' ' A' ' 221' ' ' GLU . 49.5 mtt180 -88.91 95.05 10.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.805 0.336 . . . . 62.3 111.092 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 181' ' ' LEU . 57.6 t -93.52 114.71 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.977 -0.452 . . . . 64.33 112.206 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.8 123.92 30.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.85 0.357 . . . . 75.11 110.647 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.473 HD11 ' HB1' ' A' ' 184' ' ' ALA . 96.3 mt -100.38 156.43 35.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.251 0.463 . . . . 63.22 112.251 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.508 ' HG2' HH12 ' A' ' 188' ' ' ARG . 19.4 Cg_endo -59.38 165.78 8.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.298 1.999 . . . . 53.21 112.115 175.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 68.22 25.11 7.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.027 0.441 . . . . 73.42 111.11 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 62.94 43.24 6.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.659 -0.701 . . . . 53.24 112.111 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -118.51 -179.74 3.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.02 0.438 . . . . 55.21 111.672 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 159.82 35.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.001 0.429 . . . . 62.01 112.148 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -155.41 129.01 8.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.018 0.437 . . . . 64.12 111.503 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.21 119.55 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.696 0.284 . . . . 74.11 110.314 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.45 138.54 29.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.555 0.217 . . . . 72.14 111.372 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.8 132.26 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.566 2.178 . . . . 72.11 113.039 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.78 103.46 5.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.045 0.45 . . . . 73.34 110.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.2 mtt-85 -106.5 126.35 52.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.305 -0.407 . . . . 72.15 111.395 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.8 t -75.02 115.71 14.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.813 0.34 . . . . 55.41 111.146 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.61 -1.04 27.66 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.244 -0.503 . . . . 32.3 112.58 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.72 133.03 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.743 0.306 . . . . 64.33 110.874 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 33.0 p -81.59 161.59 23.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.852 0.358 . . . . 70.43 111.585 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 212' ' ' THR . 81.3 t -56.33 -34.48 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.439 0.638 . . . . 44.21 110.424 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 47.2 ttp180 -67.35 -56.04 11.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 63.24 111.619 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.665 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 6.6 m-20 -72.22 -12.36 61.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.818 0.673 . . . . 74.44 112.818 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 62.0 p -89.18 -50.94 5.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.943 0.402 . . . . 63.25 110.767 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 159' ' ' VAL . 78.5 mt -79.73 -7.54 58.68 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.426 0.898 . . . . 71.23 113.426 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 14.0 ptpt -55.92 -27.64 53.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.979 -0.45 . . . . 75.22 111.209 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.99 -45.48 81.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.191 0.519 . . . . 70.34 110.773 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -66.77 -30.55 70.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.021 -0.536 . . . . 64.31 111.618 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 91.6 mt -75.17 -43.69 50.86 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.006 0.431 . . . . 71.42 110.709 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.17 -53.86 47.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.762 -0.653 . . . . 70.23 112.0 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' HG3' ' A' ' 188' ' ' ARG . 26.4 ptt? -64.62 -8.58 14.8 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.623 0.601 . . . . 63.42 112.623 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.508 HH12 ' HG2' ' A' ' 162' ' ' PRO . 63.2 mtm180 -119.23 5.37 11.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.849 0.315 . . . . 72.1 111.849 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.44 95.69 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.294 -0.479 . . . . 41.41 113.431 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 95.1 mt -124.43 149.87 46.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.32 0.581 . . . . 72.54 111.753 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.7 pt -104.15 152.72 39.21 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.113 -0.494 . . . . 74.41 111.088 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 -20.72 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.762 2.308 . . . . 74.2 113.825 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.65 -16.55 53.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.982 0.42 . . . . 75.33 111.847 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.7 t -90.36 -9.2 48.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.02 0.378 . . . . 72.44 112.02 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.1 m -136.41 147.69 47.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.04 0.448 . . . . 72.21 111.8 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -125.25 131.55 53.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.875 0.369 . . . . 64.44 111.466 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 224' ' ' VAL . 57.9 t -94.44 132.54 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.333 -0.394 . . . . 75.21 110.844 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 37.8 p90 -148.87 163.05 38.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 62.32 111.09 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -134.62 143.49 47.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 73.43 110.496 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.42 97.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.307 0.575 . . . . 74.42 110.133 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 108.61 19.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 75.23 110.791 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 60.73 30.99 20.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.538 0.685 . . . . 74.41 110.723 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -12.86 68.82 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.051 -0.522 . . . . 65.24 113.491 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 39.5 mt-10 -93.45 132.71 37.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 122.251 -0.558 . . . . 75.15 111.762 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 55.0 mtpt -78.07 94.88 4.74 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.917 0.389 . . . . 63.45 110.708 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 204' ' ' GLU . 33.7 mmtp -96.58 109.73 49.53 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 71.1 111.19 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.29 125.76 13.37 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.876 2.384 . . . . 72.42 112.561 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -100.27 122.09 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.285 -0.416 . . . . 53.33 111.066 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 139.72 46.55 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.319 -0.467 . . . . 41.25 113.105 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.6 m95 -60.02 -22.8 63.09 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.969 0.414 . . . . 71.41 111.603 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -78.47 -6.75 56.26 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.474 0.546 . . . . 75.32 112.474 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 177' ' ' VAL . 29.5 m -75.47 140.49 42.87 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.716 0.265 . . . . 74.43 111.716 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.18 126.86 30.02 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.111 0.481 . . . . 73.44 110.929 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.1 tt -67.05 -23.65 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.503 0.557 . . . . 74.1 112.503 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -67.44 -12.17 59.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.88 0.372 . . . . 71.12 111.708 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -70.82 -23.28 62.33 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.176 0.512 . . . . 71.45 111.197 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 222' ' ' LEU . 28.7 mt -108.66 19.93 19.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.907 -0.588 . . . . 75.51 111.531 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 155' ' ' PRO . 96.7 m -58.48 115.46 3.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.791 0.664 . . . . 62.31 112.791 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.19 -27.98 10.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.114 -0.565 . . . . 64.31 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.64 172.78 6.66 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.371 0.605 . . . . 64.24 112.161 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 158' ' ' ARG . 1.4 pm0 -108.34 149.53 28.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.545 0.688 . . . . 74.15 112.305 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 217' ' ' LEU . 85.9 mt -113.51 163.71 14.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 63.21 111.186 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.44 130.52 46.04 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.556 -0.293 . . . . 72.4 110.317 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 197' ' ' VAL . 40.1 t -118.25 119.05 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.63 0.252 . . . . 54.0 111.496 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.96 164.29 12.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 71.34 111.672 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.3 t -77.6 144.6 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.038 0.447 . . . . 71.45 112.025 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt -104.51 -50.39 3.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.391 -0.368 . . . . 71.14 111.766 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.91 167.11 26.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.981 0.419 . . . . 64.4 112.026 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -150.77 100.89 2.87 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.193 -0.458 . . . . 73.4 111.093 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 46.3 t 63.42 88.07 0.12 Allowed Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 121.12 0.486 . . . . 72.33 112.004 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.69 99.13 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.872 2.382 . . . . 62.14 113.456 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.251 1.132 0 CA-C-O 119.006 -0.521 . . . . 54.25 110.073 176.683 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.695 0.283 . . . . 65.14 111.683 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 148' ' ' MET . 1.0 OUTLIER -89.09 112.88 53.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 120.699 0.285 . . . . 54.02 111.511 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.41 98.95 1.15 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.768 2.312 . . . . 71.41 112.901 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -95.7 7.23 46.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.42 111.079 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.7 t -136.46 70.98 60.12 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.308 -0.406 . . . . 74.54 111.347 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.27 138.7 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.797 2.331 . . . . 74.43 111.846 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.14 83.46 1.0 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.374 0.607 . . . . 74.12 111.829 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -112.97 156.77 42.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.332 -0.849 . . . . 71.2 110.616 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.56 111.24 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.133 1.889 . . . . 54.24 111.926 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.2 pt -112.46 161.84 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.681 0.623 . . . . 62.2 112.681 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 57.8 t -122.56 128.76 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.786 -0.643 . . . . 75.35 110.279 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.592 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 18.9 mtp180 -96.52 107.9 20.39 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.012 0.434 . . . . 74.24 110.963 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.94 125.46 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.478 0.548 . . . . 65.53 112.478 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -82.74 113.71 20.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.261 -0.427 . . . . 45.02 110.76 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.55 146.88 32.62 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.286 -0.415 . . . . 74.41 111.046 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.07 160.33 19.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.346 2.031 . . . . 63.1 112.646 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 69.21 36.48 2.37 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.185 -0.461 . . . . 73.23 112.04 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 67.95 36.33 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.633 -0.712 . . . . 74.32 112.424 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -117.64 171.23 8.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 72.33 112.171 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.51 162.14 37.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.179 -0.464 . . . . 74.24 110.491 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.13 163.42 40.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.879 0.371 . . . . 64.52 111.452 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.6 t -121.69 128.72 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.914 0.388 . . . . 74.22 111.364 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.62 145.02 45.94 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.446 -0.343 . . . . 55.05 111.47 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.13 126.51 7.85 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 75.23 112.666 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -90.96 110.0 21.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.893 0.378 . . . . 73.41 111.969 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 172' ' ' ARG . 49.7 mtt180 -101.72 167.5 10.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 72.44 111.105 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.74 128.96 34.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.505 -0.316 . . . . 61.22 111.1 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.34 33.33 28.85 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.99 -0.624 . . . . 71.24 113.171 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.1 t -131.35 109.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.104 -0.332 . . . . 74.03 110.104 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.9 p -63.18 157.09 23.37 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 72.51 112.399 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 212' ' ' THR . 65.6 t -56.77 -30.53 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 75.23 110.648 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 18.9 ttp180 -68.99 -53.07 22.53 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.983 -0.553 . . . . 61.1 111.195 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.551 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 34.7 m-20 -63.3 -35.11 79.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.356 0.598 . . . . 73.44 111.247 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 39.9 t -66.49 -62.79 1.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.079 -0.51 . . . . 73.04 111.585 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.6 mt -83.09 -12.27 57.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.202 1.186 . . . . 71.44 114.202 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 17.9 ptpt -56.05 -28.88 59.32 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.75 0.705 . . . . 62.25 111.848 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 180' ' ' SER . 7.9 ptpp? -74.17 -29.78 61.94 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.792 0.329 . . . . 74.52 111.524 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -70.26 -42.4 72.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.229 0.538 . . . . 34.33 110.647 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.92 -29.13 58.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.168 -0.469 . . . . 63.12 111.029 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 45.4 ttm -54.81 -49.64 70.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 74.22 111.534 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.2 ptp -68.52 -10.09 53.4 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 111.883 0.327 . . . . 64.44 111.883 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 15.3 mmm180 -95.58 -10.38 29.72 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.658 -0.246 . . . . 72.34 111.031 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.02 20.04 63.88 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.385 -0.436 . . . . 73.55 112.76 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 226' ' ' VAL . 80.9 mt -120.88 153.96 36.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.997 0.427 . . . . 63.41 111.439 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.0 pt -104.97 141.3 22.27 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.788 0.327 . . . . 74.15 111.455 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.433 ' HG3' ' HB3' ' A' ' 182' ' ' LYS . 22.0 Cg_endo -60.95 -29.25 87.66 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.541 2.161 . . . . 72.14 113.05 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 178' ' ' ARG . 5.5 mm-40 -55.74 -32.84 63.75 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.998 0.428 . . . . 72.54 111.705 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 228' ' ' GLU . 52.0 t -104.18 21.77 15.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.067 0.461 . . . . 54.03 111.966 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.1 m -125.0 161.88 25.74 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.056 0.455 . . . . 74.44 111.654 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.93 131.8 47.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.835 0.35 . . . . 72.23 111.726 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 224' ' ' VAL . 20.8 t -112.44 139.03 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.396 -0.365 . . . . 62.13 110.762 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -147.86 158.61 44.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.334 0.588 . . . . 75.31 111.942 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -135.34 138.8 43.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.676 -0.693 . . . . 73.21 110.988 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 56.3 mt -84.36 118.0 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 65.4 111.381 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 24.3 mt-30 -122.66 113.92 19.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.261 -0.427 . . . . 72.02 111.212 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 59.27 20.72 8.86 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.495 0.664 . . . . 75.41 111.657 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 109.39 -22.64 24.28 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.244 -0.435 . . . . 71.13 113.899 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 10.2 pt-20 -84.12 155.2 22.74 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.578 0.689 . . . . 74.22 111.533 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.06 100.24 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.212 0.53 . . . . 73.32 109.642 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -87.69 112.72 50.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.978 -0.555 . . . . 64.0 111.581 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.64 127.54 12.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.568 2.179 . . . . 45.52 112.271 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 217' ' ' LEU . 60.4 mt -96.7 129.99 45.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 74.3 111.685 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 131.66 11.81 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.052 -0.594 . . . . 74.12 112.218 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.6 m95 -59.87 -27.11 66.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.183 0.438 . . . . 61.33 112.183 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -80.3 -5.91 57.06 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.211 0.449 . . . . 71.15 112.211 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 m -71.19 141.5 50.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.308 -0.245 . . . . 61.33 111.017 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.66 129.36 39.49 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.077 0.465 . . . . 71.35 110.824 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.91 -24.64 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.145 -0.48 . . . . 55.1 111.868 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 86.0 p -64.89 -16.24 62.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.781 0.324 . . . . 73.24 111.802 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -76.44 -11.4 59.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.015 0.436 . . . . 63.13 111.439 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.454 HD11 HG21 ' A' ' 208' ' ' ILE . 66.8 mt -114.04 14.43 18.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.074 0.464 . . . . 75.23 111.241 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.8 m -53.84 119.67 5.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.633 0.605 . . . . 60.22 112.633 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 88.88 -9.93 74.61 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.194 -0.457 . . . . 55.13 113.997 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.29 157.84 18.05 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.643 0.608 . . . . 73.44 112.643 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.4 mt-10 -103.99 114.38 28.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.821 -0.627 . . . . 74.31 110.965 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.2 mt -95.79 158.99 15.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.162 0.506 . . . . 74.33 111.973 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -122.28 121.72 37.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.452 -0.34 . . . . 72.11 110.38 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 197' ' ' VAL . 62.1 t -119.07 135.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.204 0.525 . . . . 75.13 112.09 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.3 148.95 40.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.118 -0.492 . . . . 72.14 110.914 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 190' ' ' LEU . 36.0 t -85.8 137.51 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.819 0.342 . . . . 70.14 111.879 -174.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.44 -67.38 0.72 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.375 -0.375 . . . . 73.52 111.102 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.622 ' HB2' ' SG ' ' A' ' 194' ' ' CYS . 72.5 mm-40 -105.39 138.32 41.78 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.942 0.401 . . . . 74.21 111.392 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -73.79 74.67 1.59 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.259 0.552 . . . . 54.53 111.357 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.27 92.22 48.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.276 -0.42 . . . . 71.43 111.525 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -88.89 127.73 1.88 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.166 2.577 . . . . 54.21 112.126 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 232' ' ' LEU . 7.0 mp . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.575 -0.726 . . . . 75.15 111.819 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.8 t60 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.544 0.211 . . . . 65.23 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.7 tpp -86.06 116.17 64.72 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.24 -0.287 . . . . 53.52 111.532 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.77 166.27 21.63 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.661 2.241 . . . . 65.11 113.397 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.82 171.07 14.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.889 -0.596 . . . . 73.54 110.852 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 82.4 p -159.29 103.08 1.53 Allowed Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 112.122 0.416 . . . . 61.45 112.122 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.56 153.76 64.46 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.416 2.077 . . . . 74.13 112.031 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.67 115.24 3.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.703 0.631 . . . . 75.43 112.703 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -113.09 151.02 43.84 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.979 -0.555 . . . . 71.02 110.472 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.81 147.2 95.94 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.675 2.25 . . . . 51.02 112.761 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 pt -129.37 160.24 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.472 0.653 . . . . 74.22 112.74 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 171' ' ' ALA . 88.5 t -127.1 134.61 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.554 -0.748 . . . . 74.2 110.302 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -97.48 96.79 8.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.79 0.328 . . . . 73.23 111.401 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -98.43 124.05 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.585 0.587 . . . . 73.54 112.585 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -95.28 106.36 18.39 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.264 -0.426 . . . . 71.42 111.179 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.7 mt -85.29 157.21 59.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.234 -0.439 . . . . 41.23 111.336 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.6 153.39 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.602 2.201 . . . . 75.23 113.011 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 31.6 m-80 68.93 55.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.763 0.425 . . . . 72.41 111.533 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt 51.08 23.1 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.56 1.144 . . . . 72.13 114.037 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.8 mm-40 -93.26 144.4 25.34 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.484 0.549 . . . . 44.34 112.484 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -138.69 142.95 38.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.776 0.322 . . . . 72.11 110.643 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.9 t -145.25 159.69 42.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.397 . . . . 71.24 111.707 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.35 120.25 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.282 -0.417 . . . . 72.41 110.969 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.53 152.57 55.58 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 116.377 -0.374 . . . . 54.42 111.336 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.09 127.73 11.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.44 2.094 . . . . 73.33 113.326 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -81.4 103.82 11.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.254 -0.43 . . . . 33.15 111.31 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -109.84 128.87 55.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.829 0.347 . . . . 74.35 111.599 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.23 110.56 4.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.125 0.488 . . . . 75.53 110.792 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.16 -6.42 15.07 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.347 -0.454 . . . . 71.12 112.274 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 214' ' ' ILE . 98.0 t -110.86 133.01 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.68 0.392 . . . . 75.25 110.64 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 80.8 p -87.02 156.0 19.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 71.35 111.739 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.7 t -50.18 -42.01 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.079 0.466 . . . . 64.33 111.405 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.588 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 23.0 ttt180 -63.62 -46.69 84.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.193 -0.458 . . . . 74.33 111.248 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.68 -31.46 72.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.843 0.354 . . . . 75.42 111.944 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.0 t -79.73 -44.29 21.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.89 0.376 . . . . 72.44 111.846 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.87 -15.26 45.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.193 0.812 . . . . 64.21 113.193 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.91 -45.22 41.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.993 0.425 . . . . 70.13 111.935 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -66.86 -39.51 87.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.324 -0.398 . . . . 71.41 111.969 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.12 93.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.151 0.5 . . . . 73.22 111.409 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.65 -52.33 21.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.083 -0.508 . . . . 71.41 111.459 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.4 tpt -50.03 -53.0 29.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.752 0.649 . . . . 55.44 112.752 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.9 ptp -62.98 -23.7 67.56 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.345 0.498 . . . . 61.03 112.345 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -101.61 0.24 35.98 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.067 0.395 . . . . 73.03 112.067 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 89.07 23.75 34.06 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.117 -0.563 . . . . 65.22 114.071 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.04 148.4 35.24 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.323 -0.516 . . . . 71.4 111.329 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.74 148.54 59.64 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.671 -0.24 . . . . 73.32 110.955 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 -39.0 88.68 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 122.81 2.34 . . . . 61.31 113.537 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -60.43 -24.92 65.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.927 0.394 . . . . 74.43 111.773 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 39.8 t -93.97 -2.26 53.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.787 0.327 . . . . 72.44 111.855 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 68.6 m -128.69 139.71 52.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 72.12 112.003 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -120.07 119.91 34.72 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.687 0.279 . . . . 71.22 111.373 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 224' ' ' VAL . 76.2 t -95.37 124.41 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.81 0.338 . . . . 71.3 111.486 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -136.23 155.46 50.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.425 0.631 . . . . 74.0 111.408 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 208' ' ' ILE . 10.2 ptm85 -109.66 133.04 53.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.845 -0.616 . . . . 71.53 111.42 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.4 mt -89.61 91.75 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.445 0.641 . . . . 70.23 109.978 173.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.52 123.93 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.573 -0.739 . . . . 71.24 111.382 -173.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 62.52 17.67 9.78 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.353 0.596 . . . . 61.43 110.86 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.28 -4.43 70.41 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.272 -0.422 . . . . 65.42 113.427 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -101.95 140.28 36.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.447 -0.443 . . . . 55.1 112.014 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.31 105.58 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.726 0.298 . . . . 75.52 110.814 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 123.07 38.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.818 -0.173 . . . . 74.23 111.308 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 143.36 55.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.563 2.176 . . . . 73.23 113.498 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 199' ' ' ARG . 57.3 mt -122.91 145.93 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.816 0.341 . . . . 71.3 110.875 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.57 143.38 16.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.077 -0.582 . . . . 74.01 112.808 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 95.6 m95 -61.34 -23.76 65.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 122.306 -0.526 . . . . 75.12 111.66 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -87.03 0.77 54.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.239 0.459 . . . . 74.21 112.239 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 85.7 m -75.89 142.48 42.09 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 51.44 111.194 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.54 140.4 57.98 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.987 0.422 . . . . 74.41 111.419 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 175' ' ' VAL . 14.7 tt -79.18 -23.21 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.584 0.587 . . . . 70.4 112.584 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 89.2 p -62.0 -21.89 65.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.867 0.365 . . . . 74.51 111.842 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.12 -23.62 66.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.976 0.417 . . . . 74.51 111.814 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 222' ' ' LEU . 21.9 mt -108.38 21.93 16.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.874 -0.603 . . . . 74.1 112.093 -169.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 79.4 m -65.16 118.12 8.75 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.834 0.679 . . . . 74.24 112.834 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.6 -26.04 25.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.144 0.417 . . . . 74.15 114.144 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -98.81 172.36 7.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.153 0.502 . . . . 75.24 111.787 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -109.95 137.57 47.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.336 0.865 . . . . 62.03 113.336 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 217' ' ' LEU . 63.0 mt -102.48 155.92 17.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.404 -0.816 . . . . 74.33 110.713 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -126.57 127.62 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.132 -0.355 . . . . 64.13 110.755 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 197' ' ' VAL . 54.5 t -107.23 125.01 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.188 0.44 . . . . 55.35 112.188 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -100.33 168.71 9.6 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.234 -0.439 . . . . 54.23 111.259 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.85 114.31 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.398 -0.364 . . . . 73.22 111.354 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.12 -63.05 1.49 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.219 0.533 . . . . 73.31 110.741 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.0 107.34 19.26 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.0 -0.546 . . . . 72.44 110.872 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -73.46 72.72 1.37 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.4 0.619 . . . . 74.25 110.137 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.08 100.07 9.76 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.72 -0.673 . . . . 60.1 111.27 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.21 98.88 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.048 1.832 . . . . 64.01 111.491 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.733 -0.651 . . . . 73.31 111.644 -174.059 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.687 0.28 . . . . 75.32 111.324 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 149' ' ' PRO . 89.7 mmm -104.01 115.72 62.78 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 73.11 110.612 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 148' ' ' MET . 21.3 Cg_exo -66.56 72.57 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.689 2.259 . . . . 62.3 112.748 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -82.78 134.37 35.12 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.081 -0.509 . . . . 75.23 111.456 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 t -151.02 87.24 4.7 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.311 -0.404 . . . . 73.32 111.242 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.61 87.99 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.693 2.262 . . . . 73.34 111.925 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -106.84 13.67 27.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.339 0.496 . . . . 71.11 112.339 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 157.49 82.09 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.307 -0.406 . . . . 61.3 110.838 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.41 137.2 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.067 1.845 . . . . 65.04 111.211 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 168' ' ' VAL . 2.8 pp -133.9 165.79 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.053 0.76 . . . . 52.4 113.053 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 171' ' ' ALA . 49.0 t -130.26 135.67 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.559 -0.746 . . . . 64.4 110.703 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.7 100.01 12.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.923 0.392 . . . . 71.13 111.329 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 181' ' ' LEU . 47.9 t -95.85 109.92 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.961 0.41 . . . . 70.14 111.658 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -80.8 117.98 21.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.931 0.396 . . . . 72.21 111.104 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.0 mt -93.72 157.68 37.84 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.124 -0.489 . . . . 63.35 110.707 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.581 ' HG3' HG23 ' A' ' 226' ' ' VAL . 29.9 Cg_endo -63.57 168.67 11.12 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.231 1.954 . . . . 72.31 112.986 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.38 33.59 18.72 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.168 0.432 . . . . 73.42 112.168 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 70.14 23.89 5.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.278 0.631 . . . . 71.41 112.434 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.6 mm-40 -99.62 163.56 12.44 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.04 -0.413 . . . . 74.12 111.443 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.42 159.47 31.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.036 0.446 . . . . 63.3 112.117 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -155.62 150.99 26.96 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.974 -0.557 . . . . 71.13 111.294 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 156' ' ' ILE . 39.0 t -117.8 119.41 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.761 0.315 . . . . 65.44 110.635 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 181' ' ' LEU . 29.7 m -116.0 150.36 44.94 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.144 0.424 . . . . 71.42 112.144 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 124.98 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.511 2.141 . . . . 62.15 113.606 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.76 103.78 8.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.172 0.51 . . . . 63.32 110.847 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -115.93 160.61 19.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.054 -0.521 . . . . 72.45 111.764 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.4 t -87.02 137.87 31.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 74.31 111.072 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.62 -11.74 18.19 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.145 -0.55 . . . . 60.32 113.722 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 214' ' ' ILE . 48.4 t -93.6 123.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 122.438 -0.448 . . . . 74.24 110.959 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 29.3 p -74.73 168.54 19.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.184 0.516 . . . . 74.33 111.899 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 212' ' ' THR . 60.7 t -61.64 -33.78 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.278 0.561 . . . . 74.42 110.231 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 8.7 ttm105 -66.18 -51.32 58.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.815 -0.629 . . . . 72.41 111.365 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.94 -21.14 65.99 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.241 0.46 . . . . 74.02 112.241 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.9 m -86.02 -48.88 8.26 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.838 0.31 . . . . 71.31 111.838 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 169' ' ' VAL . 78.3 mt -82.83 -2.27 54.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.717 0.636 . . . . 72.21 112.717 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -55.46 -25.81 38.7 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.977 0.417 . . . . 74.21 111.772 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.32 -48.85 11.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.957 0.408 . . . . 51.15 111.04 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -59.85 -44.52 94.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.117 -0.492 . . . . 51.32 111.973 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.428 HD11 ' CH2' ' A' ' 210' ' ' TRP . 90.9 mt -62.76 -46.57 87.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.861 0.362 . . . . 51.55 111.239 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.6 tpt -59.12 -46.86 87.25 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.287 -0.415 . . . . 61.13 111.647 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.6 ptm -67.75 -8.61 36.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.772 0.32 . . . . 62.42 111.849 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 22.3 mmm180 -112.11 2.52 16.79 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.131 -0.356 . . . . 73.12 111.249 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.5 11.76 82.56 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.569 -0.348 . . . . 54.22 113.821 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.0 176.21 6.88 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 61.12 111.846 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.552 HG13 ' HB3' ' A' ' 194' ' ' CYS . 17.6 pt -140.1 143.24 33.17 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.224 -0.444 . . . . 73.11 111.328 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.74 -49.68 15.0 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.956 2.437 . . . . 72.12 113.857 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.42 ' CD ' ' H ' ' A' ' 193' ' ' GLU . 1.3 pm0 -73.57 5.54 3.79 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.804 0.668 . . . . 74.44 112.804 -174.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.552 ' HB3' HG13 ' A' ' 191' ' ' ILE . 43.2 t -128.29 15.35 6.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.048 0.451 . . . . 65.44 111.349 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.49 137.1 50.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.848 0.356 . . . . 70.13 110.939 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.75 120.94 44.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.727 0.299 . . . . 53.31 111.747 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -98.88 139.13 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.496 -0.32 . . . . 75.41 110.614 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -146.89 153.35 40.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.38 0.61 . . . . 74.12 111.926 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.549 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.7 ptm180 -114.29 159.56 20.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.652 -0.703 . . . . 65.22 110.469 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.0 mt -101.91 95.57 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.277 0.56 . . . . 41.03 110.759 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -108.74 128.11 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.824 -0.625 . . . . 64.11 110.555 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 t70 64.71 20.17 12.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.463 0.649 . . . . 64.31 111.18 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.16 -20.09 52.19 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.333 -0.461 . . . . 45.01 113.557 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -108.36 162.2 14.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.112 0.482 . . . . 73.14 111.578 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -82.2 143.27 31.51 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.28 0.562 . . . . 52.22 111.912 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -139.89 120.58 9.33 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.89 -0.595 . . . . 64.03 111.207 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -65.76 144.2 76.82 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.698 2.266 . . . . 63.02 113.484 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 199' ' ' ARG . 66.4 mt -118.83 124.17 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.056 -0.52 . . . . 73.32 111.396 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.12 141.52 34.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.995 -0.622 . . . . 65.43 112.517 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.9 m95 -65.64 -16.08 63.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.389 0.595 . . . . 75.42 111.282 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.99 -16.37 61.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.842 -0.617 . . . . 75.54 111.762 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.2 m -69.47 136.96 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.226 -0.443 . . . . 73.44 111.509 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 4.7 m-20 -69.45 128.08 35.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 62.01 110.939 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.0 tp -59.07 -20.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.138 0.494 . . . . 54.21 111.522 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.8 p -59.84 -26.71 66.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.221 -0.445 . . . . 65.44 112.073 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -69.48 -21.56 63.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.858 0.361 . . . . 60.2 111.83 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 220' ' ' GLU . 46.5 mt -110.49 21.02 17.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.186 0.517 . . . . 70.44 111.393 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.8 m -58.8 121.32 10.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.897 0.703 . . . . 63.11 112.897 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.01 4.23 90.08 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.279 0.872 . . . . 71.34 115.279 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 217' ' ' LEU . 12.9 pt-20 -111.82 172.7 6.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.978 0.889 . . . . 64.31 111.71 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 4.2 mp0 -102.98 127.2 50.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.233 0.54 . . . . 64.41 111.572 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 159' ' ' VAL . 74.0 mt -103.67 159.62 15.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.986 -0.552 . . . . 40.54 111.148 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -128.75 127.12 41.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.652 0.263 . . . . 74.44 110.633 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 197' ' ' VAL . 46.8 t -117.84 146.78 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.283 0.563 . . . . 72.21 112.064 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.88 140.93 33.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.26 -0.427 . . . . 72.11 110.883 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 162' ' ' PRO . 61.8 t -82.9 132.45 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.047 0.451 . . . . 64.2 111.871 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 59.6 mt -77.92 -52.93 8.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.324 -0.398 . . . . 70.31 111.457 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' A' ' 230' ' ' VAL . 50.5 mt-10 -126.1 151.55 47.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.243 0.544 . . . . 73.41 111.655 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -88.42 28.44 1.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.438 -0.346 . . . . 64.35 111.703 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 228' ' ' GLU . 4.6 p -115.16 108.0 48.8 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 113.109 0.781 . . . . 52.44 113.109 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -90.29 -176.81 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.86 2.373 . . . . 61.51 111.905 169.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.2 pt? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.221 -0.895 . . . . 62.45 112.083 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.708 0.29 . . . . 75.14 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.6 ttt -74.38 122.1 86.75 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.606 -0.27 . . . . 72.01 110.445 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.63 85.8 0.29 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.339 2.026 . . . . 75.3 112.543 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.14 85.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.581 0.705 . . . . 73.14 110.973 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 48.9 p -130.37 141.84 43.32 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.409 -0.814 . . . . 74.13 110.876 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 26.6 Cg_exo -63.49 104.38 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.615 2.21 . . . . 63.25 113.38 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -83.41 122.17 28.14 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.939 -0.393 . . . . 72.13 109.939 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.14 153.23 36.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.825 0.676 . . . . 52.14 112.825 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.466 ' HB2' HG23 ' A' ' 218' ' ' THR . 21.9 Cg_endo -60.08 137.9 78.43 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.579 2.186 . . . . 64.54 111.722 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.91 158.16 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.847 0.684 . . . . 62.42 112.847 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.56 127.67 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.608 -0.724 . . . . 74.52 110.367 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 99.0 mtt180 -89.69 100.44 13.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.16 0.505 . . . . 71.44 111.37 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 181' ' ' LEU . 47.8 t -99.5 118.23 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.284 -0.416 . . . . 73.2 112.03 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.85 123.32 33.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.902 0.382 . . . . 70.44 110.536 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.3 mt -95.49 163.49 21.37 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.511 -0.313 . . . . 61.43 111.578 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.72 153.62 5.53 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.851 2.367 . . . . 64.12 113.994 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.89 42.37 10.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.757 -0.656 . . . . 54.25 111.532 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 63.47 9.25 4.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.066 0.765 . . . . 72.32 113.066 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -72.59 164.36 26.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.894 0.378 . . . . 75.42 110.814 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.428 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -156.43 151.7 26.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.857 -0.527 . . . . 75.51 112.093 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.0 t -156.19 171.21 20.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.945 -0.571 . . . . 74.52 111.137 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.87 120.34 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.844 0.355 . . . . 52.23 110.587 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 34.1 m -115.61 140.6 26.2 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.003 0.372 . . . . 61.43 112.003 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 19.6 Cg_exo -67.4 127.28 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.45 2.1 . . . . 75.52 112.682 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.74 103.21 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 42.45 110.831 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -100.38 128.05 46.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.976 -0.556 . . . . 72.43 111.807 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.24 123.19 21.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.446 -0.343 . . . . 52.42 111.121 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.46 -14.94 60.52 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.974 -0.631 . . . . 73.21 113.349 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.85 127.51 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.503 -0.41 . . . . 60.03 110.805 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.5 p -78.07 160.68 27.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.084 0.468 . . . . 74.32 111.541 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.06 -36.32 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.429 0.633 . . . . 71.34 110.163 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -60.29 -52.7 64.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.174 -0.921 . . . . 73.43 111.157 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.08 -34.8 78.45 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.102 -0.499 . . . . 71.43 112.123 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.4 t -72.85 -49.95 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.442 0.534 . . . . 71.54 112.442 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.604 HD21 HG21 ' A' ' 159' ' ' VAL . 78.7 mt -85.09 -16.52 40.32 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.474 0.916 . . . . 63.14 113.474 -173.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.71 -32.55 52.39 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.844 0.683 . . . . 74.23 112.844 -173.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.74 -39.21 67.05 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 75.53 111.404 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.2 70.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.193 0.521 . . . . 72.43 110.784 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.78 -49.38 25.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.836 -0.62 . . . . 72.51 111.02 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.3 tpt -53.24 -47.8 68.73 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.079 -0.509 . . . . 74.31 112.006 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 ptm -64.61 -9.14 17.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.291 0.478 . . . . 64.42 112.291 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -110.91 -6.17 14.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.598 0.237 . . . . 72.31 111.514 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.66 36.9 14.91 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.122 -0.561 . . . . 54.42 112.752 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.51 154.71 43.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.541 0.336 . . . . 62.32 111.394 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.62 149.57 67.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 122.362 0.265 . . . . 72.55 111.009 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.42 -37.02 60.53 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.936 2.424 . . . . 72.45 113.734 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -69.87 -18.45 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.35 0.5 . . . . 64.3 112.35 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.1 -10.33 20.56 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.499 0.555 . . . . 52.03 112.499 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.9 m -131.98 171.27 13.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.238 0.542 . . . . 71.35 112.244 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -133.08 141.26 48.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.003 -0.544 . . . . 53.35 111.549 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 224' ' ' VAL . 48.3 t -109.58 126.17 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.368 -0.378 . . . . 73.12 110.73 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -141.93 152.63 43.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.179 0.514 . . . . 73.21 111.936 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.59 160.13 16.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.88 -0.6 . . . . 72.04 110.578 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.5 mt -117.24 119.46 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.0 0.429 . . . . 74.41 111.469 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.06 149.69 29.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.14 -0.482 . . . . 73.22 109.872 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 62.93 16.46 9.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.78 0.324 . . . . 71.42 111.447 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.79 4.4 88.13 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.304 -0.474 . . . . 74.0 112.775 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -107.09 154.57 20.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.954 0.501 . . . . 71.33 111.986 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -94.82 126.19 39.98 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.88 0.371 . . . . 74.21 110.681 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.12 94.85 32.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.015 -0.365 . . . . 63.13 110.015 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.37 121.9 10.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.714 2.276 . . . . 75.2 112.443 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 58.8 mt -101.85 132.68 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.149 -0.478 . . . . 72.14 111.584 -175.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.73 126.09 26.56 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.77 -0.728 . . . . 71.01 112.358 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -51.63 -33.17 32.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.664 0.616 . . . . 73.4 112.664 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -85.74 21.37 1.89 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.426 0.528 . . . . 44.42 112.426 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 49.9 m -97.09 143.28 28.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 122.336 -0.228 . . . . 73.33 111.112 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.9 m-20 -58.2 128.27 36.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.126 0.489 . . . . 72.52 111.823 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 217' ' ' LEU . 9.3 tp -63.66 -21.2 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.98 0.419 . . . . 71.42 111.722 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.557 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 78.4 p -60.62 -26.09 66.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.216 0.45 . . . . 72.55 112.216 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.517 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 22.3 m95 -67.21 -21.53 65.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.359 . . . . 73.21 111.968 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.488 HD12 HD12 ' A' ' 214' ' ' ILE . 33.9 mt -103.83 22.07 15.16 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.138 0.494 . . . . 75.21 111.896 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 155' ' ' PRO . 77.4 m -53.71 124.71 15.95 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.893 0.701 . . . . 73.11 112.893 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.3 -5.87 66.04 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 114.401 0.521 . . . . 70.13 114.401 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.67 158.15 16.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.331 0.566 . . . . 54.12 111.742 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 51.8 mt-10 -100.69 117.84 35.62 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.143 -0.48 . . . . 70.45 110.809 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 159' ' ' VAL . 82.1 mt -93.01 148.16 22.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.056 0.455 . . . . 63.3 111.012 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -121.35 113.28 19.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 54.41 110.541 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 197' ' ' VAL . 43.5 t -108.46 130.76 60.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 71.34 111.22 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.92 157.68 45.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 61.24 111.435 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.95 130.0 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.044 -0.525 . . . . 55.0 111.453 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.45 -56.35 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.165 0.507 . . . . 64.3 110.433 176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.76 135.97 36.85 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.744 -0.662 . . . . 63.43 110.971 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -72.97 76.77 1.18 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 72.32 110.864 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.0 m -98.18 118.75 63.2 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.294 0.568 . . . . 54.14 112.483 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -92.74 113.56 0.28 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.018 2.479 . . . . 65.22 112.194 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.97 -0.538 . . . . 70.13 111.797 -178.863 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.8 m80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.609 0.242 . . . . 72.43 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.568 ' SD ' ' N ' ' A' ' 148' ' ' MET . 3.0 mpp? -92.34 111.84 52.42 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.995 0.369 . . . . 72.42 111.995 -173.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.29 105.27 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.344 2.029 . . . . 63.12 111.484 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -115.87 149.39 38.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.19 0.811 . . . . 63.14 113.19 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.3 t -133.6 82.62 50.73 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.578 -0.737 . . . . 70.44 109.751 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.21 126.24 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.68 2.253 . . . . 72.13 113.827 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -82.16 39.18 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.243 0.544 . . . . 72.24 111.223 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 154' ' ' LYS . 9.2 mmpt? -97.62 152.05 37.95 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.961 -0.563 . . . . 72.22 111.799 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.97 114.86 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.229 1.953 . . . . 65.31 110.95 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -114.65 160.7 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.102 0.778 . . . . 75.05 113.102 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.35 139.21 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.553 -0.749 . . . . 50.13 110.518 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 1.5 mpt_? -92.88 111.71 23.42 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.546 0.212 . . . . 73.42 110.543 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.23 122.33 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.35 0.5 . . . . 50.23 112.35 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.96 99.76 11.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.305 -0.407 . . . . 72.41 110.399 174.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.1 mt -65.97 144.0 98.65 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.654 -0.248 . . . . 64.33 111.27 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.23 143.52 52.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.552 2.168 . . . . 74.24 112.945 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.414 ' HB3' HH22 ' A' ' 188' ' ' ARG . 25.0 t-20 74.5 54.43 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.122 0.569 . . . . 73.52 111.534 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 67.59 22.02 9.25 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.938 1.088 . . . . 70.32 113.938 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 71.7 mm-40 -107.84 175.27 5.54 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.603 -0.686 . . . . 73.52 112.539 -175.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -146.98 152.68 39.02 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.159 0.504 . . . . 74.54 112.325 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.6 t -157.09 160.5 38.94 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.013 -0.539 . . . . 72.54 110.893 170.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.82 120.2 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.978 0.418 . . . . 75.03 110.722 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.05 141.13 37.62 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.305 -0.407 . . . . 72.41 111.909 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.4 Cg_endo -77.14 132.55 12.76 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.69 2.26 . . . . 51.2 113.487 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.78 128.85 37.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.194 0.521 . . . . 62.42 111.802 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -129.69 131.53 46.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.067 -0.515 . . . . 71.33 110.931 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -71.99 109.83 6.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 52.11 111.163 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.3 19.6 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.326 -0.464 . . . . 73.23 112.668 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 214' ' ' ILE . 96.0 t -117.72 125.84 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.939 0.399 . . . . 73.42 110.948 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 p -82.69 167.38 18.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 65.12 111.736 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.55 -36.63 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.304 0.574 . . . . 52.25 110.459 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 41.3 ttt180 -67.06 -57.68 6.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.735 -0.666 . . . . 74.44 111.187 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -28.22 58.72 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.116 0.413 . . . . 71.31 112.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 36.7 t -78.78 -47.42 16.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.896 0.379 . . . . 73.13 111.709 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.13 -1.53 54.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.157 0.799 . . . . 73.1 113.157 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.34 -41.47 76.14 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 72.42 112.136 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.24 -32.31 68.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.058 0.456 . . . . 70.13 111.09 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.55 91.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.035 0.445 . . . . 72.23 111.051 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -75.68 -38.69 58.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.155 -0.475 . . . . 74.11 110.848 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 24.7 ttt -54.67 -50.6 67.81 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.935 -0.575 . . . . 73.13 111.713 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -69.78 -4.29 19.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.52 0.563 . . . . 64.22 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 163' ' ' ASN . 70.4 mtp180 -118.28 2.42 11.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.055 0.391 . . . . 71.35 112.055 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.83 38.64 89.52 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 73.13 113.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.98 154.99 36.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.912 0.387 . . . . 75.42 111.685 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.83 146.54 46.18 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.366 -0.379 . . . . 74.21 111.396 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.6 -44.27 45.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.113 2.542 . . . . 72.31 114.141 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.01 -4.1 12.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.371 0.508 . . . . 75.12 112.371 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -100.5 -5.39 27.04 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.928 0.394 . . . . 73.11 111.425 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.36 144.12 42.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.108 0.48 . . . . 74.42 111.993 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.575 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -112.22 137.44 50.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.779 0.323 . . . . 51.12 111.483 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 224' ' ' VAL . 47.4 t -102.48 140.09 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.276 -0.42 . . . . 64.33 110.26 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -157.77 158.47 35.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.254 0.55 . . . . 62.21 112.023 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.846 HH11 ' HG3' ' A' ' 220' ' ' GLU . 79.1 mtm180 -110.41 139.46 45.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.141 -0.481 . . . . 65.23 111.239 175.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.95 96.41 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.299 0.571 . . . . 62.24 110.111 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.9 tm0? -103.75 107.54 18.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 74.31 110.097 -178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.0 20.05 7.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.298 0.571 . . . . 74.21 111.567 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.62 38.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.474 -0.393 . . . . 41.01 113.257 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.18 117.34 23.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.944 0.35 . . . . 63.44 111.944 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -80.72 109.34 15.17 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.546 0.212 . . . . 72.12 111.222 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -102.9 106.82 52.43 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.599 0.238 . . . . 72.13 111.195 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.51 116.53 4.28 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.873 2.382 . . . . 73.52 113.036 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.453 HD11 ' HG3' ' A' ' 199' ' ' ARG . 64.1 mt -101.06 133.26 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.236 0.541 . . . . 73.05 111.908 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.7 143.3 28.92 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.199 -0.524 . . . . 61.23 112.888 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 96.4 m95 -60.4 -21.89 62.72 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.352 0.576 . . . . 73.54 111.011 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.05 -5.16 50.54 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.987 -0.551 . . . . 75.41 112.204 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 177' ' ' VAL . 40.8 m -74.25 136.76 42.7 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.551 0.215 . . . . 74.13 111.353 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 18.1 t70 -72.09 129.24 38.03 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.04 0.448 . . . . 75.52 110.88 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.5 tt -66.02 -22.63 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.731 0.641 . . . . 71.31 112.731 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.544 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 41.2 t -63.39 -21.05 66.05 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.821 -0.549 . . . . 60.32 111.425 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 16.8 m95 -80.18 -10.65 59.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.013 0.435 . . . . 72.11 111.356 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 222' ' ' LEU . 49.6 mt -111.42 15.04 21.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.227 -0.442 . . . . 65.43 111.571 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.3 m -56.29 126.32 25.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.355 0.502 . . . . 74.24 112.355 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.29 10.14 84.06 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.299 -0.477 . . . . 73.02 114.087 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . 0.846 ' HG3' HH11 ' A' ' 199' ' ' ARG . 36.5 mm-40 -107.37 171.89 7.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.126 0.489 . . . . 61.23 111.53 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.1 mp0 -111.01 121.01 44.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.192 -0.458 . . . . 71.33 110.866 172.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 217' ' ' LEU . 80.2 mt -94.01 117.65 30.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.916 0.388 . . . . 60.31 111.197 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -94.41 118.74 32.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.612 -0.267 . . . . 65.32 110.484 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 197' ' ' VAL . 21.7 t -110.15 139.93 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.13 0.491 . . . . 72.21 111.158 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.98 170.45 15.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.454 -0.339 . . . . 65.41 111.369 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.29 127.04 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.862 0.363 . . . . 73.21 111.644 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 196' ' ' ALA . 86.4 mt -66.44 -45.24 80.49 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.228 -0.442 . . . . 75.13 111.99 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' ' 230' ' ' VAL . 16.2 pt-20 -80.33 170.08 16.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.287 0.565 . . . . 73.14 111.887 -177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -81.29 9.69 6.68 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.68 0.622 . . . . 73.5 112.68 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.492 ' H ' ' HG3' ' A' ' 228' ' ' GLU . 57.5 t -127.83 91.6 44.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.043 0.386 . . . . 74.24 112.043 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.17 115.64 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.258 2.639 . . . . 70.35 112.199 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.252 1.22 0 N-CA-C 112.064 0.394 . . . . 73.54 112.064 -178.092 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.726 0.298 . . . . 73.2 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mtt -130.12 150.67 76.71 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 122.432 0.293 . . . . 74.51 110.946 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.74 154.27 68.0 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.577 2.185 . . . . 72.51 113.529 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.53 152.95 27.04 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 74.22 111.815 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 79.3 p 47.52 87.45 0.12 Allowed Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.15 0.796 . . . . 74.33 113.15 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.44 97.99 0.63 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.686 2.257 . . . . 73.35 112.9 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -91.4 4.74 51.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.011 0.434 . . . . 72.43 111.187 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -67.94 132.22 92.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.996 -0.547 . . . . 55.43 111.396 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.42 135.86 44.43 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.347 2.031 . . . . 75.22 111.738 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.8 pt -123.62 161.11 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 71.45 113.051 -173.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.12 131.92 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.8 -0.636 . . . . 74.1 110.459 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 158' ' ' ARG . 64.0 mtt85 -100.96 105.14 16.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.941 0.4 . . . . 73.45 111.632 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.615 HG22 HD12 ' A' ' 222' ' ' LEU . 60.0 t -99.6 119.08 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.575 -0.284 . . . . 72.33 111.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -92.13 113.51 25.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.351 0.596 . . . . 65.12 111.888 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.5 mt -91.14 169.15 12.09 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 115.435 -0.802 . . . . 74.11 111.04 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 52.5 Cg_exo -55.26 165.29 3.14 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.427 2.085 . . . . 74.32 113.479 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.83 28.76 18.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.776 0.43 . . . . 73.44 111.954 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp 63.29 22.96 13.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.987 0.515 . . . . 75.23 112.087 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 80.3 mm-40 -82.81 168.33 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.847 0.356 . . . . 73.23 111.048 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -156.43 161.75 40.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 71.33 112.124 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.6 t -150.41 151.08 32.24 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.655 -0.702 . . . . 74.34 110.525 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.52 119.61 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.988 0.423 . . . . 73.33 111.443 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 27.1 m -120.38 144.51 38.38 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.318 -0.401 . . . . 61.11 111.449 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.8 Cg_exo -65.56 132.66 31.71 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.645 2.23 . . . . 73.03 112.992 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -73.97 117.65 16.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 75.42 111.604 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -130.37 143.55 50.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.283 -0.417 . . . . 72.34 111.194 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.41 140.99 37.24 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.636 0.255 . . . . 74.23 110.642 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.08 -25.29 10.35 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.116 -0.564 . . . . 50.13 112.314 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.91 117.54 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.926 0.394 . . . . 73.13 110.899 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 39.5 p -80.15 156.91 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.484 -0.325 . . . . 75.43 111.254 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.75 -31.7 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.552 0.692 . . . . 65.03 110.756 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.621 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.4 ttp85 -70.18 -35.23 73.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.448 -0.796 . . . . 74.23 111.59 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.27 -43.33 21.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.196 -0.456 . . . . 62.21 111.903 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -61.14 -49.81 75.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.129 0.49 . . . . 71.34 111.978 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.71 14.43 2.13 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.972 0.73 . . . . 73.02 112.972 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 183' ' ' LYS . 9.5 ptpp? -53.12 -48.3 67.96 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.286 0.476 . . . . 73.41 112.286 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 65.6 pttt -79.05 -29.75 43.66 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.05 -0.406 . . . . 64.24 111.311 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.29 88.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.142 0.496 . . . . 52.1 111.434 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -46.34 70.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.103 0.477 . . . . 74.11 110.689 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 41.2 ttm -50.93 -51.5 51.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.731 -0.668 . . . . 71.34 112.156 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.41 -19.91 65.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.298 0.481 . . . . 74.02 112.298 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -98.91 -4.47 32.8 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.821 0.344 . . . . 62.42 111.421 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 25.81 63.81 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.184 -0.531 . . . . 54.34 113.006 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.2 mt -113.89 153.97 28.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.447 . . . . 71.43 111.486 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.0 pt -128.69 156.89 76.76 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 116.305 -0.407 . . . . 70.41 110.318 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.78 -42.87 62.84 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.507 2.138 . . . . 62.53 113.159 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.65 -7.62 28.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.16 0.43 . . . . 60.44 112.16 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 -2.45 17.22 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.803 0.297 . . . . 63.31 111.803 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.08 162.53 34.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.08 0.467 . . . . 71.23 111.778 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.19 139.98 48.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.927 0.394 . . . . 54.11 111.586 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 224' ' ' VAL . 54.1 t -107.95 135.19 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.177 -0.465 . . . . 42.44 111.024 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.62 158.2 43.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.982 0.42 . . . . 73.32 111.148 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -127.58 149.1 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.89 0.376 . . . . 61.23 110.883 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.85 95.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.546 0.689 . . . . 63.01 110.206 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.46 109.14 20.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.554 -0.748 . . . . 64.12 111.259 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.8 t70 60.78 26.54 16.36 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.475 0.655 . . . . 73.31 111.006 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.55 -13.25 59.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.166 -0.47 . . . . 35.53 113.441 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 125.18 35.9 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.107 0.41 . . . . 53.23 112.107 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.02 93.92 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.147 0.498 . . . . 73.34 109.8 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -99.7 115.57 65.5 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.184 -0.462 . . . . 75.3 111.725 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.55 127.18 20.07 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.692 2.261 . . . . 64.01 112.806 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -102.34 120.47 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.117 -0.492 . . . . 70.42 110.872 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.81 135.09 46.78 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.889 -0.672 . . . . 62.31 113.197 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 83.3 m95 -55.72 -32.81 63.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.523 0.564 . . . . 72.45 112.523 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.62 11.75 8.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.852 0.686 . . . . 75.42 112.852 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.3 m -79.85 141.91 35.73 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.158 -0.339 . . . . 65.03 110.862 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 118.29 5.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.895 0.378 . . . . 65.22 111.145 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.34 -22.3 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.09 0.471 . . . . 64.04 111.845 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.488 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 23.3 t -61.28 -23.89 66.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.159 0.429 . . . . 64.32 112.159 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -66.51 -22.46 66.18 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.062 0.458 . . . . 64.45 111.388 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.0 mt -108.02 30.11 6.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.201 0.524 . . . . 74.14 111.707 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 93.9 m -62.65 116.65 5.36 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.711 0.634 . . . . 71.23 112.711 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 85.01 8.91 81.59 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.99 0.756 . . . . 64.01 114.99 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 167.34 10.96 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.73 0.765 . . . . 71.34 112.126 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -102.47 120.89 41.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.794 -0.639 . . . . 75.15 111.717 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 159' ' ' VAL . 68.4 mt -94.03 143.77 26.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.082 -0.508 . . . . 74.22 111.45 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -109.03 109.47 20.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.735 0.303 . . . . 74.31 110.203 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 197' ' ' VAL . 61.6 t -107.77 148.86 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.077 0.465 . . . . 73.3 111.517 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.21 160.24 42.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.968 0.413 . . . . 73.31 111.049 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.29 132.25 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.8 0.333 . . . . 61.52 111.771 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 196' ' ' ALA . 94.8 mt -68.34 -44.57 75.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.121 0.486 . . . . 72.13 110.335 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -69.33 110.81 4.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.944 -0.571 . . . . 72.22 110.588 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -74.8 64.59 1.28 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.246 0.546 . . . . 71.22 111.791 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.18 110.12 9.85 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.159 -0.473 . . . . 71.31 110.839 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.53 -176.9 2.7 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.646 2.231 . . . . 73.33 112.606 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 232' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.707 -0.663 . . . . 72.33 110.624 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.606 0.241 . . . . 72.02 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 84.4 mtp 60.77 84.94 0.19 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 122.869 0.468 . . . . 73.11 112.199 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.27 113.32 3.42 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.722 2.281 . . . . 73.21 112.479 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.548 ' O ' ' HD2' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -68.46 145.47 54.04 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.789 0.328 . . . . 74.41 111.582 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 77.6 p -172.48 108.15 0.35 Allowed Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 120.763 0.316 . . . . 73.43 111.747 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.59 111.89 3.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.601 2.201 . . . . 73.44 112.195 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -89.36 2.27 54.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 64.23 111.247 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -77.08 150.87 81.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.168 -0.469 . . . . 72.21 111.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.43 142.72 99.43 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.684 2.256 . . . . 72.1 112.378 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 2.9 pp -123.05 161.73 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.538 0.685 . . . . 63.14 112.814 -175.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.43 141.21 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 115.73 -0.668 . . . . 75.41 110.919 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.28 106.5 18.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.644 0.259 . . . . 70.55 111.132 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 181' ' ' LEU . 55.6 t -109.19 124.45 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.123 0.487 . . . . 73.21 112.12 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.462 ' HD1' ' HG3' ' A' ' 166' ' ' ARG . 20.6 m-85 -99.78 113.74 26.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.187 -0.46 . . . . 74.05 110.961 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 86.3 mt -90.9 160.87 37.13 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.037 -0.529 . . . . 65.03 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 29.6 Cg_endo -61.88 167.26 10.68 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.929 2.419 . . . . 75.03 113.672 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.19 29.7 18.9 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.353 0.597 . . . . 64.44 111.341 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 60.37 59.03 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.354 -0.839 . . . . 72.24 111.718 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.1 mm-40 -118.91 143.61 46.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.889 -0.596 . . . . 44.52 110.455 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' HD1' ' A' ' 160' ' ' PHE . 3.4 mpt_? -126.19 147.18 49.7 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.952 -0.468 . . . . 73.32 111.698 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.49 161.74 40.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.046 -0.525 . . . . 64.31 111.357 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 156' ' ' ILE . 61.9 t -126.89 120.14 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.837 0.351 . . . . 64.42 111.197 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -111.44 153.76 44.03 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 116.396 -0.365 . . . . 54.31 111.764 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.14 151.6 30.47 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.543 2.162 . . . . 55.45 113.532 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -105.09 112.49 25.64 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.068 -0.514 . . . . 75.44 111.882 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -126.34 148.28 49.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.522 0.329 . . . . 73.14 111.046 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.12 135.64 37.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.712 0.292 . . . . 74.2 110.921 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.12 -30.57 7.94 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.142 -0.552 . . . . 75.13 112.277 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.8 t -80.89 109.72 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.108 0.48 . . . . 63.23 110.346 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 36.9 p -76.36 163.31 27.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.272 -0.422 . . . . 61.4 111.324 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 212' ' ' THR . 60.8 t -54.02 -37.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.288 0.566 . . . . 75.01 110.23 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 3.4 tmt_? -65.64 -39.34 91.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.492 -0.776 . . . . 72.33 111.187 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 31.8 t70 -79.34 -29.07 42.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.935 0.346 . . . . 75.24 111.935 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -78.56 -55.74 4.97 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.093 0.473 . . . . 71.44 111.496 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 159' ' ' VAL . 62.4 mt -72.48 -3.56 25.09 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.797 0.665 . . . . 64.0 112.797 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 24.6 pttm -61.75 -20.65 63.77 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.026 -0.421 . . . . 75.34 110.747 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.08 -53.46 6.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.025 0.44 . . . . 75.45 110.877 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.28 70.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.055 -0.52 . . . . 50.45 111.869 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -81.79 -26.21 34.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.56 -0.291 . . . . 75.22 111.58 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.0 tpt -64.39 -41.76 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.818 0.342 . . . . 65.2 111.013 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.46 -21.3 64.64 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.013 0.435 . . . . 71.54 110.948 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -83.75 -21.16 32.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.31 -0.405 . . . . 62.23 110.808 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.61 29.61 26.39 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.41 -0.424 . . . . 55.21 113.064 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 84.4 mt -131.31 164.93 24.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.17 0.51 . . . . 75.42 111.829 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.36 143.16 26.63 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.125 -0.489 . . . . 75.32 111.159 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 178' ' ' ARG . 53.8 Cg_exo -52.42 -42.96 57.82 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 53.12 113.978 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.6 pm0 -70.29 -0.78 8.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.375 0.509 . . . . 72.43 112.375 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 52.9 t -107.15 9.83 30.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.964 0.412 . . . . 63.4 111.024 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 62.0 m -131.38 172.16 12.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.223 -0.444 . . . . 44.55 111.215 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -136.98 126.93 25.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.804 0.335 . . . . 70.31 111.638 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -99.08 125.22 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.328 -0.396 . . . . 73.42 110.805 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 55.2 p90 -136.28 146.52 46.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.525 0.678 . . . . 74.3 111.365 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.5 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.533 -0.758 . . . . 74.44 110.24 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -77.72 87.61 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.875 0.845 . . . . 63.01 109.944 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -115.66 136.73 52.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.111 -0.949 . . . . 65.34 111.105 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.19 26.24 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.285 0.564 . . . . 63.44 112.327 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.2 58.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.153 -0.546 . . . . 61.21 114.402 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.71 151.93 47.57 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.416 0.608 . . . . 72.04 111.877 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 53.6 mtpt -77.73 94.65 4.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.661 -0.496 . . . . 72.22 109.661 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.25 114.07 64.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 120.626 0.251 . . . . 73.41 111.439 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.64 155.36 43.0 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.891 2.394 . . . . 45.1 113.762 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 199' ' ' ARG . 60.9 mt -127.28 133.45 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.788 -0.642 . . . . 71.4 110.588 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.59 132.98 23.0 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.86 -0.686 . . . . 71.55 112.816 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 82.4 m95 -62.31 -22.37 65.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.269 0.47 . . . . 53.33 112.269 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.55 -11.76 59.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.962 0.356 . . . . 64.04 111.962 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 m -66.54 134.26 52.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.685 0.279 . . . . 74.15 111.501 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 2.3 m-20 -58.94 130.58 47.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.821 0.343 . . . . 74.34 111.141 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.12 -21.58 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.193 0.521 . . . . 35.05 111.373 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' SER . . . . . 0.453 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 98.9 p -61.16 -26.07 67.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.064 -0.516 . . . . 65.21 111.847 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.461 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.6 m95 -66.58 -24.72 66.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.154 0.502 . . . . 65.42 111.815 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.87 21.42 17.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.021 -0.536 . . . . 74.33 111.511 -173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.7 m -56.86 112.24 1.26 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.798 0.666 . . . . 71.33 112.798 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.49 75.32 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 115.093 0.797 . . . . 33.21 115.093 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.44 172.21 7.15 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.145 0.972 . . . . 52.43 111.737 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . 19.0 mp0 -96.28 134.25 39.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.095 -0.502 . . . . 75.23 111.565 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.46 144.67 45.82 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.499 -0.319 . . . . 54.22 110.815 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -115.34 116.3 28.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.688 0.28 . . . . 63.22 110.381 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 197' ' ' VAL . 51.0 t -115.31 127.16 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.866 0.365 . . . . 73.23 111.391 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.96 161.08 29.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.993 0.425 . . . . 70.01 111.427 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 162' ' ' PRO . 16.7 t -90.5 138.32 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 61.22 111.583 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.04 -63.98 1.22 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.977 0.418 . . . . 61.44 111.389 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -106.8 168.27 9.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.161 0.505 . . . . 74.21 111.519 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -100.06 91.06 4.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.983 0.42 . . . . 64.01 111.099 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 230' ' ' VAL . 5.9 p -147.8 87.94 5.74 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 121.481 0.658 . . . . 73.54 111.674 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.37 162.01 4.53 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.011 2.474 . . . . 74.11 113.365 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.431 HD22 ' N ' ' A' ' 232' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.256 1.419 0 CA-C-O 118.734 -0.65 . . . . 64.35 111.651 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.3 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.815 0.341 . . . . 75.32 111.561 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.6 mmm -98.84 149.84 36.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.57 -0.286 . . . . 74.2 110.842 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.68 125.71 19.49 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.659 2.239 . . . . 73.32 113.369 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 150' ' ' LYS . 17.1 ptpt -114.95 150.82 35.13 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.038 0.447 . . . . 72.54 111.937 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.5 m -77.89 134.89 63.87 Favored Pre-proline 0 N--CA 1.473 0.698 0 CA-C-N 116.057 -0.519 . . . . 62.42 111.965 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.18 117.35 4.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.675 2.25 . . . . 73.41 112.716 176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -113.59 -23.93 9.5 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.522 0.564 . . . . 73.22 112.522 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -66.98 150.96 97.61 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 112.372 0.508 . . . . 74.31 112.372 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.08 145.85 97.47 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.321 2.68 . . . . 53.33 114.55 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.41 168.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.927 -0.579 . . . . 74.02 112.268 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 171' ' ' ALA . 63.4 t -133.05 140.3 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.142 -0.481 . . . . 44.35 110.289 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -104.23 102.17 11.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.801 0.334 . . . . 72.25 111.642 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 181' ' ' LEU . 43.9 t -103.01 141.71 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.999 0.428 . . . . 74.32 111.634 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -113.3 113.43 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.056 0.455 . . . . 73.41 111.219 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 90.8 mt -85.74 160.76 52.42 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.866 -0.606 . . . . 74.53 111.039 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 25.3 Cg_endo -61.67 169.05 7.49 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.112 1.875 . . . . 74.24 112.496 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.38 32.09 16.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.12 0.415 . . . . 62.04 112.12 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.7 22.94 7.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.124 0.787 . . . . 70.2 113.124 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -99.69 163.9 12.28 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.886 0.374 . . . . 64.32 111.595 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -154.9 165.0 38.06 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.006 -0.434 . . . . 74.01 111.924 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.8 t -156.01 155.71 33.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.89 0.376 . . . . 64.32 111.33 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 62.2 t -122.92 120.12 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.765 0.317 . . . . 75.34 110.97 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.7 147.89 38.61 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.084 0.402 . . . . 64.53 112.084 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.02 127.9 15.88 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.371 2.047 . . . . 71.51 112.91 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.538 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -85.78 118.71 25.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.003 0.43 . . . . 75.1 112.046 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -136.71 157.07 47.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.195 0.521 . . . . 60.24 111.898 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 50.5 t -81.55 144.49 31.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.164 -0.471 . . . . 74.41 110.549 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.94 -12.47 61.84 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.997 -0.621 . . . . 44.44 112.527 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.66 116.82 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.574 -0.368 . . . . 73.24 110.171 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 p -81.41 161.34 23.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 62.35 111.64 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.48 -31.63 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.152 0.501 . . . . 71.43 110.714 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 46.9 ttp85 -72.97 -56.53 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.118 -0.492 . . . . 60.12 110.864 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.7 m-20 -61.38 -26.17 67.66 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.958 0.409 . . . . 75.41 111.742 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.5 t -77.73 -61.8 1.87 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.208 -0.451 . . . . 75.32 111.149 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 159' ' ' VAL . 66.1 mt -71.89 -21.65 61.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.298 0.851 . . . . 71.54 113.298 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 20.7 pttp -64.6 -12.22 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.661 0.664 . . . . 52.21 111.359 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -79.07 -49.01 13.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.028 0.442 . . . . 72.52 110.143 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.101 -0.499 . . . . 74.44 111.31 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.05 -39.35 79.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.375 -0.375 . . . . 74.52 111.044 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 28.1 ttt -58.19 -47.73 82.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.856 0.36 . . . . 60.55 111.513 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.5 ptm -70.84 -8.11 50.27 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.861 0.362 . . . . 71.24 111.694 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 3.5 mmp_? -106.65 -15.63 14.72 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.901 0.334 . . . . 73.35 111.901 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.55 40.35 9.94 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.186 -0.53 . . . . 70.51 112.891 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.87 168.62 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.717 0.407 . . . . 72.01 111.073 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.484 HD13 HD11 ' A' ' 232' ' ' LEU . 22.5 pt -132.52 149.37 72.88 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.54 -0.3 . . . . 73.12 111.406 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.86 -48.65 13.83 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.269 2.646 . . . . 74.34 114.113 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.33 4.75 3.4 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.681 0.623 . . . . 73.13 112.681 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.94 -8.15 18.81 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.862 0.363 . . . . 43.15 111.321 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.402 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 70.8 m -130.85 166.57 20.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.14 0.422 . . . . 74.02 112.14 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.49 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -135.89 121.3 19.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.431 -0.35 . . . . 75.14 111.809 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 224' ' ' VAL . 57.2 t -95.04 121.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.905 0.383 . . . . 72.04 111.558 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.646 ' CE1' ' HG3' ' A' ' 225' ' ' GLU . 27.7 p90 -138.84 142.29 38.65 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.211 0.529 . . . . 73.35 111.533 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 199' ' ' ARG . 1.3 ptm180 -110.72 124.43 51.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.884 -0.598 . . . . 71.0 110.001 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.12 107.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 71.32 111.668 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -135.19 135.93 41.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.1 -0.5 . . . . 61.54 110.202 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.36 27.46 16.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.23 0.538 . . . . 73.03 110.908 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.14 68.88 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.879 -0.6 . . . . 25.11 113.149 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -95.75 126.22 40.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.815 0.446 . . . . 73.13 112.167 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 97.5 mttt -76.98 98.82 5.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.668 0.27 . . . . 63.24 110.369 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -90.1 107.29 18.49 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.675 -0.238 . . . . 62.12 111.219 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 3.2 Cg_exo -75.31 129.1 11.77 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.776 2.317 . . . . 65.32 111.95 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.613 HG21 HD11 ' A' ' 217' ' ' LEU . 3.9 mp -98.89 122.39 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.74 -0.209 . . . . 63.4 110.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.51 126.7 38.02 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.714 -0.755 . . . . 54.34 111.782 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 69.4 m95 -55.06 -33.49 62.76 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.686 0.624 . . . . 73.21 112.686 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.47 17.68 3.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.897 0.703 . . . . 74.34 112.897 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.4 m -88.8 140.03 29.86 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.231 -0.293 . . . . 62.31 110.663 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 5.9 m-20 -57.58 125.68 23.98 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.077 0.399 . . . . 74.33 112.077 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.436 HG13 HG21 ' A' ' 157' ' ' VAL . 10.9 tp -59.45 -21.83 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.407 0.622 . . . . 74.25 110.965 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -55.34 -27.88 50.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.57 -0.741 . . . . 44.24 112.092 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -77.44 -7.02 55.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 111.859 0.318 . . . . 73.31 111.859 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.613 HD11 HG21 ' A' ' 208' ' ' ILE . 36.8 mt -122.15 22.34 10.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.283 0.563 . . . . 71.03 110.892 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 85.4 m -62.03 127.28 30.63 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.135 0.791 . . . . 62.32 113.135 -174.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.63 11.8 84.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.393 0.917 . . . . 74.42 115.393 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -126.83 173.26 9.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.244 1.022 . . . . 74.41 112.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.25 126.74 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.678 -0.692 . . . . 64.03 112.332 -172.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.12 141.5 44.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 73.11 109.911 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -120.33 142.57 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.088 -0.382 . . . . 73.32 110.516 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 70.7 t -118.09 126.43 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.051 0.76 . . . . 71.35 113.051 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.646 ' HG3' ' CE1' ' A' ' 198' ' ' TYR . 34.2 mt-10 -101.28 164.75 11.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.133 -0.485 . . . . 72.2 110.886 171.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.26 119.88 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.819 0.342 . . . . 53.54 111.48 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 196' ' ' ALA . 84.1 mt -68.35 -63.66 1.02 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.029 0.442 . . . . 53.4 110.639 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -138.12 145.76 42.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.002 -0.545 . . . . 73.14 110.071 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.44 80.01 3.16 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.347 0.594 . . . . 62.33 112.03 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.93 88.66 53.87 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 120.96 0.409 . . . . 72.42 111.767 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -93.18 101.23 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.906 2.404 . . . . 74.24 112.194 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.484 HD11 HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.283 -0.865 . . . . 75.4 112.368 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.0 m80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.317 0.58 . . . . 71.45 111.818 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.04 149.01 17.46 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.391 -0.822 . . . . 53.22 109.811 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.86 116.71 3.72 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.192 1.928 . . . . 73.44 113.152 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -76.8 20.04 0.26 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.979 0.363 . . . . 73.42 111.979 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t 72.83 86.74 0.1 Allowed Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.432 0.693 . . . . 74.42 112.204 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 58.01 6.59 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.948 2.432 . . . . 73.52 112.455 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLN . . . . . 0.402 ' O ' ' HG2' ' A' ' 153' ' ' GLN . 59.5 tt0 62.78 22.8 13.6 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.434 0.635 . . . . 64.35 111.006 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -63.38 143.04 97.87 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.103 -0.498 . . . . 75.43 111.715 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.41 147.08 86.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.538 2.158 . . . . 71.24 112.294 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.01 166.04 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.232 0.827 . . . . 62.31 113.232 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.69 128.12 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.821 -1.081 . . . . 63.52 109.334 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 83.8 mtt180 -91.45 97.29 10.98 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.987 0.422 . . . . 62.42 111.488 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 222' ' ' LEU . 44.7 t -95.69 112.55 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.17 0.434 . . . . 75.31 112.17 -176.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.6 119.6 23.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.022 0.439 . . . . 71.41 110.945 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 93.1 mt -95.99 159.44 32.26 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.213 -0.449 . . . . 65.3 111.304 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 225' ' ' GLU . 70.8 Cg_exo -52.27 162.87 1.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.537 2.158 . . . . 74.34 113.068 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.0 t30 65.96 28.97 10.44 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.162 0.506 . . . . 73.3 110.961 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 65.64 19.45 11.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.58 0.585 . . . . 73.11 112.58 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.3 mm-40 -84.04 171.87 12.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.087 0.47 . . . . 63.51 111.606 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 166' ' ' ARG . 22.2 ptt-85 -160.34 140.56 11.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.015 0.436 . . . . 72.31 111.845 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -139.53 141.54 37.27 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.027 0.442 . . . . 75.35 111.209 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.94 119.23 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.026 0.441 . . . . 75.41 110.887 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.83 149.08 47.84 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.446 -0.343 . . . . 73.22 111.582 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.17 144.84 82.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.413 2.076 . . . . 63.31 113.18 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.06 15.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.198 0.523 . . . . 74.02 111.314 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.447 ' H ' HG23 ' A' ' 214' ' ' ILE . 59.6 mtt180 -115.63 136.46 53.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.273 0.558 . . . . 53.32 112.421 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 37.2 t -99.94 133.64 44.01 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.832 -0.622 . . . . 72.14 110.518 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.18 -21.32 31.95 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.683 -0.77 . . . . 40.45 112.327 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.45 125.09 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 61.15 110.384 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 44.3 p -72.95 156.13 39.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 74.14 111.492 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.73 -36.03 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.396 0.617 . . . . 74.22 110.535 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.649 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 42.9 ttt180 -60.39 -59.59 5.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.388 -0.824 . . . . 73.1 111.905 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.78 -18.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.081 0.467 . . . . 71.13 111.398 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.2 t -82.13 -37.33 26.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.872 0.367 . . . . 63.34 111.51 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.9 mt -97.21 2.34 50.81 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.209 0.448 . . . . 75.23 112.209 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -52.55 -33.24 44.72 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.26 0.467 . . . . 75.32 112.26 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.493 ' NZ ' ' HB3' ' A' ' 183' ' ' LYS . 6.9 mtpm? -79.36 -37.83 36.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.794 0.33 . . . . 74.22 111.289 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -62.96 -46.23 88.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.14 0.495 . . . . 42.52 111.086 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.7 -44.49 96.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.189 -0.46 . . . . 63.42 110.694 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.8 ttt -53.08 -53.36 51.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.909 -0.587 . . . . 71.22 111.88 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.0 ptp -68.69 -14.14 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.474 0.546 . . . . 74.01 112.474 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 32.5 mmt180 -100.5 -8.22 23.34 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.224 -0.298 . . . . 75.23 111.671 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 79.33 18.1 74.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.213 -0.517 . . . . 64.31 112.855 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -101.74 156.8 17.28 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.085 0.469 . . . . 71.52 111.553 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 pt -127.23 138.29 32.44 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.148 -0.478 . . . . 74.31 110.73 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.08 -39.71 84.52 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.944 2.429 . . . . 70.44 113.56 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.03 -19.53 66.04 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.821 0.343 . . . . 73.13 111.888 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 228' ' ' GLU . 42.3 t -111.7 20.29 17.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.092 0.472 . . . . 71.35 111.387 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.3 m -137.49 137.26 38.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.061 0.458 . . . . 71.05 111.252 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.54 123.67 50.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.389 -0.368 . . . . 54.42 111.65 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 224' ' ' VAL . 43.1 t -99.95 138.19 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.452 -0.34 . . . . 75.5 110.852 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -146.44 151.3 37.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 75.33 110.967 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 208' ' ' ILE . 16.8 ptt-85 -120.01 152.58 37.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 72.33 110.681 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.548 HG12 ' HG2' ' A' ' 205' ' ' LYS . 37.6 mt -106.35 86.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.394 0.616 . . . . 74.1 110.11 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -104.97 120.47 41.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.654 -0.703 . . . . 60.43 110.38 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 59.34 30.89 20.67 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.081 0.467 . . . . 60.02 111.701 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.72 -9.24 77.87 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.327 -0.397 . . . . 51.41 113.628 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 206' ' ' LYS . 37.9 mm-40 -95.26 125.4 39.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.358 0.503 . . . . 73.35 112.358 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.548 ' HG2' HG12 ' A' ' 200' ' ' ILE . 98.7 mttt -84.36 96.27 9.0 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.902 0.382 . . . . 71.12 110.221 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 204' ' ' GLU . 12.8 mptt -104.58 129.68 24.56 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.374 -0.376 . . . . 73.42 111.989 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.3 125.56 11.45 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.892 2.394 . . . . 54.43 113.063 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 199' ' ' ARG . 68.5 mt -97.67 126.08 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.139 -0.482 . . . . 55.41 111.357 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.46 136.21 18.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.153 -0.546 . . . . 54.12 112.46 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 98.9 m95 -59.6 -21.0 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.182 0.515 . . . . 72.53 111.464 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -79.02 -12.52 60.03 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.549 -0.75 . . . . 72.21 112.671 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.1 m -79.27 145.83 33.33 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.773 0.32 . . . . 63.12 111.762 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.0 m-20 -64.19 134.41 54.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 73.54 111.5 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.447 HG23 ' H ' ' A' ' 172' ' ' ARG . 10.1 tt -67.56 -19.11 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.038 0.447 . . . . 73.33 111.218 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 88.5 p -60.26 -29.23 68.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.203 0.446 . . . . 61.44 112.203 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -60.01 -27.0 66.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.395 0.617 . . . . 73.24 111.125 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -104.69 15.54 27.75 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.643 -0.708 . . . . 73.33 111.772 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.4 m -56.3 109.43 0.6 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.664 0.616 . . . . 71.23 112.664 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.79 -17.06 50.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.79 0.676 . . . . 54.4 114.79 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.62 173.41 6.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.025 0.913 . . . . 73.54 112.501 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 35.8 mt-10 -105.59 124.4 49.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.886 -0.597 . . . . 65.43 111.868 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 159' ' ' VAL . 47.5 mt -98.3 160.14 14.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.031 0.443 . . . . 72.32 111.462 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -129.56 120.04 24.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.525 -0.307 . . . . 54.31 110.648 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 197' ' ' VAL . 24.5 t -116.12 138.32 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 53.33 111.507 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 162' ' ' PRO . 9.9 pt-20 -138.76 152.91 48.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.959 0.409 . . . . 74.43 111.598 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 45.8 t -81.71 143.52 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.887 0.375 . . . . 71.25 111.713 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' ALA . 87.9 mt -84.75 -60.25 2.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.18 0.514 . . . . 73.04 110.982 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLU . . . . . 0.546 ' HB2' ' SG ' ' A' ' 194' ' ' CYS . 41.7 mt-10 -76.78 94.61 3.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.941 0.401 . . . . 75.32 111.16 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -70.57 79.35 0.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.12 110.32 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.58 163.04 43.23 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.652 -0.704 . . . . 71.15 111.131 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.03 119.64 6.61 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.33 2.02 . . . . 64.0 112.497 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--O 1.253 1.271 0 CA-C-O 118.636 -0.697 . . . . 70.23 110.903 175.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.5 p80 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.552 0.205 . . . . 72.41 111.552 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.6 mtm 66.27 149.44 0.12 Allowed Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 122.891 0.476 . . . . 71.15 112.251 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.89 164.7 26.17 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.81 2.34 . . . . 63.01 113.174 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.58 8.21 17.5 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.382 -0.372 . . . . 42.42 111.665 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -68.99 113.95 19.86 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 112.25 0.463 . . . . 53.05 112.25 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.422 ' HB2' ' HG3' ' A' ' 154' ' ' LYS . 41.1 Cg_endo -100.72 -176.47 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.51 2.807 . . . . 61.44 113.891 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.64 18.28 20.44 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.419 0.628 . . . . 63.3 110.458 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 152' ' ' PRO . 66.9 mttm -73.47 157.76 87.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.654 -0.703 . . . . 74.34 112.098 -176.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 154' ' ' LYS . 41.7 Cg_endo -65.25 146.7 86.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.679 2.252 . . . . 72.25 113.368 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 168' ' ' VAL . 40.0 pt -130.06 167.82 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.455 0.645 . . . . 75.04 112.634 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.82 133.66 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 61.23 109.968 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 57.5 mtp180 -105.09 106.17 16.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.121 0.486 . . . . 71.32 111.594 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -109.57 128.83 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.541 0.571 . . . . 73.41 112.541 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.56 115.12 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.24 -0.436 . . . . 75.1 110.93 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -89.97 155.45 47.4 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.14 -0.482 . . . . 74.21 111.65 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.46 141.55 68.07 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.6 2.2 . . . . 64.1 113.346 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 72.57 65.6 0.12 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.788 0.835 . . . . 62.45 112.676 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 58.2 41.38 23.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.013 0.746 . . . . 74.33 113.013 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -129.06 152.76 48.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.23 0.538 . . . . 53.55 111.831 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -157.41 146.44 19.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.03 -0.532 . . . . 74.45 110.572 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -156.32 147.44 22.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.178 0.513 . . . . 64.24 111.821 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 156' ' ' ILE . 99.3 t -109.92 122.34 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.11 -0.495 . . . . 63.04 111.372 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 HD11 ' A' ' 214' ' ' ILE . 12.2 m -118.25 138.04 25.22 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.35 -0.386 . . . . 71.04 111.553 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 34.0 Cg_exo -60.8 139.33 84.72 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.93 2.42 . . . . 54.0 113.946 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.29 103.91 13.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.24 -0.436 . . . . 62.31 111.648 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -124.39 141.87 51.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.451 -0.34 . . . . 62.24 111.271 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.2 t -74.98 151.04 38.83 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.667 0.27 . . . . 53.21 110.771 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.11 -37.18 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.011 -0.614 . . . . 51.13 112.572 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 214' ' ' ILE . 55.8 t -80.41 113.3 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.911 0.386 . . . . 74.23 110.582 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 72.0 p -75.83 159.78 30.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.547 -0.297 . . . . 55.14 111.454 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -30.45 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.611 0.72 . . . . 43.25 110.565 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 51.3 ttt180 -66.68 -48.65 68.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.533 -0.758 . . . . 71.34 111.337 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 5.2 t70 -75.86 -24.23 55.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 73.23 111.679 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 92.8 p -74.0 -48.58 29.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.024 0.44 . . . . 73.04 111.154 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.62 -4.02 59.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 63.32 112.858 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 18.0 ptmt -53.86 -45.49 70.99 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 111.868 0.321 . . . . 54.25 111.868 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.17 -25.79 47.35 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.143 -0.348 . . . . 70.14 111.675 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.63 82.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.225 0.536 . . . . 74.25 110.857 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.8 mt -79.09 -31.74 44.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.191 -0.459 . . . . 63.2 110.808 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -54.97 -47.84 74.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.505 -0.316 . . . . 74.2 111.27 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.9 ptp -68.66 -7.88 37.28 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.125 0.417 . . . . 71.01 112.125 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -101.3 -16.22 17.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.887 0.375 . . . . 74.32 111.163 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.4 30.15 25.54 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.305 -0.474 . . . . 62.31 112.727 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.8 173.55 6.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.867 0.365 . . . . 54.21 111.496 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.74 146.37 56.89 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.437 -0.347 . . . . 64.11 110.693 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.7 -41.82 74.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.604 2.203 . . . . 73.11 113.61 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.4 mp0 -63.63 -12.11 30.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.524 0.564 . . . . 75.12 112.524 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.54 -8.4 50.37 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.93 0.395 . . . . 71.23 111.563 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.6 m -123.5 171.75 9.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 64.24 112.055 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -143.68 129.72 19.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.43 -0.35 . . . . 71.44 111.286 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 224' ' ' VAL . 54.3 t -95.26 121.05 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.516 -0.311 . . . . 65.42 111.097 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 207' ' ' PRO . 17.9 p90 -132.27 145.11 51.07 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.178 0.513 . . . . 75.25 111.254 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HG2' HD11 ' A' ' 208' ' ' ILE . 40.2 ptt180 -122.83 161.37 24.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.046 0.45 . . . . 74.44 111.163 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 205' ' ' LYS . 52.7 mt -110.14 101.62 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.147 -0.479 . . . . 70.41 110.682 177.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -120.29 123.78 44.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.994 -0.548 . . . . 65.24 110.543 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.66 30.45 19.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.202 0.525 . . . . 74.51 110.948 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 -12.41 54.45 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.036 -0.529 . . . . 75.02 113.361 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.8 120.33 25.91 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.15 0.426 . . . . 75.12 112.15 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.481 ' HG2' HG12 ' A' ' 200' ' ' ILE . 87.5 mttt -86.34 101.41 13.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.285 -0.416 . . . . 72.53 110.535 172.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -121.9 120.88 28.31 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 120.611 0.243 . . . . 63.2 111.432 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 198' ' ' TYR . 16.5 Cg_exo -69.62 126.15 13.07 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.714 2.276 . . . . 71.31 113.319 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 199' ' ' ARG . 3.6 mp -86.63 131.68 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.404 -0.362 . . . . 65.41 110.381 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.55 133.16 41.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.79 -0.719 . . . . 54.22 112.937 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -57.74 -22.05 44.51 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.071 0.462 . . . . 71.42 111.936 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.12 -10.74 59.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.426 0.528 . . . . 70.41 112.426 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.9 m -75.21 137.93 41.6 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.783 0.29 . . . . 71.31 111.783 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.04 130.26 44.73 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.875 0.369 . . . . 73.52 111.008 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 169' ' ' VAL . 9.8 tt -60.99 -23.67 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.014 0.435 . . . . 65.05 111.96 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 80.9 p -59.12 -24.98 63.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.295 0.48 . . . . 72.22 112.295 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -67.27 -27.48 67.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.961 0.356 . . . . 73.53 111.961 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 208' ' ' ILE . 51.3 mt -109.09 37.81 2.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.239 0.542 . . . . 74.52 111.712 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.6 m -67.36 120.2 13.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.73 0.641 . . . . 73.34 112.73 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.18 81.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 115.255 0.862 . . . . 74.42 115.255 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.65 172.1 7.92 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.187 0.993 . . . . 65.22 111.989 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.4 mt-10 -108.61 114.52 28.4 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.941 -0.572 . . . . 74.21 111.635 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 83.2 mt -94.81 157.53 15.89 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.102 0.477 . . . . 73.01 111.694 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -127.85 134.03 49.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.494 -0.321 . . . . 73.2 110.152 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 197' ' ' VAL . 48.0 t -119.74 136.05 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.371 0.508 . . . . 74.23 112.371 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.67 173.93 7.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.186 -0.461 . . . . 75.52 110.597 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.6 t -100.37 129.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.77 0.319 . . . . 72.31 111.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.0 mt -76.92 -78.22 0.13 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.629 0.252 . . . . 43.3 111.425 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.63 100.91 10.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.708 0.29 . . . . 71.13 110.862 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -75.86 76.19 2.79 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.255 0.55 . . . . 52.13 110.107 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.69 144.25 52.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.192 0.441 . . . . 61.54 112.192 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.74 96.76 1.11 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.178 1.919 . . . . 75.13 110.809 168.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.828 -0.606 . . . . 64.45 112.172 -173.308 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 112.309 0.485 . . . . 73.24 112.309 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 69.2 mtm 65.49 111.4 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 122.905 0.482 . . . . 51.05 112.219 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.4 127.08 22.67 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.375 2.05 . . . . 63.14 112.149 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.65 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 11.1 mmpt? -103.59 150.1 24.28 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.046 0.45 . . . . 62.44 112.126 -174.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.3 t -95.45 96.48 2.2 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.097 -0.501 . . . . 65.31 109.956 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 150' ' ' LYS . 7.6 Cg_exo -72.94 107.64 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.773 2.315 . . . . 52.05 113.735 -171.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -87.81 88.92 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.543 0.687 . . . . 72.41 110.06 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 152' ' ' PRO . 96.4 mttt -89.69 154.29 48.07 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.581 0.586 . . . . 73.14 112.581 -171.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.22 136.46 72.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.956 2.437 . . . . 51.15 113.096 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.93 162.71 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.455 0.645 . . . . 73.14 112.566 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 171' ' ' ALA . 47.3 t -130.88 130.47 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.549 -0.75 . . . . 73.24 109.847 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -98.66 101.16 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.987 0.422 . . . . 71.31 111.597 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 222' ' ' LEU . 42.9 t -96.3 117.54 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.922 0.391 . . . . 64.4 111.964 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -91.75 117.57 29.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.967 0.413 . . . . 74.52 111.196 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -97.68 160.17 29.25 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.274 -0.421 . . . . 72.12 111.431 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.76 173.02 6.12 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.397 2.065 . . . . 72.12 112.324 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 64.34 28.31 13.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.999 0.428 . . . . 73.24 111.72 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 64.13 34.86 10.74 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.891 -0.595 . . . . 71.21 111.964 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -110.33 160.76 16.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.003 0.43 . . . . 74.33 111.465 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -156.62 153.73 29.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.825 0.345 . . . . 74.31 111.182 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -152.11 137.31 17.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.058 0.456 . . . . 72.3 111.843 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.4 t -104.77 120.78 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.39 -0.368 . . . . 72.01 110.553 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.36 151.77 48.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 111.871 0.323 . . . . 53.11 111.871 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 129.18 13.2 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.562 2.175 . . . . 53.1 113.357 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.79 112.31 15.8 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.219 -0.446 . . . . 41.35 111.493 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.67 159.59 33.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.534 0.334 . . . . 74.41 111.452 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -95.28 147.54 23.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.688 0.28 . . . . 75.53 110.533 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.14 -25.3 6.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.696 -0.764 . . . . 63.52 112.262 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.58 111.82 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.048 0.451 . . . . 74.34 110.528 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 76.6 p -75.91 157.71 32.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.267 -0.424 . . . . 53.43 111.594 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.8 t -53.8 -40.9 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.261 0.553 . . . . 41.34 110.782 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 48.2 ttp180 -61.25 -37.81 84.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.571 -0.74 . . . . 72.44 111.424 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.47 -53.85 7.54 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.967 -0.56 . . . . 71.33 111.518 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.7 t -57.94 -41.14 82.17 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.222 0.453 . . . . 73.24 112.222 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 159' ' ' VAL . 69.9 mt -80.76 6.57 12.55 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.957 0.725 . . . . 74.42 112.957 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.411 ' NZ ' ' HB3' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -55.06 -36.64 65.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.992 0.425 . . . . 74.14 110.878 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -67.35 -37.45 83.25 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.231 -0.441 . . . . 61.13 111.571 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.9 32.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.986 0.422 . . . . 44.34 110.899 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 88.4 mt -55.45 -42.91 74.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.87 -0.605 . . . . 75.03 111.241 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 52.6 ttm -59.45 -57.16 14.21 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.23 111.779 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -68.8 -23.13 64.24 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.462 0.541 . . . . 65.44 112.462 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -103.99 3.32 33.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.794 0.665 . . . . 73.34 112.794 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.04 48.5 85.6 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.149 -0.548 . . . . 73.31 113.559 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 89.3 mt -127.5 159.84 33.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.899 0.381 . . . . 52.12 111.467 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.74 154.79 73.33 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.491 -0.322 . . . . 75.01 111.168 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.12 -31.86 29.85 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.188 2.592 . . . . 71.33 114.525 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.65 -15.3 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.992 -0.443 . . . . 72.14 112.135 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.18 -8.74 29.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.014 0.375 . . . . 74.41 112.014 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 190' ' ' LEU . 77.7 m -142.55 149.33 38.95 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.0 0.429 . . . . 74.14 111.869 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.79 134.53 55.2 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.29 -0.414 . . . . 54.32 111.429 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 224' ' ' VAL . 34.1 t -108.4 125.05 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 122.529 0.331 . . . . 53.32 111.075 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.9 152.0 46.07 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.89 0.376 . . . . 73.12 111.338 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 199' ' ' ARG . 6.8 ptt180 -122.92 154.97 37.64 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.321 -0.251 . . . . 74.5 110.321 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.6 mt -110.85 131.4 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.211 0.529 . . . . 74.43 111.84 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 27.1 tt0 -137.7 119.62 15.35 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.093 -0.503 . . . . 72.52 110.79 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.46 16.28 3.18 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.42 112.144 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.59 -10.02 38.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 121.331 -0.461 . . . . 62.04 114.159 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' GLU . . . . . 0.673 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 12.3 pt-20 -88.02 134.66 33.69 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.948 0.874 . . . . 75.55 111.924 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 99.7 mttt -97.74 103.81 15.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.455 -0.338 . . . . 72.25 110.425 173.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.49 113.7 65.56 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 111.905 0.335 . . . . 75.54 111.905 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.04 113.07 2.05 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.969 2.446 . . . . 51.11 112.14 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.71 129.25 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 70.33 111.484 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.55 126.13 21.4 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.678 -0.773 . . . . 62.05 112.259 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 73.7 m95 -52.05 -28.69 18.22 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.965 0.412 . . . . 75.54 111.84 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.74 14.94 2.87 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.751 0.649 . . . . 72.1 112.751 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 56.6 m -93.28 140.74 29.21 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.031 -0.418 . . . . 75.13 111.707 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.85 122.12 13.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.98 0.419 . . . . 63.45 111.223 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.0 -19.51 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.597 0.591 . . . . 52.31 112.597 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 33.8 t -61.11 -19.68 61.76 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.053 0.39 . . . . 71.21 112.053 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -78.23 -8.04 57.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.904 0.335 . . . . 71.43 111.904 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 42.6 mt -110.67 18.97 19.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.141 0.496 . . . . 72.25 111.412 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -61.56 123.17 17.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.914 0.709 . . . . 61.33 112.914 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.35 -37.33 3.61 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.712 0.645 . . . . 62.23 114.712 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.78 172.62 7.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.629 0.715 . . . . 73.42 112.684 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -93.75 139.55 30.71 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.581 -0.736 . . . . 74.12 112.596 -173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 159' ' ' VAL . 54.6 mt -103.57 140.63 37.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.066 -0.516 . . . . 53.24 110.542 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -115.51 117.37 30.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.513 -0.312 . . . . 73.52 110.565 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 197' ' ' VAL . 39.8 t -112.6 129.42 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.759 0.314 . . . . 73.03 111.547 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.21 155.02 51.38 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.928 0.394 . . . . 73.23 111.348 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.93 130.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.564 0.579 . . . . 64.32 112.564 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.17 -62.72 1.43 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.831 -0.622 . . . . 71.44 110.73 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -108.34 113.51 26.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.151 -0.477 . . . . 74.55 111.209 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -78.57 72.77 5.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.1 0.476 . . . . 62.35 111.255 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.0 t -111.72 96.44 32.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.122 -0.49 . . . . 74.23 111.611 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -87.82 161.51 7.61 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 73.05 112.578 175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 232' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 N-CA-C 112.141 0.422 . . . . 42.33 112.141 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.629 0.252 . . . . 72.44 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 149' ' ' PRO . 23.3 ptp -101.8 109.1 58.7 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 120.864 0.364 . . . . 71.01 111.343 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 148' ' ' MET . 10.3 Cg_exo -71.74 124.11 9.95 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.588 2.192 . . . . 74.45 112.677 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.48 ' HB2' ' NZ ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -64.69 122.2 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.94 0.4 . . . . 64.42 110.889 177.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 50.3 m -60.84 122.01 65.76 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.357 0.502 . . . . 61.21 112.357 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 122.29 8.18 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.376 2.051 . . . . 75.42 111.414 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -65.52 89.28 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.193 0.521 . . . . 72.35 111.98 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -101.91 153.0 38.26 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.843 -0.617 . . . . 74.41 111.153 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 135.69 23.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.263 1.975 . . . . 74.14 111.496 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.29 163.27 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 113.133 0.79 . . . . 72.32 113.133 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.5 t -122.54 137.29 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.851 -0.613 . . . . 70.32 110.917 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 71.8 mtt85 -96.78 101.4 12.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 74.12 111.312 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.519 HG21 HD21 ' A' ' 181' ' ' LEU . 60.3 t -102.03 125.73 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.966 0.412 . . . . 65.32 111.726 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -91.52 106.4 18.46 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.35 -0.386 . . . . 74.12 111.175 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.8 mt -80.09 153.25 74.65 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.302 -0.408 . . . . 73.14 111.208 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 72.5 Cg_exo -49.96 140.45 31.47 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.896 2.397 . . . . 55.24 113.921 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 86.1 m-20 75.96 46.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.486 0.714 . . . . 71.03 112.47 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 64.2 20.32 12.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.773 0.657 . . . . 73.03 112.773 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.4 mm-40 -89.35 141.56 28.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 71.52 111.188 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -117.64 143.06 46.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.246 0.546 . . . . 74.4 111.877 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.448 HG23 ' HB ' ' A' ' 159' ' ' VAL . 9.2 t -145.5 137.93 25.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.826 -0.625 . . . . 74.52 110.724 172.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.21 120.26 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.672 0.272 . . . . 72.02 110.833 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 31.2 m -114.62 147.87 39.07 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 75.44 111.813 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 11.4 Cg_exo -71.55 125.0 10.78 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.789 2.326 . . . . 75.33 112.695 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 120.81 17.61 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.042 0.449 . . . . 51.11 111.754 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 61.9 mtt-85 -127.13 159.39 34.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.368 -0.378 . . . . 64.45 111.087 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.3 t -99.17 139.32 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.678 0.275 . . . . 72.33 110.445 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.77 84.1 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.765 -0.731 . . . . 63.42 112.006 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.8 t -127.1 119.3 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.952 0.501 . . . . 73.22 110.269 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.9 p -80.43 168.48 18.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.257 0.551 . . . . 63.02 112.201 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.75 -37.92 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.352 0.596 . . . . 74.41 110.236 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 21.3 ttt85 -63.91 -35.19 79.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.664 -0.698 . . . . 75.42 111.094 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' A' ' 182' ' ' LYS . 2.1 m-20 -76.53 -51.97 10.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.392 -0.367 . . . . 44.01 111.707 175.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -56.0 -42.73 76.87 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.111 0.411 . . . . 71.24 112.111 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 159' ' ' VAL . 78.9 mt -92.08 -10.04 40.46 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.812 1.042 . . . . 64.44 113.812 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 179' ' ' ASP . 0.1 OUTLIER -58.12 -28.71 64.9 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.909 0.777 . . . . 70.0 111.483 -176.127 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.82 -45.61 64.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.095 0.474 . . . . 73.33 110.607 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.54 90.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.949 -0.568 . . . . 65.43 111.665 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.66 -47.32 69.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 60.14 110.797 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.7 ttm -57.48 -39.13 75.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.002 -0.544 . . . . 45.41 112.245 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.8 ptm -75.26 -21.69 58.37 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.071 -0.393 . . . . 75.12 111.906 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -96.25 -13.68 23.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.097 0.406 . . . . 75.22 112.097 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.22 41.51 10.17 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.95 -0.643 . . . . 73.42 112.479 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.31 158.26 34.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.683 0.393 . . . . 62.21 110.829 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.2 pt -133.33 137.7 29.77 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.682 -0.235 . . . . 72.32 111.342 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.6 -44.31 35.95 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.172 2.581 . . . . 73.25 113.654 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.02 -21.65 59.41 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.522 0.564 . . . . 53.45 112.522 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.522 ' SG ' HG13 ' A' ' 226' ' ' VAL . 32.7 t -101.18 -12.42 18.77 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.948 0.404 . . . . 64.42 112.014 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.9 m -119.55 164.41 15.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.173 0.511 . . . . 44.42 111.983 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.83 133.82 38.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.439 -0.346 . . . . 74.13 111.909 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 224' ' ' VAL . 68.0 t -98.79 138.54 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.731 0.301 . . . . 72.11 110.816 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.75 158.86 41.58 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.179 0.514 . . . . 71.35 111.738 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 206' ' ' LYS . 6.4 ptm180 -110.11 154.25 23.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.873 -0.603 . . . . 64.33 110.111 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.448 HG12 ' HG2' ' A' ' 205' ' ' LYS . 59.0 mt -118.62 120.65 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.985 0.421 . . . . 64.23 111.575 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -154.78 144.28 21.36 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.43 -0.35 . . . . 64.32 111.031 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 57.06 31.44 19.95 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.334 0.588 . . . . 70.15 111.22 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.66 -19.66 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.874 -0.603 . . . . 42.04 113.82 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.06 170.27 8.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.575 0.702 . . . . 65.33 112.732 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.0 mttp -113.45 139.58 48.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.32 -0.855 . . . . 73.31 110.947 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 199' ' ' ARG . 87.4 tttt -114.69 105.35 53.54 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.662 -0.245 . . . . 72.22 110.593 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -61.96 113.38 1.84 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.789 2.326 . . . . 64.44 112.412 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 217' ' ' LEU . 61.2 mt -96.64 134.22 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 72.43 111.615 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.3 135.17 29.3 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.145 -0.55 . . . . 72.42 113.039 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 75.9 m95 -55.34 -43.42 74.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.712 0.634 . . . . 74.43 112.712 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.56 27.93 0.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.85 0.685 . . . . 61.44 112.85 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 48.7 m -92.51 137.62 32.21 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 122.354 -0.216 . . . . 43.44 110.612 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.99 124.15 15.85 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.926 0.394 . . . . 74.32 111.794 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.25 -24.21 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.178 -0.465 . . . . 75.54 111.698 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 t -56.54 -30.61 63.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.115 0.413 . . . . 74.12 112.115 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.68 -19.1 65.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.842 0.353 . . . . 73.02 111.939 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 208' ' ' ILE . 44.0 mt -115.45 19.13 15.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.173 0.511 . . . . 72.23 111.676 -173.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.567 ' HA ' HG22 ' A' ' 157' ' ' VAL . 75.5 m -61.38 132.0 52.08 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.547 0.573 . . . . 73.01 112.547 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 93.4 -22.07 37.18 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.717 0.647 . . . . 74.42 114.717 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.16 172.78 6.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.684 0.742 . . . . 74.04 112.677 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 42.4 mt-10 -105.91 114.7 29.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.755 -0.657 . . . . 72.54 111.765 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.03 164.3 13.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.138 0.494 . . . . 75.54 111.291 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -131.7 139.1 48.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.839 0.352 . . . . 64.35 111.472 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 197' ' ' VAL . 46.4 t -123.12 126.38 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.107 -0.497 . . . . 63.05 110.746 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.72 145.72 46.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.397 . . . . 63.22 111.274 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.522 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.7 t -83.87 103.09 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 110.079 -0.341 . . . . 71.51 110.079 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -55.43 -50.19 70.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.983 0.42 . . . . 61.02 111.692 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.9 117.25 25.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.444 0.64 . . . . 62.4 110.107 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -72.56 27.37 0.05 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.126 1.158 . . . . 65.23 114.126 -168.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.06 89.58 42.92 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 121.886 -0.509 . . . . 74.31 111.487 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.79 121.91 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.2 2.6 . . . . 73.43 112.33 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 232' ' ' LEU . 6.5 mp . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.572 -0.728 . . . . 72.34 111.487 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 112.021 0.378 . . . . 54.43 112.021 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.0 mtt 66.82 102.47 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 123.007 0.523 . . . . 62.1 111.744 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -90.71 129.46 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.755 2.303 . . . . 71.31 112.621 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -72.22 77.28 0.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.469 0.652 . . . . 75.54 109.563 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 t -76.31 120.39 81.47 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 115.318 -0.855 . . . . 63.31 112.694 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.8 -160.12 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.79 2.326 . . . . 73.44 111.865 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -80.48 99.93 8.27 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.898 -0.501 . . . . 60.55 111.07 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HD3' ' H ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -100.98 145.83 31.08 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.321 -0.4 . . . . 73.41 111.392 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.59 131.03 31.82 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.663 2.242 . . . . 75.25 112.793 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.03 156.68 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.223 0.535 . . . . 72.12 112.173 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 171' ' ' ALA . 56.7 t -122.39 131.27 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.004 -0.544 . . . . 74.42 110.69 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.537 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 99.9 mtt180 -84.92 134.89 34.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.522 -0.308 . . . . 75.11 110.891 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 181' ' ' LEU . 59.7 t -130.18 119.51 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.1 0.476 . . . . 75.25 111.676 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -93.93 114.43 26.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.129 -0.487 . . . . 65.23 111.037 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 87.9 mt -98.19 158.33 32.93 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.088 -0.506 . . . . 72.34 111.181 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 172.2 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.27 1.98 . . . . 75.11 111.886 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 62.46 23.23 13.77 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.09 0.471 . . . . 74.3 110.778 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 63.02 26.91 15.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.513 0.725 . . . . 64.35 112.332 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 79.3 mm-40 -88.02 152.49 22.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.193 0.521 . . . . 74.5 111.98 -177.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -132.78 139.18 47.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.239 -0.437 . . . . 63.21 110.96 -176.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.406 HG23 ' HB ' ' A' ' 159' ' ' VAL . 8.3 t -152.45 148.52 27.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.889 0.376 . . . . 64.11 111.745 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.7 129.7 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.87 0.366 . . . . 71.15 111.057 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.33 154.55 72.16 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.603 -0.271 . . . . 74.31 111.723 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 141.07 24.53 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.524 2.149 . . . . 73.21 113.163 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -103.4 122.23 44.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.942 0.349 . . . . 54.22 111.942 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -133.89 152.28 51.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.976 0.417 . . . . 75.53 111.817 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.3 t -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 64.21 111.007 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.2 -25.77 16.14 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.961 -0.638 . . . . 72.11 112.741 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.2 t -82.59 125.93 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.777 0.323 . . . . 73.53 110.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 45.5 p -84.25 164.49 19.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.199 0.523 . . . . 71.23 112.041 -177.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 210' ' ' TRP . 61.4 t -59.2 -33.07 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.397 0.618 . . . . 72.03 110.722 174.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -63.48 -53.63 48.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.934 -0.575 . . . . 72.44 110.776 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.549 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 59.3 m-20 -59.81 -38.61 82.44 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.231 0.456 . . . . 75.4 112.231 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.0 p -76.59 -31.22 57.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.92 0.711 . . . . 54.24 112.92 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 159' ' ' VAL . 71.5 mt -106.45 -20.49 13.36 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.498 1.296 . . . . 65.21 114.498 -174.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 22.7 pttp -54.61 -33.67 60.84 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.427 0.899 . . . . 70.53 113.427 -172.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.99 -44.78 53.47 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.082 -0.386 . . . . 73.14 111.05 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.42 69.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.089 0.471 . . . . 71.22 111.334 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.57 HD11 ' CH2' ' A' ' 210' ' ' TRP . 86.4 mt -69.2 -48.96 60.63 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.033 -0.53 . . . . 62.2 110.901 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.0 tpt -56.84 -45.64 82.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.172 -0.467 . . . . 74.23 111.88 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -70.09 -8.81 52.49 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.557 0.577 . . . . 73.15 112.557 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.46 -20.61 12.15 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.954 0.353 . . . . 73.3 111.954 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.51 38.22 3.07 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.161 -0.542 . . . . 31.12 113.571 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 195' ' ' CYS . 5.0 mp -122.05 169.63 10.65 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.451 -0.441 . . . . 65.42 111.59 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.87 134.58 13.02 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.04 -0.527 . . . . 72.33 110.562 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.56 -39.9 73.9 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.792 2.328 . . . . 35.44 113.708 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.33 -11.1 56.77 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.11 0.781 . . . . 75.41 113.11 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.41 9.94 9.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.985 0.421 . . . . 60.35 111.467 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 190' ' ' LEU . 73.3 m -123.43 144.06 49.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.769 0.318 . . . . 74.43 111.611 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -122.46 119.47 31.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.524 -0.307 . . . . 75.22 111.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 224' ' ' VAL . 25.1 t -98.75 134.07 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.699 -0.228 . . . . 72.34 110.899 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.464 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 47.9 p90 -138.5 155.49 48.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.301 0.572 . . . . 64.02 111.715 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -121.27 152.17 39.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.686 -0.688 . . . . 73.41 111.192 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.5 mt -105.8 97.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.815 0.34 . . . . 73.13 110.795 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 201' ' ' GLN . 12.8 pt20 -112.23 128.54 56.28 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.618 -0.265 . . . . 61.11 110.92 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.0 t70 60.16 19.09 8.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.546 0.689 . . . . 44.5 111.687 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.13 72.42 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.197 -0.525 . . . . 65.31 113.295 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.06 126.24 52.08 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.525 -0.397 . . . . 73.42 111.273 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.464 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 58.1 mtpt -80.68 94.4 6.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.069 0.461 . . . . 63.42 110.677 174.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -94.29 118.4 67.07 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.231 -0.44 . . . . 74.23 111.389 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.1 148.83 87.91 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.67 2.247 . . . . 64.43 112.559 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.533 HD12 HG12 ' A' ' 197' ' ' VAL . 50.1 mt -118.07 148.52 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.841 0.353 . . . . 71.52 111.222 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.38 139.05 14.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.953 -0.642 . . . . 61.3 112.13 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.57 ' CH2' HD11 ' A' ' 185' ' ' LEU . 94.2 m95 -62.7 -23.28 67.07 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.359 -0.495 . . . . 71.21 111.543 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.41 15.14 11.19 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.018 -0.537 . . . . 72.24 112.032 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 m -96.2 147.53 23.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.397 0.279 . . . . 74.12 110.952 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 216' ' ' TRP . 5.1 m-20 -65.13 126.65 28.75 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.166 0.508 . . . . 72.05 111.87 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 217' ' ' LEU . 9.5 tp -62.03 -20.64 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 116.128 -0.487 . . . . 63.33 111.366 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.6 p -60.63 -23.19 64.56 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.441 -0.345 . . . . 73.24 111.903 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 213' ' ' ASP . 42.3 m95 -70.37 -20.13 62.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.038 0.446 . . . . 75.4 111.739 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 HD12 ' A' ' 214' ' ' ILE . 23.2 mt -104.97 9.81 34.41 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.098 -0.501 . . . . 62.32 111.748 -174.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.0 m -56.64 109.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.646 0.61 . . . . 75.31 112.646 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.53 1.61 60.44 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.097 -0.573 . . . . 72.32 113.981 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -103.65 158.96 16.01 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.478 . . . . 72.54 111.826 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.537 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.3 mt-10 -105.72 114.82 29.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.067 0.461 . . . . 70.3 110.683 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 mt -92.8 156.11 17.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 63.11 111.715 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -129.33 132.55 47.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 72.14 110.197 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 197' ' ' VAL . 58.5 t -109.73 123.62 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.22 0.452 . . . . 72.35 112.22 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -100.66 157.39 16.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.178 -0.464 . . . . 70.41 111.228 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.55 130.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.741 0.305 . . . . 62.33 111.016 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 196' ' ' ALA . 89.1 mt -82.47 -71.77 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 111.802 0.297 . . . . 63.41 111.802 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.55 109.91 5.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.393 0.277 . . . . 73.12 111.029 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.45 74.05 4.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.639 0.733 . . . . 73.41 111.214 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' VAL . . . . . 0.488 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 27.7 m -95.56 131.34 29.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.058 -0.519 . . . . 73.41 111.757 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 6.4 Cg_exo -75.51 135.36 18.06 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.956 2.437 . . . . 74.24 112.265 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.523 -0.751 . . . . 43.53 112.002 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.688 0.28 . . . . 64.55 111.597 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 80.3 mtp 65.18 149.76 0.11 Allowed Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.12 0.568 . . . . 54.03 112.259 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.28 113.62 1.99 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.424 2.083 . . . . 73.12 112.376 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.429 ' HB3' ' NZ ' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -68.8 93.39 0.54 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.321 0.581 . . . . 74.31 111.877 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -92.07 106.22 16.78 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-N 115.859 -0.61 . . . . 72.44 111.201 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.1 60.46 7.38 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.849 2.366 . . . . 54.51 112.675 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.87 -10.71 46.98 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.967 0.413 . . . . 72.33 112.039 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.28 138.33 71.73 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 122.218 -0.301 . . . . 73.52 111.486 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.76 128.55 19.14 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.46 2.107 . . . . 75.31 112.013 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.72 157.14 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.531 0.681 . . . . 65.34 112.76 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.77 135.37 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.436 -0.802 . . . . 74.14 110.186 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 50.0 mtt180 -90.32 98.56 11.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.936 0.398 . . . . 75.13 110.803 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.688 HG21 HD21 ' A' ' 181' ' ' LEU . 60.5 t -96.78 108.01 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.34 0.59 . . . . 74.51 111.806 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 73.1 m-85 -76.53 104.09 6.86 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.041 0.448 . . . . 64.32 110.762 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.39 157.87 89.15 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.931 -0.577 . . . . 74.35 112.274 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 11.1 Cg_endo -54.1 160.09 6.74 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.668 2.246 . . . . 61.35 112.843 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 65.0 t30 68.57 31.34 4.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.536 0.684 . . . . 64.4 110.839 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 65.6 23.03 11.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.31 -0.859 . . . . 74.32 113.031 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.92 -177.04 4.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.99 0.424 . . . . 75.35 111.776 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 28.1 ptt180 -157.84 156.86 32.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.162 0.505 . . . . 71.01 111.902 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.3 t -156.27 160.51 39.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.997 -0.547 . . . . 60.0 110.352 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.8 t -116.53 119.75 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.757 0.313 . . . . 43.22 111.041 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.23 152.67 49.37 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 111.852 0.315 . . . . 73.24 111.852 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.59 147.66 32.08 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.491 2.128 . . . . 63.44 113.273 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -103.67 126.73 51.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.959 0.409 . . . . 64.13 111.69 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -128.74 146.18 50.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.98 0.419 . . . . 62.15 111.623 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.69 132.21 40.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.834 0.35 . . . . 73.54 110.896 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.06 -23.7 30.14 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.076 -0.583 . . . . 44.25 112.437 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.26 125.26 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.097 0.475 . . . . 74.34 111.131 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 30.0 p -82.74 165.92 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.93 0.395 . . . . 74.15 111.491 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 212' ' ' THR . 62.0 t -56.96 -32.38 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.352 0.596 . . . . 73.21 110.243 172.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 4.2 tmt_? -68.04 -45.77 73.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.703 -0.681 . . . . 44.25 111.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -67.83 -33.42 74.75 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.918 0.39 . . . . 72.13 111.669 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.0 t -74.31 -44.01 54.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.25 0.463 . . . . 64.14 112.25 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 159' ' ' VAL . 68.3 mt -95.79 -4.78 43.27 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.72 1.007 . . . . 62.21 113.72 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -58.24 -43.51 87.82 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.246 0.461 . . . . 51.44 112.246 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -80.92 -27.85 36.03 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.984 0.421 . . . . 74.14 111.022 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.77 92.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.209 0.528 . . . . 65.54 111.173 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.27 -29.7 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.309 -0.405 . . . . 73.43 111.108 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.423 ' SD ' ' C ' ' A' ' 186' ' ' MET . 0.2 OUTLIER -54.63 -48.08 72.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.33 -0.396 . . . . 71.31 111.293 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -64.99 -19.12 65.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.023 0.379 . . . . 62.23 112.023 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -87.37 -5.97 58.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.774 0.321 . . . . 74.43 111.317 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.15 16.22 70.09 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.394 -0.431 . . . . 53.15 112.665 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.9 mt -117.3 171.76 7.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.016 0.436 . . . . 71.24 111.622 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 25.4 pt -133.44 143.9 49.97 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 116.086 -0.506 . . . . 65.14 111.039 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.81 -29.69 82.06 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.749 2.299 . . . . 75.34 112.941 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.34 -32.38 68.46 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.998 -0.546 . . . . 74.02 111.934 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.28 9.96 31.86 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.365 0.506 . . . . 60.41 112.365 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.0 m -118.27 166.87 12.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.98 0.419 . . . . 74.52 111.614 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.08 138.9 48.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 73.12 111.335 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 224' ' ' VAL . 61.9 t -111.17 132.11 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.288 -0.414 . . . . 71.32 111.267 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -139.06 146.89 41.33 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.252 0.548 . . . . 73.14 111.312 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' HD11 ' A' ' 208' ' ' ILE . 9.1 ptm180 -116.62 169.15 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 64.13 110.294 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' A' ' 205' ' ' LYS . 54.4 mt -104.04 115.69 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 71.14 110.101 174.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 23.2 tm0? -131.27 119.69 22.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.952 -0.567 . . . . 75.43 110.253 -177.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.31 27.01 15.96 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.335 0.588 . . . . 64.32 111.57 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.96 2.51 74.77 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.243 -0.435 . . . . 65.24 113.882 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.02 133.03 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.428 -0.454 . . . . 64.13 111.629 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.7 mttp -78.13 99.0 6.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.074 0.464 . . . . 72.44 110.895 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -93.67 112.09 55.32 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.991 -0.55 . . . . 74.12 111.859 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.19 110.23 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.92 2.413 . . . . 74.41 112.654 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.547 HD11 ' HG2' ' A' ' 199' ' ' ARG . 62.6 mt -89.13 138.59 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.26 -0.427 . . . . 61.22 112.039 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.06 138.59 34.94 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.14 -0.553 . . . . 52.5 113.219 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.1 m95 -59.45 -22.99 62.32 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.901 0.381 . . . . 70.41 111.746 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.09 -11.84 60.93 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.095 0.558 . . . . 62.51 112.228 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 177' ' ' VAL . 20.7 m -75.75 135.11 40.33 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.279 -0.419 . . . . 72.33 111.892 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 2.3 m-20 -62.03 127.21 30.29 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.513 -0.312 . . . . 41.25 111.54 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -61.31 -22.75 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.058 0.456 . . . . 73.22 111.284 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.9 t -54.89 -29.12 55.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.048 -0.524 . . . . 53.31 112.036 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -68.79 -26.74 65.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.143 0.497 . . . . 74.23 111.496 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.638 HD13 HD21 ' A' ' 222' ' ' LEU . 51.8 mt -105.47 10.88 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.0 -0.546 . . . . 72.33 112.104 -172.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 70.7 m -50.38 119.22 3.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.178 0.436 . . . . 55.13 112.178 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.73 -21.44 45.87 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.276 -0.488 . . . . 75.35 113.993 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -86.42 172.47 10.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.424 0.63 . . . . 73.01 112.418 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.1 mt-10 -111.18 119.96 40.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.875 -0.602 . . . . 74.51 111.249 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 217' ' ' LEU . 77.6 mt -97.39 155.23 17.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.908 0.385 . . . . 75.11 111.116 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -127.52 120.53 28.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.029 -0.36 . . . . 64.03 110.029 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 197' ' ' VAL . 52.5 t -115.95 140.6 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.1 0.476 . . . . 62.12 111.711 -175.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 162' ' ' PRO . 12.6 pt-20 -144.26 160.72 40.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.301 -0.409 . . . . 55.24 110.754 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.78 139.01 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.64 -0.254 . . . . 52.11 111.166 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.5 mt -60.57 -42.44 96.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.886 0.328 . . . . 73.4 111.886 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -146.03 143.13 29.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.978 0.418 . . . . 71.44 110.753 172.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -78.1 37.62 0.26 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.231 0.456 . . . . 71.23 112.231 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.2 90.39 47.35 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.966 0.358 . . . . 60.42 111.966 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.05 151.25 23.71 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.553 2.169 . . . . 62.42 112.672 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.787 -0.625 . . . . 63.21 112.104 -179.145 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m80 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.728 0.299 . . . . 73.01 111.051 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -72.53 150.06 91.21 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.638 0.256 . . . . 70.03 111.468 178.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -57.93 107.61 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.427 2.084 . . . . 73.32 112.768 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -107.9 97.59 7.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.662 0.744 . . . . 53.44 110.859 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.7 p -137.62 157.27 73.98 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 115.791 -0.641 . . . . 73.1 111.407 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.84 60.53 2.94 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.988 2.459 . . . . 62.2 113.389 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -73.68 84.25 1.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.389 0.614 . . . . 72.12 111.419 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.61 161.48 27.26 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.563 -0.744 . . . . 71.42 111.103 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.76 120.49 7.68 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.95 1.767 . . . . 71.31 111.661 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.3 pt -113.94 161.84 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.637 0.732 . . . . 73.31 112.883 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.45 133.58 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.342 -0.845 . . . . 74.24 110.275 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -95.99 96.39 8.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.011 0.434 . . . . 53.13 111.34 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.602 HG22 HD12 ' A' ' 222' ' ' LEU . 41.5 t -94.33 117.17 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.031 0.443 . . . . 54.24 112.108 -176.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.99 100.13 12.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.188 0.518 . . . . 74.23 111.112 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 98.1 mt -69.95 161.77 73.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.696 -0.683 . . . . 71.43 111.614 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 9.8 Cg_endo -52.09 153.24 12.83 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.768 2.312 . . . . 64.34 113.345 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 61.96 44.6 8.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.495 0.664 . . . . 71.22 110.901 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 61.47 23.77 13.98 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.096 0.776 . . . . 74.22 113.096 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.9 mm-40 -86.88 157.76 19.47 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.068 -0.395 . . . . 64.44 111.101 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -139.74 145.44 38.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.443 0.534 . . . . 74.54 112.443 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.1 t -148.1 161.9 40.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.795 -0.639 . . . . 64.33 110.19 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.34 120.32 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.954 0.407 . . . . 71.34 111.254 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.04 137.05 26.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.461 -0.336 . . . . 43.22 111.449 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.513 ' HG2' HH21 ' A' ' 172' ' ' ARG . 65.0 Cg_endo -74.12 126.16 10.32 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 72.14 113.007 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.74 35.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.092 0.472 . . . . 61.44 112.165 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.513 HH21 ' HG2' ' A' ' 170' ' ' PRO . 11.5 ptp180 -167.71 161.97 13.69 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.001 -0.545 . . . . 73.12 111.604 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.7 t -95.47 154.32 17.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.306 -0.407 . . . . 63.02 111.351 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 66.5 18.66 68.03 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.248 -0.501 . . . . 60.23 113.266 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.495 ' HB ' ' HG3' ' A' ' 172' ' ' ARG . 40.8 t -132.8 124.72 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.644 0.378 . . . . 72.12 110.468 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.6 p -82.84 158.05 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 64.21 111.622 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.62 -35.77 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.617 0.722 . . . . 73.33 110.017 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.9 ttp180 -56.42 -54.65 43.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.948 -1.024 . . . . 72.23 111.319 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -74.16 -12.53 60.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.18 -0.464 . . . . 71.01 111.718 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.5 m -82.79 -46.78 12.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.037 0.446 . . . . 63.43 110.944 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.72 4.94 48.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.311 0.486 . . . . 54.33 112.311 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -54.92 -26.63 37.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.878 0.37 . . . . 74.32 111.8 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.02 -52.11 6.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.68 0.276 . . . . 70.34 111.556 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.34 64.11 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.005 0.431 . . . . 65.51 112.117 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.401 HD11 ' CH2' ' A' ' 210' ' ' TRP . 87.2 mt -71.03 -53.78 13.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.934 0.397 . . . . 43.42 111.483 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.2 tpp -57.05 -42.09 79.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.358 0.503 . . . . 71.43 112.358 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.3 ptp -66.63 -15.44 63.47 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.118 0.414 . . . . 74.34 112.118 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -110.14 5.2 21.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.864 0.364 . . . . 74.34 111.551 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.05 35.54 89.34 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.464 -0.398 . . . . 75.33 113.229 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.6 159.95 15.81 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.086 0.469 . . . . 74.3 111.54 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.01 151.7 77.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.959 -0.564 . . . . 70.42 110.816 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.53 -34.3 51.42 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.683 2.255 . . . . 70.33 113.292 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -64.02 -22.03 66.75 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.2 0.524 . . . . 64.35 111.906 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.6 t -96.4 -7.49 34.86 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.335 0.494 . . . . 63.45 112.335 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' CYS . . . . . 0.403 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.4 m -134.89 131.65 37.59 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.683 0.623 . . . . 72.23 112.683 -172.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -111.31 127.33 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.18 -0.463 . . . . 55.43 111.324 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 224' ' ' VAL . 47.0 t -100.07 133.36 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.536 -0.302 . . . . 54.4 111.405 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -152.37 160.62 43.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.257 0.551 . . . . 72.51 111.812 175.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -122.93 155.94 35.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.074 -0.512 . . . . 64.32 110.677 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.95 120.75 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.8 0.333 . . . . 73.22 111.03 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -129.74 115.94 18.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.832 0.349 . . . . 72.2 111.207 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.1 t70 63.43 31.36 15.07 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.312 0.577 . . . . 73.01 111.155 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.55 50.25 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.258 -0.496 . . . . 42.01 114.221 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -102.34 155.7 18.07 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.399 0.599 . . . . 65.04 112.314 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -103.8 136.19 43.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.739 -0.664 . . . . 72.45 112.445 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -118.66 116.28 34.9 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 116.227 -0.442 . . . . 73.21 111.205 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.14 121.78 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.02 2.48 . . . . 74.24 112.911 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.85 122.79 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.171 0.51 . . . . 71.11 111.478 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.37 145.47 33.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.18 -0.533 . . . . 64.22 113.206 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.6 m95 -61.93 -27.55 68.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.922 0.391 . . . . 75.43 111.909 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.87 -10.3 59.31 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.222 -0.445 . . . . 75.32 111.675 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 90.5 m -69.52 136.97 52.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.21 111.663 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.99 126.23 27.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.89 0.376 . . . . 70.1 111.272 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 172' ' ' ARG . 12.7 tt -58.43 -19.92 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.977 0.418 . . . . 75.35 111.894 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -52.42 -33.63 44.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.255 0.465 . . . . 65.21 112.255 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -65.15 -28.34 69.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.15 0.5 . . . . 73.14 111.766 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 222' ' ' LEU . 35.7 mt -98.75 14.91 27.05 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.554 0.576 . . . . 73.22 112.554 -169.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.3 m -54.93 108.35 0.39 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.134 0.492 . . . . 74.13 112.237 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.9 69.66 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.457 -0.402 . . . . 70.45 113.954 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -84.53 163.46 19.36 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.321 0.581 . . . . 61.2 112.209 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -106.42 118.15 35.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.816 -0.629 . . . . 72.42 110.375 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.602 HD12 HG22 ' A' ' 159' ' ' VAL . 59.2 mt -93.01 111.86 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.006 0.431 . . . . 65.11 110.876 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -92.11 103.31 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.506 -0.316 . . . . 72.22 110.338 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 197' ' ' VAL . 35.3 t -99.0 123.35 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 111.998 0.37 . . . . 74.32 111.998 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -115.92 177.02 4.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.963 0.411 . . . . 74.24 111.366 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.6 138.03 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.691 0.626 . . . . 72.34 112.691 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.6 mt -100.92 -72.39 0.68 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.14 -0.482 . . . . 74.34 110.989 175.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.43 156.11 19.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.882 0.373 . . . . 75.42 111.436 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -100.85 -29.5 12.21 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.313 0.486 . . . . 73.11 112.313 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.66 125.55 59.02 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.196 0.443 . . . . 63.2 112.196 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -87.39 145.91 7.19 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.642 2.228 . . . . 74.14 113.05 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.778 -0.629 . . . . 70.22 110.345 177.082 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.3 t60 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.419 0.152 . . . . 73.31 111.187 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -81.32 141.25 49.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 120.575 0.226 . . . . 65.33 110.856 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.68 126.78 7.57 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.512 2.141 . . . . 61.45 113.227 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.495 ' H ' ' HD3' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -75.86 143.09 41.98 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.791 0.329 . . . . 75.21 111.116 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -128.45 134.17 25.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-O 120.826 0.346 . . . . 73.41 111.85 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 62.43 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.803 2.335 . . . . 72.3 112.624 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.72 38.65 0.52 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.256 0.55 . . . . 74.21 111.711 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.1 155.31 43.63 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.002 -0.545 . . . . 60.14 110.362 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.55 140.01 75.41 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.743 2.295 . . . . 73.14 113.066 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -137.48 167.71 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.342 0.591 . . . . 75.45 112.496 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 46.8 t -129.92 139.09 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.816 -0.629 . . . . 63.03 110.349 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.758 ' HG2' HG22 ' A' ' 168' ' ' VAL . 98.9 mtt180 -108.69 117.86 35.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.292 0.568 . . . . 65.11 111.574 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 181' ' ' LEU . 75.3 t -109.92 131.69 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.292 0.478 . . . . 71.01 112.292 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -89.53 94.58 9.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.125 0.488 . . . . 63.14 110.934 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 81.9 mt -68.81 154.9 94.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.904 -0.589 . . . . 73.14 111.201 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.75 154.01 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.463 2.109 . . . . 64.01 112.375 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 10.8 m120 72.09 12.74 5.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.935 0.494 . . . . 63.33 110.78 -173.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt 64.59 59.39 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.191 0.596 . . . . 73.04 112.445 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 83.8 mm-40 -113.41 135.95 53.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.004 -0.544 . . . . 74.05 110.481 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.7 mpt_? -105.89 128.67 53.92 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.026 0.441 . . . . 75.52 111.889 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -136.96 156.17 48.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.436 -0.347 . . . . 75.34 111.16 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.758 HG22 ' HG2' ' A' ' 158' ' ' ARG . 38.7 t -126.38 132.78 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.934 0.397 . . . . 71.55 111.57 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.53 146.95 56.37 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.31 -0.405 . . . . 72.22 111.011 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 156' ' ' ILE . 57.5 Cg_endo -70.46 122.44 8.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.336 2.024 . . . . 42.52 113.261 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -74.03 114.81 12.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.919 0.39 . . . . 63.23 111.134 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' ' 175' ' ' VAL . 19.2 ptt-85 -132.67 142.34 49.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 72.54 111.896 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 45.7 t -77.58 140.22 39.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.242 -0.436 . . . . 72.01 111.66 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.77 55.99 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.238 -0.506 . . . . 63.14 113.242 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' VAL . . . . . 0.453 HG21 ' HG3' ' A' ' 172' ' ' ARG . 45.5 t -134.51 135.36 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 122.476 0.31 . . . . 75.21 110.751 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.8 p -81.63 159.71 23.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.123 0.487 . . . . 74.15 111.697 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 212' ' ' THR . 81.2 t -58.09 -37.69 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.286 0.565 . . . . 55.04 110.574 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 36.9 ttp180 -59.83 -56.76 17.71 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.673 -0.694 . . . . 71.14 111.511 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 68.2 m-20 -64.19 -17.04 63.15 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 71.12 112.347 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -93.69 -39.05 10.99 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.098 -0.376 . . . . 65.23 111.775 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 159' ' ' VAL . 65.2 mt -91.83 -5.54 53.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.753 0.649 . . . . 75.42 112.753 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 20.4 ptmt -54.28 -34.42 60.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.772 0.32 . . . . 71.54 111.751 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.58 -39.91 77.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.05 0.452 . . . . 63.55 111.361 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.75 98.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.986 0.422 . . . . 70.14 111.223 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.47 -43.11 91.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.125 -0.489 . . . . 44.24 110.768 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.5 ttp -55.66 -50.71 69.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.116 -0.493 . . . . 73.44 111.488 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -72.71 -0.5 13.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.789 0.328 . . . . 74.43 111.872 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 19.3 mmm180 -117.41 1.68 12.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.787 0.292 . . . . 74.23 111.787 175.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 63.28 47.1 90.79 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.339 -0.458 . . . . 63.25 113.424 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 92.4 mt -132.86 159.92 38.45 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.987 0.422 . . . . 73.22 111.915 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.78 147.36 38.04 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.773 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.76 -47.08 26.78 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.608 2.205 . . . . 71.3 113.753 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.63 -3.47 21.76 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.727 0.64 . . . . 70.22 112.727 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -94.47 -8.54 38.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.047 0.451 . . . . 74.01 111.339 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 93.3 m -135.29 158.72 43.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.049 0.452 . . . . 75.11 111.811 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.445 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -124.93 131.72 53.39 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.304 -0.407 . . . . 70.25 111.379 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 224' ' ' VAL . 58.2 t -103.05 125.44 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.436 -0.347 . . . . 74.01 111.097 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.431 ' HE1' ' HG2' ' A' ' 225' ' ' GLU . 40.6 p90 -137.36 151.56 48.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.008 0.432 . . . . 74.11 111.111 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.456 ' HG2' HD11 ' A' ' 208' ' ' ILE . 37.4 ptt180 -111.7 142.2 44.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.031 -0.359 . . . . 70.21 110.031 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 205' ' ' LYS . 48.8 mt -82.79 103.45 10.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 74.3 109.732 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -102.82 109.77 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 75.1 110.827 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.4 t70 60.68 16.95 7.07 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.765 -0.652 . . . . 64.23 111.366 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.99 -19.45 30.15 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.519 -0.372 . . . . 70.51 113.572 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.43 123.97 33.5 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.294 -0.533 . . . . 73.04 111.969 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 200' ' ' ILE . 96.6 mttt -79.89 104.2 10.31 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.405 -0.362 . . . . 63.21 110.611 174.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.06 115.24 40.88 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.9 0.381 . . . . 72.02 111.892 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.05 133.94 46.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.515 2.81 . . . . 72.02 113.861 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.456 HD11 ' HG2' ' A' ' 199' ' ' ARG . 50.0 mt -110.03 153.05 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.623 -0.717 . . . . 61.32 110.758 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.38 150.42 21.28 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.844 -0.694 . . . . 73.22 112.9 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 90.5 m95 -67.76 -27.67 66.97 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.178 -0.601 . . . . 73.1 111.634 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.78 -3.57 51.44 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.941 0.348 . . . . 54.51 111.941 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 177' ' ' VAL . 88.7 m -68.55 141.9 55.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.938 0.399 . . . . 70.33 111.071 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.12 117.71 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.063 0.458 . . . . 72.43 111.426 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.55 -22.07 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 N-CA-C 112.392 0.516 . . . . 74.52 112.392 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.5 p -59.91 -18.21 43.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.335 0.494 . . . . 74.34 112.335 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.39 -14.43 58.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.945 0.403 . . . . 72.33 111.954 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.53 22.87 14.94 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.175 0.512 . . . . 72.41 111.491 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.9 m -61.72 121.44 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.807 0.669 . . . . 74.24 112.807 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.6 -23.44 33.94 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.32 0.888 . . . . 61.14 115.32 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -99.32 172.25 7.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.981 0.89 . . . . 73.24 112.487 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 25.7 mp0 -93.26 139.87 30.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.945 -0.571 . . . . 71.34 111.936 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 90.6 mt -111.92 152.89 27.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.436 -0.347 . . . . 74.01 111.303 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -117.14 134.49 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.567 0.222 . . . . 75.43 111.138 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 197' ' ' VAL . 64.4 t -115.79 116.47 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 71.13 111.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.431 ' HG2' ' HE1' ' A' ' 198' ' ' TYR . 61.8 mm-40 -102.97 137.43 41.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.405 -0.361 . . . . 70.54 111.016 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.88 108.83 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.842 0.353 . . . . 70.11 110.837 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 196' ' ' ALA . 95.8 mt -63.43 -63.82 1.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.095 0.474 . . . . 41.42 111.548 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -118.98 119.11 33.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.12 0.486 . . . . 73.45 111.097 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.86 -25.69 65.26 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.041 0.756 . . . . 71.22 113.041 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.1 t -94.37 109.41 42.64 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 120.501 0.191 . . . . 44.3 111.419 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.99 168.63 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.929 2.419 . . . . 61.51 113.006 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--O 1.255 1.387 0 CA-C-O 119.051 -0.499 . . . . 55.14 111.677 178.126 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 112.124 0.416 . . . . 72.42 112.124 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.6 mtm 67.3 96.83 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 122.965 0.506 . . . . 72.4 111.86 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.1 159.96 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.734 2.289 . . . . 44.31 113.392 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -97.24 145.14 26.36 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.078 0.466 . . . . 73.4 111.355 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.0 p -79.77 136.15 55.31 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 116.232 -0.44 . . . . 73.21 111.428 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.55 160.76 46.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.531 2.154 . . . . 70.31 112.649 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.57 84.75 0.43 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.283 0.563 . . . . 75.44 110.741 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 154' ' ' LYS . 1.5 pptp? -71.81 148.16 92.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.854 -0.612 . . . . 74.31 111.671 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.08 130.53 38.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.415 . . . . 72.54 113.13 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -132.33 169.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.962 0.411 . . . . 53.41 111.797 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 171' ' ' ALA . 55.0 t -130.6 132.42 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 71.14 110.531 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 85.8 mtt180 -89.13 98.41 11.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.76 0.314 . . . . 74.03 110.722 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 181' ' ' LEU . 35.6 t -99.13 111.14 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.24 0.543 . . . . 51.31 112.051 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -89.45 111.97 23.0 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.104 -0.498 . . . . 74.54 110.673 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.5 mt -90.75 161.74 35.28 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.252 -0.431 . . . . 64.35 111.624 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 50.8 Cg_exo -55.54 162.51 6.22 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.555 2.17 . . . . 63.33 113.353 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.83 36.59 22.01 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.056 0.455 . . . . 75.13 111.617 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.2 13.44 9.15 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.103 0.779 . . . . 62.45 113.103 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.5 mm-40 -76.72 159.7 29.96 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.89 0.376 . . . . 74.34 111.46 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.56 154.07 38.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.328 0.585 . . . . 72.51 112.28 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . 0.425 HG23 ' HB ' ' A' ' 159' ' ' VAL . 7.9 t -157.63 150.84 23.44 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.771 -0.65 . . . . 75.41 111.054 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.47 119.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.777 0.323 . . . . 63.23 110.244 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.57 152.41 58.34 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.495 -0.321 . . . . 74.22 111.768 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.2 132.36 19.37 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.595 2.197 . . . . 75.2 113.583 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -89.48 104.7 17.23 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.029 0.442 . . . . 51.23 111.431 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.42 140.71 52.4 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.4 -0.363 . . . . 60.04 111.917 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.98 122.35 19.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.429 -0.351 . . . . 61.1 110.79 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.67 -29.5 7.8 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.233 -0.508 . . . . 63.23 112.428 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 62.7 t -89.55 126.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.736 0.303 . . . . 54.24 111.052 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 69.6 p -87.32 160.83 18.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.896 0.379 . . . . 62.41 111.46 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.93 -39.39 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.019 0.438 . . . . 73.44 111.668 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 24.5 ttp180 -74.23 -21.16 59.91 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.34 . . . . 71.24 111.744 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 17.4 t70 -84.05 -34.38 24.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.112 0.482 . . . . 72.25 111.288 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 78.4 p -80.84 -55.1 5.03 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.114 0.483 . . . . 74.13 111.632 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 159' ' ' VAL . 86.0 mt -73.54 -2.31 22.24 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.681 0.993 . . . . 64.23 113.681 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 22.0 pttp -60.72 -29.08 69.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.619 0.645 . . . . 72.02 112.236 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -76.69 -38.94 53.59 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.167 -0.333 . . . . 72.41 110.998 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -60.15 -54.68 42.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.91 0.386 . . . . 54.44 110.958 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.4 HD11 ' CH2' ' A' ' 210' ' ' TRP . 85.4 mt -55.52 -45.74 77.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.164 -0.471 . . . . 71.43 110.789 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -55.19 -55.79 27.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.118 -0.492 . . . . 64.32 111.961 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.0 ptp -67.53 -22.18 65.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.559 0.577 . . . . 71.44 112.559 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 67.9 mmt-85 -91.97 -23.07 19.68 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.28 -0.262 . . . . 72.31 111.679 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.16 42.42 4.64 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.534 -0.365 . . . . 44.23 113.246 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.15 162.94 24.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.989 0.423 . . . . 75.2 111.417 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.81 142.86 46.44 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.564 -0.289 . . . . 72.23 111.291 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.19 -19.68 58.24 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.812 2.342 . . . . 70.21 113.782 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.15 -28.8 57.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 74.12 111.797 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 226' ' ' VAL . 51.2 t -106.89 19.1 20.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.911 0.386 . . . . 73.33 111.506 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.6 m -130.65 130.28 43.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.295 0.569 . . . . 73.21 111.911 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.0 119.44 39.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.795 -0.639 . . . . 65.41 111.209 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 224' ' ' VAL . 43.9 t -99.78 122.32 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.526 0.203 . . . . 72.41 111.051 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.411 ' HE2' ' HG3' ' A' ' 225' ' ' GLU . 42.4 p90 -134.07 152.13 51.7 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.238 0.542 . . . . 65.24 111.479 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 199' ' ' ARG . 4.1 ptm180 -115.5 142.88 46.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.582 . . . . 74.43 110.454 176.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ILE . . . . . 0.5 HG12 ' HG2' ' A' ' 205' ' ' LYS . 55.9 mt -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.904 0.383 . . . . 75.21 111.355 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.403 ' HG2' ' OD2' ' A' ' 202' ' ' ASP . 25.7 tt0 -161.62 133.41 5.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.142 -0.481 . . . . 71.11 110.827 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD2' ' HG2' ' A' ' 201' ' ' GLN . 11.1 m-20 60.72 28.65 18.37 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.895 0.379 . . . . 54.22 112.006 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.49 10.7 85.98 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.002 -0.618 . . . . 74.21 113.415 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.47 145.17 42.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.142 0.496 . . . . 62.15 111.781 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 200' ' ' ILE . 97.9 mttt -102.36 102.44 12.78 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 74.52 110.22 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.83 113.67 56.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.333 -0.394 . . . . 70.11 111.733 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.69 139.52 63.76 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.645 2.23 . . . . 70.53 112.488 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.22 142.39 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.981 0.42 . . . . 62.22 111.41 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.25 137.8 14.62 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.127 -0.558 . . . . 74.12 112.651 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -63.29 -17.17 62.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.373 -0.486 . . . . 71.41 111.8 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.49 -10.46 59.47 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.974 -0.557 . . . . 61.13 112.281 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 68.6 m -80.32 143.87 33.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.076 0.398 . . . . 54.14 112.076 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.42 132.52 52.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 64.12 111.961 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -65.38 -18.37 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.189 -0.46 . . . . 73.51 111.492 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.0 p -62.16 -23.65 66.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.975 0.417 . . . . 55.55 111.821 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -71.81 -15.77 62.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.045 0.45 . . . . 64.0 111.173 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.2 mt -113.85 13.56 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.052 -0.522 . . . . 61.51 111.307 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 98.1 m -51.9 113.77 1.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.708 0.633 . . . . 75.42 112.708 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 90.77 -17.93 52.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.308 -0.472 . . . . 73.14 113.821 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -73.99 168.06 20.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.544 0.688 . . . . 72.14 112.121 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . 0.51 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.6 mt-10 -112.72 114.74 27.47 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.586 -0.734 . . . . 74.14 110.77 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 159' ' ' VAL . 68.3 mt -93.33 147.72 22.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.122 0.487 . . . . 74.01 111.342 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -127.54 117.67 22.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 74.15 110.054 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.59 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 40.2 t -103.96 144.68 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.07 0.462 . . . . 71.53 112.215 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.411 ' HG3' ' HE2' ' A' ' 198' ' ' TYR . 22.4 mt-10 -130.75 177.85 7.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.205 -0.452 . . . . 72.2 111.633 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' VAL . . . . . 0.495 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.0 t -91.94 140.44 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.837 0.351 . . . . 73.51 111.815 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt -106.96 -86.21 0.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.144 0.424 . . . . 71.12 112.144 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.01 106.26 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.448 0.642 . . . . 73.43 111.682 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -80.56 42.29 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.659 0.743 . . . . 63.04 111.321 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.7 m -137.53 66.36 50.25 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 121.023 0.44 . . . . 71.1 111.364 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.0 102.18 1.21 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.402 2.068 . . . . 64.14 112.59 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.622 -0.704 . . . . 63.32 111.673 -179.204 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.617 0.246 . . . . 73.33 111.598 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.1 ptm -104.72 114.9 63.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 120.996 0.426 . . . . 72.04 111.035 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.92 -166.56 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.731 2.287 . . . . 72.33 112.854 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 150' ' ' LYS . 25.0 pttm -138.94 99.88 3.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.495 0.664 . . . . 74.14 111.384 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 78.9 p -95.3 110.97 53.4 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.357 -0.383 . . . . 72.41 110.377 175.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.98 54.38 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.776 2.317 . . . . 70.21 112.55 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.31 39.17 0.38 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.217 0.532 . . . . 63.53 112.295 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -98.12 151.89 37.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.283 -0.417 . . . . 61.34 109.95 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 9.3 Cg_endo -50.02 129.81 25.91 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.839 2.359 . . . . 75.52 113.367 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.62 160.92 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.36 0.6 . . . . 65.2 112.086 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 129.86 65.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.805 -0.634 . . . . 74.22 110.535 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 158' ' ' ARG . 68.2 mtt85 -96.21 98.46 10.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.736 0.303 . . . . 62.35 111.416 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 222' ' ' LEU . 41.2 t -96.26 120.09 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.068 0.461 . . . . 74.22 112.043 -176.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.09 115.32 27.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.128 0.49 . . . . 71.1 110.747 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -93.47 165.71 17.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.947 -0.57 . . . . 74.44 111.527 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 20.6 Cg_endo -60.5 168.01 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.246 1.964 . . . . 71.44 112.534 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.94 27.2 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.081 0.4 . . . . 72.13 112.081 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.34 26.76 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.728 0.411 . . . . 53.32 111.795 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 76.9 mm-40 -92.43 162.21 14.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.92 0.39 . . . . 44.3 111.131 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -151.56 156.12 39.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.938 0.399 . . . . 72.0 111.786 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 t -156.85 126.99 6.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.274 -0.421 . . . . 74.12 111.535 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.62 119.73 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.29 -0.256 . . . . 74.15 110.557 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.74 144.87 39.83 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 112.014 0.376 . . . . 63.42 112.014 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.24 139.73 67.47 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.608 2.206 . . . . 74.41 112.923 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -93.31 109.7 21.24 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 55.23 111.606 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -97.22 132.39 43.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.386 -0.37 . . . . 74.34 110.997 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.1 t -70.7 121.25 17.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.774 0.321 . . . . 73.12 111.122 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.2 -9.69 50.32 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.369 -0.444 . . . . 55.25 113.168 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.88 135.28 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 122.432 -0.452 . . . . 71.3 110.526 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 69.8 p -81.54 167.04 19.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.299 0.571 . . . . 51.24 112.266 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 212' ' ' THR . 77.9 t -59.49 -37.66 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.371 0.605 . . . . 55.44 110.773 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.561 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 31.5 ttp180 -66.36 -55.87 13.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.811 -0.631 . . . . 50.33 111.226 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.575 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 17.0 t70 -60.83 -36.0 77.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.162 -0.472 . . . . 72.43 112.004 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 81.8 p -77.14 -59.0 2.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.906 0.384 . . . . 61.1 111.874 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.89 -23.66 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.335 0.865 . . . . 64.03 113.335 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 23.3 pttp -59.96 -22.69 62.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.613 0.642 . . . . 73.13 111.538 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.68 -41.42 53.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.139 0.495 . . . . 74.32 110.562 174.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.79 81.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 74.42 110.692 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.27 -38.29 68.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.17 -0.468 . . . . 53.32 110.744 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 26.3 ttt -53.7 -48.93 69.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.305 -0.407 . . . . 73.3 111.748 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -65.97 -27.07 67.87 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.752 0.311 . . . . 64.41 111.583 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.09 -22.31 31.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.934 0.397 . . . . 71.15 111.383 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.51 17.38 45.82 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.364 -0.446 . . . . 74.24 113.124 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.55 168.63 9.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.261 0.553 . . . . 72.44 111.96 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -129.77 139.73 36.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.127 -0.488 . . . . 75.24 111.343 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.24 -36.74 97.46 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.947 2.432 . . . . 74.21 113.898 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.41 -18.85 60.74 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.947 0.403 . . . . 62.33 111.923 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.14 -5.81 32.8 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.22 0.452 . . . . 74.31 112.22 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.5 m -119.07 151.53 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.365 0.506 . . . . 63.4 112.365 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -127.64 122.71 33.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.246 -0.434 . . . . 60.35 111.362 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 224' ' ' VAL . 56.5 t -98.12 136.26 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.641 -0.254 . . . . 54.4 111.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -149.31 165.63 31.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.037 0.446 . . . . 75.42 111.165 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -141.28 158.03 44.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.276 -0.42 . . . . 74.21 110.332 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.1 mt -92.21 113.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.286 0.565 . . . . 74.54 111.719 -174.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 206' ' ' LYS . 33.8 tt0 -139.02 142.19 38.27 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.566 -0.743 . . . . 74.43 110.494 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.65 21.86 10.55 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.534 0.683 . . . . 74.31 111.021 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.8 82.96 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.252 -0.431 . . . . 61.31 113.149 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -125.82 151.54 46.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.26 0.552 . . . . 72.05 111.819 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -82.64 97.27 8.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.087 -0.506 . . . . 73.14 110.198 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 201' ' ' GLN . 67.2 mttm -96.63 111.66 57.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.938 0.347 . . . . 62.32 111.938 -175.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.48 142.94 96.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.996 2.464 . . . . 73.15 113.387 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 217' ' ' LEU . 66.5 mt -113.5 134.34 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.99 -0.55 . . . . 74.1 111.016 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.34 133.74 16.8 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.886 -0.673 . . . . 15.31 112.887 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' TRP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.1 m95 -60.57 -26.17 66.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.017 0.437 . . . . 73.22 111.31 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.11 5.81 24.72 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.437 0.532 . . . . 54.42 112.437 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.3 m -83.84 141.46 31.32 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.492 0.187 . . . . 64.24 110.98 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.3 130.52 45.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.857 0.361 . . . . 72.25 111.238 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.0 tp -59.62 -22.55 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.07 0.462 . . . . 72.25 111.654 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 71.2 p -62.65 -26.87 68.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.244 -0.435 . . . . 64.3 112.001 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' TRP . . . . . 0.407 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.2 m0 -65.37 -22.64 66.83 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.292 0.568 . . . . 74.11 111.082 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 222' ' ' LEU . 46.6 mt -108.3 13.52 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.763 -0.653 . . . . 74.21 111.622 -175.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.9 m -52.8 118.06 3.4 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.166 0.432 . . . . 74.41 112.166 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.33 79.19 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.269 0.468 . . . . 72.01 114.269 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -105.52 164.33 11.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.497 0.665 . . . . 64.34 112.451 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -103.25 117.04 33.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.392 -0.822 . . . . 74.14 110.566 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 217' ' ' LEU . 60.3 mt -93.68 145.92 24.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.013 0.435 . . . . 75.25 111.016 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.5 m80 -121.95 117.02 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.561 -0.291 . . . . 75.24 110.451 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 197' ' ' VAL . 73.3 t -104.84 121.17 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.603 0.594 . . . . 71.35 112.603 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -106.69 164.58 11.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.008 -0.542 . . . . 72.41 110.832 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.89 124.64 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.774 0.321 . . . . 73.15 111.478 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 196' ' ' ALA . 75.2 mt -75.8 -48.41 21.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.947 0.403 . . . . 72.02 111.508 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.99 168.97 25.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.173 -0.467 . . . . 73.12 111.296 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.36 5.72 46.34 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.201 -0.454 . . . . 62.35 111.037 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 40.0 t 57.28 80.0 0.3 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 121.186 0.517 . . . . 61.11 110.427 -172.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.66 -172.29 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.926 2.417 . . . . 55.34 113.913 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.839 -0.601 . . . . 73.41 110.852 179.163 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt . . . . . 0 CA--C 1.539 0.543 0 N-CA-C 109.943 -0.392 . . . . 73.329999999999998 109.943 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.98 130.74 25.18 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.727 1.618 . . . . 74.239999999999995 111.114 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.03 166.54 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 113.428 0.899 . . . . 60.210000000000001 113.428 -171.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 171' ' ' ALA . 58.3 t -124.55 137.52 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.36 -0.836 . . . . 74.319999999999993 110.439 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 23.0 mtp85 -100.54 105.54 16.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.828 0.347 . . . . 72.129999999999995 111.375 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 181' ' ' LEU . 54.4 t -107.23 122.9 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.986 0.422 . . . . 64.329999999999998 111.919 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -93.68 119.29 32.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.119 0.485 . . . . 55.32 111.135 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 92.9 mt -93.17 155.68 40.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.804 -0.634 . . . . 72.120000000000005 111.897 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.19 159.53 26.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.608 2.206 . . . . 64.420000000000002 113.099 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.507 ' HB2' HH22 ' A' ' 188' ' ' ARG . 85.7 m-20 64.76 39.24 6.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.993 -0.549 . . . . 43.200000000000003 111.993 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 66.18 27.0 10.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.18 0.807 . . . . 62.350000000000001 113.18 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.9 mm-40 -104.61 166.88 10.1 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.019 -0.425 . . . . 45.340000000000003 111.419 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -159.32 157.23 30.08 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.094 -0.379 . . . . 65.329999999999998 111.494 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -154.3 159.37 41.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.026 0.441 . . . . 72.549999999999997 111.51 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 128.74 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.322 -0.399 . . . . 73.200000000000003 110.733 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.419 HG23 HD11 ' A' ' 214' ' ' ILE . 17.3 m -125.4 141.96 40.32 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 111.835 0.309 . . . . 64.409999999999997 111.835 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.47 123.59 11.0 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.83 2.353 . . . . 65.439999999999998 113.374 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -73.68 102.76 4.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.085 0.469 . . . . 74.510000000000005 111.275 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -112.85 137.78 50.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.098 -0.501 . . . . 65.340000000000003 111.231 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -74.23 126.4 30.52 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.787 0.327 . . . . 55.119999999999997 111.372 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.73 -28.6 11.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.375 -0.44 . . . . 73.319999999999993 112.608 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.41 133.62 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.717 0.294 . . . . 54.310000000000002 111.127 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 56.7 p -82.48 155.3 24.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.009 0.433 . . . . 73.329999999999998 111.482 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 212' ' ' THR . 63.3 t -54.68 -39.03 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.05 0.452 . . . . 51.020000000000003 110.894 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.3 ttm-85 -59.94 -53.29 59.58 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 74.510000000000005 111.07 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.0 -19.76 64.95 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 73.450000000000003 111.405 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.0 m -80.66 -44.58 18.59 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.08 0.467 . . . . 72.319999999999993 111.467 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 159' ' ' VAL . 95.9 mt -92.07 -0.01 57.46 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.778 0.658 . . . . 54.310000000000002 112.778 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -51.65 -36.91 48.06 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.225 0.454 . . . . 54.240000000000002 112.225 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -67.69 -46.1 73.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.986 0.422 . . . . 75.409999999999997 111.235 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -61.3 -43.22 99.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.127 -0.488 . . . . 74.099999999999994 111.334 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 94.5 mt -64.78 -45.45 86.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.317 -0.401 . . . . 75.430000000000007 111.205 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.1 tpt -56.87 -49.57 75.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.383 -0.371 . . . . 72.319999999999993 111.696 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.8 ptm -67.2 -17.22 64.73 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.886 0.328 . . . . 74.109999999999999 111.886 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 42.2 mmm-85 -95.93 -13.71 23.67 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.153 -0.342 . . . . 61.219999999999999 111.413 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.17 27.58 61.78 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.342 -0.456 . . . . 61.350000000000001 113.106 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 90.6 mt -112.82 131.07 55.86 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.887 0.375 . . . . 74.340000000000003 111.738 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.26 142.45 38.08 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.644 -0.253 . . . . 71.219999999999999 110.885 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.02 -24.35 57.15 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.711 2.274 . . . . 63.420000000000002 113.45 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.2 -14.62 58.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.131 0.419 . . . . 70.120000000000005 112.131 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.47 11.37 32.65 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.132 0.492 . . . . 74.150000000000006 110.864 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.2 m -129.95 133.17 46.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.293 -0.412 . . . . 64.239999999999995 111.303 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.22 144.82 38.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.668 0.27 . . . . 73.430000000000007 111.265 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.18 140.49 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.852 0.358 . . . . 54.509999999999998 111.574 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.67 158.67 43.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.188 0.518 . . . . 72.450000000000003 111.8 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -122.84 161.22 24.48 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.8 -0.636 . . . . 74.530000000000001 110.41 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.0 mt -104.64 114.44 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.153 0.501 . . . . 74.040000000000006 111.536 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -124.06 119.6 29.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.732 -0.667 . . . . 72.430000000000007 110.203 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 57.19 31.97 20.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.169 0.509 . . . . 74.340000000000003 111.214 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 85.24 -2.92 87.94 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.227 -0.511 . . . . 73.530000000000001 113.715 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -101.85 139.16 37.87 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.345 -0.503 . . . . 72.299999999999997 112.092 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -89.14 103.43 16.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.147 -0.478 . . . . 65.049999999999997 110.869 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 207' ' ' PRO . 45.4 mmtm -104.11 127.54 29.02 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.685 0.279 . . . . 72.0 111.587 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 22.6 Cg_exo -65.75 152.28 82.05 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.204 2.602 . . . . 54.409999999999997 113.758 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 217' ' ' LEU . 70.6 mt -129.85 138.57 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 73.540000000000006 111.007 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.98 134.42 12.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.062 -0.589 . . . . 43.310000000000002 112.927 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.6 m95 -57.27 -30.51 64.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.287 0.477 . . . . 61.130000000000003 112.287 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -87.24 7.79 26.95 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.131 0.419 . . . . 62.039999999999999 112.131 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.8 m -82.6 140.55 33.15 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.296 -0.252 . . . . 72.310000000000002 110.797 174.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 4.2 m-20 -59.1 126.9 29.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 72.329999999999998 111.595 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 169' ' ' VAL . 12.1 tt -60.24 -21.48 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.134 -0.485 . . . . 75.329999999999998 111.819 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 76.8 p -60.65 -27.5 67.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.681 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 15.6 m95 -70.37 -16.33 62.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.955 0.407 . . . . 73.099999999999994 111.484 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 208' ' ' ILE . 80.1 mt -112.77 22.52 14.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.31 -0.404 . . . . 71.200000000000003 111.936 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.8 m -56.74 108.42 0.5 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.853 0.359 . . . . 75.450000000000003 111.919 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.46 11.12 61.25 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.171 -0.538 . . . . 50.200000000000003 114.048 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -93.8 151.32 19.69 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.342 0.571 . . . . 65.409999999999997 111.628 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -105.46 114.35 28.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.082 0.468 . . . . 64.120000000000005 110.654 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.406 HD22 HD12 ' A' ' 208' ' ' ILE . 58.1 mt -97.48 150.57 20.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.085 0.469 . . . . 43.229999999999997 111.761 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.61 127.61 44.13 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.6 -0.273 . . . . 60.439999999999998 110.458 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.73 137.51 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.399 0.518 . . . . 73.549999999999997 112.399 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.78 144.24 43.31 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.059 -0.519 . . . . 70.420000000000002 111.02 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.36 116.4 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.526 0.203 . . . . 74.329999999999998 110.95 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.472 0.654 0 CA-C-O 120.72 0.295 . . . . 73.140000000000001 111.629 -179.079 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 111.855 0.317 . . . . 71.510000000000005 111.855 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 218' ' ' THR . 43.3 Cg_endo -65.79 144.6 78.14 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.823 2.348 . . . . 64.530000000000001 112.928 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.6 pt -132.21 162.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.068 0.766 . . . . 74.540000000000006 113.068 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.02 123.23 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.251 -0.886 . . . . 54.109999999999999 109.65 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.716 ' HB2' ' HB3' ' A' ' 221' ' ' GLU . 49.5 mtt180 -88.91 95.05 10.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.805 0.336 . . . . 62.299999999999997 111.092 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 181' ' ' LEU . 57.6 t -93.52 114.71 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.977 -0.452 . . . . 64.329999999999998 112.206 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.8 123.92 30.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.647 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.473 HD11 ' HB1' ' A' ' 184' ' ' ALA . 96.3 mt -100.38 156.43 35.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.251 0.463 . . . . 63.219999999999999 112.251 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.508 ' HG2' HH12 ' A' ' 188' ' ' ARG . 19.4 Cg_endo -59.38 165.78 8.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.298 1.999 . . . . 53.210000000000001 112.115 175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 68.22 25.11 7.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.027 0.441 . . . . 73.420000000000002 111.11 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 62.94 43.24 6.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.659 -0.701 . . . . 53.240000000000002 112.111 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -118.51 -179.74 3.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.02 0.438 . . . . 55.210000000000001 111.672 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 159.82 35.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.001 0.429 . . . . 62.009999999999998 112.148 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -155.41 129.01 8.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.018 0.437 . . . . 64.120000000000005 111.503 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.21 119.55 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.696 0.284 . . . . 74.109999999999999 110.314 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.45 138.54 29.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.555 0.217 . . . . 72.140000000000001 111.372 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.8 132.26 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.566 2.178 . . . . 72.109999999999999 113.039 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.78 103.46 5.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.045 0.45 . . . . 73.340000000000003 110.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.2 mtt-85 -106.5 126.35 52.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.305 -0.407 . . . . 72.150000000000006 111.395 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.8 t -75.02 115.71 14.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.813 0.34 . . . . 55.409999999999997 111.146 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.61 -1.04 27.66 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.244 -0.503 . . . . 32.299999999999997 112.58 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.72 133.03 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.743 0.306 . . . . 64.329999999999998 110.874 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 33.0 p -81.59 161.59 23.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.852 0.358 . . . . 70.430000000000007 111.585 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 212' ' ' THR . 81.3 t -56.33 -34.48 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.439 0.638 . . . . 44.210000000000001 110.424 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 47.2 ttp180 -67.35 -56.04 11.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 63.240000000000002 111.619 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.665 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 6.6 m-20 -72.22 -12.36 61.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.818 0.673 . . . . 74.439999999999998 112.818 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 62.0 p -89.18 -50.94 5.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.943 0.402 . . . . 63.25 110.767 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 159' ' ' VAL . 78.5 mt -79.73 -7.54 58.68 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.426 0.898 . . . . 71.230000000000004 113.426 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 14.0 ptpt -55.92 -27.64 53.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.979 -0.45 . . . . 75.219999999999999 111.209 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.99 -45.48 81.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.191 0.519 . . . . 70.340000000000003 110.773 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -66.77 -30.55 70.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.021 -0.536 . . . . 64.310000000000002 111.618 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 91.6 mt -75.17 -43.69 50.86 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.006 0.431 . . . . 71.420000000000002 110.709 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.17 -53.86 47.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.762 -0.653 . . . . 70.230000000000004 112.0 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' HG3' ' A' ' 188' ' ' ARG . 26.4 ptt? -64.62 -8.58 14.8 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.623 0.601 . . . . 63.420000000000002 112.623 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.508 HH12 ' HG2' ' A' ' 162' ' ' PRO . 63.2 mtm180 -119.23 5.37 11.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.849 0.315 . . . . 72.099999999999994 111.849 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.44 95.69 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.294 -0.479 . . . . 41.409999999999997 113.431 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 95.1 mt -124.43 149.87 46.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.32 0.581 . . . . 72.540000000000006 111.753 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.7 pt -104.15 152.72 39.21 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 111.088 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 -20.72 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.762 2.308 . . . . 74.200000000000003 113.825 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.65 -16.55 53.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.847 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.7 t -90.36 -9.2 48.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.02 0.378 . . . . 72.439999999999998 112.02 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.1 m -136.41 147.69 47.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.04 0.448 . . . . 72.209999999999994 111.8 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -125.25 131.55 53.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.875 0.369 . . . . 64.439999999999998 111.466 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 224' ' ' VAL . 57.9 t -94.44 132.54 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.333 -0.394 . . . . 75.209999999999994 110.844 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 37.8 p90 -148.87 163.05 38.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 62.32 111.09 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -134.62 143.49 47.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.496 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.42 97.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 110.133 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 108.61 19.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 75.230000000000004 110.791 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 60.73 30.99 20.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.538 0.685 . . . . 74.409999999999997 110.723 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -12.86 68.82 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.051 -0.522 . . . . 65.239999999999995 113.491 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 39.5 mt-10 -93.45 132.71 37.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 122.251 -0.558 . . . . 75.150000000000006 111.762 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.469 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 55.0 mtpt -78.07 94.88 4.74 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.917 0.389 . . . . 63.450000000000003 110.708 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 204' ' ' GLU . 33.7 mmtp -96.58 109.73 49.53 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 71.099999999999994 111.19 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.29 125.76 13.37 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.876 2.384 . . . . 72.420000000000002 112.561 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -100.27 122.09 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.285 -0.416 . . . . 53.329999999999998 111.066 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 139.72 46.55 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.319 -0.467 . . . . 41.25 113.105 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.6 m95 -60.02 -22.8 63.09 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.969 0.414 . . . . 71.409999999999997 111.603 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -78.47 -6.75 56.26 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.474 0.546 . . . . 75.319999999999993 112.474 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 177' ' ' VAL . 29.5 m -75.47 140.49 42.87 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.716 0.265 . . . . 74.430000000000007 111.716 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.18 126.86 30.02 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.111 0.481 . . . . 73.439999999999998 110.929 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.1 tt -67.05 -23.65 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.503 0.557 . . . . 74.099999999999994 112.503 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -67.44 -12.17 59.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.88 0.372 . . . . 71.120000000000005 111.708 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -70.82 -23.28 62.33 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.176 0.512 . . . . 71.450000000000003 111.197 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 222' ' ' LEU . 28.7 mt -108.66 19.93 19.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.907 -0.588 . . . . 75.510000000000005 111.531 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 155' ' ' PRO . 96.7 m -58.48 115.46 3.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.791 0.664 . . . . 62.310000000000002 112.791 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.19 -27.98 10.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.114 -0.565 . . . . 64.310000000000002 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.64 172.78 6.66 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.371 0.605 . . . . 64.239999999999995 112.161 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 158' ' ' ARG . 1.4 pm0 -108.34 149.53 28.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.545 0.688 . . . . 74.150000000000006 112.305 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 217' ' ' LEU . 85.9 mt -113.51 163.71 14.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 63.210000000000001 111.186 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.44 130.52 46.04 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.556 -0.293 . . . . 72.400000000000006 110.317 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 197' ' ' VAL . 40.1 t -118.25 119.05 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.63 0.252 . . . . 54.0 111.496 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.96 164.29 12.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 71.340000000000003 111.672 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.3 t -77.6 144.6 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.038 0.447 . . . . 71.450000000000003 112.025 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt . . . . . 0 N--CA 1.47 0.568 0 CA-C-N 116.391 -0.368 . . . . 71.140000000000001 111.766 176.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm . . . . . 0 CA--C 1.539 0.526 0 N-CA-C 110.616 -0.142 . . . . 71.200000000000003 110.616 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.56 111.24 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.133 1.889 . . . . 54.240000000000002 111.926 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.2 pt -112.46 161.84 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.681 0.623 . . . . 62.200000000000003 112.681 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 57.8 t -122.56 128.76 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.786 -0.643 . . . . 75.349999999999994 110.279 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.592 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 18.9 mtp180 -96.52 107.9 20.39 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.012 0.434 . . . . 74.239999999999995 110.963 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.94 125.46 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.478 0.548 . . . . 65.530000000000001 112.478 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -82.74 113.71 20.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.261 -0.427 . . . . 45.020000000000003 110.76 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.55 146.88 32.62 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.286 -0.415 . . . . 74.409999999999997 111.046 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.07 160.33 19.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.346 2.031 . . . . 63.100000000000001 112.646 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 69.21 36.48 2.37 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 112.04 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 67.95 36.33 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.633 -0.712 . . . . 74.319999999999993 112.424 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -117.64 171.23 8.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 112.171 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.51 162.14 37.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.491 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.13 163.42 40.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.879 0.371 . . . . 64.519999999999996 111.452 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.6 t -121.69 128.72 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.914 0.388 . . . . 74.219999999999999 111.364 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.62 145.02 45.94 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.446 -0.343 . . . . 55.049999999999997 111.47 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.13 126.51 7.85 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 75.230000000000004 112.666 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -90.96 110.0 21.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.893 0.378 . . . . 73.409999999999997 111.969 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 172' ' ' ARG . 49.7 mtt180 -101.72 167.5 10.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 72.439999999999998 111.105 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.74 128.96 34.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.505 -0.316 . . . . 61.219999999999999 111.1 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.34 33.33 28.85 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.99 -0.624 . . . . 71.239999999999995 113.171 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.1 t -131.35 109.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.104 -0.332 . . . . 74.030000000000001 110.104 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.9 p -63.18 157.09 23.37 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 72.510000000000005 112.399 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 212' ' ' THR . 65.6 t -56.77 -30.53 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 75.230000000000004 110.648 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 18.9 ttp180 -68.99 -53.07 22.53 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.983 -0.553 . . . . 61.100000000000001 111.195 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.551 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 34.7 m-20 -63.3 -35.11 79.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.356 0.598 . . . . 73.439999999999998 111.247 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 39.9 t -66.49 -62.79 1.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.079 -0.51 . . . . 73.040000000000006 111.585 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.6 mt -83.09 -12.27 57.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.202 1.186 . . . . 71.439999999999998 114.202 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 17.9 ptpt -56.05 -28.88 59.32 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.75 0.705 . . . . 62.25 111.848 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 180' ' ' SER . 7.9 ptpp? -74.17 -29.78 61.94 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.792 0.329 . . . . 74.519999999999996 111.524 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -70.26 -42.4 72.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.229 0.538 . . . . 34.329999999999998 110.647 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.92 -29.13 58.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 111.029 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 45.4 ttm -54.81 -49.64 70.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 74.219999999999999 111.534 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.2 ptp -68.52 -10.09 53.4 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 111.883 0.327 . . . . 64.439999999999998 111.883 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 15.3 mmm180 -95.58 -10.38 29.72 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.658 -0.246 . . . . 72.340000000000003 111.031 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.02 20.04 63.88 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.385 -0.436 . . . . 73.549999999999997 112.76 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 226' ' ' VAL . 80.9 mt -120.88 153.96 36.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.997 0.427 . . . . 63.409999999999997 111.439 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.0 pt -104.97 141.3 22.27 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.788 0.327 . . . . 74.150000000000006 111.455 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.433 ' HG3' ' HB3' ' A' ' 182' ' ' LYS . 22.0 Cg_endo -60.95 -29.25 87.66 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.541 2.161 . . . . 72.140000000000001 113.05 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 178' ' ' ARG . 5.5 mm-40 -55.74 -32.84 63.75 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.998 0.428 . . . . 72.540000000000006 111.705 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . 0.419 ' O ' ' SG ' ' A' ' 194' ' ' CYS . 52.0 t -104.18 21.77 15.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.067 0.461 . . . . 54.030000000000001 111.966 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.1 m -125.0 161.88 25.74 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.056 0.455 . . . . 74.439999999999998 111.654 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.93 131.8 47.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.835 0.35 . . . . 72.230000000000004 111.726 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 224' ' ' VAL . 20.8 t -112.44 139.03 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.396 -0.365 . . . . 62.130000000000003 110.762 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -147.86 158.61 44.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.334 0.588 . . . . 75.310000000000002 111.942 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -135.34 138.8 43.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.676 -0.693 . . . . 73.209999999999994 110.988 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 56.3 mt -84.36 118.0 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 65.400000000000006 111.381 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 24.3 mt-30 -122.66 113.92 19.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.261 -0.427 . . . . 72.019999999999996 111.212 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 59.27 20.72 8.86 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.495 0.664 . . . . 75.409999999999997 111.657 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 109.39 -22.64 24.28 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.244 -0.435 . . . . 71.129999999999995 113.899 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 10.2 pt-20 -84.12 155.2 22.74 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.578 0.689 . . . . 74.219999999999999 111.533 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.06 100.24 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.212 0.53 . . . . 73.319999999999993 109.642 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -87.69 112.72 50.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.978 -0.555 . . . . 64.0 111.581 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.64 127.54 12.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.568 2.179 . . . . 45.520000000000003 112.271 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 217' ' ' LEU . 60.4 mt -96.7 129.99 45.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.685 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 131.66 11.81 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.052 -0.594 . . . . 74.120000000000005 112.218 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.6 m95 -59.87 -27.11 66.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.183 0.438 . . . . 61.329999999999998 112.183 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -80.3 -5.91 57.06 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.211 0.449 . . . . 71.150000000000006 112.211 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 m -71.19 141.5 50.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.308 -0.245 . . . . 61.329999999999998 111.017 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.66 129.36 39.49 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.077 0.465 . . . . 71.349999999999994 110.824 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.91 -24.64 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.145 -0.48 . . . . 55.100000000000001 111.868 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 86.0 p -64.89 -16.24 62.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.802 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -76.44 -11.4 59.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.015 0.436 . . . . 63.130000000000003 111.439 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.454 HD11 HG21 ' A' ' 208' ' ' ILE . 66.8 mt -114.04 14.43 18.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.074 0.464 . . . . 75.230000000000004 111.241 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.8 m -53.84 119.67 5.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.633 0.605 . . . . 60.219999999999999 112.633 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 88.88 -9.93 74.61 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.194 -0.457 . . . . 55.130000000000003 113.997 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.29 157.84 18.05 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.643 0.608 . . . . 73.439999999999998 112.643 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.4 mt-10 -103.99 114.38 28.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.965 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.2 mt -95.79 158.99 15.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.162 0.506 . . . . 74.329999999999998 111.973 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -122.28 121.72 37.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.452 -0.34 . . . . 72.109999999999999 110.38 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 197' ' ' VAL . 62.1 t -119.07 135.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.204 0.525 . . . . 75.129999999999995 112.09 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.3 148.95 40.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.118 -0.492 . . . . 72.140000000000001 110.914 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 190' ' ' LEU . 36.0 t -85.8 137.51 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.819 0.342 . . . . 70.140000000000001 111.879 -174.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.6 mt . . . . . 0 N--CA 1.468 0.448 0 CA-C-N 116.375 -0.375 . . . . 73.519999999999996 111.102 178.759 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm . . . . . 0 CA--C 1.543 0.684 0 N-CA-C 110.472 -0.195 . . . . 71.019999999999996 110.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.81 147.2 95.94 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.675 2.25 . . . . 51.020000000000003 112.761 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 pt -129.37 160.24 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.472 0.653 . . . . 74.219999999999999 112.74 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 171' ' ' ALA . 88.5 t -127.1 134.61 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.554 -0.748 . . . . 74.200000000000003 110.302 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -97.48 96.79 8.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.79 0.328 . . . . 73.230000000000004 111.401 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -98.43 124.05 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.585 0.587 . . . . 73.540000000000006 112.585 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -95.28 106.36 18.39 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.264 -0.426 . . . . 71.420000000000002 111.179 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.7 mt -85.29 157.21 59.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.234 -0.439 . . . . 41.229999999999997 111.336 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.6 153.39 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.602 2.201 . . . . 75.230000000000004 113.011 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 31.6 m-80 68.93 55.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.763 0.425 . . . . 72.409999999999997 111.533 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt 51.08 23.1 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.56 1.144 . . . . 72.129999999999995 114.037 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.8 mm-40 -93.26 144.4 25.34 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.484 0.549 . . . . 44.340000000000003 112.484 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -138.69 142.95 38.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.776 0.322 . . . . 72.109999999999999 110.643 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.9 t -145.25 159.69 42.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.397 . . . . 71.239999999999995 111.707 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.35 120.25 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.282 -0.417 . . . . 72.409999999999997 110.969 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.53 152.57 55.58 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 116.377 -0.374 . . . . 54.420000000000002 111.336 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.09 127.73 11.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.44 2.094 . . . . 73.329999999999998 113.326 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -81.4 103.82 11.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.254 -0.43 . . . . 33.149999999999999 111.31 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -109.84 128.87 55.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.829 0.347 . . . . 74.349999999999994 111.599 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.23 110.56 4.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 110.792 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.16 -6.42 15.07 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.347 -0.454 . . . . 71.120000000000005 112.274 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 214' ' ' ILE . 98.0 t -110.86 133.01 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.68 0.392 . . . . 75.25 110.64 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 80.8 p -87.02 156.0 19.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 71.349999999999994 111.739 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.7 t -50.18 -42.01 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.079 0.466 . . . . 64.329999999999998 111.405 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.588 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 23.0 ttt180 -63.62 -46.69 84.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.248 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.68 -31.46 72.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.843 0.354 . . . . 75.420000000000002 111.944 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.0 t -79.73 -44.29 21.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.89 0.376 . . . . 72.439999999999998 111.846 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.87 -15.26 45.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.193 0.812 . . . . 64.209999999999994 113.193 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.91 -45.22 41.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.993 0.425 . . . . 70.129999999999995 111.935 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -66.86 -39.51 87.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.324 -0.398 . . . . 71.409999999999997 111.969 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.12 93.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.151 0.5 . . . . 73.219999999999999 111.409 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.65 -52.33 21.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.083 -0.508 . . . . 71.409999999999997 111.459 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.4 tpt -50.03 -53.0 29.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.752 0.649 . . . . 55.439999999999998 112.752 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.9 ptp -62.98 -23.7 67.56 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.345 0.498 . . . . 61.030000000000001 112.345 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -101.61 0.24 35.98 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.067 0.395 . . . . 73.030000000000001 112.067 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 89.07 23.75 34.06 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.117 -0.563 . . . . 65.219999999999999 114.071 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.04 148.4 35.24 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.323 -0.516 . . . . 71.400000000000006 111.329 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.74 148.54 59.64 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.671 -0.24 . . . . 73.319999999999993 110.955 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 -39.0 88.68 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 122.81 2.34 . . . . 61.310000000000002 113.537 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -60.43 -24.92 65.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.927 0.394 . . . . 74.430000000000007 111.773 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 39.8 t -93.97 -2.26 53.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.787 0.327 . . . . 72.439999999999998 111.855 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 68.6 m -128.69 139.71 52.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 72.120000000000005 112.003 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -120.07 119.91 34.72 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.687 0.279 . . . . 71.219999999999999 111.373 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 224' ' ' VAL . 76.2 t -95.37 124.41 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.81 0.338 . . . . 71.299999999999997 111.486 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -136.23 155.46 50.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.425 0.631 . . . . 74.0 111.408 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 208' ' ' ILE . 10.2 ptm85 -109.66 133.04 53.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.845 -0.616 . . . . 71.530000000000001 111.42 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.4 mt -89.61 91.75 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.445 0.641 . . . . 70.230000000000004 109.978 173.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.52 123.93 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.573 -0.739 . . . . 71.239999999999995 111.382 -173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 62.52 17.67 9.78 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.353 0.596 . . . . 61.43 110.86 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.28 -4.43 70.41 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.272 -0.422 . . . . 65.420000000000002 113.427 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -101.95 140.28 36.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.447 -0.443 . . . . 55.100000000000001 112.014 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.31 105.58 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.726 0.298 . . . . 75.519999999999996 110.814 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 123.07 38.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.818 -0.173 . . . . 74.230000000000004 111.308 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 143.36 55.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.563 2.176 . . . . 73.230000000000004 113.498 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 199' ' ' ARG . 57.3 mt -122.91 145.93 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.816 0.341 . . . . 71.299999999999997 110.875 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.57 143.38 16.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.077 -0.582 . . . . 74.010000000000005 112.808 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 95.6 m95 -61.34 -23.76 65.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 122.306 -0.526 . . . . 75.120000000000005 111.66 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -87.03 0.77 54.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.239 0.459 . . . . 74.209999999999994 112.239 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 85.7 m -75.89 142.48 42.09 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 51.439999999999998 111.194 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.54 140.4 57.98 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.419 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 175' ' ' VAL . 14.7 tt -79.18 -23.21 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.584 0.587 . . . . 70.400000000000006 112.584 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 89.2 p -62.0 -21.89 65.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.867 0.365 . . . . 74.510000000000005 111.842 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.12 -23.62 66.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.976 0.417 . . . . 74.510000000000005 111.814 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 222' ' ' LEU . 21.9 mt -108.38 21.93 16.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.874 -0.603 . . . . 74.099999999999994 112.093 -169.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 79.4 m -65.16 118.12 8.75 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.834 0.679 . . . . 74.239999999999995 112.834 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.6 -26.04 25.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.144 0.417 . . . . 74.150000000000006 114.144 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -98.81 172.36 7.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.153 0.502 . . . . 75.239999999999995 111.787 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -109.95 137.57 47.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.336 0.865 . . . . 62.030000000000001 113.336 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 217' ' ' LEU . 63.0 mt -102.48 155.92 17.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.404 -0.816 . . . . 74.329999999999998 110.713 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -126.57 127.62 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.132 -0.355 . . . . 64.129999999999995 110.755 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 197' ' ' VAL . 54.5 t -107.23 125.01 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.188 0.44 . . . . 55.350000000000001 112.188 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -100.33 168.71 9.6 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.234 -0.439 . . . . 54.229999999999997 111.259 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.85 114.31 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.398 -0.364 . . . . 73.219999999999999 111.354 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 94.2 mt . . . . . 0 N--CA 1.471 0.597 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 110.741 175.444 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 mptt . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 120.501 0.191 . . . . 61.299999999999997 110.838 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.41 137.2 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.067 1.845 . . . . 65.040000000000006 111.211 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 168' ' ' VAL . 2.8 pp -133.9 165.79 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.053 0.76 . . . . 52.399999999999999 113.053 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 171' ' ' ALA . 49.0 t -130.26 135.67 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.559 -0.746 . . . . 64.400000000000006 110.703 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.7 100.01 12.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.923 0.392 . . . . 71.129999999999995 111.329 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 181' ' ' LEU . 47.9 t -95.85 109.92 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.961 0.41 . . . . 70.140000000000001 111.658 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -80.8 117.98 21.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.931 0.396 . . . . 72.209999999999994 111.104 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.0 mt -93.72 157.68 37.84 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.124 -0.489 . . . . 63.350000000000001 110.707 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.581 ' HG3' HG23 ' A' ' 226' ' ' VAL . 29.9 Cg_endo -63.57 168.67 11.12 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.231 1.954 . . . . 72.310000000000002 112.986 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.38 33.59 18.72 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.168 0.432 . . . . 73.420000000000002 112.168 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 70.14 23.89 5.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.278 0.631 . . . . 71.409999999999997 112.434 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.6 mm-40 -99.62 163.56 12.44 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.04 -0.413 . . . . 74.120000000000005 111.443 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.42 159.47 31.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.036 0.446 . . . . 63.299999999999997 112.117 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -155.62 150.99 26.96 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.974 -0.557 . . . . 71.129999999999995 111.294 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 156' ' ' ILE . 39.0 t -117.8 119.41 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.761 0.315 . . . . 65.439999999999998 110.635 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 181' ' ' LEU . 29.7 m -116.0 150.36 44.94 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.144 0.424 . . . . 71.420000000000002 112.144 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 124.98 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.511 2.141 . . . . 62.149999999999999 113.606 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.76 103.78 8.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.172 0.51 . . . . 63.32 110.847 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -115.93 160.61 19.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.054 -0.521 . . . . 72.450000000000003 111.764 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.4 t -87.02 137.87 31.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 111.072 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.62 -11.74 18.19 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.145 -0.55 . . . . 60.32 113.722 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 214' ' ' ILE . 48.4 t -93.6 123.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 122.438 -0.448 . . . . 74.239999999999995 110.959 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 29.3 p -74.73 168.54 19.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.184 0.516 . . . . 74.329999999999998 111.899 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 212' ' ' THR . 60.7 t -61.64 -33.78 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.278 0.561 . . . . 74.420000000000002 110.231 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 8.7 ttm105 -66.18 -51.32 58.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.815 -0.629 . . . . 72.409999999999997 111.365 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.94 -21.14 65.99 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.241 0.46 . . . . 74.019999999999996 112.241 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.9 m -86.02 -48.88 8.26 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.838 0.31 . . . . 71.310000000000002 111.838 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 169' ' ' VAL . 78.3 mt -82.83 -2.27 54.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.717 0.636 . . . . 72.209999999999994 112.717 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -55.46 -25.81 38.7 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.977 0.417 . . . . 74.209999999999994 111.772 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.32 -48.85 11.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.957 0.408 . . . . 51.149999999999999 111.04 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -59.85 -44.52 94.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.117 -0.492 . . . . 51.32 111.973 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.428 HD11 ' CH2' ' A' ' 210' ' ' TRP . 90.9 mt -62.76 -46.57 87.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.861 0.362 . . . . 51.549999999999997 111.239 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.6 tpt -59.12 -46.86 87.25 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.287 -0.415 . . . . 61.130000000000003 111.647 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.6 ptm -67.75 -8.61 36.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.772 0.32 . . . . 62.420000000000002 111.849 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 22.3 mmm180 -112.11 2.52 16.79 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.131 -0.356 . . . . 73.120000000000005 111.249 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.5 11.76 82.56 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.569 -0.348 . . . . 54.219999999999999 113.821 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.0 176.21 6.88 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 61.119999999999997 111.846 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.552 HG13 ' HB3' ' A' ' 194' ' ' CYS . 17.6 pt -140.1 143.24 33.17 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 111.328 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.74 -49.68 15.0 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.956 2.437 . . . . 72.120000000000005 113.857 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 193' ' ' GLU . 1.3 pm0 -73.57 5.54 3.79 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.804 0.668 . . . . 74.439999999999998 112.804 -174.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . 0.552 ' HB3' HG13 ' A' ' 191' ' ' ILE . 43.2 t -128.29 15.35 6.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.048 0.451 . . . . 65.439999999999998 111.349 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.49 137.1 50.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.848 0.356 . . . . 70.129999999999995 110.939 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.75 120.94 44.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.727 0.299 . . . . 53.310000000000002 111.747 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -98.88 139.13 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.496 -0.32 . . . . 75.409999999999997 110.614 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -146.89 153.35 40.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.38 0.61 . . . . 74.120000000000005 111.926 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.549 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.7 ptm180 -114.29 159.56 20.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.652 -0.703 . . . . 65.219999999999999 110.469 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.0 mt -101.91 95.57 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.277 0.56 . . . . 41.030000000000001 110.759 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -108.74 128.11 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.824 -0.625 . . . . 64.109999999999999 110.555 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 t70 64.71 20.17 12.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.463 0.649 . . . . 64.310000000000002 111.18 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.16 -20.09 52.19 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.333 -0.461 . . . . 45.009999999999998 113.557 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -108.36 162.2 14.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.112 0.482 . . . . 73.140000000000001 111.578 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -82.2 143.27 31.51 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.28 0.562 . . . . 52.219999999999999 111.912 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -139.89 120.58 9.33 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.89 -0.595 . . . . 64.030000000000001 111.207 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -65.76 144.2 76.82 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.698 2.266 . . . . 63.020000000000003 113.484 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 199' ' ' ARG . 66.4 mt -118.83 124.17 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.056 -0.52 . . . . 73.319999999999993 111.396 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.12 141.52 34.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.995 -0.622 . . . . 65.430000000000007 112.517 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.9 m95 -65.64 -16.08 63.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.389 0.595 . . . . 75.420000000000002 111.282 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.99 -16.37 61.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.842 -0.617 . . . . 75.540000000000006 111.762 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.2 m -69.47 136.96 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 111.509 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 4.7 m-20 -69.45 128.08 35.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 62.009999999999998 110.939 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.0 tp -59.07 -20.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.138 0.494 . . . . 54.210000000000001 111.522 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.8 p -59.84 -26.71 66.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.221 -0.445 . . . . 65.439999999999998 112.073 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -69.48 -21.56 63.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.858 0.361 . . . . 60.200000000000003 111.83 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 220' ' ' GLU . 46.5 mt -110.49 21.02 17.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.186 0.517 . . . . 70.439999999999998 111.393 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.8 m -58.8 121.32 10.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.897 0.703 . . . . 63.109999999999999 112.897 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.01 4.23 90.08 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.279 0.872 . . . . 71.340000000000003 115.279 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 217' ' ' LEU . 12.9 pt-20 -111.82 172.7 6.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.978 0.889 . . . . 64.310000000000002 111.71 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 4.2 mp0 -102.98 127.2 50.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.233 0.54 . . . . 64.409999999999997 111.572 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 159' ' ' VAL . 74.0 mt -103.67 159.62 15.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.986 -0.552 . . . . 40.539999999999999 111.148 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -128.75 127.12 41.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.652 0.263 . . . . 74.439999999999998 110.633 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 197' ' ' VAL . 46.8 t -117.84 146.78 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.283 0.563 . . . . 72.209999999999994 112.064 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.88 140.93 33.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 110.883 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 162' ' ' PRO . 61.8 t -82.9 132.45 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.047 0.451 . . . . 64.200000000000003 111.871 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 59.6 mt . . . . . 0 CA--C 1.537 0.463 0 CA-C-N 116.324 -0.398 . . . . 70.310000000000002 111.457 -178.79 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt . . . . . 0 CA--C 1.542 0.645 0 N-CA-C 112.825 0.676 . . . . 52.140000000000001 112.825 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.466 ' HB2' HG23 ' A' ' 218' ' ' THR . 21.9 Cg_endo -60.08 137.9 78.43 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.579 2.186 . . . . 64.540000000000006 111.722 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.91 158.16 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.847 0.684 . . . . 62.420000000000002 112.847 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.56 127.67 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.608 -0.724 . . . . 74.519999999999996 110.367 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 99.0 mtt180 -89.69 100.44 13.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.16 0.505 . . . . 71.439999999999998 111.37 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 181' ' ' LEU . 47.8 t -99.5 118.23 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.284 -0.416 . . . . 73.200000000000003 112.03 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.85 123.32 33.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.902 0.382 . . . . 70.439999999999998 110.536 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.3 mt -95.49 163.49 21.37 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.511 -0.313 . . . . 61.43 111.578 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.72 153.62 5.53 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.851 2.367 . . . . 64.120000000000005 113.994 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.89 42.37 10.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.757 -0.656 . . . . 54.25 111.532 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 63.47 9.25 4.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.066 0.765 . . . . 72.319999999999993 113.066 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -72.59 164.36 26.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.894 0.378 . . . . 75.420000000000002 110.814 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.428 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -156.43 151.7 26.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.857 -0.527 . . . . 75.510000000000005 112.093 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.0 t -156.19 171.21 20.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.945 -0.571 . . . . 74.519999999999996 111.137 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.87 120.34 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.844 0.355 . . . . 52.229999999999997 110.587 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 34.1 m -115.61 140.6 26.2 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.003 0.372 . . . . 61.43 112.003 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 19.6 Cg_exo -67.4 127.28 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.45 2.1 . . . . 75.519999999999996 112.682 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.74 103.21 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 42.450000000000003 110.831 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -100.38 128.05 46.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.976 -0.556 . . . . 72.430000000000007 111.807 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.24 123.19 21.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.446 -0.343 . . . . 52.420000000000002 111.121 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.46 -14.94 60.52 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.974 -0.631 . . . . 73.209999999999994 113.349 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.85 127.51 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.503 -0.41 . . . . 60.030000000000001 110.805 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.5 p -78.07 160.68 27.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.084 0.468 . . . . 74.319999999999993 111.541 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.06 -36.32 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.429 0.633 . . . . 71.340000000000003 110.163 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -60.29 -52.7 64.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.174 -0.921 . . . . 73.430000000000007 111.157 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.08 -34.8 78.45 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.102 -0.499 . . . . 71.430000000000007 112.123 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.4 t -72.85 -49.95 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.442 0.534 . . . . 71.540000000000006 112.442 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.604 HD21 HG21 ' A' ' 159' ' ' VAL . 78.7 mt -85.09 -16.52 40.32 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.474 0.916 . . . . 63.140000000000001 113.474 -173.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.71 -32.55 52.39 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.844 0.683 . . . . 74.230000000000004 112.844 -173.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.74 -39.21 67.05 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 75.530000000000001 111.404 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.2 70.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.193 0.521 . . . . 72.430000000000007 110.784 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.78 -49.38 25.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.836 -0.62 . . . . 72.510000000000005 111.02 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.3 tpt -53.24 -47.8 68.73 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.079 -0.509 . . . . 74.310000000000002 112.006 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 ptm -64.61 -9.14 17.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.291 0.478 . . . . 64.420000000000002 112.291 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -110.91 -6.17 14.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.598 0.237 . . . . 72.310000000000002 111.514 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.66 36.9 14.91 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.122 -0.561 . . . . 54.420000000000002 112.752 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.51 154.71 43.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.541 0.336 . . . . 62.32 111.394 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.62 149.57 67.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 122.362 0.265 . . . . 72.549999999999997 111.009 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.42 -37.02 60.53 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.936 2.424 . . . . 72.450000000000003 113.734 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -69.87 -18.45 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.35 0.5 . . . . 64.299999999999997 112.35 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.1 -10.33 20.56 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.499 0.555 . . . . 52.030000000000001 112.499 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.9 m -131.98 171.27 13.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.238 0.542 . . . . 71.349999999999994 112.244 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -133.08 141.26 48.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.003 -0.544 . . . . 53.350000000000001 111.549 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 224' ' ' VAL . 48.3 t -109.58 126.17 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.368 -0.378 . . . . 73.120000000000005 110.73 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -141.93 152.63 43.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.179 0.514 . . . . 73.209999999999994 111.936 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.59 160.13 16.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.88 -0.6 . . . . 72.040000000000006 110.578 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.5 mt -117.24 119.46 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.0 0.429 . . . . 74.409999999999997 111.469 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.06 149.69 29.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 109.872 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 62.93 16.46 9.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.78 0.324 . . . . 71.420000000000002 111.447 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.79 4.4 88.13 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.304 -0.474 . . . . 74.0 112.775 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -107.09 154.57 20.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.954 0.501 . . . . 71.329999999999998 111.986 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -94.82 126.19 39.98 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.88 0.371 . . . . 74.209999999999994 110.681 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.12 94.85 32.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.015 -0.365 . . . . 63.130000000000003 110.015 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.37 121.9 10.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.714 2.276 . . . . 75.200000000000003 112.443 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 58.8 mt -101.85 132.68 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 111.584 -175.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.73 126.09 26.56 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.77 -0.728 . . . . 71.010000000000005 112.358 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -51.63 -33.17 32.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.664 0.616 . . . . 73.400000000000006 112.664 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -85.74 21.37 1.89 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.426 0.528 . . . . 44.420000000000002 112.426 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 49.9 m -97.09 143.28 28.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 122.336 -0.228 . . . . 73.329999999999998 111.112 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.9 m-20 -58.2 128.27 36.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.126 0.489 . . . . 72.519999999999996 111.823 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 217' ' ' LEU . 9.3 tp -63.66 -21.2 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.98 0.419 . . . . 71.420000000000002 111.722 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.557 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 78.4 p -60.62 -26.09 66.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.216 0.45 . . . . 72.549999999999997 112.216 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.517 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 22.3 m95 -67.21 -21.53 65.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.359 . . . . 73.209999999999994 111.968 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.488 HD12 HD12 ' A' ' 214' ' ' ILE . 33.9 mt -103.83 22.07 15.16 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.138 0.494 . . . . 75.209999999999994 111.896 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 155' ' ' PRO . 77.4 m -53.71 124.71 15.95 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.893 0.701 . . . . 73.109999999999999 112.893 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.3 -5.87 66.04 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 114.401 0.521 . . . . 70.129999999999995 114.401 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.67 158.15 16.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.331 0.566 . . . . 54.119999999999997 111.742 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 51.8 mt-10 -100.69 117.84 35.62 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 110.809 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 159' ' ' VAL . 82.1 mt -93.01 148.16 22.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.056 0.455 . . . . 63.299999999999997 111.012 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -121.35 113.28 19.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 54.409999999999997 110.541 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 197' ' ' VAL . 43.5 t -108.46 130.76 60.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 71.340000000000003 111.22 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.92 157.68 45.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 61.240000000000002 111.435 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.95 130.0 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.044 -0.525 . . . . 55.0 111.453 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 CA--C 1.535 0.382 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 110.433 176.045 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 9.2 mmpt? . . . . . 0 CA--C 1.54 0.57 0 N-CA-C 111.799 0.296 . . . . 72.219999999999999 111.799 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.97 114.86 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.229 1.953 . . . . 65.310000000000002 110.95 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -114.65 160.7 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.102 0.778 . . . . 75.049999999999997 113.102 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.35 139.21 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.553 -0.749 . . . . 50.130000000000003 110.518 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 1.5 mpt_? -92.88 111.71 23.42 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.546 0.212 . . . . 73.420000000000002 110.543 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.23 122.33 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.35 0.5 . . . . 50.229999999999997 112.35 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.96 99.76 11.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 110.399 174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.1 mt -65.97 144.0 98.65 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.654 -0.248 . . . . 64.329999999999998 111.27 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.23 143.52 52.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.552 2.168 . . . . 74.239999999999995 112.945 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.414 ' HB3' HH22 ' A' ' 188' ' ' ARG . 25.0 t-20 74.5 54.43 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.122 0.569 . . . . 73.519999999999996 111.534 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 67.59 22.02 9.25 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.938 1.088 . . . . 70.319999999999993 113.938 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 71.7 mm-40 -107.84 175.27 5.54 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.603 -0.686 . . . . 73.519999999999996 112.539 -175.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -146.98 152.68 39.02 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.159 0.504 . . . . 74.540000000000006 112.325 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.6 t -157.09 160.5 38.94 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.013 -0.539 . . . . 72.540000000000006 110.893 170.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.82 120.2 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.978 0.418 . . . . 75.030000000000001 110.722 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.05 141.13 37.62 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 111.909 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.4 Cg_endo -77.14 132.55 12.76 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.69 2.26 . . . . 51.200000000000003 113.487 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.78 128.85 37.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.194 0.521 . . . . 62.420000000000002 111.802 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -129.69 131.53 46.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.067 -0.515 . . . . 71.329999999999998 110.931 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -71.99 109.83 6.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 52.109999999999999 111.163 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.3 19.6 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.326 -0.464 . . . . 73.230000000000004 112.668 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 214' ' ' ILE . 96.0 t -117.72 125.84 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.939 0.399 . . . . 73.420000000000002 110.948 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 p -82.69 167.38 18.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 65.120000000000005 111.736 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.55 -36.63 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.304 0.574 . . . . 52.25 110.459 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 41.3 ttt180 -67.06 -57.68 6.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.735 -0.666 . . . . 74.439999999999998 111.187 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -28.22 58.72 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.116 0.413 . . . . 71.310000000000002 112.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 36.7 t -78.78 -47.42 16.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.709 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.13 -1.53 54.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.157 0.799 . . . . 73.099999999999994 113.157 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.34 -41.47 76.14 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 72.420000000000002 112.136 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.24 -32.31 68.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.058 0.456 . . . . 70.129999999999995 111.09 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.55 91.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.035 0.445 . . . . 72.230000000000004 111.051 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -75.68 -38.69 58.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.848 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 24.7 ttt -54.67 -50.6 67.81 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.935 -0.575 . . . . 73.129999999999995 111.713 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -69.78 -4.29 19.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.52 0.563 . . . . 64.219999999999999 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 163' ' ' ASN . 70.4 mtp180 -118.28 2.42 11.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.055 0.391 . . . . 71.349999999999994 112.055 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.83 38.64 89.52 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 73.129999999999995 113.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.98 154.99 36.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.912 0.387 . . . . 75.420000000000002 111.685 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.83 146.54 46.18 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.366 -0.379 . . . . 74.209999999999994 111.396 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.6 -44.27 45.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.113 2.542 . . . . 72.310000000000002 114.141 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.01 -4.1 12.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.371 0.508 . . . . 75.120000000000005 112.371 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -100.5 -5.39 27.04 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.928 0.394 . . . . 73.109999999999999 111.425 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.36 144.12 42.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 111.993 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.575 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -112.22 137.44 50.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.779 0.323 . . . . 51.119999999999997 111.483 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 224' ' ' VAL . 47.4 t -102.48 140.09 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.276 -0.42 . . . . 64.329999999999998 110.26 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -157.77 158.47 35.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.254 0.55 . . . . 62.210000000000001 112.023 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.846 HH11 ' HG3' ' A' ' 220' ' ' GLU . 79.1 mtm180 -110.41 139.46 45.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.141 -0.481 . . . . 65.230000000000004 111.239 175.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.95 96.41 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.299 0.571 . . . . 62.240000000000002 110.111 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.75 107.54 18.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 74.310000000000002 110.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.0 20.05 7.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.298 0.571 . . . . 74.209999999999994 111.567 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.62 38.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.474 -0.393 . . . . 41.009999999999998 113.257 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.18 117.34 23.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.944 0.35 . . . . 63.439999999999998 111.944 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -80.72 109.34 15.17 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.546 0.212 . . . . 72.120000000000005 111.222 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -102.9 106.82 52.43 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.599 0.238 . . . . 72.129999999999995 111.195 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.51 116.53 4.28 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.873 2.382 . . . . 73.519999999999996 113.036 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.453 HD11 ' HG3' ' A' ' 199' ' ' ARG . 64.1 mt -101.06 133.26 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.236 0.541 . . . . 73.049999999999997 111.908 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.7 143.3 28.92 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.199 -0.524 . . . . 61.229999999999997 112.888 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 96.4 m95 -60.4 -21.89 62.72 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.352 0.576 . . . . 73.540000000000006 111.011 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.05 -5.16 50.54 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.987 -0.551 . . . . 75.409999999999997 112.204 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 177' ' ' VAL . 40.8 m -74.25 136.76 42.7 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.551 0.215 . . . . 74.129999999999995 111.353 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 18.1 t70 -72.09 129.24 38.03 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.04 0.448 . . . . 75.519999999999996 110.88 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.5 tt -66.02 -22.63 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.731 0.641 . . . . 71.310000000000002 112.731 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.544 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 41.2 t -63.39 -21.05 66.05 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.821 -0.549 . . . . 60.32 111.425 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 16.8 m95 -80.18 -10.65 59.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.013 0.435 . . . . 72.109999999999999 111.356 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 222' ' ' LEU . 49.6 mt -111.42 15.04 21.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.227 -0.442 . . . . 65.430000000000007 111.571 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.3 m -56.29 126.32 25.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.355 0.502 . . . . 74.239999999999995 112.355 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.29 10.14 84.06 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.299 -0.477 . . . . 73.019999999999996 114.087 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . 0.846 ' HG3' HH11 ' A' ' 199' ' ' ARG . 36.5 mm-40 -107.37 171.89 7.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.126 0.489 . . . . 61.229999999999997 111.53 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.1 mp0 -111.01 121.01 44.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 110.866 172.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 217' ' ' LEU . 80.2 mt -94.01 117.65 30.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.916 0.388 . . . . 60.310000000000002 111.197 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -94.41 118.74 32.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.612 -0.267 . . . . 65.319999999999993 110.484 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 197' ' ' VAL . 21.7 t -110.15 139.93 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.13 0.491 . . . . 72.209999999999994 111.158 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.98 170.45 15.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.454 -0.339 . . . . 65.409999999999997 111.369 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.29 127.04 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.862 0.363 . . . . 73.209999999999994 111.644 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 196' ' ' ALA . 86.4 mt . . . . . 0 CA--C 1.536 0.428 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 111.99 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mttm . . . . . 0 CA--C 1.543 0.685 0 N-CA-C 111.396 0.147 . . . . 55.43 111.396 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.42 135.86 44.43 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.347 2.031 . . . . 75.219999999999999 111.738 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.8 pt -123.62 161.11 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 71.450000000000003 113.051 -173.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.12 131.92 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.8 -0.636 . . . . 74.099999999999994 110.459 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 158' ' ' ARG . 64.0 mtt85 -100.96 105.14 16.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.941 0.4 . . . . 73.450000000000003 111.632 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.615 HG22 HD12 ' A' ' 222' ' ' LEU . 60.0 t -99.6 119.08 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.575 -0.284 . . . . 72.329999999999998 111.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -92.13 113.51 25.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.351 0.596 . . . . 65.120000000000005 111.888 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.5 mt -91.14 169.15 12.09 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 115.435 -0.802 . . . . 74.109999999999999 111.04 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 52.5 Cg_exo -55.26 165.29 3.14 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.427 2.085 . . . . 74.319999999999993 113.479 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.83 28.76 18.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.776 0.43 . . . . 73.439999999999998 111.954 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp 63.29 22.96 13.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.987 0.515 . . . . 75.230000000000004 112.087 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 80.3 mm-40 -82.81 168.33 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 111.048 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -156.43 161.75 40.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 71.329999999999998 112.124 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.6 t -150.41 151.08 32.24 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.655 -0.702 . . . . 74.340000000000003 110.525 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.52 119.61 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.988 0.423 . . . . 73.329999999999998 111.443 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 27.1 m -120.38 144.51 38.38 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.318 -0.401 . . . . 61.109999999999999 111.449 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.8 Cg_exo -65.56 132.66 31.71 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.645 2.23 . . . . 73.030000000000001 112.992 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -73.97 117.65 16.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 75.420000000000002 111.604 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -130.37 143.55 50.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.283 -0.417 . . . . 72.340000000000003 111.194 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.41 140.99 37.24 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.636 0.255 . . . . 74.230000000000004 110.642 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.08 -25.29 10.35 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.116 -0.564 . . . . 50.130000000000003 112.314 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.91 117.54 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.926 0.394 . . . . 73.129999999999995 110.899 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 39.5 p -80.15 156.91 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.484 -0.325 . . . . 75.430000000000007 111.254 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.75 -31.7 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.552 0.692 . . . . 65.030000000000001 110.756 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.621 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.4 ttp85 -70.18 -35.23 73.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.448 -0.796 . . . . 74.230000000000004 111.59 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.27 -43.33 21.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.196 -0.456 . . . . 62.210000000000001 111.903 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -61.14 -49.81 75.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.129 0.49 . . . . 71.340000000000003 111.978 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.71 14.43 2.13 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.972 0.73 . . . . 73.019999999999996 112.972 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 183' ' ' LYS . 9.5 ptpp? -53.12 -48.3 67.96 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.286 0.476 . . . . 73.409999999999997 112.286 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 65.6 pttt -79.05 -29.75 43.66 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.05 -0.406 . . . . 64.239999999999995 111.311 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.29 88.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.142 0.496 . . . . 52.100000000000001 111.434 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -46.34 70.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.103 0.477 . . . . 74.109999999999999 110.689 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 41.2 ttm -50.93 -51.5 51.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.731 -0.668 . . . . 71.340000000000003 112.156 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.41 -19.91 65.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.298 0.481 . . . . 74.019999999999996 112.298 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -98.91 -4.47 32.8 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.821 0.344 . . . . 62.420000000000002 111.421 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 25.81 63.81 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.184 -0.531 . . . . 54.340000000000003 113.006 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.2 mt -113.89 153.97 28.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.447 . . . . 71.430000000000007 111.486 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.0 pt -128.69 156.89 76.76 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 116.305 -0.407 . . . . 70.409999999999997 110.318 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.78 -42.87 62.84 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.507 2.138 . . . . 62.530000000000001 113.159 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.65 -7.62 28.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.16 0.43 . . . . 60.439999999999998 112.16 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 -2.45 17.22 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.803 0.297 . . . . 63.310000000000002 111.803 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.08 162.53 34.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.08 0.467 . . . . 71.230000000000004 111.778 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.19 139.98 48.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.927 0.394 . . . . 54.109999999999999 111.586 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 224' ' ' VAL . 54.1 t -107.95 135.19 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.177 -0.465 . . . . 42.439999999999998 111.024 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.62 158.2 43.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.982 0.42 . . . . 73.319999999999993 111.148 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -127.58 149.1 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.89 0.376 . . . . 61.229999999999997 110.883 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.85 95.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.546 0.689 . . . . 63.009999999999998 110.206 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.46 109.14 20.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.554 -0.748 . . . . 64.120000000000005 111.259 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.8 t70 60.78 26.54 16.36 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.475 0.655 . . . . 73.310000000000002 111.006 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.55 -13.25 59.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.166 -0.47 . . . . 35.530000000000001 113.441 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 125.18 35.9 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.107 0.41 . . . . 53.229999999999997 112.107 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.02 93.92 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.147 0.498 . . . . 73.340000000000003 109.8 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -99.7 115.57 65.5 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.184 -0.462 . . . . 75.299999999999997 111.725 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.55 127.18 20.07 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.692 2.261 . . . . 64.010000000000005 112.806 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -102.34 120.47 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.117 -0.492 . . . . 70.420000000000002 110.872 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.81 135.09 46.78 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.889 -0.672 . . . . 62.310000000000002 113.197 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 83.3 m95 -55.72 -32.81 63.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.523 0.564 . . . . 72.450000000000003 112.523 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.62 11.75 8.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.852 0.686 . . . . 75.420000000000002 112.852 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.3 m -79.85 141.91 35.73 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.158 -0.339 . . . . 65.030000000000001 110.862 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 118.29 5.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.895 0.378 . . . . 65.219999999999999 111.145 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.34 -22.3 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.09 0.471 . . . . 64.040000000000006 111.845 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.488 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 23.3 t -61.28 -23.89 66.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.159 0.429 . . . . 64.319999999999993 112.159 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -66.51 -22.46 66.18 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.062 0.458 . . . . 64.450000000000003 111.388 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.0 mt -108.02 30.11 6.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.707 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 93.9 m -62.65 116.65 5.36 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.711 0.634 . . . . 71.230000000000004 112.711 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 85.01 8.91 81.59 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.99 0.756 . . . . 64.010000000000005 114.99 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 167.34 10.96 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.73 0.765 . . . . 71.340000000000003 112.126 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -102.47 120.89 41.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.794 -0.639 . . . . 75.150000000000006 111.717 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 159' ' ' VAL . 68.4 mt -94.03 143.77 26.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.082 -0.508 . . . . 74.219999999999999 111.45 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -109.03 109.47 20.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.735 0.303 . . . . 74.310000000000002 110.203 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 197' ' ' VAL . 61.6 t -107.77 148.86 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.077 0.465 . . . . 73.299999999999997 111.517 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.21 160.24 42.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.968 0.413 . . . . 73.310000000000002 111.049 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.29 132.25 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.8 0.333 . . . . 61.520000000000003 111.771 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 196' ' ' ALA . 94.8 mt . . . . . 0 N--CA 1.469 0.521 0 CA-C-O 121.121 0.486 . . . . 72.129999999999995 110.335 175.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm . . . . . 0 CA--C 1.542 0.672 0 CA-C-O 120.467 0.175 . . . . 72.209999999999994 111.447 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.43 142.72 99.43 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.378 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 2.9 pp -123.05 161.73 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.538 0.685 . . . . 63.140000000000001 112.814 -175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.43 141.21 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 115.73 -0.668 . . . . 75.409999999999997 110.919 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.28 106.5 18.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.644 0.259 . . . . 70.549999999999997 111.132 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 181' ' ' LEU . 55.6 t -109.19 124.45 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.123 0.487 . . . . 73.209999999999994 112.12 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.462 ' HD1' ' HG3' ' A' ' 166' ' ' ARG . 20.6 m-85 -99.78 113.74 26.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.187 -0.46 . . . . 74.049999999999997 110.961 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 86.3 mt -90.9 160.87 37.13 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.037 -0.529 . . . . 65.030000000000001 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 29.6 Cg_endo -61.88 167.26 10.68 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.929 2.419 . . . . 75.030000000000001 113.672 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.19 29.7 18.9 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.353 0.597 . . . . 64.439999999999998 111.341 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 60.37 59.03 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.354 -0.839 . . . . 72.239999999999995 111.718 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.1 mm-40 -118.91 143.61 46.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.889 -0.596 . . . . 44.520000000000003 110.455 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' HD1' ' A' ' 160' ' ' PHE . 3.4 mpt_? -126.19 147.18 49.7 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.952 -0.468 . . . . 73.319999999999993 111.698 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.49 161.74 40.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.046 -0.525 . . . . 64.310000000000002 111.357 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 156' ' ' ILE . 61.9 t -126.89 120.14 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.837 0.351 . . . . 64.420000000000002 111.197 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -111.44 153.76 44.03 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 116.396 -0.365 . . . . 54.310000000000002 111.764 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.14 151.6 30.47 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.543 2.162 . . . . 55.450000000000003 113.532 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -105.09 112.49 25.64 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.068 -0.514 . . . . 75.439999999999998 111.882 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -126.34 148.28 49.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.522 0.329 . . . . 73.140000000000001 111.046 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.12 135.64 37.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.712 0.292 . . . . 74.200000000000003 110.921 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.12 -30.57 7.94 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.142 -0.552 . . . . 75.129999999999995 112.277 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.8 t -80.89 109.72 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.108 0.48 . . . . 63.229999999999997 110.346 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 36.9 p -76.36 163.31 27.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.272 -0.422 . . . . 61.399999999999999 111.324 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 212' ' ' THR . 60.8 t -54.02 -37.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.288 0.566 . . . . 75.010000000000005 110.23 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 3.4 tmt_? -65.64 -39.34 91.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.492 -0.776 . . . . 72.329999999999998 111.187 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 31.8 t70 -79.34 -29.07 42.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.935 0.346 . . . . 75.239999999999995 111.935 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -78.56 -55.74 4.97 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.093 0.473 . . . . 71.439999999999998 111.496 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 159' ' ' VAL . 62.4 mt -72.48 -3.56 25.09 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.797 0.665 . . . . 64.0 112.797 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 24.6 pttm -61.75 -20.65 63.77 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.026 -0.421 . . . . 75.340000000000003 110.747 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.08 -53.46 6.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.025 0.44 . . . . 75.450000000000003 110.877 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.28 70.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.055 -0.52 . . . . 50.450000000000003 111.869 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -81.79 -26.21 34.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.56 -0.291 . . . . 75.219999999999999 111.58 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.0 tpt -64.39 -41.76 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.818 0.342 . . . . 65.200000000000003 111.013 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.46 -21.3 64.64 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.013 0.435 . . . . 71.540000000000006 110.948 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -83.75 -21.16 32.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.31 -0.405 . . . . 62.229999999999997 110.808 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.61 29.61 26.39 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.41 -0.424 . . . . 55.210000000000001 113.064 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 84.4 mt -131.31 164.93 24.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.17 0.51 . . . . 75.420000000000002 111.829 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.36 143.16 26.63 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.125 -0.489 . . . . 75.319999999999993 111.159 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 178' ' ' ARG . 53.8 Cg_exo -52.42 -42.96 57.82 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 53.119999999999997 113.978 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.6 pm0 -70.29 -0.78 8.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.375 0.509 . . . . 72.430000000000007 112.375 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 52.9 t -107.15 9.83 30.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.964 0.412 . . . . 63.399999999999999 111.024 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 62.0 m -131.38 172.16 12.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.223 -0.444 . . . . 44.549999999999997 111.215 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -136.98 126.93 25.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.804 0.335 . . . . 70.310000000000002 111.638 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -99.08 125.22 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 110.805 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 55.2 p90 -136.28 146.52 46.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.525 0.678 . . . . 74.299999999999997 111.365 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.5 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.533 -0.758 . . . . 74.439999999999998 110.24 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -77.72 87.61 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.875 0.845 . . . . 63.009999999999998 109.944 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -115.66 136.73 52.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.111 -0.949 . . . . 65.340000000000003 111.105 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.19 26.24 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.285 0.564 . . . . 63.439999999999998 112.327 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.2 58.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.153 -0.546 . . . . 61.210000000000001 114.402 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.71 151.93 47.57 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.416 0.608 . . . . 72.040000000000006 111.877 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 53.6 mtpt -77.73 94.65 4.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.661 -0.496 . . . . 72.219999999999999 109.661 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.25 114.07 64.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 120.626 0.251 . . . . 73.409999999999997 111.439 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.64 155.36 43.0 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.891 2.394 . . . . 45.100000000000001 113.762 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 199' ' ' ARG . 60.9 mt -127.28 133.45 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.788 -0.642 . . . . 71.400000000000006 110.588 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.59 132.98 23.0 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.86 -0.686 . . . . 71.549999999999997 112.816 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 82.4 m95 -62.31 -22.37 65.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.269 0.47 . . . . 53.329999999999998 112.269 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.55 -11.76 59.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.962 0.356 . . . . 64.040000000000006 111.962 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 m -66.54 134.26 52.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.685 0.279 . . . . 74.150000000000006 111.501 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 2.3 m-20 -58.94 130.58 47.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.821 0.343 . . . . 74.340000000000003 111.141 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.12 -21.58 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.193 0.521 . . . . 35.049999999999997 111.373 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . 0.453 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 98.9 p -61.16 -26.07 67.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.064 -0.516 . . . . 65.209999999999994 111.847 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.461 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.6 m95 -66.58 -24.72 66.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.154 0.502 . . . . 65.420000000000002 111.815 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.87 21.42 17.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.021 -0.536 . . . . 74.329999999999998 111.511 -173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.7 m -56.86 112.24 1.26 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.798 0.666 . . . . 71.329999999999998 112.798 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.49 75.32 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 115.093 0.797 . . . . 33.210000000000001 115.093 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.44 172.21 7.15 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.145 0.972 . . . . 52.43 111.737 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . 19.0 mp0 -96.28 134.25 39.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.095 -0.502 . . . . 75.230000000000004 111.565 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.46 144.67 45.82 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.499 -0.319 . . . . 54.219999999999999 110.815 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -115.34 116.3 28.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.688 0.28 . . . . 63.219999999999999 110.381 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 197' ' ' VAL . 51.0 t -115.31 127.16 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.866 0.365 . . . . 73.230000000000004 111.391 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.96 161.08 29.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.993 0.425 . . . . 70.010000000000005 111.427 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 162' ' ' PRO . 16.7 t -90.5 138.32 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 61.219999999999999 111.583 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 90.2 mt . . . . . 0 N--CA 1.469 0.523 0 CA-C-O 120.977 0.418 . . . . 61.439999999999998 111.389 179.516 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt . . . . . 0 CA--C 1.548 0.89 0 N-CA-C 112.372 0.508 . . . . 74.310000000000002 112.372 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.08 145.85 97.47 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.321 2.68 . . . . 53.329999999999998 114.55 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.41 168.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.927 -0.579 . . . . 74.019999999999996 112.268 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 171' ' ' ALA . 63.4 t -133.05 140.3 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.142 -0.481 . . . . 44.350000000000001 110.289 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -104.23 102.17 11.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.801 0.334 . . . . 72.25 111.642 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 181' ' ' LEU . 43.9 t -103.01 141.71 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.634 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -113.3 113.43 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.056 0.455 . . . . 73.409999999999997 111.219 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 90.8 mt -85.74 160.76 52.42 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.866 -0.606 . . . . 74.530000000000001 111.039 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 25.3 Cg_endo -61.67 169.05 7.49 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.112 1.875 . . . . 74.239999999999995 112.496 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.38 32.09 16.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.12 0.415 . . . . 62.039999999999999 112.12 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.7 22.94 7.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.124 0.787 . . . . 70.200000000000003 113.124 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -99.69 163.9 12.28 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.886 0.374 . . . . 64.319999999999993 111.595 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -154.9 165.0 38.06 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.006 -0.434 . . . . 74.010000000000005 111.924 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.8 t -156.01 155.71 33.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.89 0.376 . . . . 64.319999999999993 111.33 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 62.2 t -122.92 120.12 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.765 0.317 . . . . 75.340000000000003 110.97 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.7 147.89 38.61 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.084 0.402 . . . . 64.530000000000001 112.084 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.02 127.9 15.88 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.371 2.047 . . . . 71.510000000000005 112.91 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.538 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -85.78 118.71 25.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.003 0.43 . . . . 75.099999999999994 112.046 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -136.71 157.07 47.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.195 0.521 . . . . 60.240000000000002 111.898 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 50.5 t -81.55 144.49 31.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.549 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.94 -12.47 61.84 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.997 -0.621 . . . . 44.439999999999998 112.527 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.66 116.82 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.574 -0.368 . . . . 73.239999999999995 110.171 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 p -81.41 161.34 23.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 62.350000000000001 111.64 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.48 -31.63 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.152 0.501 . . . . 71.430000000000007 110.714 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 46.9 ttp85 -72.97 -56.53 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.118 -0.492 . . . . 60.119999999999997 110.864 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.7 m-20 -61.38 -26.17 67.66 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 111.742 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.5 t -77.73 -61.8 1.87 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.149 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 159' ' ' VAL . 66.1 mt -71.89 -21.65 61.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.298 0.851 . . . . 71.540000000000006 113.298 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 20.7 pttp -64.6 -12.22 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.661 0.664 . . . . 52.210000000000001 111.359 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -79.07 -49.01 13.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.028 0.442 . . . . 72.519999999999996 110.143 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.101 -0.499 . . . . 74.439999999999998 111.31 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.05 -39.35 79.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.375 -0.375 . . . . 74.519999999999996 111.044 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 28.1 ttt -58.19 -47.73 82.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.856 0.36 . . . . 60.549999999999997 111.513 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.5 ptm -70.84 -8.11 50.27 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.861 0.362 . . . . 71.239999999999995 111.694 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 3.5 mmp_? -106.65 -15.63 14.72 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.901 0.334 . . . . 73.349999999999994 111.901 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.55 40.35 9.94 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.186 -0.53 . . . . 70.510000000000005 112.891 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.87 168.62 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.717 0.407 . . . . 72.010000000000005 111.073 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 22.5 pt -132.52 149.37 72.88 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.54 -0.3 . . . . 73.120000000000005 111.406 179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.86 -48.65 13.83 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.269 2.646 . . . . 74.340000000000003 114.113 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.33 4.75 3.4 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.681 0.623 . . . . 73.129999999999995 112.681 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.94 -8.15 18.81 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.862 0.363 . . . . 43.149999999999999 111.321 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.402 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 70.8 m -130.85 166.57 20.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.14 0.422 . . . . 74.019999999999996 112.14 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.49 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -135.89 121.3 19.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.431 -0.35 . . . . 75.140000000000001 111.809 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 224' ' ' VAL . 57.2 t -95.04 121.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.905 0.383 . . . . 72.040000000000006 111.558 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.646 ' CE1' ' HG3' ' A' ' 225' ' ' GLU . 27.7 p90 -138.84 142.29 38.65 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.211 0.529 . . . . 73.349999999999994 111.533 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 199' ' ' ARG . 1.3 ptm180 -110.72 124.43 51.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.884 -0.598 . . . . 71.0 110.001 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.12 107.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 71.319999999999993 111.668 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -135.19 135.93 41.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.1 -0.5 . . . . 61.539999999999999 110.202 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.36 27.46 16.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.23 0.538 . . . . 73.030000000000001 110.908 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.14 68.88 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.879 -0.6 . . . . 25.109999999999999 113.149 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -95.75 126.22 40.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.815 0.446 . . . . 73.129999999999995 112.167 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 97.5 mttt -76.98 98.82 5.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.668 0.27 . . . . 63.240000000000002 110.369 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -90.1 107.29 18.49 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.675 -0.238 . . . . 62.119999999999997 111.219 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 3.2 Cg_exo -75.31 129.1 11.77 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.776 2.317 . . . . 65.319999999999993 111.95 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.613 HG21 HD11 ' A' ' 217' ' ' LEU . 3.9 mp -98.89 122.39 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.74 -0.209 . . . . 63.399999999999999 110.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.51 126.7 38.02 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.714 -0.755 . . . . 54.340000000000003 111.782 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 69.4 m95 -55.06 -33.49 62.76 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.686 0.624 . . . . 73.209999999999994 112.686 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.47 17.68 3.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.897 0.703 . . . . 74.340000000000003 112.897 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.4 m -88.8 140.03 29.86 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.231 -0.293 . . . . 62.310000000000002 110.663 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 5.9 m-20 -57.58 125.68 23.98 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.077 0.399 . . . . 74.329999999999998 112.077 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.436 HG13 HG21 ' A' ' 157' ' ' VAL . 10.9 tp -59.45 -21.83 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.407 0.622 . . . . 74.25 110.965 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -55.34 -27.88 50.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.57 -0.741 . . . . 44.240000000000002 112.092 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -77.44 -7.02 55.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 111.859 0.318 . . . . 73.310000000000002 111.859 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.613 HD11 HG21 ' A' ' 208' ' ' ILE . 36.8 mt -122.15 22.34 10.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.283 0.563 . . . . 71.030000000000001 110.892 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 85.4 m -62.03 127.28 30.63 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.135 0.791 . . . . 62.32 113.135 -174.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.63 11.8 84.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.393 0.917 . . . . 74.420000000000002 115.393 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -126.83 173.26 9.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.244 1.022 . . . . 74.409999999999997 112.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.25 126.74 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.678 -0.692 . . . . 64.030000000000001 112.332 -172.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.12 141.5 44.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 109.911 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -120.33 142.57 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.088 -0.382 . . . . 73.319999999999993 110.516 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 70.7 t -118.09 126.43 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.051 0.76 . . . . 71.349999999999994 113.051 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.646 ' HG3' ' CE1' ' A' ' 198' ' ' TYR . 34.2 mt-10 -101.28 164.75 11.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.133 -0.485 . . . . 72.200000000000003 110.886 171.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.26 119.88 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.819 0.342 . . . . 53.539999999999999 111.48 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 196' ' ' ALA . 84.1 mt . . . . . 0 CA--C 1.538 0.517 0 CA-C-O 121.029 0.442 . . . . 53.399999999999999 110.639 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 111.715 0.265 . . . . 75.430000000000007 111.715 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.41 147.08 86.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.538 2.158 . . . . 71.239999999999995 112.294 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.01 166.04 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.232 0.827 . . . . 62.310000000000002 113.232 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.69 128.12 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.821 -1.081 . . . . 63.520000000000003 109.334 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 83.8 mtt180 -91.45 97.29 10.98 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.987 0.422 . . . . 62.420000000000002 111.488 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 222' ' ' LEU . 44.7 t -95.69 112.55 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.17 0.434 . . . . 75.310000000000002 112.17 -176.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.6 119.6 23.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.022 0.439 . . . . 71.409999999999997 110.945 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 93.1 mt -95.99 159.44 32.26 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.213 -0.449 . . . . 65.299999999999997 111.304 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 225' ' ' GLU . 70.8 Cg_exo -52.27 162.87 1.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.537 2.158 . . . . 74.340000000000003 113.068 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.0 t30 65.96 28.97 10.44 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.162 0.506 . . . . 73.299999999999997 110.961 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 65.64 19.45 11.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.58 0.585 . . . . 73.109999999999999 112.58 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.3 mm-40 -84.04 171.87 12.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.087 0.47 . . . . 63.509999999999998 111.606 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 166' ' ' ARG . 22.2 ptt-85 -160.34 140.56 11.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.015 0.436 . . . . 72.310000000000002 111.845 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -139.53 141.54 37.27 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.027 0.442 . . . . 75.349999999999994 111.209 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.94 119.23 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.026 0.441 . . . . 75.409999999999997 110.887 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.83 149.08 47.84 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.446 -0.343 . . . . 73.219999999999999 111.582 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.17 144.84 82.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.413 2.076 . . . . 63.310000000000002 113.18 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.06 15.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.198 0.523 . . . . 74.019999999999996 111.314 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.447 ' H ' HG23 ' A' ' 214' ' ' ILE . 59.6 mtt180 -115.63 136.46 53.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.273 0.558 . . . . 53.32 112.421 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 37.2 t -99.94 133.64 44.01 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.832 -0.622 . . . . 72.140000000000001 110.518 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.18 -21.32 31.95 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.683 -0.77 . . . . 40.450000000000003 112.327 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.45 125.09 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 61.149999999999999 110.384 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 44.3 p -72.95 156.13 39.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 111.492 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.73 -36.03 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.396 0.617 . . . . 74.219999999999999 110.535 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.649 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 42.9 ttt180 -60.39 -59.59 5.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.388 -0.824 . . . . 73.099999999999994 111.905 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.78 -18.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.081 0.467 . . . . 71.129999999999995 111.398 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.2 t -82.13 -37.33 26.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.872 0.367 . . . . 63.340000000000003 111.51 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.9 mt -97.21 2.34 50.81 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.209 0.448 . . . . 75.230000000000004 112.209 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -52.55 -33.24 44.72 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.26 0.467 . . . . 75.319999999999993 112.26 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.493 ' NZ ' ' HB3' ' A' ' 183' ' ' LYS . 6.9 mtpm? -79.36 -37.83 36.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.794 0.33 . . . . 74.219999999999999 111.289 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -62.96 -46.23 88.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.14 0.495 . . . . 42.520000000000003 111.086 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.7 -44.49 96.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.189 -0.46 . . . . 63.420000000000002 110.694 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.8 ttt -53.08 -53.36 51.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.909 -0.587 . . . . 71.219999999999999 111.88 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.0 ptp -68.69 -14.14 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.474 0.546 . . . . 74.010000000000005 112.474 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 32.5 mmt180 -100.5 -8.22 23.34 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.224 -0.298 . . . . 75.230000000000004 111.671 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 79.33 18.1 74.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.213 -0.517 . . . . 64.310000000000002 112.855 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -101.74 156.8 17.28 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.085 0.469 . . . . 71.519999999999996 111.553 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 pt -127.23 138.29 32.44 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.73 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.08 -39.71 84.52 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.944 2.429 . . . . 70.439999999999998 113.56 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.03 -19.53 66.04 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.821 0.343 . . . . 73.129999999999995 111.888 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.3 t -111.7 20.29 17.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.092 0.472 . . . . 71.349999999999994 111.387 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.3 m -137.49 137.26 38.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.061 0.458 . . . . 71.049999999999997 111.252 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.54 123.67 50.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.389 -0.368 . . . . 54.420000000000002 111.65 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 224' ' ' VAL . 43.1 t -99.95 138.19 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.452 -0.34 . . . . 75.5 110.852 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -146.44 151.3 37.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 75.329999999999998 110.967 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 208' ' ' ILE . 16.8 ptt-85 -120.01 152.58 37.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 72.329999999999998 110.681 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.548 HG12 ' HG2' ' A' ' 205' ' ' LYS . 37.6 mt -106.35 86.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.394 0.616 . . . . 74.099999999999994 110.11 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -104.97 120.47 41.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.654 -0.703 . . . . 60.43 110.38 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 59.34 30.89 20.67 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.081 0.467 . . . . 60.020000000000003 111.701 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.72 -9.24 77.87 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.327 -0.397 . . . . 51.409999999999997 113.628 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 206' ' ' LYS . 37.9 mm-40 -95.26 125.4 39.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.358 0.503 . . . . 73.349999999999994 112.358 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.548 ' HG2' HG12 ' A' ' 200' ' ' ILE . 98.7 mttt -84.36 96.27 9.0 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.902 0.382 . . . . 71.120000000000005 110.221 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 204' ' ' GLU . 12.8 mptt -104.58 129.68 24.56 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.374 -0.376 . . . . 73.420000000000002 111.989 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.3 125.56 11.45 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.892 2.394 . . . . 54.43 113.063 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 199' ' ' ARG . 68.5 mt -97.67 126.08 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.139 -0.482 . . . . 55.409999999999997 111.357 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.46 136.21 18.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.153 -0.546 . . . . 54.119999999999997 112.46 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 98.9 m95 -59.6 -21.0 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.182 0.515 . . . . 72.530000000000001 111.464 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -79.02 -12.52 60.03 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.549 -0.75 . . . . 72.209999999999994 112.671 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.1 m -79.27 145.83 33.33 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.773 0.32 . . . . 63.119999999999997 111.762 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.0 m-20 -64.19 134.41 54.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 73.540000000000006 111.5 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.447 HG23 ' H ' ' A' ' 172' ' ' ARG . 10.1 tt -67.56 -19.11 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.038 0.447 . . . . 73.329999999999998 111.218 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 88.5 p -60.26 -29.23 68.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.203 0.446 . . . . 61.439999999999998 112.203 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -60.01 -27.0 66.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.395 0.617 . . . . 73.239999999999995 111.125 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -104.69 15.54 27.75 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 111.772 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.4 m -56.3 109.43 0.6 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.664 0.616 . . . . 71.230000000000004 112.664 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.79 -17.06 50.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.79 0.676 . . . . 54.399999999999999 114.79 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.62 173.41 6.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.025 0.913 . . . . 73.540000000000006 112.501 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 35.8 mt-10 -105.59 124.4 49.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.886 -0.597 . . . . 65.430000000000007 111.868 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 159' ' ' VAL . 47.5 mt -98.3 160.14 14.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.031 0.443 . . . . 72.319999999999993 111.462 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -129.56 120.04 24.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.525 -0.307 . . . . 54.310000000000002 110.648 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 197' ' ' VAL . 24.5 t -116.12 138.32 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 53.329999999999998 111.507 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 162' ' ' PRO . 9.9 pt-20 -138.76 152.91 48.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.959 0.409 . . . . 74.430000000000007 111.598 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 45.8 t -81.71 143.52 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.887 0.375 . . . . 71.25 111.713 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' ALA . 87.9 mt . . . . . 0 N--CA 1.471 0.585 0 CA-C-O 121.18 0.514 . . . . 73.040000000000006 110.982 177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.421 ' HB3' ' HD2' ' A' ' 155' ' ' PRO . 66.9 mttm . . . . . 0 CA--C 1.545 0.786 0 N-CA-C 112.098 0.407 . . . . 74.340000000000003 112.098 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 154' ' ' LYS . 41.7 Cg_endo -65.25 146.7 86.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.679 2.252 . . . . 72.25 113.368 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 168' ' ' VAL . 40.0 pt -130.06 167.82 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.455 0.645 . . . . 75.040000000000006 112.634 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.82 133.66 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 61.229999999999997 109.968 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 57.5 mtp180 -105.09 106.17 16.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.121 0.486 . . . . 71.319999999999993 111.594 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -109.57 128.83 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.541 0.571 . . . . 73.409999999999997 112.541 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.56 115.12 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.24 -0.436 . . . . 75.099999999999994 110.93 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -89.97 155.45 47.4 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 111.65 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.46 141.55 68.07 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.6 2.2 . . . . 64.099999999999994 113.346 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 72.57 65.6 0.12 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.788 0.835 . . . . 62.450000000000003 112.676 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 58.2 41.38 23.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.013 0.746 . . . . 74.329999999999998 113.013 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -129.06 152.76 48.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.23 0.538 . . . . 53.549999999999997 111.831 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -157.41 146.44 19.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.03 -0.532 . . . . 74.450000000000003 110.572 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -156.32 147.44 22.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.178 0.513 . . . . 64.239999999999995 111.821 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 156' ' ' ILE . 99.3 t -109.92 122.34 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.11 -0.495 . . . . 63.039999999999999 111.372 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 HD11 ' A' ' 214' ' ' ILE . 12.2 m -118.25 138.04 25.22 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.35 -0.386 . . . . 71.040000000000006 111.553 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 34.0 Cg_exo -60.8 139.33 84.72 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.93 2.42 . . . . 54.0 113.946 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.29 103.91 13.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.24 -0.436 . . . . 62.310000000000002 111.648 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -124.39 141.87 51.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.451 -0.34 . . . . 62.240000000000002 111.271 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.2 t -74.98 151.04 38.83 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.667 0.27 . . . . 53.210000000000001 110.771 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.11 -37.18 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.011 -0.614 . . . . 51.130000000000003 112.572 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 214' ' ' ILE . 55.8 t -80.41 113.3 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.911 0.386 . . . . 74.230000000000004 110.582 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 72.0 p -75.83 159.78 30.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.547 -0.297 . . . . 55.140000000000001 111.454 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -30.45 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.611 0.72 . . . . 43.25 110.565 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 51.3 ttt180 -66.68 -48.65 68.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.533 -0.758 . . . . 71.340000000000003 111.337 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 5.2 t70 -75.86 -24.23 55.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 73.230000000000004 111.679 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 92.8 p -74.0 -48.58 29.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.024 0.44 . . . . 73.040000000000006 111.154 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.62 -4.02 59.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 63.32 112.858 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 18.0 ptmt -53.86 -45.49 70.99 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 111.868 0.321 . . . . 54.25 111.868 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.17 -25.79 47.35 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.143 -0.348 . . . . 70.140000000000001 111.675 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.63 82.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.225 0.536 . . . . 74.25 110.857 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.8 mt -79.09 -31.74 44.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.191 -0.459 . . . . 63.200000000000003 110.808 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -54.97 -47.84 74.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.505 -0.316 . . . . 74.200000000000003 111.27 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.9 ptp -68.66 -7.88 37.28 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.125 0.417 . . . . 71.010000000000005 112.125 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -101.3 -16.22 17.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.887 0.375 . . . . 74.319999999999993 111.163 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.4 30.15 25.54 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.305 -0.474 . . . . 62.310000000000002 112.727 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.8 173.55 6.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.867 0.365 . . . . 54.210000000000001 111.496 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.74 146.37 56.89 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.437 -0.347 . . . . 64.109999999999999 110.693 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.7 -41.82 74.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.604 2.203 . . . . 73.109999999999999 113.61 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.4 mp0 -63.63 -12.11 30.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.524 0.564 . . . . 75.120000000000005 112.524 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.54 -8.4 50.37 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.93 0.395 . . . . 71.230000000000004 111.563 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.6 m -123.5 171.75 9.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 64.239999999999995 112.055 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -143.68 129.72 19.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.43 -0.35 . . . . 71.439999999999998 111.286 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 224' ' ' VAL . 54.3 t -95.26 121.05 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.516 -0.311 . . . . 65.420000000000002 111.097 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 207' ' ' PRO . 17.9 p90 -132.27 145.11 51.07 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.178 0.513 . . . . 75.25 111.254 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HG2' HD11 ' A' ' 208' ' ' ILE . 40.2 ptt180 -122.83 161.37 24.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.046 0.45 . . . . 74.439999999999998 111.163 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 205' ' ' LYS . 52.7 mt -110.14 101.62 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.147 -0.479 . . . . 70.409999999999997 110.682 177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -120.29 123.78 44.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.994 -0.548 . . . . 65.239999999999995 110.543 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.66 30.45 19.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.202 0.525 . . . . 74.510000000000005 110.948 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 -12.41 54.45 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.036 -0.529 . . . . 75.019999999999996 113.361 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.8 120.33 25.91 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.15 0.426 . . . . 75.120000000000005 112.15 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.481 ' HG2' HG12 ' A' ' 200' ' ' ILE . 87.5 mttt -86.34 101.41 13.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.285 -0.416 . . . . 72.530000000000001 110.535 172.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -121.9 120.88 28.31 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 120.611 0.243 . . . . 63.200000000000003 111.432 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 198' ' ' TYR . 16.5 Cg_exo -69.62 126.15 13.07 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.714 2.276 . . . . 71.310000000000002 113.319 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 199' ' ' ARG . 3.6 mp -86.63 131.68 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.404 -0.362 . . . . 65.409999999999997 110.381 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.55 133.16 41.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.79 -0.719 . . . . 54.219999999999999 112.937 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -57.74 -22.05 44.51 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.071 0.462 . . . . 71.420000000000002 111.936 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.12 -10.74 59.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.426 0.528 . . . . 70.409999999999997 112.426 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.9 m -75.21 137.93 41.6 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.783 0.29 . . . . 71.310000000000002 111.783 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.04 130.26 44.73 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.875 0.369 . . . . 73.519999999999996 111.008 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 169' ' ' VAL . 9.8 tt -60.99 -23.67 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.014 0.435 . . . . 65.049999999999997 111.96 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 80.9 p -59.12 -24.98 63.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.295 0.48 . . . . 72.219999999999999 112.295 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -67.27 -27.48 67.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.961 0.356 . . . . 73.530000000000001 111.961 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 208' ' ' ILE . 51.3 mt -109.09 37.81 2.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.239 0.542 . . . . 74.519999999999996 111.712 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.6 m -67.36 120.2 13.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.73 0.641 . . . . 73.340000000000003 112.73 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.18 81.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 115.255 0.862 . . . . 74.420000000000002 115.255 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.65 172.1 7.92 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.187 0.993 . . . . 65.219999999999999 111.989 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.4 mt-10 -108.61 114.52 28.4 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.941 -0.572 . . . . 74.209999999999994 111.635 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 83.2 mt -94.81 157.53 15.89 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.102 0.477 . . . . 73.010000000000005 111.694 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -127.85 134.03 49.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.494 -0.321 . . . . 73.200000000000003 110.152 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 197' ' ' VAL . 48.0 t -119.74 136.05 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.371 0.508 . . . . 74.230000000000004 112.371 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.67 173.93 7.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.186 -0.461 . . . . 75.519999999999996 110.597 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.6 t -100.37 129.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.0 mt . . . . . 0 N--CA 1.471 0.599 0 CA-C-O 120.629 0.252 . . . . 43.299999999999997 111.425 178.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 112.581 0.586 . . . . 73.140000000000001 112.581 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.22 136.46 72.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.956 2.437 . . . . 51.149999999999999 113.096 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.93 162.71 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.455 0.645 . . . . 73.140000000000001 112.566 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 171' ' ' ALA . 47.3 t -130.88 130.47 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.549 -0.75 . . . . 73.239999999999995 109.847 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -98.66 101.16 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.987 0.422 . . . . 71.310000000000002 111.597 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 222' ' ' LEU . 42.9 t -96.3 117.54 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.922 0.391 . . . . 64.400000000000006 111.964 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -91.75 117.57 29.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.967 0.413 . . . . 74.519999999999996 111.196 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -97.68 160.17 29.25 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.274 -0.421 . . . . 72.120000000000005 111.431 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.76 173.02 6.12 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.397 2.065 . . . . 72.120000000000005 112.324 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 64.34 28.31 13.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.999 0.428 . . . . 73.239999999999995 111.72 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 64.13 34.86 10.74 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.891 -0.595 . . . . 71.209999999999994 111.964 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -110.33 160.76 16.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.003 0.43 . . . . 74.329999999999998 111.465 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -156.62 153.73 29.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.825 0.345 . . . . 74.310000000000002 111.182 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -152.11 137.31 17.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 111.843 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.4 t -104.77 120.78 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.39 -0.368 . . . . 72.010000000000005 110.553 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.36 151.77 48.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 111.871 0.323 . . . . 53.109999999999999 111.871 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 129.18 13.2 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.562 2.175 . . . . 53.100000000000001 113.357 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.79 112.31 15.8 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.219 -0.446 . . . . 41.350000000000001 111.493 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.67 159.59 33.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.534 0.334 . . . . 74.409999999999997 111.452 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -95.28 147.54 23.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.688 0.28 . . . . 75.530000000000001 110.533 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.14 -25.3 6.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.696 -0.764 . . . . 63.520000000000003 112.262 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.58 111.82 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 110.528 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 76.6 p -75.91 157.71 32.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.267 -0.424 . . . . 53.43 111.594 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.8 t -53.8 -40.9 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.261 0.553 . . . . 41.340000000000003 110.782 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 48.2 ttp180 -61.25 -37.81 84.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.571 -0.74 . . . . 72.439999999999998 111.424 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.47 -53.85 7.54 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.967 -0.56 . . . . 71.329999999999998 111.518 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.7 t -57.94 -41.14 82.17 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.222 0.453 . . . . 73.239999999999995 112.222 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 159' ' ' VAL . 69.9 mt -80.76 6.57 12.55 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.957 0.725 . . . . 74.420000000000002 112.957 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -55.06 -36.64 65.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.992 0.425 . . . . 74.140000000000001 110.878 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -67.35 -37.45 83.25 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.231 -0.441 . . . . 61.130000000000003 111.571 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.9 32.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.986 0.422 . . . . 44.340000000000003 110.899 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 88.4 mt -55.45 -42.91 74.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.87 -0.605 . . . . 75.030000000000001 111.241 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 52.6 ttm -59.45 -57.16 14.21 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.779 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -68.8 -23.13 64.24 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.462 0.541 . . . . 65.439999999999998 112.462 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -103.99 3.32 33.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.794 0.665 . . . . 73.340000000000003 112.794 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.04 48.5 85.6 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.149 -0.548 . . . . 73.310000000000002 113.559 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 89.3 mt -127.5 159.84 33.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.899 0.381 . . . . 52.119999999999997 111.467 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.74 154.79 73.33 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.491 -0.322 . . . . 75.010000000000005 111.168 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.12 -31.86 29.85 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.188 2.592 . . . . 71.329999999999998 114.525 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.65 -15.3 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.992 -0.443 . . . . 72.140000000000001 112.135 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.18 -8.74 29.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.014 0.375 . . . . 74.409999999999997 112.014 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 190' ' ' LEU . 77.7 m -142.55 149.33 38.95 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.0 0.429 . . . . 74.140000000000001 111.869 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.79 134.53 55.2 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.29 -0.414 . . . . 54.32 111.429 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 224' ' ' VAL . 34.1 t -108.4 125.05 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 122.529 0.331 . . . . 53.32 111.075 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.9 152.0 46.07 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.89 0.376 . . . . 73.120000000000005 111.338 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 199' ' ' ARG . 6.8 ptt180 -122.92 154.97 37.64 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.321 -0.251 . . . . 74.5 110.321 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.6 mt -110.85 131.4 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.211 0.529 . . . . 74.430000000000007 111.84 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 27.1 tt0 -137.7 119.62 15.35 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.093 -0.503 . . . . 72.519999999999996 110.79 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.46 16.28 3.18 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.420000000000002 112.144 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.59 -10.02 38.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 121.331 -0.461 . . . . 62.039999999999999 114.159 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . 0.673 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 12.3 pt-20 -88.02 134.66 33.69 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.948 0.874 . . . . 75.549999999999997 111.924 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 99.7 mttt -97.74 103.81 15.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.455 -0.338 . . . . 72.25 110.425 173.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.49 113.7 65.56 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 111.905 0.335 . . . . 75.540000000000006 111.905 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.04 113.07 2.05 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.969 2.446 . . . . 51.109999999999999 112.14 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.71 129.25 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 70.329999999999998 111.484 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.55 126.13 21.4 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.678 -0.773 . . . . 62.049999999999997 112.259 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 73.7 m95 -52.05 -28.69 18.22 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.84 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.74 14.94 2.87 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.751 0.649 . . . . 72.099999999999994 112.751 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 56.6 m -93.28 140.74 29.21 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.031 -0.418 . . . . 75.129999999999995 111.707 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.85 122.12 13.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.98 0.419 . . . . 63.450000000000003 111.223 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.0 -19.51 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.597 0.591 . . . . 52.310000000000002 112.597 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 33.8 t -61.11 -19.68 61.76 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.053 0.39 . . . . 71.209999999999994 112.053 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -78.23 -8.04 57.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.904 0.335 . . . . 71.430000000000007 111.904 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 42.6 mt -110.67 18.97 19.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.141 0.496 . . . . 72.25 111.412 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -61.56 123.17 17.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.914 0.709 . . . . 61.329999999999998 112.914 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.35 -37.33 3.61 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.712 0.645 . . . . 62.229999999999997 114.712 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.78 172.62 7.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.629 0.715 . . . . 73.420000000000002 112.684 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -93.75 139.55 30.71 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.581 -0.736 . . . . 74.120000000000005 112.596 -173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 159' ' ' VAL . 54.6 mt -103.57 140.63 37.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.066 -0.516 . . . . 53.240000000000002 110.542 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -115.51 117.37 30.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.513 -0.312 . . . . 73.519999999999996 110.565 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 197' ' ' VAL . 39.8 t -112.6 129.42 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.759 0.314 . . . . 73.030000000000001 111.547 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.21 155.02 51.38 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.928 0.394 . . . . 73.230000000000004 111.348 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.93 130.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.564 0.579 . . . . 64.319999999999993 112.564 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 91.0 mt . . . . . 0 CA--C 1.536 0.413 0 CA-C-N 115.831 -0.622 . . . . 71.439999999999998 110.73 175.587 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.474 0.178 . . . . 74.409999999999997 111.153 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 135.69 23.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.263 1.975 . . . . 74.140000000000001 111.496 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.29 163.27 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 113.133 0.79 . . . . 72.319999999999993 113.133 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.5 t -122.54 137.29 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.851 -0.613 . . . . 70.319999999999993 110.917 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 71.8 mtt85 -96.78 101.4 12.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 74.120000000000005 111.312 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.519 HG21 HD21 ' A' ' 181' ' ' LEU . 60.3 t -102.03 125.73 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.966 0.412 . . . . 65.319999999999993 111.726 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -91.52 106.4 18.46 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.35 -0.386 . . . . 74.120000000000005 111.175 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.8 mt -80.09 153.25 74.65 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.302 -0.408 . . . . 73.140000000000001 111.208 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 72.5 Cg_exo -49.96 140.45 31.47 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.896 2.397 . . . . 55.240000000000002 113.921 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 86.1 m-20 75.96 46.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.486 0.714 . . . . 71.030000000000001 112.47 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 64.2 20.32 12.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.773 0.657 . . . . 73.030000000000001 112.773 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.4 mm-40 -89.35 141.56 28.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 71.519999999999996 111.188 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -117.64 143.06 46.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.246 0.546 . . . . 74.400000000000006 111.877 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.448 HG23 ' HB ' ' A' ' 159' ' ' VAL . 9.2 t -145.5 137.93 25.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.826 -0.625 . . . . 74.519999999999996 110.724 172.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.21 120.26 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.672 0.272 . . . . 72.019999999999996 110.833 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 31.2 m -114.62 147.87 39.07 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 75.439999999999998 111.813 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 11.4 Cg_exo -71.55 125.0 10.78 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.789 2.326 . . . . 75.329999999999998 112.695 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 120.81 17.61 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.042 0.449 . . . . 51.109999999999999 111.754 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 61.9 mtt-85 -127.13 159.39 34.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.368 -0.378 . . . . 64.450000000000003 111.087 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.3 t -99.17 139.32 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.445 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.77 84.1 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.006 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.8 t -127.1 119.3 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.952 0.501 . . . . 73.219999999999999 110.269 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.9 p -80.43 168.48 18.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.257 0.551 . . . . 63.020000000000003 112.201 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.75 -37.92 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.352 0.596 . . . . 74.409999999999997 110.236 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 21.3 ttt85 -63.91 -35.19 79.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.664 -0.698 . . . . 75.420000000000002 111.094 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' A' ' 182' ' ' LYS . 2.1 m-20 -76.53 -51.97 10.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.392 -0.367 . . . . 44.009999999999998 111.707 175.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -56.0 -42.73 76.87 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.111 0.411 . . . . 71.239999999999995 112.111 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 159' ' ' VAL . 78.9 mt -92.08 -10.04 40.46 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.812 1.042 . . . . 64.439999999999998 113.812 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 179' ' ' ASP . 0.1 OUTLIER -58.12 -28.71 64.9 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.909 0.777 . . . . 70.0 111.483 -176.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.82 -45.61 64.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.095 0.474 . . . . 73.329999999999998 110.607 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.54 90.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.949 -0.568 . . . . 65.430000000000007 111.665 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.66 -47.32 69.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 60.140000000000001 110.797 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.7 ttm -57.48 -39.13 75.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.002 -0.544 . . . . 45.409999999999997 112.245 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.8 ptm -75.26 -21.69 58.37 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.071 -0.393 . . . . 75.120000000000005 111.906 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -96.25 -13.68 23.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.097 0.406 . . . . 75.219999999999999 112.097 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.22 41.51 10.17 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.95 -0.643 . . . . 73.420000000000002 112.479 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.31 158.26 34.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.683 0.393 . . . . 62.210000000000001 110.829 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.2 pt -133.33 137.7 29.77 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.682 -0.235 . . . . 72.319999999999993 111.342 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.6 -44.31 35.95 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.172 2.581 . . . . 73.25 113.654 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.02 -21.65 59.41 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.522 0.564 . . . . 53.450000000000003 112.522 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . 0.522 ' SG ' HG13 ' A' ' 226' ' ' VAL . 32.7 t -101.18 -12.42 18.77 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.948 0.404 . . . . 64.420000000000002 112.014 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.9 m -119.55 164.41 15.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.173 0.511 . . . . 44.420000000000002 111.983 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.83 133.82 38.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.439 -0.346 . . . . 74.129999999999995 111.909 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 224' ' ' VAL . 68.0 t -98.79 138.54 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.731 0.301 . . . . 72.109999999999999 110.816 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.75 158.86 41.58 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.179 0.514 . . . . 71.349999999999994 111.738 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 206' ' ' LYS . 6.4 ptm180 -110.11 154.25 23.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.873 -0.603 . . . . 64.329999999999998 110.111 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.448 HG12 ' HG2' ' A' ' 205' ' ' LYS . 59.0 mt -118.62 120.65 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.985 0.421 . . . . 64.230000000000004 111.575 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -154.78 144.28 21.36 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.031 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 57.06 31.44 19.95 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.334 0.588 . . . . 70.150000000000006 111.22 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.66 -19.66 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.874 -0.603 . . . . 42.039999999999999 113.82 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.06 170.27 8.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.575 0.702 . . . . 65.329999999999998 112.732 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.0 mttp -113.45 139.58 48.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.32 -0.855 . . . . 73.310000000000002 110.947 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 199' ' ' ARG . 87.4 tttt -114.69 105.35 53.54 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.662 -0.245 . . . . 72.219999999999999 110.593 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -61.96 113.38 1.84 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.789 2.326 . . . . 64.439999999999998 112.412 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 217' ' ' LEU . 61.2 mt -96.64 134.22 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 72.430000000000007 111.615 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.3 135.17 29.3 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.145 -0.55 . . . . 72.420000000000002 113.039 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 75.9 m95 -55.34 -43.42 74.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.712 0.634 . . . . 74.430000000000007 112.712 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.56 27.93 0.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.85 0.685 . . . . 61.439999999999998 112.85 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 48.7 m -92.51 137.62 32.21 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 122.354 -0.216 . . . . 43.439999999999998 110.612 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.99 124.15 15.85 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.926 0.394 . . . . 74.319999999999993 111.794 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.25 -24.21 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.178 -0.465 . . . . 75.540000000000006 111.698 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 t -56.54 -30.61 63.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.115 0.413 . . . . 74.120000000000005 112.115 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.68 -19.1 65.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.842 0.353 . . . . 73.019999999999996 111.939 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 208' ' ' ILE . 44.0 mt -115.45 19.13 15.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.173 0.511 . . . . 72.230000000000004 111.676 -173.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.567 ' HA ' HG22 ' A' ' 157' ' ' VAL . 75.5 m -61.38 132.0 52.08 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.547 0.573 . . . . 73.010000000000005 112.547 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 93.4 -22.07 37.18 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.717 0.647 . . . . 74.420000000000002 114.717 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.16 172.78 6.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.684 0.742 . . . . 74.040000000000006 112.677 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 42.4 mt-10 -105.91 114.7 29.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.755 -0.657 . . . . 72.540000000000006 111.765 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.03 164.3 13.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.138 0.494 . . . . 75.540000000000006 111.291 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -131.7 139.1 48.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.839 0.352 . . . . 64.349999999999994 111.472 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 197' ' ' VAL . 46.4 t -123.12 126.38 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.107 -0.497 . . . . 63.049999999999997 110.746 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.72 145.72 46.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.397 . . . . 63.219999999999999 111.274 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.522 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.7 t -83.87 103.09 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 110.079 -0.341 . . . . 71.510000000000005 110.079 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 120.983 0.42 . . . . 61.020000000000003 111.692 -176.44 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.471 0.62 0 CA-C-O 120.602 0.239 . . . . 73.409999999999997 111.392 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.59 131.03 31.82 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.663 2.242 . . . . 75.25 112.793 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.03 156.68 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.223 0.535 . . . . 72.120000000000005 112.173 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 171' ' ' ALA . 56.7 t -122.39 131.27 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.69 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.537 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 99.9 mtt180 -84.92 134.89 34.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.522 -0.308 . . . . 75.109999999999999 110.891 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 181' ' ' LEU . 59.7 t -130.18 119.51 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.1 0.476 . . . . 75.25 111.676 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -93.93 114.43 26.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.129 -0.487 . . . . 65.230000000000004 111.037 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 87.9 mt -98.19 158.33 32.93 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.088 -0.506 . . . . 72.340000000000003 111.181 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 172.2 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.27 1.98 . . . . 75.109999999999999 111.886 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 62.46 23.23 13.77 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.09 0.471 . . . . 74.299999999999997 110.778 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 63.02 26.91 15.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.513 0.725 . . . . 64.349999999999994 112.332 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 79.3 mm-40 -88.02 152.49 22.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.193 0.521 . . . . 74.5 111.98 -177.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -132.78 139.18 47.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.239 -0.437 . . . . 63.210000000000001 110.96 -176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.406 HG23 ' HB ' ' A' ' 159' ' ' VAL . 8.3 t -152.45 148.52 27.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.889 0.376 . . . . 64.109999999999999 111.745 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.7 129.7 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.87 0.366 . . . . 71.150000000000006 111.057 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.33 154.55 72.16 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.603 -0.271 . . . . 74.310000000000002 111.723 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 141.07 24.53 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.524 2.149 . . . . 73.209999999999994 113.163 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -103.4 122.23 44.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.942 0.349 . . . . 54.219999999999999 111.942 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -133.89 152.28 51.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.976 0.417 . . . . 75.530000000000001 111.817 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.3 t -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 64.209999999999994 111.007 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.2 -25.77 16.14 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.961 -0.638 . . . . 72.109999999999999 112.741 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.2 t -82.59 125.93 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.777 0.323 . . . . 73.530000000000001 110.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 45.5 p -84.25 164.49 19.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.199 0.523 . . . . 71.230000000000004 112.041 -177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 210' ' ' TRP . 61.4 t -59.2 -33.07 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.397 0.618 . . . . 72.030000000000001 110.722 174.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -63.48 -53.63 48.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.934 -0.575 . . . . 72.439999999999998 110.776 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.549 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 59.3 m-20 -59.81 -38.61 82.44 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.231 0.456 . . . . 75.400000000000006 112.231 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.0 p -76.59 -31.22 57.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.92 0.711 . . . . 54.240000000000002 112.92 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 159' ' ' VAL . 71.5 mt -106.45 -20.49 13.36 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.498 1.296 . . . . 65.209999999999994 114.498 -174.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 22.7 pttp -54.61 -33.67 60.84 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.427 0.899 . . . . 70.530000000000001 113.427 -172.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.99 -44.78 53.47 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.082 -0.386 . . . . 73.140000000000001 111.05 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.42 69.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.089 0.471 . . . . 71.219999999999999 111.334 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.57 HD11 ' CH2' ' A' ' 210' ' ' TRP . 86.4 mt -69.2 -48.96 60.63 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.033 -0.53 . . . . 62.200000000000003 110.901 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.0 tpt -56.84 -45.64 82.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.88 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -70.09 -8.81 52.49 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.557 0.577 . . . . 73.150000000000006 112.557 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.46 -20.61 12.15 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.954 0.353 . . . . 73.299999999999997 111.954 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.51 38.22 3.07 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.161 -0.542 . . . . 31.120000000000001 113.571 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 195' ' ' CYS . 5.0 mp -122.05 169.63 10.65 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.451 -0.441 . . . . 65.420000000000002 111.59 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.87 134.58 13.02 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.04 -0.527 . . . . 72.329999999999998 110.562 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.56 -39.9 73.9 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.792 2.328 . . . . 35.439999999999998 113.708 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.33 -11.1 56.77 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.11 0.781 . . . . 75.409999999999997 113.11 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.41 9.94 9.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.985 0.421 . . . . 60.350000000000001 111.467 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 190' ' ' LEU . 73.3 m -123.43 144.06 49.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.769 0.318 . . . . 74.430000000000007 111.611 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -122.46 119.47 31.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.524 -0.307 . . . . 75.219999999999999 111.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 224' ' ' VAL . 25.1 t -98.75 134.07 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.699 -0.228 . . . . 72.340000000000003 110.899 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.464 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 47.9 p90 -138.5 155.49 48.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.301 0.572 . . . . 64.019999999999996 111.715 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -121.27 152.17 39.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.686 -0.688 . . . . 73.409999999999997 111.192 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.5 mt -105.8 97.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.815 0.34 . . . . 73.129999999999995 110.795 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 201' ' ' GLN . 12.8 pt20 -112.23 128.54 56.28 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.618 -0.265 . . . . 61.109999999999999 110.92 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.0 t70 60.16 19.09 8.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.546 0.689 . . . . 44.5 111.687 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.13 72.42 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.197 -0.525 . . . . 65.310000000000002 113.295 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.06 126.24 52.08 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.525 -0.397 . . . . 73.420000000000002 111.273 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.464 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 58.1 mtpt -80.68 94.4 6.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.069 0.461 . . . . 63.420000000000002 110.677 174.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -94.29 118.4 67.07 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.231 -0.44 . . . . 74.230000000000004 111.389 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.1 148.83 87.91 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.67 2.247 . . . . 64.430000000000007 112.559 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.533 HD12 HG12 ' A' ' 197' ' ' VAL . 50.1 mt -118.07 148.52 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.841 0.353 . . . . 71.519999999999996 111.222 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.38 139.05 14.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.953 -0.642 . . . . 61.299999999999997 112.13 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.57 ' CH2' HD11 ' A' ' 185' ' ' LEU . 94.2 m95 -62.7 -23.28 67.07 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.359 -0.495 . . . . 71.209999999999994 111.543 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.41 15.14 11.19 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.018 -0.537 . . . . 72.239999999999995 112.032 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 m -96.2 147.53 23.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.397 0.279 . . . . 74.120000000000005 110.952 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 216' ' ' TRP . 5.1 m-20 -65.13 126.65 28.75 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.166 0.508 . . . . 72.049999999999997 111.87 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 217' ' ' LEU . 9.5 tp -62.03 -20.64 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 116.128 -0.487 . . . . 63.329999999999998 111.366 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.6 p -60.63 -23.19 64.56 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.441 -0.345 . . . . 73.239999999999995 111.903 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 213' ' ' ASP . 42.3 m95 -70.37 -20.13 62.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.038 0.446 . . . . 75.400000000000006 111.739 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 HD12 ' A' ' 214' ' ' ILE . 23.2 mt -104.97 9.81 34.41 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.098 -0.501 . . . . 62.32 111.748 -174.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.0 m -56.64 109.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.646 0.61 . . . . 75.310000000000002 112.646 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.53 1.61 60.44 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.097 -0.573 . . . . 72.319999999999993 113.981 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -103.65 158.96 16.01 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.478 . . . . 72.540000000000006 111.826 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.537 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.3 mt-10 -105.72 114.82 29.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.067 0.461 . . . . 70.299999999999997 110.683 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 mt -92.8 156.11 17.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 63.109999999999999 111.715 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -129.33 132.55 47.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 72.140000000000001 110.197 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 197' ' ' VAL . 58.5 t -109.73 123.62 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.22 0.452 . . . . 72.349999999999994 112.22 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -100.66 157.39 16.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 111.228 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.55 130.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.741 0.305 . . . . 62.329999999999998 111.016 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 196' ' ' ALA . 89.1 mt . . . . . 0 CA--C 1.541 0.62 0 N-CA-C 111.802 0.297 . . . . 63.409999999999997 111.802 -178.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? . . . . . 0 CA--C 1.541 0.6 0 CA-C-O 120.713 0.292 . . . . 73.519999999999996 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.76 128.55 19.14 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.46 2.107 . . . . 75.310000000000002 112.013 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.72 157.14 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.531 0.681 . . . . 65.340000000000003 112.76 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.77 135.37 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.436 -0.802 . . . . 74.140000000000001 110.186 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 50.0 mtt180 -90.32 98.56 11.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.936 0.398 . . . . 75.129999999999995 110.803 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.688 HG21 HD21 ' A' ' 181' ' ' LEU . 60.5 t -96.78 108.01 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.34 0.59 . . . . 74.510000000000005 111.806 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 73.1 m-85 -76.53 104.09 6.86 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.041 0.448 . . . . 64.319999999999993 110.762 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.39 157.87 89.15 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.931 -0.577 . . . . 74.349999999999994 112.274 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 11.1 Cg_endo -54.1 160.09 6.74 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.668 2.246 . . . . 61.350000000000001 112.843 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 65.0 t30 68.57 31.34 4.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.536 0.684 . . . . 64.400000000000006 110.839 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 65.6 23.03 11.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.31 -0.859 . . . . 74.319999999999993 113.031 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.92 -177.04 4.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.99 0.424 . . . . 75.349999999999994 111.776 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 28.1 ptt180 -157.84 156.86 32.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.162 0.505 . . . . 71.010000000000005 111.902 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.3 t -156.27 160.51 39.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.997 -0.547 . . . . 60.0 110.352 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.8 t -116.53 119.75 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.757 0.313 . . . . 43.219999999999999 111.041 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.23 152.67 49.37 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 111.852 0.315 . . . . 73.239999999999995 111.852 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.59 147.66 32.08 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.491 2.128 . . . . 63.439999999999998 113.273 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -103.67 126.73 51.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.959 0.409 . . . . 64.129999999999995 111.69 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -128.74 146.18 50.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.98 0.419 . . . . 62.149999999999999 111.623 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.69 132.21 40.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.834 0.35 . . . . 73.540000000000006 110.896 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.06 -23.7 30.14 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.076 -0.583 . . . . 44.25 112.437 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.26 125.26 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 111.131 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 30.0 p -82.74 165.92 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.93 0.395 . . . . 74.150000000000006 111.491 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 212' ' ' THR . 62.0 t -56.96 -32.38 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.352 0.596 . . . . 73.209999999999994 110.243 172.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 4.2 tmt_? -68.04 -45.77 73.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.703 -0.681 . . . . 44.25 111.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -67.83 -33.42 74.75 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.918 0.39 . . . . 72.129999999999995 111.669 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.0 t -74.31 -44.01 54.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.25 0.463 . . . . 64.140000000000001 112.25 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 159' ' ' VAL . 68.3 mt -95.79 -4.78 43.27 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.72 1.007 . . . . 62.210000000000001 113.72 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -58.24 -43.51 87.82 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.246 0.461 . . . . 51.439999999999998 112.246 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -80.92 -27.85 36.03 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 111.022 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.77 92.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.209 0.528 . . . . 65.540000000000006 111.173 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.27 -29.7 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.309 -0.405 . . . . 73.430000000000007 111.108 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.423 ' C ' ' SD ' ' A' ' 186' ' ' MET . 0.2 OUTLIER -54.63 -48.08 72.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.33 -0.396 . . . . 71.310000000000002 111.293 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -64.99 -19.12 65.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.023 0.379 . . . . 62.229999999999997 112.023 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -87.37 -5.97 58.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.774 0.321 . . . . 74.430000000000007 111.317 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.15 16.22 70.09 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.394 -0.431 . . . . 53.149999999999999 112.665 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.9 mt -117.3 171.76 7.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.016 0.436 . . . . 71.239999999999995 111.622 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 25.4 pt -133.44 143.9 49.97 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 116.086 -0.506 . . . . 65.140000000000001 111.039 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.81 -29.69 82.06 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.749 2.299 . . . . 75.340000000000003 112.941 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.34 -32.38 68.46 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.998 -0.546 . . . . 74.019999999999996 111.934 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.28 9.96 31.86 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.365 0.506 . . . . 60.409999999999997 112.365 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.0 m -118.27 166.87 12.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.98 0.419 . . . . 74.519999999999996 111.614 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.08 138.9 48.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 73.120000000000005 111.335 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 224' ' ' VAL . 61.9 t -111.17 132.11 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.288 -0.414 . . . . 71.319999999999993 111.267 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -139.06 146.89 41.33 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.252 0.548 . . . . 73.140000000000001 111.312 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' HD11 ' A' ' 208' ' ' ILE . 9.1 ptm180 -116.62 169.15 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 64.129999999999995 110.294 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' A' ' 205' ' ' LYS . 54.4 mt -104.04 115.69 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 110.101 174.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.27 119.69 22.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.952 -0.567 . . . . 75.430000000000007 110.253 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.31 27.01 15.96 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.335 0.588 . . . . 64.319999999999993 111.57 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.96 2.51 74.77 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.243 -0.435 . . . . 65.239999999999995 113.882 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.02 133.03 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.428 -0.454 . . . . 64.129999999999995 111.629 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.7 mttp -78.13 99.0 6.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.074 0.464 . . . . 72.439999999999998 110.895 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -93.67 112.09 55.32 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.991 -0.55 . . . . 74.120000000000005 111.859 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.19 110.23 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.92 2.413 . . . . 74.409999999999997 112.654 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.547 HD11 ' HG2' ' A' ' 199' ' ' ARG . 62.6 mt -89.13 138.59 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.26 -0.427 . . . . 61.219999999999999 112.039 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.06 138.59 34.94 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.14 -0.553 . . . . 52.5 113.219 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.1 m95 -59.45 -22.99 62.32 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.901 0.381 . . . . 70.409999999999997 111.746 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.09 -11.84 60.93 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.095 0.558 . . . . 62.509999999999998 112.228 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 177' ' ' VAL . 20.7 m -75.75 135.11 40.33 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.279 -0.419 . . . . 72.329999999999998 111.892 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 2.3 m-20 -62.03 127.21 30.29 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.513 -0.312 . . . . 41.25 111.54 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -61.31 -22.75 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 111.284 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.9 t -54.89 -29.12 55.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.048 -0.524 . . . . 53.310000000000002 112.036 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -68.79 -26.74 65.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.496 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.638 HD13 HD21 ' A' ' 222' ' ' LEU . 51.8 mt -105.47 10.88 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.0 -0.546 . . . . 72.329999999999998 112.104 -172.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 70.7 m -50.38 119.22 3.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.178 0.436 . . . . 55.130000000000003 112.178 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.73 -21.44 45.87 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.276 -0.488 . . . . 75.349999999999994 113.993 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -86.42 172.47 10.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.424 0.63 . . . . 73.010000000000005 112.418 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.1 mt-10 -111.18 119.96 40.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.875 -0.602 . . . . 74.510000000000005 111.249 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 217' ' ' LEU . 77.6 mt -97.39 155.23 17.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 111.116 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -127.52 120.53 28.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.029 -0.36 . . . . 64.030000000000001 110.029 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 197' ' ' VAL . 52.5 t -115.95 140.6 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.1 0.476 . . . . 62.119999999999997 111.711 -175.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 162' ' ' PRO . 12.6 pt-20 -144.26 160.72 40.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.301 -0.409 . . . . 55.240000000000002 110.754 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.78 139.01 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.64 -0.254 . . . . 52.109999999999999 111.166 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.5 mt . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 111.886 0.328 . . . . 73.400000000000006 111.886 -178.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt . . . . . 0 CA--C 1.54 0.583 0 CA-C-O 120.587 0.232 . . . . 71.420000000000002 111.103 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.76 120.49 7.68 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.95 1.767 . . . . 71.310000000000002 111.661 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.3 pt -113.94 161.84 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.637 0.732 . . . . 73.310000000000002 112.883 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.45 133.58 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.342 -0.845 . . . . 74.239999999999995 110.275 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -95.99 96.39 8.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.011 0.434 . . . . 53.130000000000003 111.34 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.602 HG22 HD12 ' A' ' 222' ' ' LEU . 41.5 t -94.33 117.17 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.031 0.443 . . . . 54.240000000000002 112.108 -176.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.99 100.13 12.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.112 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 98.1 mt -69.95 161.77 73.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.696 -0.683 . . . . 71.430000000000007 111.614 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 9.8 Cg_endo -52.09 153.24 12.83 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.768 2.312 . . . . 64.340000000000003 113.345 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 61.96 44.6 8.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.495 0.664 . . . . 71.219999999999999 110.901 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 61.47 23.77 13.98 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.096 0.776 . . . . 74.219999999999999 113.096 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.9 mm-40 -86.88 157.76 19.47 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.068 -0.395 . . . . 64.439999999999998 111.101 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -139.74 145.44 38.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.443 0.534 . . . . 74.540000000000006 112.443 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.1 t -148.1 161.9 40.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.795 -0.639 . . . . 64.329999999999998 110.19 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.34 120.32 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.954 0.407 . . . . 71.340000000000003 111.254 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.04 137.05 26.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.461 -0.336 . . . . 43.219999999999999 111.449 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.513 ' HG2' HH21 ' A' ' 172' ' ' ARG . 65.0 Cg_endo -74.12 126.16 10.32 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 72.140000000000001 113.007 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.74 35.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.092 0.472 . . . . 61.439999999999998 112.165 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.513 HH21 ' HG2' ' A' ' 170' ' ' PRO . 11.5 ptp180 -167.71 161.97 13.69 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.001 -0.545 . . . . 73.120000000000005 111.604 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.7 t -95.47 154.32 17.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.306 -0.407 . . . . 63.020000000000003 111.351 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 66.5 18.66 68.03 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.248 -0.501 . . . . 60.229999999999997 113.266 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.495 ' HB ' ' HG3' ' A' ' 172' ' ' ARG . 40.8 t -132.8 124.72 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.644 0.378 . . . . 72.120000000000005 110.468 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.6 p -82.84 158.05 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 64.209999999999994 111.622 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.62 -35.77 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.617 0.722 . . . . 73.329999999999998 110.017 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.9 ttp180 -56.42 -54.65 43.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.948 -1.024 . . . . 72.230000000000004 111.319 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -74.16 -12.53 60.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.18 -0.464 . . . . 71.010000000000005 111.718 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.5 m -82.79 -46.78 12.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.037 0.446 . . . . 63.43 110.944 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.72 4.94 48.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.311 0.486 . . . . 54.329999999999998 112.311 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -54.92 -26.63 37.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.878 0.37 . . . . 74.319999999999993 111.8 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.02 -52.11 6.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.68 0.276 . . . . 70.340000000000003 111.556 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.34 64.11 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.005 0.431 . . . . 65.510000000000005 112.117 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.401 HD11 ' CH2' ' A' ' 210' ' ' TRP . 87.2 mt -71.03 -53.78 13.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.934 0.397 . . . . 43.420000000000002 111.483 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.2 tpp -57.05 -42.09 79.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.358 0.503 . . . . 71.430000000000007 112.358 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.3 ptp -66.63 -15.44 63.47 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.118 0.414 . . . . 74.340000000000003 112.118 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -110.14 5.2 21.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 111.551 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.05 35.54 89.34 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.464 -0.398 . . . . 75.329999999999998 113.229 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.6 159.95 15.81 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.086 0.469 . . . . 74.299999999999997 111.54 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.01 151.7 77.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.959 -0.564 . . . . 70.420000000000002 110.816 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.53 -34.3 51.42 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.683 2.255 . . . . 70.329999999999998 113.292 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -64.02 -22.03 66.75 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.2 0.524 . . . . 64.349999999999994 111.906 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.6 t -96.4 -7.49 34.86 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.335 0.494 . . . . 63.450000000000003 112.335 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . 0.403 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.4 m -134.89 131.65 37.59 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.683 0.623 . . . . 72.230000000000004 112.683 -172.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -111.31 127.33 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.18 -0.463 . . . . 55.43 111.324 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 224' ' ' VAL . 47.0 t -100.07 133.36 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.536 -0.302 . . . . 54.399999999999999 111.405 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -152.37 160.62 43.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.257 0.551 . . . . 72.510000000000005 111.812 175.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -122.93 155.94 35.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.074 -0.512 . . . . 64.319999999999993 110.677 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.95 120.75 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.8 0.333 . . . . 73.219999999999999 111.03 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -129.74 115.94 18.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.832 0.349 . . . . 72.200000000000003 111.207 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.1 t70 63.43 31.36 15.07 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.312 0.577 . . . . 73.010000000000005 111.155 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.55 50.25 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.258 -0.496 . . . . 42.009999999999998 114.221 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -102.34 155.7 18.07 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.399 0.599 . . . . 65.040000000000006 112.314 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -103.8 136.19 43.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.739 -0.664 . . . . 72.450000000000003 112.445 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -118.66 116.28 34.9 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 111.205 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.14 121.78 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.02 2.48 . . . . 74.239999999999995 112.911 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.85 122.79 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.171 0.51 . . . . 71.109999999999999 111.478 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.37 145.47 33.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.18 -0.533 . . . . 64.219999999999999 113.206 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.6 m95 -61.93 -27.55 68.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.922 0.391 . . . . 75.430000000000007 111.909 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.87 -10.3 59.31 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.675 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 90.5 m -69.52 136.97 52.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.209999999999994 111.663 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.99 126.23 27.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.89 0.376 . . . . 70.099999999999994 111.272 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 172' ' ' ARG . 12.7 tt -58.43 -19.92 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.977 0.418 . . . . 75.349999999999994 111.894 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -52.42 -33.63 44.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.255 0.465 . . . . 65.209999999999994 112.255 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -65.15 -28.34 69.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.15 0.5 . . . . 73.140000000000001 111.766 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 222' ' ' LEU . 35.7 mt -98.75 14.91 27.05 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.554 0.576 . . . . 73.219999999999999 112.554 -169.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.3 m -54.93 108.35 0.39 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.134 0.492 . . . . 74.129999999999995 112.237 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.9 69.66 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.457 -0.402 . . . . 70.450000000000003 113.954 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -84.53 163.46 19.36 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.321 0.581 . . . . 61.200000000000003 112.209 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -106.42 118.15 35.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.816 -0.629 . . . . 72.420000000000002 110.375 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.602 HD12 HG22 ' A' ' 159' ' ' VAL . 59.2 mt -93.01 111.86 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.006 0.431 . . . . 65.109999999999999 110.876 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -92.11 103.31 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.506 -0.316 . . . . 72.219999999999999 110.338 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 197' ' ' VAL . 35.3 t -99.0 123.35 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 111.998 0.37 . . . . 74.319999999999993 111.998 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -115.92 177.02 4.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.963 0.411 . . . . 74.239999999999995 111.366 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.6 138.03 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.691 0.626 . . . . 72.340000000000003 112.691 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.6 mt . . . . . 0 CA--C 1.537 0.47 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.989 175.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 CA--C 1.54 0.596 0 N-CA-C 110.362 -0.236 . . . . 60.140000000000001 110.362 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.55 140.01 75.41 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.743 2.295 . . . . 73.140000000000001 113.066 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -137.48 167.71 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.342 0.591 . . . . 75.450000000000003 112.496 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 46.8 t -129.92 139.09 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.816 -0.629 . . . . 63.030000000000001 110.349 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.758 ' HG2' HG22 ' A' ' 168' ' ' VAL . 98.9 mtt180 -108.69 117.86 35.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.292 0.568 . . . . 65.109999999999999 111.574 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 181' ' ' LEU . 75.3 t -109.92 131.69 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.292 0.478 . . . . 71.010000000000005 112.292 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -89.53 94.58 9.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.125 0.488 . . . . 63.140000000000001 110.934 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 81.9 mt -68.81 154.9 94.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 111.201 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.75 154.01 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.463 2.109 . . . . 64.010000000000005 112.375 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . 0.503 HD22 ' NH2' ' A' ' 188' ' ' ARG . 60.4 m-20 72.09 12.74 5.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.935 0.494 . . . . 63.329999999999998 110.78 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt 64.59 59.39 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.191 0.596 . . . . 73.040000000000006 112.445 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 83.8 mm-40 -113.41 135.95 53.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.004 -0.544 . . . . 74.049999999999997 110.481 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . 0.431 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 4.7 mpt_? -105.89 128.67 53.92 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.026 0.441 . . . . 75.519999999999996 111.889 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -136.96 156.17 48.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.436 -0.347 . . . . 75.340000000000003 111.16 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.758 HG22 ' HG2' ' A' ' 158' ' ' ARG . 38.7 t -126.38 132.78 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.934 0.397 . . . . 71.549999999999997 111.57 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.53 146.95 56.37 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.31 -0.405 . . . . 72.219999999999999 111.011 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 156' ' ' ILE . 57.5 Cg_endo -70.46 122.44 8.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.336 2.024 . . . . 42.520000000000003 113.261 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -74.03 114.81 12.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.919 0.39 . . . . 63.229999999999997 111.134 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' ' 175' ' ' VAL . 19.2 ptt-85 -132.67 142.34 49.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 72.540000000000006 111.896 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 45.7 t -77.58 140.22 39.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 111.66 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.77 55.99 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.238 -0.506 . . . . 63.140000000000001 113.242 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . 0.453 HG21 ' HG3' ' A' ' 172' ' ' ARG . 45.5 t -134.51 135.36 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 122.476 0.31 . . . . 75.209999999999994 110.751 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.8 p -81.63 159.71 23.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.123 0.487 . . . . 74.150000000000006 111.697 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 212' ' ' THR . 81.2 t -58.09 -37.69 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.286 0.565 . . . . 55.039999999999999 110.574 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 36.9 ttp180 -59.83 -56.76 17.71 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.673 -0.694 . . . . 71.140000000000001 111.511 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 68.2 m-20 -64.19 -17.04 63.15 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 71.120000000000005 112.347 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -93.69 -39.05 10.99 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.098 -0.376 . . . . 65.230000000000004 111.775 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 159' ' ' VAL . 65.2 mt -91.83 -5.54 53.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.753 0.649 . . . . 75.420000000000002 112.753 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 20.4 ptmt -54.28 -34.42 60.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.772 0.32 . . . . 71.540000000000006 111.751 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.58 -39.91 77.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.05 0.452 . . . . 63.549999999999997 111.361 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.75 98.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.986 0.422 . . . . 70.140000000000001 111.223 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.47 -43.11 91.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.125 -0.489 . . . . 44.240000000000002 110.768 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.5 ttp -55.66 -50.71 69.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.488 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -72.71 -0.5 13.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 111.872 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.503 ' NH2' HD22 ' A' ' 163' ' ' ASN . 19.3 mmm180 -117.41 1.68 12.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.787 0.292 . . . . 74.230000000000004 111.787 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 63.28 47.1 90.79 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.339 -0.458 . . . . 63.25 113.424 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 92.4 mt -132.86 159.92 38.45 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.987 0.422 . . . . 73.219999999999999 111.915 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.78 147.36 38.04 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.773 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.76 -47.08 26.78 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.608 2.205 . . . . 71.299999999999997 113.753 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.63 -3.47 21.76 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.727 0.64 . . . . 70.219999999999999 112.727 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -94.47 -8.54 38.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.047 0.451 . . . . 74.010000000000005 111.339 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 93.3 m -135.29 158.72 43.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.049 0.452 . . . . 75.109999999999999 111.811 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.445 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -124.93 131.72 53.39 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.304 -0.407 . . . . 70.25 111.379 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 224' ' ' VAL . 58.2 t -103.05 125.44 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.097 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.431 ' HE1' ' HG2' ' A' ' 225' ' ' GLU . 40.6 p90 -137.36 151.56 48.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.008 0.432 . . . . 74.109999999999999 111.111 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.456 ' HG2' HD11 ' A' ' 208' ' ' ILE . 37.4 ptt180 -111.7 142.2 44.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.031 -0.359 . . . . 70.209999999999994 110.031 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 205' ' ' LYS . 48.8 mt -82.79 103.45 10.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 74.299999999999997 109.732 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -102.82 109.77 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 75.099999999999994 110.827 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.4 t70 60.68 16.95 7.07 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.765 -0.652 . . . . 64.230000000000004 111.366 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.99 -19.45 30.15 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.519 -0.372 . . . . 70.510000000000005 113.572 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.43 123.97 33.5 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.294 -0.533 . . . . 73.040000000000006 111.969 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 200' ' ' ILE . 96.6 mttt -79.89 104.2 10.31 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.405 -0.362 . . . . 63.210000000000001 110.611 174.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.06 115.24 40.88 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.9 0.381 . . . . 72.019999999999996 111.892 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.05 133.94 46.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.515 2.81 . . . . 72.019999999999996 113.861 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.456 HD11 ' HG2' ' A' ' 199' ' ' ARG . 50.0 mt -110.03 153.05 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.623 -0.717 . . . . 61.32 110.758 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.38 150.42 21.28 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.844 -0.694 . . . . 73.219999999999999 112.9 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 90.5 m95 -67.76 -27.67 66.97 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.178 -0.601 . . . . 73.099999999999994 111.634 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.78 -3.57 51.44 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.941 0.348 . . . . 54.509999999999998 111.941 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 177' ' ' VAL . 88.7 m -68.55 141.9 55.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.938 0.399 . . . . 70.329999999999998 111.071 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.12 117.71 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.063 0.458 . . . . 72.430000000000007 111.426 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.55 -22.07 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 N-CA-C 112.392 0.516 . . . . 74.519999999999996 112.392 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.5 p -59.91 -18.21 43.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.335 0.494 . . . . 74.340000000000003 112.335 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.39 -14.43 58.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.945 0.403 . . . . 72.329999999999998 111.954 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.53 22.87 14.94 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.175 0.512 . . . . 72.409999999999997 111.491 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.9 m -61.72 121.44 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.807 0.669 . . . . 74.239999999999995 112.807 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.6 -23.44 33.94 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.32 0.888 . . . . 61.140000000000001 115.32 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -99.32 172.25 7.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.981 0.89 . . . . 73.239999999999995 112.487 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 25.7 mp0 -93.26 139.87 30.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.945 -0.571 . . . . 71.340000000000003 111.936 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 90.6 mt -111.92 152.89 27.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.303 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -117.14 134.49 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.567 0.222 . . . . 75.430000000000007 111.138 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 197' ' ' VAL . 64.4 t -115.79 116.47 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 71.129999999999995 111.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.431 ' HG2' ' HE1' ' A' ' 198' ' ' TYR . 61.8 mm-40 -102.97 137.43 41.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.405 -0.361 . . . . 70.540000000000006 111.016 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.88 108.83 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.842 0.353 . . . . 70.109999999999999 110.837 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 196' ' ' ALA . 95.8 mt . . . . . 0 N--CA 1.469 0.479 0 CA-C-O 121.095 0.474 . . . . 41.420000000000002 111.548 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 1.5 pptp? . . . . . 0 CA--C 1.541 0.619 0 CA-C-O 120.686 0.279 . . . . 74.310000000000002 111.671 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.08 130.53 38.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.415 . . . . 72.540000000000006 113.13 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -132.33 169.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.962 0.411 . . . . 53.409999999999997 111.797 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 171' ' ' ALA . 55.0 t -130.6 132.42 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 71.140000000000001 110.531 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 85.8 mtt180 -89.13 98.41 11.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.722 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 181' ' ' LEU . 35.6 t -99.13 111.14 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.24 0.543 . . . . 51.310000000000002 112.051 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -89.45 111.97 23.0 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.673 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.5 mt -90.75 161.74 35.28 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.252 -0.431 . . . . 64.349999999999994 111.624 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 50.8 Cg_exo -55.54 162.51 6.22 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.555 2.17 . . . . 63.329999999999998 113.353 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.83 36.59 22.01 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.617 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.2 13.44 9.15 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.103 0.779 . . . . 62.450000000000003 113.103 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.5 mm-40 -76.72 159.7 29.96 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.89 0.376 . . . . 74.340000000000003 111.46 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.56 154.07 38.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.328 0.585 . . . . 72.510000000000005 112.28 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . 0.425 HG23 ' HB ' ' A' ' 159' ' ' VAL . 7.9 t -157.63 150.84 23.44 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 111.054 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.47 119.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.777 0.323 . . . . 63.229999999999997 110.244 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.57 152.41 58.34 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.495 -0.321 . . . . 74.219999999999999 111.768 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.2 132.36 19.37 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.595 2.197 . . . . 75.200000000000003 113.583 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -89.48 104.7 17.23 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.029 0.442 . . . . 51.229999999999997 111.431 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.42 140.71 52.4 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.4 -0.363 . . . . 60.039999999999999 111.917 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.98 122.35 19.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.429 -0.351 . . . . 61.100000000000001 110.79 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.67 -29.5 7.8 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.233 -0.508 . . . . 63.229999999999997 112.428 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 62.7 t -89.55 126.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.736 0.303 . . . . 54.240000000000002 111.052 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 69.6 p -87.32 160.83 18.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.896 0.379 . . . . 62.409999999999997 111.46 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.93 -39.39 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.019 0.438 . . . . 73.439999999999998 111.668 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 24.5 ttp180 -74.23 -21.16 59.91 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.34 . . . . 71.239999999999995 111.744 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 17.4 t70 -84.05 -34.38 24.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.112 0.482 . . . . 72.25 111.288 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 78.4 p -80.84 -55.1 5.03 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.114 0.483 . . . . 74.129999999999995 111.632 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 159' ' ' VAL . 86.0 mt -73.54 -2.31 22.24 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.681 0.993 . . . . 64.230000000000004 113.681 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 22.0 pttp -60.72 -29.08 69.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.619 0.645 . . . . 72.019999999999996 112.236 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -76.69 -38.94 53.59 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.167 -0.333 . . . . 72.409999999999997 110.998 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -60.15 -54.68 42.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.91 0.386 . . . . 54.439999999999998 110.958 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.4 HD11 ' CH2' ' A' ' 210' ' ' TRP . 85.4 mt -55.52 -45.74 77.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.789 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -55.19 -55.79 27.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 111.961 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.0 ptp -67.53 -22.18 65.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.559 0.577 . . . . 71.439999999999998 112.559 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 67.9 mmt-85 -91.97 -23.07 19.68 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.28 -0.262 . . . . 72.310000000000002 111.679 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.16 42.42 4.64 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.534 -0.365 . . . . 44.229999999999997 113.246 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.15 162.94 24.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.989 0.423 . . . . 75.200000000000003 111.417 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.81 142.86 46.44 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.564 -0.289 . . . . 72.230000000000004 111.291 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.19 -19.68 58.24 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.812 2.342 . . . . 70.209999999999994 113.782 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.15 -28.8 57.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.797 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 226' ' ' VAL . 51.2 t -106.89 19.1 20.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.506 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.6 m -130.65 130.28 43.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.295 0.569 . . . . 73.209999999999994 111.911 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.0 119.44 39.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.795 -0.639 . . . . 65.409999999999997 111.209 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 224' ' ' VAL . 43.9 t -99.78 122.32 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.526 0.203 . . . . 72.409999999999997 111.051 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.411 ' HE2' ' HG3' ' A' ' 225' ' ' GLU . 42.4 p90 -134.07 152.13 51.7 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 111.479 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 199' ' ' ARG . 4.1 ptm180 -115.5 142.88 46.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.582 . . . . 74.430000000000007 110.454 176.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . 0.5 HG12 ' HG2' ' A' ' 205' ' ' LYS . 55.9 mt -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.904 0.383 . . . . 75.209999999999994 111.355 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.403 ' HG2' ' OD2' ' A' ' 202' ' ' ASP . 25.7 tt0 -161.62 133.41 5.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.142 -0.481 . . . . 71.109999999999999 110.827 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD2' ' HG2' ' A' ' 201' ' ' GLN . 11.1 m-20 60.72 28.65 18.37 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.895 0.379 . . . . 54.219999999999999 112.006 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.49 10.7 85.98 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.002 -0.618 . . . . 74.209999999999994 113.415 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.47 145.17 42.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.142 0.496 . . . . 62.149999999999999 111.781 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 200' ' ' ILE . 97.9 mttt -102.36 102.44 12.78 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 74.519999999999996 110.22 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.83 113.67 56.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.333 -0.394 . . . . 70.109999999999999 111.733 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.69 139.52 63.76 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.645 2.23 . . . . 70.530000000000001 112.488 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.22 142.39 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.981 0.42 . . . . 62.219999999999999 111.41 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.25 137.8 14.62 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.127 -0.558 . . . . 74.120000000000005 112.651 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -63.29 -17.17 62.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.373 -0.486 . . . . 71.409999999999997 111.8 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.49 -10.46 59.47 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.974 -0.557 . . . . 61.130000000000003 112.281 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 68.6 m -80.32 143.87 33.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.076 0.398 . . . . 54.140000000000001 112.076 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.42 132.52 52.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 64.120000000000005 111.961 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -65.38 -18.37 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 111.492 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.0 p -62.16 -23.65 66.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.975 0.417 . . . . 55.549999999999997 111.821 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -71.81 -15.77 62.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.045 0.45 . . . . 64.0 111.173 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.2 mt -113.85 13.56 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.052 -0.522 . . . . 61.509999999999998 111.307 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 98.1 m -51.9 113.77 1.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.708 0.633 . . . . 75.420000000000002 112.708 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 90.77 -17.93 52.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.308 -0.472 . . . . 73.140000000000001 113.821 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -73.99 168.06 20.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 112.121 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . 0.51 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.6 mt-10 -112.72 114.74 27.47 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.586 -0.734 . . . . 74.140000000000001 110.77 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 159' ' ' VAL . 68.3 mt -93.33 147.72 22.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.122 0.487 . . . . 74.010000000000005 111.342 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -127.54 117.67 22.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.054 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.59 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 40.2 t -103.96 144.68 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.07 0.462 . . . . 71.530000000000001 112.215 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.411 ' HG3' ' HE2' ' A' ' 198' ' ' TYR . 22.4 mt-10 -130.75 177.85 7.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 111.633 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . 0.495 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.0 t -91.94 140.44 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.837 0.351 . . . . 73.510000000000005 111.815 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 112.144 0.424 . . . . 71.120000000000005 112.144 178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt . . . . . 0 CA--C 1.543 0.68 0 N-CA-C 109.95 -0.389 . . . . 61.340000000000003 109.95 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 9.3 Cg_endo -50.02 129.81 25.91 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.839 2.359 . . . . 75.519999999999996 113.367 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.62 160.92 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.36 0.6 . . . . 65.200000000000003 112.086 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 129.86 65.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 110.535 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 158' ' ' ARG . 68.2 mtt85 -96.21 98.46 10.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.736 0.303 . . . . 62.350000000000001 111.416 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 222' ' ' LEU . 41.2 t -96.26 120.09 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 112.043 -176.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.09 115.32 27.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.128 0.49 . . . . 71.099999999999994 110.747 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -93.47 165.71 17.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.947 -0.57 . . . . 74.439999999999998 111.527 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 20.6 Cg_endo -60.5 168.01 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.246 1.964 . . . . 71.439999999999998 112.534 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.94 27.2 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.081 0.4 . . . . 72.129999999999995 112.081 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.34 26.76 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.728 0.411 . . . . 53.32 111.795 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 76.9 mm-40 -92.43 162.21 14.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.92 0.39 . . . . 44.299999999999997 111.131 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -151.56 156.12 39.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.938 0.399 . . . . 72.0 111.786 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 t -156.85 126.99 6.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.274 -0.421 . . . . 74.120000000000005 111.535 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.62 119.73 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.29 -0.256 . . . . 74.150000000000006 110.557 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.74 144.87 39.83 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 112.014 0.376 . . . . 63.420000000000002 112.014 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.24 139.73 67.47 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.608 2.206 . . . . 74.409999999999997 112.923 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -93.31 109.7 21.24 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 55.229999999999997 111.606 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -97.22 132.39 43.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.386 -0.37 . . . . 74.340000000000003 110.997 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.1 t -70.7 121.25 17.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.774 0.321 . . . . 73.120000000000005 111.122 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.2 -9.69 50.32 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.369 -0.444 . . . . 55.25 113.168 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.88 135.28 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 122.432 -0.452 . . . . 71.299999999999997 110.526 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 69.8 p -81.54 167.04 19.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.299 0.571 . . . . 51.240000000000002 112.266 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 212' ' ' THR . 77.9 t -59.49 -37.66 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.371 0.605 . . . . 55.439999999999998 110.773 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.561 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 31.5 ttp180 -66.36 -55.87 13.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.811 -0.631 . . . . 50.329999999999998 111.226 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.575 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 17.0 t70 -60.83 -36.0 77.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 112.004 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 81.8 p -77.14 -59.0 2.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.906 0.384 . . . . 61.100000000000001 111.874 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.89 -23.66 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.335 0.865 . . . . 64.030000000000001 113.335 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 23.3 pttp -59.96 -22.69 62.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.613 0.642 . . . . 73.129999999999995 111.538 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.68 -41.42 53.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.139 0.495 . . . . 74.319999999999993 110.562 174.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.79 81.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 74.420000000000002 110.692 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.27 -38.29 68.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.17 -0.468 . . . . 53.32 110.744 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 26.3 ttt -53.7 -48.93 69.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 111.748 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -65.97 -27.07 67.87 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.752 0.311 . . . . 64.409999999999997 111.583 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.09 -22.31 31.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.934 0.397 . . . . 71.150000000000006 111.383 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.51 17.38 45.82 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.364 -0.446 . . . . 74.239999999999995 113.124 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.55 168.63 9.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.261 0.553 . . . . 72.439999999999998 111.96 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -129.77 139.73 36.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.343 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.24 -36.74 97.46 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.947 2.432 . . . . 74.209999999999994 113.898 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.41 -18.85 60.74 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.947 0.403 . . . . 62.329999999999998 111.923 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.14 -5.81 32.8 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.22 0.452 . . . . 74.310000000000002 112.22 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.5 m -119.07 151.53 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.365 0.506 . . . . 63.399999999999999 112.365 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -127.64 122.71 33.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.246 -0.434 . . . . 60.350000000000001 111.362 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 224' ' ' VAL . 56.5 t -98.12 136.26 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.641 -0.254 . . . . 54.399999999999999 111.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -149.31 165.63 31.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 111.165 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -141.28 158.03 44.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.276 -0.42 . . . . 74.209999999999994 110.332 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.1 mt -92.21 113.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.286 0.565 . . . . 74.540000000000006 111.719 -174.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 206' ' ' LYS . 33.8 tt0 -139.02 142.19 38.27 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.566 -0.743 . . . . 74.430000000000007 110.494 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.65 21.86 10.55 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.534 0.683 . . . . 74.310000000000002 111.021 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.8 82.96 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.252 -0.431 . . . . 61.310000000000002 113.149 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -125.82 151.54 46.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.26 0.552 . . . . 72.049999999999997 111.819 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -82.64 97.27 8.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.087 -0.506 . . . . 73.140000000000001 110.198 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 201' ' ' GLN . 67.2 mttm -96.63 111.66 57.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.938 0.347 . . . . 62.32 111.938 -175.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.48 142.94 96.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.996 2.464 . . . . 73.150000000000006 113.387 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 217' ' ' LEU . 66.5 mt -113.5 134.34 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.99 -0.55 . . . . 74.099999999999994 111.016 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.34 133.74 16.8 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.886 -0.673 . . . . 15.31 112.887 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' TRP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.1 m95 -60.57 -26.17 66.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.017 0.437 . . . . 73.219999999999999 111.31 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.11 5.81 24.72 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.437 0.532 . . . . 54.420000000000002 112.437 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.3 m -83.84 141.46 31.32 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.492 0.187 . . . . 64.239999999999995 110.98 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.3 130.52 45.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.857 0.361 . . . . 72.25 111.238 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.0 tp -59.62 -22.55 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.07 0.462 . . . . 72.25 111.654 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 71.2 p -62.65 -26.87 68.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.244 -0.435 . . . . 64.299999999999997 112.001 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' TRP . . . . . 0.407 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.2 m0 -65.37 -22.64 66.83 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.292 0.568 . . . . 74.109999999999999 111.082 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 222' ' ' LEU . 46.6 mt -108.3 13.52 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.763 -0.653 . . . . 74.209999999999994 111.622 -175.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.9 m -52.8 118.06 3.4 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.166 0.432 . . . . 74.409999999999997 112.166 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.33 79.19 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.269 0.468 . . . . 72.010000000000005 114.269 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -105.52 164.33 11.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.497 0.665 . . . . 64.340000000000003 112.451 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -103.25 117.04 33.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.392 -0.822 . . . . 74.140000000000001 110.566 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 217' ' ' LEU . 60.3 mt -93.68 145.92 24.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.013 0.435 . . . . 75.25 111.016 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -121.95 117.02 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.561 -0.291 . . . . 75.239999999999995 110.451 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 197' ' ' VAL . 73.3 t -104.84 121.17 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.603 0.594 . . . . 71.349999999999994 112.603 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -106.69 164.58 11.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.008 -0.542 . . . . 72.409999999999997 110.832 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.89 124.64 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.774 0.321 . . . . 73.150000000000006 111.478 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 196' ' ' ALA . 75.2 mt . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.947 0.403 . . . . 72.019999999999996 111.508 177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 84.7 t60 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.909 0.385 . . . . 74.439999999999998 111.73 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 59.5 mtm -131.76 153.6 81.52 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.026 -0.534 . . . . 75.5 110.163 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -65.51 171.88 8.76 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.286 1.991 . . . . 64.310000000000002 112.747 177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.421 ' NZ ' ' HB3' ' A' ' 150' ' ' LYS . 0.3 OUTLIER -63.93 144.75 56.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.802 0.335 . . . . 64.109999999999999 111.289 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 36.1 t -132.57 80.76 61.38 Favored Pre-proline 0 N--CA 1.473 0.69 0 CA-C-O 120.972 0.415 . . . . 70.120000000000005 111.631 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -88.5 37.9 0.44 Allowed 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 123.548 2.832 . . . . 74.349999999999994 112.932 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -80.35 32.71 0.29 Allowed 'General case' 0 CA--C 1.549 0.92 0 CA-C-O 121.756 0.788 . . . . 74.219999999999999 111.483 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 68.5 mmtt -113.56 152.52 45.46 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-N 116.114 -0.493 . . . . 73.329999999999998 109.943 178.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.98 130.74 25.18 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 121.727 1.618 . . . . 74.239999999999995 111.114 172.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -131.03 166.54 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 N-CA-C 113.428 0.899 . . . . 60.210000000000001 113.428 -171.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.423 HG23 ' HB2' ' A' ' 171' ' ' ALA . 58.3 t -124.55 137.52 57.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 115.36 -0.836 . . . . 74.319999999999993 110.439 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.533 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 23.0 mtp85 -100.54 105.54 16.97 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.828 0.347 . . . . 72.129999999999995 111.375 -176.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.457 HG21 HD21 ' A' ' 181' ' ' LEU . 54.4 t -107.23 122.9 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 CA-C-O 120.986 0.422 . . . . 64.329999999999998 111.919 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -93.68 119.29 32.5 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.119 0.485 . . . . 55.32 111.135 178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.453 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 92.9 mt -93.17 155.68 40.9 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-N 115.804 -0.634 . . . . 72.120000000000005 111.897 -176.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.19 159.53 26.1 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.608 2.206 . . . . 64.420000000000002 113.099 178.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.507 ' HB2' HH22 ' A' ' 188' ' ' ARG . 85.7 m-20 64.76 39.24 6.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.993 -0.549 . . . . 43.200000000000003 111.993 -177.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt 66.18 27.0 10.46 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 113.18 0.807 . . . . 62.350000000000001 113.18 172.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 78.9 mm-40 -104.61 166.88 10.1 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 122.019 -0.425 . . . . 45.340000000000003 111.419 -179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.414 ' HD3' ' N ' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -159.32 157.23 30.08 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 122.094 -0.379 . . . . 65.329999999999998 111.494 -178.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -154.3 159.37 41.2 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 121.026 0.441 . . . . 72.549999999999997 111.51 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.9 t -124.56 128.74 73.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 116.322 -0.399 . . . . 73.200000000000003 110.733 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.419 HG23 HD11 ' A' ' 214' ' ' ILE . 17.3 m -125.4 141.96 40.32 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 111.835 0.309 . . . . 64.409999999999997 111.835 -179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -67.47 123.59 11.0 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.83 2.353 . . . . 65.439999999999998 113.374 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.423 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -73.68 102.76 4.04 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.085 0.469 . . . . 74.510000000000005 111.275 177.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -112.85 137.78 50.69 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-N 116.098 -0.501 . . . . 65.340000000000003 111.231 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -74.23 126.4 30.52 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.787 0.327 . . . . 55.119999999999997 111.372 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 107.73 -28.6 11.95 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 121.375 -0.44 . . . . 73.319999999999993 112.608 -176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 58.7 t -89.41 133.62 30.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 CA-C-O 120.717 0.294 . . . . 54.310000000000002 111.127 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 56.7 p -82.48 155.3 24.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.009 0.433 . . . . 73.329999999999998 111.482 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 212' ' ' THR . 63.3 t -54.68 -39.03 45.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-O 121.05 0.452 . . . . 51.020000000000003 110.894 175.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.3 ttm-85 -59.94 -53.29 59.58 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.017 -0.538 . . . . 74.510000000000005 111.07 177.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -68.0 -19.76 64.95 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-N 115.962 -0.563 . . . . 73.450000000000003 111.405 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 67.0 m -80.66 -44.58 18.59 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 121.08 0.467 . . . . 72.319999999999993 111.467 176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.457 HD21 HG21 ' A' ' 159' ' ' VAL . 95.9 mt -92.07 -0.01 57.46 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 112.778 0.658 . . . . 54.310000000000002 112.778 -175.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -51.65 -36.91 48.06 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 112.225 0.454 . . . . 54.240000000000002 112.225 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -67.69 -46.1 73.25 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.986 0.422 . . . . 75.409999999999997 111.235 176.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.511 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -61.3 -43.22 99.24 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.127 -0.488 . . . . 74.099999999999994 111.334 179.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.472 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 94.5 mt -64.78 -45.45 86.27 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.317 -0.401 . . . . 75.430000000000007 111.205 176.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.1 tpt -56.87 -49.57 75.09 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.383 -0.371 . . . . 72.319999999999993 111.696 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.8 ptm -67.2 -17.22 64.73 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 111.886 0.328 . . . . 74.109999999999999 111.886 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.511 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 42.2 mmm-85 -95.93 -13.71 23.67 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 122.153 -0.342 . . . . 61.219999999999999 111.413 175.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.17 27.58 61.78 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 121.342 -0.456 . . . . 61.350000000000001 113.106 -178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 90.6 mt -112.82 131.07 55.86 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 120.887 0.375 . . . . 74.340000000000003 111.738 -177.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.6 pt -85.26 142.45 38.08 Favored Pre-proline 0 CA--C 1.543 0.677 0 CA-C-N 116.644 -0.253 . . . . 71.219999999999999 110.885 174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -57.02 -24.35 57.15 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.711 2.274 . . . . 63.420000000000002 113.45 -177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -80.2 -14.62 58.3 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 112.131 0.419 . . . . 70.120000000000005 112.131 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -105.47 11.37 32.65 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.132 0.492 . . . . 74.150000000000006 110.864 177.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.2 m -129.95 133.17 46.64 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.293 -0.412 . . . . 64.239999999999995 111.303 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -110.22 144.82 38.33 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.668 0.27 . . . . 73.430000000000007 111.265 178.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . . . . . . . . . 87.1 t -124.18 140.49 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 CA-C-O 120.852 0.358 . . . . 54.509999999999998 111.574 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.8 p90 -146.67 158.67 43.95 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.188 0.518 . . . . 72.450000000000003 111.8 175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -122.84 161.22 24.48 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.8 -0.636 . . . . 74.530000000000001 110.41 176.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.0 mt -104.64 114.44 44.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 CA-C-O 121.153 0.501 . . . . 74.040000000000006 111.536 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.9 tp60 -124.06 119.6 29.98 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 115.732 -0.667 . . . . 72.430000000000007 110.203 178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 57.19 31.97 20.93 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.169 0.509 . . . . 74.340000000000003 111.214 -177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 85.24 -2.92 87.94 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 121.227 -0.511 . . . . 73.530000000000001 113.715 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -101.85 139.16 37.87 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 122.345 -0.503 . . . . 72.299999999999997 112.092 -178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -89.14 103.43 16.05 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 116.147 -0.478 . . . . 65.049999999999997 110.869 178.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 207' ' ' PRO . 45.4 mmtm -104.11 127.54 29.02 Favored Pre-proline 0 N--CA 1.472 0.649 0 CA-C-O 120.685 0.279 . . . . 72.0 111.587 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 206' ' ' LYS . 22.6 Cg_exo -65.75 152.28 82.05 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 123.204 2.602 . . . . 54.409999999999997 113.758 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.518 HG21 HD11 ' A' ' 217' ' ' LEU . 70.6 mt -129.85 138.57 53.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 CA-C-N 116.072 -0.513 . . . . 73.540000000000006 111.007 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -83.98 134.42 12.72 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 121.062 -0.589 . . . . 43.310000000000002 112.927 177.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.6 m95 -57.27 -30.51 64.74 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.287 0.477 . . . . 61.130000000000003 112.287 -179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -87.24 7.79 26.95 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 112.131 0.419 . . . . 62.039999999999999 112.131 -175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 177' ' ' VAL . 98.8 m -82.6 140.55 33.15 Favored 'General case' 0 N--CA 1.468 0.427 0 O-C-N 122.296 -0.252 . . . . 72.310000000000002 110.797 174.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.468 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 4.2 m-20 -59.1 126.9 29.58 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 121.081 0.467 . . . . 72.329999999999998 111.595 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 169' ' ' VAL . 12.1 tt -60.24 -21.48 22.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.134 -0.485 . . . . 75.329999999999998 111.819 -178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 76.8 p -60.65 -27.5 67.86 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.809 0.338 . . . . 74.450000000000003 111.681 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.468 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 15.6 m95 -70.37 -16.33 62.96 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 120.955 0.407 . . . . 73.099999999999994 111.484 177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 HG21 ' A' ' 208' ' ' ILE . 80.1 mt -112.77 22.52 14.42 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 116.31 -0.404 . . . . 71.200000000000003 111.936 -177.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.8 m -56.74 108.42 0.5 Allowed 'General case' 0 N--CA 1.474 0.735 0 CA-C-O 120.853 0.359 . . . . 75.450000000000003 111.919 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.46 11.12 61.25 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 121.171 -0.538 . . . . 50.200000000000003 114.048 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -93.8 151.32 19.69 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-N 117.342 0.571 . . . . 65.409999999999997 111.628 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.533 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 45.1 mt-10 -105.46 114.35 28.47 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.082 0.468 . . . . 64.120000000000005 110.654 173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.406 HD22 HD12 ' A' ' 208' ' ' ILE . 58.1 mt -97.48 150.57 20.92 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.085 0.469 . . . . 43.229999999999997 111.761 -176.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -127.61 127.61 44.13 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 116.6 -0.273 . . . . 60.439999999999998 110.458 176.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . . . . . . . . . 54.5 t -96.73 137.51 24.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 112.399 0.518 . . . . 73.549999999999997 112.399 -176.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 81.6 mm-40 -113.78 144.24 43.31 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.059 -0.519 . . . . 70.420000000000002 111.02 175.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 41.5 t -94.36 116.4 35.56 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-O 120.526 0.203 . . . . 74.329999999999998 110.95 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 77.4 mt -70.45 -47.95 58.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 120.72 0.295 . . . . 73.140000000000001 111.629 -179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -125.73 114.21 18.33 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.888 0.375 . . . . 71.299999999999997 110.678 173.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -74.27 -34.88 63.71 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 112.364 0.505 . . . . 71.150000000000006 112.364 -172.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 46.8 t -77.57 115.37 49.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 120.568 0.223 . . . . 75.299999999999997 111.222 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -81.79 111.58 2.27 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 122.786 2.324 . . . . 74.420000000000002 113.554 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 C--O 1.253 1.241 0 CA-C-O 118.812 -0.613 . . . . 60.200000000000003 111.298 176.224 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.3 m80 . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 120.282 0.087 . . . . 73.099999999999994 110.976 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 65.6 mtt 70.63 118.27 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 123.233 0.613 . . . . 72.5 112.604 177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -82.84 95.62 0.84 Allowed 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.775 2.317 . . . . 63.530000000000001 111.477 169.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 35.2 mmtp -63.86 115.54 4.94 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.765 0.317 . . . . 65.239999999999995 111.698 -176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 74.4 m 64.88 85.21 0.16 Allowed Pre-proline 0 N--CA 1.474 0.729 0 CA-C-N 115.819 -0.628 . . . . 74.120000000000005 112.319 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -58.53 136.49 74.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.656 2.237 . . . . 73.040000000000006 112.389 174.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 45.9 tt0 -72.78 99.18 2.57 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.245 0.545 . . . . 74.310000000000002 111.281 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -87.79 156.44 52.71 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.969 -0.559 . . . . 71.510000000000005 111.855 -178.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.513 ' HB2' HG23 ' A' ' 218' ' ' THR . 43.3 Cg_endo -65.79 144.6 78.14 Favored 'Trans proline' 0 CA--C 1.539 0.775 0 C-N-CA 122.823 2.348 . . . . 64.530000000000001 112.928 178.084 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.6 pt -132.21 162.55 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 N-CA-C 113.068 0.766 . . . . 74.540000000000006 113.068 -175.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 57.8 t -128.02 123.23 60.16 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 115.251 -0.886 . . . . 54.109999999999999 109.65 171.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.716 ' HB2' ' HB3' ' A' ' 221' ' ' GLU . 49.5 mtt180 -88.91 95.05 10.15 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.805 0.336 . . . . 62.299999999999997 111.092 -176.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.594 HG21 HD21 ' A' ' 181' ' ' LEU . 57.6 t -93.52 114.71 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 O-C-N 121.977 -0.452 . . . . 64.329999999999998 112.206 -176.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -83.8 123.92 30.39 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.647 174.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.473 HD11 ' HB1' ' A' ' 184' ' ' ALA . 96.3 mt -100.38 156.43 35.25 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 112.251 0.463 . . . . 63.219999999999999 112.251 -173.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.508 ' HG2' HH12 ' A' ' 188' ' ' ARG . 19.4 Cg_endo -59.38 165.78 8.7 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.298 1.999 . . . . 53.210000000000001 112.115 175.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 68.22 25.11 7.33 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.027 0.441 . . . . 73.420000000000002 111.11 -172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 62.94 43.24 6.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 115.659 -0.701 . . . . 53.240000000000002 112.111 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -118.51 -179.74 3.88 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 121.02 0.438 . . . . 55.210000000000001 111.672 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.79 159.82 35.57 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.001 0.429 . . . . 62.009999999999998 112.148 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 4.8 t -155.41 129.01 8.47 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.018 0.437 . . . . 64.120000000000005 111.503 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 94.7 t -95.21 119.55 43.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.696 0.284 . . . . 74.109999999999999 110.314 174.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.7 m -122.45 138.54 29.35 Favored Pre-proline 0 CA--C 1.54 0.573 0 CA-C-O 120.555 0.217 . . . . 72.140000000000001 111.372 -178.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -60.8 132.26 41.65 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.566 2.178 . . . . 72.109999999999999 113.039 178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -75.78 103.46 5.88 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 121.045 0.45 . . . . 73.340000000000003 110.868 178.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 32.2 mtt-85 -106.5 126.35 52.15 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.305 -0.407 . . . . 72.150000000000006 111.395 -175.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.8 t -75.02 115.71 14.94 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-O 120.813 0.34 . . . . 55.409999999999997 111.146 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 111.61 -1.04 27.66 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 121.244 -0.503 . . . . 32.299999999999997 112.58 -177.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.6 t -112.72 133.03 59.8 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 120.743 0.306 . . . . 64.329999999999998 110.874 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 33.0 p -81.59 161.59 23.45 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.852 0.358 . . . . 70.430000000000007 111.585 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 212' ' ' THR . 81.3 t -56.33 -34.48 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.439 0.638 . . . . 44.210000000000001 110.424 174.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.576 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 47.2 ttp180 -67.35 -56.04 11.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.71 -0.677 . . . . 63.240000000000002 111.619 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.665 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 6.6 m-20 -72.22 -12.36 61.13 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.818 0.673 . . . . 74.439999999999998 112.818 -175.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 62.0 p -89.18 -50.94 5.85 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 120.943 0.402 . . . . 63.25 110.767 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.594 HD21 HG21 ' A' ' 159' ' ' VAL . 78.5 mt -79.73 -7.54 58.68 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.426 0.898 . . . . 71.230000000000004 113.426 -176.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.665 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 14.0 ptpt -55.92 -27.64 53.11 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 121.979 -0.45 . . . . 75.219999999999999 111.209 176.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 64.6 mttp -65.99 -45.48 81.45 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.191 0.519 . . . . 70.340000000000003 110.773 173.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.473 ' HB1' HD11 ' A' ' 161' ' ' LEU . . . -66.77 -30.55 70.78 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.021 -0.536 . . . . 64.310000000000002 111.618 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.405 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 91.6 mt -75.17 -43.69 50.86 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.006 0.431 . . . . 71.420000000000002 110.709 174.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 48.0 ttm -54.17 -53.86 47.66 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 115.762 -0.653 . . . . 70.230000000000004 112.0 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . 0.422 ' HG3' ' HG3' ' A' ' 188' ' ' ARG . 26.4 ptt? -64.62 -8.58 14.8 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 112.623 0.601 . . . . 63.420000000000002 112.623 -176.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.508 HH12 ' HG2' ' A' ' 162' ' ' PRO . 63.2 mtm180 -119.23 5.37 11.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 111.849 0.315 . . . . 72.099999999999994 111.849 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.69 45.44 95.69 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 121.294 -0.479 . . . . 41.409999999999997 113.431 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 95.1 mt -124.43 149.87 46.29 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.32 0.581 . . . . 72.540000000000006 111.753 -178.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.7 pt -104.15 152.72 39.21 Favored Pre-proline 0 CA--C 1.542 0.663 0 CA-C-N 116.113 -0.494 . . . . 74.409999999999997 111.088 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.89 -20.72 23.59 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 122.762 2.308 . . . . 74.200000000000003 113.825 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -80.65 -16.55 53.74 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 120.982 0.42 . . . . 75.329999999999998 111.847 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.7 t -90.36 -9.2 48.55 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.02 0.378 . . . . 72.439999999999998 112.02 -177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.1 m -136.41 147.69 47.4 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.04 0.448 . . . . 72.209999999999994 111.8 -175.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.44 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -125.25 131.55 53.1 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 120.875 0.369 . . . . 64.439999999999998 111.466 178.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 224' ' ' VAL . 57.9 t -94.44 132.54 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.333 -0.394 . . . . 75.209999999999994 110.844 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.469 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 37.8 p90 -148.87 163.05 38.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.253 0.549 . . . . 62.32 111.09 177.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 23.4 ptt180 -134.62 143.49 47.34 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.263 -0.426 . . . . 73.430000000000007 110.496 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.42 97.56 4.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.307 0.575 . . . . 74.420000000000002 110.133 176.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -103.01 108.61 19.84 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.594 -0.73 . . . . 75.230000000000004 110.791 -175.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 60.73 30.99 20.07 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-O 121.538 0.685 . . . . 74.409999999999997 110.723 -179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 93.46 -12.86 68.82 Favored Glycine 0 CA--C 1.528 0.889 0 CA-C-N 116.051 -0.522 . . . . 65.239999999999995 113.491 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.418 ' HB3' ' HE3' ' A' ' 206' ' ' LYS . 39.5 mt-10 -93.45 132.71 37.45 Favored 'General case' 0 N--CA 1.471 0.623 0 O-C-N 122.251 -0.558 . . . . 75.150000000000006 111.762 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.469 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 55.0 mtpt -78.07 94.88 4.74 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.917 0.389 . . . . 63.450000000000003 110.708 173.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.418 ' HE3' ' HB3' ' A' ' 204' ' ' GLU . 33.7 mmtp -96.58 109.73 49.53 Favored Pre-proline 0 CA--C 1.539 0.536 0 CA-C-N 116.343 -0.39 . . . . 71.099999999999994 111.19 -179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.29 125.76 13.37 Favored 'Trans proline' 0 C--N 1.354 0.857 0 C-N-CA 122.876 2.384 . . . . 72.420000000000002 112.561 178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -100.27 122.09 51.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 116.285 -0.416 . . . . 53.329999999999998 111.066 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.95 139.72 46.55 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 121.319 -0.467 . . . . 41.25 113.105 178.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.576 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.6 m95 -60.02 -22.8 63.09 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-O 120.969 0.414 . . . . 71.409999999999997 111.603 179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -78.47 -6.75 56.26 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 112.474 0.546 . . . . 75.319999999999993 112.474 -179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.406 ' O ' HG23 ' A' ' 177' ' ' VAL . 29.5 m -75.47 140.49 42.87 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 111.716 0.265 . . . . 74.430000000000007 111.716 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -66.18 126.86 30.02 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-O 121.111 0.481 . . . . 73.439999999999998 110.929 178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 14.1 tt -67.05 -23.65 31.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 N-CA-C 112.503 0.557 . . . . 74.099999999999994 112.503 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -67.44 -12.17 59.62 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.88 0.372 . . . . 71.120000000000005 111.708 -177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 16.3 m0 -70.82 -23.28 62.33 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-O 121.176 0.512 . . . . 71.450000000000003 111.197 174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.543 HD13 HD21 ' A' ' 222' ' ' LEU . 28.7 mt -108.66 19.93 19.12 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 115.907 -0.588 . . . . 75.510000000000005 111.531 -172.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.513 HG23 ' HB2' ' A' ' 155' ' ' PRO . 96.7 m -58.48 115.46 3.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.791 0.664 . . . . 62.310000000000002 112.791 -178.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 111.19 -27.98 10.21 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 121.114 -0.565 . . . . 64.310000000000002 114.046 174.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -102.64 172.78 6.66 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.371 0.605 . . . . 64.239999999999995 112.161 -177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.716 ' HB3' ' HB2' ' A' ' 158' ' ' ARG . 1.4 pm0 -108.34 149.53 28.55 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.545 0.688 . . . . 74.150000000000006 112.305 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.543 HD21 HD13 ' A' ' 217' ' ' LEU . 85.9 mt -113.51 163.71 14.57 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.64 -0.709 . . . . 63.210000000000001 111.186 -179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -129.44 130.52 46.04 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.556 -0.293 . . . . 72.400000000000006 110.317 176.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.495 HG22 HG22 ' A' ' 197' ' ' VAL . 40.1 t -118.25 119.05 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 120.63 0.252 . . . . 54.0 111.496 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -107.96 164.29 12.4 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.946 0.403 . . . . 71.340000000000003 111.672 179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.3 t -77.6 144.6 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.721 0 CA-C-O 121.038 0.447 . . . . 71.450000000000003 112.025 -177.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.44 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt -104.51 -50.39 3.33 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.391 -0.368 . . . . 71.140000000000001 111.766 176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -148.91 167.11 26.59 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.981 0.419 . . . . 64.400000000000006 112.026 -177.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -150.77 100.89 2.87 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.193 -0.458 . . . . 73.400000000000006 111.093 177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 46.3 t 63.42 88.07 0.12 Allowed Pre-proline 0 CA--C 1.545 0.777 0 CA-C-O 121.12 0.486 . . . . 72.329999999999998 112.004 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -82.69 99.13 0.91 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.872 2.382 . . . . 62.140000000000001 113.456 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.6 tt . . . . . 0 C--O 1.251 1.132 0 CA-C-O 119.006 -0.521 . . . . 54.25 110.073 176.683 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 120.695 0.283 . . . . 65.140000000000001 111.683 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 148' ' ' MET . 1.0 OUTLIER -89.09 112.88 53.73 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-O 120.699 0.285 . . . . 54.020000000000003 111.511 -179.29 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -74.41 98.95 1.15 Allowed 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 122.768 2.312 . . . . 71.409999999999997 112.901 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 72.1 mmtt -95.7 7.23 46.88 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-O 121.076 0.465 . . . . 62.420000000000002 111.079 174.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 46.7 t -136.46 70.98 60.12 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 116.308 -0.406 . . . . 74.540000000000006 111.347 178.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -78.27 138.7 16.14 Favored 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.797 2.331 . . . . 74.430000000000007 111.846 176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -72.14 83.46 1.0 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 121.374 0.607 . . . . 74.120000000000005 111.829 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -112.97 156.77 42.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 CA-C-N 115.332 -0.849 . . . . 71.200000000000003 110.616 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.56 111.24 1.27 Allowed 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.133 1.889 . . . . 54.240000000000002 111.926 174.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.2 pt -112.46 161.84 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.681 0.623 . . . . 62.200000000000003 112.681 -176.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 57.8 t -122.56 128.76 75.46 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 115.786 -0.643 . . . . 75.349999999999994 110.279 172.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.592 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 18.9 mtp180 -96.52 107.9 20.39 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 121.012 0.434 . . . . 74.239999999999995 110.963 -178.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 58.2 t -104.94 125.46 59.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 112.478 0.548 . . . . 65.530000000000001 112.478 -174.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -82.74 113.71 20.58 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 116.261 -0.427 . . . . 45.020000000000003 110.76 173.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 98.2 mt -93.55 146.88 32.62 Favored Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.286 -0.415 . . . . 74.409999999999997 111.046 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.07 160.33 19.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.346 2.031 . . . . 63.100000000000001 112.646 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 69.21 36.48 2.37 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 116.185 -0.461 . . . . 73.230000000000004 112.04 -178.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 32.9 mmtp 67.95 36.33 3.44 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 115.633 -0.712 . . . . 74.319999999999993 112.424 172.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 86.8 mm-40 -117.64 171.23 8.17 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.416 0.627 . . . . 72.329999999999998 112.171 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -158.51 162.14 37.43 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 116.179 -0.464 . . . . 74.239999999999995 110.491 176.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.13 163.42 40.26 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.879 0.371 . . . . 64.519999999999996 111.452 176.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 76.6 t -121.69 128.72 75.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-O 120.914 0.388 . . . . 74.219999999999999 111.364 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 29.6 m -123.62 145.02 45.94 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.446 -0.343 . . . . 55.049999999999997 111.47 179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.13 126.51 7.85 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.391 2.061 . . . . 75.230000000000004 112.666 176.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -90.96 110.0 21.24 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.893 0.378 . . . . 73.409999999999997 111.969 -177.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 172' ' ' ARG . 49.7 mtt180 -101.72 167.5 10.06 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 121.01 0.433 . . . . 72.439999999999998 111.105 176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 41.9 t -84.74 128.96 34.87 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 116.505 -0.316 . . . . 61.219999999999999 111.1 177.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 81.34 33.33 28.85 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 120.99 -0.624 . . . . 71.239999999999995 113.171 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 60.1 t -131.35 109.98 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 110.104 -0.332 . . . . 74.030000000000001 110.104 177.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.9 p -63.18 157.09 23.37 Favored 'General case' 0 N--CA 1.47 0.525 0 CA-C-O 121.305 0.574 . . . . 72.510000000000005 112.399 -174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 212' ' ' THR . 65.6 t -56.77 -30.53 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-N 115.92 -0.582 . . . . 75.230000000000004 110.648 175.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.54 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 18.9 ttp180 -68.99 -53.07 22.53 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.983 -0.553 . . . . 61.100000000000001 111.195 179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.551 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 34.7 m-20 -63.3 -35.11 79.28 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 121.356 0.598 . . . . 73.439999999999998 111.247 176.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 183' ' ' LYS . 39.9 t -66.49 -62.79 1.28 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 116.079 -0.51 . . . . 73.040000000000006 111.585 178.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 63.6 mt -83.09 -12.27 57.24 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.202 1.186 . . . . 71.439999999999998 114.202 -170.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 17.9 ptpt -56.05 -28.88 59.32 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 118.75 0.705 . . . . 62.25 111.848 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 180' ' ' SER . 7.9 ptpp? -74.17 -29.78 61.94 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 120.792 0.329 . . . . 74.519999999999996 111.524 177.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.413 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -70.26 -42.4 72.22 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.229 0.538 . . . . 34.329999999999998 110.647 176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 97.7 mt -75.92 -29.13 58.28 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.168 -0.469 . . . . 63.119999999999997 111.029 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 45.4 ttm -54.81 -49.64 70.5 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-O 120.955 0.407 . . . . 74.219999999999999 111.534 177.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.2 ptp -68.52 -10.09 53.4 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 111.883 0.327 . . . . 64.439999999999998 111.883 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.413 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 15.3 mmm180 -95.58 -10.38 29.72 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 116.658 -0.246 . . . . 72.340000000000003 111.031 175.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.02 20.04 63.88 Favored Glycine 0 CA--C 1.529 0.948 0 C-N-CA 121.385 -0.436 . . . . 73.549999999999997 112.76 -176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.42 HD13 HG21 ' A' ' 226' ' ' VAL . 80.9 mt -120.88 153.96 36.48 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.997 0.427 . . . . 63.409999999999997 111.439 -175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 35.0 pt -104.97 141.3 22.27 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 120.788 0.327 . . . . 74.150000000000006 111.455 177.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.433 ' HG3' ' HB3' ' A' ' 182' ' ' LYS . 22.0 Cg_endo -60.95 -29.25 87.66 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.541 2.161 . . . . 72.140000000000001 113.05 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 178' ' ' ARG . 5.5 mm-40 -55.74 -32.84 63.75 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-O 120.998 0.428 . . . . 72.540000000000006 111.705 -178.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.622 ' SG ' ' HB2' ' A' ' 228' ' ' GLU . 52.0 t -104.18 21.77 15.93 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.067 0.461 . . . . 54.030000000000001 111.966 -176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.1 m -125.0 161.88 25.74 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.056 0.455 . . . . 74.439999999999998 111.654 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -128.93 131.8 47.57 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.835 0.35 . . . . 72.230000000000004 111.726 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 224' ' ' VAL . 20.8 t -112.44 139.03 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 116.396 -0.365 . . . . 62.130000000000003 110.762 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 38.3 p90 -147.86 158.61 44.12 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.334 0.588 . . . . 75.310000000000002 111.942 175.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.7 ptm85 -135.34 138.8 43.75 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 115.676 -0.693 . . . . 73.209999999999994 110.988 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.405 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 56.3 mt -84.36 118.0 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 121.028 0.442 . . . . 65.400000000000006 111.381 -178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.533 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 24.3 mt-30 -122.66 113.92 19.9 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.261 -0.427 . . . . 72.019999999999996 111.212 -179.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 38.6 t70 59.27 20.72 8.86 Favored 'General case' 0 CA--C 1.551 1.009 0 CA-C-O 121.495 0.664 . . . . 75.409999999999997 111.657 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 109.39 -22.64 24.28 Favored Glycine 0 CA--C 1.532 1.1 0 CA-C-N 116.244 -0.435 . . . . 71.129999999999995 113.899 -177.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.533 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 10.2 pt-20 -84.12 155.2 22.74 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-N 117.578 0.689 . . . . 74.219999999999999 111.533 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.06 100.24 10.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.212 0.53 . . . . 73.319999999999993 109.642 169.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 28.4 tptp -87.69 112.72 50.56 Favored Pre-proline 0 CA--C 1.541 0.628 0 CA-C-N 115.978 -0.555 . . . . 64.0 111.581 -175.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -72.64 127.54 12.51 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 122.568 2.179 . . . . 45.520000000000003 112.271 177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.454 HG21 HD11 ' A' ' 217' ' ' LEU . 60.4 mt -96.7 129.99 45.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.919 0.39 . . . . 74.299999999999997 111.685 -176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.44 131.66 11.81 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 121.052 -0.594 . . . . 74.120000000000005 112.218 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.54 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.6 m95 -59.87 -27.11 66.4 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.183 0.438 . . . . 61.329999999999998 112.183 -178.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -80.3 -5.91 57.06 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.211 0.449 . . . . 71.150000000000006 112.211 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.462 ' O ' HG23 ' A' ' 177' ' ' VAL . 63.7 m -71.19 141.5 50.66 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 122.308 -0.245 . . . . 61.329999999999998 111.017 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -65.66 129.36 39.49 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 121.077 0.465 . . . . 71.349999999999994 110.824 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.1 tp -62.91 -24.64 36.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-N 116.145 -0.48 . . . . 55.100000000000001 111.868 -175.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 86.0 p -64.89 -16.24 62.98 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 120.781 0.324 . . . . 73.239999999999995 111.802 -179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 14.4 m95 -76.44 -11.4 59.88 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 121.015 0.436 . . . . 63.130000000000003 111.439 175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.454 HD11 HG21 ' A' ' 208' ' ' ILE . 66.8 mt -114.04 14.43 18.35 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 121.074 0.464 . . . . 75.230000000000004 111.241 -178.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 68.8 m -53.84 119.67 5.3 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 112.633 0.605 . . . . 60.219999999999999 112.633 -178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 88.88 -9.93 74.61 Favored Glycine 0 CA--C 1.526 0.769 0 CA-C-N 116.194 -0.457 . . . . 55.130000000000003 113.997 176.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -89.29 157.84 18.05 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.643 0.608 . . . . 73.439999999999998 112.643 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.592 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 36.4 mt-10 -103.99 114.38 28.59 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.965 178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.2 mt -95.79 158.99 15.2 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.162 0.506 . . . . 74.329999999999998 111.973 -174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -122.28 121.72 37.44 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.452 -0.34 . . . . 72.109999999999999 110.38 175.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.58 HG22 HG22 ' A' ' 197' ' ' VAL . 62.1 t -119.07 135.65 58.8 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 CA-C-O 121.204 0.525 . . . . 75.129999999999995 112.09 -177.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -141.3 148.95 40.59 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.118 -0.492 . . . . 72.140000000000001 110.914 173.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.42 HG21 HD13 ' A' ' 190' ' ' LEU . 36.0 t -85.8 137.51 20.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 CA-C-O 120.819 0.342 . . . . 70.140000000000001 111.879 -174.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 86.6 mt -77.44 -67.38 0.72 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-N 116.375 -0.375 . . . . 73.519999999999996 111.102 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.622 ' HB2' ' SG ' ' A' ' 194' ' ' CYS . 72.5 mm-40 -105.39 138.32 41.78 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.942 0.401 . . . . 74.209999999999994 111.392 177.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -73.79 74.67 1.59 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.259 0.552 . . . . 54.530000000000001 111.357 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.5 t -124.27 92.22 48.48 Favored Pre-proline 0 CA--C 1.542 0.653 0 CA-C-N 116.276 -0.42 . . . . 71.430000000000007 111.525 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_endo -88.89 127.73 1.88 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.166 2.577 . . . . 54.210000000000001 112.126 174.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.425 ' N ' HD12 ' A' ' 232' ' ' LEU . 7.0 mp . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.575 -0.726 . . . . 75.150000000000006 111.819 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.8 t60 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.544 0.211 . . . . 65.230000000000004 110.948 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 50.7 tpp -86.06 116.17 64.72 Favored Pre-proline 0 CA--C 1.541 0.613 0 O-C-N 122.24 -0.287 . . . . 53.520000000000003 111.532 -179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.77 166.27 21.63 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 122.661 2.241 . . . . 65.109999999999999 113.397 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.82 171.07 14.75 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 115.889 -0.596 . . . . 73.540000000000006 110.852 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 82.4 p -159.29 103.08 1.53 Allowed Pre-proline 0 N--CA 1.47 0.56 0 N-CA-C 112.122 0.416 . . . . 61.450000000000003 112.122 -178.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -61.56 153.76 64.46 Favored 'Trans proline' 0 CA--C 1.543 0.97 0 C-N-CA 122.416 2.077 . . . . 74.129999999999995 112.031 170.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -61.67 115.24 3.8 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 112.703 0.631 . . . . 75.430000000000007 112.703 -174.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 13.9 mmmm -113.09 151.02 43.84 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 115.979 -0.555 . . . . 71.019999999999996 110.472 174.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -60.81 147.2 95.94 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.675 2.25 . . . . 51.020000000000003 112.761 -179.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 pt -129.37 160.24 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 CA-C-O 121.472 0.653 . . . . 74.219999999999999 112.74 -175.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.488 HG23 ' HB2' ' A' ' 171' ' ' ALA . 88.5 t -127.1 134.61 65.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-N 115.554 -0.748 . . . . 74.200000000000003 110.302 173.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 63.2 mtt180 -97.48 96.79 8.57 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 120.79 0.328 . . . . 73.230000000000004 111.401 -174.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 48.0 t -98.43 124.05 51.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.585 0.587 . . . . 73.540000000000006 112.585 -174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -95.28 106.36 18.39 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 116.264 -0.426 . . . . 71.420000000000002 111.179 174.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.544 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.7 mt -85.29 157.21 59.36 Favored Pre-proline 0 CA--C 1.543 0.676 0 CA-C-N 116.234 -0.439 . . . . 41.229999999999997 111.336 -179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -55.6 153.39 29.63 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 122.602 2.201 . . . . 75.230000000000004 113.011 176.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.491 ' O ' ' HG2' ' A' ' 165' ' ' GLN . 31.6 m-80 68.93 55.07 0.44 Allowed 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 122.763 0.425 . . . . 72.409999999999997 111.533 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt 51.08 23.1 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.56 1.144 . . . . 72.129999999999995 114.037 176.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.544 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.8 mm-40 -93.26 144.4 25.34 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 112.484 0.549 . . . . 44.340000000000003 112.484 -177.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 58.9 ttt-85 -138.69 142.95 38.96 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.776 0.322 . . . . 72.109999999999999 110.643 177.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.9 t -145.25 159.69 42.63 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.933 0.397 . . . . 71.239999999999995 111.707 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 79.5 t -128.35 120.25 52.6 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 116.282 -0.417 . . . . 72.409999999999997 110.969 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.1 m -120.53 152.57 55.58 Favored Pre-proline 0 N--CA 1.473 0.72 0 CA-C-N 116.377 -0.374 . . . . 54.420000000000002 111.336 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.09 127.73 11.6 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 122.44 2.094 . . . . 73.329999999999998 113.326 -178.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -81.4 103.82 11.42 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 116.254 -0.43 . . . . 33.149999999999999 111.31 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 79.5 mtt180 -109.84 128.87 55.6 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.829 0.347 . . . . 74.349999999999994 111.599 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.3 t -69.23 110.56 4.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.125 0.488 . . . . 75.530000000000001 110.792 177.182 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 118.16 -6.42 15.07 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 121.347 -0.454 . . . . 71.120000000000005 112.274 -175.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.433 ' O ' HG22 ' A' ' 214' ' ' ILE . 98.0 t -110.86 133.01 57.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 122.68 0.392 . . . . 75.25 110.64 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 80.8 p -87.02 156.0 19.93 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.881 0.372 . . . . 71.349999999999994 111.739 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 66.7 t -50.18 -42.01 19.46 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.079 0.466 . . . . 64.329999999999998 111.405 178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.588 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 23.0 ttt180 -63.62 -46.69 84.57 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 116.193 -0.458 . . . . 74.329999999999998 111.248 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -64.68 -31.46 72.69 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 120.843 0.354 . . . . 75.420000000000002 111.944 -176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 38.0 t -79.73 -44.29 21.03 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 120.89 0.376 . . . . 72.439999999999998 111.846 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.2 mt -84.87 -15.26 45.25 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.193 0.812 . . . . 64.209999999999994 113.193 -176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.91 -45.22 41.11 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-O 120.993 0.425 . . . . 70.129999999999995 111.935 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.5 pttp -66.86 -39.51 87.57 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.324 -0.398 . . . . 71.409999999999997 111.969 179.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.12 93.52 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.151 0.5 . . . . 73.219999999999999 111.409 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 87.6 mt -70.65 -52.33 21.92 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 116.083 -0.508 . . . . 71.409999999999997 111.459 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 13.4 tpt -50.03 -53.0 29.73 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.752 0.649 . . . . 55.439999999999998 112.752 -176.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.9 ptp -62.98 -23.7 67.56 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.345 0.498 . . . . 61.030000000000001 112.345 -176.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 47.4 mtp180 -101.61 0.24 35.98 Favored 'General case' 0 CA--C 1.541 0.626 0 N-CA-C 112.067 0.395 . . . . 73.030000000000001 112.067 -178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 89.07 23.75 34.06 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.117 -0.563 . . . . 65.219999999999999 114.071 175.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 85.6 mt -113.04 148.4 35.24 Favored 'General case' 0 CA--C 1.54 0.564 0 O-C-N 122.323 -0.516 . . . . 71.400000000000006 111.329 179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.7 pt -124.74 148.54 59.64 Favored Pre-proline 0 CA--C 1.543 0.695 0 CA-C-N 116.671 -0.24 . . . . 73.319999999999993 110.955 177.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -54.28 -39.0 88.68 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 122.81 2.34 . . . . 61.310000000000002 113.537 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.4 mp0 -60.43 -24.92 65.58 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-O 120.927 0.394 . . . . 74.430000000000007 111.773 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 39.8 t -93.97 -2.26 53.38 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.787 0.327 . . . . 72.439999999999998 111.855 -179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.457 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 68.6 m -128.69 139.71 52.1 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 120.952 0.406 . . . . 72.120000000000005 112.003 -172.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -120.07 119.91 34.72 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.687 0.279 . . . . 71.219999999999999 111.373 178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 224' ' ' VAL . 76.2 t -95.37 124.41 47.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-O 120.81 0.338 . . . . 71.299999999999997 111.486 -178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -136.23 155.46 50.08 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.425 0.631 . . . . 74.0 111.408 174.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.508 ' HB3' HD11 ' A' ' 208' ' ' ILE . 10.2 ptm85 -109.66 133.04 53.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.845 -0.616 . . . . 71.530000000000001 111.42 -178.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 50.4 mt -89.61 91.75 3.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 121.445 0.641 . . . . 70.230000000000004 109.978 173.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.5 tt0 -114.52 123.93 50.61 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 115.573 -0.739 . . . . 71.239999999999995 111.382 -173.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 30.9 t70 62.52 17.67 9.78 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-O 121.353 0.596 . . . . 61.43 110.86 -178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 94.28 -4.43 70.41 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-N 116.272 -0.422 . . . . 65.420000000000002 113.427 -177.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -101.95 140.28 36.45 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 122.447 -0.443 . . . . 55.100000000000001 112.014 -178.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -82.31 105.58 13.49 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 120.726 0.298 . . . . 75.519999999999996 110.814 173.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -108.87 123.07 38.12 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-N 116.818 -0.173 . . . . 74.230000000000004 111.308 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.85 143.36 55.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.563 2.176 . . . . 73.230000000000004 113.498 -177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.508 HD11 ' HB3' ' A' ' 199' ' ' ARG . 57.3 mt -122.91 145.93 29.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 120.816 0.341 . . . . 71.299999999999997 110.875 179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -90.57 143.38 16.78 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 121.077 -0.582 . . . . 74.010000000000005 112.808 178.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.588 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 95.6 m95 -61.34 -23.76 65.98 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 122.306 -0.526 . . . . 75.120000000000005 111.66 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -87.03 0.77 54.67 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 112.239 0.459 . . . . 74.209999999999994 112.239 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 85.7 m -75.89 142.48 42.09 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.246 -0.284 . . . . 51.439999999999998 111.194 177.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -66.54 140.4 57.98 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.987 0.422 . . . . 74.409999999999997 111.419 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.433 HG22 ' O ' ' A' ' 175' ' ' VAL . 14.7 tt -79.18 -23.21 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 112.584 0.587 . . . . 70.400000000000006 112.584 -173.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 89.2 p -62.0 -21.89 65.23 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 120.867 0.365 . . . . 74.510000000000005 111.842 -177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 9.9 m0 -66.12 -23.62 66.53 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.976 0.417 . . . . 74.510000000000005 111.814 177.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.539 HD13 HD11 ' A' ' 222' ' ' LEU . 21.9 mt -108.38 21.93 16.64 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 115.874 -0.603 . . . . 74.099999999999994 112.093 -169.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 79.4 m -65.16 118.12 8.75 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.834 0.679 . . . . 74.239999999999995 112.834 -176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 99.6 -26.04 25.91 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 114.144 0.417 . . . . 74.150000000000006 114.144 173.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 18.0 pt-20 -98.81 172.36 7.5 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.153 0.502 . . . . 75.239999999999995 111.787 -176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -109.95 137.57 47.53 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 113.336 0.865 . . . . 62.030000000000001 113.336 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.539 HD11 HD13 ' A' ' 217' ' ' LEU . 63.0 mt -102.48 155.92 17.94 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.404 -0.816 . . . . 74.329999999999998 110.713 176.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 68.0 m-70 -126.57 127.62 45.55 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 122.132 -0.355 . . . . 64.129999999999995 110.755 176.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 197' ' ' VAL . 54.5 t -107.23 125.01 63.45 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 112.188 0.44 . . . . 55.350000000000001 112.188 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -100.33 168.71 9.6 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 116.234 -0.439 . . . . 54.229999999999997 111.259 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.8 t -95.85 114.31 32.26 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-N 116.398 -0.364 . . . . 73.219999999999999 111.354 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 94.2 mt -81.12 -63.05 1.49 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.219 0.533 . . . . 73.310000000000002 110.741 175.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -94.0 107.34 19.26 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.0 -0.546 . . . . 72.439999999999998 110.872 178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -73.46 72.72 1.37 Allowed 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.4 0.619 . . . . 74.25 110.137 176.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.4 t -137.08 100.07 9.76 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.72 -0.673 . . . . 60.100000000000001 111.27 -175.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.21 98.88 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.048 1.832 . . . . 64.010000000000005 111.491 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 2.0 tt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 118.733 -0.651 . . . . 73.310000000000002 111.644 -174.059 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 55.0 m80 . . . . . 0 N--CA 1.489 1.485 0 CA-C-O 120.687 0.28 . . . . 75.319999999999993 111.324 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 149' ' ' PRO . 89.7 mmm -104.01 115.72 62.78 Favored Pre-proline 0 CA--C 1.538 0.486 0 CA-C-N 116.569 -0.287 . . . . 73.109999999999999 110.612 179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 148' ' ' MET . 21.3 Cg_exo -66.56 72.57 0.42 Allowed 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 122.689 2.259 . . . . 62.299999999999997 112.748 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -82.78 134.37 35.12 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 116.081 -0.509 . . . . 75.230000000000004 111.456 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 23.6 t -151.02 87.24 4.7 Favored Pre-proline 0 N--CA 1.471 0.599 0 CA-C-N 116.311 -0.404 . . . . 73.319999999999993 111.242 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.61 87.99 0.35 Allowed 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 122.693 2.262 . . . . 73.340000000000003 111.925 176.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -106.84 13.67 27.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.339 0.496 . . . . 71.109999999999999 112.339 -175.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -66.43 157.49 82.09 Favored Pre-proline 0 CA--C 1.54 0.595 0 CA-C-N 116.307 -0.406 . . . . 61.299999999999997 110.838 174.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -63.41 137.2 59.01 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.067 1.845 . . . . 65.040000000000006 111.211 174.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.405 ' HB ' HG12 ' A' ' 168' ' ' VAL . 2.8 pp -133.9 165.79 30.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 113.053 0.76 . . . . 52.399999999999999 113.053 -174.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 171' ' ' ALA . 49.0 t -130.26 135.67 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 115.559 -0.746 . . . . 64.400000000000006 110.703 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.568 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 0.0 OUTLIER -89.7 100.01 12.9 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.923 0.392 . . . . 71.129999999999995 111.329 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.51 HG21 HD21 ' A' ' 181' ' ' LEU . 47.9 t -95.85 109.92 23.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 CA-C-O 120.961 0.41 . . . . 70.140000000000001 111.658 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -80.8 117.98 21.93 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.931 0.396 . . . . 72.209999999999994 111.104 176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.0 mt -93.72 157.68 37.84 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-N 116.124 -0.489 . . . . 63.350000000000001 110.707 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.581 ' HG3' HG23 ' A' ' 226' ' ' VAL . 29.9 Cg_endo -63.57 168.67 11.12 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 122.231 1.954 . . . . 72.310000000000002 112.986 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 61.38 33.59 18.72 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.168 0.432 . . . . 73.420000000000002 112.168 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 42.1 mmtm 70.14 23.89 5.12 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.278 0.631 . . . . 71.409999999999997 112.434 175.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.6 mm-40 -99.62 163.56 12.44 Favored 'General case' 0 CA--C 1.541 0.616 0 O-C-N 122.04 -0.413 . . . . 74.120000000000005 111.443 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -160.42 159.47 31.01 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.036 0.446 . . . . 63.299999999999997 112.117 178.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.0 t -155.62 150.99 26.96 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.974 -0.557 . . . . 71.129999999999995 111.294 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.405 HG12 ' HB ' ' A' ' 156' ' ' ILE . 39.0 t -117.8 119.41 61.5 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-O 120.761 0.315 . . . . 65.439999999999998 110.635 177.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 181' ' ' LEU . 29.7 m -116.0 150.36 44.94 Favored Pre-proline 0 N--CA 1.473 0.721 0 N-CA-C 112.144 0.424 . . . . 71.420000000000002 112.144 -175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.21 124.98 10.94 Favored 'Trans proline' 0 CA--C 1.542 0.923 0 C-N-CA 122.511 2.141 . . . . 62.149999999999999 113.606 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.76 103.78 8.93 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.172 0.51 . . . . 63.32 110.847 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -115.93 160.61 19.99 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.054 -0.521 . . . . 72.450000000000003 111.764 -174.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.4 t -87.02 137.87 31.98 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.183 -0.462 . . . . 74.310000000000002 111.072 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 77.62 -11.74 18.19 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.145 -0.55 . . . . 60.32 113.722 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 214' ' ' ILE . 48.4 t -93.6 123.66 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 O-C-N 122.438 -0.448 . . . . 74.239999999999995 110.959 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.436 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 29.3 p -74.73 168.54 19.65 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.184 0.516 . . . . 74.329999999999998 111.899 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 212' ' ' THR . 60.7 t -61.64 -33.78 58.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 CA-C-O 121.278 0.561 . . . . 74.420000000000002 110.231 172.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.555 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 8.7 ttm105 -66.18 -51.32 58.84 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.815 -0.629 . . . . 72.409999999999997 111.365 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 38.0 m-20 -66.94 -21.14 65.99 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.241 0.46 . . . . 74.019999999999996 112.241 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.9 m -86.02 -48.88 8.26 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.838 0.31 . . . . 71.310000000000002 111.838 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 169' ' ' VAL . 78.3 mt -82.83 -2.27 54.17 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.717 0.636 . . . . 72.209999999999994 112.717 -176.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -55.46 -25.81 38.7 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 120.977 0.417 . . . . 74.209999999999994 111.772 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -81.32 -48.85 11.44 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 120.957 0.408 . . . . 51.149999999999999 111.04 175.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.406 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -59.85 -44.52 94.06 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.117 -0.492 . . . . 51.32 111.973 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.428 HD11 ' CH2' ' A' ' 210' ' ' TRP . 90.9 mt -62.76 -46.57 87.44 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.861 0.362 . . . . 51.549999999999997 111.239 177.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 5.6 tpt -59.12 -46.86 87.25 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 116.287 -0.415 . . . . 61.130000000000003 111.647 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.6 ptm -67.75 -8.61 36.89 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-O 120.772 0.32 . . . . 62.420000000000002 111.849 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 22.3 mmm180 -112.11 2.52 16.79 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 122.131 -0.356 . . . . 73.120000000000005 111.249 174.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 74.5 11.76 82.56 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 121.569 -0.348 . . . . 54.219999999999999 113.821 179.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.4 mt -90.0 176.21 6.88 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.113 0.482 . . . . 61.119999999999997 111.846 -176.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.552 HG13 ' HB3' ' A' ' 194' ' ' CYS . 17.6 pt -140.1 143.24 33.17 Favored Pre-proline 0 CA--C 1.543 0.706 0 CA-C-N 116.224 -0.444 . . . . 73.109999999999999 111.328 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_exo -55.74 -49.68 15.0 Favored 'Trans proline' 0 N--CA 1.483 0.881 0 C-N-CA 122.956 2.437 . . . . 72.120000000000005 113.857 -176.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.42 ' H ' ' CD ' ' A' ' 193' ' ' GLU . 1.3 pm0 -73.57 5.54 3.79 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 112.804 0.668 . . . . 74.439999999999998 112.804 -174.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.552 ' HB3' HG13 ' A' ' 191' ' ' ILE . 43.2 t -128.29 15.35 6.68 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.048 0.451 . . . . 65.439999999999998 111.349 175.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 78.2 m -129.49 137.1 50.63 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.848 0.356 . . . . 70.129999999999995 110.939 178.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -109.75 120.94 44.03 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-O 120.727 0.299 . . . . 53.310000000000002 111.747 -178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -98.88 139.13 21.41 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 116.496 -0.32 . . . . 75.409999999999997 110.614 175.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -146.89 153.35 40.02 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 121.38 0.61 . . . . 74.120000000000005 111.926 175.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.549 ' HB3' HD11 ' A' ' 208' ' ' ILE . 1.7 ptm180 -114.29 159.56 20.05 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.652 -0.703 . . . . 65.219999999999999 110.469 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.0 mt -101.91 95.57 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 CA-C-O 121.277 0.56 . . . . 41.030000000000001 110.759 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -108.74 128.11 54.59 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.824 -0.625 . . . . 64.109999999999999 110.555 -175.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 8.4 t70 64.71 20.17 12.05 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-O 121.463 0.649 . . . . 64.310000000000002 111.18 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.16 -20.09 52.19 Favored Glycine 0 CA--C 1.526 0.776 0 C-N-CA 121.333 -0.461 . . . . 45.009999999999998 113.557 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -108.36 162.2 14.32 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.112 0.482 . . . . 73.140000000000001 111.578 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -82.2 143.27 31.51 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-O 121.28 0.562 . . . . 52.219999999999999 111.912 -177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 33.7 mmtm -139.89 120.58 9.33 Favored Pre-proline 0 N--CA 1.473 0.679 0 CA-C-N 115.89 -0.595 . . . . 64.030000000000001 111.207 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -65.76 144.2 76.82 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 122.698 2.266 . . . . 63.020000000000003 113.484 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.549 HD11 ' HB3' ' A' ' 199' ' ' ARG . 66.4 mt -118.83 124.17 72.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.056 -0.52 . . . . 73.319999999999993 111.396 -178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.12 141.52 34.42 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 120.995 -0.622 . . . . 65.430000000000007 112.517 175.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.555 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 91.9 m95 -65.64 -16.08 63.39 Favored 'General case' 0 CA--C 1.543 0.681 0 CA-C-N 117.389 0.595 . . . . 75.420000000000002 111.282 178.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -72.99 -16.37 61.52 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.842 -0.617 . . . . 75.540000000000006 111.762 174.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.424 ' O ' HG23 ' A' ' 177' ' ' VAL . 19.2 m -69.47 136.96 52.19 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 111.509 -177.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 4.7 m-20 -69.45 128.08 35.28 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 116.451 -0.34 . . . . 62.009999999999998 110.939 176.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 175' ' ' VAL . 10.0 tp -59.07 -20.73 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 CA-C-O 121.138 0.494 . . . . 54.210000000000001 111.522 -179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 65.8 p -59.84 -26.71 66.02 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 116.221 -0.445 . . . . 65.439999999999998 112.073 177.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 29.3 m95 -69.48 -21.56 63.69 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 120.858 0.361 . . . . 60.200000000000003 111.83 177.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.421 ' O ' ' HG2' ' A' ' 220' ' ' GLU . 46.5 mt -110.49 21.02 17.11 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.186 0.517 . . . . 70.439999999999998 111.393 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.8 m -58.8 121.32 10.81 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 112.897 0.703 . . . . 63.109999999999999 112.897 -176.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 83.01 4.23 90.08 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 115.279 0.872 . . . . 71.340000000000003 115.279 170.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 217' ' ' LEU . 12.9 pt-20 -111.82 172.7 6.75 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 117.978 0.889 . . . . 64.310000000000002 111.71 179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.568 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 4.2 mp0 -102.98 127.2 50.3 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-O 121.233 0.54 . . . . 64.409999999999997 111.572 -178.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.484 HD12 HG22 ' A' ' 159' ' ' VAL . 74.0 mt -103.67 159.62 15.46 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 115.986 -0.552 . . . . 40.539999999999999 111.148 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -128.75 127.12 41.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 120.652 0.263 . . . . 74.439999999999998 110.633 176.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 197' ' ' VAL . 46.8 t -117.84 146.78 21.86 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-O 121.283 0.563 . . . . 72.209999999999994 112.064 -178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -141.88 140.93 33.01 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 116.26 -0.427 . . . . 72.109999999999999 110.883 174.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.581 HG23 ' HG3' ' A' ' 162' ' ' PRO . 61.8 t -82.9 132.45 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.047 0.451 . . . . 64.200000000000003 111.871 -177.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 59.6 mt -77.92 -52.93 8.06 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 116.324 -0.398 . . . . 70.310000000000002 111.457 -178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.491 ' HB3' HG12 ' A' ' 230' ' ' VAL . 50.5 mt-10 -126.1 151.55 47.08 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.243 0.544 . . . . 73.409999999999997 111.655 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -88.42 28.44 1.1 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.438 -0.346 . . . . 64.349999999999994 111.703 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 228' ' ' GLU . 4.6 p -115.16 108.0 48.8 Favored Pre-proline 0 CA--C 1.545 0.777 0 N-CA-C 113.109 0.781 . . . . 52.439999999999998 113.109 -174.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -90.29 -176.81 1.16 Allowed 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.86 2.373 . . . . 61.509999999999998 111.905 169.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.54 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.2 pt? . . . . . 0 C--O 1.253 1.278 0 CA-C-O 118.221 -0.895 . . . . 62.450000000000003 112.083 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.708 0.29 . . . . 75.140000000000001 111.16 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 26.6 ttt -74.38 122.1 86.75 Favored Pre-proline 0 CA--C 1.539 0.55 0 CA-C-N 116.606 -0.27 . . . . 72.010000000000005 110.445 175.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.63 85.8 0.29 Allowed 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 122.339 2.026 . . . . 75.299999999999997 112.543 -177.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -63.14 85.95 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.581 0.705 . . . . 73.140000000000001 110.973 -179.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.42 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 48.9 p -130.37 141.84 43.32 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-N 115.409 -0.814 . . . . 74.129999999999995 110.876 -176.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 151' ' ' SER . 26.6 Cg_exo -63.49 104.38 0.43 Allowed 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.615 2.21 . . . . 63.25 113.38 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -83.41 122.17 28.14 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 109.939 -0.393 . . . . 72.129999999999995 109.939 175.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 40.7 mtpt -58.14 153.23 36.64 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 112.825 0.676 . . . . 52.140000000000001 112.825 -174.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.466 ' HB2' HG23 ' A' ' 218' ' ' THR . 21.9 Cg_endo -60.08 137.9 78.43 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 122.579 2.186 . . . . 64.540000000000006 111.722 177.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -117.91 158.16 18.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.847 0.684 . . . . 62.420000000000002 112.847 -174.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.5 t -127.56 127.67 68.92 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 115.608 -0.724 . . . . 74.519999999999996 110.367 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.552 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 99.0 mtt180 -89.69 100.44 13.25 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.16 0.505 . . . . 71.439999999999998 111.37 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.604 HG21 HD21 ' A' ' 181' ' ' LEU . 47.8 t -99.5 118.23 45.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 CA-C-N 116.284 -0.416 . . . . 73.200000000000003 112.03 -175.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -88.85 123.32 33.12 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.902 0.382 . . . . 70.439999999999998 110.536 175.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.3 mt -95.49 163.49 21.37 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 116.511 -0.313 . . . . 61.43 111.578 -176.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -49.72 153.62 5.53 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 122.851 2.367 . . . . 64.120000000000005 113.994 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 63.3 t30 61.89 42.37 10.41 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.757 -0.656 . . . . 54.25 111.532 -177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp 63.47 9.25 4.04 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.066 0.765 . . . . 72.319999999999993 113.066 174.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.549 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -72.59 164.36 26.58 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.894 0.378 . . . . 75.420000000000002 110.814 179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.428 ' N ' ' HD2' ' A' ' 166' ' ' ARG . 0.0 OUTLIER -156.43 151.7 26.56 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 121.857 -0.527 . . . . 75.510000000000005 112.093 -177.419 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 8.0 t -156.19 171.21 20.57 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 115.945 -0.571 . . . . 74.519999999999996 111.137 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 46.2 t -131.87 120.34 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.488 0 CA-C-O 120.844 0.355 . . . . 52.229999999999997 110.587 178.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.402 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 34.1 m -115.61 140.6 26.2 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 112.003 0.372 . . . . 61.43 112.003 -176.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 19.6 Cg_exo -67.4 127.28 16.26 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 122.45 2.1 . . . . 75.519999999999996 112.682 176.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.557 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.74 103.21 2.51 Favored 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 121.248 0.547 . . . . 42.450000000000003 110.831 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -100.38 128.05 46.54 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.976 -0.556 . . . . 72.430000000000007 111.807 -177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 43.1 t -70.24 123.19 21.05 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 116.446 -0.343 . . . . 52.420000000000002 111.121 177.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 99.46 -14.94 60.52 Favored Glycine 0 CA--C 1.524 0.641 0 C-N-CA 120.974 -0.631 . . . . 73.209999999999994 113.349 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.9 t -99.85 127.51 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 O-C-N 122.503 -0.41 . . . . 60.030000000000001 110.805 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.5 p -78.07 160.68 27.95 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.084 0.468 . . . . 74.319999999999993 111.541 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.7 t -57.06 -36.32 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 121.429 0.633 . . . . 71.340000000000003 110.163 173.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 46.7 ttt180 -60.29 -52.7 64.14 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.174 -0.921 . . . . 73.430000000000007 111.157 177.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -67.08 -34.8 78.45 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.102 -0.499 . . . . 71.430000000000007 112.123 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 35.4 t -72.85 -49.95 27.01 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 112.442 0.534 . . . . 71.540000000000006 112.442 -175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.604 HD21 HG21 ' A' ' 159' ' ' VAL . 78.7 mt -85.09 -16.52 40.32 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.474 0.916 . . . . 63.140000000000001 113.474 -173.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 22.1 pttp -53.71 -32.55 52.39 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.844 0.683 . . . . 74.230000000000004 112.844 -173.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -72.74 -39.21 67.05 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.943 0.401 . . . . 75.530000000000001 111.404 176.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -68.16 -31.2 70.59 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.193 0.521 . . . . 72.430000000000007 110.784 177.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 93.8 mt -73.78 -49.38 25.64 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 115.836 -0.62 . . . . 72.510000000000005 111.02 175.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.3 tpt -53.24 -47.8 68.73 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 116.079 -0.509 . . . . 74.310000000000002 112.006 -179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 ptm -64.61 -9.14 17.34 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 112.291 0.478 . . . . 64.420000000000002 112.291 -179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 33.0 mmt180 -110.91 -6.17 14.75 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 120.598 0.237 . . . . 72.310000000000002 111.514 178.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.66 36.9 14.91 Favored Glycine 0 CA--C 1.527 0.781 0 C-N-CA 121.122 -0.561 . . . . 54.420000000000002 112.752 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 42.5 mt -126.51 154.71 43.42 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.541 0.336 . . . . 62.32 111.394 -176.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 36.5 pt -136.62 149.57 67.6 Favored Pre-proline 0 N--CA 1.474 0.729 0 C-N-CA 122.362 0.265 . . . . 72.549999999999997 111.009 177.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -51.42 -37.02 60.53 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 122.936 2.424 . . . . 72.450000000000003 113.734 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -69.87 -18.45 63.42 Favored 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 112.35 0.5 . . . . 64.299999999999997 112.35 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.7 t -101.1 -10.33 20.56 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 112.499 0.555 . . . . 52.030000000000001 112.499 -176.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.9 m -131.98 171.27 13.8 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-O 121.238 0.542 . . . . 71.349999999999994 112.244 -174.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -133.08 141.26 48.11 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 116.003 -0.544 . . . . 53.350000000000001 111.549 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 224' ' ' VAL . 48.3 t -109.58 126.17 66.72 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 116.368 -0.378 . . . . 73.120000000000005 110.73 178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 54.8 p90 -141.93 152.63 43.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.179 0.514 . . . . 73.209999999999994 111.936 175.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -109.59 160.13 16.52 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.88 -0.6 . . . . 72.040000000000006 110.578 177.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 58.5 mt -117.24 119.46 61.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.0 0.429 . . . . 74.409999999999997 111.469 -179.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -152.06 149.69 29.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.14 -0.482 . . . . 73.219999999999999 109.872 177.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 62.93 16.46 9.22 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 120.78 0.324 . . . . 71.420000000000002 111.447 -177.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.79 4.4 88.13 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 121.304 -0.474 . . . . 74.0 112.775 -174.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -107.09 154.57 20.96 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 122.954 0.501 . . . . 71.329999999999998 111.986 -175.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -94.82 126.19 39.98 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 120.88 0.371 . . . . 74.209999999999994 110.681 171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -113.12 94.85 32.33 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 110.015 -0.365 . . . . 63.130000000000003 110.015 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -58.37 121.9 10.77 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.714 2.276 . . . . 75.200000000000003 112.443 176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 58.8 mt -101.85 132.68 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 116.149 -0.478 . . . . 72.140000000000001 111.584 -175.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -66.73 126.09 26.56 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 120.77 -0.728 . . . . 71.010000000000005 112.358 175.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -51.63 -33.17 32.16 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 112.664 0.616 . . . . 73.400000000000006 112.664 -177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -85.74 21.37 1.89 Allowed 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.426 0.528 . . . . 44.420000000000002 112.426 -176.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 49.9 m -97.09 143.28 28.07 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 122.336 -0.228 . . . . 73.329999999999998 111.112 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.517 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.9 m-20 -58.2 128.27 36.28 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.126 0.489 . . . . 72.519999999999996 111.823 178.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.488 HD12 HD12 ' A' ' 217' ' ' LEU . 9.3 tp -63.66 -21.2 28.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-O 120.98 0.419 . . . . 71.420000000000002 111.722 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.557 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 78.4 p -60.62 -26.09 66.76 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 112.216 0.45 . . . . 72.549999999999997 112.216 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.517 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 22.3 m95 -67.21 -21.53 65.75 Favored 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 111.968 0.359 . . . . 73.209999999999994 111.968 178.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.488 HD12 HD12 ' A' ' 214' ' ' ILE . 33.9 mt -103.83 22.07 15.16 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 121.138 0.494 . . . . 75.209999999999994 111.896 -172.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.466 HG23 ' HB2' ' A' ' 155' ' ' PRO . 77.4 m -53.71 124.71 15.95 Favored 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 112.893 0.701 . . . . 73.109999999999999 112.893 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 81.3 -5.87 66.04 Favored Glycine 0 CA--C 1.53 0.969 0 N-CA-C 114.401 0.521 . . . . 70.129999999999995 114.401 174.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -92.67 158.15 16.1 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.331 0.566 . . . . 54.119999999999997 111.742 -177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.552 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 51.8 mt-10 -100.69 117.84 35.62 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.143 -0.48 . . . . 70.450000000000003 110.809 175.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.533 HD12 HG22 ' A' ' 159' ' ' VAL . 82.1 mt -93.01 148.16 22.23 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 121.056 0.455 . . . . 63.299999999999997 111.012 -178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -121.35 113.28 19.67 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.886 0.374 . . . . 54.409999999999997 110.541 178.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.569 HG22 HG22 ' A' ' 197' ' ' VAL . 43.5 t -108.46 130.76 60.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.136 -0.484 . . . . 71.340000000000003 111.22 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.92 157.68 45.31 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.121 0.486 . . . . 61.240000000000002 111.435 178.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.1 t -73.95 130.0 36.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 116.044 -0.525 . . . . 55.0 111.453 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 96.2 mt -80.45 -56.35 4.25 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.165 0.507 . . . . 64.299999999999997 110.433 176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -137.76 135.97 36.85 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 115.744 -0.662 . . . . 63.43 110.971 179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 36.9 m-80 -72.97 76.77 1.18 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.196 0.522 . . . . 72.319999999999993 110.864 177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 28.0 m -98.18 118.75 63.2 Favored Pre-proline 0 CA--C 1.543 0.697 0 CA-C-O 121.294 0.568 . . . . 54.140000000000001 112.483 -175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -92.74 113.56 0.28 Allowed 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.018 2.479 . . . . 65.219999999999999 112.194 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 C--O 1.253 1.246 0 CA-C-O 118.97 -0.538 . . . . 70.129999999999995 111.797 -178.863 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.8 m80 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.609 0.242 . . . . 72.430000000000007 110.922 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.568 ' N ' ' SD ' ' A' ' 148' ' ' MET . 3.0 mpp? -92.34 111.84 52.42 Favored Pre-proline 0 CA--C 1.541 0.634 0 N-CA-C 111.995 0.369 . . . . 72.420000000000002 111.995 -173.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -66.29 105.27 0.84 Allowed 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 122.344 2.029 . . . . 63.119999999999997 111.484 175.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -115.87 149.39 38.71 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.19 0.811 . . . . 63.140000000000001 113.19 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 44.3 t -133.6 82.62 50.73 Favored Pre-proline 0 N--CA 1.472 0.63 0 CA-C-N 115.578 -0.737 . . . . 70.439999999999998 109.751 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -79.21 126.24 6.87 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.68 2.253 . . . . 72.129999999999995 113.827 -174.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 28.2 pt20 -82.16 39.18 0.57 Allowed 'General case' 0 CA--C 1.542 0.665 0 CA-C-O 121.243 0.544 . . . . 72.239999999999995 111.223 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 154' ' ' LYS . 9.2 mmpt? -97.62 152.05 37.95 Favored Pre-proline 0 CA--C 1.54 0.57 0 CA-C-N 115.961 -0.563 . . . . 72.219999999999999 111.799 -175.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.97 114.86 4.15 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.229 1.953 . . . . 65.310000000000002 110.95 169.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -114.65 160.7 13.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 113.102 0.778 . . . . 75.049999999999997 113.102 -172.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 48.5 t -123.35 139.21 50.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 115.553 -0.749 . . . . 50.130000000000003 110.518 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.571 ' HB2' ' HG3' ' A' ' 221' ' ' GLU . 1.5 mpt_? -92.88 111.71 23.42 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.546 0.212 . . . . 73.420000000000002 110.543 -179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 52.6 t -110.23 122.33 64.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 N-CA-C 112.35 0.5 . . . . 50.229999999999997 112.35 -175.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -84.96 99.76 11.19 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 110.399 174.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.535 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.1 mt -65.97 144.0 98.65 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.654 -0.248 . . . . 64.329999999999998 111.27 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -53.23 143.52 52.12 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 122.552 2.168 . . . . 74.239999999999995 112.945 -175.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.414 ' HB3' HH22 ' A' ' 188' ' ' ARG . 25.0 t-20 74.5 54.43 0.09 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 123.122 0.569 . . . . 73.519999999999996 111.534 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp 67.59 22.02 9.25 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.938 1.088 . . . . 70.319999999999993 113.938 169.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 71.7 mm-40 -107.84 175.27 5.54 Favored 'General case' 0 N--CA 1.476 0.863 0 O-C-N 121.603 -0.686 . . . . 73.519999999999996 112.539 -175.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 6.1 ptp180 -146.98 152.68 39.02 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 121.159 0.504 . . . . 74.540000000000006 112.325 -175.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.6 t -157.09 160.5 38.94 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.013 -0.539 . . . . 72.540000000000006 110.893 170.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.1 t -130.82 120.2 47.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 CA-C-O 120.978 0.418 . . . . 75.030000000000001 110.722 176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 16.7 m -125.05 141.13 37.62 Favored Pre-proline 0 CA--C 1.543 0.683 0 CA-C-N 116.305 -0.407 . . . . 72.409999999999997 111.909 -176.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 156' ' ' ILE . 73.4 Cg_endo -77.14 132.55 12.76 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.69 2.26 . . . . 51.200000000000003 113.487 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.544 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -70.78 128.85 37.45 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.194 0.521 . . . . 62.420000000000002 111.802 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -129.69 131.53 46.39 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.067 -0.515 . . . . 71.329999999999998 110.931 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 53.1 t -71.99 109.83 6.08 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 120.93 0.395 . . . . 52.109999999999999 111.163 178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 116.99 -1.3 19.6 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 121.326 -0.464 . . . . 73.230000000000004 112.668 -176.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.432 ' O ' HG22 ' A' ' 214' ' ' ILE . 96.0 t -117.72 125.84 74.38 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 CA-C-O 120.939 0.399 . . . . 73.420000000000002 110.948 -179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 p -82.69 167.38 18.27 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.076 0.465 . . . . 65.120000000000005 111.736 -178.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.55 -36.63 42.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.304 0.574 . . . . 52.25 110.459 174.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.593 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 41.3 ttt180 -67.06 -57.68 6.36 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 115.735 -0.666 . . . . 74.439999999999998 111.187 178.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.41 -28.22 58.72 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.116 0.413 . . . . 71.310000000000002 112.116 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 36.7 t -78.78 -47.42 16.77 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.896 0.379 . . . . 73.129999999999995 111.709 178.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 94.6 mt -94.13 -1.53 54.11 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.157 0.799 . . . . 73.099999999999994 113.157 -174.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 65.3 pttt -56.34 -41.47 76.14 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 112.136 0.421 . . . . 72.420000000000002 112.136 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 tttm -71.24 -32.31 68.61 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.058 0.456 . . . . 70.129999999999995 111.09 178.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.8 -38.55 91.37 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.035 0.445 . . . . 72.230000000000004 111.051 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 88.9 mt -75.68 -38.69 58.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.848 175.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 24.7 ttt -54.67 -50.6 67.81 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-N 115.935 -0.575 . . . . 73.129999999999995 111.713 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -69.78 -4.29 19.29 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 112.52 0.563 . . . . 64.219999999999999 112.52 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.414 HH22 ' HB3' ' A' ' 163' ' ' ASN . 70.4 mtp180 -118.28 2.42 11.93 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.055 0.391 . . . . 71.349999999999994 112.055 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.83 38.64 89.52 Favored Glycine 0 CA--C 1.528 0.855 0 C-N-CA 121.112 -0.566 . . . . 73.129999999999995 113.616 179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.6 mt -121.98 154.99 36.49 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-O 120.912 0.387 . . . . 75.420000000000002 111.685 -178.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 26.9 pt -121.83 146.54 46.18 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 116.366 -0.379 . . . . 74.209999999999994 111.396 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -51.6 -44.27 45.21 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.113 2.542 . . . . 72.310000000000002 114.141 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -68.01 -4.1 12.23 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 112.371 0.508 . . . . 75.120000000000005 112.371 -178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -100.5 -5.39 27.04 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.928 0.394 . . . . 73.109999999999999 111.425 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.9 m -137.36 144.12 42.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.108 0.48 . . . . 74.420000000000002 111.993 -176.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.575 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -112.22 137.44 50.32 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.779 0.323 . . . . 51.119999999999997 111.483 177.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 224' ' ' VAL . 47.4 t -102.48 140.09 21.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 116.276 -0.42 . . . . 64.329999999999998 110.26 176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -157.77 158.47 35.32 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.254 0.55 . . . . 62.210000000000001 112.023 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.846 HH11 ' HG3' ' A' ' 220' ' ' GLU . 79.1 mtm180 -110.41 139.46 45.6 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 116.141 -0.481 . . . . 65.230000000000004 111.239 175.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.0 mt -100.95 96.41 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.299 0.571 . . . . 62.240000000000002 110.111 175.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -103.75 107.54 18.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.134 -0.484 . . . . 74.310000000000002 110.097 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.0 20.05 7.84 Favored 'General case' 0 CA--C 1.551 1.018 0 CA-C-O 121.298 0.571 . . . . 74.209999999999994 111.567 -179.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.62 38.23 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 121.474 -0.393 . . . . 41.009999999999998 113.257 -178.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -84.18 117.34 23.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 111.944 0.35 . . . . 63.439999999999998 111.944 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 58.1 mtpt -80.72 109.34 15.17 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 120.546 0.212 . . . . 72.120000000000005 111.222 174.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 46.5 mmtm -102.9 106.82 52.43 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-O 120.599 0.238 . . . . 72.129999999999995 111.195 177.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -67.51 116.53 4.28 Favored 'Trans proline' 0 CA--C 1.539 0.736 0 C-N-CA 122.873 2.382 . . . . 73.519999999999996 113.036 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.453 HD11 ' HG3' ' A' ' 199' ' ' ARG . 64.1 mt -101.06 133.26 44.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-O 121.236 0.541 . . . . 73.049999999999997 111.908 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.7 143.3 28.92 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 121.199 -0.524 . . . . 61.229999999999997 112.888 176.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.593 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 96.4 m95 -60.4 -21.89 62.72 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 117.352 0.576 . . . . 73.540000000000006 111.011 176.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -78.05 -5.16 50.54 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 115.987 -0.551 . . . . 75.409999999999997 112.204 178.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.414 ' O ' HG23 ' A' ' 177' ' ' VAL . 40.8 m -74.25 136.76 42.7 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.551 0.215 . . . . 74.129999999999995 111.353 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.459 ' HB3' ' CD1' ' A' ' 216' ' ' TRP . 18.1 t70 -72.09 129.24 38.03 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.04 0.448 . . . . 75.519999999999996 110.88 178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.432 HG22 ' O ' ' A' ' 175' ' ' VAL . 12.5 tt -66.02 -22.63 30.74 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 N-CA-C 112.731 0.641 . . . . 71.310000000000002 112.731 -173.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.544 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 41.2 t -63.39 -21.05 66.05 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.821 -0.549 . . . . 60.32 111.425 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.459 ' CD1' ' HB3' ' A' ' 213' ' ' ASP . 16.8 m95 -80.18 -10.65 59.77 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.013 0.435 . . . . 72.109999999999999 111.356 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.538 HD13 HD21 ' A' ' 222' ' ' LEU . 49.6 mt -111.42 15.04 21.47 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.227 -0.442 . . . . 65.430000000000007 111.571 -176.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.3 m -56.29 126.32 25.75 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 112.355 0.502 . . . . 74.239999999999995 112.355 -177.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.29 10.14 84.06 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 121.299 -0.477 . . . . 73.019999999999996 114.087 176.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . 0.846 ' HG3' HH11 ' A' ' 199' ' ' ARG . 36.5 mm-40 -107.37 171.89 7.13 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.126 0.489 . . . . 61.229999999999997 111.53 179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.571 ' HG3' ' HB2' ' A' ' 158' ' ' ARG . 5.1 mp0 -111.01 121.01 44.26 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.192 -0.458 . . . . 71.329999999999998 110.866 172.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.538 HD21 HD13 ' A' ' 217' ' ' LEU . 80.2 mt -94.01 117.65 30.4 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-O 120.916 0.388 . . . . 60.310000000000002 111.197 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 24.5 m-70 -94.41 118.74 32.09 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.612 -0.267 . . . . 65.319999999999993 110.484 177.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 197' ' ' VAL . 21.7 t -110.15 139.93 31.35 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 121.13 0.491 . . . . 72.209999999999994 111.158 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -142.98 170.45 15.66 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.454 -0.339 . . . . 65.409999999999997 111.369 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.7 t -92.29 127.04 44.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.625 0 CA-C-O 120.862 0.363 . . . . 73.209999999999994 111.644 -175.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 196' ' ' ALA . 86.4 mt -66.44 -45.24 80.49 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.228 -0.442 . . . . 75.129999999999995 111.99 179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.492 ' HG3' ' H ' ' A' ' 230' ' ' VAL . 16.2 pt-20 -80.33 170.08 16.88 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.287 0.565 . . . . 73.140000000000001 111.887 -177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -81.29 9.69 6.68 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 112.68 0.622 . . . . 73.5 112.68 -176.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.492 ' H ' ' HG3' ' A' ' 228' ' ' GLU . 57.5 t -127.83 91.6 44.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.043 0.386 . . . . 74.239999999999995 112.043 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -84.17 115.64 2.0 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 123.258 2.639 . . . . 70.349999999999994 112.199 173.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 3.8 pp . . . . . 0 C--O 1.252 1.22 0 N-CA-C 112.064 0.394 . . . . 73.540000000000006 112.064 -178.092 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.726 0.298 . . . . 73.200000000000003 111.075 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 64.9 mtt -130.12 150.67 76.71 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 122.432 0.293 . . . . 74.510000000000005 110.946 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -69.74 154.27 68.0 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.577 2.185 . . . . 72.510000000000005 113.529 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -81.53 152.95 27.04 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 120.915 0.388 . . . . 74.219999999999999 111.815 -178.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 79.3 p 47.52 87.45 0.12 Allowed Pre-proline 0 N--CA 1.477 0.923 0 N-CA-C 113.15 0.796 . . . . 74.329999999999998 113.15 177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.44 97.99 0.63 Allowed 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.686 2.257 . . . . 73.349999999999994 112.9 179.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.4 pt20 -91.4 4.74 51.71 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-O 121.011 0.434 . . . . 72.430000000000007 111.187 177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -67.94 132.22 92.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 CA-C-N 115.996 -0.547 . . . . 55.43 111.396 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -65.42 135.86 44.43 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.347 2.031 . . . . 75.219999999999999 111.738 176.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.8 pt -123.62 161.11 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 N-CA-C 113.051 0.76 . . . . 71.450000000000003 113.051 -173.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.5 t -127.12 131.92 70.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 115.8 -0.636 . . . . 74.099999999999994 110.459 174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 158' ' ' ARG . 64.0 mtt85 -100.96 105.14 16.34 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 120.941 0.4 . . . . 73.450000000000003 111.632 -176.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.615 HG22 HD12 ' A' ' 222' ' ' LEU . 60.0 t -99.6 119.08 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 CA-C-N 116.575 -0.284 . . . . 72.329999999999998 111.735 -179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -92.13 113.51 25.8 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.351 0.596 . . . . 65.120000000000005 111.888 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.475 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 89.5 mt -91.14 169.15 12.09 Favored Pre-proline 0 CA--C 1.544 0.741 0 CA-C-N 115.435 -0.802 . . . . 74.109999999999999 111.04 -178.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 52.5 Cg_exo -55.26 165.29 3.14 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 122.427 2.085 . . . . 74.319999999999993 113.479 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 12.2 m120 59.83 28.76 18.29 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 122.776 0.43 . . . . 73.439999999999998 111.954 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 29.0 mtpp 63.29 22.96 13.58 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.987 0.515 . . . . 75.230000000000004 112.087 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.475 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 80.3 mm-40 -82.81 168.33 17.24 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 120.847 0.356 . . . . 73.230000000000004 111.048 177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 19.2 ptt180 -156.43 161.75 40.06 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 121.509 0.671 . . . . 71.329999999999998 112.124 177.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.6 t -150.41 151.08 32.24 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 115.655 -0.702 . . . . 74.340000000000003 110.525 175.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.52 119.61 52.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.988 0.423 . . . . 73.329999999999998 111.443 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 27.1 m -120.38 144.51 38.38 Favored Pre-proline 0 N--CA 1.47 0.554 0 CA-C-N 116.318 -0.401 . . . . 61.109999999999999 111.449 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 23.8 Cg_exo -65.56 132.66 31.71 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 122.645 2.23 . . . . 73.030000000000001 112.992 177.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -73.97 117.65 16.01 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.025 0.441 . . . . 75.420000000000002 111.604 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 54.0 mtt180 -130.37 143.55 50.83 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 116.283 -0.417 . . . . 72.340000000000003 111.194 -178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.5 t -79.41 140.99 37.24 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 120.636 0.255 . . . . 74.230000000000004 110.642 174.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 89.08 -25.29 10.35 Favored Glycine 0 CA--C 1.525 0.691 0 C-N-CA 121.116 -0.564 . . . . 50.130000000000003 112.314 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 57.3 t -87.91 117.54 31.92 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-O 120.926 0.394 . . . . 73.129999999999995 110.899 177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 39.5 p -80.15 156.91 26.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.484 -0.325 . . . . 75.430000000000007 111.254 -179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 46.9 t -54.75 -31.7 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.552 0.692 . . . . 65.030000000000001 110.756 174.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.621 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.4 ttp85 -70.18 -35.23 73.81 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.448 -0.796 . . . . 74.230000000000004 111.59 179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.27 -43.33 21.53 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.196 -0.456 . . . . 62.210000000000001 111.903 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 83.1 p -61.14 -49.81 75.73 Favored 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 121.129 0.49 . . . . 71.340000000000003 111.978 -176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 88.4 mt -80.71 14.43 2.13 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 112.972 0.73 . . . . 73.019999999999996 112.972 -176.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.469 ' HG3' ' N ' ' A' ' 183' ' ' LYS . 9.5 ptpp? -53.12 -48.3 67.96 Favored 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 112.286 0.476 . . . . 73.409999999999997 112.286 -177.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.469 ' N ' ' HG3' ' A' ' 182' ' ' LYS . 65.6 pttt -79.05 -29.75 43.66 Favored 'General case' 0 N--CA 1.469 0.518 0 O-C-N 122.05 -0.406 . . . . 64.239999999999995 111.311 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.07 -46.29 88.16 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-O 121.142 0.496 . . . . 52.100000000000001 111.434 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 86.7 mt -68.18 -46.34 70.96 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.103 0.477 . . . . 74.109999999999999 110.689 176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 41.2 ttm -50.93 -51.5 51.56 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 115.731 -0.668 . . . . 71.340000000000003 112.156 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp -63.41 -19.91 65.1 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 112.298 0.481 . . . . 74.019999999999996 112.298 -179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -98.91 -4.47 32.8 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 120.821 0.344 . . . . 62.420000000000002 111.421 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 76.89 25.81 63.81 Favored Glycine 0 CA--C 1.529 0.906 0 C-N-CA 121.184 -0.531 . . . . 54.340000000000003 113.006 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.2 mt -113.89 153.97 28.31 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.04 0.447 . . . . 71.430000000000007 111.486 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 31.0 pt -128.69 156.89 76.76 Favored Pre-proline 0 N--CA 1.47 0.574 0 CA-C-N 116.305 -0.407 . . . . 70.409999999999997 110.318 174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.78 -42.87 62.84 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 122.507 2.138 . . . . 62.530000000000001 113.159 -179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.65 -7.62 28.2 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.16 0.43 . . . . 60.439999999999998 112.16 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 40.9 t -109.87 -2.45 17.22 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 111.803 0.297 . . . . 63.310000000000002 111.803 -179.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 68.6 m -139.08 162.53 34.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 121.08 0.467 . . . . 71.230000000000004 111.778 -176.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.45 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.19 139.98 48.55 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.927 0.394 . . . . 54.109999999999999 111.586 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 224' ' ' VAL . 54.1 t -107.95 135.19 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 CA-C-N 116.177 -0.465 . . . . 42.439999999999998 111.024 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.62 158.2 43.95 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 120.982 0.42 . . . . 73.319999999999993 111.148 175.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -127.58 149.1 50.31 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.89 0.376 . . . . 61.229999999999997 110.883 175.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 51.3 mt -92.85 95.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.546 0.689 . . . . 63.009999999999998 110.206 178.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 51.2 tt0 -104.46 109.14 20.9 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.554 -0.748 . . . . 64.120000000000005 111.259 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 5.8 t70 60.78 26.54 16.36 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-O 121.475 0.655 . . . . 73.310000000000002 111.006 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 100.55 -13.25 59.7 Favored Glycine 0 CA--C 1.528 0.89 0 CA-C-N 116.166 -0.47 . . . . 35.530000000000001 113.441 -178.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 125.18 35.9 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 112.107 0.41 . . . . 53.229999999999997 112.107 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -81.02 93.92 6.47 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 121.147 0.498 . . . . 73.340000000000003 109.8 171.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 23.5 tptm -99.7 115.57 65.5 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-N 116.184 -0.462 . . . . 75.299999999999997 111.725 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -62.55 127.18 20.07 Favored 'Trans proline' 0 CA--C 1.541 0.854 0 C-N-CA 122.692 2.261 . . . . 64.010000000000005 112.806 177.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 63.8 mt -102.34 120.47 52.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.117 -0.492 . . . . 70.420000000000002 110.872 178.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -61.81 135.09 46.78 Favored Glycine 0 CA--C 1.528 0.875 0 C-N-CA 120.889 -0.672 . . . . 62.310000000000002 113.197 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.621 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 83.3 m95 -55.72 -32.81 63.67 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.523 0.564 . . . . 72.450000000000003 112.523 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -84.62 11.75 8.32 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 112.852 0.686 . . . . 75.420000000000002 112.852 -177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 37.3 m -79.85 141.91 35.73 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 122.158 -0.339 . . . . 65.030000000000001 110.862 176.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -59.47 118.29 5.85 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 120.895 0.378 . . . . 65.219999999999999 111.145 176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.7 tp -57.34 -22.3 16.96 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 CA-C-O 121.09 0.471 . . . . 64.040000000000006 111.845 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.488 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 23.3 t -61.28 -23.89 66.01 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.159 0.429 . . . . 64.319999999999993 112.159 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -66.51 -22.46 66.18 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.062 0.458 . . . . 64.450000000000003 111.388 177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.0 mt -108.02 30.11 6.67 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 121.201 0.524 . . . . 74.140000000000001 111.707 -173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 93.9 m -62.65 116.65 5.36 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 112.711 0.634 . . . . 71.230000000000004 112.711 -177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 85.01 8.91 81.59 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 114.99 0.756 . . . . 64.010000000000005 114.99 170.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -115.48 167.34 10.96 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.73 0.765 . . . . 71.340000000000003 112.126 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 15.3 mp0 -102.47 120.89 41.3 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 115.794 -0.639 . . . . 75.150000000000006 111.717 -177.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.615 HD12 HG22 ' A' ' 159' ' ' VAL . 68.4 mt -94.03 143.77 26.06 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.082 -0.508 . . . . 74.219999999999999 111.45 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -109.03 109.47 20.51 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.735 0.303 . . . . 74.310000000000002 110.203 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.472 HG22 HG22 ' A' ' 197' ' ' VAL . 61.6 t -107.77 148.86 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.458 0 CA-C-O 121.077 0.465 . . . . 73.299999999999997 111.517 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -147.21 160.24 42.7 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.968 0.413 . . . . 73.310000000000002 111.049 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.8 t -83.29 132.25 31.85 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.629 0 CA-C-O 120.8 0.333 . . . . 61.520000000000003 111.771 -177.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 196' ' ' ALA . 94.8 mt -68.34 -44.57 75.0 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.121 0.486 . . . . 72.129999999999995 110.335 175.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -69.33 110.81 4.85 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 115.944 -0.571 . . . . 72.219999999999999 110.588 175.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -74.8 64.59 1.28 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.246 0.546 . . . . 71.219999999999999 111.791 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 14.3 m -136.18 110.12 9.85 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.159 -0.473 . . . . 71.310000000000002 110.839 178.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -84.53 -176.9 2.7 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.646 2.231 . . . . 73.329999999999998 112.606 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.429 HD22 ' N ' ' A' ' 232' ' ' LEU . 3.2 mm? . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.707 -0.663 . . . . 72.329999999999998 110.624 175.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 65.2 m80 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.606 0.241 . . . . 72.019999999999996 111.522 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 84.4 mtp 60.77 84.94 0.19 Allowed Pre-proline 0 CA--C 1.544 0.734 0 C-N-CA 122.869 0.468 . . . . 73.109999999999999 112.199 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -70.27 113.32 3.42 Favored 'Trans proline' 0 CA--C 1.539 0.744 0 C-N-CA 122.722 2.281 . . . . 73.209999999999994 112.479 175.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.548 ' HD2' ' O ' ' A' ' 150' ' ' LYS . 0.1 OUTLIER -68.46 145.47 54.04 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-O 120.789 0.328 . . . . 74.409999999999997 111.582 179.248 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 77.6 p -172.48 108.15 0.35 Allowed Pre-proline 0 N--CA 1.471 0.608 0 CA-C-O 120.763 0.316 . . . . 73.430000000000007 111.747 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_exo -72.59 111.89 3.34 Favored 'Trans proline' 0 CA--C 1.538 0.702 0 C-N-CA 122.601 2.201 . . . . 73.439999999999998 112.195 177.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -89.36 2.27 54.65 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.976 0.417 . . . . 64.230000000000004 111.247 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -77.08 150.87 81.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 116.168 -0.469 . . . . 72.209999999999994 111.447 175.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_endo -59.43 142.72 99.43 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 122.684 2.256 . . . . 72.099999999999994 112.378 178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.438 ' HB ' ' CG1' ' A' ' 168' ' ' VAL . 2.9 pp -123.05 161.73 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.538 0.685 . . . . 63.140000000000001 112.814 -175.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 44.1 t -126.43 141.21 46.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 CA-C-N 115.73 -0.668 . . . . 75.409999999999997 110.919 179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -93.28 106.5 18.46 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 120.644 0.259 . . . . 70.549999999999997 111.132 -177.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.616 HG21 HD21 ' A' ' 181' ' ' LEU . 55.6 t -109.19 124.45 65.88 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.123 0.487 . . . . 73.209999999999994 112.12 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.462 ' HD1' ' HG3' ' A' ' 166' ' ' ARG . 20.6 m-85 -99.78 113.74 26.44 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-N 116.187 -0.46 . . . . 74.049999999999997 110.961 177.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.565 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 86.3 mt -90.9 160.87 37.13 Favored Pre-proline 0 CA--C 1.545 0.775 0 CA-C-N 116.037 -0.529 . . . . 65.030000000000001 111.467 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 29.6 Cg_endo -61.88 167.26 10.68 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.929 2.419 . . . . 75.030000000000001 113.672 -178.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 61.19 29.7 18.9 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-O 121.353 0.597 . . . . 64.439999999999998 111.341 -177.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 28.8 mmtp 60.37 59.03 2.39 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 115.354 -0.839 . . . . 72.239999999999995 111.718 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.565 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.1 mm-40 -118.91 143.61 46.9 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.889 -0.596 . . . . 44.520000000000003 110.455 177.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.462 ' HG3' ' HD1' ' A' ' 160' ' ' PHE . 3.4 mpt_? -126.19 147.18 49.7 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 121.952 -0.468 . . . . 73.319999999999993 111.698 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -155.49 161.74 40.87 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.046 -0.525 . . . . 64.310000000000002 111.357 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.438 ' CG1' ' HB ' ' A' ' 156' ' ' ILE . 61.9 t -126.89 120.14 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 120.837 0.351 . . . . 64.420000000000002 111.197 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -111.44 153.76 44.03 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-N 116.396 -0.365 . . . . 54.310000000000002 111.764 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -77.14 151.6 30.47 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.543 2.162 . . . . 55.450000000000003 113.532 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.453 ' HB1' ' HA ' ' A' ' 215' ' ' SER . . . -105.09 112.49 25.64 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-N 116.068 -0.514 . . . . 75.439999999999998 111.882 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -126.34 148.28 49.59 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 122.522 0.329 . . . . 73.140000000000001 111.046 177.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -78.12 135.64 37.72 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 120.712 0.292 . . . . 74.200000000000003 110.921 178.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 95.12 -30.57 7.94 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 121.142 -0.552 . . . . 75.129999999999995 112.277 -174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 64.8 t -80.89 109.72 15.59 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 CA-C-O 121.108 0.48 . . . . 63.229999999999997 110.346 175.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 36.9 p -76.36 163.31 27.12 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 116.272 -0.422 . . . . 61.399999999999999 111.324 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 212' ' ' THR . 60.8 t -54.02 -37.1 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 CA-C-O 121.288 0.566 . . . . 75.010000000000005 110.23 174.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.57 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 3.4 tmt_? -65.64 -39.34 91.31 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.492 -0.776 . . . . 72.329999999999998 111.187 177.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.529 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 31.8 t70 -79.34 -29.07 42.09 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 111.935 0.346 . . . . 75.239999999999995 111.935 -179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 48.4 t -78.56 -55.74 4.97 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 121.093 0.473 . . . . 71.439999999999998 111.496 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.616 HD21 HG21 ' A' ' 159' ' ' VAL . 62.4 mt -72.48 -3.56 25.09 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.797 0.665 . . . . 64.0 112.797 -176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.529 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 24.6 pttm -61.75 -20.65 63.77 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 122.026 -0.421 . . . . 75.340000000000003 110.747 176.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -80.08 -53.46 6.68 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-O 121.025 0.44 . . . . 75.450000000000003 110.877 172.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.76 -35.28 70.53 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.055 -0.52 . . . . 50.450000000000003 111.869 -179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 98.1 mt -81.79 -26.21 34.59 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 116.56 -0.291 . . . . 75.219999999999999 111.58 177.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 182' ' ' LYS . 3.0 tpt -64.39 -41.76 96.49 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.818 0.342 . . . . 65.200000000000003 111.013 177.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -68.46 -21.3 64.64 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.013 0.435 . . . . 71.540000000000006 110.948 175.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mmm180 -83.75 -21.16 32.34 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.31 -0.405 . . . . 62.229999999999997 110.808 174.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.61 29.61 26.39 Favored Glycine 0 CA--C 1.526 0.757 0 C-N-CA 121.41 -0.424 . . . . 55.210000000000001 113.064 -178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 84.4 mt -131.31 164.93 24.55 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.17 0.51 . . . . 75.420000000000002 111.829 -176.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 29.3 pt -107.36 143.16 26.63 Favored Pre-proline 0 CA--C 1.545 0.764 0 CA-C-N 116.125 -0.489 . . . . 75.319999999999993 111.159 176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . 0.425 ' HB2' ' HG2' ' A' ' 178' ' ' ARG . 53.8 Cg_exo -52.42 -42.96 57.82 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.122 2.548 . . . . 53.119999999999997 113.978 -178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.431 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.6 pm0 -70.29 -0.78 8.7 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 112.375 0.509 . . . . 72.430000000000007 112.375 -178.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 52.9 t -107.15 9.83 30.22 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.964 0.412 . . . . 63.399999999999999 111.024 173.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 62.0 m -131.38 172.16 12.51 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.223 -0.444 . . . . 44.549999999999997 111.215 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -136.98 126.93 25.84 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.804 0.335 . . . . 70.310000000000002 111.638 -179.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 224' ' ' VAL . 43.4 t -99.08 125.22 52.62 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-N 116.328 -0.396 . . . . 73.420000000000002 110.805 176.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.403 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 55.2 p90 -136.28 146.52 46.76 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.525 0.678 . . . . 74.299999999999997 111.365 175.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.557 ' HB3' HD11 ' A' ' 208' ' ' ILE . 0.5 OUTLIER -109.98 127.2 54.65 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 115.533 -0.758 . . . . 74.439999999999998 110.24 -179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 54.4 mt -77.72 87.61 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.875 0.845 . . . . 63.009999999999998 109.944 177.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -115.66 136.73 52.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.111 -0.949 . . . . 65.340000000000003 111.105 -172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 26.3 t70 55.19 26.24 8.15 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-O 121.285 0.564 . . . . 63.439999999999998 112.327 174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 87.64 17.2 58.81 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.153 -0.546 . . . . 61.210000000000001 114.402 177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -138.71 151.93 47.57 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.416 0.608 . . . . 72.040000000000006 111.877 177.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.403 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 53.6 mtpt -77.73 94.65 4.49 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 109.661 -0.496 . . . . 72.219999999999999 109.661 170.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -98.25 114.07 64.75 Favored Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 120.626 0.251 . . . . 73.409999999999997 111.439 -175.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.64 155.36 43.0 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 122.891 2.394 . . . . 45.100000000000001 113.762 -177.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.557 HD11 ' HB3' ' A' ' 199' ' ' ARG . 60.9 mt -127.28 133.45 68.03 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 CA-C-N 115.788 -0.642 . . . . 71.400000000000006 110.588 177.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -70.59 132.98 23.0 Favored Glycine 0 CA--C 1.528 0.868 0 C-N-CA 120.86 -0.686 . . . . 71.549999999999997 112.816 177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.57 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 82.4 m95 -62.31 -22.37 65.99 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 112.269 0.47 . . . . 53.329999999999998 112.269 -178.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -77.55 -11.76 59.89 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 111.962 0.356 . . . . 64.040000000000006 111.962 179.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.478 ' O ' HG23 ' A' ' 177' ' ' VAL . 58.5 m -66.54 134.26 52.02 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.685 0.279 . . . . 74.150000000000006 111.501 -178.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 2.3 m-20 -58.94 130.58 47.7 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 120.821 0.343 . . . . 74.340000000000003 111.141 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.3 tp -60.12 -21.58 22.57 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.77 0 CA-C-O 121.193 0.521 . . . . 35.049999999999997 111.373 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . 0.453 ' HA ' ' HB1' ' A' ' 171' ' ' ALA . 98.9 p -61.16 -26.07 67.45 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 116.064 -0.516 . . . . 65.209999999999994 111.847 178.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.461 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.6 m95 -66.58 -24.72 66.38 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 121.154 0.502 . . . . 65.420000000000002 111.815 178.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 41.2 mt -106.87 21.42 17.55 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 116.021 -0.536 . . . . 74.329999999999998 111.511 -173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 89.7 m -56.86 112.24 1.26 Allowed 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.798 0.666 . . . . 71.329999999999998 112.798 -178.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 84.52 12.49 75.32 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 115.093 0.797 . . . . 33.210000000000001 115.093 172.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -114.44 172.21 7.15 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 118.145 0.972 . . . . 52.43 111.737 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.433 ' HB3' ' CE2' ' A' ' 160' ' ' PHE . 19.0 mp0 -96.28 134.25 39.63 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.095 -0.502 . . . . 75.230000000000004 111.565 -177.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 64.7 mt -118.46 144.67 45.82 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.499 -0.319 . . . . 54.219999999999999 110.815 178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 60.3 m-70 -115.34 116.3 28.05 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.688 0.28 . . . . 63.219999999999999 110.381 174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 197' ' ' VAL . 51.0 t -115.31 127.16 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-O 120.866 0.365 . . . . 73.230000000000004 111.391 -178.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -127.96 161.08 29.95 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 120.993 0.425 . . . . 70.010000000000005 111.427 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 162' ' ' PRO . 16.7 t -90.5 138.32 19.73 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-O 121.078 0.466 . . . . 61.219999999999999 111.583 -176.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 90.2 mt -87.04 -63.98 1.22 Allowed 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 120.977 0.418 . . . . 61.439999999999998 111.389 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 76.3 mm-40 -106.8 168.27 9.3 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 121.161 0.505 . . . . 74.209999999999994 111.519 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -100.06 91.06 4.6 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.983 0.42 . . . . 64.010000000000005 111.099 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.403 HG13 ' O ' ' A' ' 230' ' ' VAL . 5.9 p -147.8 87.94 5.74 Favored Pre-proline 0 CA--C 1.546 0.809 0 CA-C-O 121.481 0.658 . . . . 73.540000000000006 111.674 178.39 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -90.37 162.01 4.53 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.011 2.474 . . . . 74.109999999999999 113.365 177.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.431 ' N ' HD22 ' A' ' 232' ' ' LEU . 3.1 mm? . . . . . 0 C--O 1.256 1.419 0 CA-C-O 118.734 -0.65 . . . . 64.349999999999994 111.651 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 51.3 m80 . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 120.815 0.341 . . . . 75.319999999999993 111.561 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 96.6 mmm -98.84 149.84 36.12 Favored Pre-proline 0 CA--C 1.542 0.657 0 CA-C-N 116.57 -0.286 . . . . 74.200000000000003 110.842 177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -53.68 125.71 19.49 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 122.659 2.239 . . . . 73.319999999999993 113.369 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 150' ' ' LYS . 17.1 ptpt -114.95 150.82 35.13 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.038 0.447 . . . . 72.540000000000006 111.937 -177.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.5 m -77.89 134.89 63.87 Favored Pre-proline 0 N--CA 1.473 0.698 0 CA-C-N 116.057 -0.519 . . . . 62.420000000000002 111.965 -178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -58.18 117.35 4.05 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.675 2.25 . . . . 73.409999999999997 112.716 176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -113.59 -23.93 9.5 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.522 0.564 . . . . 73.219999999999999 112.522 -173.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -66.98 150.96 97.61 Favored Pre-proline 0 CA--C 1.548 0.89 0 N-CA-C 112.372 0.508 . . . . 74.310000000000002 112.372 -173.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -60.08 145.85 97.47 Favored 'Trans proline' 0 N--CA 1.487 1.135 0 C-N-CA 123.321 2.68 . . . . 53.329999999999998 114.55 -172.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 46.5 pt -133.41 168.41 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 115.927 -0.579 . . . . 74.019999999999996 112.268 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 171' ' ' ALA . 63.4 t -133.05 140.3 47.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 116.142 -0.481 . . . . 44.350000000000001 110.289 173.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 58.1 mtt180 -104.23 102.17 11.88 Favored 'General case' 0 N--CA 1.471 0.596 0 CA-C-O 120.801 0.334 . . . . 72.25 111.642 -176.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 181' ' ' LEU . 43.9 t -103.01 141.71 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 120.999 0.428 . . . . 74.319999999999993 111.634 -178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -113.3 113.43 25.26 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.056 0.455 . . . . 73.409999999999997 111.219 178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.413 ' HB3' ' HD2' ' A' ' 162' ' ' PRO . 90.8 mt -85.74 160.76 52.42 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-N 115.866 -0.606 . . . . 74.530000000000001 111.039 -178.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.413 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 25.3 Cg_endo -61.67 169.05 7.49 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.112 1.875 . . . . 74.239999999999995 112.496 176.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.38 32.09 16.99 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 112.12 0.415 . . . . 62.039999999999999 112.12 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 68.7 22.94 7.24 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 113.124 0.787 . . . . 70.200000000000003 113.124 174.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -99.69 163.9 12.28 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 120.886 0.374 . . . . 64.319999999999993 111.595 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 4.4 ppt_? -154.9 165.0 38.06 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 122.006 -0.434 . . . . 74.010000000000005 111.924 176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.8 t -156.01 155.71 33.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.89 0.376 . . . . 64.319999999999993 111.33 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 62.2 t -122.92 120.12 59.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 120.765 0.317 . . . . 75.340000000000003 110.97 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.8 m -113.7 147.89 38.61 Favored Pre-proline 0 CA--C 1.543 0.695 0 N-CA-C 112.084 0.402 . . . . 64.530000000000001 112.084 -176.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -69.02 127.9 15.88 Favored 'Trans proline' 0 CA--C 1.544 1.004 0 C-N-CA 122.371 2.047 . . . . 71.510000000000005 112.91 177.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.538 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -85.78 118.71 25.44 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.003 0.43 . . . . 75.099999999999994 112.046 -177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -136.71 157.07 47.62 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.195 0.521 . . . . 60.240000000000002 111.898 178.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 50.5 t -81.55 144.49 31.25 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.164 -0.471 . . . . 74.409999999999997 110.549 174.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 86.94 -12.47 61.84 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 120.997 -0.621 . . . . 44.439999999999998 112.527 -177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 47.0 t -100.66 116.82 44.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 O-C-N 122.574 -0.368 . . . . 73.239999999999995 110.171 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 p -81.41 161.34 23.77 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.908 0.385 . . . . 62.350000000000001 111.64 -178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 212' ' ' THR . 59.7 t -55.48 -31.63 28.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.644 0 CA-C-O 121.152 0.501 . . . . 71.430000000000007 110.714 174.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.632 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 46.9 ttp85 -72.97 -56.53 5.02 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.118 -0.492 . . . . 60.119999999999997 110.864 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.44 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 23.7 m-20 -61.38 -26.17 67.66 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.958 0.409 . . . . 75.409999999999997 111.742 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.5 t -77.73 -61.8 1.87 Allowed 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.208 -0.451 . . . . 75.319999999999993 111.149 176.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.444 HD21 HG21 ' A' ' 159' ' ' VAL . 66.1 mt -71.89 -21.65 61.62 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.298 0.851 . . . . 71.540000000000006 113.298 -173.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.44 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 20.7 pttp -64.6 -12.22 43.24 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.661 0.664 . . . . 52.210000000000001 111.359 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.5 mtmt -79.07 -49.01 13.33 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 121.028 0.442 . . . . 72.519999999999996 110.143 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -61.06 -39.4 89.71 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 116.101 -0.499 . . . . 74.439999999999998 111.31 177.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 91.2 mt -69.05 -39.35 79.21 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 116.375 -0.375 . . . . 74.519999999999996 111.044 176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 28.1 ttt -58.19 -47.73 82.52 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 120.856 0.36 . . . . 60.549999999999997 111.513 177.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.5 ptm -70.84 -8.11 50.27 Favored 'General case' 0 CA--C 1.547 0.836 0 CA-C-O 120.861 0.362 . . . . 71.239999999999995 111.694 178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.475 ' HA ' ' NE ' ' A' ' 188' ' ' ARG . 3.5 mmp_? -106.65 -15.63 14.72 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 111.901 0.334 . . . . 73.349999999999994 111.901 176.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 82.55 40.35 9.94 Favored Glycine 0 CA--C 1.532 1.114 0 C-N-CA 121.186 -0.53 . . . . 70.510000000000005 112.891 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 93.0 mt -130.87 168.62 16.98 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 122.717 0.407 . . . . 72.010000000000005 111.073 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.484 HD13 HD11 ' A' ' 232' ' ' LEU . 22.5 pt -132.52 149.37 72.88 Favored Pre-proline 0 N--CA 1.472 0.657 0 CA-C-N 116.54 -0.3 . . . . 73.120000000000005 111.406 179.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -46.86 -48.65 13.83 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 123.269 2.646 . . . . 74.340000000000003 114.113 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -72.33 4.75 3.4 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 112.681 0.623 . . . . 73.129999999999995 112.681 -177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 42.4 t -104.94 -8.15 18.81 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.862 0.363 . . . . 43.149999999999999 111.321 174.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.402 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 70.8 m -130.85 166.57 20.59 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 112.14 0.422 . . . . 74.019999999999996 112.14 -175.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.49 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -135.89 121.3 19.27 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 116.431 -0.35 . . . . 75.140000000000001 111.809 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.406 HG22 HG22 ' A' ' 224' ' ' VAL . 57.2 t -95.04 121.74 45.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.905 0.383 . . . . 72.040000000000006 111.558 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.646 ' CE1' ' HG3' ' A' ' 225' ' ' GLU . 27.7 p90 -138.84 142.29 38.65 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.211 0.529 . . . . 73.349999999999994 111.533 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.454 HH11 ' HD3' ' A' ' 199' ' ' ARG . 1.3 ptm180 -110.72 124.43 51.94 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.884 -0.598 . . . . 71.0 110.001 175.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 52.1 mt -91.12 107.51 18.75 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 71.319999999999993 111.668 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -135.19 135.93 41.41 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.1 -0.5 . . . . 61.539999999999999 110.202 -179.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 59.36 27.46 16.56 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.23 0.538 . . . . 73.030000000000001 110.908 -174.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 77.2 -0.14 68.88 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-N 115.879 -0.6 . . . . 25.109999999999999 113.149 -176.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -95.75 126.22 40.87 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 122.815 0.446 . . . . 73.129999999999995 112.167 -175.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.424 ' O ' ' HD3' ' A' ' 207' ' ' PRO . 97.5 mttt -76.98 98.82 5.07 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 120.668 0.27 . . . . 63.240000000000002 110.369 170.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -90.1 107.29 18.49 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 116.675 -0.238 . . . . 62.119999999999997 111.219 178.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.424 ' HD3' ' O ' ' A' ' 205' ' ' LYS . 3.2 Cg_exo -75.31 129.1 11.77 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.776 2.317 . . . . 65.319999999999993 111.95 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.613 HG21 HD11 ' A' ' 217' ' ' LEU . 3.9 mp -98.89 122.39 50.56 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 CA-C-N 116.74 -0.209 . . . . 63.399999999999999 110.939 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -54.51 126.7 38.02 Favored Glycine 0 CA--C 1.524 0.605 0 C-N-CA 120.714 -0.755 . . . . 54.340000000000003 111.782 172.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.632 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 69.4 m95 -55.06 -33.49 62.76 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.686 0.624 . . . . 73.209999999999994 112.686 -173.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 35.8 m-20 -86.47 17.68 3.69 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 112.897 0.703 . . . . 74.340000000000003 112.897 179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.411 ' O ' HG23 ' A' ' 177' ' ' VAL . 37.4 m -88.8 140.03 29.86 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.231 -0.293 . . . . 62.310000000000002 110.663 173.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.483 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 5.9 m-20 -57.58 125.68 23.98 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.077 0.399 . . . . 74.329999999999998 112.077 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.436 HG13 HG21 ' A' ' 157' ' ' VAL . 10.9 tp -59.45 -21.83 21.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 CA-C-O 121.407 0.622 . . . . 74.25 110.965 177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 31.7 t -55.34 -27.88 50.1 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 115.57 -0.741 . . . . 44.240000000000002 112.092 175.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.483 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -77.44 -7.02 55.51 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 111.859 0.318 . . . . 73.310000000000002 111.859 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.613 HD11 HG21 ' A' ' 208' ' ' ILE . 36.8 mt -122.15 22.34 10.22 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 121.283 0.563 . . . . 71.030000000000001 110.892 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' HG22 ' A' ' 157' ' ' VAL . 85.4 m -62.03 127.28 30.63 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 113.135 0.791 . . . . 62.32 113.135 -174.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 76.63 11.8 84.96 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 115.393 0.917 . . . . 74.420000000000002 115.393 170.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -126.83 173.26 9.7 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 118.244 1.022 . . . . 74.409999999999997 112.531 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -88.25 126.74 35.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.678 -0.692 . . . . 64.030000000000001 112.332 -172.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 89.6 mt -111.12 141.5 44.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.952 -0.567 . . . . 73.109999999999999 109.911 171.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -120.33 142.57 49.01 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.088 -0.382 . . . . 73.319999999999993 110.516 178.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 196' ' ' ALA . 70.7 t -118.09 126.43 74.93 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 N-CA-C 113.051 0.76 . . . . 71.349999999999994 113.051 -178.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.646 ' HG3' ' CE1' ' A' ' 198' ' ' TYR . 34.2 mt-10 -101.28 164.75 11.63 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 116.133 -0.485 . . . . 72.200000000000003 110.886 171.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 57.9 t -100.26 119.88 48.95 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-O 120.819 0.342 . . . . 53.539999999999999 111.48 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.49 HD21 ' HB2' ' A' ' 196' ' ' ALA . 84.1 mt -68.35 -63.66 1.02 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.029 0.442 . . . . 53.399999999999999 110.639 177.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -138.12 145.76 42.01 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 116.002 -0.545 . . . . 73.140000000000001 110.071 175.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 3.0 p-10 -76.44 80.01 3.16 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.347 0.594 . . . . 62.329999999999998 112.03 -179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 47.7 t -125.93 88.66 53.87 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 120.96 0.409 . . . . 72.420000000000002 111.767 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -93.18 101.23 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.906 2.404 . . . . 74.239999999999995 112.194 175.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.484 HD11 HD13 ' A' ' 191' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.162 0 CA-C-O 118.283 -0.865 . . . . 75.400000000000006 112.368 -178.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 31.0 m80 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.317 0.58 . . . . 71.450000000000003 111.818 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.1 ppp? -157.04 149.01 17.46 Favored Pre-proline 0 CA--C 1.54 0.575 0 CA-C-N 115.391 -0.822 . . . . 53.219999999999999 109.811 173.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.86 116.71 3.72 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 122.192 1.928 . . . . 73.439999999999998 113.152 -176.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 19.7 ptmt -76.8 20.04 0.26 Allowed 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 111.979 0.363 . . . . 73.420000000000002 111.979 -179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 39.8 t 72.83 86.74 0.1 Allowed Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.432 0.693 . . . . 74.420000000000002 112.204 178.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -81.72 58.01 6.59 Favored 'Trans proline' 0 CA--C 1.542 0.903 0 C-N-CA 122.948 2.432 . . . . 73.519999999999996 112.455 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 153' ' ' GLN . 59.5 tt0 62.78 22.8 13.6 Favored 'General case' 0 CA--C 1.549 0.938 0 CA-C-O 121.434 0.635 . . . . 64.349999999999994 111.006 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.6 pptp? -63.38 143.04 97.87 Favored Pre-proline 0 CA--C 1.544 0.73 0 CA-C-N 116.103 -0.498 . . . . 75.430000000000007 111.715 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -65.41 147.08 86.88 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.538 2.158 . . . . 71.239999999999995 112.294 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.5 pt -133.01 166.04 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 N-CA-C 113.232 0.827 . . . . 62.310000000000002 113.232 -175.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 62.0 t -133.69 128.12 53.72 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 114.821 -1.081 . . . . 63.520000000000003 109.334 172.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.536 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 83.8 mtt180 -91.45 97.29 10.98 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 120.987 0.422 . . . . 62.420000000000002 111.488 -176.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.523 HG22 HD12 ' A' ' 222' ' ' LEU . 44.7 t -95.69 112.55 28.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 N-CA-C 112.17 0.434 . . . . 75.310000000000002 112.17 -176.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -80.6 119.6 23.45 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.022 0.439 . . . . 71.409999999999997 110.945 173.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.458 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 93.1 mt -95.99 159.44 32.26 Favored Pre-proline 0 CA--C 1.54 0.569 0 CA-C-N 116.213 -0.449 . . . . 65.299999999999997 111.304 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.539 ' HG3' ' HA ' ' A' ' 225' ' ' GLU . 70.8 Cg_exo -52.27 162.87 1.86 Allowed 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.537 2.158 . . . . 74.340000000000003 113.068 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 59.0 t30 65.96 28.97 10.44 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-O 121.162 0.506 . . . . 73.299999999999997 110.961 -178.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 73.0 mmtt 65.64 19.45 11.45 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.58 0.585 . . . . 73.109999999999999 112.58 178.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.458 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 88.3 mm-40 -84.04 171.87 12.53 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.087 0.47 . . . . 63.509999999999998 111.606 -178.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 166' ' ' ARG . 22.2 ptt-85 -160.34 140.56 11.51 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 121.015 0.436 . . . . 72.310000000000002 111.845 -179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.0 t -139.53 141.54 37.27 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.027 0.442 . . . . 75.349999999999994 111.209 176.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 60.6 t -105.94 119.23 54.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-O 121.026 0.441 . . . . 75.409999999999997 110.887 178.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.8 m -119.83 149.08 47.84 Favored Pre-proline 0 CA--C 1.538 0.514 0 CA-C-N 116.446 -0.343 . . . . 73.219999999999999 111.582 -177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.17 144.84 82.78 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 122.413 2.076 . . . . 63.310000000000002 113.18 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -78.25 113.06 15.86 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-O 121.198 0.523 . . . . 74.019999999999996 111.314 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.447 ' H ' HG23 ' A' ' 214' ' ' ILE . 59.6 mtt180 -115.63 136.46 53.05 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 121.273 0.558 . . . . 53.32 112.421 -173.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 37.2 t -99.94 133.64 44.01 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 115.832 -0.622 . . . . 72.140000000000001 110.518 177.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 90.18 -21.32 31.95 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.683 -0.77 . . . . 40.450000000000003 112.327 -176.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 59.7 t -97.45 125.09 50.65 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.005 0.431 . . . . 61.149999999999999 110.384 175.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.413 ' HB ' ' O ' ' A' ' 210' ' ' TRP . 44.3 p -72.95 156.13 39.16 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.305 -0.407 . . . . 74.140000000000001 111.492 -178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.8 t -50.73 -36.03 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 CA-C-O 121.396 0.617 . . . . 74.219999999999999 110.535 175.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.649 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 42.9 ttt180 -60.39 -59.59 5.16 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 115.388 -0.824 . . . . 73.099999999999994 111.905 178.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -70.78 -18.19 62.76 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.081 0.467 . . . . 71.129999999999995 111.398 -174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 23.2 t -82.13 -37.33 26.42 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 120.872 0.367 . . . . 63.340000000000003 111.51 176.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 91.9 mt -97.21 2.34 50.81 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 112.209 0.448 . . . . 75.230000000000004 112.209 -179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 18.7 ptmt -52.55 -33.24 44.72 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.26 0.467 . . . . 75.319999999999993 112.26 -177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.493 ' NZ ' ' HB3' ' A' ' 183' ' ' LYS . 6.9 mtpm? -79.36 -37.83 36.48 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 120.794 0.33 . . . . 74.219999999999999 111.289 178.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.501 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -62.96 -46.23 88.72 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.14 0.495 . . . . 42.520000000000003 111.086 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.7 -44.49 96.83 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.189 -0.46 . . . . 63.420000000000002 110.694 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.8 ttt -53.08 -53.36 51.43 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.909 -0.587 . . . . 71.219999999999999 111.88 178.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.0 ptp -68.69 -14.14 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.474 0.546 . . . . 74.010000000000005 112.474 -177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.501 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 32.5 mmt180 -100.5 -8.22 23.34 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 122.224 -0.298 . . . . 75.230000000000004 111.671 177.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 79.33 18.1 74.75 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 121.213 -0.517 . . . . 64.310000000000002 112.855 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -101.74 156.8 17.28 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-O 121.085 0.469 . . . . 71.519999999999996 111.553 -177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 19.2 pt -127.23 138.29 32.44 Favored Pre-proline 0 CA--C 1.538 0.489 0 CA-C-N 116.148 -0.478 . . . . 74.310000000000002 110.73 176.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.08 -39.71 84.52 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 122.944 2.429 . . . . 70.439999999999998 113.56 -174.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -65.03 -19.53 66.04 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.821 0.343 . . . . 73.129999999999995 111.888 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.546 ' SG ' ' HB2' ' A' ' 228' ' ' GLU . 42.3 t -111.7 20.29 17.22 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.092 0.472 . . . . 71.349999999999994 111.387 -179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 71.3 m -137.49 137.26 38.49 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 121.061 0.458 . . . . 71.049999999999997 111.252 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.413 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.54 123.67 50.37 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 116.389 -0.368 . . . . 54.420000000000002 111.65 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 224' ' ' VAL . 43.1 t -99.95 138.19 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 CA-C-N 116.452 -0.34 . . . . 75.5 110.852 176.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -146.44 151.3 37.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.999 0.428 . . . . 75.329999999999998 110.967 174.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.509 ' HB3' HD11 ' A' ' 208' ' ' ILE . 16.8 ptt-85 -120.01 152.58 37.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.335 -0.393 . . . . 72.329999999999998 110.681 179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.548 HG12 ' HG2' ' A' ' 205' ' ' LYS . 37.6 mt -106.35 86.01 0.88 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-O 121.394 0.616 . . . . 74.099999999999994 110.11 177.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -104.97 120.47 41.54 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.654 -0.703 . . . . 60.43 110.38 -176.721 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 53.1 m-20 59.34 30.89 20.67 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-O 121.081 0.467 . . . . 60.020000000000003 111.701 -178.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.72 -9.24 77.87 Favored Glycine 0 CA--C 1.528 0.859 0 CA-C-N 116.327 -0.397 . . . . 51.409999999999997 113.628 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 206' ' ' LYS . 37.9 mm-40 -95.26 125.4 39.87 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 112.358 0.503 . . . . 73.349999999999994 112.358 -176.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.548 ' HG2' HG12 ' A' ' 200' ' ' ILE . 98.7 mttt -84.36 96.27 9.0 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 120.902 0.382 . . . . 71.120000000000005 110.221 172.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.407 ' HD3' ' HB3' ' A' ' 204' ' ' GLU . 12.8 mptt -104.58 129.68 24.56 Favored Pre-proline 0 CA--C 1.541 0.613 0 CA-C-N 116.374 -0.376 . . . . 73.420000000000002 111.989 -177.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.3 125.56 11.45 Favored 'Trans proline' 0 C--N 1.353 0.793 0 C-N-CA 122.892 2.394 . . . . 54.43 113.063 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 199' ' ' ARG . 68.5 mt -97.67 126.08 50.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 116.139 -0.482 . . . . 55.409999999999997 111.357 -179.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -76.46 136.21 18.83 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 121.153 -0.546 . . . . 54.119999999999997 112.46 176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.649 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 98.9 m95 -59.6 -21.0 59.77 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 121.182 0.515 . . . . 72.530000000000001 111.464 178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -79.02 -12.52 60.03 Favored 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 115.549 -0.75 . . . . 72.209999999999994 112.671 179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 53.1 m -79.27 145.83 33.33 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 120.773 0.32 . . . . 63.119999999999997 111.762 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.441 ' HB2' ' CD1' ' A' ' 216' ' ' TRP . 3.0 m-20 -64.19 134.41 54.75 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.98 0.419 . . . . 73.540000000000006 111.5 176.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.447 HG23 ' H ' ' A' ' 172' ' ' ARG . 10.1 tt -67.56 -19.11 24.77 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-O 121.038 0.447 . . . . 73.329999999999998 111.218 177.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 88.5 p -60.26 -29.23 68.65 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 112.203 0.446 . . . . 61.439999999999998 112.203 178.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 19.5 m95 -60.01 -27.0 66.52 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.395 0.617 . . . . 73.239999999999995 111.125 175.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 20.3 mt -104.69 15.54 27.75 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 115.643 -0.708 . . . . 73.329999999999998 111.772 -171.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.4 m -56.3 109.43 0.6 Allowed 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.664 0.616 . . . . 71.230000000000004 112.664 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 103.79 -17.06 50.32 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 114.79 0.676 . . . . 54.399999999999999 114.79 174.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -98.62 173.41 6.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 118.025 0.913 . . . . 73.540000000000006 112.501 -175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.536 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 35.8 mt-10 -105.59 124.4 49.49 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 115.886 -0.597 . . . . 65.430000000000007 111.868 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.523 HD12 HG22 ' A' ' 159' ' ' VAL . 47.5 mt -98.3 160.14 14.48 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.031 0.443 . . . . 72.319999999999993 111.462 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -129.56 120.04 24.67 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 116.525 -0.307 . . . . 54.310000000000002 110.648 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.584 HG22 HG22 ' A' ' 197' ' ' VAL . 24.5 t -116.12 138.32 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.79 0.329 . . . . 53.329999999999998 111.507 -178.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.539 ' HA ' ' HG3' ' A' ' 162' ' ' PRO . 9.9 pt-20 -138.76 152.91 48.34 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 120.959 0.409 . . . . 74.430000000000007 111.598 175.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 45.8 t -81.71 143.52 12.05 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.887 0.375 . . . . 71.25 111.713 -177.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.413 HD21 ' HB2' ' A' ' 196' ' ' ALA . 87.9 mt -84.75 -60.25 2.11 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.18 0.514 . . . . 73.040000000000006 110.982 177.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . 0.546 ' HB2' ' SG ' ' A' ' 194' ' ' CYS . 41.7 mt-10 -76.78 94.61 3.88 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.941 0.401 . . . . 75.319999999999993 111.16 177.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -70.57 79.35 0.58 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.503 0.668 . . . . 74.120000000000005 110.32 175.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.58 163.04 43.23 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-N 115.652 -0.704 . . . . 71.150000000000006 111.131 -177.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.03 119.64 6.61 Favored 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.33 2.02 . . . . 64.0 112.497 174.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 7.5 mp . . . . . 0 C--O 1.253 1.271 0 CA-C-O 118.636 -0.697 . . . . 70.230000000000004 110.903 175.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 30.5 p80 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 111.552 0.205 . . . . 72.409999999999997 111.552 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 60.6 mtm 66.27 149.44 0.12 Allowed Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 122.891 0.476 . . . . 71.150000000000006 112.251 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -65.89 164.7 26.17 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 122.81 2.34 . . . . 63.009999999999998 113.174 176.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.58 8.21 17.5 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 116.382 -0.372 . . . . 42.420000000000002 111.665 179.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 51.0 m -68.99 113.95 19.86 Favored Pre-proline 0 N--CA 1.474 0.752 0 N-CA-C 112.25 0.463 . . . . 53.049999999999997 112.25 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.422 ' HB2' ' HG3' ' A' ' 154' ' ' LYS . 41.1 Cg_endo -100.72 -176.47 0.15 Allowed 'Trans proline' 0 CA--C 1.545 1.053 0 C-N-CA 123.51 2.807 . . . . 61.439999999999998 113.891 177.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -109.64 18.28 20.44 Favored 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 121.419 0.628 . . . . 63.299999999999997 110.458 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.422 ' HG3' ' HB2' ' A' ' 152' ' ' PRO . 66.9 mttm -73.47 157.76 87.43 Favored Pre-proline 0 CA--C 1.545 0.786 0 CA-C-N 115.654 -0.703 . . . . 74.340000000000003 112.098 -176.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.421 ' HD2' ' HB3' ' A' ' 154' ' ' LYS . 41.7 Cg_endo -65.25 146.7 86.85 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.679 2.252 . . . . 72.25 113.368 -178.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.538 HD12 HG11 ' A' ' 168' ' ' VAL . 40.0 pt -130.06 167.82 24.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 CA-C-O 121.455 0.645 . . . . 75.040000000000006 112.634 -177.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 58.6 t -130.82 133.66 62.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.474 -0.785 . . . . 61.229999999999997 109.968 173.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 221' ' ' GLU . 57.5 mtp180 -105.09 106.17 16.54 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 121.121 0.486 . . . . 71.319999999999993 111.594 -172.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 46.7 t -109.57 128.83 65.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.673 0 N-CA-C 112.541 0.571 . . . . 73.409999999999997 112.541 -173.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -96.56 115.12 26.9 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.24 -0.436 . . . . 75.099999999999994 110.93 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.471 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -89.97 155.45 47.4 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-N 116.14 -0.482 . . . . 74.209999999999994 111.65 -176.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -65.46 141.55 68.07 Favored 'Trans proline' 0 CA--C 1.54 0.823 0 C-N-CA 122.6 2.2 . . . . 64.099999999999994 113.346 -177.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 72.57 65.6 0.12 Allowed 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.788 0.835 . . . . 62.450000000000003 112.676 177.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 96.7 mttt 58.2 41.38 23.71 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 113.013 0.746 . . . . 74.329999999999998 113.013 171.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.471 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.3 mm-40 -129.06 152.76 48.31 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.23 0.538 . . . . 53.549999999999997 111.831 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.412 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 0.9 OUTLIER -157.41 146.44 19.84 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-N 116.03 -0.532 . . . . 74.450000000000003 110.572 178.879 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 9.8 t -156.32 147.44 22.24 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.178 0.513 . . . . 64.239999999999995 111.821 177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.538 HG11 HD12 ' A' ' 156' ' ' ILE . 99.3 t -109.92 122.34 64.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-N 116.11 -0.495 . . . . 63.039999999999999 111.372 177.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.487 HG23 HD11 ' A' ' 214' ' ' ILE . 12.2 m -118.25 138.04 25.22 Favored Pre-proline 0 CA--C 1.544 0.738 0 CA-C-N 116.35 -0.386 . . . . 71.040000000000006 111.553 -178.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 34.0 Cg_exo -60.8 139.33 84.72 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 122.93 2.42 . . . . 54.0 113.946 -178.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -83.29 103.91 13.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.24 -0.436 . . . . 62.310000000000002 111.648 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -124.39 141.87 51.74 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 116.451 -0.34 . . . . 62.240000000000002 111.271 -178.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.2 t -74.98 151.04 38.83 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.667 0.27 . . . . 53.210000000000001 110.771 175.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.11 -37.18 3.01 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 121.011 -0.614 . . . . 51.130000000000003 112.572 -177.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.463 ' O ' HG22 ' A' ' 214' ' ' ILE . 55.8 t -80.41 113.3 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-O 120.911 0.386 . . . . 74.230000000000004 110.582 176.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 72.0 p -75.83 159.78 30.64 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.547 -0.297 . . . . 55.140000000000001 111.454 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -30.45 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.611 0.72 . . . . 43.25 110.565 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.548 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 51.3 ttt180 -66.68 -48.65 68.66 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 115.533 -0.758 . . . . 71.340000000000003 111.337 176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.456 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 5.2 t70 -75.86 -24.23 55.72 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 73.230000000000004 111.679 -176.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 92.8 p -74.0 -48.58 29.26 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 121.024 0.44 . . . . 73.040000000000006 111.154 178.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 93.9 mt -85.62 -4.02 59.04 Favored 'General case' 0 CA--C 1.543 0.71 0 N-CA-C 112.858 0.688 . . . . 63.32 112.858 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 18.0 ptmt -53.86 -45.49 70.99 Favored 'General case' 0 CA--C 1.547 0.858 0 N-CA-C 111.868 0.321 . . . . 54.25 111.868 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 38.3 mtmm -78.17 -25.79 47.35 Favored 'General case' 0 CA--C 1.54 0.586 0 O-C-N 122.143 -0.348 . . . . 70.140000000000001 111.675 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -67.62 -37.63 82.79 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.225 0.536 . . . . 74.25 110.857 176.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 90.8 mt -79.09 -31.74 44.41 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.191 -0.459 . . . . 63.200000000000003 110.808 174.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -54.97 -47.84 74.03 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 116.505 -0.316 . . . . 74.200000000000003 111.27 176.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.9 ptp -68.66 -7.88 37.28 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 112.125 0.417 . . . . 71.010000000000005 112.125 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 75.8 mtp180 -101.3 -16.22 17.01 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-O 120.887 0.375 . . . . 74.319999999999993 111.163 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 85.4 30.15 25.54 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.305 -0.474 . . . . 62.310000000000002 112.727 -176.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 89.0 mt -119.8 173.55 6.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.867 0.365 . . . . 54.210000000000001 111.496 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.74 146.37 56.89 Favored Pre-proline 0 N--CA 1.472 0.626 0 CA-C-N 116.437 -0.347 . . . . 64.109999999999999 110.693 175.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.7 -41.82 74.25 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.604 2.203 . . . . 73.109999999999999 113.61 -177.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . 0.421 ' CD ' HH21 ' A' ' 178' ' ' ARG . 1.4 mp0 -63.63 -12.11 30.81 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.524 0.564 . . . . 75.120000000000005 112.524 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.5 t -90.54 -8.4 50.37 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-O 120.93 0.395 . . . . 71.230000000000004 111.563 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.6 m -123.5 171.75 9.25 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.27 0.557 . . . . 64.239999999999995 112.055 -177.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.425 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -143.68 129.72 19.61 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.43 -0.35 . . . . 71.439999999999998 111.286 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 224' ' ' VAL . 54.3 t -95.26 121.05 45.47 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-N 116.516 -0.311 . . . . 65.420000000000002 111.097 178.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 207' ' ' PRO . 17.9 p90 -132.27 145.11 51.07 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.178 0.513 . . . . 75.25 111.254 176.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.541 ' HG2' HD11 ' A' ' 208' ' ' ILE . 40.2 ptt180 -122.83 161.37 24.16 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.046 0.45 . . . . 74.439999999999998 111.163 177.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 205' ' ' LYS . 52.7 mt -110.14 101.62 12.81 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-N 116.147 -0.479 . . . . 70.409999999999997 110.682 177.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -120.29 123.78 44.0 Favored 'General case' 0 CA--C 1.536 0.43 0 CA-C-N 115.994 -0.548 . . . . 65.239999999999995 110.543 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 58.66 30.45 19.92 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.202 0.525 . . . . 74.510000000000005 110.948 -174.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 84.16 -12.41 54.45 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 116.036 -0.529 . . . . 75.019999999999996 113.361 -177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -83.8 120.33 25.91 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 112.15 0.426 . . . . 75.120000000000005 112.15 -176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.481 ' HG2' HG12 ' A' ' 200' ' ' ILE . 87.5 mttt -86.34 101.41 13.07 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 116.285 -0.416 . . . . 72.530000000000001 110.535 172.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -121.9 120.88 28.31 Favored Pre-proline 0 CA--C 1.541 0.6 0 CA-C-O 120.611 0.243 . . . . 63.200000000000003 111.432 -177.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 198' ' ' TYR . 16.5 Cg_exo -69.62 126.15 13.07 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.714 2.276 . . . . 71.310000000000002 113.319 177.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.541 HD11 ' HG2' ' A' ' 199' ' ' ARG . 3.6 mp -86.63 131.68 34.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 116.404 -0.362 . . . . 65.409999999999997 110.381 176.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -63.55 133.16 41.53 Favored Glycine 0 CA--C 1.529 0.938 0 C-N-CA 120.79 -0.719 . . . . 54.219999999999999 112.937 179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.548 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -57.74 -22.05 44.51 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-O 121.071 0.462 . . . . 71.420000000000002 111.936 179.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -75.12 -10.74 59.75 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.426 0.528 . . . . 70.409999999999997 112.426 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 16.9 m -75.21 137.93 41.6 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 111.783 0.29 . . . . 71.310000000000002 111.783 -177.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.04 130.26 44.73 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-O 120.875 0.369 . . . . 73.519999999999996 111.008 175.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.487 HD11 HG23 ' A' ' 169' ' ' VAL . 9.8 tt -60.99 -23.67 30.51 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.014 0.435 . . . . 65.049999999999997 111.96 -177.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 80.9 p -59.12 -24.98 63.45 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.295 0.48 . . . . 72.219999999999999 112.295 -179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 13.4 m95 -67.27 -27.48 67.23 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 111.961 0.356 . . . . 73.530000000000001 111.961 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.491 HD11 HG21 ' A' ' 208' ' ' ILE . 51.3 mt -109.09 37.81 2.47 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.239 0.542 . . . . 74.519999999999996 111.712 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 97.6 m -67.36 120.2 13.47 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.73 0.641 . . . . 73.340000000000003 112.73 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 91.17 -6.18 81.32 Favored Glycine 0 CA--C 1.529 0.917 0 N-CA-C 115.255 0.862 . . . . 74.420000000000002 115.255 170.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -97.65 172.1 7.92 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 118.187 0.993 . . . . 65.219999999999999 111.989 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.458 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 41.4 mt-10 -108.61 114.52 28.4 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 115.941 -0.572 . . . . 74.209999999999994 111.635 -177.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 83.2 mt -94.81 157.53 15.89 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 121.102 0.477 . . . . 73.010000000000005 111.694 -178.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 74.0 m-70 -127.85 134.03 49.4 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 116.494 -0.321 . . . . 73.200000000000003 110.152 177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 197' ' ' VAL . 48.0 t -119.74 136.05 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 112.371 0.508 . . . . 74.230000000000004 112.371 -176.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -122.67 173.93 7.41 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 116.186 -0.461 . . . . 75.519999999999996 110.597 173.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 60.6 t -100.37 129.0 51.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.77 0.319 . . . . 72.310000000000002 111.668 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.425 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.0 mt -76.92 -78.22 0.13 Allowed 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.629 0.252 . . . . 43.299999999999997 111.425 178.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -106.63 100.91 10.4 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.708 0.29 . . . . 71.129999999999995 110.862 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 43.7 t-20 -75.86 76.19 2.79 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 121.255 0.55 . . . . 52.130000000000003 110.107 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 26.8 m -132.69 144.25 52.12 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 112.192 0.441 . . . . 61.539999999999999 112.192 -175.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.74 96.76 1.11 Allowed 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.178 1.919 . . . . 75.129999999999995 110.809 168.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 36.4 tp . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.828 -0.606 . . . . 64.450000000000003 112.172 -173.308 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.6 p-80 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 112.309 0.485 . . . . 73.239999999999995 112.309 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 69.2 mtm 65.49 111.4 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.76 0 C-N-CA 122.905 0.482 . . . . 51.049999999999997 112.219 -178.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -52.4 127.08 22.67 Favored 'Trans proline' 0 CA--C 1.537 0.671 0 C-N-CA 122.375 2.05 . . . . 63.140000000000001 112.149 174.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.65 ' HA ' ' HE2' ' A' ' 150' ' ' LYS . 11.1 mmpt? -103.59 150.1 24.28 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-O 121.046 0.45 . . . . 62.439999999999998 112.126 -174.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 41.3 t -95.45 96.48 2.2 Favored Pre-proline 0 N--CA 1.472 0.634 0 CA-C-N 116.097 -0.501 . . . . 65.310000000000002 109.956 170.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 150' ' ' LYS . 7.6 Cg_exo -72.94 107.64 2.4 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.773 2.315 . . . . 52.049999999999997 113.735 -171.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -87.81 88.92 7.8 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 121.543 0.687 . . . . 72.409999999999997 110.06 173.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 152' ' ' PRO . 96.4 mttt -89.69 154.29 48.07 Favored Pre-proline 0 CA--C 1.54 0.572 0 N-CA-C 112.581 0.586 . . . . 73.140000000000001 112.581 -171.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -59.22 136.46 72.69 Favored 'Trans proline' 0 C--N 1.354 0.863 0 C-N-CA 122.956 2.437 . . . . 51.149999999999999 113.096 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.9 pt -123.93 162.71 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 CA-C-O 121.455 0.645 . . . . 73.140000000000001 112.566 -176.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.414 HG23 ' HB2' ' A' ' 171' ' ' ALA . 47.3 t -130.88 130.47 64.23 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.549 -0.75 . . . . 73.239999999999995 109.847 173.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 69.4 mtt-85 -98.66 101.16 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 120.987 0.422 . . . . 71.310000000000002 111.597 -174.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.61 HG22 HD12 ' A' ' 222' ' ' LEU . 42.9 t -96.3 117.54 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.922 0.391 . . . . 64.400000000000006 111.964 -176.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -91.75 117.57 29.89 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.967 0.413 . . . . 74.519999999999996 111.196 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 88.0 mt -97.68 160.17 29.25 Favored Pre-proline 0 CA--C 1.542 0.665 0 CA-C-N 116.274 -0.421 . . . . 72.120000000000005 111.431 -177.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -64.76 173.02 6.12 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.397 2.065 . . . . 72.120000000000005 112.324 174.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 64.34 28.31 13.74 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 120.999 0.428 . . . . 73.239999999999995 111.72 -179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm 64.13 34.86 10.74 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 115.891 -0.595 . . . . 71.209999999999994 111.964 178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -110.33 160.76 16.27 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.003 0.43 . . . . 74.329999999999998 111.465 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 18.9 ptp180 -156.62 153.73 29.04 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.825 0.345 . . . . 74.310000000000002 111.182 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.7 t -152.11 137.31 17.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 121.058 0.456 . . . . 72.299999999999997 111.843 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 96.4 t -104.77 120.78 55.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.39 -0.368 . . . . 72.010000000000005 110.553 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 17.6 m -117.36 151.77 48.43 Favored Pre-proline 0 CA--C 1.543 0.697 0 N-CA-C 111.871 0.323 . . . . 53.109999999999999 111.871 -176.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.79 129.18 13.2 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 122.562 2.175 . . . . 53.100000000000001 113.357 -179.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.414 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -78.79 112.31 15.8 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 116.219 -0.446 . . . . 41.350000000000001 111.493 178.119 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -126.67 159.59 33.2 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 122.534 0.334 . . . . 74.409999999999997 111.452 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 51.0 t -95.28 147.54 23.38 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.688 0.28 . . . . 75.530000000000001 110.533 175.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 85.14 -25.3 6.21 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.696 -0.764 . . . . 63.520000000000003 112.262 -174.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 44.1 t -93.58 111.82 25.55 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-O 121.048 0.451 . . . . 74.340000000000003 110.528 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 76.6 p -75.91 157.71 32.9 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.267 -0.424 . . . . 53.43 111.594 -179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 56.8 t -53.8 -40.9 45.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 CA-C-O 121.261 0.553 . . . . 41.340000000000003 110.782 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.592 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 48.2 ttp180 -61.25 -37.81 84.45 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 115.571 -0.74 . . . . 72.439999999999998 111.424 178.043 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -76.47 -53.85 7.54 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.967 -0.56 . . . . 71.329999999999998 111.518 -177.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 41.7 t -57.94 -41.14 82.17 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.222 0.453 . . . . 73.239999999999995 112.222 -178.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.408 HD21 HG21 ' A' ' 159' ' ' VAL . 69.9 mt -80.76 6.57 12.55 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.957 0.725 . . . . 74.420000000000002 112.957 -177.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.411 ' HB3' ' NZ ' ' A' ' 182' ' ' LYS . 0.1 OUTLIER -55.06 -36.64 65.8 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-O 120.992 0.425 . . . . 74.140000000000001 110.878 179.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -67.35 -37.45 83.25 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.231 -0.441 . . . . 61.130000000000003 111.571 177.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -70.62 -50.9 32.15 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.986 0.422 . . . . 44.340000000000003 110.899 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 190' ' ' LEU . 88.4 mt -55.45 -42.91 74.91 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.87 -0.605 . . . . 75.030000000000001 111.241 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 52.6 ttm -59.45 -57.16 14.21 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 116.179 -0.464 . . . . 72.230000000000004 111.779 178.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.2 ptt? -68.8 -23.13 64.24 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.462 0.541 . . . . 65.439999999999998 112.462 -176.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 28.2 mmt180 -103.99 3.32 33.32 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 112.794 0.665 . . . . 73.340000000000003 112.794 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 59.04 48.5 85.6 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 121.149 -0.548 . . . . 73.310000000000002 113.559 177.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.475 ' O ' ' HB3' ' A' ' 185' ' ' LEU . 89.3 mt -127.5 159.84 33.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.899 0.381 . . . . 52.119999999999997 111.467 -178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 14.2 pt -138.74 154.79 73.33 Favored Pre-proline 0 CA--C 1.546 0.808 0 CA-C-N 116.491 -0.322 . . . . 75.010000000000005 111.168 177.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -50.12 -31.86 29.85 Favored 'Trans proline' 0 CA--C 1.545 1.028 0 C-N-CA 123.188 2.592 . . . . 71.329999999999998 114.525 -176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -84.65 -15.3 45.89 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.992 -0.443 . . . . 72.140000000000001 112.135 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.8 t -97.18 -8.74 29.29 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 112.014 0.375 . . . . 74.409999999999997 112.014 179.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.403 ' SG ' HD22 ' A' ' 190' ' ' LEU . 77.7 m -142.55 149.33 38.95 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-O 121.0 0.429 . . . . 74.140000000000001 111.869 -177.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . . . . . . . . . . . -119.79 134.53 55.2 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.29 -0.414 . . . . 54.32 111.429 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 224' ' ' VAL . 34.1 t -108.4 125.05 65.19 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 122.529 0.331 . . . . 53.32 111.075 178.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 51.5 p90 -139.9 152.0 46.07 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 120.89 0.376 . . . . 73.120000000000005 111.338 177.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 199' ' ' ARG . 6.8 ptt180 -122.92 154.97 37.64 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 110.321 -0.251 . . . . 74.5 110.321 178.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.53 ' HA ' ' O ' ' A' ' 204' ' ' GLU . 51.6 mt -110.85 131.4 62.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 CA-C-O 121.211 0.529 . . . . 74.430000000000007 111.84 -174.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.673 ' O ' ' HG2' ' A' ' 204' ' ' GLU . 27.1 tt0 -137.7 119.62 15.35 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 116.093 -0.503 . . . . 72.519999999999996 110.79 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 57.46 16.28 3.18 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 112.144 0.424 . . . . 71.420000000000002 112.144 -178.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 107.59 -10.02 38.33 Favored Glycine 0 CA--C 1.534 1.226 0 C-N-CA 121.331 -0.461 . . . . 62.039999999999999 114.159 -179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . 0.673 ' HG2' ' O ' ' A' ' 201' ' ' GLN . 12.3 pt-20 -88.02 134.66 33.69 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 117.948 0.874 . . . . 75.549999999999997 111.924 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 99.7 mttt -97.74 103.81 15.78 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.455 -0.338 . . . . 72.25 110.425 173.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -100.49 113.7 65.56 Favored Pre-proline 0 CA--C 1.539 0.526 0 N-CA-C 111.905 0.335 . . . . 75.540000000000006 111.905 -178.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -64.04 113.07 2.05 Favored 'Trans proline' 0 C--N 1.354 0.817 0 C-N-CA 122.969 2.446 . . . . 51.109999999999999 112.14 176.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -86.71 129.25 38.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.326 -0.397 . . . . 70.329999999999998 111.484 -177.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.55 126.13 21.4 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 120.678 -0.773 . . . . 62.049999999999997 112.259 175.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.592 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 73.7 m95 -52.05 -28.69 18.22 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.84 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -82.74 14.94 2.87 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 112.751 0.649 . . . . 72.099999999999994 112.751 -177.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 56.6 m -93.28 140.74 29.21 Favored 'General case' 0 N--CA 1.475 0.781 0 O-C-N 122.031 -0.418 . . . . 75.129999999999995 111.707 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -59.85 122.12 13.45 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-O 120.98 0.419 . . . . 63.450000000000003 111.223 176.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 15.5 tt -63.0 -19.51 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.597 0.591 . . . . 52.310000000000002 112.597 -174.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 33.8 t -61.11 -19.68 61.76 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.053 0.39 . . . . 71.209999999999994 112.053 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 22.6 m95 -78.23 -8.04 57.87 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 111.904 0.335 . . . . 71.430000000000007 111.904 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 42.6 mt -110.67 18.97 19.13 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.141 0.496 . . . . 72.25 111.412 -176.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 85.4 m -61.56 123.17 17.12 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.914 0.709 . . . . 61.329999999999998 112.914 -174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 100.35 -37.33 3.61 Favored Glycine 0 CA--C 1.529 0.965 0 N-CA-C 114.712 0.645 . . . . 62.229999999999997 114.712 171.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -96.78 172.62 7.77 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 117.629 0.715 . . . . 73.420000000000002 112.684 -174.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -93.75 139.55 30.71 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.581 -0.736 . . . . 74.120000000000005 112.596 -173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.61 HD12 HG22 ' A' ' 159' ' ' VAL . 54.6 mt -103.57 140.63 37.28 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.066 -0.516 . . . . 53.240000000000002 110.542 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 57.6 m-70 -115.51 117.37 30.18 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.513 -0.312 . . . . 73.519999999999996 110.565 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.621 HG22 HG22 ' A' ' 197' ' ' VAL . 39.8 t -112.6 129.42 68.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 CA-C-O 120.759 0.314 . . . . 73.030000000000001 111.547 -178.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -135.21 155.02 51.38 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-O 120.928 0.394 . . . . 73.230000000000004 111.348 177.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 58.9 t -78.93 130.94 35.43 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.564 0.579 . . . . 64.319999999999993 112.564 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 91.0 mt -88.17 -62.72 1.43 Allowed 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.831 -0.622 . . . . 71.439999999999998 110.73 175.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 30.9 mm-40 -108.34 113.51 26.64 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 116.151 -0.477 . . . . 74.549999999999997 111.209 178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 14.8 m-80 -78.57 72.77 5.11 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.1 0.476 . . . . 62.350000000000001 111.255 -177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.0 t -111.72 96.44 32.86 Favored Pre-proline 0 CA--C 1.541 0.63 0 CA-C-N 116.122 -0.49 . . . . 74.230000000000004 111.611 -178.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -87.82 161.51 7.61 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.697 2.265 . . . . 73.049999999999997 112.578 175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.426 ' O ' HD12 ' A' ' 232' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--O 1.252 1.193 0 N-CA-C 112.141 0.422 . . . . 42.329999999999998 112.141 -179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 120.629 0.252 . . . . 72.439999999999998 111.21 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.409 ' HA ' ' HD3' ' A' ' 149' ' ' PRO . 23.3 ptp -101.8 109.1 58.7 Favored Pre-proline 0 CA--C 1.546 0.799 0 CA-C-O 120.864 0.364 . . . . 71.010000000000005 111.343 -177.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 148' ' ' MET . 10.3 Cg_exo -71.74 124.11 9.95 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.588 2.192 . . . . 74.450000000000003 112.677 178.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.48 ' NZ ' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -64.69 122.2 16.3 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 120.94 0.4 . . . . 64.420000000000002 110.889 177.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 50.3 m -60.84 122.01 65.76 Favored Pre-proline 0 N--CA 1.47 0.559 0 N-CA-C 112.357 0.502 . . . . 61.210000000000001 112.357 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 122.29 8.18 Favored 'Trans proline' 0 CA--C 1.537 0.656 0 C-N-CA 122.376 2.051 . . . . 75.420000000000002 111.414 173.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -65.52 89.28 0.1 Allowed 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.193 0.521 . . . . 72.349999999999994 111.98 -176.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -101.91 153.0 38.26 Favored Pre-proline 0 CA--C 1.54 0.558 0 CA-C-N 115.843 -0.617 . . . . 74.409999999999997 111.153 178.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -72.84 135.69 23.95 Favored 'Trans proline' 0 CA--C 1.537 0.652 0 C-N-CA 122.263 1.975 . . . . 74.140000000000001 111.496 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -126.29 163.27 28.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 N-CA-C 113.133 0.79 . . . . 72.319999999999993 113.133 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.567 HG22 ' HA ' ' A' ' 218' ' ' THR . 48.5 t -122.54 137.29 56.55 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 CA-C-N 115.851 -0.613 . . . . 70.319999999999993 110.917 178.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.443 ' HB2' ' HG2' ' A' ' 221' ' ' GLU . 71.8 mtt85 -96.78 101.4 12.99 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.696 0.284 . . . . 74.120000000000005 111.312 -178.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.519 HG21 HD21 ' A' ' 181' ' ' LEU . 60.3 t -102.03 125.73 56.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-O 120.966 0.412 . . . . 65.319999999999993 111.726 -178.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -91.52 106.4 18.46 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 116.35 -0.386 . . . . 74.120000000000005 111.175 177.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.536 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 95.8 mt -80.09 153.25 74.65 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.302 -0.408 . . . . 73.140000000000001 111.208 177.83 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.423 ' O ' ' HB2' ' A' ' 163' ' ' ASN . 72.5 Cg_exo -49.96 140.45 31.47 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.896 2.397 . . . . 55.240000000000002 113.921 -178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.423 ' HB2' ' O ' ' A' ' 162' ' ' PRO . 86.1 m-20 75.96 46.82 0.09 Allowed 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.486 0.714 . . . . 71.030000000000001 112.47 178.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt 64.2 20.32 12.13 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 112.773 0.657 . . . . 73.030000000000001 112.773 173.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.536 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 81.4 mm-40 -89.35 141.56 28.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.095 0.474 . . . . 71.519999999999996 111.188 -178.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -117.64 143.06 46.51 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.246 0.546 . . . . 74.400000000000006 111.877 179.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.448 HG23 ' HB ' ' A' ' 159' ' ' VAL . 9.2 t -145.5 137.93 25.78 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.826 -0.625 . . . . 74.519999999999996 110.724 172.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 54.9 t -118.21 120.26 63.88 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-O 120.672 0.272 . . . . 72.019999999999996 110.833 179.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . 0.422 ' HA ' ' HD3' ' A' ' 170' ' ' PRO . 31.2 m -114.62 147.87 39.07 Favored Pre-proline 0 N--CA 1.471 0.614 0 CA-C-O 120.781 0.324 . . . . 75.439999999999998 111.813 -176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 169' ' ' VAL . 11.4 Cg_exo -71.55 125.0 10.78 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.789 2.326 . . . . 75.329999999999998 112.695 177.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.5 120.81 17.61 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-O 121.042 0.449 . . . . 51.109999999999999 111.754 -179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 61.9 mtt-85 -127.13 159.39 34.39 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.368 -0.378 . . . . 64.450000000000003 111.087 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.3 t -99.17 139.32 35.0 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.678 0.275 . . . . 72.329999999999998 110.445 175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 80.01 11.77 84.1 Favored Glycine 0 CA--C 1.525 0.696 0 C-N-CA 120.765 -0.731 . . . . 63.420000000000002 112.006 -174.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 82.8 t -127.1 119.3 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 122.952 0.501 . . . . 73.219999999999999 110.269 178.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 17.9 p -80.43 168.48 18.93 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.257 0.551 . . . . 63.020000000000003 112.201 -174.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.75 -37.92 79.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.352 0.596 . . . . 74.409999999999997 110.236 172.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 21.3 ttt85 -63.91 -35.19 79.83 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 115.664 -0.698 . . . . 75.420000000000002 111.094 178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.547 ' HA ' ' HE2' ' A' ' 182' ' ' LYS . 2.1 m-20 -76.53 -51.97 10.67 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.392 -0.367 . . . . 44.009999999999998 111.707 175.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.5 m -56.0 -42.73 76.87 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 112.111 0.411 . . . . 71.239999999999995 112.111 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 159' ' ' VAL . 78.9 mt -92.08 -10.04 40.46 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.812 1.042 . . . . 64.439999999999998 113.812 -174.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.547 ' HE2' ' HA ' ' A' ' 179' ' ' ASP . 0.1 OUTLIER -58.12 -28.71 64.9 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.909 0.777 . . . . 70.0 111.483 -176.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 63.4 mttp -70.82 -45.61 64.25 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.095 0.474 . . . . 73.329999999999998 110.607 174.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -62.69 -38.54 90.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 115.949 -0.568 . . . . 65.430000000000007 111.665 179.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 89.8 mt -67.66 -47.32 69.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 60.140000000000001 110.797 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 53.7 ttm -57.48 -39.13 75.74 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 116.002 -0.544 . . . . 45.409999999999997 112.245 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.8 ptm -75.26 -21.69 58.37 Favored 'General case' 0 N--CA 1.473 0.678 0 O-C-N 122.071 -0.393 . . . . 75.120000000000005 111.906 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.3 mmm180 -96.25 -13.68 23.24 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 112.097 0.406 . . . . 75.219999999999999 112.097 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 81.22 41.51 10.17 Favored Glycine 0 CA--C 1.525 0.712 0 C-N-CA 120.95 -0.643 . . . . 73.420000000000002 112.479 -176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 88.7 mt -125.31 158.26 34.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 122.683 0.393 . . . . 62.210000000000001 110.829 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 12.2 pt -133.33 137.7 29.77 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 116.682 -0.235 . . . . 72.319999999999993 111.342 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -49.6 -44.31 35.95 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 123.172 2.581 . . . . 73.25 113.654 -176.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -59.02 -21.65 59.41 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 112.522 0.564 . . . . 53.450000000000003 112.522 -178.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.522 ' SG ' HG13 ' A' ' 226' ' ' VAL . 32.7 t -101.18 -12.42 18.77 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-O 120.948 0.404 . . . . 64.420000000000002 112.014 -179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 72.9 m -119.55 164.41 15.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.173 0.511 . . . . 44.420000000000002 111.983 -175.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.404 ' O ' ' HA ' ' A' ' 224' ' ' VAL . . . -135.83 133.82 38.23 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.439 -0.346 . . . . 74.129999999999995 111.909 -179.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 224' ' ' VAL . 68.0 t -98.79 138.54 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-O 120.731 0.301 . . . . 72.109999999999999 110.816 176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.3 p90 -153.75 158.86 41.58 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 121.179 0.514 . . . . 71.349999999999994 111.738 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.572 ' HG2' ' HB3' ' A' ' 206' ' ' LYS . 6.4 ptm180 -110.11 154.25 23.54 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 115.873 -0.603 . . . . 64.329999999999998 110.111 176.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.448 HG12 ' HG2' ' A' ' 205' ' ' LYS . 59.0 mt -118.62 120.65 64.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.705 0 CA-C-O 120.985 0.421 . . . . 64.230000000000004 111.575 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -154.78 144.28 21.36 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.43 -0.35 . . . . 64.319999999999993 111.031 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 57.06 31.44 19.95 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.334 0.588 . . . . 70.150000000000006 111.22 -177.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 83.66 -19.66 14.53 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-N 115.874 -0.603 . . . . 42.039999999999999 113.82 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -101.06 170.27 8.38 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.575 0.702 . . . . 65.329999999999998 112.732 -175.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.448 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.0 mttp -113.45 139.58 48.8 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 115.32 -0.855 . . . . 73.310000000000002 110.947 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.572 ' HB3' ' HG2' ' A' ' 199' ' ' ARG . 87.4 tttt -114.69 105.35 53.54 Favored Pre-proline 0 N--CA 1.47 0.526 0 CA-C-N 116.662 -0.245 . . . . 72.219999999999999 110.593 173.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_exo -61.96 113.38 1.84 Allowed 'Trans proline' 0 CA--C 1.539 0.731 0 C-N-CA 122.789 2.326 . . . . 64.439999999999998 112.412 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.484 HG21 HD11 ' A' ' 217' ' ' LEU . 61.2 mt -96.64 134.22 35.11 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 116.314 -0.403 . . . . 72.430000000000007 111.615 -176.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -68.3 135.17 29.3 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 121.145 -0.55 . . . . 72.420000000000002 113.039 178.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 75.9 m95 -55.34 -43.42 74.99 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 112.712 0.634 . . . . 74.430000000000007 112.712 -176.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -83.56 27.93 0.58 Allowed 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 112.85 0.685 . . . . 61.439999999999998 112.85 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 48.7 m -92.51 137.62 32.21 Favored 'General case' 0 N--CA 1.476 0.825 0 O-C-N 122.354 -0.216 . . . . 43.439999999999998 110.612 173.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -54.99 124.15 15.85 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-O 120.926 0.394 . . . . 74.319999999999993 111.794 178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 10.1 tp -59.25 -24.21 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 116.178 -0.465 . . . . 75.540000000000006 111.698 -179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 39.3 t -56.54 -30.61 63.29 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.115 0.413 . . . . 74.120000000000005 112.115 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 26.7 m95 -66.68 -19.1 65.69 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-O 120.842 0.353 . . . . 73.019999999999996 111.939 178.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.484 HD11 HG21 ' A' ' 208' ' ' ILE . 44.0 mt -115.45 19.13 15.65 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.173 0.511 . . . . 72.230000000000004 111.676 -173.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.567 ' HA ' HG22 ' A' ' 157' ' ' VAL . 75.5 m -61.38 132.0 52.08 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 112.547 0.573 . . . . 73.010000000000005 112.547 -179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 93.4 -22.07 37.18 Favored Glycine 0 CA--C 1.529 0.928 0 N-CA-C 114.717 0.647 . . . . 74.420000000000002 114.717 172.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -101.16 172.78 6.8 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 117.684 0.742 . . . . 74.040000000000006 112.677 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 158' ' ' ARG . 42.4 mt-10 -105.91 114.7 29.01 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.755 -0.657 . . . . 72.540000000000006 111.765 -176.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 69.7 mt -94.03 164.3 13.14 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.138 0.494 . . . . 75.540000000000006 111.291 -179.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 58.4 m-70 -131.7 139.1 48.94 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 120.839 0.352 . . . . 64.349999999999994 111.472 176.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.551 HG22 HG22 ' A' ' 197' ' ' VAL . 46.4 t -123.12 126.38 73.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.107 -0.497 . . . . 63.049999999999997 110.746 179.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -119.72 145.72 46.28 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 120.935 0.397 . . . . 63.219999999999999 111.274 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.522 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.7 t -83.87 103.09 10.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.41 0 N-CA-C 110.079 -0.341 . . . . 71.510000000000005 110.079 174.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . . . . . . . . . 93.5 mt -55.43 -50.19 70.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.983 0.42 . . . . 61.020000000000003 111.692 -176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -122.9 117.25 25.14 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.444 0.64 . . . . 62.399999999999999 110.107 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 20.7 p-10 -72.56 27.37 0.05 Allowed 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 114.126 1.158 . . . . 65.230000000000004 114.126 -168.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 56.3 t -120.06 89.58 42.92 Favored Pre-proline 0 CA--C 1.543 0.68 0 O-C-N 121.886 -0.509 . . . . 74.310000000000002 111.487 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -83.79 121.91 2.95 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.2 2.6 . . . . 73.430000000000007 112.33 175.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 232' ' ' LEU . 6.5 mp . . . . . 0 C--O 1.252 1.209 0 CA-C-O 118.572 -0.728 . . . . 72.340000000000003 111.487 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.3 t-80 . . . . . 0 N--CA 1.489 1.48 0 N-CA-C 112.021 0.378 . . . . 54.43 112.021 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 68.0 mtt 66.82 102.47 0.04 OUTLIER Pre-proline 0 N--CA 1.48 1.036 0 C-N-CA 123.007 0.523 . . . . 62.100000000000001 111.744 -175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -90.71 129.46 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.755 2.303 . . . . 71.310000000000002 112.621 177.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 10.1 mtmp? -72.22 77.28 0.98 Allowed 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.469 0.652 . . . . 75.540000000000006 109.563 174.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 21.0 t -76.31 120.39 81.47 Favored Pre-proline 0 N--CA 1.47 0.573 0 CA-C-N 115.318 -0.855 . . . . 63.310000000000002 112.694 -169.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -84.8 -160.12 0.11 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.79 2.326 . . . . 73.439999999999998 111.865 172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -80.48 99.93 8.27 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.898 -0.501 . . . . 60.549999999999997 111.07 177.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.734 ' HD3' ' H ' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -100.98 145.83 31.08 Favored Pre-proline 0 N--CA 1.471 0.62 0 CA-C-N 116.321 -0.4 . . . . 73.409999999999997 111.392 -179.41 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -62.59 131.03 31.82 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 122.663 2.242 . . . . 75.25 112.793 -179.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -124.03 156.68 31.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-O 121.223 0.535 . . . . 72.120000000000005 112.173 -177.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.491 HG23 ' HB2' ' A' ' 171' ' ' ALA . 56.7 t -122.39 131.27 73.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.004 -0.544 . . . . 74.420000000000002 110.69 178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.537 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 99.9 mtt180 -84.92 134.89 34.25 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.522 -0.308 . . . . 75.109999999999999 110.891 178.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.578 HG21 HD21 ' A' ' 181' ' ' LEU . 59.7 t -130.18 119.51 46.86 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.1 0.476 . . . . 75.25 111.676 179.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -93.93 114.43 26.63 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.129 -0.487 . . . . 65.230000000000004 111.037 176.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.488 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 87.9 mt -98.19 158.33 32.93 Favored Pre-proline 0 CA--C 1.536 0.439 0 CA-C-N 116.088 -0.506 . . . . 72.340000000000003 111.181 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.03 172.2 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.27 1.98 . . . . 75.109999999999999 111.886 174.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 62.46 23.23 13.77 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.09 0.471 . . . . 74.299999999999997 110.778 -173.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 63.02 26.91 15.7 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.513 0.725 . . . . 64.349999999999994 112.332 177.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.488 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 79.3 mm-40 -88.02 152.49 22.0 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-O 121.193 0.521 . . . . 74.5 111.98 -177.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 59.5 ttt180 -132.78 139.18 47.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.239 -0.437 . . . . 63.210000000000001 110.96 -176.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.406 HG23 ' HB ' ' A' ' 159' ' ' VAL . 8.3 t -152.45 148.52 27.53 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-O 120.889 0.376 . . . . 64.109999999999999 111.745 177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.9 t -128.7 129.7 68.6 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.87 0.366 . . . . 71.150000000000006 111.057 178.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 33.9 m -125.33 154.55 72.16 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.603 -0.271 . . . . 74.310000000000002 111.723 -177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.61 141.07 24.53 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 122.524 2.149 . . . . 73.209999999999994 113.163 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.491 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -103.4 122.23 44.43 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 111.942 0.349 . . . . 54.219999999999999 111.942 -178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 40.9 mtm180 -133.89 152.28 51.81 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.976 0.417 . . . . 75.530000000000001 111.817 179.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 46.3 t -71.46 135.3 47.11 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.19 -0.459 . . . . 64.209999999999994 111.007 177.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 92.2 -25.77 16.14 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 120.961 -0.638 . . . . 72.109999999999999 112.741 -177.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 93.2 t -82.59 125.93 39.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 120.777 0.323 . . . . 73.530000000000001 110.852 177.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 45.5 p -84.25 164.49 19.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.199 0.523 . . . . 71.230000000000004 112.041 -177.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.485 ' HB ' ' HA ' ' A' ' 210' ' ' TRP . 61.4 t -59.2 -33.07 49.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-O 121.397 0.618 . . . . 72.030000000000001 110.722 174.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 30.4 ttm-85 -63.48 -53.63 48.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 115.934 -0.575 . . . . 72.439999999999998 110.776 177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.549 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 59.3 m-20 -59.81 -38.61 82.44 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.231 0.456 . . . . 75.400000000000006 112.231 -179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 55.0 p -76.59 -31.22 57.35 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 112.92 0.711 . . . . 54.240000000000002 112.92 -174.555 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.578 HD21 HG21 ' A' ' 159' ' ' VAL . 71.5 mt -106.45 -20.49 13.36 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.498 1.296 . . . . 65.209999999999994 114.498 -174.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.549 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 22.7 pttp -54.61 -33.67 60.84 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 113.427 0.899 . . . . 70.530000000000001 113.427 -172.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -73.99 -44.78 53.47 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 122.082 -0.386 . . . . 73.140000000000001 111.05 175.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -57.0 -35.42 69.2 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.089 0.471 . . . . 71.219999999999999 111.334 176.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.57 HD11 ' CH2' ' A' ' 210' ' ' TRP . 86.4 mt -69.2 -48.96 60.63 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 116.033 -0.53 . . . . 62.200000000000003 110.901 176.04 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 15.0 tpt -56.84 -45.64 82.23 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.172 -0.467 . . . . 74.230000000000004 111.88 -177.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.6 ptm -70.09 -8.81 52.49 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 112.557 0.577 . . . . 73.150000000000006 112.557 -178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 26.3 mmt180 -111.46 -20.61 12.15 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 111.954 0.353 . . . . 73.299999999999997 111.954 177.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 102.51 38.22 3.07 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 121.161 -0.542 . . . . 31.120000000000001 113.571 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . 0.416 ' HB3' ' SG ' ' A' ' 195' ' ' CYS . 5.0 mp -122.05 169.63 10.65 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 122.451 -0.441 . . . . 65.420000000000002 111.59 177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 20.2 pt -142.87 134.58 13.02 Favored Pre-proline 0 CA--C 1.543 0.703 0 CA-C-N 116.04 -0.527 . . . . 72.329999999999998 110.562 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -52.56 -39.9 73.9 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.792 2.328 . . . . 35.439999999999998 113.708 -174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -67.33 -11.1 56.77 Favored 'General case' 0 CA--C 1.543 0.703 0 N-CA-C 113.11 0.781 . . . . 75.409999999999997 113.11 -177.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 48.7 t -122.41 9.94 9.78 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-O 120.985 0.421 . . . . 60.350000000000001 111.467 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.416 ' SG ' ' HB3' ' A' ' 190' ' ' LEU . 73.3 m -123.43 144.06 49.74 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.769 0.318 . . . . 74.430000000000007 111.611 -178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.487 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -122.46 119.47 31.06 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.524 -0.307 . . . . 75.219999999999999 111.56 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 224' ' ' VAL . 25.1 t -98.75 134.07 38.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 CA-C-N 116.699 -0.228 . . . . 72.340000000000003 110.899 179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.464 ' CE2' ' HE3' ' A' ' 205' ' ' LYS . 47.9 p90 -138.5 155.49 48.38 Favored 'General case' 0 N--CA 1.472 0.647 0 CA-C-O 121.301 0.572 . . . . 64.019999999999996 111.715 175.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 15.5 ptt180 -121.27 152.17 39.2 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.686 -0.688 . . . . 73.409999999999997 111.192 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 57.5 mt -105.8 97.49 5.69 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-O 120.815 0.34 . . . . 73.129999999999995 110.795 178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.433 ' O ' ' HG3' ' A' ' 201' ' ' GLN . 12.8 pt20 -112.23 128.54 56.28 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 116.618 -0.265 . . . . 61.109999999999999 110.92 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 33.0 t70 60.16 19.09 8.41 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 121.546 0.689 . . . . 44.5 111.687 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.54 5.13 72.42 Favored Glycine 0 CA--C 1.527 0.811 0 C-N-CA 121.197 -0.525 . . . . 65.310000000000002 113.295 -176.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.06 126.24 52.08 Favored 'General case' 0 N--CA 1.467 0.379 0 O-C-N 122.525 -0.397 . . . . 73.420000000000002 111.273 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.464 ' HE3' ' CE2' ' A' ' 198' ' ' TYR . 58.1 mtpt -80.68 94.4 6.34 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.069 0.461 . . . . 63.420000000000002 110.677 174.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 41.7 mmtm -94.29 118.4 67.07 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.231 -0.44 . . . . 74.230000000000004 111.389 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -60.1 148.83 87.91 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.67 2.247 . . . . 64.430000000000007 112.559 175.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.533 HD12 HG12 ' A' ' 197' ' ' VAL . 50.1 mt -118.07 148.52 20.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.841 0.353 . . . . 71.519999999999996 111.222 -177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -97.38 139.05 14.26 Favored Glycine 0 CA--C 1.525 0.693 0 C-N-CA 120.953 -0.642 . . . . 61.299999999999997 112.13 174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.57 ' CH2' HD11 ' A' ' 185' ' ' LEU . 94.2 m95 -62.7 -23.28 67.07 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 122.359 -0.495 . . . . 71.209999999999994 111.543 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -90.41 15.14 11.19 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.018 -0.537 . . . . 72.239999999999995 112.032 177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.428 ' O ' HG23 ' A' ' 177' ' ' VAL . 69.0 m -96.2 147.53 23.66 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.397 0.279 . . . . 74.120000000000005 110.952 174.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.453 ' HB2' ' HD1' ' A' ' 216' ' ' TRP . 5.1 m-20 -65.13 126.65 28.75 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.166 0.508 . . . . 72.049999999999997 111.87 178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.656 HD12 HD12 ' A' ' 217' ' ' LEU . 9.5 tp -62.03 -20.64 24.41 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 CA-C-N 116.128 -0.487 . . . . 63.329999999999998 111.366 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.6 p -60.63 -23.19 64.56 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 116.441 -0.345 . . . . 73.239999999999995 111.903 178.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.453 ' HD1' ' HB2' ' A' ' 213' ' ' ASP . 42.3 m95 -70.37 -20.13 62.98 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 121.038 0.446 . . . . 75.400000000000006 111.739 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.656 HD12 HD12 ' A' ' 214' ' ' ILE . 23.2 mt -104.97 9.81 34.41 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 116.098 -0.501 . . . . 62.32 111.748 -174.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 42.0 m -56.64 109.98 0.71 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 112.646 0.61 . . . . 75.310000000000002 112.646 -178.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.53 1.61 60.44 Favored Glycine 0 CA--C 1.528 0.884 0 C-N-CA 121.097 -0.573 . . . . 72.319999999999993 113.981 177.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 53.6 mm-40 -103.65 158.96 16.01 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.105 0.478 . . . . 72.540000000000006 111.826 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.537 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.3 mt-10 -105.72 114.82 29.2 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 121.067 0.461 . . . . 70.299999999999997 110.683 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 42.0 mt -92.8 156.11 17.21 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.192 0.52 . . . . 63.109999999999999 111.715 -174.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 77.9 m-70 -129.33 132.55 47.13 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.328 -0.396 . . . . 72.140000000000001 110.197 176.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 197' ' ' VAL . 58.5 t -109.73 123.62 65.77 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 N-CA-C 112.22 0.452 . . . . 72.349999999999994 112.22 -176.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -100.66 157.39 16.72 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-N 116.178 -0.464 . . . . 70.409999999999997 111.228 178.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.55 130.54 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-O 120.741 0.305 . . . . 62.329999999999998 111.016 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.487 HD21 ' HB2' ' A' ' 196' ' ' ALA . 89.1 mt -82.47 -71.77 0.47 Allowed 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 111.802 0.297 . . . . 63.409999999999997 111.802 -178.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 50.3 mt-10 -143.55 109.91 5.42 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 122.393 0.277 . . . . 73.120000000000005 111.029 -179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 24.4 p-10 -77.45 74.05 4.02 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 121.639 0.733 . . . . 73.409999999999997 111.214 178.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . 0.488 ' HA ' ' HD3' ' A' ' 231' ' ' PRO . 27.7 m -95.56 131.34 29.71 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.058 -0.519 . . . . 73.409999999999997 111.757 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 230' ' ' VAL . 6.4 Cg_exo -75.51 135.36 18.06 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 122.956 2.437 . . . . 74.239999999999995 112.265 175.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . 0.435 HD23 ' N ' ' A' ' 232' ' ' LEU . 1.9 pt? . . . . . 0 C--O 1.254 1.311 0 CA-C-O 118.523 -0.751 . . . . 43.530000000000001 112.002 -179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.688 0.28 . . . . 64.549999999999997 111.597 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 80.3 mtp 65.18 149.76 0.11 Allowed Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.12 0.568 . . . . 54.030000000000001 112.259 -178.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -62.28 113.62 1.99 Allowed 'Trans proline' 0 CA--C 1.538 0.707 0 C-N-CA 122.424 2.083 . . . . 73.120000000000005 112.376 176.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.429 ' NZ ' ' HB3' ' A' ' 150' ' ' LYS . 0.4 OUTLIER -68.8 93.39 0.54 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.321 0.581 . . . . 74.310000000000002 111.877 -178.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 17.8 m -92.07 106.22 16.78 Favored Pre-proline 0 N--CA 1.472 0.661 0 CA-C-N 115.859 -0.61 . . . . 72.439999999999998 111.201 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 3.9 Cg_exo -78.1 60.46 7.38 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 122.849 2.366 . . . . 54.509999999999998 112.675 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -88.87 -10.71 46.98 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-O 120.967 0.413 . . . . 72.329999999999998 112.039 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -75.28 138.33 71.73 Favored Pre-proline 0 CA--C 1.541 0.6 0 O-C-N 122.218 -0.301 . . . . 73.519999999999996 111.486 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -66.76 128.55 19.14 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.46 2.107 . . . . 75.310000000000002 112.013 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.8 pp -124.72 157.14 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 121.531 0.681 . . . . 65.340000000000003 112.76 -175.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 63.0 t -125.77 135.37 64.14 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 CA-C-N 115.436 -0.802 . . . . 74.140000000000001 110.186 175.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.431 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 50.0 mtt180 -90.32 98.56 11.84 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.936 0.398 . . . . 75.129999999999995 110.803 -178.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.688 HG21 HD21 ' A' ' 181' ' ' LEU . 60.5 t -96.78 108.01 20.74 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 CA-C-O 121.34 0.59 . . . . 74.510000000000005 111.806 -177.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . 0.545 ' HA ' ' HA ' ' A' ' 166' ' ' ARG . 73.1 m-85 -76.53 104.09 6.86 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 121.041 0.448 . . . . 64.319999999999993 110.762 175.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . . . . . . . . . 99.4 mt -71.39 157.87 89.15 Favored Pre-proline 0 CA--C 1.544 0.723 0 CA-C-N 115.931 -0.577 . . . . 74.349999999999994 112.274 -177.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.472 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . 11.1 Cg_endo -54.1 160.09 6.74 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 122.668 2.246 . . . . 61.350000000000001 112.843 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 65.0 t30 68.57 31.34 4.78 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.536 0.684 . . . . 64.400000000000006 110.839 -175.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm 65.6 23.03 11.73 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 115.31 -0.859 . . . . 74.319999999999993 113.031 173.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 -91.92 -177.04 4.61 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 120.99 0.424 . . . . 75.349999999999994 111.776 178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.545 ' HA ' ' HA ' ' A' ' 160' ' ' PHE . 28.1 ptt180 -157.84 156.86 32.19 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 121.162 0.505 . . . . 71.010000000000005 111.902 176.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 15.3 t -156.27 160.51 39.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.997 -0.547 . . . . 60.0 110.352 173.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.8 t -116.53 119.75 62.89 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.757 0.313 . . . . 43.219999999999999 111.041 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 34.9 m -117.23 152.67 49.37 Favored Pre-proline 0 CA--C 1.543 0.711 0 N-CA-C 111.852 0.315 . . . . 73.239999999999995 111.852 -177.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -75.59 147.66 32.08 Favored 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 122.491 2.128 . . . . 63.439999999999998 113.273 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -103.67 126.73 51.0 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 120.959 0.409 . . . . 64.129999999999995 111.69 -179.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 89.5 mtt180 -128.74 146.18 50.97 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.98 0.419 . . . . 62.149999999999999 111.623 -179.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.1 t -75.69 132.21 40.38 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.834 0.35 . . . . 73.540000000000006 110.896 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 94.06 -23.7 30.14 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.076 -0.583 . . . . 44.25 112.437 -176.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 89.8 t -85.26 125.26 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.097 0.475 . . . . 74.340000000000003 111.131 177.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 30.0 p -82.74 165.92 19.51 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.93 0.395 . . . . 74.150000000000006 111.491 -179.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 212' ' ' THR . 62.0 t -56.96 -32.38 39.31 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-O 121.352 0.596 . . . . 73.209999999999994 110.243 172.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.496 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 4.2 tmt_? -68.04 -45.77 73.02 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 115.703 -0.681 . . . . 44.25 111.321 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -67.83 -33.42 74.75 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 120.918 0.39 . . . . 72.129999999999995 111.669 177.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 47.0 t -74.31 -44.01 54.36 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.25 0.463 . . . . 64.140000000000001 112.25 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.688 HD21 HG21 ' A' ' 159' ' ' VAL . 68.3 mt -95.79 -4.78 43.27 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 113.72 1.007 . . . . 62.210000000000001 113.72 -173.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -58.24 -43.51 87.82 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 112.246 0.461 . . . . 51.439999999999998 112.246 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -80.92 -27.85 36.03 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 120.984 0.421 . . . . 74.140000000000001 111.022 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -64.24 -38.77 92.24 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.209 0.528 . . . . 65.540000000000006 111.173 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 96.5 mt -79.27 -29.7 42.67 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 116.309 -0.405 . . . . 73.430000000000007 111.108 176.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.423 ' C ' ' SD ' ' A' ' 186' ' ' MET . 0.2 OUTLIER -54.63 -48.08 72.68 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.33 -0.396 . . . . 71.310000000000002 111.293 179.129 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 25.9 ptt? -64.99 -19.12 65.83 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.023 0.379 . . . . 62.229999999999997 112.023 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 49.7 mmm-85 -87.37 -5.97 58.66 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.774 0.321 . . . . 74.430000000000007 111.317 175.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 83.15 16.22 70.09 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 121.394 -0.431 . . . . 53.149999999999999 112.665 -176.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 68.9 mt -117.3 171.76 7.75 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.016 0.436 . . . . 71.239999999999995 111.622 -176.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 25.4 pt -133.44 143.9 49.97 Favored Pre-proline 0 N--CA 1.471 0.613 0 CA-C-N 116.086 -0.506 . . . . 65.140000000000001 111.039 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -56.81 -29.69 82.06 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 122.749 2.299 . . . . 75.340000000000003 112.941 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.34 -32.38 68.46 Favored 'General case' 0 CA--C 1.542 0.665 0 CA-C-N 115.998 -0.546 . . . . 74.019999999999996 111.934 -178.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.28 9.96 31.86 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 112.365 0.506 . . . . 60.409999999999997 112.365 -174.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 84.0 m -118.27 166.87 12.09 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.98 0.419 . . . . 74.519999999999996 111.614 -178.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.423 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -132.08 138.9 48.33 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.384 -0.371 . . . . 73.120000000000005 111.335 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 224' ' ' VAL . 61.9 t -111.17 132.11 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 CA-C-N 116.288 -0.414 . . . . 71.319999999999993 111.267 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 55.9 p90 -139.06 146.89 41.33 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.252 0.548 . . . . 73.140000000000001 111.312 173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.547 ' HG2' HD11 ' A' ' 208' ' ' ILE . 9.1 ptm180 -116.62 169.15 9.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.188 -0.46 . . . . 64.129999999999995 110.294 175.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.404 HG12 ' HG2' ' A' ' 205' ' ' LYS . 54.4 mt -104.04 115.69 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.116 0.484 . . . . 71.140000000000001 110.101 174.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -131.27 119.69 22.14 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.952 -0.567 . . . . 75.430000000000007 110.253 -177.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 25.0 t70 59.31 27.01 15.96 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.335 0.588 . . . . 64.319999999999993 111.57 -179.471 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 89.96 2.51 74.77 Favored Glycine 0 CA--C 1.528 0.9 0 CA-C-N 116.243 -0.435 . . . . 65.239999999999995 113.882 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -116.02 133.03 56.45 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 122.428 -0.454 . . . . 64.129999999999995 111.629 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.404 ' HG2' HG12 ' A' ' 200' ' ' ILE . 63.7 mttp -78.13 99.0 6.0 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.074 0.464 . . . . 72.439999999999998 110.895 175.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -93.67 112.09 55.32 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-N 115.991 -0.55 . . . . 74.120000000000005 111.859 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -66.19 110.23 1.72 Allowed 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.92 2.413 . . . . 74.409999999999997 112.654 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.547 HD11 ' HG2' ' A' ' 199' ' ' ARG . 62.6 mt -89.13 138.59 18.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.26 -0.427 . . . . 61.219999999999999 112.039 -176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -67.06 138.59 34.94 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 121.14 -0.553 . . . . 52.5 113.219 177.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.1 m95 -59.45 -22.99 62.32 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.901 0.381 . . . . 70.409999999999997 111.746 178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -72.09 -11.84 60.93 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.095 0.558 . . . . 62.509999999999998 112.228 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.409 ' O ' HG23 ' A' ' 177' ' ' VAL . 20.7 m -75.75 135.11 40.33 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 116.279 -0.419 . . . . 72.329999999999998 111.892 -175.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 2.3 m-20 -62.03 127.21 30.29 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.513 -0.312 . . . . 41.25 111.54 176.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.0 tt -61.31 -22.75 28.35 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 CA-C-O 121.058 0.456 . . . . 73.219999999999999 111.284 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 47.9 t -54.89 -29.12 55.02 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 116.048 -0.524 . . . . 53.310000000000002 112.036 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.3 m0 -68.79 -26.74 65.35 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.143 0.497 . . . . 74.230000000000004 111.496 178.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.638 HD13 HD21 ' A' ' 222' ' ' LEU . 51.8 mt -105.47 10.88 33.11 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 116.0 -0.546 . . . . 72.329999999999998 112.104 -172.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 70.7 m -50.38 119.22 3.55 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 112.178 0.436 . . . . 55.130000000000003 112.178 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 96.73 -21.44 45.87 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 121.276 -0.488 . . . . 75.349999999999994 113.993 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -86.42 172.47 10.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.424 0.63 . . . . 73.010000000000005 112.418 -176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.431 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.1 mt-10 -111.18 119.96 40.7 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.875 -0.602 . . . . 74.510000000000005 111.249 -179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.638 HD21 HD13 ' A' ' 217' ' ' LEU . 77.6 mt -97.39 155.23 17.0 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 120.908 0.385 . . . . 75.109999999999999 111.116 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 65.5 m-70 -127.52 120.53 28.47 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.029 -0.36 . . . . 64.030000000000001 110.029 175.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.516 HG22 HG22 ' A' ' 197' ' ' VAL . 52.5 t -115.95 140.6 37.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-O 121.1 0.476 . . . . 62.119999999999997 111.711 -175.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.472 ' HA ' ' HB3' ' A' ' 162' ' ' PRO . 12.6 pt-20 -144.26 160.72 40.5 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.301 -0.409 . . . . 55.240000000000002 110.754 174.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 40.3 t -81.78 139.01 18.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.472 0 CA-C-N 116.64 -0.254 . . . . 52.109999999999999 111.166 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.5 mt -60.57 -42.44 96.67 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 111.886 0.328 . . . . 73.400000000000006 111.886 -178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -146.03 143.13 29.23 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.978 0.418 . . . . 71.439999999999998 110.753 172.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -78.1 37.62 0.26 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.231 0.456 . . . . 71.230000000000004 112.231 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 42.0 t -121.2 90.39 47.35 Favored Pre-proline 0 CA--C 1.544 0.716 0 N-CA-C 111.966 0.358 . . . . 60.420000000000002 111.966 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -79.05 151.25 23.71 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.553 2.169 . . . . 62.420000000000002 112.672 176.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 91.6 mt . . . . . 0 C--O 1.255 1.347 0 CA-C-O 118.787 -0.625 . . . . 63.210000000000001 112.104 -179.145 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 63.1 m80 . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.728 0.299 . . . . 73.010000000000005 111.051 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.492 ' SD ' ' N ' ' A' ' 148' ' ' MET . 0.0 OUTLIER -72.53 150.06 91.21 Favored Pre-proline 0 CA--C 1.542 0.646 0 CA-C-O 120.638 0.256 . . . . 70.030000000000001 111.468 178.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -57.93 107.61 0.33 Allowed 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.427 2.084 . . . . 73.319999999999993 112.768 177.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -107.9 97.59 7.28 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-O 121.662 0.744 . . . . 53.439999999999998 110.859 179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 65.7 p -137.62 157.27 73.98 Favored Pre-proline 0 N--CA 1.473 0.693 0 CA-C-N 115.791 -0.641 . . . . 73.099999999999994 111.407 -173.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -71.84 60.53 2.94 Favored 'Trans proline' 0 CA--C 1.545 1.051 0 C-N-CA 122.988 2.459 . . . . 62.200000000000003 113.389 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -73.68 84.25 1.6 Allowed 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.389 0.614 . . . . 72.120000000000005 111.419 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -113.61 161.48 27.26 Favored Pre-proline 0 CA--C 1.54 0.583 0 CA-C-N 115.563 -0.744 . . . . 71.420000000000002 111.103 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -65.76 120.49 7.68 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 121.95 1.767 . . . . 71.310000000000002 111.661 172.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 45.3 pt -113.94 161.84 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.512 0 CA-C-O 121.637 0.732 . . . . 73.310000000000002 112.883 -174.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.45 133.58 68.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 CA-C-N 115.342 -0.845 . . . . 74.239999999999995 110.275 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . . . . . . . . . 68.4 mtt180 -95.99 96.39 8.85 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-O 121.011 0.434 . . . . 53.130000000000003 111.34 -176.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.602 HG22 HD12 ' A' ' 222' ' ' LEU . 41.5 t -94.33 117.17 37.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 121.031 0.443 . . . . 54.240000000000002 112.108 -176.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -91.99 100.13 12.84 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-O 121.188 0.518 . . . . 74.230000000000004 111.112 174.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.53 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 98.1 mt -69.95 161.77 73.0 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-N 115.696 -0.683 . . . . 71.430000000000007 111.614 179.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.487 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 9.8 Cg_endo -52.09 153.24 12.83 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 122.768 2.312 . . . . 64.340000000000003 113.345 -179.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 61.96 44.6 8.11 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-O 121.495 0.664 . . . . 71.219999999999999 110.901 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm 61.47 23.77 13.98 Favored 'General case' 0 CA--C 1.544 0.716 0 N-CA-C 113.096 0.776 . . . . 74.219999999999999 113.096 170.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 31.9 mm-40 -86.88 157.76 19.47 Favored 'General case' 0 N--CA 1.471 0.619 0 O-C-N 122.068 -0.395 . . . . 64.439999999999998 111.101 178.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 39.3 ttp85 -139.74 145.44 38.29 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.443 0.534 . . . . 74.540000000000006 112.443 -178.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 10.1 t -148.1 161.9 40.48 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 115.795 -0.639 . . . . 64.329999999999998 110.19 172.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 57.3 t -126.34 120.32 56.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-O 120.954 0.407 . . . . 71.340000000000003 111.254 -178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 27.5 m -121.04 137.05 26.14 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 116.461 -0.336 . . . . 43.219999999999999 111.449 -179.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.513 ' HG2' HH21 ' A' ' 172' ' ' ARG . 65.0 Cg_endo -74.12 126.16 10.32 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 122.505 2.137 . . . . 72.140000000000001 113.007 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -70.25 158.74 35.3 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.092 0.472 . . . . 61.439999999999998 112.165 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.513 HH21 ' HG2' ' A' ' 170' ' ' PRO . 11.5 ptp180 -167.71 161.97 13.69 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 116.001 -0.545 . . . . 73.120000000000005 111.604 -174.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 42.7 t -95.47 154.32 17.26 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 116.306 -0.407 . . . . 63.020000000000003 111.351 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 66.5 18.66 68.03 Favored Glycine 0 CA--C 1.528 0.885 0 C-N-CA 121.248 -0.501 . . . . 60.229999999999997 113.266 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.495 ' HB ' ' HG3' ' A' ' 172' ' ' ARG . 40.8 t -132.8 124.72 51.23 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.644 0.378 . . . . 72.120000000000005 110.468 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 30.6 p -82.84 158.05 22.89 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.817 0.341 . . . . 64.209999999999994 111.622 -177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 47.5 t -55.62 -35.77 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 CA-C-O 121.617 0.722 . . . . 73.329999999999998 110.017 173.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.521 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 33.9 ttp180 -56.42 -54.65 43.16 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.948 -1.024 . . . . 72.230000000000004 111.319 176.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . . . . . . . . . 55.5 m-20 -74.16 -12.53 60.61 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.18 -0.464 . . . . 71.010000000000005 111.718 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 69.5 m -82.79 -46.78 12.67 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.037 0.446 . . . . 63.43 110.944 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 89.2 mt -89.72 4.94 48.05 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 112.311 0.486 . . . . 54.329999999999998 112.311 -178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 15.1 ptmm? -54.92 -26.63 37.32 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-O 120.878 0.37 . . . . 74.319999999999993 111.8 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -84.02 -52.11 6.57 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 120.68 0.276 . . . . 70.340000000000003 111.556 175.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -52.82 -41.34 64.11 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.005 0.431 . . . . 65.510000000000005 112.117 -178.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.401 HD11 ' CH2' ' A' ' 210' ' ' TRP . 87.2 mt -71.03 -53.78 13.52 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 120.934 0.397 . . . . 43.420000000000002 111.483 178.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 42.2 tpp -57.05 -42.09 79.91 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.358 0.503 . . . . 71.430000000000007 112.358 -174.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.3 ptp -66.63 -15.44 63.47 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 112.118 0.414 . . . . 74.340000000000003 112.118 -179.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 30.9 mtp85 -110.14 5.2 21.79 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 120.864 0.364 . . . . 74.340000000000003 111.551 174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 67.05 35.54 89.34 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 121.464 -0.398 . . . . 75.329999999999998 113.229 -178.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 96.2 mt -106.6 159.95 15.81 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.086 0.469 . . . . 74.299999999999997 111.54 -179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 24.3 pt -134.01 151.7 77.16 Favored Pre-proline 0 CA--C 1.541 0.612 0 CA-C-N 115.959 -0.564 . . . . 70.420000000000002 110.816 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.53 -34.3 51.42 Favored 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.683 2.255 . . . . 70.329999999999998 113.292 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -64.02 -22.03 66.75 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-O 121.2 0.524 . . . . 64.349999999999994 111.906 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 27.6 t -96.4 -7.49 34.86 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.335 0.494 . . . . 63.450000000000003 112.335 -177.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . 0.403 ' HB3' ' CG1' ' A' ' 224' ' ' VAL . 73.4 m -134.89 131.65 37.59 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 112.683 0.623 . . . . 72.230000000000004 112.683 -172.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.466 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -111.31 127.33 55.6 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.18 -0.463 . . . . 55.43 111.324 178.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 224' ' ' VAL . 47.0 t -100.07 133.36 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 CA-C-N 116.536 -0.302 . . . . 54.399999999999999 111.405 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -152.37 160.62 43.28 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 121.257 0.551 . . . . 72.510000000000005 111.812 175.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 4.6 ptm180 -122.93 155.94 35.7 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 116.074 -0.512 . . . . 64.319999999999993 110.677 177.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 62.1 mt -112.95 120.75 63.73 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 CA-C-O 120.8 0.333 . . . . 73.219999999999999 111.03 178.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -129.74 115.94 18.04 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 120.832 0.349 . . . . 72.200000000000003 111.207 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 4.1 t70 63.43 31.36 15.07 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-O 121.312 0.577 . . . . 73.010000000000005 111.155 178.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 97.46 -20.55 50.25 Favored Glycine 0 CA--C 1.529 0.914 0 C-N-CA 121.258 -0.496 . . . . 42.009999999999998 114.221 176.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -102.34 155.7 18.07 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 117.399 0.599 . . . . 65.040000000000006 112.314 -178.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 5.5 mtpm? -103.8 136.19 43.94 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.739 -0.664 . . . . 72.450000000000003 112.445 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -118.66 116.28 34.9 Favored Pre-proline 0 N--CA 1.471 0.604 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 111.205 174.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.14 121.78 8.8 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.02 2.48 . . . . 74.239999999999995 112.911 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 60.5 mt -101.85 122.79 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.171 0.51 . . . . 71.109999999999999 111.478 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -75.37 145.47 33.17 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.18 -0.533 . . . . 64.219999999999999 113.206 179.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.521 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 93.6 m95 -61.93 -27.55 68.91 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.922 0.391 . . . . 75.430000000000007 111.909 -179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -75.87 -10.3 59.31 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 116.222 -0.445 . . . . 75.319999999999993 111.675 -179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 90.5 m -69.52 136.97 52.09 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 120.821 0.343 . . . . 75.209999999999994 111.663 -179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.99 126.23 27.35 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 120.89 0.376 . . . . 70.099999999999994 111.272 177.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . 0.445 HG23 ' H ' ' A' ' 172' ' ' ARG . 12.7 tt -58.43 -19.92 14.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.754 0 CA-C-O 120.977 0.418 . . . . 75.349999999999994 111.894 -178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 30.5 t -52.42 -33.63 44.77 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 112.255 0.465 . . . . 65.209999999999994 112.255 176.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 11.8 m95 -65.15 -28.34 69.34 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.15 0.5 . . . . 73.140000000000001 111.766 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.511 HD13 HD21 ' A' ' 222' ' ' LEU . 35.7 mt -98.75 14.91 27.05 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 112.554 0.576 . . . . 73.219999999999999 112.554 -169.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.3 m -54.93 108.35 0.39 Allowed 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 121.134 0.492 . . . . 74.129999999999995 112.237 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.14 -7.9 69.66 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 121.457 -0.402 . . . . 70.450000000000003 113.954 178.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 50.9 mm-40 -84.53 163.46 19.36 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 121.321 0.581 . . . . 61.200000000000003 112.209 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -106.42 118.15 35.89 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 115.816 -0.629 . . . . 72.420000000000002 110.375 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.602 HD12 HG22 ' A' ' 159' ' ' VAL . 59.2 mt -93.01 111.86 23.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.006 0.431 . . . . 65.109999999999999 110.876 -177.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -92.11 103.31 15.82 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.506 -0.316 . . . . 72.219999999999999 110.338 -179.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 197' ' ' VAL . 35.3 t -99.0 123.35 51.58 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 N-CA-C 111.998 0.37 . . . . 74.319999999999993 111.998 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -115.92 177.02 4.83 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 120.963 0.411 . . . . 74.239999999999995 111.366 176.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.6 138.03 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.691 0.626 . . . . 72.340000000000003 112.691 -172.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 196' ' ' ALA . 96.6 mt -100.92 -72.39 0.68 Allowed 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 116.14 -0.482 . . . . 74.340000000000003 110.989 175.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -107.43 156.11 19.3 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-O 120.882 0.373 . . . . 75.420000000000002 111.436 178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -100.85 -29.5 12.21 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.313 0.486 . . . . 73.109999999999999 112.313 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.2 p -90.66 125.55 59.02 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.196 0.443 . . . . 63.200000000000003 112.196 -176.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -87.39 145.91 7.19 Favored 'Trans proline' 0 CA--C 1.543 0.926 0 C-N-CA 122.642 2.228 . . . . 74.140000000000001 113.05 174.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.4 tt . . . . . 0 C--O 1.253 1.281 0 CA-C-O 118.778 -0.629 . . . . 70.219999999999999 110.345 177.082 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 79.3 t60 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 120.419 0.152 . . . . 73.310000000000002 111.187 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 1.4 pmm? -81.32 141.25 49.34 Favored Pre-proline 0 CA--C 1.544 0.719 0 CA-C-O 120.575 0.226 . . . . 65.329999999999998 110.856 177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -78.68 126.78 7.57 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 122.512 2.141 . . . . 61.450000000000003 113.227 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.495 ' HD3' ' H ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -75.86 143.09 41.98 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.791 0.329 . . . . 75.209999999999994 111.116 177.544 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 64.3 m -128.45 134.17 25.97 Favored Pre-proline 0 N--CA 1.476 0.844 0 CA-C-O 120.826 0.346 . . . . 73.409999999999997 111.85 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.94 62.43 7.39 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.803 2.335 . . . . 72.299999999999997 112.624 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -81.72 38.65 0.52 Allowed 'General case' 0 CA--C 1.543 0.707 0 CA-C-O 121.256 0.55 . . . . 74.209999999999994 111.711 -179.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -112.1 155.31 43.63 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-N 116.002 -0.545 . . . . 60.140000000000001 110.362 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -54.55 140.01 75.41 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.743 2.295 . . . . 73.140000000000001 113.066 -178.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . 0.458 HG22 ' HA ' ' A' ' 170' ' ' PRO . 2.9 pp -137.48 167.71 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-O 121.342 0.591 . . . . 75.450000000000003 112.496 -175.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.479 HG23 ' HB2' ' A' ' 171' ' ' ALA . 46.8 t -129.92 139.09 52.42 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 115.816 -0.629 . . . . 63.030000000000001 110.349 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.758 ' HG2' HG22 ' A' ' 168' ' ' VAL . 98.9 mtt180 -108.69 117.86 35.28 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 121.292 0.568 . . . . 65.109999999999999 111.574 -178.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.407 HG21 HD21 ' A' ' 181' ' ' LEU . 75.3 t -109.92 131.69 60.21 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 N-CA-C 112.292 0.478 . . . . 71.010000000000005 112.292 -174.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -89.53 94.58 9.92 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.125 0.488 . . . . 63.140000000000001 110.934 175.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.464 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 81.9 mt -68.81 154.9 94.3 Favored Pre-proline 0 CA--C 1.54 0.565 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 111.201 178.383 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -54.75 154.01 22.4 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.463 2.109 . . . . 64.010000000000005 112.375 178.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . 0.503 HD22 ' NH2' ' A' ' 188' ' ' ARG . 60.4 m-20 72.09 12.74 5.92 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 122.935 0.494 . . . . 63.329999999999998 110.78 -173.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 50.3 mtmt 64.59 59.39 0.96 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.191 0.596 . . . . 73.040000000000006 112.445 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 83.8 mm-40 -113.41 135.95 53.31 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.004 -0.544 . . . . 74.049999999999997 110.481 173.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . 0.431 ' HD2' ' N ' ' A' ' 166' ' ' ARG . 4.7 mpt_? -105.89 128.67 53.92 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.026 0.441 . . . . 75.519999999999996 111.889 -177.595 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 12.9 t -136.96 156.17 48.8 Favored 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.436 -0.347 . . . . 75.340000000000003 111.16 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.758 HG22 ' HG2' ' A' ' 158' ' ' ARG . 38.7 t -126.38 132.78 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 120.934 0.397 . . . . 71.549999999999997 111.57 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 30.4 m -125.53 146.95 56.37 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-N 116.31 -0.405 . . . . 72.219999999999999 111.011 178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . 0.458 ' HA ' HG22 ' A' ' 156' ' ' ILE . 57.5 Cg_endo -70.46 122.44 8.93 Favored 'Trans proline' 0 CA--C 1.541 0.853 0 C-N-CA 122.336 2.024 . . . . 42.520000000000003 113.261 -178.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.479 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -74.03 114.81 12.78 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 120.919 0.39 . . . . 63.229999999999997 111.134 178.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.453 ' HG3' HG21 ' A' ' 175' ' ' VAL . 19.2 ptt-85 -132.67 142.34 49.04 Favored 'General case' 0 N--CA 1.468 0.47 0 CA-C-O 121.083 0.468 . . . . 72.540000000000006 111.896 -175.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 45.7 t -77.58 140.22 39.66 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.242 -0.436 . . . . 72.010000000000005 111.66 -178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 82.3 23.77 55.99 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 121.238 -0.506 . . . . 63.140000000000001 113.242 -178.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . 0.453 HG21 ' HG3' ' A' ' 172' ' ' ARG . 45.5 t -134.51 135.36 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 122.476 0.31 . . . . 75.209999999999994 110.751 179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 28.8 p -81.63 159.71 23.95 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.123 0.487 . . . . 74.150000000000006 111.697 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 212' ' ' THR . 81.2 t -58.09 -37.69 63.23 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-O 121.286 0.565 . . . . 55.039999999999999 110.574 174.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.565 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 36.9 ttp180 -59.83 -56.76 17.71 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.673 -0.694 . . . . 71.140000000000001 111.511 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.432 ' HA ' ' HD2' ' A' ' 182' ' ' LYS . 68.2 m-20 -64.19 -17.04 63.15 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.347 0.499 . . . . 71.120000000000005 112.347 -175.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 12.8 t -93.69 -39.05 10.99 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 122.098 -0.376 . . . . 65.230000000000004 111.775 179.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.407 HD21 HG21 ' A' ' 159' ' ' VAL . 65.2 mt -91.83 -5.54 53.22 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 112.753 0.649 . . . . 75.420000000000002 112.753 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.432 ' HD2' ' HA ' ' A' ' 179' ' ' ASP . 20.4 ptmt -54.28 -34.42 60.82 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-O 120.772 0.32 . . . . 71.540000000000006 111.751 179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -69.58 -39.91 77.04 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.05 0.452 . . . . 63.549999999999997 111.361 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -63.36 -42.75 98.91 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-O 120.986 0.422 . . . . 70.140000000000001 111.223 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 74.7 mt -65.47 -43.11 91.3 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.125 -0.489 . . . . 44.240000000000002 110.768 175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 57.5 ttp -55.66 -50.71 69.51 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 116.116 -0.493 . . . . 73.439999999999998 111.488 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 27.0 ptt? -72.71 -0.5 13.32 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.789 0.328 . . . . 74.430000000000007 111.872 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.503 ' NH2' HD22 ' A' ' 163' ' ' ASN . 19.3 mmm180 -117.41 1.68 12.38 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 111.787 0.292 . . . . 74.230000000000004 111.787 175.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 63.28 47.1 90.79 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.339 -0.458 . . . . 63.25 113.424 -179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 92.4 mt -132.86 159.92 38.45 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 120.987 0.422 . . . . 73.219999999999999 111.915 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 23.9 pt -114.78 147.36 38.04 Favored Pre-proline 0 N--CA 1.472 0.643 0 CA-C-N 116.136 -0.484 . . . . 71.25 110.773 173.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.76 -47.08 26.78 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 122.608 2.205 . . . . 71.299999999999997 113.753 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -71.63 -3.47 21.76 Favored 'General case' 0 N--CA 1.474 0.743 0 N-CA-C 112.727 0.64 . . . . 70.219999999999999 112.727 -175.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 44.4 t -94.47 -8.54 38.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.047 0.451 . . . . 74.010000000000005 111.339 177.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 93.3 m -135.29 158.72 43.64 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-O 121.049 0.452 . . . . 75.109999999999999 111.811 -176.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.445 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -124.93 131.72 53.39 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 116.304 -0.407 . . . . 70.25 111.379 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 224' ' ' VAL . 58.2 t -103.05 125.44 57.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.097 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.431 ' HE1' ' HG2' ' A' ' 225' ' ' GLU . 40.6 p90 -137.36 151.56 48.73 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.008 0.432 . . . . 74.109999999999999 111.111 176.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.456 ' HG2' HD11 ' A' ' 208' ' ' ILE . 37.4 ptt180 -111.7 142.2 44.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.031 -0.359 . . . . 70.209999999999994 110.031 173.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.444 HG12 ' HG2' ' A' ' 205' ' ' LYS . 48.8 mt -82.79 103.45 10.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.186 0.517 . . . . 74.299999999999997 109.732 174.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -102.82 109.77 21.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.992 -0.549 . . . . 75.099999999999994 110.827 -174.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 27.4 t70 60.68 16.95 7.07 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.765 -0.652 . . . . 64.230000000000004 111.366 -179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 108.99 -19.45 30.15 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.519 -0.372 . . . . 70.510000000000005 113.572 -177.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -88.43 123.97 33.5 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 122.294 -0.533 . . . . 73.040000000000006 111.969 179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.444 ' HG2' HG12 ' A' ' 200' ' ' ILE . 96.6 mttt -79.89 104.2 10.31 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.405 -0.362 . . . . 63.210000000000001 110.611 174.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -116.06 115.24 40.88 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-O 120.9 0.381 . . . . 72.019999999999996 111.892 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_exo -62.05 133.94 46.81 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.515 2.81 . . . . 72.019999999999996 113.861 -178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.456 HD11 ' HG2' ' A' ' 199' ' ' ARG . 50.0 mt -110.03 153.05 11.91 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 CA-C-N 115.623 -0.717 . . . . 61.32 110.758 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -89.38 150.42 21.28 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 120.844 -0.694 . . . . 73.219999999999999 112.9 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.565 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 90.5 m95 -67.76 -27.67 66.97 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 122.178 -0.601 . . . . 73.099999999999994 111.634 -179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -80.78 -3.57 51.44 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 111.941 0.348 . . . . 54.509999999999998 111.941 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.427 ' O ' HG23 ' A' ' 177' ' ' VAL . 88.7 m -68.55 141.9 55.37 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-O 120.938 0.399 . . . . 70.329999999999998 111.071 177.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.12 117.71 9.53 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 121.063 0.458 . . . . 72.430000000000007 111.426 -178.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 13.4 tt -61.55 -22.07 27.02 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.712 0 N-CA-C 112.392 0.516 . . . . 74.519999999999996 112.392 -175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 32.5 p -59.91 -18.21 43.16 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.335 0.494 . . . . 74.340000000000003 112.335 -179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 10.7 m95 -79.39 -14.43 58.96 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-O 120.945 0.403 . . . . 72.329999999999998 111.954 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.53 22.87 14.94 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 121.175 0.512 . . . . 72.409999999999997 111.491 -175.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 90.9 m -61.72 121.44 12.85 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.807 0.669 . . . . 74.239999999999995 112.807 -175.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 95.6 -23.44 33.94 Favored Glycine 0 CA--C 1.529 0.946 0 N-CA-C 115.32 0.888 . . . . 61.140000000000001 115.32 170.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -99.32 172.25 7.46 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 117.981 0.89 . . . . 73.239999999999995 112.487 -174.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.456 ' HA ' ' O ' ' A' ' 158' ' ' ARG . 25.7 mp0 -93.26 139.87 30.16 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.945 -0.571 . . . . 71.340000000000003 111.936 -177.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 90.6 mt -111.92 152.89 27.5 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.436 -0.347 . . . . 74.010000000000005 111.303 177.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.0 m-70 -117.14 134.49 54.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 120.567 0.222 . . . . 75.430000000000007 111.138 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.553 HG22 HG22 ' A' ' 197' ' ' VAL . 64.4 t -115.79 116.47 52.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.564 0 CA-C-O 120.987 0.422 . . . . 71.129999999999995 111.899 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.431 ' HG2' ' HE1' ' A' ' 198' ' ' TYR . 61.8 mm-40 -102.97 137.43 41.18 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 116.405 -0.361 . . . . 70.540000000000006 111.016 176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.88 108.83 10.51 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.577 0 CA-C-O 120.842 0.353 . . . . 70.109999999999999 110.837 176.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.445 HD21 ' HB2' ' A' ' 196' ' ' ALA . 95.8 mt -63.43 -63.82 1.07 Allowed 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 121.095 0.474 . . . . 41.420000000000002 111.548 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -118.98 119.11 33.34 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-O 121.12 0.486 . . . . 73.450000000000003 111.097 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -59.86 -25.69 65.26 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 113.041 0.756 . . . . 71.219999999999999 113.041 -175.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 60.1 t -94.37 109.41 42.64 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-O 120.501 0.191 . . . . 44.299999999999997 111.419 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.99 168.63 24.42 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.929 2.419 . . . . 61.509999999999998 113.006 177.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 85.5 mt . . . . . 0 C--O 1.255 1.387 0 CA-C-O 119.051 -0.499 . . . . 55.140000000000001 111.677 178.126 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 . . . . . 0 N--CA 1.494 1.766 0 N-CA-C 112.124 0.416 . . . . 72.420000000000002 112.124 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 41.6 mtm 67.3 96.83 0.04 OUTLIER Pre-proline 0 N--CA 1.478 0.945 0 C-N-CA 122.965 0.506 . . . . 72.400000000000006 111.86 -178.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -85.1 159.96 11.51 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 122.734 2.289 . . . . 44.310000000000002 113.392 179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.4 pttm -97.24 145.14 26.36 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.078 0.466 . . . . 73.400000000000006 111.355 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 91.0 p -79.77 136.15 55.31 Favored Pre-proline 0 N--CA 1.469 0.507 0 CA-C-N 116.232 -0.44 . . . . 73.209999999999994 111.428 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -67.55 160.76 46.52 Favored 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 122.531 2.154 . . . . 70.310000000000002 112.649 178.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -69.57 84.75 0.43 Allowed 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.283 0.563 . . . . 75.439999999999998 110.741 -179.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.405 ' HG3' ' H ' ' A' ' 154' ' ' LYS . 1.5 pptp? -71.81 148.16 92.12 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-N 115.854 -0.612 . . . . 74.310000000000002 111.671 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -58.08 130.53 38.48 Favored 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 122.923 2.415 . . . . 72.540000000000006 113.13 -177.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 2.9 pp -132.33 169.96 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-O 120.962 0.411 . . . . 53.409999999999997 111.797 179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.503 HG23 ' HB2' ' A' ' 171' ' ' ALA . 55.0 t -130.6 132.42 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-N 116.329 -0.396 . . . . 71.140000000000001 110.531 176.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.51 ' HD2' ' HG2' ' A' ' 221' ' ' GLU . 85.8 mtt180 -89.13 98.41 11.75 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.76 0.314 . . . . 74.030000000000001 110.722 -178.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 HD21 ' A' ' 181' ' ' LEU . 35.6 t -99.13 111.14 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.24 0.543 . . . . 51.310000000000002 112.051 -175.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -89.45 111.97 23.0 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-N 116.104 -0.498 . . . . 74.540000000000006 110.673 175.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.492 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 90.5 mt -90.75 161.74 35.28 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.252 -0.431 . . . . 64.349999999999994 111.624 -176.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 224' ' ' VAL . 50.8 Cg_exo -55.54 162.51 6.22 Favored 'Trans proline' 0 C--N 1.355 0.875 0 C-N-CA 122.555 2.17 . . . . 63.329999999999998 113.353 178.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 59.83 36.59 22.01 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.056 0.455 . . . . 75.129999999999995 111.617 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt 66.2 13.44 9.15 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 113.103 0.779 . . . . 62.450000000000003 113.103 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.492 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 84.5 mm-40 -76.72 159.7 29.96 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-O 120.89 0.376 . . . . 74.340000000000003 111.46 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -149.56 154.07 38.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 121.328 0.585 . . . . 72.510000000000005 112.28 -179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . 0.425 HG23 ' HB ' ' A' ' 159' ' ' VAL . 7.9 t -157.63 150.84 23.44 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.771 -0.65 . . . . 75.409999999999997 111.054 174.286 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 49.7 t -125.47 119.83 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.777 0.323 . . . . 63.229999999999997 110.244 175.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 31.0 m -121.57 152.41 58.34 Favored Pre-proline 0 CA--C 1.543 0.679 0 CA-C-N 116.495 -0.321 . . . . 74.219999999999999 111.768 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -72.2 132.36 19.37 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 122.595 2.197 . . . . 75.200000000000003 113.583 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.503 ' HB2' HG23 ' A' ' 157' ' ' VAL . . . -89.48 104.7 17.23 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-O 121.029 0.442 . . . . 51.229999999999997 111.431 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -122.42 140.71 52.4 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 116.4 -0.363 . . . . 60.039999999999999 111.917 -175.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 48.8 t -69.98 122.35 19.16 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.429 -0.351 . . . . 61.100000000000001 110.79 177.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 113.67 -29.5 7.8 Favored Glycine 0 CA--C 1.526 0.727 0 C-N-CA 121.233 -0.508 . . . . 63.229999999999997 112.428 -176.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 62.7 t -89.55 126.49 42.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-O 120.736 0.303 . . . . 54.240000000000002 111.052 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 69.6 p -87.32 160.83 18.25 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-O 120.896 0.379 . . . . 62.409999999999997 111.46 179.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 59.4 t -52.93 -39.39 31.96 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.019 0.438 . . . . 73.439999999999998 111.668 178.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.574 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 24.5 ttp180 -74.23 -21.16 59.91 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-N 116.453 -0.34 . . . . 71.239999999999995 111.744 -178.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.417 ' O ' ' HG2' ' A' ' 182' ' ' LYS . 17.4 t70 -84.05 -34.38 24.25 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.112 0.482 . . . . 72.25 111.288 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 78.4 p -80.84 -55.1 5.03 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.114 0.483 . . . . 74.129999999999995 111.632 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.601 HD21 HG21 ' A' ' 159' ' ' VAL . 86.0 mt -73.54 -2.31 22.24 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.681 0.993 . . . . 64.230000000000004 113.681 -174.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.417 ' HG2' ' O ' ' A' ' 179' ' ' ASP . 22.0 pttp -60.72 -29.08 69.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 118.619 0.645 . . . . 72.019999999999996 112.236 -178.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -76.69 -38.94 53.59 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 122.167 -0.333 . . . . 72.409999999999997 110.998 173.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.483 ' O ' ' HG2' ' A' ' 188' ' ' ARG . . . -60.15 -54.68 42.99 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-O 120.91 0.386 . . . . 54.439999999999998 110.958 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.4 HD11 ' CH2' ' A' ' 210' ' ' TRP . 85.4 mt -55.52 -45.74 77.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.164 -0.471 . . . . 71.430000000000007 110.789 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 25.2 ttt -55.19 -55.79 27.29 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.118 -0.492 . . . . 64.319999999999993 111.961 -179.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.0 ptp -67.53 -22.18 65.43 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.559 0.577 . . . . 71.439999999999998 112.559 -176.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.483 ' HG2' ' O ' ' A' ' 184' ' ' ALA . 67.9 mmt-85 -91.97 -23.07 19.68 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 122.28 -0.262 . . . . 72.310000000000002 111.679 178.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.16 42.42 4.64 Favored Glycine 0 CA--C 1.529 0.916 0 C-N-CA 121.534 -0.365 . . . . 44.229999999999997 113.246 -178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 87.2 mt -127.15 162.94 24.93 Favored 'General case' 0 CA--C 1.541 0.62 0 CA-C-O 120.989 0.423 . . . . 75.200000000000003 111.417 -178.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 33.4 pt -128.81 142.86 46.44 Favored Pre-proline 0 N--CA 1.475 0.781 0 CA-C-N 116.564 -0.289 . . . . 72.230000000000004 111.291 178.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -60.19 -19.68 58.24 Favored 'Trans proline' 0 N--CA 1.484 0.945 0 C-N-CA 122.812 2.342 . . . . 70.209999999999994 113.782 -175.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 51.8 mm-40 -76.15 -28.8 57.53 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.93 0.395 . . . . 74.120000000000005 111.797 177.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . 0.495 ' SG ' HG13 ' A' ' 226' ' ' VAL . 51.2 t -106.89 19.1 20.95 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.911 0.386 . . . . 73.329999999999998 111.506 -176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 73.6 m -130.65 130.28 43.73 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.295 0.569 . . . . 73.209999999999994 111.911 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.522 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -110.0 119.44 39.33 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.795 -0.639 . . . . 65.409999999999997 111.209 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.512 HG22 HG22 ' A' ' 224' ' ' VAL . 43.9 t -99.78 122.32 51.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 120.526 0.203 . . . . 72.409999999999997 111.051 179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.411 ' HE2' ' HG3' ' A' ' 225' ' ' GLU . 42.4 p90 -134.07 152.13 51.7 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.238 0.542 . . . . 65.239999999999995 111.479 175.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 199' ' ' ARG . 4.1 ptm180 -115.5 142.88 46.12 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.919 -0.582 . . . . 74.430000000000007 110.454 176.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . 0.5 HG12 ' HG2' ' A' ' 205' ' ' LYS . 55.9 mt -101.37 130.07 51.47 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 CA-C-O 120.904 0.383 . . . . 75.209999999999994 111.355 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.403 ' HG2' ' OD2' ' A' ' 202' ' ' ASP . 25.7 tt0 -161.62 133.41 5.59 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 116.142 -0.481 . . . . 71.109999999999999 110.827 177.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.403 ' OD2' ' HG2' ' A' ' 201' ' ' GLN . 11.1 m-20 60.72 28.65 18.37 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 120.895 0.379 . . . . 54.219999999999999 112.006 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.49 10.7 85.98 Favored Glycine 0 CA--C 1.525 0.689 0 C-N-CA 121.002 -0.618 . . . . 74.209999999999994 113.415 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -114.47 145.17 42.21 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.142 0.496 . . . . 62.149999999999999 111.781 177.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . 0.5 ' HG2' HG12 ' A' ' 200' ' ' ILE . 97.9 mttt -102.36 102.44 12.78 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 115.784 -0.644 . . . . 74.519999999999996 110.22 173.349 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -88.83 113.67 56.87 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 116.333 -0.394 . . . . 70.109999999999999 111.733 -176.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -64.69 139.52 63.76 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 122.645 2.23 . . . . 70.530000000000001 112.488 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . . . . . . . . . 54.0 mt -118.22 142.39 33.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 120.981 0.42 . . . . 62.219999999999999 111.41 -176.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -88.25 137.8 14.62 Favored Glycine 0 CA--C 1.526 0.729 0 C-N-CA 121.127 -0.558 . . . . 74.120000000000005 112.651 176.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 92.8 m95 -63.29 -17.17 62.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.373 -0.486 . . . . 71.409999999999997 111.8 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -81.49 -10.46 59.47 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-N 115.974 -0.557 . . . . 61.130000000000003 112.281 179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . . . . . . . . . 68.6 m -80.32 143.87 33.25 Favored 'General case' 0 N--CA 1.472 0.644 0 N-CA-C 112.076 0.398 . . . . 54.140000000000001 112.076 -176.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.42 132.52 52.83 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-O 121.099 0.476 . . . . 64.120000000000005 111.961 175.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 12.2 tt -65.38 -18.37 23.72 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.798 0 CA-C-N 116.189 -0.46 . . . . 73.510000000000005 111.492 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 78.0 p -62.16 -23.65 66.71 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-O 120.975 0.417 . . . . 55.549999999999997 111.821 177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . . . . . . . . . 23.8 m95 -71.81 -15.77 62.16 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.045 0.45 . . . . 64.0 111.173 176.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 44.2 mt -113.85 13.56 18.43 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 116.052 -0.522 . . . . 61.509999999999998 111.307 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 98.1 m -51.9 113.77 1.1 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 112.708 0.633 . . . . 75.420000000000002 112.708 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 90.77 -17.93 52.7 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 121.308 -0.472 . . . . 73.140000000000001 113.821 176.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -73.99 168.06 20.25 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.544 0.688 . . . . 72.140000000000001 112.121 -177.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . 0.51 ' HG2' ' HD2' ' A' ' 158' ' ' ARG . 49.6 mt-10 -112.72 114.74 27.47 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 115.586 -0.734 . . . . 74.140000000000001 110.77 178.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.48 HD12 HG22 ' A' ' 159' ' ' VAL . 68.3 mt -93.33 147.72 22.68 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.122 0.487 . . . . 74.010000000000005 111.342 -176.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.2 m-70 -127.54 117.67 22.5 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.201 -0.454 . . . . 74.150000000000006 110.054 177.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.59 ' HB ' ' HD3' ' A' ' 162' ' ' PRO . 40.2 t -103.96 144.68 13.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 CA-C-O 121.07 0.462 . . . . 71.530000000000001 112.215 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.411 ' HG3' ' HE2' ' A' ' 198' ' ' TYR . 22.4 mt-10 -130.75 177.85 7.09 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 111.633 175.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . 0.495 HG13 ' SG ' ' A' ' 194' ' ' CYS . 60.0 t -91.94 140.44 16.14 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 CA-C-O 120.837 0.351 . . . . 73.510000000000005 111.815 -179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.522 HD21 ' HB2' ' A' ' 196' ' ' ALA . 80.9 mt -106.96 -86.21 0.5 Allowed 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 112.144 0.424 . . . . 71.120000000000005 112.144 178.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -86.01 106.26 17.04 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.448 0.642 . . . . 73.430000000000007 111.682 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 59.7 t30 -80.56 42.29 0.6 Allowed 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 121.659 0.743 . . . . 63.039999999999999 111.321 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 8.7 m -137.53 66.36 50.25 Favored Pre-proline 0 CA--C 1.545 0.776 0 CA-C-O 121.023 0.44 . . . . 71.099999999999994 111.364 179.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -82.0 102.18 1.21 Allowed 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 122.402 2.068 . . . . 64.140000000000001 112.59 -179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--O 1.252 1.232 0 CA-C-O 118.622 -0.704 . . . . 63.32 111.673 -179.204 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.0 t60 . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 120.617 0.246 . . . . 73.329999999999998 111.598 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 25.1 ptm -104.72 114.9 63.48 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 120.996 0.426 . . . . 72.040000000000006 111.035 177.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -82.92 -166.56 0.39 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.731 2.287 . . . . 72.329999999999998 112.854 178.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 150' ' ' LYS . 25.0 pttm -138.94 99.88 3.89 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.495 0.664 . . . . 74.140000000000001 111.384 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 78.9 p -95.3 110.97 53.4 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 116.357 -0.383 . . . . 72.409999999999997 110.377 175.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -76.98 54.38 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 122.776 2.317 . . . . 70.209999999999994 112.55 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLN . . . . . . . . . . . . . 97.3 mt-30 -79.31 39.17 0.38 Allowed 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.217 0.532 . . . . 63.530000000000001 112.295 -175.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -98.12 151.89 37.75 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 116.283 -0.417 . . . . 61.340000000000003 109.95 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 171' ' ' ALA . 9.3 Cg_endo -50.02 129.81 25.91 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.839 2.359 . . . . 75.519999999999996 113.367 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 47.3 pt -130.62 160.92 41.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-O 121.36 0.6 . . . . 65.200000000000003 112.086 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . . . . . . . . . 61.9 t -130.29 129.86 65.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 CA-C-N 115.805 -0.634 . . . . 74.219999999999999 110.535 174.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 158' ' ' ARG . 68.2 mtt85 -96.21 98.46 10.33 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.736 0.303 . . . . 62.350000000000001 111.416 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.498 HG22 HD12 ' A' ' 222' ' ' LEU . 41.2 t -96.26 120.09 45.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-O 121.068 0.461 . . . . 74.219999999999999 112.043 -176.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -95.09 115.32 27.28 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.128 0.49 . . . . 71.099999999999994 110.747 176.043 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LEU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 165' ' ' GLN . 91.9 mt -93.47 165.71 17.61 Favored Pre-proline 0 CA--C 1.542 0.639 0 CA-C-N 115.947 -0.57 . . . . 74.439999999999998 111.527 -176.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 161' ' ' LEU . 20.6 Cg_endo -60.5 168.01 7.26 Favored 'Trans proline' 0 CA--C 1.541 0.852 0 C-N-CA 122.246 1.964 . . . . 71.439999999999998 112.534 174.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 64.94 27.2 12.76 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 112.081 0.4 . . . . 72.129999999999995 112.081 -178.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm 63.34 26.76 15.15 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 122.728 0.411 . . . . 53.32 111.795 -179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.528 ' HB2' ' HB2' ' A' ' 161' ' ' LEU . 76.9 mm-40 -92.43 162.21 14.33 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.92 0.39 . . . . 44.299999999999997 111.131 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 22.8 ptt180 -151.56 156.12 39.85 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 120.938 0.399 . . . . 72.0 111.786 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 7.1 t -156.85 126.99 6.41 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 116.274 -0.421 . . . . 74.120000000000005 111.535 175.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 48.2 t -101.62 119.73 50.25 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 O-C-N 122.29 -0.256 . . . . 74.150000000000006 110.557 176.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' VAL . . . . . . . . . . . . . 35.2 m -120.74 144.87 39.83 Favored Pre-proline 0 N--CA 1.473 0.716 0 N-CA-C 112.014 0.376 . . . . 63.420000000000002 112.014 -177.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -64.24 139.73 67.47 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 122.608 2.206 . . . . 74.409999999999997 112.923 175.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.405 ' HB3' ' HB2' ' A' ' 155' ' ' PRO . . . -93.31 109.7 21.24 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 121.068 0.461 . . . . 55.229999999999997 111.606 -178.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -97.22 132.39 43.02 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.386 -0.37 . . . . 74.340000000000003 110.997 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' CYS . . . . . . . . . . . . . 52.1 t -70.7 121.25 17.6 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 120.774 0.321 . . . . 73.120000000000005 111.122 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 104.2 -9.69 50.32 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 121.369 -0.444 . . . . 55.25 113.168 -178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' VAL . . . . . . . . . . . . . 63.3 t -98.88 135.28 34.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 O-C-N 122.432 -0.452 . . . . 71.299999999999997 110.526 176.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.461 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 69.8 p -81.54 167.04 19.72 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-O 121.299 0.571 . . . . 51.240000000000002 112.266 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 212' ' ' THR . 77.9 t -59.49 -37.66 71.17 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 121.371 0.605 . . . . 55.439999999999998 110.773 174.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.561 ' HB2' ' HB3' ' A' ' 210' ' ' TRP . 31.5 ttp180 -66.36 -55.87 13.81 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 115.811 -0.631 . . . . 50.329999999999998 111.226 179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.575 ' HA ' ' HE3' ' A' ' 182' ' ' LYS . 17.0 t70 -60.83 -36.0 77.97 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 116.162 -0.472 . . . . 72.430000000000007 112.004 -176.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 81.8 p -77.14 -59.0 2.96 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 120.906 0.384 . . . . 61.100000000000001 111.874 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 41.3 mt -67.89 -23.66 65.13 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 113.335 0.865 . . . . 64.030000000000001 113.335 -174.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . 0.575 ' HE3' ' HA ' ' A' ' 179' ' ' ASP . 23.3 pttp -59.96 -22.69 62.83 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 118.613 0.642 . . . . 73.129999999999995 111.538 -179.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? -75.68 -41.42 53.83 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.139 0.495 . . . . 74.319999999999993 110.562 174.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . . . . . . . . . . . -65.79 -35.79 81.69 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-O 121.272 0.558 . . . . 74.420000000000002 110.692 176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 94.3 mt -72.27 -38.29 68.85 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.17 -0.468 . . . . 53.32 110.744 174.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 26.3 ttt -53.7 -48.93 69.08 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 116.305 -0.407 . . . . 73.299999999999997 111.748 178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.1 ptt? -65.97 -27.07 67.87 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 120.752 0.311 . . . . 64.409999999999997 111.583 178.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 37.8 mmt180 -84.09 -22.31 31.21 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 120.934 0.397 . . . . 71.150000000000006 111.383 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 92.51 17.38 45.82 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 121.364 -0.446 . . . . 74.239999999999995 113.124 -177.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LEU . . . . . . . . . . . . . 97.2 mt -103.55 168.63 9.03 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-O 121.261 0.553 . . . . 72.439999999999998 111.96 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 15.4 pt -129.77 139.73 36.53 Favored Pre-proline 0 CA--C 1.545 0.763 0 CA-C-N 116.127 -0.488 . . . . 75.239999999999995 111.343 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.24 -36.74 97.46 Favored 'Trans proline' 0 CA--C 1.542 0.919 0 C-N-CA 122.947 2.432 . . . . 74.209999999999994 113.898 -176.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -61.41 -18.85 60.74 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 120.947 0.403 . . . . 62.329999999999998 111.923 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' CYS . . . . . . . . . . . . . 43.4 t -98.14 -5.81 32.8 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.22 0.452 . . . . 74.310000000000002 112.22 -177.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' CYS . . . . . . . . . . . . . 61.5 m -119.07 151.53 38.1 Favored 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 112.365 0.506 . . . . 63.399999999999999 112.365 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ALA . . . . . 0.424 ' HB2' HD21 ' A' ' 227' ' ' LEU . . . -127.64 122.71 33.78 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.246 -0.434 . . . . 60.350000000000001 111.362 178.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 224' ' ' VAL . 56.5 t -98.12 136.26 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 116.641 -0.254 . . . . 54.399999999999999 111.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 41.5 p90 -149.31 165.63 31.39 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.037 0.446 . . . . 75.420000000000002 111.165 173.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -141.28 158.03 44.43 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.276 -0.42 . . . . 74.209999999999994 110.332 174.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ILE . . . . . . . . . . . . . 63.1 mt -92.21 113.02 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.286 0.565 . . . . 74.540000000000006 111.719 -174.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLN . . . . . 0.479 ' HB3' ' HD2' ' A' ' 206' ' ' LYS . 33.8 tt0 -139.02 142.19 38.27 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.566 -0.743 . . . . 74.430000000000007 110.494 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . . . . . . . . . 37.9 t70 59.65 21.86 10.55 Favored 'General case' 0 CA--C 1.547 0.852 0 CA-C-O 121.534 0.683 . . . . 74.310000000000002 111.021 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 78.09 13.8 82.96 Favored Glycine 0 CA--C 1.528 0.869 0 CA-C-N 116.252 -0.431 . . . . 61.310000000000002 113.149 -178.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -125.82 151.54 46.66 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 121.26 0.552 . . . . 72.049999999999997 111.819 -178.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -82.64 97.27 8.42 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.087 -0.506 . . . . 73.140000000000001 110.198 173.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' LYS . . . . . 0.479 ' HD2' ' HB3' ' A' ' 201' ' ' GLN . 67.2 mttm -96.63 111.66 57.85 Favored Pre-proline 0 CA--C 1.538 0.512 0 N-CA-C 111.938 0.347 . . . . 62.32 111.938 -175.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -61.48 142.94 96.83 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 122.996 2.464 . . . . 73.150000000000006 113.387 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' ILE . . . . . 0.485 HG21 HD11 ' A' ' 217' ' ' LEU . 66.5 mt -113.5 134.34 56.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 CA-C-N 115.99 -0.55 . . . . 74.099999999999994 111.016 -178.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . . . . . . . . . . . -74.34 133.74 16.8 Favored Glycine 0 CA--C 1.527 0.828 0 C-N-CA 120.886 -0.673 . . . . 15.31 112.887 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' TRP . . . . . 0.561 ' HB3' ' HB2' ' A' ' 178' ' ' ARG . 94.1 m95 -60.57 -26.17 66.75 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-O 121.017 0.437 . . . . 73.219999999999999 111.31 178.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -84.11 5.81 24.72 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 112.437 0.532 . . . . 54.420000000000002 112.437 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' THR . . . . . 0.463 ' O ' HG23 ' A' ' 177' ' ' VAL . 96.3 m -83.84 141.46 31.32 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.492 0.187 . . . . 64.239999999999995 110.98 175.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.461 ' HA ' ' HA ' ' A' ' 176' ' ' THR . 7.1 m-20 -62.3 130.52 45.69 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.857 0.361 . . . . 72.25 111.238 177.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ILE . . . . . . . . . . . . . 11.0 tp -59.62 -22.55 23.63 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 CA-C-O 121.07 0.462 . . . . 72.25 111.654 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' SER . . . . . . . . . . . . . 71.2 p -62.65 -26.87 68.85 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.244 -0.435 . . . . 64.299999999999997 112.001 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' TRP . . . . . 0.407 ' CD1' ' HB2' ' A' ' 213' ' ' ASP . 11.2 m0 -65.37 -22.64 66.83 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.292 0.568 . . . . 74.109999999999999 111.082 175.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 222' ' ' LEU . 46.6 mt -108.3 13.52 25.6 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 115.763 -0.653 . . . . 74.209999999999994 111.622 -175.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 87.9 m -52.8 118.06 3.4 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 112.166 0.432 . . . . 74.409999999999997 112.166 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 82.21 13.33 79.19 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 114.269 0.468 . . . . 72.010000000000005 114.269 177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -105.52 164.33 11.97 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.497 0.665 . . . . 64.340000000000003 112.451 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 18.7 mp0 -103.25 117.04 33.63 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.392 -0.822 . . . . 74.140000000000001 110.566 175.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 217' ' ' LEU . 60.3 mt -93.68 145.92 24.21 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.013 0.435 . . . . 75.25 111.016 -179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 73.4 m-70 -121.95 117.02 25.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.561 -0.291 . . . . 75.239999999999995 110.451 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' VAL . . . . . 0.548 HG22 HG22 ' A' ' 197' ' ' VAL . 73.3 t -104.84 121.17 56.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.603 0.594 . . . . 71.349999999999994 112.603 -175.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 32.3 mm-40 -106.69 164.58 11.97 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 116.008 -0.542 . . . . 72.409999999999997 110.832 173.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' VAL . . . . . . . . . . . . . 59.7 t -89.89 124.64 42.66 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 CA-C-O 120.774 0.321 . . . . 73.150000000000006 111.478 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' LEU . . . . . 0.424 HD21 ' HB2' ' A' ' 196' ' ' ALA . 75.2 mt -75.8 -48.41 21.77 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.947 0.403 . . . . 72.019999999999996 111.508 177.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -157.99 168.97 25.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.173 -0.467 . . . . 73.120000000000005 111.296 -177.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ASN . . . . . . . . . . . . . 16.7 m120 -99.36 5.72 46.34 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.201 -0.454 . . . . 62.350000000000001 111.037 174.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' VAL . . . . . . . . . . . . . 40.0 t 57.28 80.0 0.3 Allowed Pre-proline 0 CA--C 1.539 0.548 0 CA-C-O 121.186 0.517 . . . . 61.109999999999999 110.427 -172.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.66 -172.29 0.24 Allowed 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 122.926 2.417 . . . . 55.340000000000003 113.913 -173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LEU . . . . . . . . . . . . . 4.7 tt . . . . . 0 C--O 1.252 1.186 0 CA-C-O 118.839 -0.601 . . . . 73.409999999999997 110.852 179.163 . . . . . . . . 0 0 . 1 stop_ save_